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Adela Fernández-Agulló, Aı́da Castro-Iglesias, Marı́a Sonia Freire 
and Julia González- Álvarez
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Professor Isabel C.F.R. Ferreira has worked on the Chemistry of Natural Products, specifically
the extraction, purification, and stabilization of myco and phytochemicals; development of natural
ingredients, nutraceuticals, and innovative functional food formulations. She has developed numerous
methodologies for the extraction, refinement, and chemical characterization of bioactive molecules
from mushrooms and plants, and also improved the analytical methodologies of different biomolecules.
She has prospected more than 300 species and discovered natural sources of ingredients with different
capacities: bioactive, preservative, and coloring. In 2007, she led the research leading to the discovery
that Portuguese wild mushrooms are powerful sources of compounds with bioactive properties.
Subsequently, she showed that not only wild, but also commercial mushrooms are sources of bioactive
compounds and equilibrated nutrients, leading to the first studies on species from Serbia, Ghana,
Brazil, China, and Argentina, among others. In 2012, Isabel C.F.R. Ferreira discovered that specific
mushroom species have significant antitumor, antimicrobial, and anti-inflammatory activities that can
be improved modifying chemical substituents in specific molecules identified in those species.
In 2009, she began prospecting plant species and discovered specific parts of vegetables, flowers,
and medicinal plants that are unique sources of bioactive molecules, particularly in the class of
phenolic compounds. Subsequent to this, she showed for the first time that synergistic effects can
be achieved by mixing defined species and that in vitro culture under optimized conditions can
increase the concentration of these compounds. She has also developed novel cheminformatic tools
and models to predict bioactive properties and organize molecule databases, and has carried out
docking studies on bioactive cellular targets. She has been working with many mushroom and plant
producing companies, and in 2011 she started to study physical conservation methods, discovering that
gamma rays and electron-beams can decontaminate the mentioned raw materials without changing
their nutritional/chemical profile, and also improve the extraction of bioactive molecules. She also
discovered that modified atmospheres can recover the use of traditional plant species.
More recently, Professor Isabel C.F.R. Ferreira developed, improved, and optimized several
extraction methodologies for different natural molecules with bioactive, coloring, and preservative
capacities to be used as natural food ingredients/additives, and also their stabilization. With these
stabilized ingredients, she has developed innovative food and cosmetic products (registered patents)
with plant and mushroom-origin preservatives, colorants, and bioactives. Isabel F.C.F. Ferreira revision
articles on bioactive molecules/properties of mushrooms and plants, natural preservatives, colorants,
and conservation technologies, which are some of the most highly cited papers in the field.
The research performed by Professor Isabel C.F.R. Ferreira has placed her in top positions, being
listed as a Highly Cited Researcher since 2015. She has published more than 675 articles and several
innovative patents, supervised many students, and has been the principal researcher of numerous
national and international projects. She has also gained a range of awards for her impact in Food
Chemistry, for her advancement of research in Portugal, and for her outstanding work as one of the
country’s top women in science. Now, she is working for the Portuguese Government as Secretary of
State for Interior Valorization.
The special issue in honor of Professor Isabel C.F.R. Ferreira, with the thematic “Antioxidants
Properties of Natural Products” has twenty-three original research or review articles. Within the
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reviews performed, Rusu et al. [1] revised the clinical trials and cohort studies published in the last
decade on the influence of antioxidant diets on nuts and peanuts in preventing or delaying age-related
illnesses in middle-aged and elderly individuals. Meanwhile, Afonso et al. [2] reviewed the use of
brown macroalgae, considered as safe for consumption in Europe, as a valuable ingredient namely
for the development pf phaeophyta-enriched food products. Gomez-Zavaglia et al. [3] reviewed the
up to date literature on the chemical composition and bioactive effects of seaweeds, and reported
a critical discussion about their potential as natural sources of new functional ingredients. Root
vegetables as an alternative source of natural red–purple color ingredients for pharmaceutical or food
applications were extensively revised by Spyridon and contributors [4]. Furthermore, a discussion
of the main bioactivities of these potential sources of natural colorants were also explored by the
authors. Additionally, Di Gioia et al. [5] continued this study (part 2) and revised the health effects of
red–purple vegetables, including leafy vegetables, fruits, and others, in which the chemical composition
and bioactivities of the investigated matrices were discussed. Finally, the revision performed by
Balakrishman et al. [6] provides insight into the major components of Murraya koenigii (L.) Sprengel,
and their pharmacological activities against different pathological conditions.
Regarding the original research works performed, Reyes-Fermín et al. [7] evaluated α-mangostin,
a phytochemical found in Garcinia mangostana L., regarding its antioxidant action in the preservation of
mitochondrial function against cis-dichlorodiammineplatinum II induced damage using in vitro assays.
Moreover, the antioxidant activity during the seven stages of development of Amaranthus caudatus was
determined by Kamarać et al. [8], through several assays (ABTS•+, DPPH•, O2•− scavenging activity,
FRAP, and Fe2+ chelating ability). In addition, the phenolic profile of the plant in each stage was also
described by the authors. Petropoulos et al. [9] performed the nutritional and chemical composition
evaluation of different parts of Portulaca oleracea L., namely stems and leaves, harvested in three growth
stages. Additionally, the cytotoxicity of these samples was also assessed. In the research performed by
Molina and contributors [10], the Lonicera caerulea L. berry was assessed in terms of nutritional and
chemical composition and bioactive properties, namely antioxidant and antimicrobial activities. Also,
the stabilization of the anthocyanins from the fruit juice was accomplished by microencapsulation.
Tanase et al. [11] characterized Fagus sylvatica L. bark in terms of phytochemical profile and
bioactive potential. In addition, the improvement of the phenolic compounds extraction by microwave
assisted extraction was carried out using a design experiment approach. Hou et al. [12] optimized the
extraction of flavonoids from Pteris cretica L. by ultrasound-assisted extraction through a Response
Surface Methodology. Furthermore, the identification of the major compounds was performed by
chromatographic analysis, and the optimal extract was evaluated in terms of its antioxidant potential.
Añibarro-Ortega et al. [13] characterized the nutritional composition, organic acids, and phenolic
compounds of Aloe vera leaf (fillet, mucilage, and rind) and flowers, and their bioactive features,
in order to enhance the exploitation of this plant as a valuable source of compounds for food and
pharmaceutical industries application. Biosynthesis of silver nanoparticles (AgNP) using Fagus sylvatica
L. bark polyphenolic extract was accomplished by Tanase et al. [14] and the obtained AgNPs were
explored in terms of their antioxidant and antimicrobial activities. Rusu et al. [15] obtained bioactive
rich molecules from the by-products of Corylus avellana L. (hazelnut involucre) using optimized
conditions. The extract was evaluated through in vitro antioxidant tests and enzymatic inhibitory
assays. Additionally, the cytotoxic and antioxidant effects of this extract was evaluated on two tumor
cell lines and one normal cell line. Medrano-Padial et al. [16] evaluated the cytotoxic activity of a
stilbenes-rich extract obtained from grapevine shoots on two tumor cell lines, with the aim of providing
more evidence on the use of this kind of phytochemicals in wine preservation. Pereira-Maróstica and
coauthors [17] studied the capability of methyl jasmonate to reduce articular and hepatic inflammation
and oxidative stress in rats with adjuvant-induced arthritis. In the report performed by Lall et al. [18],
the nutritional profile of Sideritis perfoliata L. was described. In addition, interesting bioactivities, such as
anti-tyrosinase, antibacterial, and anti-elastase potential were evaluated to support the use of this plant
as a potential cosmetic ingredient. The influence of cultivars and maturation stage on the phenolic
2
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composition of Lycium barbarum L. fruits were determined by Mocan and contributors [19]. Additionally,
the authors correlated the phytochemical profiles obtained from the fruit extracts with the antioxidant
and anti-fungal activities, as also, with tyrosinase inhibition. Molecular mechanisms involved in
the biological effects of quercetin were studied by Ayuda-Durán et al. [20], using Caenorhabditis
elegans as a model organism with different methodological approaches. Lee et al. [21] assessed the
3,3′-Diindolylmethane, a metabolite of indole-3-carbinol present in Brassicaceae vegetables, regarding
its potential for prevention and therapy of neurodegenerative diseases. The authors evaluated in vitro
effects of this compound against oxidative stress-induced issues. In order to provide a means for the
disposal and valorization of walnut leaves, a phenolic-rich extract with high antioxidant activity from
this matrix was obtained by Fernández-Agulló et al. [22], under optimized conditions for a maceration
extraction system. Finally, Cásedas et al. [23] surveyed the neuroprotective action of urolithin A, as a
gastrointestinal metabolite from ellagitannins, against oxidative-stress provoked in neuro-2a cells.
Overall, this special issue includes research related to the work that Professor Isabel C.F.R.
Ferreira has been performing across her career, which is to exploit natural products, including natural
compounds obtained from plants, mushrooms, marine, bee products, among others, focusing on
the structural characterization and/or isolation of compounds with bioactivity; chemical, biological,
or biochemical methods for the evaluation of in vivo and in vitro bioactivity; clinical and nutritional
trials focused on the bioactive properties of compounds, and elucidation of the mechanisms of action
of bioactive compounds.
May this themed issue be able to honor someone who, one day, proudly stated: “Never giving up is
my helm, and the pleasure of discovery is my anchor”. A motivation to keep in mind in science, as in life.
Acknowledgments: The conclusion of this special issue would not have been possible without the generous
support and dedication of all researchers in this field of expertise; therefore, I would like to thank all the authors
for their contribution in this special issue. I would like to thank Isabel C.F.R. Ferreira for all the knowledge and
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Coimbra, M.; et al. Compositional features and bioactive properties of Aloe vera Leaf (fillet, mucilage, and
rind) and flower. Antioxidants 2019, 8, 444. [CrossRef] [PubMed]
14. Tanase, C.; Berta, L.; Coman, N.; Ros, ca, I.; Man, A.; Toma, F.; Mocan, A.; Jakab-Farkas, L.; Biró, D.;
Mare, A. Investigation of in vitro antioxidant and antibacterial potential of silver nanoparticles obtained by
biosynthesis using beech bark extract. Antioxidants 2019, 8, 459. [CrossRef] [PubMed]
15. Rusu, M.; Fizes, an, I.; Pop, A.; Gheldiu, A.; Mocan, A.; Cris, an, G.; Vlase, L.; Loghin, F.; Popa, D.; Tomuta, I.
Enhanced recovery of antioxidant compounds from hazelnut (Corylus avellana L.) involucre based on extraction
optimization: Phytochemical profile and biological activities. Antioxidants 2019, 8, 460. [CrossRef] [PubMed]
16. Medrano-Padial, C.; Puerto, M.; Moreno, F.J.; Richard, T.; Cantos-Villar, E.; Pichardo, S. In vitro toxicity assessment
of stilbene extract for its potential use as antioxidant in the wine industry. Antioxidants 2019, 8, 467. [CrossRef]
17. Pereira-Maróstica, H.; Castro, L.; Gonçalves, G.; Silva, F.; Bracht, L.; Bersani-Amado, C.; Peralta, R.; Comar, J.;
Bracht, A.; Sá-Nakanishi, A. Methyl jasmonate reduces inflammation and oxidative stress in the brain of
arthritic rats. Antioxidants 2019, 8, 485. [CrossRef]
18. Lall, N.; Chrysargyris, A.; Lambrechts, I.; Fibrich, B.; Blom Van Staden, A.; Twilley, D.; de Canha, M.N.;
Oosthuizen, C.B.; Bodiba, D.; Tzortzakis, N. Sideritis perfoliata (subsp. Perfoliata) nutritive value and its
potential medicinal properties. Antioxidants 2019, 8, 521. [CrossRef]
19. Mocan, A.; Cairone, F.; Locatelli, M.; Cacciagrano, F.; Carradori, S.; Vodnar, D.C.; Cris, an, G.; Simonetti, G.;
Cesa, S. Polyphenols from Lycium barbarum (Goji) Fruit european cultivars at different maturation steps:
Extraction, HPLC-DAD analyses, and biological evaluation. Antioxidants 2019, 8, 562. [CrossRef]
20. Ayuda-Durán, B.; González-Manzano, S.; Miranda-Vizuete, A.; Sánchez-Hernández, E.; R. Romero, M.;
Dueñas, M.; Santos-Buelga, C.; González-Paramás, A.M. Exploring target genes involved in the effect of
quercetin on the response to oxidative stress in Caenorhabditis elegans. Antioxidants 2019, 8, 585. [CrossRef]
21. Lee, B.D.; Yoo, J.-M.; Baek, S.Y.; Li, F.Y.; Sok, D.-E.; Kim, M.R. 3,3′-Diindolylmethane promotes BDNF
and antioxidant enzyme formation via TrkB/Akt pathway activation for neuroprotection against oxidative
stress-induced apoptosis in hippocampal neuronal cells. Antioxidants 2019, 9, 3. [CrossRef] [PubMed]
22. Fernández-Agulló, A.; Castro-Iglesias, A.; Freire, M.S.; González-Álvarez, J. Optimization of the extraction
of bioactive compounds from walnut (Juglans major 209 x Juglans regia) leaves: Antioxidant capacity and
phenolic profile. Antioxidants 2019, 9, 18. [CrossRef] [PubMed]
23. Cásedas, G.; Les, F.; Choya-Foces, C.; Hugo, M.; López, V. The metabolite urolithin-A ameliorates oxidative stress
in Neuro-2a Cells, becoming a potential neuroprotective agent. Antioxidants 2020, 9, 177. [CrossRef] [PubMed]
© 2020 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution




Health Benefits of Nut Consumption in Middle-Aged
and Elderly Population
Marius Emil Rusu 1, Andrei Mocan 2,3, Isabel C. F. R. Ferreira 4,* and Daniela-Saveta Popa 5
1 Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, “Iuliu Hatieganu”
University of Medicine and Pharmacy, 8 Victor Babes, 400012 Cluj-Napoca, Romania
2 Department of Pharmaceutical Botany, Faculty of Pharmacy, “Iuliu Hatieganu” University of Medicine and
Pharmacy, 8 Victor Babes, 400012 Cluj-Napoca, Romania
3 Laboratory of Chromatography, ICHAT, University of Agricultural Sciences and Veterinary Medicine,
400372 Cluj-Napoca, Romania
4 Centro de Investigação de Montanha (CIMO), Instituto Politécnico de Bragança (IPB), Campus de Santa
Apolónia, 5300-253 Bragança, Portugal
5 Department of Toxicology, Faculty of Pharmacy, “Iuliu Hatieganu” University of Medicine and Pharmacy,
8 Victor Babes, 400012 Cluj-Napoca, Romania
* Correspondence: iferreira@ipb.pt
Received: 23 June 2019; Accepted: 31 July 2019; Published: 12 August 2019
Abstract: Aging is considered the major risk factor for most chronic disorders. Oxidative stress and
chronic inflammation are two major contributors for cellular senescence, downregulation of stress
response pathways with a decrease of protective cellular activity and accumulation of cellular damage,
leading in time to age-related diseases. This review investigated the most recent clinical trials and
cohort studies published in the last ten years, which presented the influence of tree nut and peanut
antioxidant diets in preventing or delaying age-related diseases in middle-aged and elderly subjects
(≥55 years old). Tree nut and peanut ingestion has the possibility to influence blood lipid count,
biochemical and anthropometric parameters, endothelial function and inflammatory biomarkers,
thereby positively affecting cardiometabolic morbidity and mortality, cancers, and cognitive disorders,
mainly through the nuts’ healthy lipid profile and antioxidant and anti-inflammatory mechanisms of
actions. Clinical evidence and scientific findings demonstrate the importance of diets characterized
by a high intake of nuts and emphasize their potential in preventing age-related diseases, validating
the addition of tree nuts and peanuts in the diet of older adults. Therefore, increased consumption of
bioactive antioxidant compounds from nuts clearly impacts many risk factors related to aging and
can extend health span and lifespan.
Keywords: tree nuts; peanuts; middle-aged population; antioxidants; age-related diseases; elderly;
nut-enriched Mediterranean diet; inflammation; oxidative stress
1. Introduction
Healthy diet, along with physical and cognitive activity, is a modifiable lifestyle factor that has
been associated with overall health in old age. Aging is a collective, multifactorial progression of
physiological dysfunctions at cellular and tissue levels, as well as the deregulation of normal cell
pathways and lost synchronicity among defense mechanisms in the body, leading to the development
of age-related diseases [1].
A number of studies explored the phytochemical composition, bioactivity, and antioxidant
potential of nuts [2,3]. Scientific evidence demonstrated the potential benefits of a higher intake of nuts
or nut-enriched Mediterranean diets (MDs) against risk factors associated with pathological conditions
linked with aging, such as cardiometabolic diseases, cancer, or cognitive disorders [4–8]. This review
Antioxidants 2019, 8, 302; doi:10.3390/antiox8080302 www.mdpi.com/journal/antioxidants5
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focused on middle-aged and older adults, a constantly growing group, with particular attention given
to how these individuals can benefit from healthy dietary plans enhanced with tree nuts and peanuts,
and how the extra bioactive antioxidant compounds may add quality to the increased life expectancy.
The aim of this study was to present up-to-date evidence confirming that nut intake and
nut-enriched MDs [9] can be beneficial in delaying aging and can support modern medicine in treating
age-related diseases. We investigated human studies that assessed the effects of nut consumption
on the health of a middle-aged and elderly population 55 years of age and older. We searched
PubMed/MEDLINE and EMBASE databases for peer-reviewed articles published in the decade
from 2009 to June 2019. We also examined studies found in the references of meta-analysis that
were in accordance with our inclusion criteria: subject age ≥55 years and nuts with antioxidant
and anti-inflammatory activities added in the diet. In this review, the word “nuts” includes tree
nuts, such as walnuts (Juglans regia), almonds (Prunus dulcis), hazelnuts (Corylus avellana), pistachios
(Pistacia vera), pecans (Carya illinoinensis), cashews (Anacardium occidentale), pine nuts (Pinus pinea),
Brazil nuts (Bertholletia excelsa), macadamias (Macadamia integrifolia), and also peanuts (Arachis hypogaea),
botanically classified as legumes but with a nutrient profile comparable to tree nuts.
In addition, we summarized several nut phytochemicals with biological antioxidant activity, their
possible mechanisms of actions, as well as the influence of nuts on gut microbiota (GM).
2. Association between Nut Consumption and Cardiometabolic Disorders
Globally, cardiometabolic diseases including type 2 diabetes mellitus (T2DM), coronary heart
disease (CHD), coronary artery disease (CAD), and stroke are leading causes of morbidity and
mortality [10]. Most of these diseases could be prevented by changing behavioral risk factors such as
suboptimal diet [11].
Tree nuts and peanuts, because of their healthy antioxidant biochemical profile, can improve the
lipid profile, increase insulin sensitivity and metabolism, and favorably influence other cardiometabolic
risk factors [12].
2.1. Nut Consumption in Cardiometabolic Morbidity and Mortality
Clinical trials and lengthy prospective studies, focusing on men and women over the age of
55, showed that higher weekly nut intake can lower all causes and cause-specific morbidity and
mortality [13–21] (Table 1).
Subjects at high cardiovascular (CV) risk, who supplemented their MD with 30 grams of tree nuts
per day, at any point in time during the 4 years study period, had a 53% lower diabetes incidence
compared to the control group [13]. Pan et al. [14] observed that women in the highest nut serving
group were 26% less likely to develop diabetes than participants in the very low nut intake group,
with 95% confidence that the true value is lying between 16%–35%. Similarly, when comparing high to
very low nut intake, the prevalence of diabetes, obesity, and MS were 13%, 39%, and 26% less likely,
respectively [15].
A single meta-analysis [22] confirmed that subjects in the highest total nut intake group had 32%
less risk of dying from diabetes than those in the lowest group (relative risk, RR = 0.68, 95% confidence
interval, CI: 0.52–0.90).
6
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One prospective study showed a nonsignificant reduction in cardiovascular disease (CVD)
mortality when comparing the highest with the lowest nut intake population groups [17]. However,
two others concluded that participants who were fed nut-enhanced MDs had a significantly lower
risk for CVD and CHD, as well as lower CVD, CHD, and all-cause mortality compared to the no-nut
group [16,18]. Participants who consumed walnuts ≥1 serving per week had 19%, 21%, and 17%
lower risk for CVD, CHD, and stroke, respectively, while those who consumed walnuts >3 servings
per week had 47% lower risk of CV mortality compared with subjects who did not eat walnuts [18].
A very recent prospective study demonstrated lower CVD incidence (hazard ratio, HR = 0.83, 95% CI:
0.71–0.98) and CHD incidence (HR = 0.80, 95% CI: 0.67–0.96), 31% lower all-cause mortality and 34%
lower CVD mortality for at least 5 servings of nuts per week compared to less than one per month [21].
In the same study, total nut intake was not significantly associated with stroke incidence. Moreover,
a recent intervention study showed that individuals at high CV risk had a lower incidence of major
CV events (myocardial infarction, stroke, death from CV causes) when nuts were added daily to MD
compared with a low-fat, nut-free control diet [20]. Also, three or more servings of nuts per week,
as compared to none, can even lower the risk of atrial fibrillation and heart failure [19].
Peripheral arterial disease (PAD), often caused by atherosclerosis, can lead to heart attack and
stroke. A large cross-sectional study on mature adults indicated that daily nut consumption was
associated with lower odds of PAD (OR = 0.79; 95% CI: 0.77–0.80, p < 0.001) compared to participants
with the lowest intake of nuts [23].
A very recent meta-analysis of 11 observational studies confirmed that tree nut (but not peanut)
consumption was negatively associated with metabolic syndrome (MS) (p = 0.04) [24]. Another
meta-analysis showed a significantly reduced risk for CVD and CHD for higher nut consumption
(including peanuts) [22]. Luu et al. [24] showed that in different ethnic groups, nut consumption
was associated with decreased overall mortality and CVD mortality and that a higher versus lower
quintile of nut intake had a statistically significant inverse association for ischemic heart disease
(IHD). Mayhew et al. [25], after reviewing several large prospective cohort studies, concluded that
nut consumption was inversely associated with total CVD, CVD mortality, total CHD, CHD mortality,
and sudden cardiac death. While one meta-analysis established that daily nut intake can reduce
the risk of stroke [26], another study did not find a significant association with stroke, but indicated
an inverse association with IHD, overall CVD, and all-cause mortality for nut consumption [27].
A meta-analysis of randomized controlled trials (RCTs) and observational studies identified that nut
feeding was inversely linked with nonfatal and fatal IHD and diabetes, but not stroke [28]. However,
a meta-analysis of prospective cohorts to evaluate the relation between nuts and stroke risk and
mortality, reported that nut consumption was inversely associated with stroke risk (RR 0.90, 95% CI:
0.83–0.98) and stroke mortality, when comparing the highest with the lowest nut intake [29].
High blood pressure (BP) is a major risk factor for CVD. The previous feeding studies showed that
tree nuts or peanuts had no effect on BP. However, a very recent RCT on an elderly cohort (age, 69 years)
proved that walnuts (42.5 grams per day) reduced systolic BP in the walnut group (−4.61 mm Hg,
95% CI: −7.43 to −1.79 mm Hg) compared to the no-walnut group (−0.59 mm Hg, 95% CI: −3.38 to
2.21 mm Hg) (p = 0.051) [30]. As no changes in diastolic BP were noticed, it is safe to say that walnut
intake can reduce systolic BP in mature subjects, mainly in those with mild hypertension.
2.2. Nut Consumption and Blood Lipids
The effects of tree nut and peanut consumption on lipid profiles from intervention studies
published in the last ten years [31–43] are summarized in Table 2. The results of these clinical
trials in a middle-aged population indicate a causal association between higher nut intake and
lower levels of total cholesterol (T-C), low density lipoprotein-cholesterol (LDL-C), non-high density
lipoprotein-cholesterol (non-HDL-C), triglycerides (TG), and apolipoprotein B (apoB), all markers of
CV morbidity and mortality.
9
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After a 12 week trial and daily intake of 56 g almonds, compared with a no-nut control diet, plasma
apoB, apoB/apoA-1 ratio, T-C, LDL-C, and LDL-C/HDL-C ratio decreased significantly by 15.6%, 17.4%,
6.0%, 11.6%, and 9.7%, respectively, in patients with T2DM [31]. Similarly, the inclusion of almonds in
the diet of patients on chronic statin therapy revealed a 4.9% reduction in non–HDL-C compared with
the no-nut group, and non-statistical significance decreases in LDL-C and TG [34]. Consumed before
breakfast, 10 g almonds proved to increase serum HDL-C by 15% after 12 weeks in CAD patients with
low initial HDL-C [35]. A new trial, comparing almond snacks with isocaloric carbohydrate snacks,
demonstrated that almond snacks can improve the serum T-C/HDL-C ratio in women but not in men,
with no change in body weight (BW) or inflammatory biomarkers in overweight and obese adults with
high T2DM risk [43]. The short 8 weeks trial might be the cause for the differential gender results.
Our findings are aligned with data from a meta-analysis conducted by Musa-Veloso et al. [44] in
which almond consumption was confirmed to significantly decrease T-C (p < 0.001), LDL-C (p = 0.001),
and TG (p = 0.042), with no modification in HDL-C (p = 0.207). Also, Nishi et al. [45] showed that the
daily consumption of almonds by middle-aged adults can improve the blood lipid profile, and a 3.5%
decrease in the 10-year CHD risk was noticed for every 30 g increase in almond intake.
Consistent with the effects of other nuts, Brazil nuts and cashews can also improve lipid profiles.
In a group of hypertensive and dyslipidemic subjects, the intake of partially defatted Brazil nuts
significantly increased plasma selenium and the antioxidant activity of the glutathione peroxidase
enzyme, and reduced oxidation in LDL-C compared to the baseline [37]. Mah et al. [39] demonstrated
that adding cashews into the diet of a population with high LDL-C risk could lower the T-C, LDL-C,
and LDL-C/HDL-C ratio. In agreement with these results, a very recent trial showed a significant
decrease for the LDL-C/HDL-C ratio in a cashew diet group compared with a no-cashew control
group [46].
Pistachio, a biochemically-rich tree nut, proved to have a lowering effect on CV risk factors.
Daily pistachio intake significantly decreased the T-C and T-C/HDL-C ratio (p < 0.05), and TG levels
(p = 0.003) compared to the control in T2DM adults [38]. Also, after 4 months of 57 g pistachio daily,
small LDL particles and non-HDL particles significantly decreased compared to the nut-free diet [33].
This change of lipoprotein particle size may explain the decrease of CVD risk. Kay et al. [47] showed
that the consumption of a pistachio-enriched diet, when compared to the control, significantly increased
serum concentration of antioxidants, including beta-carotene, gamma-tocopherol, and lutein, and
significantly decreased serum oxidized-LDL, an important factor in CVD.
Walnut, one of the most versatile tree nuts with its higher content of polyunsaturated fatty
acids (PUFAs) including α-linolenic acid, and high antioxidant activity, may influence CVD risks via
its lipid-lowering impact. Compared with a control diet without walnuts, a walnut-included diet
for 6 months significantly decreased T-C and LDL-C and improved diet quality [36]. In a shorter
cross-over trial, a walnut-enriched diet significantly reduced non-HDL-C (p= 0.025) and apoB (p = 0.009)
compared with a control diet, while T-C displayed a tendency toward reduction (p = 0.073) [32].
Bamberger et al. [40] indicated that a walnut-enriched diet versus a control diet caused a significant
decrease in fasting cholesterol (p = 0.002), LDL-C (p = 0.029), non-HDL-C (p ≤ 0.001), TG (p = 0.015),
and apoB (p ≤ 0.001) in healthy mature adults. Also, 15 mL walnut oil daily (corresponding to ~28 g
walnuts) added for 90 days to the diet of hyperlipidemic T2DM patients significantly decreased the
T-C, LDL-C, T-C/HDL-C ratio (p < 0.001 for all), and TG level (p = 0.021), compared with the control
group, while the HDL level showed an increased trend (p = 0.06) [48]. Similarly, Austel et al. [49]
noticed beneficial changes in blood lipids after replacing saturated fats with walnut oil.
A meta-analysis of 26 trials confirmed that walnut-enriched diets compared with control groups
significantly reduced T-C (p < 0.001), LDL-C (p < 0.001), TG (p = 0.03), and apoB (p = 0.008), with no
significant modifications in BW or blood pressure [50].
Integrated into a typical Western diet, pecans, another tree nut with higher contents of PUFAs,
showed a borderline significant lowering of T-C and LDL-C as compared to a nut-free control diet in
overweight or obese adults with central adiposity [41].
12
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A new trial confirmed that, compared to a carbohydrate control diet, adding 75 g per day of
mixed nuts (tree nuts and peanuts) to healthy diets could significantly lower small LDL-C (p = 0.018),
with a trend towards reduction for T-C (p = 0.066) and non-HDL-C (p = 0.067) in T2DM elderly
patients [42].
These outcomes are validated by a meta-analysis of 61 trials which concluded that nut intake
significantly lowered the levels of T-C, LDL-C, apoB, and TG, with the key factor of changing lipid
profile appearing to be nut dose rather than nut type [51].
As many strategies for reducing T-C and LDL-C levels could lower HDL-C levels, all the
dietary plans for lowering LDL-C levels should aim to maintain or even increase HDL-C. In their
2017 guidelines, the American Association of Clinical Endocrinologists and American College of
Endocrinology recommend a minimum blood HDL-C level of 40 mg/dL in CVD risk individuals [52].
However, data [53] showed that small HDL particles present only a weak defense, the strong protection
against CVD risks coming from large HDL units. Equally, small LDL particles, due to their proneness to
oxidation compared with larger ones, are responsible for atherosclerosis progress and CVD, while large
LDL components are only weakly linked with CVD [53]. Based on these many results, nut consumption
can evidently aid in the management of a healthy lipid profile in mature adults.
2.3. Nut Consumption and Biochemical and Anthropometric Parameters
The outcome of tree nut and peanut consumption on biochemical and anthropometric parameters
found in clinical trials published in the last ten years [31,41,42,54–60] are summarized in Table 3.
The trial of Li et al. [31] revealed that in Chinese T2DM patients, almond intake, compared
with a control diet had a beneficial effect on glycemic control, lowering fasting insulin, fasting
glucose, and Homeostatic Model Assessment—Insulin Resistance (HOMA-IR) by 4.1%, 0.8%, and 9.2%,
respectively. The ingestion of a single serving (28 g) of almonds before a high-starch meal significantly
reduced hemoglobin A1c (HbA1c) (p = 0.045) and postprandial glycemia (p = 0.043) in individuals with
uncomplicated T2DM [54]. Another intervention study showed that almonds significantly decreased
post-interventional fasting glucose by 5.9% (p = 0.01) and HbA1c by 3.0% (p = 0.04) as compared with
that of control in T2DM subjects [59]. In the study of Hou et al. [60], the T2DM patients who replaced
part of their starchy food with almonds or peanuts had decreased values for fasting blood glucose
and 2-h postprandial blood glucose (p < 0.05) compared with the baseline. In addition, in the almond
group a decrease in the HbA1c level from the baseline was found (p < 0.05) and none of the nut groups
showed an increase of body mass index (BMI).
Several dietary interventions within the frame of the PREDIMED study tried to establish a relation
between MDs supplemented with mixed nuts (walnuts, hazelnuts, and almonds) and biochemical or
anthropometric parameters. In a clinical trial with high CV risk participants but no CVD at enrolment,
data showed that MD supplemented with 30 g per day mixed nuts for 1 year significantly decreased
waist circumference (Wc) compared to baseline, and also lowered LDL-C and shifted LDL size to a less
atherogenic pattern [55]. Lasa et al. [56] indicated that a daily quantity of 30 g nuts (walnuts, hazelnuts,
and almonds) added to MDs was associated with a significant reduction in BW (p = 0.021) compared
with the control, with improved glucose metabolism in both the nut group and low-fat diet group.
Rodríguez-Rejón et al. [58] concluded that the nut-enhanced MD lowered glycemic index and glycemic
load, two indices that can be associated with T2DM and CHD.
An RCT conducted on patients with diabetes established that 75 g mixed nuts (tree nuts and
peanuts) added to the diet for 3 months, besides improving the lipid profile, also significantly lowered
HbA1c compared with a carbohydrate diet (p = 0.026) [42]. In another trial conducted on T2DM
subjects, the addition of 15 mL walnut oil to the diet for three month significantly decreased HbA1c
level by 7.86% (p = 0.005) and fasting blood glucose by 8.24% (p = 0.001) compared to control [61].
13
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The supplementation of the diet with pistachios for 9 months in prediabetic participants had
a significant lowering effect in fasting plasma glucose, fasting plasma insulin, and HOMA-IR (p < 0.001
for all), but only borderline significance in decreasing Wc, BW, and BMI [57]. Also, a short 4 week trial
with a pecan-rich diet showed significant reductions in serum insulin and HOMA-IR compared to the
control diet (p < 0.05) [41].
Similar to our findings, two meta-analysis of RCTs pointed out that nut consumption was related
to a significant decrease in BW, BMI, and Wc [62,63].
One reason for these outcomes can be the fact that the metabolizable energy content, or energy
available to the body, of several nuts is less than predicted by the Atwater factors: 5% less for
pistachios [64], 16% less for cashews [65], 21% less for walnuts [66], and as much as 32% less in the
case of almonds [67]. Also, despite 10% higher energy intake from peanuts in another trial, a less than
expected increase in BW compared to the control was found [68].
The meta-analysis of Viguiliouk et al. [69] established that tree nut intake significantly lowered
fasting blood glucose (p = 0.03) and HbA1c (p = 0.0003) compared with control diets, but no
significant effects were detected for fasting insulin and HOMA-IR. The very recent meta-analysis from
Tindall et al. [70] observed that consumption of tree nuts or peanuts significantly decreased fasting
insulin and HOMA-IR with no significant effect on fasting blood glucose or HbA1c.
Positive associations between nut consumption and cardiometabolic biomarkers were seen in
two cross-sectional studies reported in the literature in the last ten years, although the strength of
the association is weaker in these types of studies, which look at a single point in time, compared to
longitudinal and intervention studies. A cross-sectional study conducted on an elderly population at
high CV risk, showed that nut intake decreased both Wc and BMI (p-trend < 0.005 in both) [71]. In the
study of Jaceldo-Siegl et al. [72] obesity was 11% less likely in the high peanut/low tree nut group (odds
ratio, OR = 0.89; 95% CI: 0.53–1.48), 37% less likely in the high tree nut/high peanut group (OR = 0.63;
95% CI: 0.40–0.99), and 46% less likely in the high tree nut/low peanut group (OR = 0.54; 95% CI:
0.34–0.88) (p-trend = 0.006) compared to low tree nut/low peanut group. Moreover, in a large US
population cross-sectional survey, walnut consumers had a significantly lower prevalence of diabetes
with lower levels of fasting blood glucose and HbA1c [73].
2.4. Nut Consumption Effect on Endothelial Function and Inflammation Markers
The studies, summarized in Table 4, proved that tree nut-enhanced diets can have beneficial effects
on endothelial function or inflammatory markers [74–79]. Endothelial dysfunction, characterized
by a decreased bioavailability of nitric oxide (NO), an endogenous vasodilator synthesized from the
amino acid L-arginine, is linked with a greater risk of CV events [80]. Since tree nuts are a rich source
of L-arginine, their intake might potentially improve endothelial dysfunction.
The trial of Ma et al. [74] on T2DM patients revealed that consumption of an ad libitum diet
supplemented with 56 g walnuts daily for a period of 8 weeks significantly improved flow mediated
dilation (FMD), a measure of endothelial function, as compared to a nut-free ad libitum diet. In a larger
trial on overweight adults with visceral adiposity, the same research team found again that after
daily ingestion of walnuts, FMD improved significantly (p = 0.019) as compared with the control diet,
suggesting the potential for overall cardiac risk reduction [75]. Similarly, in hypercholesterolemic
subjects, a diet with walnuts and walnut oil amended FMD (+34%) and reduced total peripheral
resistance [81]. The study of Chen et al. [78] in patients with CAD established that almonds can also
increase FMD, but did not significantly change C-reactive protein (CRP), tumor necrosis factor-alpha
(TNF-α), or E-selectin compared to control. These results align with a meta-analysis published by
Neale et al. [82] where nut intake had a significant effect on FMD (p = 0.0004). Equally, a recent
meta-analysis of RCTs showed that nut consumption significantly increased FMD (p = 0.001) [83].
Bhardwaj et al. [84] noticed that walnut and almond diets, besides positively effecting FMD, can also
decrease soluble vascular cell adhesion molecules.
16
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While walnut and almond diets increased FMD, pistachios had no effect on this measure [38].
This fact was confirmed by the meta-analysis of Fogacci et al. [85] which did not notice a significant
change in FMD, but the brachial artery diameter (BAD) significantly improved (p < 0.001) following
pistachio consumption.
A very recent review [86] established that tree nut and peanut intake had the potential to improve
vascular function, which was linked with increased risk of CVD.
In regard to inflammatory markers, the results of Liu et al. [76] proposed that the integration of
almonds into a healthy diet in diabetic Chinese patients, as compared to the control diet, can decrease
interleukin-6 (IL-6), TNF-α, and CRP. Both IL-6 and TNF-α are mediators of CRP synthesis in the liver.
An increased IL-6 level was associated with insulin resistance, hyperglycemia, and T2DM [76]. The trial
conducted by Sweazea et al. [77] concluded that almond intake, compared with control, significantly
lowered CRP (p = 0.029) in diabetic U.S. patients, as well. In a recent study, Borkowski et al. [87]
showed that walnuts can reduce the TNFα-mediated production of pro-inflammatory cytokines IL-6
and IL-8 in human adipocytes.
These findings are consistent with the results of a cross-sectional analysis which showed that
higher tree nut and peanut intake was associated with decreased amounts of CRP and IL-6 [79].
However, the meta-analysis of Mazidi et al. [88] disclosed that nut consumption had no significant
effect on CRP, IL6, TNF-α, and adiponectin, but significantly decreased leptin.
A low level of adiponectin, a protein with anti-inflammatory and anti-atherogenic properties
secreted by adipocytes, is perceived as risk factor for CV events. An addition of 9 g of walnut oil
or mixed plant oil in the diet increased adiponectin levels in T2DM subjects (+6.84% and +4.47%,
respectively, compared to baseline) with borderline significance (p = 0.051) [89].
The favorable effects on inflammatory markers may be attributed to tree nuts, as a 12-week RCT on
healthy mature adults with peanut intake failed to find any changes in inflammatory biomarkers [68].
The conclusion from these cohort and intervention studies is that the consumption of tree nuts and
peanuts, with their high content of biologically active antioxidant compounds, should be encouraged
for maintaining lower blood lipid counts and better biochemical and anthropometric parameters,
in order to improve the prospect of cardiometabolic morbidity and mortality.
3. Association between Nuts and Cancer
Nutrition was demonstrated to have a causal and protective role in the progress of several types
of cancer, the second leading cause of death worldwide [90].
A number of studies published in the last ten years have demonstrated the influence of nut
consumption on cancer [91–107] (Table 5). Despite the fact that, in the observational studies, no
causality could be proven, there were still several obvious strengths: prospective design for the
majority of the studies, large population size, high retention rates with long-term follow-up, and
adjustments for a multitude of other potential risk factors.
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Several studies indicated that patients in the highest tree nut and peanut-intake group compared to
the lowest intake group at any point in time during the study period were: 40%, 25%, and 14% less likely
to die from total cancer, gastric noncardia adenocarcinoma, and lung cancer, respectively [16,97,98].
Also, they were 46%, 45%, and 47% less likely to die from esophageal squamous cell carcinoma, estrogen
receptor negative breast cancer, and estrogen-progesterone receptor breast cancer, respectively [100,102].
Subjects having at least two servings of nuts per week had 0.68 times the risk of pancreatic cancer
compared with subjects having nuts never or almost never [93]. The oil extracted from walnuts
exhibited in vitro ability to reduce the viability of esophageal cancer cells, induced necrosis and cell
cycle arrest, and displayed anticarcinogenic effect, thus it may present favorable effects in esophageal
cancer in humans [108].
A recent prospective study showed that nut intake was not strongly associated with hepatocellular
carcinoma but a significant inverse association with tree nut consumption was noted [106]. Higher
intake of tree nuts and peanuts, but not peanut butter, was associated with a significantly reduced risk
for small cell carcinoma (lung cancer subtype), after adjusting for smoking frequency and duration,
and a non-significant decrease in lung cancer risk for men, results which have not been replicated in
women [107].
The following case control studies also reported inverse associations between nut consumption
and different types of cancer. In the highest intake group the outcomes were 57% and 28% less likely for
prostate cancer and ovarian cancer, respectively [91,92]. Similarly, peanut consumption was linked with
a lower risk of esophageal squamous cell carcinoma [103]. Lee et al. [104] noticed that odd ratios were
70% less likely for colorectal cancer in women and men, 60% (in women) and 77% (in men) less likely
for rectal cancer, and 87% (in women) and 61% (in men) less likely for distal colon cancer, for the highest
nut-intake group. Also, the results from a very recently published study suggest that, particularly
among women, moderate to high nut intakes (2 to 5.5 servings/week) may be associated with a lower
risk of colorectal adenomas, the precursor to most colorectal cancers [109]. Yang et al. [95] showed that
the colorectal cancer risk for women who consumed tree nuts and peanuts ≥2 times per week was 13%
lower compared to non-consumers, with a borderline statistical significance (p-trend = 0.06). Fadelu
et al. [101] proved that higher total nut intake was linked with a significantly reduced incidence of
cancer relapse and death in subjects with stage III colon cancer, but the benefit was limited to tree
nut consumption.
These results confirm those of Casari and Falasca [110], who linked nut intake with a positive
effect against cancer, and Aune et al. [22], who noticed a 15% decreased cancer risk in subjects eating
28 g of nuts daily compared to subjects who did not have nuts.
A new clinical trial showed that walnuts could alter tumor gene expression in women with
confirmed breast cancer in ways expected to decrease cancer growth, delay proliferation, reduce
metastasis, and increase cancer cell death [105]. Toledo et al. [111] indicated also that walnut-enriched
diets could modulate breast cancer growth. These results are in accordance with those reported by
Soriano-Hernandez et al. [112] where, in the group that consumed higher amounts of walnuts, almonds
and peanuts, the breast cancer risk was between 55 and 67% less likely.
Higher nut consumption might influence cancer risk through its association with lower circulating
levels of total cholesterol, CRP, IL-6, and insulin. Different compounds, such as flavonoids from
nuts or their by-products might lower the risk of head and neck cancer [113] and could present
chemopreventive properties and anticancer potential [114–116]. These bioactive antioxidant molecules
can act alone or most likely in synergism to regulate the inflammatory response and immunological
activity, prevent the development of prostaglandins or pro-inflammatory cytokines, and potentially
inhibit cancer risk.
4. Association between Nuts and Cognitive Disorders
Inflammation-associated chronic pathologies, such as dementia, Parkinson’s disease (PD), or
Alzheimer’s disease (AD), lead to one of the most unfavorable health problems in the elderly:
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age-related cognitive deterioration, a condition which may be prevented or delayed by modifiable
lifestyle factors, including antioxidant diets [117].
Quite a few studies have examined the association between diets supplemented with nuts and
cognitive performance [118–124] (Table 6).
In an elderly population, consumption of walnuts was related to better cognitive performance,
mainly working memory, although the causality could not be inferred [120]. These results were
consistent with another cross-sectional study that indicated a positive association between nut
consumption and cognitive function in mature Chinese adults. Patients with mild cognition impairment
symptoms had less tree nuts and peanuts in their diet compared to healthy subjects (p = 0.031) [125].
Similarly, positive relations between cognitive functions and nut intake were shown in the US
population. Significant improvements in almost all cognitive test scores were noted among older
adults who added walnuts in their diet [126].
The scores from two neuropsychological tests, the Mini-Mental State Examination (an indicator
of cognitive impairment) and the Clock Drawing Test (a neuropsychological test which evaluates
cognitive decline and dementia), were higher for subjects allocated to the nut-enhanced MD compared
to the low-fat, nut-free diet group [121]. Comparable results were obtained by Valls-Pedret et al. [123];
in an older population, MD supplemented with tree nuts (walnuts, almonds, hazelnuts) was associated
with improved cognitive functions. Also, a high consumption of tree nuts and peanuts was linked to
better cognitive function at baseline and might reduce cognitive decline in mature adults [119]. Equally,
O’Brien et al. [122] suggested that long-term tree nut and peanut intake was related to overall level of
cognition but had no effect on cognitive decline.
A recent RCT demonstrated that peanut consumption could improve vascular and cognitive
functions in overweight middle-aged subjects. Small artery elasticity, cerebrovascular reactivity, as
well as measures of verbal fluency, processing speed, and short-term memory were all greater after
higher intake of roasted, unsalted peanuts with skin [124]. Also, the addition of walnuts (15% of
energy) to an ad libitum diet confirmed that regular nut consumption can delay the onset of age-related
neurodegenerative disorders. Compared with the control, individuals in the walnut group reported
significantly lower intake of animal protein, total carbohydrates, saturated fatty acids, and sodium, but
significantly higher ingestion of vegetable protein, antioxidant n-3 and n-6 PUFAs [127].
Brain-derived neurotrophic factor (BDNF), a protein belonging to the neurotrophic family, controls
axonal elongation, neurotransmitter release, growth, differentiation, and survival of presynaptic
structure. While low plasma levels of BDNF could lead to the atrophy of specific brain areas in
mammals such as the hippocampus and frontal cortex. Higher concentrations of BDNF provided
by enhanced-nut MD were likely to prevent depression, memory loss, and cognitive decline [118].
It seems that n-3 PUFA, with its powerful antioxidant potential, is responsible for the increased levels
of the BDNF signaling factor [128]. Blondeau et al. [129] noticed that alpha-linolenic acid (ALA), the
plant-based n-3 PUFA, may increase BDNF, thus walnut intake can have a role in neuroprotection,
neuroplasticity, and vasodilation of brain arteries.
Major depressive disorder (MDD) is a chronic disease where healthy dietary practices in
combination with current treatments may prevent or delay its evolution. Increased consumption of
nuts, seeds, vegetables, fruits, and legumes, with proven antioxidant and anti-inflammatory capacities,
is the principal nutritional recommendation, with a key reminder that the beneficial effects are possible
to come from wholesome nutritious diets rather than from individual nutrients [130]. Ali-Sisto et
al. [131] showed that MDD is characterized by a decreased arginine level, an amino acid found in nuts
and a precursor of NO, which is needed to modulate neuronal and vasodilation functions, to prevent
oxidation of LDL-C, aggregation of platelets, or vascular inflammation, and inhibit oxidation in
the central nervous system (CNS). MDD is associated with increased CV events, and the biological
mechanism connecting MDD and CVD is apparently a chronic inflammation induced by a low level or
bioavailability of arginine [131].
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A study on Chinese adults demonstrated that, even after adjusting for potential confounders, the
frequency of tree nut and peanut intake (more than 4 times per week) might be associated with a lower
incidence of depressive symptoms [132]. Also, Arab et al. [133] reported that U.S. nut consumers,
especially walnut eaters, had significantly lower depression scores as compared to no-nut consumers,
and the difference was strongest among women.
Optimal dietary choices, such as increasing bioactive antioxidant compound intake through
higher nut, fruit, and vegetable consumption, can improve endothelial function, decrease inflammatory
biomarkers, protect neuronal and cell-signaling function, increase cognitive performance, and prevent
or delay the onset of cognitive dysfunction during aging [134]. In anxiety-based psychopathology,
replacing pro-inflammatory saturated fats with anti-inflammatory walnut oil might result in faster,
more profound elimination of fear-based learning [135].
5. Other Possible Beneficial Association of Nuts
As the population of the world is getting older, a global priority for the aging population should
be the maintenance of independence and freedom of movement. One of the hallmarks of aging and
a major public health concern is the loss of mobility due to sarcopenia and dynapenia, or progressive
loss of skeletal muscle mass and muscle strength, respectively. Another gerontological condition,
described by physical inactivity, slow walking speed, fatigue, and weakness, is frailty [136].
In the elderly, both conditions, sarcopenia and frailty, are characterized by increased levels of
pro-inflammatory cytokines, including TNF-α, IL-6, and CRP. Therefore, knowing its antioxidant and
anti-inflammatory potential, dietary intake of food rich in monounsaturated fatty acids (MUFAs) and
PUFAs is of particular interest for this age group [137]. One recent study mentioned that quantities of
2 to 5 g per day of marine n-3 PUFA, corresponding to approximately 20 to 50 g walnuts, is shown
to reduce muscle wasting and augment the intracellular anabolic signaling, thus having beneficial
effects for the prevention and treatment of sarcopenia in mature adults [138]. Also in this age group,
malnutrition and sarcopenia frequently overlap. In order to overcome the loss of lean mass and meet
the increased energy requirements, the recommended protein intake is higher (1.2–1.4 g/kg/day) than
that of healthy adults [139]. Because the protein level is between 15 to 21% in most tree nuts and
around 26% in peanuts, nuts should be included in healthy diets as plant food sources of protein [140].
Nutrition is a factor that could influence osteoarthritis (OA), the most dominant form of arthritis
with limited treatment, mainly through symptom management [141]. As food impacts systemic lipid
levels, high consumption of saturated fat is linked with higher levels of pro-inflammatory fatty acids,
while diets rich in less-inflammatory MUFAs and PUFAs, lipids also found in tree nuts and peanuts
(Table 7) may reduce cartilage degradation and OA progression [142].










Total fat 49.9 67.1 43.8 60.7 75.8 72.0 68.4 45.3 65.2 49.2
SFA 3.8 16.1 7.8 4.5 12.1 6.2 4.9 5.9 6.1 6.8
MUFA 31.6 23.9 23.8 45.7 58.9 40.8 18.8 23.3 8.9 24.4
PUFA 12.3 24.4 7.8 7.9 1.5 21.6 34.1 14.4 47.2 15.6
(MUFA +
PUFA)/SFA 11.6 3.0 4.1 11.9 5.0 10.1 8.8 6.4 9.2 5.9
MUFA—monounsaturated fatty acids; PUFA—polyunsaturated fatty acids; SFA—saturated fatty acids.
In a group of postmenopausal women, MD enhanced with up to 20 g/day nuts was significantly
associated with bone mineral density (p = 0.045), indicating that nuts may be beneficial in osteoporosis
prevention [143].
Two biomarkers of aging, advanced glycation end products (AGEs) and length of telomeres, can
be influenced by nut diets. AGEs, a complex class of compounds, can be formed in vivo, as part
of normal metabolism, or acquired exogenously from unhealthy diets or environment. They can
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accumulate in tissues during aging. Data suggests that AGEs can have damaging effects in CVD,
neurodegenerative diseases, T2DM, cancer, or sarcopenia [144–146]. It was shown that nut-enhanced
MD may constitute a good instrument towards the inhibition of AGEs formation and absorption [145].
Telomeres, protecting DNA sequences at the end of the chromosomes, present a defensive mechanism
against risk factors for a number of age-related diseases, including osteoporosis, CVD, CHD, T2DM,
pulmonary fibrosis, AD, and cancer [147–149]. Several studies demonstrated that reactive oxygen
species (ROS) can accelerate telomere attrition, induce DNA damage response, and senescence [150].
Sirtuins or the action of telomerase can counter telomere shortening. Among the environmental factors
lessening telomere attrition are polyphenols, n-3 PUFA, or vitamin E, active antioxidant molecules [150].
A recent study linked regular nut consumption with telomere length and a significant reduction in
cellular aging and biologic senescence [151]. Fiber, another valuable compound in nuts, can mediate
longer telomeres and reduce biologic aging [152]. A two year trial conducted by Freitas-Simoes et
al. [153] in an elderly population confirmed that supplying the diet with walnuts at 15% of daily energy
(30 to 60 g/day) postponed leukocyte telomere attrition, potentially influencing the aging process.
Together with physical exercises, long-term daily intake of tree nuts and/or peanuts may contribute
to maintaining the health of the skeletal system, muscle mass and strength, as well as the well-being of
middle-aged and elderly population.
6. Phytochemicals and Mechanisms Responsible for the Beneficial Activity
Biologically active antioxidant compounds found in nuts can modulate essential physiological
processes inside human bodies and influence key mechanisms of actions involved in aging and
age-associated diseases [154].
Nut antioxidant polyphenols, the majority of which are found in the pellicle of nuts, can
have anti-carcinogenic potential. They retard the initiation, differentiation, and proliferation of
cancer cells, modulate signaling pathways related to cell survival, attenuate the growth of tumors,
diminish angiogenesis and metastasis, and stimulate the expression of detoxification enzymes and
antioxidants [155,156].
Some polyphenols are found in significant amounts in certain types of nuts, giving them specific
biological actions. Thus, ellagic acid (EA), physiologically hydrolyzed from ellagitannins (ETs)
abundant in walnuts, found also in pecans and pine nuts, could reduce adipocyte expansion and might
be beneficial in the management of obesity and the metabolic complications related to obesity [157].
Another example is anacardic acid, a strong antioxidant polyphenol contained in cashew nut shells,
which was shown to have anticancer potential, inhibited prostate tumor angiogenesis, cell proliferation,
and prompted apoptosis [158–160].
Other polyphenols, found only in very small amounts in nuts, can contribute to beneficial health
effects through their hormetic and/or synergistic actions with other polyphenols. In pistachios, the small
amounts of genistein, (-) epigallocatechin-3-gallate (EGCG) or resveratrol can act synergistically
through common or complementary action pathways with proven antioxidant and anti-aging
activity. Thus, the flavonoid (isoflavone) genistein has demonstrated antioxidant, chemopreventive,
and chemotherapeutic effects [161]. Growing evidence suggests that EGCG, also present in pecans
and hazelnuts, can contribute to the anti-cancer potential [162]. It has an inhibitory proliferation
effect on human pancreatic cancer cells [163]. In oral cancer, EGCG exerted an apoptotic therapeutic
role, controlling cancer cell proliferation, and in breast cancer showed an anti-angiogenic effect [164].
Resveratrol, another antioxidant phytochemical also found in peanuts besides pistachios, proved
to have neurogenesis activity and cancer chemoprevention potential [165,166]. Pterostilbene (PTS),
a natural dimethylated analog of resveratrol, had the capability to significantly inhibit secretion of
TNF-α and alter the cytokine production in IGROV-1 ovarian cancer cell line [167].
Melatonin, found in walnuts in quantities of 3.5 ± 1.0 ng/g, could be protective against CV damage
and cancer initiation and propagation [168].
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Selenium, a trace element supplied mostly by Brazil nuts, is associated with reduced risks for
prostate cancer [169] and hepatocellular carcinoma [170].
Nuts are characterized as fatty foods, with total lipid content ranging from 46% in cashew to 76%
in macadamia (Table 7). However, the healthy lipid profile of tree nuts and peanuts, mostly MUFAs
and PUFAs and low or very low amounts of saturated fatty acids, is a key mechanism of action in the
prevention of several age-related diseases [154,171].
Lipophilic bioactive compounds found in nuts can also influence the aging process. Among those
compounds, phytosterols can reduce CV risk [172]. Increasing evidence recommends phytosterols
for lowering LDL-C [173–175]. Phytosterols, being more hydrophobic than cholesterol, can dislocate
cholesterol from intestinal micelles and reduce LDL-C absorption [176]. In combination with n-3 PUFAs,
phytosterols show both complementary and synergistic lipid-lowering effects in hyperlipidemic mature
adults [177].
Lipophilic isomers of vitamin E (tocopherols and tocotrienols), via their antioxidant properties,
might inhibit the propagation of free radical damage in biological membranes and enhance immune
functions [91]. Oxidation stress and inflammation, processes involved in the decline of cognitive
function and neural capacity of the aging brain, can be reduced by tocols through their antioxidant
and anti-inflammatory properties [178,179]. It was suggested that dietary intake of tocotrienols could
be sufficient to support neuroprotection [180,181].
The lipophilic antioxidant phytochemicals, even in minute amounts, showed increased
bioavailability and bioaccessibility, with their intestinal absorption being favored by the presence of
lipids in tree nuts and peanuts. Lutein, the most abundant antioxidant carotenoid in the human retina
and brain, can be found in pistachios [182]. Age-related macular degeneration (AMD), the primary
cause of blindness and vision impairment in old age, can be amended or prevented by lutein [183].
Data indicated the significant impact macular pigment density, a biomarker of brain lutein, might also
have on the brain health and cognition in the elderly by improving neurobiological efficiency, neural
structure and efficacy, visual perception, and decision-making [184,185]. Recent scientific evidence
showed that lutein could stop neuroinflammation, a pathological condition of many neurodegenerative
disorders, diminish lipid peroxidation, and, by down-regulation of the NF-κB (the nuclear factor
kappa-light-chain-enhancer of activated B cells) pathway, decrease the release of pro-inflammatory
cytokines [186]. Compared to other sources, the amount of lutein found in pistachios is low, but as
mentioned before, the intestinal absorption of lutein is enhanced by the presence of fatty acids in the
tree nut.
Two mechanisms of actions, increased cholesterol efflux and improved endothelial function,
favorably affected by whole walnuts and walnut oil, may answer in part the CV benefits of walnut
consumption [187]. The favorable effect walnuts have on endothelial function could be credited to
ALA, oxylipins (PUFA metabolites with a protective role in CVD and aging), polyphenols, L-arginine,
and magnesium [176]. Walnut kernels provide ~9% ALA, while walnut oil provides ~10% ALA [81].
Similarly, ALA might be the factor for the decreased number of atherogenic small and dense
LDL-C particles and increased number of large HDL-C particles noticed after walnut intake, as well
as the reduction of detrimental lipid classes, such as ceramides and sphingomyelins, associated with
CVD risk [188].
The synergistic influence exerted by MUFAs and PUFAs, antioxidant polyphenols and lipophilic
compounds, and fiber in the modulation of specific miRNAs, have resulted in the improvement of
insulin sensitivity via the PI3K-AKT signaling pathway in pre-diabetic and diabetic population [189].
In pathological conditions, such as AD, there is a diminished expression of glucose transporters,
which apparently contributes to a reduced utilization of glucose in cognition-critical brain areas.
However, transport and metabolism of ketone bodies (KBs), metabolites produced by the liver as
alternative energy sources, are not affected in AD [190]. For that reason, periods of ketogenic diets
(KDs) can possibly be effective preventive or treatment measures for neurological disorders [191].
We argue that nuts, due to their phytochemical profile (fat content between 49 and 75%, low amounts
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of carbohydrates, and high content of ketogenic amino acids including leucine) and strong antioxidant
potential, can be part of KDs. Important actions of KDs are related to decrease oxidative stress and
inflammatory activity and improve mitochondrial function [192].
As seen in this review, higher nut intake by mature adults was associated with a reduced risk of
diabetes, CHD, CVD, several types of cancer, and cognitive disorders. For most of these outcomes, there
were indications of nonlinear associations between tree nut and peanut consumption and decreased
risk noticed up to an intake of around 15–20 g per day, or 4–5 servings per week, with no further
decrease with higher intakes. One study revealed that walnuts had a beneficial effect against diabetes
at about 5 grams per day, a little more than one serving per week, with again no additional results
for greater intake amount. The intake of both tree nuts and peanuts was linked with reduced risks of
diabetes, CHD, CVD, and cancer, as well as increased cognitive function and performance. Although,
only tree nuts showed increase in flow-mediated dilation and decrease in LDL-C or certain biochemical
and anthropometric parameters (fasting insulin, HOMA-IR, HbA1c, BW, Wc). The results of our study
are in line with other analyses that have investigated the relationship between nut intake and chronic
diseases [22,94].
7. The Association between Nut Intake and Gastrointestinal Microbiota
The relationship between gut microbiota (GM), diet, and healthy aging has been established in
many studies [193–195]. Nutrition is a vital instrument in keeping a friendly microbiome, and this
is more important in aging, when increased usage of medication can reduce healthy GM diversity
and stability [196]. GM can impact CNS function, via gut-brain axis, and regulate the immune
system [197,198]. Also, GM can be involved in several brain disorders (autism, PD, schizophrenia) [199].
Patients having PD, a high incidence neurodegenerative disorder among those over 60 years old,
revealed pro-inflammatory bacteria in their gastrointestinal tract. Pathological by-products of these
microorganisms could leak from the intestinal lumen in the enteric nervous system and aggregate into
insoluble fibrils in the CNS [200,201].
Nut polyphenols were reported to increase the abundance of Bifidobacterium and Lactobacillus
bacteria, probiotic strains related to significant lowering of CRP concentrations and increase in plasma
HDL-C, cancer prevention, immune-modulation, as well as reductions of pathogenic Clostridium species
and enteropathogens Salmonella typhimurium or Staphylococcus aureus [202,203]. Walnut ingestion
increased the abundance of Lactobacillus [204], while decreasing microbial derived, proinflammatory
LDL-C and secondary bile acids in healthy mature adults [205]. Similar results were achieved in
a very recent 8-week long RCT, including 194 healthy individuals (mean age 63 years), where after
43 g/day walnut-enriched diet, the probiotic and butyric acid-producing species (Ruminococcaceae
and Bifidobacteria) significantly increased (p < 0.02), while Clostridium species significantly decreased
(p < 0.05) [206]. Also, pistachio and almond consumption via the prebiotic compounds may stimulate
the growth of beneficial butyrate-producing bacteria and inhibit the development of pathogenic
ones [207]. Holscher et al. [208] demonstrated that daily consumption of around 42 g almonds for at
least 3 weeks can increase the abundance of Roseburia species, a favorable genus known to be negatively
affected by age.
The favorable effect of walnut diets on BP may be linked to changes in the GM. As walnuts
are not completely metabolized in the upper gastrointestinal tract, they provide substrate to the gut
microbiome and may stimulate the production of short-chain fatty acids, including butyrate, which
have been associated with normal BP management [209].
Human diet influences the relative abundance of bacterial communities present in the
gastrointestinal tract [210]. A significant diversity and number of bacteria ensure a greater ability
to resist metabolic changes and infections and constitute the prerequisite for a healthy status of the
gut [202]. Consequently, a nut enhanced diet characterized by high antioxidant and anti-inflammatory
activities can delay age-related microbiota changes and positively alter the microbial composition of
the human GM with benefits for health.
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8. Conclusions
Given that population aging has become a global trend, it is necessary to carefully evaluate
age-associated diseases and identify strategies for promoting healthy lifestyle leading to healthy
aging. Main goals should be the preservation of physical and cognitive functions, the maintenance
of high standards of life quality and independence. Clearly, there is a need to design personalized
recommendations to prevent, manage, or treat pathological conditions prevalent in the elderly.
As demonstrated in the present review, nuts, via their numerous biological active compounds
(proteins, MUFAs and PUFAs, vitamins, minerals, fiber, polyphenols, phytosterols), have antioxidant
and anti-inflammatory properties and might ensure cardioprotective benefits, safeguard against
metabolic conditions, lower carcinogenic risk, help in cognitive disorders, or aid in sarcopenia and
frailty. Just one bioactive compound cannot explain all these health benefits. It seems that antioxidant
phytochemicals act synergistically to decrease the age-related oxidative stress and inflammation.
Nuts, as complete functional foods, may positively adjust aging processes and play key roles in the
relationship between lifespan and health span. Recent data favor the inclusion of robust antioxidant
nuts in healthy diets of middle-aged and elderly population, a category steadily growing worldwide.
The scientific findings of our review stress the beneficial effects tree nut and peanut consumption
can have in lowering risk factors related to several age-related diseases and highlight the importance
of including nuts in healthy dietary plans. Moreover, the study has the potential to advance the
perception of nuts as strong antioxidants between nutritionists, nurses, physicians, or general public
and could be helpful in public health and health policy decisions.
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AD Alzheimer’s disease
AGEs advanced glycation end products
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apoB apolipoprotein B
BDNF brain-derived neurotrophic factor
BMI body mass index
BP blood pressure
BW body weight
CAD coronary artery disease
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HbA1c hemoglobin A1c
HDL-C high density lipoprotein-cholesterol
HOMA-IR Homeostatic Model Assessment—Insulin Resistance
HR hazard ratio




LDL-C low density lipoprotein-cholesterol
MDD major depressive disorder
MD Mediterranean diet
MS metabolic syndrome





PUFAs polyunsaturated fatty acids
RCT randomized controlled trial
ROS reactive oxygen species
RR relative risk
T-C total cholesterol
T2DM type 2 diabetes mellitus
TG triglycerides
TNF-α tumor necrosis factor-α
VLDL-C very-low-density lipoprotein cholesterol
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Abstract: Due to the balanced nutritional value and abundance of bioactive compounds, seaweeds
represent great candidates to be used as health-promoting ingredients by the food industry. In this
field, Phaeophyta, i.e., brown macroalgae, have been receiving great attention particularly due to
their abundance in complex polysaccharides, phlorotannins, fucoxanthin and iodine. In the past
decade, brown algae and their extracts have been extensively studied, aiming at the development of
well-accepted products with the simultaneous enhancement of nutritional value and/or shelf-life.
However, the reports aiming at their bioactivity in in vivo models are still scarce and need additional
exploration. Therefore, this manuscript revises the relevant literature data regarding the development
of Phaeophyta-enriched food products, namely those focused on species considered as safe for human
consumption in Europe. Hopefully, this will create awareness to the need of further studies in order
to determine how those benefits can translate to human beings.
Keywords: Phaeophyceae; food fortification; algae; fibres; phlorotannins; fucoxanthin; minerals; iodine;
nutrition; health-benefits; functional food
1. Introduction
Marine macroalgae i.e., seaweeds, have been well recognised for centuries by their importance
in the diet of many Far Eastern countries, such as Japan and Korea [1,2]. They are nutritionally very
wealthy, being claimed as a great source of complex polysaccharides, minerals, proteins and vitamins,
as well as of several phycochemicals [3,4]. Actually, a regular seafood consumption, in which seaweeds
are included, has been associated with a myriad of health benefits and a longer life expectancy [5,6]
and these combined facts are leading to an increased interest in the manufacture and consumption of
high-value macroalgae-derived products in Western cultures. Their consumption is also in line with
the increasing awareness of consumers’ perceptions towards organic products and of environmentally
sustainable products. As a result, according to the Seafood Source report, the global seaweed market is
expected to grow to USD 22.1 billion by 2024 [7].
Nowadays, amongst all three types of macroalgae (green, red and brown), brown algae are
the most consumed species (66.5%), followed by red (33%) and green (5%) algae [8]. Phaeophyceae
possess a high content of diverse phycochemicals and have been repeatedly claimed to exert important
therapeutic properties, which turn them into great candidates to be used as bioactive agents in many
industries, including the functional food market [9–11].
Europe has been recently highlighted as one of the most innovative regions regarding the use of
seaweeds as a food ingredient with new products emerging on the European market increasing at
exponential rates [12]. In fact, according to the Seafood Source report, the new products containing
this new ingredient launched on the European market increased by 147% between 2011 and 2015,
making Europe the most innovative region globally after Asia [13]. In this region, algae are considered
as novel foods and a limited number of brown macroalgae species are considered to be safe for
human consumption, namely Fucus vesiculosus, Fucus serratus, Himanthalia elongata, Undaria pinnatifida,
Ascophyllum nodosum, Laminaria digitata, Laminaria saccharina, Laminaria japonica and Alaria esculenta [14].
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The present manuscript reviews the current knowledge on the incorporation of these brown seaweed
species and brown seaweed-derived high-value products in common food products.
2. Chemical Particularities of Brown Macroalgae
The health-claims of Phaeophyceae are mainly associated with their abundance in specific nutrients
and phycochemicals, particularly fibres, phlorotannins, fucoxanthin and minerals. However, their levels
are greatly variable according to distinct factors, including the algae genera and species, maturity and
the environmental conditions, i.e., the variations to which the natural habitat of algae might be subjected,
namely season, temperature, salinity, oceanic currents, waves or even depth of immersion, as well as
post-harvesting storage and processing conditions [9,10,15–18]. As such, this section describes their
main structural characteristics as well as some of their most relevant bioactivities, highlighting their
overall abundance in the targeted macroalgae of this review.
2.1. Polysaccharides
Brown macroalgae are known to produce different types of polysaccharides and/or fibres which,
despite their variability, represent major components that can reach up to 70% of their dried weight
(DW) [19]. In fact, previous reported data set the polysaccharide contents of relevant species, namely
L. japonica, F. vesiculosus, A. nodosum, Saccharina longicruis, U. pinnatifida and Sargassum vulgare at 37.5%,
65.7%, 69.6%, 57.8%, 35.2% and 67.8% DW, respectively [20–23]. Amongst them, alginates, fucoidans
and laminarins are the most representative ones.
Alginic acids or alginates, i.e., the salts of alginic acid, are the main polysaccharides in brown
seaweeds [24], reaching up to 16.9% DW in S. vulgare, 20% DW in S. longicruris, 24% DW in A. nodosum,
32% DW in Sargassum carpophyllum, 40% DW in Laminaria hyperborean [25], 41% in Sargassum siliquosum
and even to 59% DW in F. vesiculosus [26]. Within the cell wall, these polysaccharides are known to
be partially responsible for the seaweed’s flexibility [3] and therefore, expectedly, brown seaweeds
grown under turbulent conditions usually have superior alginate contents than those of calm waters.
In terms of structure, alginic acids or their corresponding extracted salts consist of α-l-guluronic acid
(G) and β-d-mannuronic acid (M) (1→4)-linked residues arranged either in heteropolymeric (MG)
and/or homopolymeric (M or G) blocks (Figure 1A–C). Regardless, the variations caused by diverse
factors (e.g., algae species, seasonability, parts of the algae) are expected [16]. Noteworthy, alginates are
considered one of the most important food colloids, with many applications in several industries such
as foods, paper, pharmaceutical or cosmetics [27]. In fact, G-blocks in the presence of ions, such as Ca2+
form is the so-called egg-box, thus granting stiffness to the overall structure and conferring gel-forming
properties to these polysaccharides [28]. Therefore, they are usually used as thickeners, gels, emulsifiers
and stabilizers in order to improve quality parameters, especially in food grade products [29]. In addition
to their wide applications, more recently, dietary alginates are being associated with positive health
benefits in the gastrointestinal tract and appetite regulation, as well as antihypertensive and anti-diabetic
effects [30]. Alginates are also considered great prebiotics as they were demonstrated to significantly
promote the growth of several bacteria, including Bifidobacterium bifidum, Bifidobacterium longum and
Lactobacilli, alongside with the increase of acetic acid, propionic acid and several short chain fatty
acid metabolites, while decreasing deleterious metabolites, including faecal sulphide, phenol, p-cresol,
indole, ammonia and skatole [31].
Fucoidans i.e., metabolites belonging to the fucans family, also have a structural role in brown
algae, mostly preventing dehydration [3]. Their reported content in Phaeophytae is variable, ranging
from approximately 6–8% DW in L. japonica, 3.2–16% DW in U. pinnatifida, and 3.4–25.7% DW in
F. vesiculosus [10,32]. These polysaccharides are mainly composed of fucose and sulphate, although the
presence of other types of monosaccharides (glucose, galactose, mannose, xylose and uronic acids),
acetyl groups and proteins also occur [33]. Despite being molecules with high structural diversity,
the representative backbone of fucoidans consists of (1→3)- and (1→4)-linked α-l-fucopyranose
residues, and these polysaccharides are commonly divided in two types, the first being characterized
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by long chains of (1→3)-linked α-l-fucopyranose residues (mainly present in L. saccharina, L. digitata,
C. okamuranus, and Chorda filum) and the second consisting of alternating (1→3)- and (1→4)-linked
α-l-fucopyranose residues (characteristic from A. nodosum and Fucus spp.) (Figure 1D,E) [24,34].
Over the last years, extensive biological activities (e.g., antitumor, antioxidant, anticoagulant,
antithrombotic, immunoregulatory, antiviral, anti-inflammatory among others) have been demonstrated
with promising preclinical results, as recently reviewed [35]. As an example of in vivo studies,
the effectiveness of a F. vesiculosus fucoidan injection towards oxidative stress in hyperoxaluric rats
was demonstrated by Veena et al. [36] to be mediated by the stimulation of antioxidant enzymes,
such as superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx). Moreover,
Huang et al. [37] reported that the ingestion of fucoidans isolated from L. japonica reduced the serum
levels of total cholesterol, triglycerides, and low-density lipoprotein cholesterol in hyperlipidaemic rats,
while increasing the enzymatic activity of lipoprotein lipase, hepatic lipase and lecithin cholesterol
acyltransferase. In addition, their relevance in obesity and/or diabetes was also highlighted, in particular,
by Xan et al. [38], who reported F. vesiculosus fucoidans’ ability to inhibit α-glucosidase in vitro and
to decrease the fasting blood glucose and glycosylated haemoglobin levels of db/db mice, as well as
by Kim et al. [39], when administrating U. pinnatifida fucoidans to the same animal model. Although
there is limited evidence to implicate a role of fucoidans in the gut microbiota, some works reported
that fucoidans from different brown algae species greatly contributed for the increase in the growth of
Bifidobacterium, Lactobacillus and Ruminococcaceae, either in mice or human faecal samples [31].
Figure 1. The structure of representative polysaccharides found in brown algae: (A–C) alginic acids;
(D–E) fucoidans from A. nodusum/F. vesiculosus and S. latissima, respectively; (F–G) laminarins M and
G chains.
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Laminarins, also named laminarans or leucosins, on the other hand, belong to the glucan family
and serve as reserve metabolites in brown algae [40]. These are commonly found in the fronds
of Laminaria and Saccharina macroalgae and, to a lesser extent, in Ascophyllum, Fucus and Undaria
species [41]. In general, they are relatively small polysaccharides composed of β-(1→3)-linked glucose
monomers, containing large amounts of sugars and a low fraction of uronic acids (Figure 1F,G) [42].
Depending on the type of sugar at the reducing end, they are classified in two distinct types, specifically
the M chains, which have a terminal 1-O-substituted d-mannitol, and the G chains, possessing a
terminal glucose [16]. The content of these polysaccharides is also season-dependent, since seaweeds
show no production or very less amounts in the winter and maximum production during summer and
autumn [23]. As previously stated, Laminariales are known to produce high amounts of laminarins,
with contents reaching up to 35% DW, particularly in L. saccharina and L. digitata [40]. Other reported
values of laminarins content comprise those of A. esculenta, U. pinnatifida, A. nodosum and F. serratus
(11.1%, 3%, 4.5% and up to 19% DW, respectively) [22–24,40].
The bioactivities of laminarins are scarcely exploited, but still they are considered as fibres and
therefore can be partially or totally fermented by the endogenous intestinal microflora. This was
demonstrated by Devillé et al. [43], when comparing the results from in vitro digestibility tests,
where no hydrolysis of this fibre occurred, to those of in vivo tests, for which no traces of laminarin
were detected in the faeces of fed Winstar rats after ingestion.
It should be noted that oligosaccharides from brown macroalgae polysaccharides may also exhibit
interesting bioactivities, which can differ from those of the original polysaccharides. In this topic,
alginate oligosaccharides have been claimed to possess radical scavenging activities with the great
potential for application in the food industry [44], and even promising effects on neuro-inflammation,
promoting microglial phagocytosis. This could be of great relevance for their application as a
nutraceutical agent for neurodegenerative diseases, such as Alzheimer’s disease [45]. In turn, in vivo
experiments on renovascular hypertensive rats revealed that fucoidan oligosaccharides exhibited
anti-hypertensive effects comparable to those of captopril, i.e., an approved drug used for the treatment
of hypertension [46].
2.2. Phlorotannins
Phlorotannins are phenolic compounds almost exclusive to Phaeophytae and also represent their
main phenolic pool. In brown seaweeds, they are associated with a myriad of functions, ranging
from structural cell wall components, to biosyinthetic percursors and defensive mediators against
natural enemies, acting as herbivore deterrents, inhibitors of digestion and agents against bacteria [11].
Phlorotannins are known to accumulate mostly in physodes (i.e., specialized membrane-bound vesicles
of the cell cytoplasm), with levels that might represent up to 25% of seaweed’s DW, despite variations
which occur depending on distinct factors [47]. For example, the higher levels of phlorotannins in
Fucus spp. are associated with high salinity waters and solar exposure during summer [10].
Being part of the tannins group, phlorotannins present a polymeric structure derived from several
phloroglucinol (1,3,5-trihydroxybenzene) units and possess a high number of hydroxy groups, thus
conferring them solubility in water [48]. Depending on the linkage between phloroglucinol monomer
units, a wide range of compounds with different molecular weights can be obtained [49], which overall,
are divided in four categories for each type of linkage: Fuhalols and phlorethols based on ether linkage,
fucols based on C-C linkage, fucophlorethols for a combination of the previous ones, and, finally,
eckols and carmalols, based on dibenzodioxin linkage (Figure 2).
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Figure 2. Some representative phlorotannins from brown seaweeds: (A) Fucol; (B) Fucophlorethol;
(C) Phlorethol; (D) Fuhalol; (E) Carmalol; (F) Eckol.
Phenolic extracts from brown seaweeds have been demonstrated to exhibit various biological
activities, including antioxidant, antidiabetic, anti-inflammatory and others [11,50,51]. In this regard,
O’Sullivan et al. [52] observed the augment of glutathione levels in Caco-2 cell models when incubated
with A. nodosum, F. vesiculosus and F. serratus phlorotannins extracts, while also highlighting the
protective effects of the latter on the same model pretreated with H2O2. In vivo experiments have
even demonstrated that the oral administration of 200 mg/kg/day of F. vesiculosus polyhenol-rich
extracts over 4 weeks to Sprague-Dawley rats could increase the blood plasma reducing power,
paraoxonase/arylesterase 1 (PON-1) activity and O2•− scavenging activity by 29%, 33% and 25%,
respectively [53]. Likewise, the antidiabetic properties of A. nodosum and F. vesiculosus phenolic-rich
extract were observed in vivo as the postprandial blood glucose levels and insulin peak decreased 90%
and 40%, respectively, on rats under hyperglycemic diets supplemented with 7.5 mg/kg compared to
the unsupplemented group [54]. In fact, the ingestion of 500 mg of this mixture containing A. nodosum
and F. vesiculosus 30 min prior to the consumption of carbohydrates was shown to reduce the insulin
incremental area of the curve and an increase in insulin sensitivity in a human clinical trial [55]. Human
trials have also been carried out to evaluate the potential antiobesity effect of polyphenolic-rich extracts
of A. nodosum (100 mg/day for 8 weeks). Although the treatment did not exhibit any significant
benefits (no significant changes in C-reactive protein, antioxidant status or inflammatory cytokines),
with the exception of a modest decrease of the DNA damage in the obese group, several phlorotannin
metabolites were detected in the subjects plasma and urine, indicating that these compounds are
metabolised and absorbed into the systemic circulation [56]. These observations are in line with those
reported by Corona et al. [57] who also described the appearance of phlorotannin metabolites in urine
and plasma collected from humans after consuming a capsule of A. nodosum extract containing about
100 mg of polyphenols.
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2.3. Fucoxanthin
In opposition to red and green macroalgae, Phaophytae are characterized by the presence of
the carotenoid fucoxanthin, which is responsible for their specific coloration. Fucoxanthin is a
xanthophyll belonging to the tetraterpenoid family with a structure consisting of an unusual allenic
bond and a 5,6-monoepoxide in its molecule (Figure 3). The content of this pigment is highly
variable amongst different species, as well as dependent on extrinsic factors, with a large range being
even described within the same species. The reported levels comprise in 171 mg/kg (Fucus spiralis),
224 mg/kg (Fucus distichus), 364 mg/kg (Fucus evanescens), 172–660 mg/kg (A. nodosum), 178–468 mg/kg
(Laminaria spp.) [41,58].
Recently, this xanthophyll has earned particular attention mainly because of its promising effects
in terms of antidiabetic, anti-obesity and antioxidant activities [59,60], with claims being supported by
in vivo studies. For instance, the administration of U. pinnatifida lipids rich in fucoxanthin to male
diabetic mice were associated with insulin resistance amelioration and the reduction of blood glucose
levels [61]. Moreover, fucoxanthin isolated from the same macraolgae species was also shown to
inhibit the differentiation of 3T3-L1 preadipocytes into adipocytes by down-regulating peroxisome
proliferator-activated receptor gamma (PPARγ) [62]. Furthermore, a diet based on U. pinnatifida
fucoxanthin was capable of inducing uncoupling protein 1 (UCP1) expression in white adipose tissue
(WAT) of obese mice. When added as a supplement to rats fed with a high-fat diet, it prompted
a decrement of the mRNA expression of significant enzymes associated with lipid metabolism,
such as fatty acid synthase, acyl-CoA cholesterol acyltransferase, hepatic acetyl-CoA carboxylase,
glucose-6-phosphate dehydrogenase, hydroxy-3-methylglutaryl coenzyme A and SREBP-1C [63,64].
 
Figure 3. Structure of fucoxanthin.
2.4. Minerals
Due to their structural and physiological features, brown macroalgae are recognized for their
superior ability to accumulate minerals. Although the content of minerals like calcium, magnesium,
phosphorus, potassium, sodium and iron is usually high within the macroalgae matrix, one of
the standout aspects, comparatively to plants in general, are both their low Na/K ratios and high
iodine levels [4]. In fact, it is well accepeted that low Na/K ratios are an important aspect for good
maintenance of cardiovascular health [65]. Therefore, according to the World Health Organization
(WHO), the recommended value for this should be close to one, so consumption of food products with
this proportion or below should be considered for healthy cardiovascular purposes [66]. In fact, several
studies point to a Na/K ratio ranging between 0.3 and 1.5 in brown seaweeds, with particular interest
for Laminaria spp. (0.3–0.4) from Spain origins, wich are significantly lower than diverse food products,
such as cheddar cheese (8.7), olives (43.6), and sausages (4.9) [4,67–70]. Additionally, Phaeophyceae
seaweeds, due to the rich composition in alginates and sulphated polysaccharides coupled with the
presence of haloperoxidases in the cell walls, allow the accumulation of iodine to more than 30,000 times
over its concentration in the surrounding environment which is even higher than any edible plant [71].
The major contents of iodine were documented for L. digitata, A. nodosum, H. elogata and U. pinnatifida
exhibiting concentrations of 70, 18.2, 10.7 and 3.9 mg/100 g wet weight, respectively [72]. Moreover,
other studies also highlight the particular affinity of Laminarales to accumulate iodine, particularly
L. digitata, in which values are known to reach 9014 and 8122 mg/kg DW, in spring and autumn,
respectively [23].
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3. Use of Brown Macroalgae as Food Ingredient
Being considered as a rich and balanced source of nutrients and bioactive compounds, consumers
and food industries have a growing interest to introduce macroalgae, including Phaeophytae, into the
dietary habits of the western countries, with new products already being launched in the markets at
high rates in Europe. The usage of brown species as food ingredients has, however, to overcome huge
challenges, that go from the guarantee of enough biomass to sustain the market development, to the
gain of consistent knowledge of their physicochemical features, as well as understanding the extension
of their impact when used as ingredients in foods. This section highlights some of the developed foods
in the field of seaweed-fortified products, categorized by the respective incorporated algae species,
considering the authorized seaweeds for human consumption in France/Europe [14], and finalising
with the influence this incorporation has on the foods’ chemical, functional and structural behaviour.
3.1. Fucus vesiculosus
F. vesiculosus has found application as a functional ingredient in many different food matrices,
mostly as a source of phlorotannins and antioxidant compounds, aiming to prevent food spoilage
resultant from oxidative deterioration (Table 1). Fish and fish-derived products are one of the
main matrices where several studies with this seaweed have been conducted. In this context,
Dellarosa et al. [73] reported that neither aqueous nor 80% ethanol extracts from F. vesiculosus had
significant effects on the lipid oxidation of fish cakes enriched with omega-3 polyunsaturated fatty
acids, throughout a 28-days refrigerate storage. Nevertheless, the authors showed that no off flavour
was detected in any samples tested, with low scores of rancid odour and flavour being registered in
the sensory analysis. On the other hand, some studies conducted on cod fish muscle and/or protein
indicated that the incorporation of F. vesiculosus extracts could indeed prevent the lipid peroxidation
events and even improve some of their sensorial aspects. In fact, the effects of the incorporation of
1% and 2% of the antioxidant dietary fibre extracted from F. vesiculosus into minced horse mackerel
revealed a significant reduction of the fish mince lipid oxidation throughout the 5 months of storage
at –20 ◦C. These factors reduced the total drip after thawing and cooking the horse mackerel mince
up to 3 months of frozen storage, a fact that could be due to the water holding capacities of the fibre.
Furthermore, although the addition of 2% (but not 1%) of antioxidant dietary fibre caused changes in
the fish mince flavour compared to the control, these were actually considered positive by the sensory
panellists [74].
In a different approach, Wang et al. observed that some oligomeric phlorotannin sub-fractions
obtained by Sephadex LH-20 chromatography from an 80% ethanol extract of F. vesiculosus were able
to completely inhibit the haemoglobin-catalysed lipid oxidation in both washed cod muscle and cod
protein isolates systems, during an 8-day period of ice storage. Moreover, with a concentration of
300 mg/kg, the effectiveness of these phlorotannins sub-fractions were comparable to that of 100 mg/kg
propyl gallate, i.e., a highly effective synthetic antioxidant in muscle foods, thus evidencing the great
potential of oligomeric phlorotannins to be exploited as natural antioxidants in fish and fish-derived
products [75]. Similar results were further reported by Jónsdóttir et al. [76], who observed an
inhibition of the lipid oxidation in haemoglobin-fortified washed cod mince system after incorporating
300 mg phloroglucinol equivalents/kg of an ethyl acetate fraction obtained from an 80% ethanol
extract of F. vesiculosus. Other authors also demonstrated that the incorporation of a F. vesiculosus
phlorotannin-rich fraction (obtained with 80% ethanol and further purified with ethyl acetate) into
cod protein hydrolysates, not only prevented the lipid oxidation reactions during storage, but also
increased their final antioxidant activity [77,78] and could even improve the bitter, soap, fish oil and
rancidity taste of the final protein hydrolysates [77].
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Table 1. Selected studies reporting the effects of the incorporation of F. vesiculosus or isolates as
ingredients in different food matrices.
Functional Food Functional Ingredient Results Ref.
Fish cakes F. vesiculosus extracts:100% H2O, 80% EtOH
No off-flavours and lower rancid odour and flavour
None of the extracts had influence on lipid








↓ Lipid oxidation in both fish muscle and protein
isolates
300 mg/kg of the oligomeric phlorotannin fractions













↓ Lipid hydroperoxide and TBARS formation
during protein hydrolyzation








↓ Lipid oxidation during protein hydrolysates
freeze drying
↑ Antioxidant activity of the final protein
hydrolysates







↓ Lipid oxidation during 5 months of storage at
−20 ◦C
↓ Total dripping after thawing and cooking after up
to 3 months of frozen storage





F. vesiculosus 100% H2O,
70% acetone and 80%
EtOH extracts
↓ Oxidation products after storage
↓ Iron-lipid interactions
Acetone and EtOH extracts provided additional
lipid oxidation protection
↑ Phenolic content, radical scavenging activity and






F. vesiculosus 100% H2O,
70% acetone and 80%
EtOH extracts
↓ Lipid oxidation during storage
↑ Effectiveness for lower concentrations of EtOH
and acetone extracts
↑ Phenolic content, radical scavenging activity and







fraction from an 80%
EtOH extract, 100% H2O
↑ Lipid stability and ↓ oxidation of EPA and DHA
and subsequent secondary degradation products in
both foods—H2O extract at 2.0 g/100 g exerted






H2O, 70% acetone, and
80% EtOH extracts
Dose-dependent inhibition of lipid oxidation
exhibited by EtOH and acetone extracts
H2O extract increased peroxide formation
[82]
Pork liver pâté F. vesiculosus commercialextract
Decrease in lightness values after storage
Redness and yellowness maintained after storage
Protection against oxidation comparable to BHT
samples
↓ Total volatile compounds
[83]
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Table 1. Cont.
Functional Food Functional Ingredient Results Ref.
Pork patties F. vesiculosus 50% EtOHextracts
↓ TBARS slightly
Did not improve colour, surface discoloration or
odour attributes
No significant differences between seaweed and
control samples in sensory analysis
Milk F. vesiculosus 60% EtOHextracts
↑Milk lipid stability and shelf-life characteristics
Appearance of greenish colour and fishy taste
Overall sensory attributes were worsened
[84]
Yoghurts F. vesiculosus 60% EtOHextracts
No influence on chemical and microbiological
characteristics
↑ Yogurts lipid stability and shelf-life
characteristics






Dose-, time- and temperature-dependent
bacteriostatic and bactericidal effects against
L. monocytogenes and S. typhimurium
S. typhimurium showed higher sensitivity to the
extract
[86]
Bread F. vesiculosus powder
↑ Dough viscosity and wheat dough consistency
↓ Porosity
↑ Density, crumb firmness and green colour of crust
4% seaweed powder was considered optimal
[87]
↑: increased; ↓: decreased; BHT: 2,6-di-tert-butyl-4-methylphenol; DHA: docosahexaenoic acid; EPA: eicosapentanoic
acid; EtOAc: ethyl acetate; EtOH: ethanol; TBARS: Thiobarbituric acid reactive substances.
The fortification of food matrices with fish oils rich in n-3 long chain polyunsaturated fatty acids has
been in high demand during recent years due to increasing consumer awareness of the beneficial effects
of docosahexaenoic and eicosapentaenoic acids (DHA and EPA, respectively). However, this usually
decreases the foods’ oxidative stability, leading to the development of undesirable off-flavours and
consequent shelf-life reduction [88]. In this field, F. vesiculosus extracts were found to be highly
promising. According to Karadağ et al., [79] the introduction of 0.5 and 1 g/100 g of both F. vesiculosus
ethanol and acetone extracts into fish oil-enriched granola bars effectively improved their lipid stability,
contributing to an increase of the foods’ phenolic content, radical scavenging activity, interfacial affinity
of phenolics and eventual regeneration of tocopherol, which consequently cause the reduction of the
iron-lipid interactions as well as the lipid oxidation during the storage period. These results agree with
previous data demonstrating that addition of both ethanol and acetone F. vesiculosus extracts to granola
bars enriched with multi-layered fish oil emulsion contributed to the reduction of the formation of
primary and secondary oxidation products over the period of storage at 20 ◦C [80]. Enhancement of
lipid stability was also described in two other fish oil-fortified food matrices, namely mayonnaise and
milk, after incorporation of 1.0–2.0 g/100 g of an ethyl acetate fraction, obtained from F. vesiculosus
80% ethanol extract (rich in phenolics and carotenoids) [81], as well as in fish oil-fortified mayonnaise
added with 1.5–2.0 g/kg of both acetone and ethanol extracts of this seaweed species [82]. Interestingly,
in the particular case of fish oil-fortified mayonnaise, Hermund et al. [81] found that, despite its
lower content of phenolics and carotenoids, F. vesiculosus water extracts, at high concentrations, could
prevent the peroxides formation more effectively than the ethyl acetate fraction, much likely due to its
higher metal chelating capacity resultant from the presence of polysaccharides or other highly polar
compounds with strong metal chelating capacities. This outcome was, however, refuted in a latter
study that reported an increased peroxide formation in fish oil-enriched mayonnaise also incorporated
with F. vesiculosus water extracts [82]. The disparity found between these two works might be related
to the differences in the trace metal contents of the aqueous extracts performed in each study since the
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former had much lower iron content than the latter, which might be responsible for the induction of
lipid oxidation in the food matrix.
Recently, the fortification of canola oil with 500 ppm of F. vesiculosus water extract was reported
to reduce approximately 70% of the peroxides formation and 50% of the thiobarbituric acid reactive
substances (TBARS) value compared to the control samples, both under accelerated storage conditions
(60 ◦C). This confirms that this extract may in fact hold the potential to be exploited as a food antioxidant
agent. Indeed, under similar conditions, butylated hydroxytoluene (BHT) (at 50 ppm) only inhibited
peroxides formation and TBARS by 25% and 20%, respectively, thus showing that seaweed extracts
could be used as a potential substitute for synthetic antioxidants. In the same line, in a different food
matrix, namely low-fat pork liver pâté, the incorporation of 500 mg/kg of a commercial antioxidant
extract of F. vesiculosus was also shown to be as effective as 50 ppm of BHT at inhibiting the formation
of primary and secondary oxidation products over 180 days under storage at 4 ◦C, as well as in the
maintenance of the redness and yellowness which were lowered in the control samples [83]. On the
other hand, the fortification of pork patties with F. vesiculosus 50% ethanol extracts (250–1000 mg/kg)
showed low performances on samples oxidative stability, with modest inhibitory effects on TBARS,
compared to the control samples, but very far from that exhibited by BHT. Additionally, regardless the
good acceptability in the sensory analysis, the incorporation of these F. vesiculosus extracts failed to
improve colour, surface discoloration or odour attributes [89]. Therefore, further studies are necessary
to conclude whether extracts of this seaweed are suitable for the application as oxidation inhibitors for
the long-term storage of meat products.
Further aiming lipid stabilization in dairies, O’Sullivan et al. [84,85] tested the incorporation
of 0.25% and 0.5% (w/w) of 60% and 40% ethanol extracts from F. vesiculosus into milk and yogurt,
respectively. Indeed, both products showed a significant reduction of lipid oxidation alongside with
improvements on their shelf-life characteristics. However, neither were well accepted in the sensory
analysis, even for the lower concentrations, as the panellists reported an unpleasant green/yellowish
colour and a fishy taste.
Although the majority of the studies carried out with this seaweed species were focused on
their antioxidant activity and capacity to enhance foods’ lipid stability, other authors have tried
the incorporation of F. vesiculosus with different purposes. In a recent work, the incorporation of
F. vesiculosus fucoidans into a new functional pasteurized apple beverage was found to be useful for
controlling the growth of an undesirable microorganism, since strong bacteriostatic and bactericidal
effects against Listeria monocytogenes and Salmonella typhimuium were observed in a dose-, time- and
temperature-dependent manner [86]. On the other hand, Arufe et al. [87] studied the influence of
the addition of different concentrations (2–8% w/w) of F. vesiculosus seaweed powder into wheat flour
to the final rheological properties of the dough, such as the density and crumb texture. The authors
found that for concentrations above 4%, the addition of F. vesiculosus powder caused the increase of the
elongational dough viscosity and consequent decrease of its porosity, as well as the increase in the
bread density, crumb firmness and appearance of a green colour. Therefore, 4% of F. vesiculosus powder
would be the maximum amount that could be added to the bread without impairing its properties.
3.2. Himanthalia elongata
H. elongata has also been object of many studies comprising the development of seaweed-enriched
foods, which, in addition to the improvement stability and/or shelf-life extension, also aimed to
provide enhanced nutritional properties to the foods. In this field, many works reporting H. elongata
fortified-foods were carried out on meat and meat-based products (Table 2). One of the most exploited
attributes of this seaweed species is perhaps its wealthy mineral composition, which makes H. elongata
a good candidate to be used as a salt replacer, contributing to the reduction of salt consumption and
related health complications typical of western high-NaCl diets. It also increases the consumption of
other elements, such as calcium potassium or iodine, which are usually lacking or below recommended
levels in regular diets [4].
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Table 2. Selected studies reporting the effects of the incorporation of H. elongata or isolates as ingredients
in different food matrices.
Functional Food Functional Ingredient Results Ref.
Poultry steaks 3% dry matter H. elongata
↑ Purge loss slightly
↓ Cooking loss
↑ Levels of total viable counts, lactic acid bacteria,
tyramine and spermidine
No important changes observed during chilled storage




2.5% and 5% dry matter
H. elongata
↑Water and fat binding properties
↑ Hardness and chewiness of cooked products






↑ Content of n-3 PUFA
↓ n-6/n-3 PUFA ratio
↓ Thrombogenic index
↑ Concentrations of K, Ca, Mg and Mn
[91]
Pork meat batter 3.4% powder H. elongata
↑Water/oil retention capacity, hardness and elastic
modulus.
Thermal denaturation of protein fraction was
prevented by seaweed alginates
Nutritional enhancement
[92]
Restructured meat 5% powder H. elongata
Effects in rats:
↓ Total cholesterol
↑ CYP7A1, GPx, SOD, GR expression
↓ CAT expression
[93]
Restructured meat 5% powder H. elongata
↓ HSL and FAS and ↑ ACC (p < 0.05) expression on
rats fed with seaweed fortified meat comparing with
rats under hypercholesterolemic diet
[94]
Frankfurters 3.3% H. elongata powder
↑ Cooking loss
↓ Emulsion stability
Combination of ingredients provided healthier meat
products with lower fat and salt contents
Worsened physicochemical and sensory characteristics
[95]
Beef patties 10–40% (w/w) H. elongata
↓ Cooking loss
↑ Tenderness, dietary fibre levels, TPC and antioxidant
activity
↓Microbiological counts and lipid oxidation
Patties with 40% seaweed had the highest overall
acceptability
[96]
Bread sticks 2.93–17.07% H. elongatapowder
Highest concentration had higher phycochemical
constituents, acceptable edible texture and overall
colour
[97]
Bread 8% (w/w)H. elongata
↑ TPC
↑ Antioxidant activity in DPPH•, ORAC and TEAC [98]
Yoghurt and Quark 0.25–1% dehydratedH. elongata
Alterations in all yoghurt attributes except for buttery
odour, and acid and salty flavours
Alterations in all quark attributes except yogurt odour,
acid flavour and sweet flavour.
Sensory characteristics worsened
[99]
↑: increased; ↓: decreased; ACC: acetyl CoA carboxylase; CAT: Catalase; CYP7A1: liver cytochrome P450 7A1; DPPH•:
2,2-diphenyl-1-picrylhydrazyl radical; FAS: fatty acid synthase; GPx: Glutathione peroxidase; GR: Glutathione
reductase; HSL: hormone-sensitive lipase; ORAC: oxygen radical absorbance capacity; PUFA: polyunsaturated fatty
acids; SOD: superoxide dismutase; TEAC: trolox equivalent antioxidant capacity; TPC: Total phenolic content.
Many of these studies were carried out by the group of Jiménez-Colmenero et al., who have
developed several meat products in which the content of sodium chloride was partially replaced by
different species of edible seaweeds, including H. elongata. Among the seaweed-containing formulations,
frankfurters, restructured meats and meat emulsions were shown to have at least 50 to 75% less NaCl
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than their conventional recipes [1,90,91,95,100,101]. Apart from the NaCl replacement, the fortification
of frankfurters and meat emulsions with H. elongata also contributed to the increase of K content and
subsequent reduction of the Na/K ratio from 3 to values below 1 (i.e., close to those recommended by
WHO for maintaining a healthy cardiovascular condition). Additionally, the Ca, Mg and Mn contents
in these two meat products increased to >1000%, >300% and >700%, respectively, compared with the
conventional formulas, alongside with their water and fat binding properties [1,101]. Other effects
resultant from H. elongata fortification in these matrices included the reduced cooking loss and increase
in the Kramer shear force in restructured poultry meat [90]; increased water and oil retention in pork
meat batter [92]; increased dietary fibre content in frankfurters [101]; and increased phenolic content
and antioxidant activity in meat emulsions [91]. Overall, these products were well-accepted in the
sensory analysis, with exception of frankfurters that were reported unpleasant mainly due to the
increase of the dryness feeling and seaweed-like taste.
Cox and Abu-Ghannam [96] also reported that H. elongata-fortified beef patties (10–40% w/w) were
very well accepted in the sensory analysis, particularly those with 40% of seaweed, getting even better
scores than the control samples. This was mainly due to the improvements on the samples’ texture and
overall mouthfeel, which resulted from the decrease in the cooking loss (associated to the incremented
fibre content) and the increase in tenderness for more than 50%. Furthermore, a significant enhancement
of the phenolic content and antioxidant activity (in a dose-dependent manner), as well as a lowered
microbiological count and lipid oxidation before the chilling stage and after 30 days of storage, were
observed in all patties containing seaweed. In fact, at the end of the experiment, the samples containing
above 20% of H. elongata, showed no bacterial growth at all, as well as considerably low levels of the
lipid oxidation marker.
In vivo studies on rat models revealed that the introduction of restructured pork meat enriched
with 5% H. elongata (RPS) in the animals’ hypercholesterolemic diet significantly lowered the
serum cholesterol levels that were augmented in the group under a non-RPS supplemented
hypercholesterolemic diet. Moreover, a significant increase in SOD and GPx, alongside with a decrease
of glutathione reductase (GR) expressions, were observed in both groups under hypercholesterolemic
and regular RPS-supplemented diets, although increased glutathione reductase activity was also
verified. Interestingly, the combined cholesterol and seaweed diet predisposed an increase in the
expression of GR, SOD and liver cytochrome P450 7A1 (CYP7A1), i.e., a gene that encodes for
the enzyme responsible for the elimination of cholesterol through the production of bile acids,
but a decrease in the expression of CAT and GPx, suggesting a possible blocking effect of the
hypercholesterolemic agent induced by seaweed incorporation [93]. In a similar study, rats under
RPS-supplemented hypercholesterolemic diets, not only exhibited lower plasma cholesterol levels
but also lower liver apoptosis markers, namely cellular cycle DNA, caspase-3 and cytochrome
c [102]. Supporting these results, González-Torres et al. [94] confirmed that the administration of
H. elongata-fortified restructured pork meat (at 5%) to rats under cholesterol-rich diets, partially blocked
the hypercholesterolemic effect of the dietary pattern while changing the lipogenic/lipolytic enzyme
expression (decreasing hormone-sensitive lipase and fatty acid synthase while increasing acetyl CoA
carboxylase expressions compared with subjects under hypercholesterolemic diet) and reducing the
wasting effect of hypercholesterolemia on adipose tissue in rats.
Apart from meat products, H. elongata powder has also been used to enrich breadsticks in order to
enhance their nutritional properties. From the 10 formulations tested (with seaweed concentrations of
2.63 to 17.07% w/w), the highest was reported to have the most significant influence on the chemical
properties of breadsticks. Furthermore, this sample also had higher levels of total dietary fibre, while the
total phenolic content and antiradical activity were maximized at 138.25 mg GAE/100 g dry basis and
61.01%, respectively, maintaining an acceptable edible texture and colour of the samples. Therefore,
since no significant difference was seen between the control and seaweed enriched breadsticks in
terms of sensory analysis, this product could have great acceptability, especially to non-seaweed
consumers [97]. The augmented phenolic content as well as the enhanced antioxidant activity were
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also described on functional breads developed with 8% of H. elongata flour [98]. On the other hand,
an attempt to supplement yogurt and quark with dehydrated H. elongata (0.25–1% w/w) turned out
to negatively affect almost all the sensory parameters analysed, which makes this seaweed not very
suitable for application in these two dairies, at least in these conditions [99].
3.3. Undaria pinnatifida
Similar to H. elongata, the applications of U. pinnatifida as functional ingredients have mostly been
reported in meat and meat-derived products (Table 3). For instance, the incorporation of U. pinnatifida
(1–4%) into pork beef patties increased their ash content as well as their juiciness due to the lower
cooking losses compared to the control [103]. In a similar approach, the reformulation of low-salt (0.5%)
and low-fat (<10%) beef patties by the addition of 3% of U. pinnatifida and partial or total replacement
of pork backfat with olive oil-in-water emulsion, significantly affected the frozen storage characteristics
of the products. This presented enhancements in terms of technological, sensory and nutritional
properties, as well as improvements in their physiological benefits. These reformulated patties
demonstrated less thawing and cooking losses, and were texturally softer than the samples without
seaweed, most likely due to the microstructural changes caused by the formation of alginate chains.
Table 3. Selected studies reporting the effects of the incorporation of U. pinnatifida or isolates as
ingredients in different food matrices.
Functional Food Functional Ingredient Results Ref.
Beef patties 3% dry matterU. pinnatifida
↑ Binding properties and cooking retention values of, fat,
fatty acids and ash
Replacement of animal fat with olive-in-water emulsion
and/or seaweed was reportedly healthier.
↓ Thawing and↑ softer texture
Changes on the microstructure due to formation of
alginate chains
Overall acceptable products and fit for consumption
[104,105]
Chicken breast 200 mg/kg U. pinnatifida
↑ Redness and yellowness
↓ Lipid oxidation in chilling storage and after cooking




2.5% and 5% dry matter
U. pinnatifida
↑Water and fat binding properties
↑ Hardness and chewiness of cooked products






↑ Content of n-3 PUFA
↓ n-6/n-3 PUFA ratio








10% U. pinnatifida was the most acceptable
↑ Amino acid, fatty acid profile and nutritional value of
the product
Fucoxanthin was not affected by pasta making and
cooking step
[107]
Yoghurt and Quark 0.25–1% dehydratedU. pinnatifida
↑ Seaweed flavour with ↓ flavour quality for 0.5% seaweed
Alterations in all yoghurt attributes except for buttery
odour, and acid and salty flavours
Alterations in all quark attributes except yogurt odour,
and acid and sweet flavours.
Sensory characteristics worsened
[99]
Bread 8% (w:w)U. pinnatifida:wheat flour
↑ TPC,
↑ Antioxidant activity in DPPH•, ORAC and TEAC [98]
↑: increased; ↓: decreased; DPPH•: 2,2-diphenyl-1-picrylhydrazyl radical; ORAC: oxygen radical absorbance
capacity; PUFA: polyunsaturated fatty acids; TEAC: trolox equivalent antioxidant capacity; TPC: Total
phenolic content.
Moreover, the incorporation of U. pinnatifida in the patties’ formulation did not hamper their lipid
oxidation or microbiological counts, and although the content of Na and K were twice as high as the
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control samples, the Na/K ratio were still close to 1. Likewise, magnesium and calcium levels were
higher in seaweed-fortified samples, corresponding three and six-fold, respectively, to those of the
conventional recipe. Interestingly, although a different flavour was pointed out in the sensory analysis,
panellists generally described the reformulated patties to be more pleasant and palatable than the
control [104]. This reformulation with U. pinnatifida also resulted in significant improvements in several
parameters on cooked patties, namely in the binding properties and retention values of moisture,
ash and particularly fat and fatty acids, the latter parameter being usually the most affected by the
cooking process. This means that the incorporation of this seaweed in the patties greatly interfere with
the fat and energy content of these food matrices, as well as their fatty acids profile [105]. Identical
results were reported on low-salt gel/emulsion meat systems added with 2.5–5% of U. pinnatifida,
which exhibited better firmness and chewiness due to improvements of the water and fat-biding
properties [1]. The incorporation of 5.6% of this species in such systems was also reported to contribute
to the increment of the products’ phenolic content and antioxidant properties, as well as to improve
their mineral profile, increasing the K, Mg, Ca and Mn contents while decreasing the Na content, thus
consequently reducing the Na/K ratio from 3.5 in the control samples, to approximately 1. Contrastingly,
despite the potential beneficial health effects, increasing the algae was considered a non-satisfactory
strategy to achieve healthier lipid meat formulations, since it could affect the food’s sensory properties
and their lipid content was very low [91]. In turn, Sasaki et al. [106] observed that the addition of
200 mg/kg fucoxanthin extract from U. pinnatifida to raw ground chicken breast meat did not prevent
the lipid oxidation during their freeze storage period (1 or 6 days). However, it did inhibit TBARS
formation of cooked samples stored under the same conditions and improved the products’ overall
appearance, indicating that fucoxanthin could prevent the oxidation in these products and effectively
extend their shelf-life.
Apart from the nutritional stability of the foods, the incorporation of U. pinnatifida into foods
have also been demonstrated to have great beneficial effects in distinct parameters with impact in the
cardiovascular system. According to Moreira et al. [108], the administration of U. pinnatifida-fortified
restructured pork meat to Wistar rats under a cholesterol-rich diet, not only caused the lowering
of the plasma redox index by increasing total and reduced glutathione together with the GR
and SOD activity, but also contributed to the decrease of the caspase-3 activity and therefore,
hypercholesterolemic-induced apoptotic response of their hepatocytes [102].
Only few studies have focused the use of U. pinnatifida in products other than meat. Nevertheless,
Prabhasankar et al. [107] reported significantly higher phenolic content and antioxidant activity in the
aqueous extracts of uncooked pasta containing different concentrations of U. pinnatifida (5–30% w/w)
compared to the controls. Although the cooking process caused a loss in these two parameters,
they were still significantly higher on seaweed-added pasta compared to the values observed in the
conventional pasta. Importantly, the heat processes involved in pasta preparation and cooking did
not damaged fucoxanthin. The seaweed incorporation also contributed to the improvement of the
pasta amino acid and fatty acid profiles, as well as the increase of bioactive compounds. The pasta
incorporated with 10% seaweed, which demonstrated the highest radical scavenging activities, was
also the most well accepted in the sensory analysis. The augmented phenolic content and antioxidant
activity were also described on functional breads developed with 8% of U. pinnatifida flour, although
other seaweeds, such as H. elongata exhibited better results [98].
The incorporation of U. pinnatifida, up to 15% in cottage cheeses, was reported to cause a
dose-dependent increment of their Ca, Fe and Mg. However, the textural quality was best for cheeses
containing 9% of seaweed [109]. On the other hand, Nuñez and Picon [99] found that, among
the 5 different seaweeds used to incorporate in yogurts and quark cheese, dehydrated U. pinnatifida at
0.5% (w/w) was the formulation that showed the highest seaweed flavour and the lowest flavour quality
in both dairies, worsening almost all of their sensory aspects and making this seaweed unattractive
for application in such dairies. To overcome this disadvantage, it would be interesting to explore
alternative approaches, such as the application of seaweed in flavoured dairies, the application of
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algae extracts instead of whole algae or the encapsulation of algae or extracts thereof, in order to assess
whether these or other strategies could mask the negative impacts that U. pinnatifida has on the sensory
aspects of these dairies.
3.4. Ascophyllum Nodosum
Although A. nodosum has not been much studied as a functional ingredient for incorporation
in foods, some authors have reported promising results in this field (Table 4). For instance,
Dierick et al. [110] found that, feeding pigs with 20 g of A. nodosum/kg of feed over 21 days caused the
levels of iodine in muscle and internal organs to increase 2.7 and 6.8 times, respectively, compared
to the pigs fed under a regular diet. This could be a viable approach to increase the daily intake of
this mineral which is usually deficient in several European countries [4]. Alternatively, A. nodosum
extracts applied to low-fat pork liver pâtés (500 mg/kg) was described to increase the protein content by
approximately 4% compared to the control samples, without interfering with the chemical composition
or microbial characteristics of the samples, throughout 180 days of storage at 4 ◦C. Furthermore, at the
end of the experiment, the oxidative parameters on seaweed-added samples were comparable to those
of BHT-added samples, both showing a similar degree of protection against oxidation as well as a
significant reduction of volatile compounds after storage [83].
Table 4. Selected studies reporting the effects of the incorporation of A. nodosum or isolates as ingredients
in different food matrices.
Functional Food Functional Ingredient Results Ref.
Pork 20 g A. nodosum /kg feed ↑ I content in piglet’s muscles and internal organs [110]
Pork liver paté A. nodosum extract at500 mg/kg
↑ Protein content
↑ Redness and yellowness after storage
Degree of protection against oxidation
comparable to BHT samples
↓ Total volatile compounds
[83]
Milk
A. nodosum (100% H2O
and 80% EtOH) extracts
(0.25 and 0.5 (w/w))
↓ TBARS formation
↑ Radical scavenging and ferrous-ion-chelating
activities before and after digestion
Supplementation on Caco-2 cells did not affect
cellular antioxidant status
EtOH extracts had greenish colour and overall
sensory attributes were worsened
[84]
Yoghurts
A. nodosum (100% H2O
and 80% EtOH) extracts
(0.25 and 0.5 (w/w))
No influence on chemical characteristics
Yoghurts had antioxidant activity before and
after digestion
Supplementation on Caco-2 cells did not affect
cellular antioxidant status
Overall sensory attributes were worsened
[85]
Bread 1–4% A. nodosum per 400g loaf
All samples sensorially accepted
↓ Energy intake after 4 h
Glucose and cholesterol blood levels not affected
[111]
↑: increased; ↓: decreased; BHT: butylated hydroxytoluene; EtOH: ethanol; TBARS: thiobarbituric acid
reactive substances.
On another perspective, A. nodosum extracts have proven to be effective in the inhibition of lipid
oxidation and the improvement of antioxidant activity in dairies. Indeed, the incorporation of either
aqueous or 80% ethanol extracts (0.25% and 0.5%) of this species in milk significantly decreased the
TBARS formation and increased the radical scavenging and ferrous-ion-chelating activities either
before or after in vitro digestion. However, this did not affect the cellular antioxidant activity or protect
against DNA damage in human colon adenocarcinoma Caco-2 cells, suggesting that the fortification
with A. nodosum extracts could improve certain milk qualities and shelf-life characteristics, but not
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provide significant biological activity. Interestingly, despite fortified-milk with aqueous extract had
good acceptability in the sensory analysis, those formulated with 80% ethanol extract was pointed
to have a fishy taste and off flavour, thus having low acceptability by the panellists. Nevertheless,
this issue could potentially be addressed by using food flavourings or through micro-encapsulation
to camouflage the undesirable flavours [84]. A new set of studies on fortified yogurts with the same
A. nodosum extracts also revealed the increment of the radical scavenging activity before and after
in vitro digestion, which was shown not to affect parameters, such as the product’s acidity, microbiology
or whey separation. However, as previously stated, the biological activity on cellular models was
absent and the sensorial analysis was positive for A. nodosum aqueous extracts but not for the 80%
ethanol extracts [85]. On another approach, Hall et al. [111] reported that the addition of A. nodosum
(1–4%) in bread significantly reduced the energy intake after a test meal in a single blind cross trial.
Moreover, the same was verified after 24 h of seaweed-enriched bread consumption and no differences
were observed in blood glucose and cholesterol levels. The authors highlighted, however, the need of
a long-term interventional study to establish the real potential of A. nodosum-enriched bread energy
intake, in addition to the metabolism of glucose and lipids.
3.5. Laminaria sp.
Laminaria is one of the most economically important algae genus since it comprises 31 species,
being most widely exploited worldwide as raw materials for alginates production [112]. On the other
hand, the studies focusing the use of these seaweeds as functional ingredients in foods are quite limited
(Table 5). Nevertheless, due to their high content in iodine, some authors have investigated the use of
Laminaria sp. as animal feed aiming to increase the iodine content in their muscle before slaughter.
Indeed, the work carried out by Schmid et al. [113] demonstrated that feeding chars (Salvelinus sp.)
with L. digitata-fortified fish meal (0.8%) over nine months, contributed to an increase of their total
iodine content in approximately four times the levels found in the control fishes. Similar observations
were described in other species, such as gilthead seabream (Sparus aurata) and rainbow trout, which
revealed an increased iodine content in their fillets after L. digitata was introduced in their meals as
well [114,115]. An identical experiment carried out with pigs also revealed that the supplementation of
L. digitata in the animal’s feed over 3 months resulted in an accumulation of 45% more I in muscle tissue
and up to 213% in other internal organs compared to the pigs under a normal diet [116]. In a different
approach, four group of pigs were assigned to different diets 35 days pre-slaughter in order to test
whether alterations of their diets would affect bacterial count, lipid peroxidation and total antioxidant
capacity of fresh meat during storage. Interestingly, the meat excised from the group fed with the
Laminaria sp.-supplemented diet exhibited the best overall results, showing the highest antioxidant
activity, the lowest lipid peroxidation and microbial counts, suggesting that feeding the animals with
seaweeds might have a significant impact on the quality and shelf-life of their meat [117].
Alternatively, Moroney et al. [118] tested whether the incorporation of different concentrations
(0.01%, 0.1% and 0.5% w/w) of L. digitata extract, containing laminaran and fucoidan in chopped pork
patties would affect their quality and shelf-life period. The results showed that the surface redness of
fortified raw patties, upon 14 days under modified atmosphere packages at 4 ◦C, decreased compared
to the control samples, which led to a slight decrease of their quality parameters. Fortification with the
extract at 0.5% caused a notable reduction of lipid oxidation in the cooked samples, but the formulated
product was not very well accepted in the sensory analysis. A similar work was later conducted
with fresh and cooked pork homogenates and commercial horse heart oxymyoglobin incorporated
with L. digitata-extracted fucoidan, laminaran and a mixture of both. Although fucoidan showed the
strongest radical scavenging activity, cooking and digestion of the samples caused a significant decrease
of the antioxidant potential in the samples added with this fibre, which could possibly be attributed to
its more acidic nature. Interestingly, despite this, polysaccharide was found to reduce lipid oxidation
and also was responsible for catalysing the oxidation of oxymyoglobin. Notably, when the digested
samples containing the mixture of laminaran and fucoidan were evaluated for their bioaccessibility in
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a Caco-2 cell model, a decrease in radical scavenging activity of 44.2% and 36.6% was observed after 4
and 20 h of incubation, indicating a theoretical uptake of these polysaccharides. These results highlight
the potential use of seaweed extracts as functional ingredients in pork with the advantage of possibly
improving the human antioxidant defences [42].
Table 5. Selected studies reporting the effects of the incorporation of Laminaria sp. or isolates as
ingredients in different food matrices.
Functional Food Functional Ingredient Results Ref.
Chars Laminaria digitata(0.8% in fish meal) ↑ 4 times the I content in fish muscle [113]
Gilthead seabream Laminaria digitata (10% infish meal) ↑ I content in fish fillets [114]
Rainbow trout Laminaria digitata(0.65% in fish meal) ↑ I content in fish fillets [115]
Pork Laminaria digitata(1.16 and 1.86 g/kg feed)
↑ I content in pigs’ muscles by 45%
and internal organs by 213% [116]






0.01%, 0.1% and 0.5%
(w/w) of 9.3% laminarin
and 7.8% fucoidan from
L. digitata
↑ Lipid antioxidant activity for L/F
extract (0.5%)
No effect in colour, lipid oxidation,
texture or sensorial acceptance
when adding L/F extract
[118]
Pork homogenates
3 and 6 mg/mL of
laminaran, fucoidan and
both from L. digitata
L had no antioxidant activity
The L/F extract had higher
antioxidant activity than F, after
cooking and post digestion of
minced pork.
DPPH• antioxidant activity lower in
Caco-2 cell model with L/F extracts
Seaweed extracts containing F had
higher antioxidant activity of the
functional cooked meat products.
[42]
Sausages 1–4% L. japonica powder
No changes in moisture, protein,
and fat contents
↓ Lightness and redness values
↓ Cooking loss
↑ Emulsion stability, hardness,
gumminess, and chewiness






(replacement od 2.25 g of
pork/chicken for an equal
amount of seaweed)
↓ Increased in postprandial glucose
blood levels;
↓ TC and LDL-C
[120]
Yoghurt Laminaria spp. (0.2% or0.5% w/w) ↑ I, Ca, K, Na, Mg, and Fe [121]
↑: increased; ↓: decreased; DPPH•: 2,2-diphenyl-1-picrylhydrazyl radical; F: fucoidan; L: Laminarin; LDL-C: low
density lipoprotein; L/F: Laminarin and Fucoidan; TC: total cholesterol.
In addition to L. digitata, other species of this genus have been reported for their positive effects
as functional ingredients in foods. This is the case of Laminaria japonica, which was incorporated
(1–4% w/w) in breakfast sausages contributing to a significant dose-dependent increase of their ash
content, as well as to the improvements on the emulsion stability and textural parameters such
as hardness, gumminess and chewiness. Moreover, the seaweed addition lowered samples’ pH,
lightness, redness and yellowness, and lowered cooking and water losses, particularly in samples
added with 4%. Nevertheless, despite the higher benefits that were observed for higher seaweed
59
Antioxidants 2019, 8, 365
powder concentrations, the sensory evaluations determined that the 1% L. japonica sausage had the
highest overall acceptability [119]. In addition, the incorporation of L. japonica in chicken or pork patties
was inclusively demonstrated to have positive effects in the post-plasma glucose and lipids profiles in
borderline-hyperlipidaemic adults voluntaries. The consumption of fortified-patties with 2.25 g of this
species not only lowered the increased post-prandial serum glucose levels compared to the control
group, but also the total cholesterol and low density lipoprotein concentrations, while maintaining the
same levels of high density lipoprotein [120].
In an alternative to meat products, a new probiotic yogurt containing different concentrations
of Laminaria sp. was developed with the aim of increasing its iodine content. Indeed, contrarily to
the conventional yogurt, the fortified formulation contained not only high levels of I (average of
570 μg I/100 g), but also considerably incremented amounts of Ca, K, Na, Mg, and Fe [121], overall
improving their mineral profile.
4. Future Considerations
Previous studies focusing brown seaweed-fortified products have demonstrated that in general,
macroalgae can improve the nutritional value of the food products, either by incrementing levels
of dietary fibres and/or minerals or their lipidic profiles. Thus, fortified foods with seaweed and/or
seaweed extracts come out as possible nutritional alternatives to the original formulations. Moreover,
the reported information seems to be solid regarding the fact that the fortification of foods with brown
seaweeds and/or their extracts in general have positive impacts on both their oxidative stability and
microbial inhibition effects. However, discrepant results are reported regarding the technological
properties of the fortified products, namely on the stability of the food’s structure. Hence, there is
the need to guarantee the compatibility of seaweeds and the overall food matrix, which is not only
a result of the seaweed itself, but of the combination of the seaweed with the proper ingredients.
In addition, the incorporation of seaweeds in foods frequently comprises their sensorial attributes
due to colour changes and the appearance of off-flavours. Nevertheless, some strategies such as
fermentation, enzymatic processing or encapsulation of seaweeds or their extracts have already shown
interesting effects at cloaking seaweeds’ negative sensorial characteristics while maintaining their
nutritional properties and stability of bioactive components [122–124]. Nevertheless, further research
in this field is necessary to understand if the cost-benefit of the application of such techniques is viable
on a larger scale.
Being a crucial factor in nutrition, the bioavailability of relevant nutrients and/or phytochemicals
is another critical issue that will require much attention in the following years. This is highly dependent
on food components and on individual gastrointestinal conditions. Alginic acid, fucoidans and
laminarans are considered dietary fibres, meaning that they may be fermented by colon microflora,
therefore surviving the majority of the digestion [125]. The rest of the compounds seem, however,
to be absorbed at earlier stages. For instance, in vitro studies suggested that dietary fucoxanthin is
metabolized to fucoxanthinol and amarouciaxanthin A [126,127]. In fact, daily administered dietary
fucoxanthin (L. japonica and U. pinnatifida origin) was shown to accumulate as amarouciaxanthin A
and fucoxanthinol in several mice tissues [128,129]. In humans, however, the plasma concentrations of
fucoxanthin metabolites before and after 1-week dietary interventions with U. pinnatifida were shown
to be either low (fucoxanthinol) or non-existent (fucoxanthin and amarouciaxanthin A), although a
higher subject group would be required in order to confirm these results [130].
As for phlorotannins, to the authors knowledge, only one bioavailability study was made using
this particular compound from any of the seaweeds of interest to this review. Recently, in a work
developed by Corona et al. (2016), a food-grade phlorotannin extract from A. nodosum was submitted
to in vitro and in vivo assays, the latter involving the oral administration of a 100 mg capsule with
the same extract [57]. The in vitro digestion and fermentation allowed for the identification of
11 compounds including hydroxytrifuhalol A, a C-O-C dimer of phloroglucinol, diphlorethol/difucol
and 7-hydroxyeckol, some of which were also detected in the urine and plasma of human participants,
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thus confirming their absorption into the blood circulation. Moreover, although brown seaweeds
are considered a great source of iodine, there is limited information regarding its bioavailability.
Domínguez-Gonzaléz et al. [131] found out that despite the high in vitro bioaccessibility of iodine
from U. pinnatifida and S. japonica, only a small percentage was bioavailable using dialysis membranes
and an even lower in a biological system model consisting of two major cell types present in the
intestine. Nevertheless, more favourable results were demonstrated when iodine-insufficient women
were supplemented with encapsulated A. nodosum, since one third of the ingested iodine was found to
be bioavailable [132].
Hence, it is clear that, not only is there a lack of information regarding the bioavailability of
nutrients/phycochemicals in seaweeds and seaweeds-fortified foods in general, but also the relationship
between seaweed-fortified products and their potential functionality remains almost unexploited.
Indeed, evidences of biological effects of seaweeds-fortified products were barely proven in cellular
models and even more rarely in in vivo trials and hence, must still be made to assure the conformity of
the results. According to Plaza et al. [133], the principal guideline to follow in the design of a new
functional food is to increase as much as possible the benefit/risk ratio, by increasing the benefit to the
maximum and reducing the risk to the minimum, considering toxicity studies, for example. Increasing
the benefit implies looking for a physiological wide effect, assuring the existing bioavailability and that
the mentioned bioavailability is going to be kept along all the useful life of the food. Therefore, since
the in vivo biological activity of phycochemicals depends on their bioavailability, in the future, it would
be interesting to further access how important properties claimed for brown algae can transpose to
human beings through seaweed fortified products. In order to reduce the risk, it is necessary to carry
out toxicity studies, to use the functional ingredient in minimal effective doses and to use as functional
ingredients, the products naturally found in foods or natural sources.
5. Conclusions
In conclusion, seaweeds are very valuable food sources with reportedly high nutritional value and
high in bioactive compounds. In this regard, brown macroalgae are particularly known to accumulate
specific metabolites, such as the polysaccharides alginic acids, laminarans and fucoidans, the phenolic
compounds phlorotannins, the carotenoid fucoxanthin and exceptionally high levels of iodine with
simultaneous low Na/K ratios, which overall confer them great potential to be used as functional
ingredients. Thus far, most of the recent studies’ main objectives focusing on testing the incorporation
of macroalgae in foods, namely those considered as safe for consumption in Europe i.e., F. vesiculosus,
F. serratus, H. elongata, U. pinnatifida, A. nodosum, L. digitata, L. saccharina, L. japonica and A. esculenta,
were the increment of the product’s shelf-life and the sensory properties culminating in the potential
commercialization. From an economic point of view, this is rather important, but in terms of the
benefits they could bring to the consumer, there is a lot of work to be done. Therefore, in order
to effectively exploit this very promising raw material, the focus should be on their bioavailability,
especially in humans.
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Abstract: Two thirds of the world is covered by oceans, whose upper layer is inhabited by algae.
This means that there is a large extension to obtain these photoautotrophic organisms. Algae have
undergone a boom in recent years, with consequent discoveries and advances in this field. Algae
are not only of high ecological value but also of great economic importance. Possible applications
of algae are very diverse and include anti-biofilm activity, production of biofuels, bioremediation,
as fertilizer, as fish feed, as food or food ingredients, in pharmacology (since they show antioxidant or
contraceptive activities), in cosmeceutical formulation, and in such other applications as filters or for
obtaining minerals. In this context, algae as food can be of help to maintain or even improve human
health, and there is a growing interest in new products called functional foods, which can promote
such a healthy state. Therefore, in this search, one of the main areas of research is the extraction and
characterization of new natural ingredients with biological activity (e.g., prebiotic and antioxidant)
that can contribute to consumers’ well-being. The present review shows the results of a bibliographic
survey on the chemical composition of macroalgae, together with a critical discussion about their
potential as natural sources of new functional ingredients.
Keywords: seaweeds; macroalgae; invasive species; prebiotics; antioxidants; functional foods
1. Macroalgae Classification
We live on a planet of which ~72% of the surface is water. Since all the necessary elements for life
are found in seawater, every form of life emerged from that immense original matrix. These elements
and many others, since all the elements of the periodic table are in the sea, have the advantage of being
present in quantities that are generally stable and constant along the marine surface, contrary to what
happens on earth [1]. However, traces of our marine origins can also be found on earth, since there are
similarities between the composition and some properties of the sea and those of biological fluids [2–4].
The oceans contain and give life to approximately 500,000 species, which means that almost
three quarters of all known species inhabit seawater. Among them are algae which, although the
vast majority inhabit salt water, can also survive in freshwater. These are very peculiar living beings,
to whom the development of life on our planet is due, since the algae were pioneers of photosynthesis,
thanks to the evolution of chlorophyll function 3200 million years ago [1,5]. Photosynthesis probably
began in some blue-green prokaryotic microorganisms that were formerly considered algae, and that
currently belong to the Phylum Cyanobacteria, which is included in the Monera Kingdom [6].
Antioxidants 2019, 8, 406; doi:10.3390/antiox8090406 www.mdpi.com/journal/antioxidants69
Antioxidants 2019, 8, 406
More than 30,000 species of algae have been described, and their scientific study is called phycology.
According to the current definition of algae, the blue-green variety is not considered algae, as they are
prokaryotic organisms, and only eukaryotic organisms belong to this category (either unicellular, such as
microalgae phytoplankton, or multicellular, such as macroalgae) [3]. The taxonomic classification of algae is
complex due to the number of existing varieties and the many applicable classification criteria. They are
a polyphyletic group, which means that they belong to different kin groups. Therefore, the classification is
not well defined, and may vary according to the authors, but they are currently included in the Protista
kingdom, with some exceptions of macroalgae belonging to in the Plantae kingdom [7,8].
The microalgae, Protista microorganisms that are classed as phytoplankton, are important in nature
because they represent the first trophic level in the food chain, serving as nutrients to thousands of
marine species. They are also essential in chlorophyll function, since they are primary producers,
being responsible for 30%–50% of the oxygen contained in the atmosphere [4].
Macroalgae are also a very varied group, with sizes ranging from a few centimeters to specimens
that can reach 100 m in length. Approximately 15,000 species of this group have been described [9].
They are also autotrophic and photosynthetic beings, so their habitat is limited to a certain depth,
which is usually a maximum of 60 m, always within the intertidal zone, and its growth is usually
vertical, looking for sunlight [10,11]. The differences between them and terrestrial plants are that they
do not present conductive tissues, but rather they adsorb nutrients throughout their whole surface.
They also lack roots, though some present rhizoids or basal discs that allow them to adhere to rocks as
a method of restraint, but not to nourish themselves. They form large underwater meadows and are
generators of ecosystems in which many different species of bacteria, corals, mollusks, fish, and other
marine creatures accumulate and coexist [7,12–14].
Much of the literature agrees that macroalgae can be divided into 3 large groups: The Chlorophytas,
commonly known as green algae, the Rhodophytas or red algae, both included in the Plantae kingdom;
and the Ochrophytas, mostly classified in the Phaeophyceae class. These are also called brown seaweed
and belong to the Protista kingdom, as well as the microalgae kingdom. The classification of this
algae macrogroup was made taking into account the pigment that composes it, and through which
it manages to perform photosynthesis to carry out autotrophic feeding [13]. There are authors that
include some green macroalgae in another differentiated group and at a taxonomic level equivalent
to Chlorophytas, which are responsible for life expanding beyond the oceans, and are a precursor of
terrestrial plants [15]. Table 1 summarizes the phylogeny of these four large groups of macroalgae.
The mentioned differences between algae pigments are collected in Table 2.
Table 1. Phylogenetic summary of the most common macroalgae.
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Table 2. Pigment content of the 3 common groups of macroalgae. Bold pigments represent the
predominant ones in each group.
Pigment Class Green Algae Brown Algae Red Algae Reference
Chlorophylls Chlorophyll a and b,and derivatives
Chlorophylls b and c,
and derivatives
Chlorophylls a and d,
and derivatives [16]
Carotenoids β-carotene, xanthophylls Fucoxanthin andxanthophylls, β-carotene Xanthophylls [13,16,17]
Phycobiliproteins - - Phycoerythrinand phycocyanin [13,16]
Example
Halimeda sp Fucus serratus Palmaria palmata
2. The Potential of Invasive Seaweeds
Due to increasing globalization as well as climate change, the arrival of invasive algae to coastal
areas of different regions is becoming more common. However, these are not the only causes of the
increased proliferation of these non-indigenous marine species. Other causes, such as those related
to the marine industry (aquaculture, fisheries, and marine tourism) must also be considered [18–20].
That is why marine biodiversity is seriously threatened by macroalgae invasions. In fact, macroalgae
represent between 10% and 40% of the total number of species introduced into the marine ecosystem [21].
These algae not only cause an environmental problem by displacing other native species,
causing a loss of biodiversity, damage in the structure and function of the native ecosystem,
and a homogenization of the landscape, but also cause losses in the fishing, recreational sector,
and many other industrial sectors related with aquatic environment. However, this abundance can
also present opportunities. It is therefore of great interest to find possible applications to give added
value to these algae. Furthermore, most of the foods humans eat in the modern world come from
a small number of domestic animals and plants widely raised and cultivated, most of them having been
introduced voluntarily by humans. One of these applications could be the obtainment of compounds
of natural origin.
Because invasive algae pose a serious threat in coastal areas, the interest in developing protocols
for the control of these exogenous species is booming, although in parallel, researchers are also trying to
develop strategies that allow them to be used as a natural source of secondary metabolites. One of the
measures proposed is the eradication of the species, which is a promising solution for areas declared
as protected, such as Marine Protected Areas. In this sense, the enormous production of biomass
by this type of algae can become a benefit, since it offers the possibility of recycling or reuse at the
time of eradication. In any case, it should be taken into account that the impact-control studies do
not always allow us to reach an accurate conclusion about the impact of a certain invasive algae,
since these studies are designed mainly with the intention of evaluating the anthropogenic impacts,
when a control-impact evaluation before and after the invasion would be more accurate [22].
The species of marine algae that are in the top five of “potentially invasive”, which means that
they meet certain characteristics (relating to the mechanisms of reproduction, growth and defense,
resistance to pollution, among others), as well as having a high ecological impact, are, from least
to greatest: Grateloupia turuturu (as Grateloupia doryphora), Asparagopsis armata, Undaria pinnatifida,
Caulerpa taxifolia, and Codium fragile subsp. tomentosoides [23]. Some authors [24] classify the factors that
favor such invasive attacks of macroalgae in two groups: The abiotic ones, such as salinity and waves,
and the biotic ones, such as those related to the competitive abilities of the species. Other authors [25]
proposed the Tilman’s R* rule, where R refers to the resources available in an area and R* to the balance
of available resources, from which one can predict where the invasion is favored, since if the R* of the
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endogenous species is greater than that of the exogenous species, the invasion is more likely to occur,
and may occur in two ways: The invader needs fewer resources than the resident, or the range of
acquisition of resources of the invader is greater than that of the endogenous one. On the other hand,
there is a study [24] that discusses about the enemy release hypothesis (ERH), based on the fact that
the invader has escaped from its habitat due to the presence of enemies and/or herbivores. This can
also be the explanation of why invasive algae tend to have greater resistance to herbivores than native
ones. For example, Fucus evanescens, presents higher amounts of phlorotannins, compounds known to
cause animosity to herbivores [24], than the native species [26].
Laminaria sp. (brown algae) show a great adaptability and relocation thanks to their gametophytes,
formed by filamentous tufts of approximately 1 or 2 cm. These reproductive structures can be
considered as “seed stocks”, so their presence is extremely important when colonizing a certain area,
as does, for example, the species Undaria sp. [27]. Regarding the interactions between the invasive
species themselves, information is scarce, so it is an area still to be explored that concerns the entire
globe, since invasive algae are not governed by national borders.
Many of these algae contain bioactive compounds that could be contemplated for a wide range of
commercial applications like nutrition and pharmaceutical ones. In this regard, invasive algae present
great advantages because, according to some authors [20], invasive algae present fast growth rates and
biomass accumulation, high levels of repellency against herbivores, and often low levels of epiphytism.
Moreover, according to these authors, the low cost of algae farming, along with good economic results
and the high demand for products obtained from algae, has led to the intentional introduction of
potentially invasive algae in overcoat low-wages countries.
3. Algae Aquaculture
Aquaculture is the science of cultivating aquatic animals, plants, and related organisms like fish,
shellfish, seaweed, and microalgae, for human use and consumption, and would be a fast-growing
industry. Nowadays, many authors are focused on performing Life Cycle Assessment (LCA) of
seafood production to provide new insights into its environmental impacts and therefore to improve
environmental sustainability of the aquaculture production systems [28]. Although the technologies
related to aquaculture of algae have undergone tremendous development in the last 70 years, especially
in Asia, but also in America and Europe, there is still much to improve regarding their science and
the social acceptance that entails. One of the main challenges is the development of strains that
are thermo-resistant, of rapid growth, with high production of compounds of interest, resistance to
morbidity, and antifouling capacity, as well as the development of efficient and economical hatcheries,
capable of withstanding storms in the open sea [29]. One fact to keep in mind is that algae aquaculture
offers advantages to ecosystems, since it improves the conditions of coastal waters, favoring other species
and the environment. Interestingly, although more than 10,000 species of algae are known, aquaculture
of algae is mostly made (more than 81% of production) using very few of them [30]: The brown algae,
Saccharina japonica and Undaria pinnatifida, and the red algae Porphyra sp., Kappaphycus alvarezii and
Eucheuma striatum (carrageenophytes), and Gracilaria/Gracilariopsis sp. (agarophytes).
One of the priorities when developing aquaculture is to be sustainable, that is, to ensure the
minimum possible adverse effects for the environment. One way to achieve this is by developing
improved methods for waste treatment. Integrated Multi-Trophic Aquaculture (IMTA) combines the
aquaculture of food (for example, of fish) with that of extraction (for example, algae) to create a more
balanced ecosystem [31]. However, caution should be exercised, since coastal waters containing high
amounts of nutrients may favor the emergence of potentially harmful, invasive, or opportunistic algae,
which may have negative consequences for the coastal zone [32–34]. There is another similar concept
that excludes the feeding concept, called nutrient bioextraction, which can be applied even to urbanized
estuaries, where excess nutrients are currently a problem. In both aquaculture systems described,
algae can be used as a solution to eliminate inorganic nutrients (phosphorus compounds, nitrogen,
carbon dioxide, and other compounds used for their metabolism), thus decreasing the negative impacts
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on the environment [35–38]. In this way, while algae are cultivated, the levels of nutrients in the
water are reduced, so its acceptance is much greater by users and those who are positioned against
aquaculture, since the presence of seaweed provides advantages in the aquaculture system, such as
minimal environmental adverse effects and reduction of costs, due to the utilization of wastes to feed
other levels [31].
4. General Current Seaweed Industrial Applications
General current seaweed industrial applications are important because these days consumers
look for products with a natural origin. This is a new use of algae, which is in high demand. A brief
and general bibliographic review allowed us to define the main biological activities (antioxidant,
antibacterial, anti-inflammatory, antifungal/antiprotozoal, antiviral, cytotoxicity/antiproliferative,
adipogenesis, MAA/UV protection, matrix metalloproteinases and blood fluidity) of algae (summarized
next in Table 3).

















Other applications: Filter [69]
Mineralogenic [43,70]
4.1. Anti-Biofilm Applications
Anti-biofilm activity has been investigated with models based on Gram-positive and -negative
bacteria. This is important because biofilms may cause diverse diseases. Several studies concerning
anti-biofilm activity can be used as practical examples. For instance, there is a research about how
seaweeds can attack Salmonella enterica biofilms. That is important because this organism is one of the
most prominent causes of bacterial food-borne diseases. In that study, it was observed that brominated
furanones obtained by extraction from the red algae Delisea pulchra, interfere in this biofilm formation,
but more studies are needed to determine a long term efficiency [41]. Another work [40] reported that
Sesbania grandiflora extract has anti-biofilm and anti-bacterial activity against Staphylococcus aureus.
Antimicrobial, anti-biofilm, and antifouling properties of sulfated polysaccharides obtained from
marine macroalgae were also studied using dental plaque bacteria as model [39].
4.2. Biofuel and Bioremediation Applications
Algae can also be used in the production of biofuels. However, for making the process of obtaining
biofuel feasible economically, algae should present a co-production of some other components that
could be used biochemically and that have a proven commercial value [42]. This approach would
also decrease the cost of algae treatments and should mitigate the eutrophication of lakes. However,
using algae as a fuel has several advantages. One of them is that a single algal biomass can be used to
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produce several different kinds of renewable biofuels depending on the treatment applied (anaerobic
digestion and biodiesel derived from algal oil, among others) [32].
Regarding bioremediation, the accumulation of high amounts of organic and inorganic matter
is a risk factor for many ecosystems, and therefore, for human health, that is why new solutions
are sought to remedy this accumulation. Algae can be one remedy at the aquatic ecosystem level,
since they participate actively in the control and biomonitoring of organic pollutants [48].
Algae are a group of great interest for this purpose, since they are ideal for the bioremediation of
wastewater thanks to their culture being very economical and easy to achieve on a large scale, since
they are capable of capturing a high percentage of metal ions. Furthermore, according to the large
amount of biomass that is produced by algae growing in wastewater, a dual-purpose crop could be
considered to bioremediate wastewater, and to obtain a production system for other substances of
interest, such as compounds with bioactivities [47].
Another study [46] reported that certain algae act as “hyper-accumulators” and “hyper-adsorbents”
with a high selectivity for different elements. They also contribute to an alkaline environment, leading
heavy metals to precipitate during treatments.
However, in all cases it is necessary to control some parameters such as temperature, pH, nutrients,
and availability, among others, to reach the optimum conditions under which algae show the best
absorption, removal, and biodegradation of different pollutants [46–48].
4.3. Fish Feed Applications
Most of the fish feed used in aquaculture is made from other fish meat. This has an enormous
disadvantage as fishes have to be fed twice and that costs a lot. Moreover, the world’s fish stocks are
decreasing, and aquaculture is increasing, which makes that system unsustainable.
As for the nutritional aspects of microalgae, they are strongly dependent on culture conditions as
well as on factors such as culture phase, temperature, and availability of nutrients [71].
There are evidences of good nutritional properties of algae biomass as a source of micronutrients
or as a bulk feedstuff. Moreover, they have a positive effect on the physiological state of the larvae due
to, for example, the diversification of bacterial flora [72].
The use of algae as a bulk feedstuff or as a supplement depends on the biomass availability, as well
as its composition and cost [73]. However, their use should be limited to a certain concentration due to
the amount of toxic metals they may have, such as arsenic, which is one of the main limiting factors.
The consumption of microalgae is carried out directly, in the case of mollusks and crustaceans,
and indirectly in urine from previous ingestion by zooplankton species [71].
Algae can be used for animal feed as well. They are used among others in ruminants’ nutrition.
4.4. General Food Applications
The main use of algae is the one with direct food applications (“seaweed as a vegetable”). This use
represents the main world market for algae. This is mainly due to the great consumption that exists
in Asian countries, where they are traditional products of high consumption. The main seaweeds
used as human food are [74]: Nori or purple laver (Porphyra spp.), aonori or green laver (Monostroma
spp. and Enteromorpha spp.), kombu (Laminaria japonica), wakame, (Undaria pinnatifida), Hiziki
(Hizikia fusiforme), mozuku (Cladosiphon okamuranus), sea grapes or green caviar (Caulerpa lentillifera),
dulse (Palmaria palmata), Irish moss (Chondrus crispus), winged kelp (Alaria esculenta), ogo (Gracilaria
spp.), and Callophyllis variegate. Algae products are consumed as food in different ways: Dried, in sushi,
in soups, in salads, in tea, in mustard, in pasta, in breads, and many other similar food products.
Algae also contain some compounds that can be used as food ingredients. For example,
phycocolloids are a group of natural polymers constituted by polysaccharides with the ability to form
gels (hydrocolloid) derived from macroalgae. They are used in almost all industries (food, drugs,
paintings, cosmetics, etc.) due to their physical–chemical characteristics. These are the second-most
common use of algae. The majority of obtained hydrocolloids are alginate, carrageenan, and agar.
74
Antioxidants 2019, 8, 406
According to a previous study [74], several red and brown algae are used in the production of three
hydrocolloids: Agar, alginate, and carrageenan. These compounds are water-soluble carbohydrates
mainly used to increase aqueous solutions viscosity, to produce different types of gels, to form
water-soluble films, and to stabilize some products. Other functional ingredients present in algae
are carotenoids (used as food colorants, feed supplements, and nutraceuticals), lipids, proteins,
polysaccharides, and phenolic compounds [32].
4.5. Pharmacology and/or Medical Applications
Algae produce bioactive compounds with rich pharmacological potential. They generate these
compounds as a response to environmental conditions or characteristics (competition for space,
maintenance of unfolded surfaces, repulsion of predators, etc.) [75]. In recent years, seaweeds have
been recognized as producers of an enormous range of biologically active compounds, but the
bioactivity of the same species could vary depending on the geographical zone due to environmental
and seasonal parameters [75].
4.5.1. Contraceptive Activity Applications
Different studies [49,50] with extracts from red algae were carried out. These extracts were
administrated to female rats in the first seven days of their pregnancies. As result, it was demonstrated
that these extracts have post-coital contraceptive protection in the rats without showing any relevant
adverse effect.
4.5.2. Antibiotic, Antiviral, and Antifungal Activity
Algae’s antibiotic activity was demonstrated for several authors through tests of the extracts
obtained from algae against Gram-positive and -negative bacteria. Finding these new sources of
antibiotics is interesting because microorganisms are getting more resistant to drugs, so providing new
drugs is of utmost importance nowadays. That is why novel natural antimicrobial compounds with
high potential, good availability, less toxicity, and fewer adverse effects are required [56].
According to a recent article [55], isolated chemical compounds from marine seaweed have
been shown to owe bioactivities such as antimicrobial, antioxidant, and anti-inflammatory properties,
as well as anticoagulant and apoptotic effects. Viral diseases are still one of the main causes of
death in the world. Treatments sometimes fail because of the side effects of infectious diseases or
because of drug resistance. Therefore, the study of algae compounds with antiviral activity is of great
interest. According to other authors [58,76], algae from the three large groups (green, brown, and red
algae) produce interesting polysaccharides that show antibacterial activity against some pathogen
bacteria such as Aeromonas salmonicida or Pseudomonas aeruginosa, both being of importance because of
their high pathogenicity, resistance, and incidence in humans. Specifically, some red algae produce
sulfated polysaccharides showing antiviral capacity against viruses responsible for different infectious
diseases. As an example, red algae Gracilaria gracilis extracts have shown antimicrobial activity against
Bacillus subtilis, an extreme conditions resistant bacteria [77]. One of the main areas of interest is to find
new treatments towards herpes simplex virus type 1 (HSV-1), as it is an endemic disease, the virus is
developing resistance, and other available drugs have side effects [57].
4.5.3. Anticancer Activity
Actually, cancer is one of the principal causes of death around the world, thus, finding new
treatments for this disease is a big challenge. Some studies have linked the anticancer capacity of
a certain algae with the content of compounds with antioxidant properties.
Most studies of anticancer properties in algae have been performed on microalga extracts or
fractions obtained using low-resolution methods (liquid–liquid extraction, solid–liquid extraction) [59].
Extracts from algae Bryopsis sp. contain some compounds (depsipeptides kahalalide A and F)
whose future seems to lie with the development of kahalalide F for treatment of lung cancer, tumors,
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and AIDS. This is due to the fact that kahalalide F has anticancer properties, namely the control
of tumors causing colon, lung and prostate cancer [58]. It happens the same with chondriamide
A, a compound obtained from Chondria atropurpurea that presents antiproliferative activity towards
human nasopharyngeal and colorectal cancer cells [60].
Other compounds present in algae, such as several polysaccharides with sulfur groups—e.g.,
fucoids—have also shown cytotoxic properties [78]. Another example are terpenes. A study carried
out using Chlorella sorokiniana and Chaetoceros calcitrans extracts concluded than they present interesting
activities compared to commercially available marine anti-cancer drugs [59]. L. papillosa algae was
also studied and the conclusion was that it contains some bioactive compounds that could serve as
a promising potential antioxidant, antimicrobial, and anticancer agents [56].
4.5.4. Anticoagulant Activity
Phlorotannins and sulfated polysaccharides such as fucoidans in brown algae, carrageenans
in red algae, and ulvans in green algae have been recognized as potential anticoagulant agents [61–64].
For example, in a study carried out by [79], they tested the effect of some polysaccharides rich extracts
obtained from green algae Ulva fasciata and red algae Agardhiella subulata in the thromboplastin time
and prothrombin time, resulting that both algal extracts showed that prolong those mentioned times
during the coagulation cascade, avoiding blood coagulation. However, the anticoagulant activity has
been mainly investigated in vitro or in mouse. Hence, and due to the important value of that property,
more studies are needed [62].
4.5.5. Anti-Inflammatory Activity
Several studies have demonstrated that some extracts and compounds from a wide variety of
algae have potential anti-inflammatory compounds. For example, [66] studied the anti-inflamatory
capacity of methanolic extracts obtained from red seaweed Dichotomaria obtusata. Other authors [65]
reported the enhanced anti-inflamatory ability of brown kelp Laminaria japonica by fermentation with
Bacillus subtilis. Likewise, [67] reported anti-inflammatory properties of several marine algae collected
from the Mannar coast gulf (Tuticorin, South India).
4.5.6. Antioxidant Activity
An excessive amount of reactive oxygen species may result in lipid peroxidation, which change
the structure of body biomolecules, causing cellular disorders, premature aging, mutations or cell
death. Different researches have demonstrated seaweed antioxidant capacity in vitro, attributed to the
presence of new antioxidant compounds like carotenoids, certain polysaccharides, and polyphenols,
which show scavenger activity, being able to neutralize those reactive oxygen species through their
own oxidation, since their affinity to those oxidative compounds is very high [56,68,80–85].
As a curiosity that strengthens the utilization of algae as antioxidant tools, a study carried out
by [86] in which fishes were fed with red algae Gracilaria gracilis powder, demonstrates that this
nutritional input favors genetic expression of some antioxidant enzymes, like superoxide dismutase
and catalase, what it also improves the state of the body’s immune system.
4.6. General Cosmeceuticals Applications
Another possible use is to obtain compounds with cosmeceutical bioactivity, that is, compounds
to be used as ingredients for skin care products. Many of the invasive species have been demonstrated
to include these compounds. However, metabolite amounts often vary according to geographical and
seasonal conditions, so environmental variability has to be taken into consideration [87]. For that
type of product, brown and red marine seaweeds are the most used species. Extracts rich in potential
cosmeceutical ingredients, such as phlorotannins, polysaccharides, carotenoids, fatty acids, as well as
bioactive proteins, vitamins, and minerals can be obtained from seaweed [52]. These compounds are
incorporated into cosmetics to optimize their properties; their capacity to stabilize and preserve products
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and the bioactive activities of the compounds found (antioxidant, photo-protection, anti-wrinkling,
anti-cellulite, moisturizing, and whitening) [88,89]. In vitro studies also demonstrated that these
compounds are UV protective, or have an inhibitory effect on melanogenesis [51].
4.7. Other Applications
Traditionally seaweeds have also been collected and used by coastal communities as fertilizers.
They are appropriate for that use since they have the characteristic of enriching the soil with N, P,
and K, favoring agriculture, and they have the ability to promote seed germination, increase frost
resistance, and improve resistance to fungal and insect pests [32,43,53]. The main species that are
used for agricultural applications are Ascophyllum nodosum, Ecklonia maxima, Laminaria sp., Lessonia
species, and Macrocytis pyriphea [74]. The most common extractive modality to obtain these interesting
compounds is alkaline extraction for which potash is added and heat is applied [90].
Another interesting property of algae is that they are able to take many minerals from the
sea, with no substantial differences in the quantity among different types of algae. The most
important macroelements they contain are sodium, calcium, magnesium, potassium, chloride, sulfur,
and phosphorus. Regarding oligoelements, iodine, iron, zinc, selenium, copper, molybdenum, fluorine,
manganese, boron, cobalt, and nickel are the most relevant ones. Iodine is very important as many
people suffer from iodine deficiency. The bioavailability depends on the algae species and on the
treatment during harvesting and processing [70]. According to this, it can be said that algae possess
mineralogenic properties, which represents a useful tool, since these minerals are worthy in both
fertilizer and animal feed [43].
Finally, fish farming, as well as intensive livestock production, produces effluents with a high
content of inorganic nitrogen and phosphorus, compounds that are needed to produce a biomass of
algae and have a high cost. Using these wastes for the production of algae biomass, environmental
benefits could be obtained due to the seaweed biofiltration and depuration capacities, favoring the
purification of effluents, as well as promoting a reduction of costs thanks to the use of waste waters as
a source of necessary compounds [69].
5. Food and Technical Uses of Algae
Although algae extracts can be used in several products, they are mainly used as food ingredients
in the formulation of food products (Table 4) [91,92]. In East Asia, as well as in the Pacific Islands, food
has been based for centuries on the direct consumption of seaweed, the red seaweed Nori, or laver
(Porphyra) being the most common commercial ones. In Japan, there are farms in shallow bays and
seas comprising approximately 100,000 hectares. The Porphyra algae has a life cycle that includes
two phases: A small and shell-boring. The first phase can be favored and augmented by humans,
by planting on special platforms containing sea beds to which oyster shells are attached by using ropes
or nets. In turn, the second phase consists on the germination of the conchospores and their growth
along the platforms. It is at this time that the nets or ropes are removed to collect, wash and press the
algae so that their drying is accelerated [93].
Table 4. Food and feed applications of the main red, brown and green macroalgae.
Name Applications Region/Country References
Red Alga (Rhodophyta)
Porphyra (alga nori) Cultivated for food Asia [93]
Saccharina japonica Cultivated for food Japan [93]
Palmaria palmata (Dulse) Culinary ingredient, flavor-enhancer USA, Canada, Scotland,Ireland, Iceland [93]
Gelidium sp., Gracilaria sp.,
Pterocladia sp., Acanthopeltis sp.,
Ahnfeltia sp.
Instant pie fillings, canned meats or fish,
bakery icings, beer and wine clarifiers Asia [93]
Eucheuma sp., Chondria sp.,
Iridaea sp.
Thickening and stabilizers, imitation
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Table 4. Cont.
Name Applications Region/Country References




Farmed in small quantities (poultry,
improves quality of eggs) Europe, Asia, North America [93]
Ascophyllum nodosum Animal feed (ruminant and poultrydiets), human consumption Norway, UK, Portugal, USA [93]
Undaria sp., Hizikia sp. Fried in oil, boiled in soup Japan, Korea, China [91]
Macrocystis sp., Laminaria sp. Ice-creams, syrups, salad dressings(texturizers, emulsifiers, thickeners) Europe, USA [93]
Ascophyllum sp. Land animal feed (i.e., ruminants) Iceland [93]
Laminaria digitata, L. hyperborea,
L. latissima Animal feed Europe, Asia [91]
Laminaria japonica Soup, fried in oil, with soy sauce Asia [91]
Fucus vesiculosum Pigs diet Sweden [93]
Enteromorpha prolifera Poultry diet Europe [93]
Pelvetia canaliculata Pigs diet, human consumption duringtimes of famine Scotland, Ireland [93]
Green Alga (Chlorophyta)
Caulerpa sp.
Farmed in small quantities (poultry,
improves quality of eggs), food
(“green caviar”)
Europe, Asia, Northamerica [93]
Monostroma sp. Salads, soups, relishes, meat andfish dishes Europe, Asia [93]
Ulva lactuca Lambs feed, soups, salads Europe, USA, Asia, Australia,New Zealand [93]
Ulva intestinalis Rabbits feed Egypt, Saudi Arabia [93]
Chaetomorpha linum Lambs’ feed Tunisia [93]
Palmaria palmata, also belonging to the group of red algae, is the most consumed in the north
zone of the Atlantic Ocean. It is known by different names, such as Dulse, duileasg, duileasc, or söl,
depending on the region, and its use as a food ingredient is quite widespread. In some areas of the
mentioned regions it is also used as a flavor enhancer. Obtaining it is based on the hand collecting of
the marine rocks in which they are trapped and accessible when the tide is low [93].
This method of manual collection is also carried out to obtain some brown algae, such as Laminaria
and Undaria, in some Asian countries, such as Japan or Korea. [91], in which the food is supported
robustly on the use of algae, using them for the accompaniment of numerous foods such as fish and
meat, or for the elaboration of other recipes such as soups [94]. There are green algae whose leaves are
similar to those of lettuce, belonging to the species Monostroma and Ulva, which are used precisely for
the preparation of salads, although they are also included in soups and other types of dishes.
From a nutritional viewpoint, seaweeds are an alternative sources of proteins, certain brown
species presenting much more protein content than other vegetarian sources, such as soy beans [95].
In the same way, their lipid content includes a concentration of fatty acids within 1 and 6 g/100 g of dry
weight. In addition, it should be noted that some species have high concentrations of polyunsaturated
fatty acids, namely eicosapentaenoic acid (up to 24%) [95].
One of the most important nutritionally relevant components of seaweeds are polysaccharides,
most of them cannot be digested by humans, and thus, they can be considered as dietary fiber (33%–75%
of the total composition) [96,97]. In turn, soluble fractions account between 50% and 85% of total
dietary fiber content [96]. Some algae polysaccharides with particularly industrial relevance are
described below:
Red algae (Rhodophyta) represent a particularly interesting group when considering polysaccharides,
as they contain high quantity of sulfated galactans, such as agar or carrageenans. In the past decades,
carrageenans have been used as natural ingredients in the elaboration of gels and as thickeners in a wide
range of food applications [98]. They can be classified into three groups, according to their industrial use
(kappa-, iota-, and lambda-), differing in the quantity and position of their sulfate ester substituents, as well
as in the 3,6-anhydro-d-galactose content. The conformation of carrageenans is directly related with their
technological properties (i.e., gelification, thickener). Kappa- and iota-carrageenans are gel forming and
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contain a 3,6-anhydro-galactose unit. In turn, lambda-carrageenans have only galactose residues and are
used as thickeners. They lack of 3,6-anhydro-D-galactose ether linkages and, thus, the 4-linked substituent




Figure 1. Different carrageenan types from red seaweeds.
Fucans, another kind of polysaccharides, generally present in brown algae, are classified into
three main groups: Fucoidans, glycorunogalactofucans, and xylofucoglycuronans. Fucoidans are
the leading components of the soluble fiber present in such kind of algae [96]. They are branched
polysaccharides sulfate esters, soluble in water and acid, consisting in (1→3) and (1→4)-linked-l-fucose
residues, that may be organized as (1→3)-α-fucan chains or as alternating (1→3) and (1→4)-bonded
α-l-fucose residues. The l-fucose residues are often substituted with sulfate (SO3) groups on C-2 or
C-4 (rarely on C-3) [99,100]. Besides fucose, fucoidans also contain galactose, mannose, rhamnose,
uronic acids, glucose, and xylose [99] (Figure 2).
fucoidan 
laminaran 
Figure 2. Structure of fucoidans and laminarans present in brown algae.
Xylofucoglycuronans or ascophyllans consist of a polyuronide backbone, mainly poly-b-(1,4)-d-
mannuronic acid branched with 3-O-d-xylosyl-l-fucose-4-sulfate or, sometimes, with uronic acid.
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Glycuronogalactofucans composition can be described as linear chains of (1,4)-d-galactose branched
with l-fucosyl-3-sulfate or, sometimes, uronic acid at C-5 [101].
Laminarans are other type of polysaccharides present in Pheophytes (Laminaria species). They are
responsible for the food reserve of brown algae. Although laminaran composition is species dependent,
they contain of 20–25 units of glucose on average, and consist in (1,3)-β-d-glucan with β(1,6)
branching [102]. Laminaran chains can be classified into two types (M or G): M chains have a mannitol
residue at the reducing end, and G chains, a glucose residue [99] (Figure 2).
Other remarkable compounds are alginic acid derivatives, also named alginates, that are constituted
by linear polysaccharides with 1,4-linked β-d-mannuronic and α-l-guluronic acid residues distributed
unregularly along the chain [99]. Alginates are present in brown seaweeds as sodium and calcium
alginate, conforming highly viscous solutions, used for several technological applications (Figure 3).
Alginate 
Figure 3. Structure of alginate.
The solubility in water of the above-mentioned algae polysaccharides certainly facilitates their
commercial extraction. In fact, certain phycocolloids present in the cell walls of many algae can be
easily extracted with hot water. Phycocolloids classification includes three major groups: Alginates,
carrageenans, and agars, and are interesting because they are safe for humans and animals’ consumption.
Many of these compounds are currently included in a wide range of processed and ready-to-eat foods,
such as instant cakes or synthetic toppings [103]. An example is the use of industrially extracted
alginates of brown algae species, such as Macrocystis, Ascophyllum and Laminaria, for the elaboration of
ice cream, to avoid the formation of large amounts of ice and give them a creamy and smooth texture.
Such alginates have been also used for the elaboration of energetic or sweet bars, and of dressings
for salads as satiating agents, or in the preparation of syrups as thickeners and / or emulsifiers [104].
Alginates can also be extracted from red algae, such as Gelidium, Gracilaria, Acanthopeltis, Pterocladia,
and Ahnfeltia, but their food use is reduced to special fillings for baking, canned food products,
and as clarifiers in wine or beermaking. However, the use of agar in the R&D industry, as well
as in microbiological and analytical laboratories, is really widespread, mainly for the preparation
of culture media compatible with a wide variety of cell lines [105]. Carrageenans, also described
previously, can be obtained from several species of red marine algae like Eucheuma (Philippines),
Chondrus (United States), and Iridaea (Chile). Their main uses are thickening and stabilization of some
dairy products like syrups, puddings or canned foods for animals, and they are also used in the
elaboration of some medicines and some cosmetics as shampoos and creams [98].
During the 18th century, soda was obtained from brown macroalgae (Phaeophyceae) by collecting
and scorching. In the following century, the main source of this compound was moved to the
soda-rich mines discovered in Austria, among others, so the use of algae for this purpose drastically
decreased. However, as the century progressed, they regained importance as a source of salts and
iodine, so their exploitation suffered a tremendous boom, until the discovery of iodides and cooking
salt, which practically plunged them back into disuse. Later, by the time of the First World War they
were revalued for the production of fertilizers, such as potash, and acetone, used for the manufacture
of smokeless gunpowder [106].
As mentioned above, algae have been used throughout the world as fertilizers for centuries.
It is one of the most widespread uses of algae, as farmers from all coastal areas have collected
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them since ancient times, both at the oceans and reefs where they were trapped during storms or
tides. Once harvested, they were left to dry spread out on the ground, obtaining a dry raw material
with a mineral content that can amount up to 50% of the weight, in addition to high amounts of
organic nitrogen derivatives. Currently, algae-based fertilizers that are commercialized include a set of
micronutrients and macronutrients that help the plants grow properly [107].
6. Prebiotics from Algae
As shown in the previous section, macroalgae are responsible for the production of a large
range of primary and secondary metabolites that can be used for different applications in food,
cosmetic, pharmaceutical, and other industries [108]. Many of these compounds have well-established
antiinflammatory, antimutagenic, antitumor, antidiabetic, hepatoprotective, free radical scavengers,
anticoagulants, thrombolytic, and antihyperthensive properties [108,109]. In this section, the properties
of non-digestible carbohydrates from algae will be addressed. A brief summary of those health
beneficial effects is displayed in Table 5.
Table 5. Prebiotic or prebiotic candidates extracted from marine algae.
Prebiotic/Prebiotic Canditate Origin/Source Health Beneficial Effects References
AGAROS





and α-glucosidase inhibitory activities
[110]
NAOS
(neoagaro-oligosaccharides) Gracilaria sp., Monostroma sp.
ROS scavenging, antioxidant and
immunomodulatory effects,





Kappaphycus sp., Porphyria sp.,
Gracilaria sp.
Immunomodulation, skin whitening,







Ascophyllum sp., Fucus sp.,
Undaria sp., Sargassum sp.,
Laminaria sp. and Macrocystis sp.
Reactive oxygen species (ROS)
scavenging, antioxidant and
immunomodulatory effects, weight
control, reduction of cholesterol,
diabetes control (hypoglycemic and
hypolipidemic properties), promotion
of fecal microbiota metabolism,
production of short chain fatty acids
by the gut microbiota;
decrease of putrefactive compounds











(reduction of insulin resistance),
anti-hypertensive, antioxidant
[99,114,116,117]
Fucus evanescens Anticoagulant, antioxidant [109,118]
Fucus vesciculosus Anticancer, antimetastatic [109]
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Table 5. Cont.
Prebiotic/Prebiotic Canditate Origin/Source Health Beneficial Effects References
Galactofucans


















Lobophora variegata Antioxidant, anticoagulant,anti-inflammatory [119]







Arabinoxylans Ascophyllum Modulation of intestinal microbiota [120]
Glucans Chlorela vulgaris Antitumor, infection preventive agent [119]
Laminarin
Ascophyllum sp., Fucus sp.,
Laminaria sp., Saccharina sp.,
Undaria, Enteromorpha sp.
Antilipidemic, hypocholesterolaemic,
fast decrease of blood glucose [114,116]
According to the last accepted definition, prebiotics are substrates that are selectively used by host
microorganisms conferring health benefits [121]. As the target of most prebiotic compounds is the gut,
such ingredients must not be hydrolyzed in the upper part of the gastro-intestinal tract. This ensures
their safe arrival to the colon, where they stimulate the growth and/or activity of one or a limited
number of bacteria, thus positively modulating the intestinal microbiota [121]. Although prebiotic
properties must be well-demonstrated both in vivo and in vitro [121], the capacity to safe arrive to the
gut converts non-digestible ingredients in potential prebiotic compounds (or prebiotic candidates).
6.1. Chemistry and Obtaining of Prebiotic Compounds from Seaweeds
Some prebiotics (or prebiotic candidates) naturally occurring in seaweeds are saccharides presenting
a degree of polymerization (DP) within 2 and 9 (sometimes within 8 and 20). Some researchers consider
up to 25 sugar residues [122]. Such oligo/polysaccharides include galacto-oligosaccharides (GOS),
agarose-derived oligosaccharides (AGAROS), xylo-oligosaccharides (XOS), neoagaro-oligosaccharides
(NAOS), alginate-derived oligosaccharides (ALGOS), arabinoxylans, galactans and glucans [114]. Although
not all of them fulfill all the criteria requested for a compound to be considered as prebiotic (i.e., be refracting to
hydrolysis and absorption in the upper part of the gastro-intestinal tract, selective promotion of bifidobacteria
and/or lactobacilli in the colon, beneficial effect of their fermentation products, stability towards technological
processes when incorporated into food products) [121], none of them is degraded by enzymes in the first
part of the gastro-intestinal tract. Therefore, they achieve at least one of the requested criteria and take part
of the dietary fiber.
Prebiotic oligosaccharides from seaweeds can be obtained by the hydrolysis of naturally occurring
polysaccharides. This process has encouraged the development of new extraction techniques, as algae
polysaccharides have a wide variety of chemical bonds and conformations, including α or β bonds,
cis or trans configurations, d or l, or R or S chiral centers. This issue is of great importance since
certain bonds can be hydrolyzed with enzymes, whereas others require other techniques as no natural
enzymes are able to hydrolyze them [120,123]. Therefore, it is necessary to look for other techniques to
obtain oligosaccharides from polysaccharides. Some authors [122] summarized the characteristics of
different techniques, as well as their suitability to be used for the hydrolysis of some polysaccharides.
Hence, the main non-enzymatic hydrolytic techniques used at an industrial level are ultrasound (in the
case of carrageenans, agarose and xylan), microwaves (for hydrolysis of exopolysaccharides obtained
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from Porphyridium cruentum), use of free radicals (for fucoidan and algae galactan), or the application
of diluted acids (for example, phosphoric acid) [124–130].
In the case of acids, they can be used as hydrolytic agents only for neutral polysaccharides, namely
fucoidans, carrageenans, or galactans. In addition, certain components can be lost during the process and
most of the glycosidic bonds are not specifically hydrolyzed, thus giving rise to various low molecular
weight derivatives. In spite of that, phosphoric acid is capable of effectively hydrolyzing polysaccharides
of some algae species, such as Chlorella vulgaris and Spirulina platensis [128], mostly composed of uronic
acids and giving rise to interesting oligosaccharides with potential prebiotic properties [122].
The use of free radicals is another effective technique for the hydrolysis of polysaccharides, since it
does not affect the structure of the compounds when it is correctly performed [122]. Other authors have
demonstrated that this technique can be applied for the hydrolysis of fucoidans in low molecular weight
compounds (≈8 kDa), although then it is necessary to apply other procedures for the purification of
the obtained products [129]. Additionally, the obtained products demonstrated a better anticoagulant
capacity with respect to the original polysaccharide [129].
The physical technique of microwaves also gives rise to glucidic compounds of low molecular
weight (≈12 kDa) from natural polysaccharides extracted from algae. The obtained products do not
undergo structural changes and have a surprisingly enhanced immunomodulatory and anticancer
capacities with regard to the original substrate. The higher solubility of the products (with lower
molecular weight) was remarked as a possible explanation for such observations [131]. Therefore,
the use of this technique offers several clear advantages: it is economical, easy to use, non-toxic and
is green, since the energetic and time consumption are not environmentally harmful [132]. All these
techniques can be optimized to guarantee the highest results [133].
6.2. Prebiotic Properties of Oligo and Polysaccharides from Seaweeds
Taking into account that some oligo and polysaccharides extracted from algae are not hydrolyzed
in the upper part of the gastro-intestinal tract, they represent novel potentially useful raw materials
for the obtaining of prebiotics [134]. To determine whether oligo and polysaccharides extracted from
seaweeds are prebiotics, their fermentation by microorganisms from the intestinal microbiota is usually
assessed [134]. First of all, the stability of algae polysaccharides when exposed to saliva, gastric and
intestinal environments is assessed. The activity of intestinal microbiota is commonly evaluated by
measuring metabolic end products, such as gases and short-chain fatty acids (i.e., acetic, propionic,
butyric acids). Using molecular methods such as fluorescence in situ hybridization (FISH), polymerase
chain reaction (PCR), denaturing gradient gel electrophoresis (DGGE) and 16S rRNA gene sequencing
provides a complete representation of the in vitro effect of prebiotic candidates from seaweeds on the
modulation of intestinal microbiota by increasing the amount of beneficial bacteria and decreasing
prejudicial microorganisms [134,135] (Figure 4).
In turn, for in vivo studies, prebiotic candidates are orally administrated to the host (mouse, rats,
monogastric, ruminants, and humans), and modifications in the composition of intestinal microbiota
(Firmicutes/Bacteroidetes ratio, the two phyla present in the microbiota), and production of short
chain fatty acids are determined. Recently, it was reported that polysaccharides obtained from the
brown alga Ascophyllum nodosum increase the quantity of Bacteroidetes and Firmicutes, suggesting the
potential of Ascophyllum nodosum polysaccharides to decrease the risk of obesity. Furthermore, the total
short chain fatty acids content after fermentation increased significantly. These results suggest that
Ascophyllum nodosum polysaccharides have potential uses as functional food components to improve
human gut health [117]. Other authors evaluated the prebiotic properties of the brown seaweed
Ecklonia radiata oligosaccharides in vivo, when administered the polysaccharide fraction of seaweed
(rich in fucoidan and alginate) to rats. Such fractions lead to a decrease in the levels of toxic protein
fermentation products, enhancement of the numbers of butyrate-producing Faecalibacterium prausnitzii,
and decrease of the numbers of potentially pathogenic Enterococcus, thus demonstrating a potential
prebiotic effect [136]. Some authors [137] demonstrated an increase in the population of bifidobacteria
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and lactobacilli both in the cecum and feces of rats fed with diets supplemented with alginate
oligosaccharides. Such prebiotic effect was even greater than that of rats fed with a diet containing
FOS, a well-established prebiotic. Similar increases were observed by [138] in mice fed with diets
supplemented with agarose hydrolysates (NAOS). Moreover, a lower number of Bacteroides compared
to the controls fed with FOS, were observed [135]. In addition, laminarin supplementation of rats
feed also enhanced the cecal population of bifidobacteria, with no significant effect on lactobacilli.
Moreover, laminarin also suppressed certain putrefactive compounds considered as risk markers for









Figure 4. Beneficial bacteria and suppressing pathogenic microorganism.
In turn, green algae, such as Enteromorpha prolifera and Laminaria japonica, spread all over the
Chinese Qingdao coast, can also be fermented by intestinal microbiota [140]. A close relation between
the metabolic products of polysaccharides from marine algae and the regulation of enteroendocrine
hormone secretion, blood glucose, and lipid metabolism has been recently reported, thus suggesting
their effect on alleviation of metabolic syndrome symptoms [116,141] (Figure 5).
The prebiotic effect of polysaccharides from seaweeds has been also evaluated on farm animals [135].
Many studies have evaluated the effects of seaweed polysaccharides (i.e., laminarin) in pigs, lambs,
or cattle [142]. However, the differences in digestive physiology and anatomy must be considered
when attempting to extrapolate data from ruminants (cattle and sheep) to monogastrics, such as pigs.
Some in vitro studies in some animals such as pigs, rabbits, birds, and some ruminants conclude
that some algae have the ability to meet the energy and protein requirements for healthy growth,
while other algae contain certain compounds that have biological activities, so that both types could be
used as prebiotics to favor the breeding of such animals [93].
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Figure 5. Effects of polysaccharides from marine algae on metabolic syndrome [116].
To summarize this section, algae are an excellent natural source of natural polysaccharides,
that can be extracted and hydrolyzed for the obtaining of prebiotic saccharides. Extraction processes
based on physical methods are the most efficient ones, since they present minimal or no adverse effects
on human health. Besides that, these methods do not alter the original structure of the compounds
and are environmentally friendly [132]. Additionally, many of the compounds obtained show good
bioactive capacities, so their use as prebiotics is highly recommended [143].
Regarding the functionality of seaweeds, further studies are still necessary to gain information
about their intestinal benefits, and if mixtures of polysaccharides can be tailored to improve health
benefits. This would be of great importance for the formulation of functional ingredients, improving
fermentability by gut microorganisms. In this context, it appears that in the future, human beings
could modulate the microbiome through the consumption of drugs and prebiotics, which could be at
the cutting edge in the prevention of some diseases [116].
7. Antioxidants from Algae
In spite of having previously named the properties of antioxidants in algae, it is necessary to
expand the given information because there are many different compounds, of different natures,
that present this quality, whether they are water-soluble (i.e., phenolic compounds or vitamins), or
soluble in apolar solvents (i.e., carotenoids or tocopherols) [143].
7.1. Carotenoid Pigments
Carotenoids are one of the most known and widespread natural pigments in the world.
Their structure corresponds to that of hydrophobic tetraterpenes with a structure of branched
hydrocarbons with a methyl group bound at C-40 [144,145]. The pigmentation produced by carotenoids
has to do with the conjugated double bonds that appear in the carbonate skeleton, since they have the
ability to capture photons at different wavelengths of the visible spectrum. All organisms that carry out
photosynthesis contain carotenoids, which does not mean that they are exclusive compounds of these
autotrophic organisms, since they are also present in some bacteria and fungi [146]. More than 600 types
of carotenoids are known, which can be divided into two large groups according to their molecular
structure: Carotenoids and xanthophylls. The first group is characterized by having linear or cyclic
hydrocarbons at one or both ends of the molecule (like β-carotene). In turn, xanthophylls are described
as oxygenated derivatives of carotenes (such as violaxanthin), and can be found in green algae, as well
as in more developed plants, although there are compounds (i.e., canthaxanthin and loroxanthin) that
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are exclusive from green algae [147,148]. Similarly, brown algae and some flagellated microalgae are
capable of producing another type of xanthophylls, such as diatoxanthin or fucoxanthin [149].
Carotenoid essentially plays a photoprotector role in algae, preventing their photosynthetic system
from damage. In addition, they also participate in processes such as phototaxis (movements resulting
from the intensity of light) or phototropism (movements in the direction of the light). Some microalgae
are capable of generating high amounts of carotenes in response to external stimuli that cause
stress, so that they can adapt to new changes [150]. The microalgae species producing the highest
amounts of carotenoids are Dunaliella salina, which produces β-carotene, and Haematococcus pluvialis,
which produces astaxanthin. Currently, the use of β-carotene is widespread in the industry because
it is a natural ingredient that provides color to matrices, either in food (such as cheeses and butter)
or cosmetic formulations [151]. In addition, carotenoids have an associated provitamin A activity.
Despite being less known, astaxanthin is also a skin and eye protector, muscle strengthener, immune
modulator, and coloring agent. There are studies claiming that the daily ingestion of this astaxanthin
slows down the aging process, as it has a regenerative capacity and is a free radical scavenger [152].
7.2. Phycobilin Pigments
Phycobiliproteins are secondary pigments generated by microalgae, which help them to exploit the
light energy while protecting them from harmful radiation. It seems that the antioxidant mechanisms
within the organisms that create them are very similar to those carried out in food matrices or in the
human organism [153]. The main microalgae producing these compounds are cyanobacteria (Spirulina,
which produces phycocyanin, blue) and cryptomonads, but are also found in red algae (Porphyridium,
which produces phycoerythrin, red). Despite being a labile molecule, phycocyanin is capable of
generating a blue color that other natural dyes do not achieve, so it is used in the manufacture of
foods such as ice cream, yogurt, chewing gum, and beverages, as well as in various cosmetic products,
mainly in Japan [154].
7.3. Phenolic Compounds
Phenolic compounds are a group of secondary metabolites comprising a wide variety of compounds
produced by both terrestrial and aquatic plants, which include, of course, algae [155]. Despite the
well-known diversity of structures of phenolic compounds, they must possess a benzene ring having
at least one hydrogen substituted with a hydroxyl group. One of their most outstanding features
is their antioxidant properties, as they prevent the formation of many free radicals because of their
metal ion chelating capacity [156,157]. Phenolic compounds are commonly classified into 5 large
groups: Flavonoids (the largest subgroup and associated with different bioactivities, among which,
as previously described, the antioxidant, and radical scavenging activity) [158,159], lignans, tannins,
tocopherols, and phenolic acids [160]. They are common compounds in algae, especially in brown
ones, since some species of brown seaweed have phlorotannins, which are polymers of phloroglucinols
(1,3,5-trihydroxybenzene) that can reach up to 15% of the dry weight of these algae [161]. In addition,
they are composed of up to eight rings interconnected with each other, which give antioxidant
properties much higher than many polyphenols obtained from terrestrial plants, since most of them
contain only three or four rings in its structure [155].
7.4. Vitamins and Minerals
Vitamins are well-known for their high antioxidant capacity. However, when attempting to
reproduce their synthesis artificially, a decrease in activity with respect to those obtained directly
from natural matrices was observed [162]. That is why new natural sources containing essential
vitamins are continuously searched. Among them, microalgae biomass contains most of the essential
vitamins (e.g., A, B1, B2, B6, B12, C, E, nicotinate, biotin folic acid, and pantothenic acid), as well
as an interesting variety of minerals (e.g., Na, K, Ca, Mg, Fe, and Zn) [163]. In fact, some species of
microalgae contain high levels of some essential vitamins that are requested in higher quantities by
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humans. This is the case of B12 vitamin, which can be combined with a mineral content, such as iron,
thus converting it in an ideal dietary supplement for vegetarian diets. An example of such combination
is Spirulina. However, and as expected, not all algae contain the same amounts of the same vitamins.
The vitamin content of each species of algae depends on endogenous factors, such as their life cycles,
their growth status and genotype, as well as on exogenous factors, such as the amount of nutrients
in their habitat, the intensity of the light reaching them and the processes they suffer since they are
collected. Therefore, there are several different factors that can be modulated to achieve the desired
amounts of algae vitamins [33].
8. Production and Consumption Statistics and Future Markets
A senior FAO official [31,164] announced in 2017 during the High Level International Meeting
on the Global Initiative “Blue Growth” for Latin America and the Caribbean, held in Mexico City,
that “aquaculture worldwide is the productive sector with the greatest growth, exceeding as of 2011
the growth rates of bovine cattle”. Thus, according to statistics from 2015, the world aquaculture
production consisted in 51.9 Mt of fish (68%), 16.4 Mt of mollusks (21%), 7.4 Mt of crustaceans (10%),
and 0.9 Mt of other aquatic animal species (1%). In particular, aquaculture in inland waters represents
the most important sector of the production of edible organisms (43.6 Mt), which represents 59% of
world production. The average annual growth rate of aquaculture production for 2001–2015 was 5.9%,
significantly lower than in the last two decades of the 20th century, which stood at 10.8% and 9.5%,
respectively. However, the contribution of aquaculture to production has been increasing steadily,
reaching 45% in 2015 from 26% in 2000. If we focus on the world production of aquatic plants, mainly
marine algae, reached 30.5 Mt in 2015. In this case the extractive processes are merely testimonial since
96% of the production (29.4 Mt) were obtained through aquaculture. Analyzing the distribution of
aquatic production at the continental level and according to statistics for 2015, it would be headed by
the Asian continent with a production of 68.4 Mtm. America and Europe would be at a distance with
3.3 Mtm and 3.0 Mtm. Africa produced the order of 1.8 and Oceania would scarcely contribute with
0.2 Mtm. The percentage of world production is shown in Figure 6. Figure 7 shows the weight of the
top 10 world producers in aquaculture. Table 6 presents the evolution in Mtm of the production of the
main producers in aquaculture in recent years.
(a) by continents (b) 10 leading aquatic producers 
  
Figure 6. (a) Distribution by continents of world aquiculture production (2017) (Source: FAO [31,164–166])
and (b) production of the 10 leading aquatic producers in the world (2017) (Source: FAO [31,164–166]).
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Figure 7. Time evolution of world aquaculture algae production in millions of tons from 1990 to 2016
(source: FAO [31,164–166]).
Table 6. Production in aquaculture (Mtm) of main producers in 2015–2016 (Food and Agriculture














Access to statistics on seaweed production is largely dependent on annual publications of the
Food and Agriculture Organization of the United Nations (FAO), such as ‘The State of World’s Fisheries
and Aquaculture.’ The report published in 2018 only comprises production statistics for 2016 [164].
Table 6 shows the production in aquaculture (Mtm) of main producers in 2015–2016.
Meanwhile Figure 6 shows the distribution by continents of world aquiculture production (2017)
(Source: FAO) and the production of the 10 leading aquatic producers in the world [31,164–166].
In 2016, aquaculture was the source of 96.5% of the total volume of 31.2 million tons, including
wild-collected and farmed plants together. When it comes to aquatic plants cultivation, it mainly
refers to seaweeds. Their cultivation almost triplicated in the last ten years. This fact supports the
increase in the use of algae, although the demand still exceeds the supply offered by aquaculture.
Conversely, the production of algae is decreasing (~5%) because of the collection of natural habitats [164].
Figure 7 shows the world evolution of cultivated aquatic plants.
Macroalgae have a large number of applications being the most relevant the production of human
food products [74] and 15% is attributed to algae extracts, like hydrocolloids for their use in fertilizers,
animal feeds and for its biological activities [167]. Nowadays, 221 species of algae are collected globally,
from which 145 are for human nutrition and 101 for phycocolloid production. These include 125
rhodophytes, 64 phaeophytes and 32 chlorophytes [168]. From these, ten are largely cultivated, specially
the brown ones Laminaria japonica, Undaria pinnatifida and the red ones, Porphyra spp., Porphyra tenera,
Eucheuma spp., Kappaphycus alvarezii and Gracilaria spp. and Gracilaria verrucosa [169].
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In 2010, 19 million tons of aquatic plants were produced in aquaculture globally, being sewed
the largest percentage by far with 99.5% of the total. Of all the seaweed used in the world in 2010,
99.5% was prevenient from aquaculture, being a growing economy with a 7.7% per year increase
since the 1970s [170]. The production of Algae is dominated by countries in East and Southeast Asia,
reaching to 99.6% of quantity in 2010. China has the major portion of the production, contributing
with approximately 58% of worldwide cultivated algae production by quantity. Indonesia, Philippines,
South Korea, Japan, and North Korea are some of the other major seaweed producers. Japan has a high
value of production, ranking in third position, due to its high-value of Phorfira production, accounting
for 20% [165,166]. Almost all cultured species produced in East Asia are used for human consumption,
with the exception of a small amount of Japanese brown algae that is also used as a source for the
extraction of algin and iodine. Contrary, in Southeast Asia, Eucheuma algae are the principal cultivated
species, used principally as a source for carrageenan obtaining. Aside Asia, a small fraction is also
cultivated in Zanzibar (Tanzania) and Chile.
Nowadays, algae have several important uses in the food, cosmetic, and fertilizers industries
and in the production of hydrocolloids, such as alginates and agar, being the last one the mainly
current commercial exploitation. Furthermore, the production of bioactives and future commercial
opportunities for seaweed compounds has increased and more than 15 000 different molecules have
been isolated to date [170] hoping to be incorporated in human food, nutraceuticals, pharmaceuticals
and animal stock feeds—but also fertilizers, biofuels, and soil conditioners. Opportunities for utilization
aquafeeds, in food, feed, and nutraceuticals have presented as offering the most promising results
in a reasonable period [171]. The production of seaweed globally has increased over the years as well
has consequently the by-products and co-products derived from them.
9. Conclusions on Trends and Challenges for the Sector
The term “functional food” can be defined as foods claiming to have additional function(s) by
incorporating new ingredients or greater amounts of the existing ones. Such ingredients, called
“functional ingredients” have specific health benefits, including immunomodulation, and reduction
of the risk of certain diseases, among others. Seaweeds that can be consumed by humans appear as
innovative resources with an interesting potential to be used as functional ingredients. Some of them
contain high insoluble dietary fiber. In particular, the high content of non-digestible polysaccharides
converts marine algae in a rich source of prebiotics or prebiotic candidates. Further investigations about
prebiotic properties both in vitro and in vivo are still necessary to incorporate such ingredients in the
formulation of functional foods. On the other hand, certain secondary metabolites from marine algae,
including antioxidants, are able to decelerate or prevent oxidation processes, thus being favorable
health related compounds. Therefore, there is a need to solve problems such as the determination
of the identity of the harvests as fresh materials for functional foods, and the regularization of the
products, because seaweeds from different locations can produce different levels of active compounds.
In addition of being a source of novel, beneficial, and natural products, algae and their cultivation
offer advantages on a larger scale, since aquaculture is an environmentally friendly process and favors
the production of compounds rich in biomass and proteins that could supply or mitigate industries
with many more toxic waste. Furthermore, the implementation of this technique in developing
countries could entail great financial advantages. However, to do so, it would be first necessary to
solve problems, such as the lack of marine spaces, where to carry it out, or the initial economic support.
For the development of the aquatic plants cultivation industry (i.e., algae), the transfer of technological
improvements (i.e., creation of sea beds not requiring coastal areas) to tropical areas would be very
convenient. This way, the problems of lack of cultivable surfaces would be overcome.
In conclusion, governments shRedondelaould become part of this booming industry, supporting
sustainable development through investments in infrastructure, personnel, materials, and projects
aimed at research, development and innovation, thus committing to a green future for our planet.
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Abstract: During the last few decades, the food and beverage industry faced increasing demand
for the design of new functional food products free of synthetic compounds and artificial additives.
Anthocyanins are widely used as natural colorants in various food products to replenish blue color
losses during processing and to add blue color to colorless products, while other compounds such
as carotenoids and betalains are considered as good sources of other shades. Root vegetables are
well known for their broad palette of colors, and some species, such as black carrot and beet root, are
already widely used as sources of natural colorants in the food and drug industry. Ongoing research
aims at identifying alternative vegetable sources with diverse functional and structural features
imparting beneficial effects onto human health. The current review provides a systematic description
of colored root vegetables based on their belowground edible parts, and it highlights species and/or
cultivars that present atypical colors, especially those containing pigment compounds responsible for
hues of blue color. Finally, the main health effects and antioxidant properties associated with the
presence of coloring compounds are presented, as well as the effects that processing treatments may
have on chemical composition and coloring compounds in particular.
Keywords: anthocyanins; antioxidant activity; beet root; betacyanins; cyanidin; blue potatoes;
carotenoids; flavonoids; natural colorants; sweet potato
1. Introduction
Root vegetables display various colors which usually depend on the presence of three major
classes of compounds, namely, flavonoids, betalains, and carotenoids, which they may define their
visual appearance and consumer perception [1,2]. Anthocyanins are flavonoids responsible for the
different shades of plant epidermal tissues such as purple, blue, red, and pink colors, aiming at
attracting pollinators and contributing to the overall plant antioxidant mechanisms under abiotic
and biotic stress conditions [3]. They also participate in several physiological processes of the plant,
including photosynthesis and plant interactions with the environment [4]. They are produced via the
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phenylpropanoid pathway and the conversion of leucoanthocyanidins into colored anthocyanidin
and glycoside derivatives via anthocyanidin synthase and other enzymes [1,5]. The great number of
anthocyanins isolated in nature so far and their high structural variation across plant species raised
research interest in these compounds during the last few years in search of novel natural colorants [6,7].
The structural variation of anthocyanins is related to the substitution of hydroxyl and methoxyl groups
in the B ring, glycosidic substitution at positions 3 and 5 of the A and C rings, and the possible acylation
of glycosidic substitutes with aliphatic and cinnamic acids (Figures 1 and 2) [6]. These structural
differences may infer significant variations in the biological activities and antioxidant properties
of vegetable products. For example, Oki et al. [8] suggested that antioxidant activities of purple
sweet-potato extracts from peonidin-rich cultivars were attributed to anthocyanins, whereas, in those
extracts from cyanidin-rich cultivars, the antioxidant capacity was due to the phenolic compounds.
Other compounds that transfuse blue color in nature are quinones, quinodes, and various alkaloids
which are usually present in fungi, bacteria, and in the animal kingdom [9]. Quinones and quinodes
include carbonyl groups within aromatic rings, and they also show a great variation from a structural
point of view [9], while alkaloids contain nitrogen atoms and are divided into several distinct classes,
including pyridine alkaloids, phenazine alkaloids, and linear tetrapyrrole and indole alkaloids, with
different coloring attributes [9].
Figure 1. The core structure of anthocyanins with two aromatic benzol rings (A and B rings) and a
portion cyclized with oxygen (C ring).
On the other hand, carotenoids are mainly responsible for yellow and orange color with
several distinct compounds being detected so far in various vegetables [6,10–12], while betalains
such as betacyanins and betaxanthins are also important for the violet and yellow pigmentations,
respectively [13]. The main detected carotenoids are β-carotene and lycopene, which are unsaturated
hydrocarbons, and they differ in terms of the β-rings, where β-carotene molecules have both ends
(Figure 3), and they usually present synergistic effects [14]. Both are fat-soluble, and the number of
conjugate double bonds in their structure is closely related to their superoxide inhibitory effect [15,16].
Betacyanins and betaxanthins differ in the moiety derived from betalamic acid, as towel as the fact that
betaxanthins are produced from the condensation of betalamic acid with amino acids and they never
show glycosidation, whereas betacyanins are the result of condensation of betalamic acid with imino
compounds (Figure 4) [17,18]. Further differences are observed within each main class of betalains,
namely, betacyanins and betaxanthins, with several structures identified resulting in different individual
compounds with different absorption and stability capacity [19]. In particular, the various betacyanins
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are differentiated through the glycosyl groups attached to the o-position of the cyclo-dopa moiety [20],
while betaxanthins are differentiated through the conjugated moiety of betalamic acid (amino acids or
amines) [20]. The main pigments isolated in the various root vegetables are presented in Table 1.
Figure 2. The main anthocyanins detected in root vegetables.
Figure 3. The main carotenoids detected in root vegetables.
Figure 4. The main betalains detected in root vegetables.
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The first coloring agents used in food products to improve their visual appearance were produced
from natural sources; however, the high cost for the production of these coloring agents, the variation
in color shades due to the inert variability in natural matrix compositions, and the increasing needs
of the market resulted in the use of synthetic compounds originally derived from coal tar and then
produced from petroleum and crude oil (e.g., FD&C blue No. 1 and blue No. 2) [9,59]. The consumer
concerns about additives and synthetic compounds, amplified by the reports regarding the health
risks and the environmental impact associated with these compounds [60–62], necessitated the shift
to the root food industry dyes; recently, the food and beverage industry is seeking natural coloring
agents that could substitute synthetic dyes and coloring additives [63,64]. The colorant content
of root vegetable products is associated with various health benefits including the prevention of
modern chronic diseases [65–67]. However, they are often highly concentrated in the epidermal
layers and skin tissues which are commonly discarded during domestic processing or in industrial
applications [68–70]. For this reason, the research interest in obtaining natural pigments and bioactive
compounds from agro-food waste is gaining ground within the context of circular economy and the
sustainable use of natural resources [70–74]. There are also several cases where colorants can be found
in high concentrations in the flesh due to the presence of pigments in parenchymal cells, increasing the
antioxidant capacity and functional value of these products (e.g., potatoes, beets, carrots, and other
root vegetables having colored flesh) [3]. Pigment compounds contribute to the overall antioxidant
capacity in a dose-dependent and compound-specific manner [75–77], although the bioavailability and
the absorption mechanisms within human body still need to be addressed [78]. Notwithstanding the
genetic background of each species and/or cultivar, color attributes may be modulated by environmental
factors such as the light and temperature conditions, through biotic and abiotic elicitors that may affect
chemical composition, hormonal signaling, and enzymatic activities. Although not directly exposed
to solar radiation, the pigmentation of root vegetables developing belowground may be indirectly
modulated by the level and quality of radiation to which the aboveground plant is exposed [79].
In addition to pre-harvest factors, post-harvest conditions and processing methods may have an
impact on bioavailability and biostability of natural matrices and coloring compounds [13,80,81].
Anthocyanins in particular are considered a good option as natural coloring agents due to their low
toxicity and the wide range of health effects they present [82]. However, the stability and bioavailability
of anthocyanins are affected by several factors (chemical structure and concentration, pH of food
matrix, temperature, light, presence of co-pigments, enzymes, and metallic ions, among others), which
determine the processing method specificity, and which need to be considered before using these
compounds as natural coloring agents in the food industry [83,84]. Moreover, the association of
structural differences with biostability and bioavailability is further reflected in the biological activities
of these compounds, since, for example, acylated forms are less prone to degradation due to pH
variations [14,85]. Therefore, although, for some species, there are already defined protocols for the
extraction and processing requirements for obtaining natural colorants (e.g., black carrot, beet root
colorants) [71,86–88], there is still a gap in the literature for other colored vegetables which could prove
valuable candidates for yielding coloring agents.
The present review aims to present the main colored root vegetable crops, focusing on cultivars
with colors atypical for the species. Special attention is given to blue- and purple-colored vegetables
since natural colorants of these shades are less common in nature and are highly sought by the
food industry, since blue shades are more difficult to replicate in food and beverages due to the
susceptibility of coloring compounds to external factors (e.g., pH of the food matrix, extraction
conditions). Furthermore, the main compounds responsible for uncommon colors are presented,
as well as their antioxidant capacity and health-promoting effects. Finally, the effects of processing
treatments on color stability are addressed. The presented information in this review was obtained
from worldwide accepted databases such as Scopus, ScienceDirect, PubMed, Google Scholar, and
ResearchGate, using the respective names of the studied species (both common and Latin names) and
the additional terms of the main colorants and “health effects” as keywords.
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2. Main Colored Root Vegetables
2.1. Potato
Potato (Solanum tuberosum L., Solanaceae) is the third most important food crop in the world, after
wheat and rice [89]. In addition to its nutritional and calorific value, potato varieties also offer bioactive
compounds with beneficial effects for human health, such as phenolic compounds and carotenoids,
among others [12,23]. Several reports highlighted the beneficial effects of antioxidant-rich potatoes
against various diseases, such as cardiovascular diseases [90] and various types of cancer [91,92].
Although yellow- and white-fleshed tubers are the most commonly used ones throughout the world,
potato has the highest genetic diversity among cultivated species, with approximately 5000 known
varieties with broad variability in terms of flesh and skin color [93]. Red- and blue-fleshed potatoes
are particularly rich in phenolic compounds, presenting about three times higher amounts of total
polyphenolic content than traditional yellow-fleshed tubers, as well as two to three times higher
antioxidant activity [12,23,24,94].
Acylated forms of anthocyanins were reported to be the main compounds responsible for the red
and purple flesh color of potatoes [94]. In particular, the deep-purple color of potato flesh and skin is
associated with the presence of petunidin derivatives, although studies on metabolite profiling revealed
a genotype- and tissue-specific pattern regarding the anthocyanin composition [22]. Petunidin was the
major anthocyanidin compound found both in the flesh and the peel of purple potato varieties studied
by Yine et al. [21]. In this study, petunidin accounted for 63–66% of the total anthocyanidin content
of purple peel and flesh. The same findings were observed by Kita et al. [23] when studying purple-
and red-fleshed potato cultivars, where petunidin-3-p-coumaroylrutinoside-5-glucoside was the major
anthocyanin compound found in the purple-fleshed varieties Salad Blue (29.31 ± 0.73 mg·100 g−1 dry
weight (dw)), Valfi (43.11± 0.37 mg·100 g−1 dw), and Blue Congo (36.32± 0.33 mg·100 g−1 dw). Similarly,
Nemś et al. [24] identified petunidin-2-p-coumarylrutinoside-5-glucoside as the major anthocyanin
present in the cultivars Salad Blue (28.34± 9.30 mg·100 g−1 dw), Valfi (57.77 ± 28.75 mg·100 g−1 dw), and
Blue Congo (75.97 ± 12.38 mg·100 g−1 dw). On the other hand, in red-fleshed potatoes, pelargonidin
acyl-glycoside derivatives appear as the main anthocyanin compounds. Kita et al. [23] found
pelargonidin-3-p-coumaroylrutinoside-5-glucoside as the major anthocyanin present in red-fleshed
varieties, such as Rosalinde (15.14 ± 0.12 mg·100 g−1 dw), Herbie 26 (44.46 ± 0.23 mg·100 g−1 dw), and
Highland Burgundy Red (126.38 ± 0.71 mg·100 g−1 dw). Yin et al. [21] carried out an acid hydrolysis of
the anthocyanins, studying the composition of the aglycones (anthocyanidins), reporting pelargonidin
as the main anthocyanidin present in the red-fleshed cultivar Red Cloud No. 1, with a concentration
of 11.73 ± 0.16 mg·100 g−1 fresh weight (fw), which corresponded to 82% of the total anthocyanidin
content. Other anthocyanin compounds were reported in the literature for red- and purple-fleshed
potatoes, including delphinidin, cyanidin, peonidin, and malvidin acyl-glycoside derivatives [21,23].
Moreover, the simulation of domestic cooking processing and gastrointestinal digestion of Solanum
tuberosum L. cv Vitelotte noire extracts revealed significant antimicrobial and anti-proliferative activities
against Bacillus cereus and Escherichia coli in the first case (domestic cooking processes) and colon
(Caco-2 and SW48) and breast cancer (MCF7, MDA-MB-231) cell lines in the latter case (gastrointestinal
digestion) [95].
Carotenoids are fat-soluble pigments that can exert antioxidant properties, and they are also present
in colored-flesh potatoes. According to Kotíková et al. [25] who compared the carotenoid content of
yellow-fleshed, white-fleshed, purple-fleshed, and red-fleshed potato cultivars, significant differences
were observed. Interestingly, yellow potatoes showed a much higher average total carotenoid content
(26.22μg·g−1 dw) in comparison to the red and purple-fleshed cultivars (5.69 μg·g−1 dw), indicating that
carotenoid pigments are not highly concentrated in the flesh of purple- and red-fleshed potatoes [25].
Yin et al. [21] investigated 10 colored potato cultivars from China and compared the composition
and antioxidant activities of their flesh and peel. The authors found that potato peels were on average
15.34 times richer in anthocyanins than the flesh; the antioxidant activity of the peels extracts was also
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5.75 times higher on average than that of the flesh extracts [21]. In the same study, the flesh extracts of
cv. Purple Cloud No.1 showed the strongest antioxidant activity among all the tested varieties, along
with the highest total content of anthocyanidins (43.38 mg·100 g−1 fw), a correlation which indicates
anthocyanins as a major contributor to the antioxidant activity of colored potatoes [21].
Recently, there was increasing interest by consumers and food producers in colored potato
varieties, due to their attractive organoleptic features (color and taste) and health-promoting chemical
composition [12]. The increasing interest of the market for colored potato is stimulating private
and public breeding programs to release new specialty potato cultivars such as the red-skin and
red-flesh TerraRossa and AmaRosa or the purple-skin yellow-flesh cultivar Huckleberry Gold and
Peter Wilcox, marketed as “Purple Sun” or “Blue Gold”, which are also characterized by a higher
content of anthocyanins, anthocyanidins, and other phenolic compounds [96]. The consumption of
anthocyanin-rich food products such as purple-flesh potatoes is associated with the modification
of the expression of various genes involved in the metabolism of lipids, inflammation, and energy
homeostasis in liver and/or fat tissues [97,98]. Moreover, extracts from purple potato tubers may
improve the differentiation of gut epithelia and its barrier function against gut epithelial inflammation
through the activation of AMP-activated protein kinase (AMPK) and the increase of CDX2 gene [99].
Color-fleshed potatoes are an excellent source of bioactive compounds that are effective against
human colon cancer cell lines (HCT-116 and HT-29); however, prolonged storage may affect their
antiproliferative and pro-apoptotic activities [100]. Red- and purple-fleshed potato extracts were also
effective against tert-butyl hydroperoxide (t-BHP)-induced hepatotoxicity through the recovery of
serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) enzyme activities [101].
Therefore, a market niche for colored potato-based food products was created, such as potato chips and
crisps. However, the frying process to produce colored potato crisps can cause a 38–70% degradation of
anthocyanin compounds, with pelargonidin and malvidin acyl-glycoside derivatives being more stable
during the frying process in comparison to petunidin acyl-glycoside derivatives [23]. Nevertheless,
despite the reduced contents of anthocyanins in processed compared to raw potatoes, colored potato
crisps can present bright attractive colors, in addition to 2–3 times higher antioxidant activities and
40% higher contents of polyphenols than standard snacks made of commonly used yellow potatoes
and corn [23,24]. Moreover, in a recent study, Nemś and Pęksa [94] incorporated dried red- and
purple-fleshed potatoes into fried snacks and doughs, reporting a beneficial effect on the inhibition
of oxidative changes in lipids compared to control material (yellow snacks), particularly when
incorporating material from purple-fleshed potato varieties of Blue Congo and Valfi. These effects
were attributed to the higher content of colored snacks in polyphenols and anthocyanins than control,
with petunidin 2-p-coumaroyl-rutinoside-5-glucoside being the major anthocyanin present in both
cultivars [94]. Other domestic cooking processes such as boiling, baking, steaming, and microwaving
may also affect the anthocyanin content and antioxidant capacity of colored potatoes, with processing
(steaming and microwaving) showing the best results in retaining anthocyanin content and antioxidant
activity [102–106]. Thermal processing affects not only anthocyanins but also carotenoids which are
heat-sensitive and may be degraded, isomerized, or oxidized after domestic cooking processes [25].
According to Qiu et al. [107], anthocyanin content decreased with prolonged drying time and high
drying temperatures due to higher degradation rates and shorter half-life values compared to shorter
drying procedures with lower temperatures. Therefore, the antioxidant properties of colored potatoes
can be beneficial not only to human health but also to the shelf life of processed food products. Another
important aspect of processed food products based on processed colored potatoes is that the various
types of processing (French fries, chips, and puree) reduce the content of antinutritional factors such as
the glykoalkaloids α-chaconine and α-solanine, thus increasing the overall nutritional quality of the
semi-processed and final products [108].
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2.2. Sweet Potato
Sweet potato (Ipomoea batatas (L.) Lam., Convolvulaceae) is a perennial species native to Latin
America which is highly appreciated for its fleshly tuberous roots that are widely used in the food and
non-food industry depending on starch content and properties [109,110]. In Japan, purple sweet-potato
anthocyanins are used as ingredients in several food products and beverages [111,112]. The flesh of the
roots is usually white, yellow, or orange, although several cultivars with purple-colored flesh and a high
content of anthocyanins also exist [113,114]. It is the fourth most produced vegetable in the world after
potato, cassava, and tomato with a total production of 113 million tons in 2017, most of which (63.8%)
were produced in China [115]. The nutritional value of the edible roots consists in the richness of
carbohydrates, dietary fibers, vitamins, and minerals, while several polyphenolic compounds, peptides,
and carotenoids are also present in considerable amounts in the flesh [116] and peels [74] of the tubers.
The high calorific value of sweet potato roots makes the species one of the most important food crops
in terms of calorific contributors to the human diet [117]. Starch is the main calorific component of
sweet-potato tubers with significant variation in its structural and functional properties which depend
mostly on the genotype and are not correlated with flesh color [118], although, using a proteomic
approach, a recent study revealed that starch degradation may contribute to anthocyanin biosynthesis
and accumulation in purple sweet-potato roots [119]. Chlorogenic acid, protocatechuic acid, salicylic
acid, and caffeoylquinic acid derivatives are the main phenolic acids detected in purple sweet-potato
roots and are responsible for their antioxidant capacity [48,120,121], while orange-fleshed sweet-potato
cultivars are rich in provitamin A and also show significant antioxidant activity [113,122,123]. Moreover,
in the study of Lebot et al. [124], the antioxidant activity of sweet-potato cultivars with purple, orange,
and white flesh was correlated mostly with the presence of caffeoylquinic acid derivatives and less with
total anthocyanin content, whereas, according to Oki et al. [8], the contribution of phenolic compounds
in radical-scavenging activity is also dependent on the genotype. In contrast, according to the study of
Kubow et al. [125], anthocyanins are responsible for the antioxidant capacity of sweet-potato tubers.
In the same study, it was reported that the anthocyanin species were detected in the small intestinal and
the ascending colonic vessel, depending on the sweet-potato genotype, and the antioxidant activity
was increased accordingly [125]. According to the report of Meng et al. [126] who studied the digestion
kinetics of sweet-potato polyphenols, the maximum release was recorded 2 h after intestinal digestion
and was induced by gastric acid and pepsin [126]. Moreover, acylated anthocyanins from sweet potato
are considered as complex and less susceptible to intestinal degradation [127,128], while Sun et al. [129]
suggested a prebiotic-like activity of anthocyanins through the modulation of microbiota in the intestine.
These results highlight the importance of unraveling the bioavailability and bioaccessibility patterns
influencing the antioxidant potential of purple-fleshed sweet potatoes [125].
Acylated anthocyanins are responsible for the intense color of purple-fleshed sweet
potatoes [66,130], which renders them good candidates sources for natural colorants with practical
application in the food industry [131]. Moreover, peels are also a good source of natural
pigments since they contain significant amounts of anthocyanins, and the exploitation of this
by-product for obtaining coloring agents would increase the added value of the sweet-potato
crop [74]. The total anthocyanin content and compositional profile may differ among the various
genotypes, with a total of 39 different anthocyanins isolated so far [132,133]. The main anthocyanins
isolated from purple sweet-potato extracts were identified as cyanidin, peonidin, and pelargonidin
derivatives [26–30,110,134,135], which were effective against alcohol-induced liver injury in rats when
administrated at median doses (100 mg·kg−1 body weight), whereas higher doses (300 mg·kg−1
body weight) had a pro-oxidant effect and promoted liver injury [136]. Moreover, cyanidin
3-caffeoyl-p-hydroxybenzoyl sophoroside-5-glucoside which was isolated from purple-fleshed sweet
potatoes was shown to be effective both in vitro and in vivo in inhibiting hepatic glucose secretion and
reducing blood glucose [137–139], while peonidin suppressed the excessive expression of the HER2
protein showing anticancer activities [140]. According to Luo et al. [141], cyanidin 3-caffeoyl-feruloyl
sophoroside-5-glucoside and peonidin 3-dicaffeoyl sophoroside-5-glucoside were the most effective
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anthocyanins isolated from the purple sweet-potato cultivar Eshu No. 8. In another study, the oral
administration of purple sweet-potato color attenuated cognitive deficits in domoic acid-treated
mice through mitochondrial biogenesis signaling and the decrease of p47phox and gp91phox
expression [142], while similar results were reported by Zhuang et al. [143], who suggested the
regulation of AMPK/autophagy signaling as the mechanism of action. The same pigment was effective
against neuroinflammation in mouse brain through the inhibition of mitogen-activated protein kinase
(MAPK) and the activation of nuclear factor κB (NF-κB) [144], as well as against bladder cancer
through the inhibition of the signaling of phosphatidylinositol-4,5-bisphosphate 3-kinase/Akt or
protein kinase B (PI3K/Akt) [145]. In particular, for mitochondrial biogenesis, it was reported that
anthocyanins can bind and stimulate estrogen receptor-α and then increase the expression of nuclear
respiratory factor-1 (NRF-1) [146]. Anthocyanin-rich extracts from purple sweet potato were moderately
effective against human colon cancer cell lines (HCT-116 and HT-29) through the inhibition of tyrosine
kinase activity, whereas they showed no effectiveness against the CCD-33Co cell line [67]. Moreover,
Yoshimoto et al. reported that the antimutagenic activity of sweet-potato extracts was attributed
mainly to cyanidin content (63% inhibition of mutagenicity of Trp-1 against Salmonella tymphimurium
TA 98 at the dose of 1.5 mM) [147], while Zhao et al. suggested that anthocyanin-rich extracts from
sweet potato are potent anti-aging (at the dose of 1000 mg/kg body weight), anti-hyperglycemic
(at the dose of 1 g/kg body weight), and anti-tumor agents (68% tumor inhibition at the dose of
1000 mg/kg body weight) [148]. In another study, highly acylated anthocyanins showed effectiveness
against hyperuricemia and kidney inflammation in allopurinol-induced hyperuricemic mice [149],
while purple sweet-potato color reduced renal damage through the downregulation of vascular
endothelial growth factor receptor (VEGFR2) expression [150]. The regular intake of anthocyanins is
also highly associated with the prevention of various chronic liver diseases, and it can reduce lipid
accumulation in liver tissues and alleviate oxidative stress and hepatic inflammation [25,102,151–156].
Other hepatoprotective effects of purple sweet potatoes include hepatic insulin resistance in high-fat
diet-treated mice through the decrease of reactive oxygen species (ROS) production and the inhibition
of endoplasmic reticulum (ER) liver stress (administration of purple sweet-potato color at the dose
of 700 mg/kg/day) [157], through the decrease in the expression of ionized calcium-binding adapter
molecule 1 (Iba1), tumor necrosis factor-α, interleukin-1β, suppressors of cytokine signaling3 (SOCS3),
and galectin-3 (administration of purple sweet potato color at the dose of 500 mg/kg/day) [158],
or through the inhibition of nucleotide-binding domain, leucine-rich repeat (NLR) family, pyrin
domain containing 3 (NLRP3) inflammasome activation (administration of purple sweet potato color
at the dose of 700 mg/kg/day) [159]. Moreover, the combinative use of black soybean and purple
sweet potato (mixtures of 2:2 for black soybean and purple sweet potato) resulted in improved
insulin sensitivity in streptozotocin-induced diabetic rats through the improvement of insulin and
insulin receptor substrate-1 (IRS-1) expression, the increase of superoxide dismutase (SOD) levels,
and reduced pancreatic necrosis [160]. In a similar study, the mixture of Curcuma longa L. and sweet
potato (at the dose of 2–5 mg/kg body weight) showed significant immunomodulating properties
in murine leukemia retrovirus-infected mice [161]. The administration of purple sweet potato to
obese mice fed with a high-fat diet exhibited anti-obesity effects and attenuated gain weight [162].
Other bioactive compounds of purple sweet potatoes include alkali-soluble polysaccharides which
presented anti-inflammatory properties in lipopolysaccharide (LPS)-treated macrophages (RAW
264.7) through the inhibition of nitric oxide, interleukin (IL)-6, IL-1β, and tumor necrosis factor
alpha (TNF-α) and the increase of IL-10 [163], as well as anti-inflammatory effects against intestinal
inflammation on dextran sulfate sodium (DSS)-induced mice [164], hepatoprotective properties [165],
and immunomodulatory effects [166–168]. Non-flavonoid compounds and kaempferol derivatives
are also present in sweet-potato tuber tissues, and they contribute to the overall bioactive capacity of
sweet potato [28].
Processing and storage conditions are important for the chemical composition and the visual
quality of sweet-potato tubers, with heating treatments and higher pH having a detrimental effect on
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anthocyanins and starch content and on flesh color [139,169–172]. Pretreatments such as blanching,
osmotic dehydration, ultrasound-assisted dehydration, and ultrasound-assisted osmotic dehydration
before microwave drying also had an impact on total phenolic and anthocyanin content of orange- and
purple-fleshed sweet-potato slices [173]. Domestic cooking processes may also affect total anthocyanin
and total phenolic content, with steaming suggested as the mildest process to retain the highest amount
of total anthocyanins compared to fresh samples, while, at the same time, an increase in total phenolic
content was observed by Phan et al. [174]. In a similar study, steaming, roasting, and boiling were
suggested as the best cooking methods for retaining total phenolic, anthocyanin, and carotenoid
content, respectively, in white, yellow, orange, light-purple, and deep-purple sweet-potato tubers [10].
2.3. Carrot
Carrot (Daucus carota L. ssp. sativus Hoffm.) belongs to the Apiaceae family and is a highly
appreciated vegetable consumed for its edible fleshy roots. There are two cultivar groups depending on
root color, namely, the carotene or western carrot (Daucus carota ssp. sativus var. sativus) and the eastern
or anthocyanin carrot (Daucus carota ssp. sativus var. atrorubens Alef.), which are widely cultivated
throughout the world with an annual production of 42.8 million tons including turnips [115]. Although
the orange-colored carrots are the most popular ones, a broad genetic basis exists with many other
shades of root flesh (red, white, yellow, black, purple, or multi-color) which attract interest due to their
nutritional value and associated health effects [175]. Recently, new genetically biofortified cultivars
were developed which contain not only α- and β-carotene but also anthocyanins and lycopene [176].
In particular, for black or purple carrots, several research reports highlighted their beneficial health
effects on human health, and they are widely used so far as natural sources of blue color and functional
ingredients in the food industry [33,40].
Black carrots contain high amounts of mono-acylated anthocyanins which are less prone to thermal
degradation, while they can retain their color at various pH values and storage conditions [31,32,34].
These functional and structural characteristics of colored carrot pigments make them good candidates
for the extraction of natural colorant agents with practical applications in the food industry, especially
in food products with low pH, in beverages and confectioneries [40,131,177]. However, despite
their stability under various conditions, Espinosa-Acosta et al. [82] did not suggest their use in food
models such as yoghurt and jelly, except for the case of ethanolic extracts of black carrots, which
could be incorporated into jellies to increase the antioxidant activity of the final product. Moreover,
Assous et al. [86] suggested the use of black-carrot pigments as coloring agents in hard candy and
sweet jelly without significant differences in the sensorial profile compared to the control, while the
same pigments protected sunflower oil from lipid peroxidation. The use of black-carrot extracts was
also proposed for the preparation of jams and marmalades, where the main anthocyanins were slightly
affected after gastric ingestion and storage at 4 ◦C [178], as well in co-pigmentation with other natural
colorants (e.g., plum, jamun, strawberry, and pomegranate juices), to increase the color stability to heat
treatments and pH variation [179]. On the other hand, red and yellow carrots are rich in carotenoids
and lycopene and β-carotene in particular [37,38], which, according to Horvitz et al. [180], are both
bioavailable and can provide a significant amount of these carotenoids to human diet.
The main anthocyanins detected are mostly cyanidin derivatives, and, according to
Frond et al. [48], the most abundant anthocyanin identified in black-carrot extracts was
cyanidin-3-(p-coumaroyl)-diglucoside-5-glucoside. In the study of Montilla et al. [33], the main
detected anthocyanins in Daucus carota subsp. sativus var. atrorubens Alef. were identified as acylated
cyanidin 3-xylosyl(glucosyl)galactosides with sinapic acid, ferulic acid, and coumaric acid, and
significant differences were observed between genotypes (Antonina, Beta Sweet, Deep Purple, and
Purple Haze) in terms of total and individual anthocyanin content. Similar results were reported
in the earlier study of Kammerer et al. [181], with acylated and non-acylated cyanidin derivatives
found in the highest amounts, while they also suggested significant differences between 15 different
black-carrot cultivars, as well as between roots of the same cultivar. Moreover, in black-carrot juice,
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two more compounds were identified, namely, cyanidin-3-xylosyl-galactoside and cyanidin-3-xylosyl
(feruloylglucosyl)galactoside [35], while Schwarz et al. [36] isolated four more pigments identified as
vinylphenol and vinylguaiacol adducts of cyanidin derivatives which are formed during the storage
of juice through the reaction of phenolic acids with anthocyanins. Regarding the health effects of
anthocyanins, extracts from purple carrot were moderately effective against HCT-116 human colon
cancer cell lines through the inhibition of tyrosine kinase activity, whereas they showed no effectiveness
against HT-29 and CCD-33Co cell lines [67]. Yet, black-carrot crude extracts exhibited significant
antioxidant, cytoprotective, and anti-angiogenic properties, indicating a synergistic effect of the
various polyphenols (anthocyanins, phenolic acids, and flavonoids) contained in the root extracts [182].
Although non-digested purple carrot extract is more potent than the digested extract, Olejnik et al. [183]
reported that gastrointestinal digested purple-carrot extract had intracellular ROS-inhibitory activity
and protected colonic cells against oxidative stress by reducing oxidative DNA damage by 20.7%.
According to Blando et al. [184], the anthocyanin-rich extracts from black carrots contained mostly
anthocyanins acylated with cinnamic-acid derivatives, which exhibited anti-inflammatory activities
through the reduction of the expression of endothelial inflammatory antigens. Apart from anthocyanins,
black carrots are a good source of phenolic acids, namely, chlorogenic and caffeic acids, which contribute
to the overall antioxidant capacity [48,185].
Processing may affect the chemical composition and antioxidant properties of black-carrot
juice, and the use of pectinase during maceration increased the total anthocyanin content, the overall
antioxidant capacity, and the juice yield of enzyme-treated compared to normally pressed juice [186,187].
The use of ultrasound and mild heating (50 ◦C) may increase the extraction yield of anthocyanins from
black-carrot pomace, especially the content of cyanidin-3-xyloside-galactoside-glucoside-ferrulic acid
and cyanidin-3-xyloside-galactoside, which were detected in the highest amounts [71]. Another
processing treatment which could increase the bioavailability and stability of anthocyanins in
black-carrot-based food products is the microencapsulation of anthocyanin-rich extracts [83]. Moreover,
wounding stress may increase anthocyanin content, chlorogenic acid in particular, thus improving the
nutritional and functional value of the obtained food products [188].
2.4. Beet Root
Beet or table beet (Beta vulgaris L.) belongs to the Amaranthaceae family and is commonly used
for its edible fleshy red roots and tender leaves. Beet roots contain betalains, a class of compounds
which is further divided into betacyanins and betaxanthins [39]. The composition of betalains and the
ratio of betacyanins to betaxanthins depends on tyrosine production and its conversion to betalains,
with significant differences observed between red and yellow beet roots [189]. The most commonly
found betacyanins are betanins which are responsible for the red vivid color of beet roots, and they are
water-soluble and sensitive to prolonged heating [40]. Betanins are commercially available as color
additives (E162) in powder form or as juice concentrates following vacuum evaporation [39]; however,
there is a great diversity in flesh color among the beet-root genotypes with variable intensities of red color
or other shades ranging from white to orange. Apart from the genotype, color intensity is also affected
by growing conditions and maturity stage, storage conditions, and processing treatments [88,190,191].
Beet roots with yellow color are most abundant in betaxanthins, while betacyanins are present in lesser
amounts [41]. In the study of Wettasinghe et al. [192], beet-root genotypes with diverse flesh colors
exhibited significant differences in antioxidant activity and in phase II enzyme induction capacity,
which is associated with cancer chemoprotective effects [192]. Moreover, Lee et al. [42] reported that
betanine and betaine extracted from red- and yellow-colored beet roots were effective against HepG2
cell proliferation in a dose-dependent manner. In the same study, the main identified betalains detected
in the cultivar with yellow roots (Burpee’s Golden Globe) were vulgaxanthin I and betanin [42].
Vulić et al. [193] also reported that the beet-root pomace, a by-product of the beet-root juice extraction,
has a high content of betalains and phenolic compounds which exhibited in vitro antiradical activities
against 2,2-diphenyl-1-picrylhydrazyl (DPPH) radicals and in vivo antioxidant and hepatoprotective
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activity, suggesting that it could be used as an excellent nutraceutical resource or an ingredient of
functional food products.
2.5. Yam
Yam includes various species of the Dioscorea genus (Dioscoreaceae), although sometimes it is
confused with other root vegetables such as sweet potatoes, oca, taro, etc., which locally may be referred
to as yams [194]. Tuber flesh color can be white, yellow, red, or purple depending on the cultivar, with
significant differences in bioactive compound content and antioxidant properties [194,195]. Purple
yam or water yam (Dioscorea alata purpurea) is usually cultivated in tropical and subtropical regions of
the world, and its edible roots are very rich in starch and amylose [196], although a great variation
in chemical composition of the edible parts of the species was reported [197]. Resistant starch from
purple yam (D. alata) was effective against hyperlipidemia in high-fat diet-fed hamsters through
the amelioration of lipid metabolism and the modulation of gut microbiota [196,198]. Moreover,
extracts from roots significantly reduced blood glucose levels in Wistar rats with alloxan-induced
hyperglycemia [199] or cholesterol (total and low-density lipoprotein (LDL)) and triglycerides in
hypercholesterolemic rats [200], ameliorated doxorubicin (DOX)-induced cardiotoxicity [201], showed
protective effects against aniline-induced spleen toxicity [202] and in vivo anti-inflammatory activities
against λ-carrageenan-induced paw edema in mice [203], and could be used as an adjuvant in
bone-marrow-derived dendritic cell (DC)-based vaccines for cancer therapy [204]. D. alata root extracts
may also alleviate cellular fibrosis through the downregulation of the transforming growth factor-beta
(TGF-β)/Smad signaling pathway and the modulation of epithelial–mesenchymal transition (EMT)
expression in kidneys [205]. On the other hand, according to Chan et al. [206], root extracts are
also effective against CCl4-induced liver injury and hepatic fibrosis. Other health effects include
the improvement in function of large bowel and modulation of fecal microflora [207], beneficial
effects in gastrointestinal function [208] and cognitive ability [209,210], and the activation of the
immune system [211]. The root color of purple yam (D. alata) is attributed to the high content of
anthocyanins which exhibit significant antibacterial activities [212], anti-inflammatory effects on
trinitrobenzenesulfonic acid (TNBS)-induced colitis in mice [213], antiglycative properties [214], and
antidiabetic properties [215,216]. The main detected anthocyanins in this species were identified as
cyanidin, pelargonidin, and peonidin-type compounds and alatanins A–C [43]; however, the individual
compound profile and the overall anthocyanin content are affected by maturity stage and the expression
of the concomitant genes [44]. Apart from D. alata, which is considered the main purple yam, there
are also cultivars of D. trifida or cush-cush yam which contain peonidin, cyanidin, and pelargonidin
aglycones [45]. Other compounds with bioactive properties are also present, namely, phenolic acids
such as ferulic, sinapic, vanillic, caffeic acid, and p-coumaric acid, and others, which presented
immunomodulatory properties [217,218], proteins with estrogen-stimulating activities that may relieve
menopausal syndrome [219], allantoin and dioscin [220], dioscorin [221], or β-sitosterol and ethyl
linoleate with anti-atherosclerotic activity [222]. On the other hand, carotenoids and β-carotene in
particular are responsible for the root color of yellow yam (D. cayennensis) [47]. Yam roots may
contain antinutritional factors such as tannins and diosgenin, which also present bioactive properties.
For example, antidyslipidemic effects were reported for diosgenin extracts from purple and yellow
yams without affecting body weight gain [220,223], while diosgenin and furostanol glycosides and
spirostanol glycosides were effective against the proliferation of various cancer cell lines (MCF-7, A
549, and Hep G2) [224].
A very common use of purple yam is the substitution of wheat flour for bakery products and food
products in general without affecting the sensorial acceptance of the products by consumers [225–227],
while yam flour can be used for gluten-free bakery products [228].
110
Antioxidants 2019, 8, 617
2.6. Onion
Onion (Allium cepa L., Alliaceae) is one of the most important species of the Allium genus, which is 
commonly used for its edible bulbs. There is a great number of cultivars available with a great diversity 
in color, which usually refers to bulb skin color, since, in most cases, the presence of pigments is limited 
to the outer skins of the bulb [229]. In many countries, onion bulbs are considered the main dietary 
source of flavonoids, a high proportion of which is attributed to the anthocyanin content [70,230]. 
However, most of the studies refer to red-onion cultivars which contain various polyphenols including 
acylated and non-acylated cyanidin glucosides, and less information is available about the profile 
of anthocyanins in purple onions [48,49]. The biosynthesis of anthocyanins involves the shikimate 
pathway and the activity of anthocyanidin synthase, which catalyzes the production of anthocyanidins, 
and, after further enzymatic reactions, the various anthocyanins are produced [5]. Comparing green, 
yellow, red, and purple onion, Benkeblia [231] observed higher total phenolic content and antioxidant 
properties in red and purple onion-bulb extracts. Similar results were reported by Zhang et al. [232] 
in a study comparing white, yellow, and red onion, with the latter showing considerably higher 
total anthocyanin, flavonoid, and polyphenol content, which was also correlated to high antioxidant 
activity measured through DPPH, 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS•+), and 
fluorescence recovery after photobleaching (FRAP) assays. Bulb extracts are potent bioactive natural 
matrices, and, according to the study of Oboh et al. [233], extracts of purple onion were effective against 
angiotensin-converting enzyme, α-amylase, and α-glucosidase activity, showing significant antidiabetic 
and anti-hypertensive effects. Moreover, skins of pearl onion exhibited significant anti-inflammatory 
properties and inhibitory effects against radical-induced DNA scission [234]. In terms of antioxidant 
activity, purple onions exhibited higher oxygen radical absorbance capacity (ORAC) values than white 
onions, which indicates a higher concentration of bioactive compounds [235]. A preliminary study 
conducted by Khiari et al. [236] suggested that, depending on the quality of the plant residues, onion 
solid waste, also constituted primarily by the outer dry layers of the bulbs, may be used to extract 
polyphenols with potential antioxidant activity, and the yield of total polyphenols can be optimized 
using ethanol extracts, with extraction time up to 6 h, while maintaining relatively low extraction 
temperature (40 ◦C gave better results than 60 ◦C).
2.7. Other Root Vegetables
Radish (Raphanus sativus L., Brassicaceae) is a cruciferous species, well known for its normally 
white edible fleshy hypocotyls which come in different shapes, sizes, and skin colors. Apart from 
white-fleshed cultivars, there are also genotypes with pink and purple hypocotyls due to the presence of 
pigments in the xylem [50]. Pigmentation may also change with the hypocotyl development stage [237]. 
Purple color implies the presence of anthocyanins, and, according to the study of Reference [51], 60 
different compounds were detected and identified as cyanidin glucosides. Most of the anthocyanins 
are present in acylated forms of cyanidin glucosides which increase their stability, and they could be 
easily used as natural colorants in functional foods [7,50,238,239], while root extracts may also exhibit 
beneficial health effects against gastric injuries [240].
Purple kohlrabi (Brassica oleracea var. gongylodes) is another species of the Brassicaceae family with 
intense purple color, whose edible part is the swollen fleshy meristem. The pigments are located in the 
meristem skin and consist of cyanidin and cyanidin glucosides which are responsible for the strong 
antioxidant properties of the species [54–57]. Examining the antioxidant activity of kohlrabi ethanol and 
water extracts, Pak et al. [241] observed strong DPPH radical-scavenging activity, and purple kohlrabi 
extracts had higher antioxidant capacity compared to green kohlrabi extracts. Similarly, comparing 
green and red kohlrabi, Jung et al. [242] observed that the latter had double the total phenolic content, 
as well as a higher antioxidant (DPPH, ABTS, and peroxynitrite scavenging activity assay (ONOO−)) 
effect compared to green kohlrabi. In the same study, red kohlrabi methanol extract had stronger 
anti-inflammatory, antidiabetic, and antioxidant effects than the green kohlrabi methanol extract.
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Taro (Colocasia esculenta L.) is a root vegetable of the Araceae family with great genetic diversity
in plant morphology, including the color of corm flesh, which can be white, purple, brown, or
blackish [57,243,244]. The main detected anthocyanins were identified as cyanidin and pelargonidin
glucosides, and they exhibit significant antioxidant and anti-inflammatory activities [58].
3. Conclusions
Root vegetables with intense and uncommon colors are very important in the human diet, not
only because they increase the overall intake of health-promoting compounds, but also because they
diversify the daily diet in terms of color, flavor, and chemical composition, which imparts distinct
functional effects on the human body. The inclusion of such root vegetables either raw in fresh
salads or in cooked dishes may increase palatability and appeal for healthier food products, although
proper marketing is always an issue since consumers are usually reluctant to introduce new flavors
and unconventional products that break the mold. Nevertheless, the current trends in the food
and beverage market and the increased public demand for substituting synthetic compounds with
natural alternatives could boost the establishment of these species and help the crossing over from
niche products to widely accepted ones with diverse uses in the food industry. Further research is
also needed in order to (i) identify those correlations and mechanisms of action responsible for the
antioxidant properties and health effects of the pigmented vegetables, (ii) evaluate agronomic practices
that will increase the bioactive capacity of the final products through the improved pigmentation,
(iii) study post-harvest and processing treatments that will make these compounds less prone to
degradation and easier to use in the design of functional foods and as natural coloring agents, and
(iv) define efficient extraction protocols that will allow high yields and high stability and quality of
coloring agents extracted from plant sources. Finally, increasing the knowledge about the chemical
composition and the health effects of individual compounds of colored root vegetables could be further
exploited through breeding programs for the production of elite genotypes with increased content of
coloring compounds and tailor-made health effects, as well as through plant in vitro strategies for the
production of specific natural secondary metabolites and further use in the pharmaceutical and the
food and beverage industries.
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32. Kirca, A.; Özkan, M.; Cemeroǧlu, B. Effects of temperature, solid content and pH on the stability of black
carrot anthocyanins. Food Chem. 2007, 101, 212–218. [CrossRef]
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anthocyanins and glycoalkaloids in blue-fleshed potatoes and changes in the content of α-solanine and
α-chaconine during manufacture of fried and dried products. Int. J. Food Sci. Technol. 2018, 53, 719–727.
[CrossRef]
109. Zhang, L.; Zhao, L.; Bian, X.; Guo, K.; Zhou, L.; Wei, C. Characterization and comparative study of starches
from seven purple sweet potatoes. Food Hydrocoll. 2018, 80, 168–176. [CrossRef]
110. Li, A.; Xiao, R.; He, S.; An, X.; He, Y.; Wang, C.; Yin, S.; Wang, B.; Shi, X.; He, J. Research advances of purple
sweet potato anthocyanins: extraction, identification, stability, bioactivity, application, and biotransformation.
Molecules 2019, 24, 3816. [CrossRef]
111. Suda, I.; Oki, T.; Masuda, M.; Kobayashi, M.; Nishiba, Y.; Furuta, S. Physiological functionality of
purple-fleshed sweet potatoes containing anthocyanins and their utilization in foods. Jpn. Agric. Res. Q.
2003, 37, 167–173. [CrossRef]
112. Bassa, I.A.; Francis, F.J. Stability of anthocyanins from sweet potatoes in a model beverage. J. Food Sci. 1987,
52, 1753–1754. [CrossRef]
117
Antioxidants 2019, 8, 617
113. Drapal, M.; Rossel, G.; Heider, B.; Fraser, P.D. Metabolic diversity in sweet potato (Ipomoea batatas, L.) leaves
and storage roots. Hortic. Res. 2019, 6, 2. [CrossRef]
114. Rosero, A.; Granda, L.; Pérez, J.L.; Rosero, D.; Burgos-Paz, W.; Martínez, R.; Morelo, J.; Pastrana, I.; Burbano, E.;
Morales, A. Morphometric and colourimetric tools to dissect morphological diversity: An application in
sweet potato [Ipomoea batatas (L.) Lam.]. Genet. Resour. Crop Evol. 2019, 66, 1257–1278. [CrossRef]
115. FAO. Statistics Division Production and Trade Statistics; FAO: Rome, Italy, 2017.
116. Cui, R.; Zhu, F. Physicochemical properties and bioactive compounds of different varieties of sweetpotato
flour treated with high hydrostatic pressure. Food Chem. 2019, 299, 125129. [CrossRef] [PubMed]
117. De Albuquerque, T.M.R.; Sampaio, K.B.; de Souza, E.L. Sweet potato roots: Unrevealing an old food as a
source of health promoting bioactive compounds–A review. Trends Food Sci. Technol. 2019, 85, 277–286.
[CrossRef]
118. Guo, K.; Liu, T.; Xu, A.; Zhang, L.; Bian, X.; Wei, C. Structural and functional properties of starches from root
tubers of white, yellow, and purple sweet potatoes. Food Hydrocoll. 2019, 89, 829–836. [CrossRef]
119. Wang, S.; Pan, D.; Lv, X.; Song, X.; Qiu, Z.; Huang, C.; Huang, R.; Chen, W. Proteomic approach reveals
that starch degradation contributes to anthocyanin accumulation in tuberous root of purple sweet potato.
J. Proteom. 2016, 143, 298–305. [CrossRef]
120. Zhao, J.G.; Yan, Q.Q.; Xue, R.Y.; Zhang, J.; Zhang, Y.Q. Isolation and identification of colourless caffeoyl
compounds in purple sweet potato by HPLC-DAD-ESI/MS and their antioxidant activities. Food Chem. 2014,
161, 22–26. [CrossRef]
121. Kim, M.Y.; Lee, B.W.; Lee, H.; Lee, Y.Y.; Kim, M.H.; Lee, J.Y.; Lee, B.K.; Woo, K.S.; Kim, H. Phenolic compounds
and antioxidant activity of sweet potato after heat treatment. J. Sci. Food Agric. 2019. [CrossRef]
122. Moumouni Koala, A.H.; Somé, K.; Palé, E.; Sérémé, A.; Belem, J.; Nacro, M. Evaluation of eight orange
fleshed sweetpotato (OFSP) varieties for their total antioxidant, total carotenoid and polyphenolic contents.
Evaluation 2013, 3, 67–73.
123. Neela, S.; Fanta, S.W. Review on nutritional composition of orange-fleshed sweet potato and its role in
management of vitamin A deficiency. Food Sci. Nutr. 2019, 7, 1920–1945. [CrossRef]
124. Lebot, V.; Michalet, S.; Legendre, L. Identification and quantification of phenolic compounds responsible for
the antioxidant activity of sweet potatoes with different flesh colours using high performance thin layer
chromatography (HPTLC). J. Food Compos. Anal. 2016, 49, 94–101. [CrossRef]
125. Kubow, S.; Iskandar, M.M.; Sabally, K.; Azadi, B.; Sadeghi, S.; Kumarathasan, P.; Dhar, D.; Prakash, S.;
Burgos, G. Biotransformation of anthocyanins from two purple-fleshed sweet potato accessions in a dynamic
gastrointestinal system. Food Chem. 2016, 192, 171–177. [CrossRef] [PubMed]
126. Meng, X.J.; Tan, C.; Feng, Y. Solvent extraction and in vitro simulated gastrointestinal digestion of phenolic
compounds from purple sweet potato. Int. J. Food Sci. Technol. 2019, 2887–2896. [CrossRef]
127. Oliveira, H.; Perez-Gregório, R.; de Freitas, V.; Mateus, N.; Fernandes, I. Comparison of the in vitro
gastrointestinal bioavailability of acylated and non-acylated anthocyanins: Purple-fleshed sweet potato vs
red wine. Food Chem. 2019, 276, 410–418. [CrossRef] [PubMed]
128. Yang, Z.W.; Tang, C.E.; Zhang, J.L.; Zhou, Q.; Zhang, Z.C. Stability and antioxidant activity of anthocyanins
from purple sweet potato (Ipomoea batatas L. cultivar Eshu No. 8) subjected to simulated in vitro
gastrointestinal digestion. Int. J. Food Sci. Technol. 2019, 2604–2614. [CrossRef]
129. Sun, H.; Zhang, P.; Zhu, Y.; Lou, Q.; He, S. Antioxidant and prebiotic activity of five peonidin-based
anthocyanins extracted from purple sweet potato (Ipomoea batatas (L.) Lam.). Sci. Rep. 2018, 8, 5018.
[CrossRef] [PubMed]
130. Esatbeyoglu, T.; Rodríguez-werner, M.; Schlösser, A.; Winterhalter, P.; Rimbach, G. Fractionation, enzyme
inhibitory and cellular antioxidant activity of bioactives from purple sweet potato (Ipomoea batatas). Food Chem.
2017, 221, 447–456. [CrossRef]
131. Gérard, V.; Ay, E.; Morlet-Savary, F.; Graff, B.; Galopin, C.; Ogren, T.; Mutilangi, W.; Lalevée, J. Thermal and
photochemical stability of anthocyanins from black carrot, grape juice, and purple sweet potato in model
beverages in the presence of ascorbic acid. J. Agric. Food Chem. 2019, 67, 5647–5660. [CrossRef]
132. Gras, C.C.; Nemetz, N.; Carle, R.; Schweiggert, R.M. Anthocyanins from purple sweet potato (Ipomoea batatas
(L.) Lam.) and their color modulation by the addition of phenolic acids and food-grade phenolic plant
extracts. Food Chem. 2017, 235, 265–274. [CrossRef]
118
Antioxidants 2019, 8, 617
133. He, W.; Zeng, M.; Chen, J.; Jiao, Y.; Niu, F.; Tao, G.; Zhang, S.; Qin, F.; He, Z. Identification and quantitation of
anthocyanins in purple-fleshed sweet potatoes cultivated in China by UPLC-PDA and UPLC-QTOF-MS/MS.
J. Agric. Food Chem. 2016, 64, 171–177. [CrossRef]
134. Truong, V.D.; Nigel, D.; Thompson, R.T.; Mcfeeters, R.F.; Dean, L.O.; Pecota, K.V.;
Yencho, G.C. Characterization of anthocyanins and anthocyanidins in purple-fleshed sweetpotatoes by
HPLC-DAD/ESI-MS/MS. J. Agric. Food Chem. 2010, 58, 404–410. [CrossRef]
135. Li, J.; Li, X.D.; Zhang, Y.; Zheng, Z.D.; Qu, Z.Y.; Liu, M.; Zhu, S.H.; Liu, S.; Wang, M.; Qu, L. Identification
and thermal stability of purple-fleshed sweet potato anthocyanins in aqueous solutions with various pH
values and fruit juices. Food Chem. 2013, 136, 1429–1434. [CrossRef] [PubMed]
136. Cai, Z.; Song, L.; Qian, B.; Xu, W.; Ren, J.; Jing, P.; Oey, I. Understanding the effect of anthocyanins extracted
from purple sweet potatoes on alcohol-induced liver injury in mice. Food Chem. 2018, 245, 463–470. [CrossRef]
[PubMed]
137. Jang, H.H.; Kim, H.W.; Kim, S.Y.; Kim, S.M.; Kim, J.B.; Lee, Y.M. In vitro and in vivo hypoglycemic effects of
cyanidin 3-caffeoyl-p-hydroxybenzoylsophoroside-5-glucoside, an anthocyanin isolated from purple-fleshed
sweet potato. Food Chem. 2019, 272, 688–693. [CrossRef] [PubMed]
138. Wang, L.; Zhao, Y.; Zhou, Q.; Luo, C.L.; Deng, A.P.; Zhang, Z.C.; Zhang, J.L. Characterization and
hepatoprotective activity of anthocyanins from purple sweet potato (Ipomoea batatas L. cultivar Eshu No. 8).
J. Food Drug Anal. 2017, 25, 607–618. [CrossRef]
139. Xu, J.; Su, X.; Lim, S.; Griffin, J.; Carey, E.; Katz, B.; Tomich, J.; Smith, J.S.; Wang, W. Characterisation and
stability of anthocyanins in purple-fleshed sweet potato P40. Food Chem. 2015, 186, 90–96. [CrossRef]
140. Laksmiani, N.P.L.; Widiastari, M.I.; Reynaldi, K.R. The inhibitory activity of peonidin purple sweet potato
in human epidermal receptor-2 receptor (her-2) expression by in silico study. J. Phys. Conf. Ser. 2018,
1040, 012010. [CrossRef]
141. Luo, C.; Zhou, Q.; Yang, Z.; Wang, R.; Zhang, J. Evaluation of structure and bioprotective activity of key high
molecular weight acylated anthocyanin compounds isolated from the purple sweet potato (Ipomoea batatas L.
cultivar Eshu No. 8 ). Food Chem. 2018, 241, 23–31. [CrossRef]
142. Lu, J.; Wu, D.M.; Zheng, Y.L.; Hu, B.; Cheng, W.; Zhang, Z.F. Purple sweet potato color attenuates domoic
acid-induced cognitive deficits by promoting estrogen receptor-α-mediated mitochondrial biogenesis
signaling in mice. Free Radic. Biol. Med. 2012, 52, 646–659. [CrossRef]
143. Zhuang, J.; Lu, J.; Wang, X.; Wang, X.; Hu, W.; Hong, F.; Zhao, X.X.; Zheng, Y. lin Purple sweet potato color
protects against high-fat diet-induced cognitive deficits through AMPK-mediated autophagy in mouse
hippocampus. J. Nutr. Biochem. 2019, 65, 35–45. [CrossRef]
144. Li, J.; Shi, Z.; Mi, Y. Purple sweet potato color attenuates high fat-induced neuroinflammation in mouse brain
by inhibiting mapk and NF-κB activation. Mol. Med. Rep. 2018, 17, 4823–4831. [CrossRef]
145. Li, W.L.; Yu, H.Y.; Zhang, X.J.; Ke, M.; Hong, T. Purple sweet potato anthocyanin exerts antitumor effect in
bladder cancer. Oncol. Rep. 2018, 40, 73–82. [CrossRef]
146. Schmitt, E.; Stopper, H. Estrogenic activity of naturally occurring anthocyanidins. Nutr. Cancer 2001,
41, 145–149. [CrossRef]
147. Yoshimoto, M.; Okuno, S.; Yamaguchi, M.; Yamakawa, O. Antimutagenicity of deacylated anthocyanins in
purple-fleshed sweetpotato. Biosci. Biotechnol. Biochem. 2001, 65, 1652–1655. [CrossRef] [PubMed]
148. Zhao, J.G.; Yan, Q.Q.; Lu, L.Z.; Zhang, Y.Q. In vivo antioxidant, hypoglycemic, and anti-tumor activities of
anthocyanin extracts from purple sweet potato. Nutr. Res. Pract. 2013, 7, 359–365. [CrossRef] [PubMed]
149. Zhang, Z.; Zhou, Q.; Yang, Y.; Wang, Y.; Zhang, J. Highly Acylated Anthocyanins from purple sweet potato
(Ipomoea batatas L.) alleviate hyperuricemia and kidney inflammation in hyperuricemic mice: Possible
attenuation effects on allopurinol. J. Agric. Food Chem. 2019, 67, 6202–6211. [CrossRef] [PubMed]
150. Zheng, G.H.; Shan, Q.; Mu, J.J.; Wang, Y.J.; Zhang, Z.F.; Fan, S.H.; Hu, B.; Li, M.Q.; Xie, J.; Chen, P.; et al.
Purple sweet potato color attenuates kidney damage by blocking VEGFR2/ROS/NLRP3 signaling in high-fat
diet-treated mice. Oxid. Med. Cell. Longev. 2019, 2019. [CrossRef]
151. Jiang, Z.; Chen, C.; Xie, W.; Wang, M.; Wang, J.; Zhang, X. Anthocyanins attenuate alcohol-induced hepatic
injury by inhibiting pro-inflammation signalling. Nat. Prod. Res. 2016, 30, 469–473. [CrossRef]
152. Valenti, L.; Riso, P.; Mazzocchi, A.; Porrini, M.; Fargion, S.; Agostoni, C. Dietary anthocyanins as nutritional
therapy for nonalcoholic fatty liver disease. Oxid. Med. Cell. Longev. 2013, 2013. [CrossRef]
119
Antioxidants 2019, 8, 617
153. Del Rio, D.; Rodriguez-Mateos, A.; Spencer, J.P.E.; Tognolini, M.; Borges, G.; Crozier, A. Dietary (poly)phenolics
in human health: structures, bioavailability, and evidence of protective effects against chronic diseases.
Antioxid. Redox Signal. 2012, 18, 1818–1892. [CrossRef]
154. Han, K.H.; Shimada, K.I.; Sekikawa, M.; Fukushima, M. Anthocyanin-rich red potato flakes affect serum
lipid peroxidation and hepatic SOD mRNA level in rats. Biosci. Biotechnol. Biochem. 2007, 71, 1356–1359.
[CrossRef]
155. Hwang, Y.P.; Choi, J.H.; Choi, J.M.; Chung, Y.C.; Jeong, H.G. Protective mechanisms of anthocyanins from
purple sweet potato against tert-butyl hydroperoxide-induced hepatotoxicity. Food Chem. Toxicol. 2011,
49, 2081–2089. [CrossRef] [PubMed]
156. Suda, I.; Ishikawa, F.; Hatakeyama, M.; Miyawaki, M.; Kudo, T.; Hirano, K.; Ito, A.; Yamakawa, O.; Horiuchi, S.
Intake of purple sweet potato beverage affects on serum hepatic biomarker levels of healthy adult men with
borderline hepatitis. Eur. J. Clin. Nutr. 2008, 62, 60–67. [CrossRef] [PubMed]
157. Zhang, Z.F.; Lu, J.; Zheng, Y.L.; Wu, D.M.; Hu, B.; Shan, Q.; Cheng, W.; Li, M.Q.; Sun, Y.Y. Purple sweet
potato color attenuates hepatic insulin resistance via blocking oxidative stress and endoplasmic reticulum
stress in high-fat-diet-treated mice. J. Nutr. Biochem. 2013, 24, 1008–1018. [CrossRef] [PubMed]
158. Qin, S.; Sun, D.; Mu, J.; Ma, D.; Tang, R.; Zheng, Y. Purple sweet potato color improves hippocampal
insulin resistance via down-regulating SOCS3 and galectin-3 in high-fat diet mice. Behav. Brain Res. 2019,
359, 370–377. [CrossRef] [PubMed]
159. Wang, X.; Zhang, Z.F.; Zheng, G.H.; Wang, A.M.; Sun, C.H.; Qin, S.P.; Zhuang, J.; Lu, J.; Ma, D.F.; Zheng, Y.L.
The inhibitory effects of purple sweet potato color on hepatic inflammation is associated with restoration of
NAD+ levels and attenuation of nlrp3 inflammasome activation in high-fat-diet-treated mice. Molecules 2017,
22, 1315. [CrossRef] [PubMed]
160. Gofur, A.; Witjoro, A.; Ningtiyas, E.W.; Setyowati, E.; Mukharromah, S.A.; Athoillah, M.F.; Lestari, S.R. The
evaluation of dietary black soybean and purple sweet potato on insulin sensitivity in streptozotocin-induced
diabetic rats. Pharmacogn. J. 2019, 11, 639–646. [CrossRef]
161. Park, S.-J.; Lee, D.; Lee, M.; Kwon, H.-O.; Kim, H.; Park, J.; Jeon, W.; Cha, M.; Jun, S.; Park, K.; et al. The Effects
of Curcuma longa L., Purple sweet potato, and mixtures of the two on immunomodulation in C57BL/6J mice
infected with LP-BM5 murine leukemia retrovirus. J. Med. Food 2018, 21, 689–700. [CrossRef]
162. Ju, R.; Zheng, S.; Luo, H.; Wang, C.; Duan, L.; Sheng, Y.; Zhao, C.; Xu, W.; Huang, K. Purple Sweet Potato
Attenuate Weight Gain in High Fat Diet Induced Obese Mice. J. Food Sci. 2017, 82, 787–793. [CrossRef]
163. Chen, H.; Sun, J.; Liu, J.; Gou, Y.; Zhang, X.; Wu, X.; Sun, R.; Tang, S.; Kan, J.; Qian, C.; et al. Structural
characterization and anti-inflammatory activity of alkali-soluble polysaccharides from purple sweet potato.
Int. J. Biol. Macromol. 2019, 131, 484–494. [CrossRef]
164. Gou, Y.; Sun, J.; Liu, J.; Chen, H.; Kan, J.; Qian, C.; Zhang, N.; Jin, C. Structural characterization of
a water-soluble purple sweet potato polysaccharide and its effect on intestinal inflammation in mice.
J. Funct. Foods 2019, 61, 103502. [CrossRef]
165. Sun, J.; Zhou, B.; Tang, C.; Gou, Y.; Chen, H.; Wang, Y.; Jin, C.; Liu, J.; Niu, F.; Kan, J.; et al. Characterization,
antioxidant activity and hepatoprotective effect of purple sweetpotato polysaccharides. Int. J. Biol. Macromol.
2018, 115, 69–76. [CrossRef] [PubMed]
166. Tang, C.; Sun, J.; Liu, J.; Jin, C.; Wu, X.; Zhang, X.; Chen, H.; Gou, Y.; Kan, J.; Qian, C.; et al. Immune-enhancing
effects of polysaccharides from purple sweet potato. Int. J. Biol. Macromol. 2019, 123, 923–930. [CrossRef]
[PubMed]
167. Tang, C.; Sun, J.; Zhou, B.; Jin, C.; Liu, J.; Gou, Y.; Chen, H.; Kan, J.; Qian, C.; Zhang, N. Immunomodulatory
effects of polysaccharides from purple sweet potato on lipopolysaccharide treated RAW 264.7 macrophages.
J. Food Biochem. 2018, 42, e12535. [CrossRef]
168. Tang, C.; Sun, J.; Zhou, B.; Jin, C.; Liu, J.; Kan, J.; Qian, C.; Zhang, N. Effects of polysaccharides from purple
sweet potatoes on immune response and gut microbiota composition in normal and cyclophosphamide
treated mice. Food Funct. 2018, 9, 937–950. [CrossRef]
169. Jiang, T.; Mao, Y.; Sui, L.; Yang, N.; Li, S.; Zhu, Z.; Wang, C.; Yin, S.; He, J.; He, Y. Degradation of anthocyanins
and polymeric color formation during heat treatment of purple sweet potato extract at different pH. Food Chem.
2019, 274, 460–470. [CrossRef]
120
Antioxidants 2019, 8, 617
170. Quan, W.; He, W.; Lu, M.; Yuan, B.; Zeng, M.; Gao, D.; Qin, F.; Chen, J.; He, Z. Anthocyanin composition and
storage degradation kinetics of anthocyanins-based natural food colourant from purple-fleshed sweet potato.
Int. J. Food Sci. Technol. 2019, 54, 2529–2539. [CrossRef]
171. Thi Lan Khanh, P.; Chittrakorn, S.; Rutnakornpituk, B.; Phan Tai, H.; Ruttarattanamongkol, K. Processing
effects on anthocyanins, phenolic acids, antioxidant activity, and physical characteristics of Vietnamese
purple-fleshed sweet potato flours. J. Food Process. Preserv. 2018, 42, e13722. [CrossRef]
172. Yea, C.S.; Nevara, G.A.; Muhammad, K.; Ghazali, H.M.; Karim, R. Physical properties, resistant starch
content and antioxidant profile of purple sweet potato powder after 12 months of storage. Int. J. Food Prop.
2019, 22, 974–984. [CrossRef]
173. Lagnika, C.; Jiang, N.; Song, J.; Li, D.; Liu, C.; Huang, J.; Wei, Q.; Zhang, M. Effects of pretreatments on
properties of microwave-vacuum drying of sweet potato slices. Dry. Technol. 2018, 37, 1901–1914. [CrossRef]
174. Phan, K.T.L.; Chittrakorn, S.; Tai, H.P.; Ruttarattanamongkol, K. Effects of cooking methods on the changes
of total anthocyanins, phenolics content and physical characteristics of purple-fleshed sweet potato (Ipomoea
batatas L.) grown in Vietnam. Int. J. Adv. Sci. Eng. Inf. Technol. 2018, 8, 227–233. [CrossRef]
175. Kamiloglu, S.; Van Camp, J.; Capanoglu, E. Black carrot polyphenols: Effect of processing, storage and
digestion—An overview. Phytochem. Rev. 2018, 17, 379–395. [CrossRef]
176. Arscott, S.A.; Tanumihardjo, S.A. Carrots of many colors provide basic nutrition and bioavailable
phytochemicals acting as a functional food. Compr. Rev. Food Sci. Food Saf. 2010, 9, 223–239. [CrossRef]
177. Kamiloglu, S.; Capanoglu, E.; Bilen, F.D.; Gonzales, G.B.; Grootaert, C.; Van de Wiele, T.; Van Camp, J.
Bioaccessibility of polyphenols from plant-processing byproducts of black carrot (Daucus carota L.). J. Agric.
Food Chem. 2016, 64, 2450–2458. [CrossRef] [PubMed]
178. Kamiloglu, S.; Pasli, A.A.; Ozcelik, B.; Van Camp, J.; Capanoglu, E. Influence of different processing and
storage conditions on in vitro bioaccessibility of polyphenols in black carrot jams and marmalades. Food Chem.
2015, 186, 74–82. [CrossRef] [PubMed]
179. Kumar, M.; Dahuja, A.; Sachdev, A.; Kaur, C.; Varghese, E.; Saha, S.; Sairam, K.V.S.S. Black Carrot (Daucus
carota ssp.) and Black Soybean (Glycine max (L.) Merr.) Anthocyanin Extract: A Remedy to Enhance Stability and
Functionality of Fruit Juices by Copigmentation, Waste and Biomass Valorization; Springer: Berlin/Heidelberg,
Germany, 2018.
180. Horvitz, M.A.; Simon, P.W.; Tanumihardjo, S.A. Lycopene and β-carotene are bioavailable from lycopene
“red” carrots in humans. Eur. J. Clin. Nutr. 2004, 58, 803–811. [CrossRef] [PubMed]
181. Kammerer, D.; Carle, R.; Schieber, A. Quantification of anthocyanins in black carrot extracts (Daucus carota
ssp. sativus var. atrorubens Alef.) and evaluation of their color properties. Eur. Food Res. Technol. 2004,
219, 479–486. [CrossRef]
182. Smeriglio, A.; Denaro, M.; Barreca, D.; D’Angelo, V.; Germanò, M.P.; Trombetta, D. Polyphenolic profile
and biological activities of black carrot crude extract (Daucus carota L. ssp. sativus var. atrorubens Alef.).
Fitoterapia 2018, 124, 49–57. [CrossRef]
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Šaponjac, V.T.T. In vivo and in vitro antioxidant effects of beetroot pomace extracts. J. Funct. Foods 2014,
6, 168–175. [CrossRef]
194. Leng, M.S.; Tobit, P.; Demasse, A.M.; Wolf, K.; Gouado, I.; Ndjouenkeu, R.; Rawel, H.M.; Schweigert, F.J.
Nutritional and anti-oxidant properties of yam (Dioscorea schimperiana) based complementary food
formulation. Sci. African 2019, 5, e00132. [CrossRef]
195. Champagne, A.; Hilbert, G.; Legendre, L.; Lebot, V. Diversity of anthocyanins and other phenolic compounds
among tropical root crops from Vanuatu, South Pacific. J. Food Compos. Anal. 2011, 24, 315–325. [CrossRef]
196. Li, T.; Teng, H.; An, F.; Huang, Q.; Chen, L.; Song, H. The beneficial effects of purple yam (Dioscorea alata L.)
resistant starch on hyperlipidemia in high-fat-fed hamsters. Food Funct. 2019, 10, 2642–2650. [CrossRef]
197. Patel, K.S.; Karmakar, N.; Desai, K.D.; Narwade, A.V.; Chakravarty, G.; Debnath, M.K. Exploring of greater
yam (Dioscorea alata L.) genotypes through biochemical screening for better cultivation in south Gujarat zone
of India. Physiol. Mol. Biol. Plants 2019, 25, 1235–1249. [CrossRef]
198. Li, T.; Chen, L.; Xiao, J.; An, F.; Wan, C.; Song, H. Prebiotic effects of resistant starch from purple yam
(Dioscorea alata L.) on the tolerance and proliferation ability of Bifidobacterium adolescentis in vitro. Food Funct.
2018, 9, 2416–2425. [CrossRef]
199. Estiasih, T.; Umaro, D.; Harijono, H. Hypoglycemic effect of crude water soluble polysaccharide extracted
from tubers of purple and yellow water yam (Dioscorea alata L.) on alloxan-induced hyperglycemia Wistar
rats. Prog. Nutr. 2018, 20, 59–67.
200. Rosida; Purnawati, A.; Susiloningsih, E.K. Hypocholesterolemic and hypoglycemic effects of
autoclaved-cooled water yam (Dioscorea alata) on hypercholesterolemia rats. Int. Food Res. J. 2018,
25, S181–S184.
201. Chen, C.T.; Wang, Z.H.; Hsu, C.C.; Lin, H.H.; Chen, J.H. Taiwanese and Japanese yam (Dioscorea spp.) extracts
attenuate doxorubicin-induced cardiotoxicity in mice. J. Food Drug Anal. 2017, 25, 872–880. [CrossRef]
202. Khan, R.; Upaganlawar, A.B.; Upasani, C. Protective effects of Dioscorea alata L. in aniline exposure-induced
spleen toxicity in rats: A biochemical study. Toxicol. Int. 2014, 21, 294–299.
203. Chiu, C.S.; Deng, J.S.; Chang, H.Y.; Chen, Y.C.; Lee, M.M.; Hou, W.C.; Lee, C.Y.; Huang, S.S.; Huang, G.J.
Antioxidant and anti-inflammatory properties of taiwanese yam (Dioscorea japonica Thunb. var. pseudojaponica
(Hayata) Yamam.) and its reference compounds. Food Chem. 2013, 141, 1087–1096. [CrossRef]
204. Chang, W.T.; Chen, H.M.; Yin, S.Y.; Chen, Y.H.; Wen, C.C.; Wei, W.C.; Lai, P.; Wang, C.H.; Yang, N.S.
Specific dioscorea phytoextracts enhance potency of TCL-loaded DC-based cancer vaccines. Evidence-Based
Complement. Altern. Med. 2013, 2013. [CrossRef]
205. Liu, S.F.; Chang, S.Y.; Lee, T.C.; Chuang, L.Y.; Guh, J.Y.; Hung, C.Y.; Hung, T.J.; Hung, Y.J.; Chen, P.Y.;
Hsieh, P.F.; et al. Dioscorea alata attenuates renal interstitial cellular fibrosis by regulating smad- and
epithelial-mesenchymal transition signaling pathways. PLoS ONE 2012, 7, e47482. [CrossRef]
206. Chan, Y.C.; Chang, S.C.; Liu, S.Y.; Yang, H.L.; Hseu, Y.C.; Liao, J.W. Beneficial effects of yam on carbon
tetrachloride-induced hepatic fibrosis in rats. J. Sci. Food Agric. 2010, 90, 161–167. [CrossRef]
207. Wang, C.-H.; Tsai, C.-H.; Lin, H.-J.; Wang, T.-C.; Chen, H.-L. Uncooked Taiwanese yam (Dioscorea alata L. cv.
Tainung No. 2) beneficially modulated the large bowel function and faecal microflora in BALB/c mice. J. Sci.
Food Agric. 2006, 87, 1374–1380. [CrossRef]
122
Antioxidants 2019, 8, 617
208. Hsu, C.C.; Huang, Y.C.; Yin, M.C.; Lin, S.J. Effect of yam (Dioscorea alata compared to Dioscorea japonica) on
gastrointestinal function and antioxidant activity in mice. J. Food Sci. 2006, 71, 5–8. [CrossRef]
209. Chan, Y.-C.; Hsu, C.-K.; Wang, M.-F.; Liao, J.-W.; Su, T.-Y. Beneficial effect of yam on the amyloid β-protein,
monoamine oxidase B and cognitive deficit in mice with accelerated senescence. J. Sci. Food Agric. 2006,
86, 1517–1525. [CrossRef]
210. Chan, Y.C.; Hsu, C.K.; Wang, M.F.; Su, T.Y. A diet containing yam reduces the cognitive deterioration and
brain lipid peroxidation in mice with senescence accelerated. Int. J. Food Sci. Technol. 2004, 39, 99–107.
[CrossRef]
211. Fu, S.L.; Hsu, Y.H.; Lee, P.Y.; Hou, W.C.; Hung, L.C.; Lin, C.H.; Chen, C.M.; Huang, Y.J. Dioscorin isolated
from Dioscorea alata activates TLR4-signaling pathways and induces cytokine expression in macrophages.
Biochem. Biophys. Res. Commun. 2006, 339, 137–144. [CrossRef]
212. Mahmad, N.; Taha, R.M.; Othman, R.; Abdullah, S.; Anuar, N.; Elias, H.; Rawi, N. Anthocyanin as potential
source for antimicrobial activity in Clitoria ternatea L. and Dioscorea alata L. Pigment Resin Technol. 2018,
47, 490–495. [CrossRef]
213. Chen, T.; Hu, S.; Zhang, H.; Guan, Q.; Yang, Y.; Wang, X. Anti-inflammatory effects of Dioscorea alata L.
anthocyanins in a TNBS-induced colitis model. Food Funct. 2017, 8, 659–669. [CrossRef]
214. Guo, X.; Sha, X.; Cai, S.; Wang, O.; Ji, B. Antiglycative and antioxidative properties of ethyl acetate fraction of
Chinese purple yam (Dioscorea alata L.) extracts. Food Sci. Technol. Res. 2015, 21, 563–571. [CrossRef]
215. Guo, X.X.; Sha, X.H.; Liu, J.; Cai, S.B.; Wang, Y.; Ji, B.P. Chinese purple yam (Dioscorea alata L.) extracts inhibit
diabetes-related enzymes and protect HepG2 cells against oxidative stress and insulin resistance induced by
FFA. Food Sci. Technol. Res. 2015, 21, 677–683. [CrossRef]
216. Mahmoudian-Sani, M.R.; Asadi-Samani, M.; Luther, T.; Saeedi-Boroujeni, A.; Gholamian, N. A new approach
for treatment of type 1 diabetes: Phytotherapy and phytopharmacology of regulatory T cells. J. Ren. Inj. Prev.
2017, 6, 158–163. [CrossRef]
217. Zhang, J.; Tian, H.; Zhan, P.; Du, F.; Zong, A.; Xu, T. Isolation and identification of phenolic compounds
in Chinese purple yam and evaluation of antioxidant activity. LWT Food Sci. Technol. 2018, 96, 161–165.
[CrossRef]
218. Dey, P.; Ray, S.; Chaudhuri, T.K. Immunomodulatory activities and phytochemical characterisation of the
methanolic extract of Dioscorea alata aerial tuber. J. Funct. Foods 2016, 23, 315–328. [CrossRef]
219. Lu, J.; Wong, R.N.S.; Zhang, L.; Wong, R.Y.L.; Ng, T.B.; Lee, K.F.; Zhang, Y.B.; Lao, L.X.; Liu, J.Y.; Sze, S.C.W.
Comparative Analysis of Proteins with Stimulating Activity on Ovarian Estradiol Biosynthesis from Four
Different Dioscorea Species in vitro Using Both Phenotypic and Target-based Approaches: Implication for
Treating Menopause. Appl. Biochem. Biotechnol. 2016, 180, 79–93. [CrossRef]
220. Wu, Z.G.; Jiang, W.; Nitin, M.; Bao, X.Q.; Chen, S.L.; Tao, Z.M. Characterizing diversity based on nutritional
and bioactive compositions of yam germplasm (Dioscorea spp.) commonly cultivated in China. J. Food
Drug Anal. 2016, 24, 367–375. [CrossRef]
221. Han, C.H.; Liu, J.C.; Fang, S.U.; Hou, W.C. Antioxidant activities of the synthesized thiol-contained peptides
derived from computer-aided pepsin hydrolysis of yam tuber storage protein, dioscorin. Food Chem. 2013,
138, 923–930. [CrossRef]
222. Koo, H.J.; Park, H.J.; Byeon, H.E.; Kwak, J.H.; Um, S.H.; Kwon, S.T.; Rhee, D.K.; Pyo, S. Chinese yam extracts
containing β-sitosterol and ethyl linoleate protect against atherosclerosis in apolipoprotein e-deficient mice
and inhibit muscular expression of VCAM-1 in vitro. J. Food Sci. 2014, 79, H719–H729. [CrossRef]
223. Harijono, T.E.; Ariestiningsih, A.D.; Wardani, N.A.K. The effect of crude diosgenin extract from purple and
yellow greater yams (Dioscorea alata) on the lipid profile of dyslipidemia rats. Emirates J. Food Agric. 2016,
28, 506–512. [CrossRef]
224. Lee, Y.C.; Lin, J.T.; Wang, C.K.; Chen, C.H.; Yang, D.J. Antiproliferative effects of fractions of furostanol and
spirostanol glycosides from yam (Dioscorea pseudojaponica Yamamoto) and diosgenin on cancer and normal
cells and their apoptotic effects for MCF-7 cells. J. Food Biochem. 2012, 36, 75–85. [CrossRef]
225. Jailani, F.; Kusumawardani, S.; Puspitasari, C.; Maula, A.; Purwandari, U. Annealled purple yam (Dioscorea
alata var. purpurea) flour improved gelatinisation profile, but increased glycemic index of substituted bread.
Int. Food Res. J. 2013, 20, 865–871.
123
Antioxidants 2019, 8, 617
226. Hsu, C.L.; Hurang, S.L.; Chen, W.; Weng, Y.M.; Tseng, C.Y. Qualities and antioxidant properties of bread as
affected by the incorporation of yam flour in the formulation. Int. J. Food Sci. Technol. 2004, 39, 231–238.
[CrossRef]
227. Li, P.H.; Huang, C.C.; Yang, M.Y.; Wang, C.C.R. Textural and sensory properties of salted noodles containing
purple yam flour. Food Res. Int. 2012, 47, 223–228. [CrossRef]
228. Seguchi, M.; Ozawa, M.; Nakamura, C.; Tabara, A. Development of gluten-free bread baked with yam flour.
Food Sci. Technol. Res. 2012, 18, 543–548. [CrossRef]
229. Brewster, J.L. Onions and Other Vegetable Alliums, 2nd ed.; CABI: Wallingford, UK, 2008; ISBN 9781845933999.
230. Slimestad, R.; Fossen, T.; Vågen, I.M. Onions: A source of unique dietary flavonoids. J. Agric. Food Chem.
2007, 55, 10067–10080. [CrossRef]
231. Benkeblia, N. Free-Radical Scavenging capacity and antioxidant properties of some selected onions (Allium
cepa L.) and garlic ( Allium sativum L.) extracts. Brazilian Arch. Biol. Technol. 2005, 48, 753–759. [CrossRef]
232. Zhang, S.; Deng, P.; Xu, Y.C.; Lü, S.W.; Wang, J.J. Quantification and analysis of anthocyanin and flavonoids
compositions, and antioxidant activities in onions with three different colors. J. Integr. Agric. 2016,
15, 2175–2181. [CrossRef]
233. Oboh, G.; Ademiluyi, A.O.; Agunloye, O.M.; Ademosun, A.O.; Ogunsakin, B.G. Inhibitory Effect of garlic,
purple onion, and white onion on key enzymes linked with type 2 diabetes and hypertension. J. Diet. Suppl.
2019, 16, 105–118. [CrossRef]
234. Albishi, T.; John, J.A.; Al-Khalifa, A.S.; Shahidi, F. Antioxidant, anti-inflammatory and DNA scission
inhibitory activities of phenolic compounds in selected onion and potato varieties. J. Funct. Foods 2013,
5, 930–939. [CrossRef]
235. Ou, B.; Huang, D.; Hampsch-Woodill, M.; Flanagan, J.A.; Deemer, E.K. Analysis of antioxidant activities of
common vegetables employing oxygen radical absorbance capacity (ORAC) and ferric reducing antioxidant
power (FRAP) assays: A comparative study. J. Agric. Food Chem. 2002, 50, 3122–3128. [CrossRef]
236. Khiari, Z.; Makris, D.P.; Kefalas, P. An Investigation on the Recovery of Antioxidant Phenolics from Onion
Solid Wastes Employing Water/Ethanol-Based Solvent Systems. Food Process. Technol. 2009, 2, 337–343.
[CrossRef]
237. Hanlon, P.R.; Barnes, D.M. Phytochemical composition and biological activity of 8 varieties of radish
(Raphanus sativus L.) sprouts and mature taproots. J. Food Sci. 2011, 76, 185–192. [CrossRef]
238. Masukawa, T.; Kadowaki, M.; Matsumoto, T.; Nakatsuka, A.; Cheon, K.S.; Kato, K.; Tatsuzawa, F.;
Kobayashi, N. Enhancement of food functionality of a local pungent radish “izumo orochi daikon” ‘susanoo’
by introduction of a colored root character. Hortic. J. 2018, 87, 356–363. [CrossRef]
239. Tatsuzawa, F.; Saito, N.; Toki, K.; Shinoda, K.; Shigihara, A.; Honda, T. Acylated cyanidin
3-sophoroside-5-glucosides from the purple roots of red radish (Raphanus sativus L.) “Benikanmi.”. J. Jpn.
Soc. Hortic. Sci. 2010, 79, 103–107. [CrossRef]
240. Ahn, M.; Koh, R.; Kim, G.O.; Shin, T. Aqueous extract of purple Bordeaux radish, Raphanus sativus L.
ameliorates ethanol-induced gastric injury in rats. Orient. Pharm. Exp. Med. 2013, 13, 247–252. [CrossRef]
241. Pak, W.M.; Kim, K.B.W.R.; Kim, M.J.; Kang, B.K.; Bark, S.W.; Kim, B.R.; Ahn, N.K.; Choi, Y.U.; Yoon, S.R.;
Ahn, D.H. Antioxidative effect of extracts from different parts of Kohlrabi. J. Appl. Biol. Chem. 2014,
57, 353–358. [CrossRef]
242. Jung, H.A.; Karki, S.; Ehom, N.; Yoon, M.; Kim, E.J.; Choi, J.S. Anti-diabetic and anti-inflammatory effects of
green and red kohlrabi cultivars (Brassica oleracea var. gongylodes). 2014, 19, 281–290. [CrossRef]
243. Paull, R.E.; Uruu, G.; Arakaki, A. Variation in the cooked and chipping quality of taro. Horttechnology 2000,
10, 823–829. [CrossRef]
244. Beyene, T.M. Morpho−Agronomical Characterization of Taro (Colocasia esculenta) Accessions in Ethiopia.
Plant 2013, 1, 1–9. [CrossRef]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution




Grown to Be Blue—Antioxidant Properties and
Health Effects of Colored Vegetables. Part II:
Leafy, Fruit, and Other Vegetables
Francesco Di Gioia 1, Nikolaos Tzortzakis 2, Youssef Rouphael 3, Marios C. Kyriacou 4,
Shirley L. Sampaio 5, Isabel C.F.R. Ferreira 5 and Spyridon A. Petropoulos 6,*
1 Department of Plant Science, The Pennsylvania State University, University Park, PA 16802, USA;
fxd92@psu.edu
2 Department of Agricultural Sciences, Biotechnology and Food Science, Cyprus University of Technology,
3603 Lemesos, Cyprus; nikolaos.tzortzakis@cut.ac.cy
3 Department of Agricultural Sciences, University of Naples Federico II, 80055 Portici, Italy;
youssef.rouphael@unina.it
4 Department of Vegetable Crops, Agricultural Research Institute, 1516 Nicosia, Cyprus;
m.kyriacou@ari.gov.cy
5 Centro de Investigação de Montanha (CIMO), Instituto Politécnico de Bragança, Campus de Santa Apolónia,
5300-253 Bragança, Portugal; shirleylsampaio@gmail.com (S.L.S.); iferreira@ipb.pt (I.C.F.R.F.)
6 Department of Agriculture, Crop Production and Rural Environment, University of Thessaly,
38446 N. Ionia, Magnissia, Greece
* Correspondence: spetropoulos@uth.gr; Tel.: +30-242-109-3196
Received: 30 December 2019; Accepted: 20 January 2020; Published: 23 January 2020
Abstract: The current trend for substituting synthetic compounds with natural ones in the design
and production of functional and healthy foods has increased the research interest about natural
colorants. Although coloring agents from plant origin are already used in the food and beverage
industry, the market and consumer demands for novel and diverse food products are increasing and
new plant sources are explored. Fresh vegetables are considered a good source of such compounds,
especially when considering the great color diversity that exists among the various species or even
the cultivars within the same species. In the present review we aim to present the most common
species of colored vegetables, focusing on leafy and fruit vegetables, as well as on vegetables where
other plant parts are commercially used, with special attention to blue color. The compounds that are
responsible for the uncommon colors will be also presented and their beneficial health effects and
antioxidant properties will be unraveled.
Keywords: anthocyanins; antioxidants; flavonoids; fruit vegetables; functional quality; leafy
vegetables; inflorescence; lettuce; natural colorants; tomato
1. Introduction
Vegetables are considered an invaluable ingredient of human diet, since they diversify color
of various food products and they also possess beneficial health effects due to their content in
various phytochemicals such as flavonoids, betalains and carotenoids and the overall high antioxidant
capacity [1–3]. Consumption of purple/blue fresh produce is associated with increased nutrient intake
and reduced risk for metabolic syndrome [4]. Based on food intake data from NHANES 2001–2002,
the daily intake of anthocyanins was estimated to be 12.5 mg/day/person in the United States [5].
The predominant dietary anthocyanins are malvidin, delphinidin, and peonidin glycosides [6], which
can be found in many plant foods, including berries, purple sweet potatoes, grapes, and wine [7].
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In comparison with other flavonoids, anthocyanins possess a positive charge on their C-ring, which
leads to different colors in response to various pH [8].
Anthocyanins not only have aesthetic importance by generating characteristic purple, bluish,
orange, and reddish pigments in various plant tissues [9], but also have biological functions including
protective effects against radiation, reactive oxygen species scavenging, defense against pathogens
and stress conditions, and attracting seed and pollen dispersers [10–12]. These compounds also have
nutritional value and potential health benefits [13].
Leafy vegetables are widely consumed throughout the world and they significantly contribute to
the overall recommended daily intake for several nutrients essential for human body [14]. They include
several species among which lettuce is considered the most important salad vegetable and several
reports highlighted its significance in human nutrition [15,16]. On the other hand, the Solanaceae family
has approximately 2700 species and 99 genera and includes some of the most important fruit vegetables
consumed globally. Solanum, the largest and most complex genus in this family, is of great economic
importance with several species used as foods, medicines, and ornamental plants [17]. In other
popular vegetables consumed worldwide such as broccoli, cauliflower, and artichoke, the immature
inflorescence constitutes the edible portion and represent a rich source of flavonoids, anthocyanins,
and other bioactive compounds that are also responsible for their pigmentation [18–21]. In the case of
sweet corn, another popular vegetable used for fresh consumption as well as for canned and freezing
processing, differing from the regular corn only for a higher accumulation of sugar in the kernels, the
ear including cob and kernels constitute a rich source of natural colorants including carotenoids and
flavonoids [22]. Yet, in other cases like asparagus the edible portion and source of anthocyanins is
constituted by the young stems [23].
Recently we published a review paper regarding colored root vegetable species focusing on
the most important coloring compounds and their antioxidant effects. With the present review we
aim to continue this work and present the rest of colored vegetable crops, focusing on leafy and
fruit vegetables and relevant species where other plant parts are consumed. Having in mind the
same context, the main coloring compounds are highlighted, while a special section for each species
is allocated to their health effects and antioxidant properties. The information presented in this
review was systematically gathered from scientific databases such as Scopus, ScienceDirect, PubMed,
Google Scholar, and ResearchGate by using various keywords and key phrases, e.g., the common and
Latin of the main species and/or the terms “health effects”, “antioxidant compounds”, “colored leafy
vegetables”, “colored fruit vegetables”, “blue vegetables”, “purple vegetables”, and “anthocyanins”.
2. Leafy Vegetables
2.1. Lettuce
Lettuce (Lactuca sativa L.) belongs to the Asteraceae (Compositae) family and is a very popular
vegetable crop used for fresh consumption and as salad ingredient owing to its sensory and
health-promoting properties [14,24–26]. Lettuce is widely cultivated throughout the globe and
it is rightly considered the most important of leafy greens as it ranks highest in production (27 million
tons in 2017; [27]). Lettuce comes in a wide variety of head formations, textures, sizes, leaf shapes,
and colors and it is conventionally classified according to Mou [28] into six major groups (i.e., types):
(i) Butterhead, (ii) Cos or Romaine, (iii) Crisphead, (iv) Leaf or Cutting, v) Stalk or Stem, and vi)
Latin. Compared to several other leafy vegetables, lettuce is an excellent source of vitamin B9
and total flavonoids. Wang et al. [29] and Gan and Azrina [30] reported that total vitamin B9 and
flavonoid contents in lettuce were higher by 16% and 220%, respectively, compared to spinach,
which is another important and widely consumed leafy green. Quali-quantitative variation in
lettuce vitamins and secondary metabolites (i.e., phytochemicals) depends on many pre-harvest
factors such as genotype, environmental conditions, harvest maturity, and agricultural practices [31].
However, the genetic material is the predominant pre-harvest factor and the major determinant of
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the biosynthesis and accumulation of lipophilic (i.e., carotenoids, chlorophylls, and vitamin E) and
hydrophilic (i.e., phenolic compounds and vitamin C) antioxidant molecules [32]. Vitamins are essential
micronutrients required for human metabolism and functionalities implicated in the reduction of
cardiovascular and degenerative diseases [33]. Folate (vitamin B9) and vitamin C (as ascorbic and
dehydroascorbic acids) are eminently present in lettuce [14]. In their review article Kim and co-workers
reported that folate and vitamin C contents vary with leaf type and particularly leaf coloration, with
red leaf, butterhead, and romaine lettuces being particularly good sources of folate [15,29,34], while
leaf green lettuce had the highest vitamin C concentration [24,25,34,35].
Carotenoids, which constitute an important group of lipophilic pigments frequently present in
yellow-orange vegetables and in dark green leafy vegetables, vary in concentration among lettuce
types and colors. Mou [36] assessed the genetic variability in β-carotene and lutein content, the most
abundant carotenoids in lettuce, across 52 genotypes (including butterhead, crisphead, Latin, leaf,
primitive, romaine, stem lettuce and wild species) that were categorized by type in the following
order: Romaine and green leaf > red leaf > butterhead > crisphead. The author also reported that
the two target carotenoids were significantly and positively correlated with chlorophyll a and b as
well as with total chlorophyll content. Contrarily to the findings of Mou [36], Baslam et al. [37], and
Nicolle et al. [25] demonstrated that the content of β-carotene and lutein may not entirely correlate
with leaf green pigmentation, since the carotenoids content appeared to be lower in green compared to
red-pigmented lettuce plants. The contradiction between these results may indicate that the content
in carotenoids may not be consistently related to leaf pigmentation [14]. Nevertheless, the frequent
consumption of carotenoids-rich lettuce could be of high importance since several epidemiological
studies demonstrated that the onset of chronic diseases such as heart disease, vision impairment, and
certain types of cancer (lung, prostate, and colon) could be reduced [38–41].
Several authors reported that the contents of secondary metabolites in lettuce differed
greatly among genotypes and depended particularly on leaf color (dark red, red, green/red, and
green) [14,42]. According to Mulabagal et al. [43] red lettuce contains a single anthocyanin, namely
cyanidin-3-O-(6”-malonyl-β-glucopyranoside) which is further converted in two cyanidin derivatives
(cyanidin-3-O-(6”-malonyl-β-glucopyranoside methyl ester) and cyanidin-3-O-β-glucopyranoside),
all presenting significant antioxidant activities against lipid peroxidation and cyclooxygenase activity.
Kim et al. [42] explored the genetic material of 23 lettuce cultivars belonging to three major lettuce groups
(crisphead, oak-leaf, and romaine) in respect to their phytochemical content and antioxidant potential.
The authors reported that most phytochemicals varied significantly with genetic material and were
associated mainly with leaf color. The red-leaf and to a lesser extent the green/red cultivars exhibited
the highest concentration of the following antioxidant molecules: Cyanidin, carotenoids (lutein,
violaxanthin and lactucaxanthin), fatty acids such as α-linolenic and linoleic acid, total polyphenols,
and antioxidant potential [42]. In the same study, the authors were also able to demonstrate that
the methanolic extract of red-pigmented lettuce contained potent scavengers of ABTS (scavenging
assay of 2,2-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid) diammonium salt radical) and DPPH
(scavenging assay of 2,2-diphenyl-1-picrylhydrazyl radical) radicals. The higher radical-quenching
activity of red-pigmented lettuce cultivars irrespective of type renders them more bioactive thus their
systematic inclusion in the human diet could be an efficient tool to minimize the impact of oxidative
stress-related diseases [25]. Similarly, Hao et al. [44], reported the differences in nutritive quality
(e.g., cellulose, protein, starch, sugar, and vitamin C contents) among 74 red/purple and green varieties
of leaf lettuce using grey correlation analysis (a methodology of treating and analyzing qualitative
data according to grey system procedure). The authors concluded that purple-leaf lettuce “P-S23”
exhibited significantly higher grey comprehensive evaluation value (0.8) in comparison to the green
counterparts (values < 0.5). In addition, leaf pigmentation significantly correlates to the constitution
and concentration of phenolic compounds belonging mainly in the subgroups of phenolic acids,
flavonoids, and anthocyanins [14]. Chicoric, caffeic, and chlorogenic acids and their derivatives are the
most abundant phenolic acids present in lettuce, whereas the most outstanding flavonoids include
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anthocyanins, quercetin, kaempferol, and flavone luteolin [35,45–47]. Several authors reported a higher
total phenolic content in red butterhead, red leaf and red romaine lettuces compared to their green
counterparts [16,35,48–51]. The red color of lettuce has been associated with a higher total phenolics
content, known to impart a greater antioxidant activity than vitamins C and E [52], and has been
attributed primarily to anthocyanins, an important group of flavonoids responsible for the red/purple
coloration [53].
Regarding the health benefits attributed to lettuce, according to an in vivo study carried out by
Lee et al. [54] on mice fed with a high-fat diet, supplementation of the diet with 8% red lettuce on a
body weight (bw) basis decreased the total cholesterol and the low density lipoprotein (LDL) by 9%
and 123%, respectively, thus highlighting the potential effects of red-pigmented lettuce consumption
against cardiovascular disease. A putative mechanism behind the cholesterol reduction could be
the synergistic effects of lipophilic and hydrophilic antioxidant molecules such as α-tocopherol,
anthocyanins, β-carotene, and phenolic compounds. Similarly, Nicolle et al. [24] observed that
feeding male rats with 20% of red oak-leaf lettuce decreased significantly the LDL (low density
lipoproteins)/HDL (high-density lipoproteins) cholesterol ratio and the liver cholesterol content.
In addition to preclinical trials, clinical studies demonstrated that weekly consumption of lettuce
was able to reduce the incidence of colorectal cancer [55]. The protective effect of frequent lettuce
consumption against colorectal cancer has been attributed to the presence of β-carotene and vitamin C
and not to Ca and vitamins B9 and E contents [55]. Recently, Qin [56] reported that the new cultivar
B-2 of red-pigmented lettuce, characterized by high concentration of anthocyanins, flavones, and
phenolic acids, can minimize oxidative stress-related diseases, leading to anti-tumor effects against
human lung adenocarcinoma, hepatoma, and human cancer colorectal adenoma cell lines. Based on
the above considerations, clinical and preclinical studies demonstrated that frequent consumption
of fresh lettuce, in particular the red-pigmented varieties, carries potential anti-diabetic, cholesterol
lowering, and anti-tumor properties.
2.2. Basil
Basil (Ocimum basilicum L.) belongs to the Lamiaceae family and it is one of the most important
aromatic herbs cultivated worldwide as it flourishes under a wide range of climatic conditions.
Basil cultivated both in open-field and under greenhouse conditions is an essential ingredient of
renowned pesto sauce (widely consumed in Italy), while it is also used for fresh consumption and
as a culinary spice [57]. In addition, the extraction of essential oils from basil is of high interest to
both cosmetic and pharmaceutical industries. Basil comes in a wide variety of types, conventionally
classified into seven morphotypes: (i) Large-leafed “Italian” basil, (ii) tall, slender basil, (iii) dwarf
“Bush” basil, (iv) compact “Thai” basil, (v) purple basil (with clove-like aroma), (vi) citriodorum
basil (flavored types), and (vii) purpurascens basil (sweet purple-colored basil) [58]. The herbs of the
Lamiaceae family, such as basil, are characterized by strong antioxidant capacity. Basil in particular is
a rich source of phenolic compounds, including phenolic acids such as rosmarinic, caffeic, chicoric
and caftaric acids [59–61], vitamin C, and carotenoids such as lutein and β-carotene [62]. Furthermore,
certain purple/red cultivars also have important concentrations of the hydrophilic anthocyanins,
especially the “Dark Opal”, “Purple Ruffles”, and “Rubin” cultivars” [61,63].
The main carotenoids detected in basil are mostly lutein and β-carotene; but Calucci et al. [64]
ranks basil first among aromatic herbs with respect to the concentrations of xanthophyll carotenoids.
In the study of Kopsell et al. [62], the main detected carotenoids in sweet basil were identified as lutein,
β-carotene, and zeaxanthin, and significant differences in carotenoid profiles were observed between
different growing conditions (open-field versus greenhouse) and cultivars (“Cinnamon”, “Genovese”,
“Italian large leaf”, “Nufar”, “Osmin purple”, “Red Rubin”, “Spicy bush”, and “Sweet Tai”). According
to Marchand et al. [38] and Johnson et al. [40], the frequent consumption of vegetables and herbs was
more strongly correlated with reduced risk of certain types of cancer and degenerative ophthalmic
diseases, in comparison to the ingestion of monomolecular carotenoid supplements. In addition
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to carotenoids, basil is considered also an important source of vitamin C. It is well established that
vitamin C is crucial for immune and antioxidant functions, and according to the WHO, 80–90 mg
of vitamin C should be ingested daily [65]. However, due to the water solubility of ascorbic acid,
regular dietary intake is essential to normal metabolic functioning [66]. According to Murarikova and
Neugebauerova [65] the ascorbic acid content varied from 34.3 to 220.0 mg/kg fresh weight among
the tested varieties (“Dark Green”, “Lettuce Leaf”, “Mammolo Genovese”, “Manes”, “Ohre”, “Purple
Opal”, and “Red Rubin”) and the different growing seasons.
Rosmarinic acid is noted in the scientific literature as the most abundant phenolic constituent of
basil [59,60]. On the other hand, a study carried out by Kwee and Niemeyer [61] showed that 9 over 15
basil cultivars contained other caffeic acid derivatives, such as chicoric acid, in higher concentrations
than rosmarinic acid. Moreover, the antioxidant and antimicrobial properties of “Napoletano” green
and purple basil were analyzed by Tenore et al. [67], who reported that the main phenolic acids in
purple basil were rosmarinic, ferulic and gallic acid; while in green basil, the most abundant phenolic
constituents were gallic acid, followed by rosmarinic and ferulic acids. Interestingly, the functional
molecule rosmarinic acid detected in “Napoletano” type basil was by far higher than what on average
has been reported for other common varieties such as “Sweet basil”, “Thai basil”, “Genovese Italiano”,
and “Purple Petra” (112, 128, 117, and 352 per 100 g fresh weight, respectively) [59]. The main
anthocyanins detected in purple basil extract were cyanidin-based p-coumaril and malonil acids, acting
as powerful antioxidants with potential use as medicinal agents [68]. Tenore and co-workers also
demonstrated in the same study that extracts of “Napoletano” green and purple basil both had a broad
antimicrobial spectrum able to reduce the growth of all human pathogenic and food spoilage bacteria
and molds tested [67].
Regarding the health-promoting effects of basil, several preclinical and clinical studies showed
that extracts from basil, particularly the purple one, may alleviate hyperglycemia associated with type
2 diabetes [69,70]. The anti-diabetic beneficial effects of basil extract may be due in part to catechin
and especially to rosmarinic acid, which has been found to inhibit key enzymes such as α-amylase,
α-glucosidase, and aldose reductase [71–73]. In addition to being anti-diabetic, basil extract may also
be an efficient tool against hyperlipidemia by effecting lower cholesterol and triglyceride levels in
the blood [74,75]. Reduced uptake of lipids and lower values of total cholesterol and low density
lipoprotein may reduce the risk of cardiovascular diseases.
2.3. Perilla
Perilla (Perilla frutescens L. Briit) belongs to the Lamiaceae family (formely Labiateae) which
consists of 235 genera and more than 700 species [76]. Perilla is an edible herb widely consumed in
Asian countries such as China, Korea, Japan, and India. Similar to spinach, perilla leaves are also
characterized by a high concentration of carotenoids. In fact, according to Müller-Waldeck et al. [77],
perilla may contain high contents of carotenoids, especially up to five-fold higher lutein than other
carotenoid-rich leafy vegetables. The leaves of perilla contain a range of bioactive phenolic molecules
such as caffeic acid, catechin, chrysoeriol, ferrulic acid, luteolin, quercetin, and rosmarinic acid [78,79].
In particular, secondary metabolites such as rosmarinic acid and perillaldehyde (an essential oil
constituent) have demonstrated potential to prevent a wide range of diseases particularly owing
to their anti-diabetic, anti-depressant, anti-bacterial, anti-cancer, and antimicrobial properties [76].
Thus the concentrations of these two phytochemicals are crucial for their clinical and culinary
applications. It is worth noting that these two secondary metabolites are produced in perilla by
two different biosynthetic pathways, namely the monoterpene and phenylpropanoid pathways,
and may increase independently in relation to the perilla chemotype and abiotic environmental
stress conditions [80]. Perilla is present in nature in two main chemical-varietal phenotypes:
(i) The red-pigmented cultivar P. frutescens var. crispa, known as “Zi-So” and widely grown in
China where it is used as a spicy herb, leafy vegetable, and medicinal plant, and (ii) the non-pigmented
green cultivar P. frutescens var. frutescens known in Japan as “Shisoyo” or “Shiso” and mainly
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used as an oil crop but also as ingredient of skin creams and food products [81,82]. According to
Meng et al. [78,83], three cinnamic derivates (caffeic acid, coumaroyl tartaric acid, and rosmarinic acid)
ranged from 0.1 to 11 mg/g; six flavonoids (apigenin 7-O-caffeoylglucoside, apigenin 7-O-diglucuronide,
luteolin 7-O-diglucuronide, luteolin 7-O-glucuronide, scutellarein 7-O-diglucuronide, and scutellarein
7-O-glucuronide) ranged from 3.5 to 18.5 mg/g; and six anthocyanins (0.7–2 mg/g) including cis-shisonin,
cyanidin 3-O-(E)-caffeoylglucoside-5-O-malonylglucoside malonylshisonin and shisonin were detected
on eight tested cultivars of perilla. Concerning the health effects of perilla extract, Narisawa et al. [84]
reported that perilla leaves carry anti-tumor properties. In their work, the authors showed that
treatment of female rats with a 12% fat diet based on perilla extract and safflower oil in 1:3 or 1:1 ratio
effected better protection against colon cancers as compared to safflower oil alone [84].
Comparing green (Korean cultivar) and red-pigmented (Japanese cultivar) perilla,
Rouphael et al. [82] observed that green perilla produced exclusively perilla ketone (PK), whereas the
red perilla contained perillaldehyde (PA). Similar results were reported by Martinetti et al. [81] in a
study profiling two red-leaf (“Aka Shiso” and “Purple Zi Su”) and three green-leaf cultivars (“Ao Shiso”,
“Qing Su”, and “Korean perilla”) with the later containing PK instead of PA. The terpenoid component
present in green-pigmented perilla has been demonstrated to be toxic for cattle and horses, since PK
is considered a potent lung toxin [77,85], but the health-effect as well as the toxic dose/concentration
to humans is still controversial, therefore Müller-Waldeck and co-workers [77] concluded that some
Korean genotypes (green-pigmented cultivars) are not suitable/recommended for fresh consumption.
Interestingly, several authors showed that PA and PK present in red and green perilla can stimulate
the TRPA1 (Transient Receptor Potential) cation channels which are actively involved in multiple
biological mechanisms such as pain perception and their functional role in the prevention of certain
types of tumor has been proved [86,87].
2.4. Swiss Chard
Green chard also known as Swiss chard (Beta vulgaris var. cicla L.) belongs to the
Amaranthaceae-Chenopodiaceae family and is considered an important leafy vegetable grown for
its green or reddish leaves and the white, yellow, or red leaf stalk. Green beet belongs to the same
family of the root vegetable red beet (Beta vulgaris var. rubra L.). Traditionally, Swiss chard has been
employed for its health-promoting properties as folk remedy for liver/kidney diseases, for triggering
the hematopoietic and immune systems and also as a target diet in some tumors treatment [88].
As they grow, Swiss chard leaves accumulate a wide range of macro and micro minerals such as P,
K, Ca, Mg, and Fe and several lipophilic vitamins (such as A and E and also carotenoids), as well
as hydrophilic vitamins (such as B3, B5, B9, and C) [89]. According to Mzoughi et al. [90] Swiss
chard leaves have a nutritional and functional profile catering to modern human diets. In the latter
study, Swiss chard leaves were characterized by high concentrations of secondary metabolites such as
(myricitrin, p-coumaric, and rosmarinic acid), flavonoids, carotenoids (β-carotene, chlorophyll, and
lycopene) and some target volatile compounds (decanal, E-anethole, and octanoic acid). Mzoughi
and co-workers demonstrated that the high antioxidant capacity on ABTS and DPPH of Swiss chard
ethanol extract was accompanied with significant inhibitory effects on α-amylase and α-glucosidase;
thus the Swiss chard extract could be explored in the near future as potential functional food with
antioxidant and anti-diabetic properties [90].
In a recent review paper, Ninfali et al. [91] reported that green beet extract may regulate the
hematic concentration of glucose, decrease lipid peroxidation, lower triglycerides and cholesterol
levels, and improve glutathione levels. The health protective secondary metabolites found in B. vulgaris
cicla have been identified as a class of G-Glycosyl flavonoids including (i) isovitexin, (ii) vitexin,
(iii) vitexin-2-O-xyloside and iv) vitexin-2-O-rhamnoside, which are characterized by high biological
activity [91]. According to Lee et al. [92], vitexin is able to reduce drastically the mitochondrial
membrane potential in leukemia cell. Similarly, Nifali et al. [93] and Gennari et al. [94] reported
that vitexin-2-O-xyloside and vitexin-2-O-rhamnoside were able to reduce the proliferation rate of
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MCF-7 breast and RKO cancer cells. Concerning the anti-inflammatory properties of Swiss chard,
Borghi et al. [95] demonstrated that the administration of 10 mg/kg of vitexin is able to decrease
the levels of pro-inflammatory cytokines. Overall, in vitro and in vivo experiments carried out
on animals and humans demonstrated that the biological activity of vitexin, vitexin-2-O-xyloside,
and vitexin-2-O-rhamnoside can trigger the expression of a wide range of genes associated with
inhibition of cancer cell proliferation and anti-inflammation activities.
2.5. Brassica Leafy Vegetables
The group of brassicaceous leafy vegetables, formerly referred to as cruciferous vegetables,
includes a wide range of species with potential health-promoting properties such as kale (Brassica
oleracea var. sabellica), pack choi (Brassica rapa var. chinensis), mizuna (Brassica rapa var. japonica),
watercress (Nasturtium officinale R.Br.), wild and salad rocket (Diplotaxis tenuifolia [L.] DC and Eruca
cesicaria [L.] Cav., respectively). According to FAOSTAT [27] database, roughly 12% of the vegetables
grown worldwide are members of the Brassicaceae family. Recent reports [96,97] have suggested
that brassicaceous leafy vegetables constitute valuable sources of phytochemicals. They contain high
levels of vitamins (C, E [as α- and γ-tocopherols] and K [phylloquinone]), carotenoids, and phenolic
compounds. In addition to the latter phytochemicals, Brassica leafy vegetables are characterized by
sulfur-containing glucosinolates and methylcysteinsulfoxide compounds. The genetic factor is the
most important and influential one in terms of modulating the biosynthesis and accumulation of
phytochemicals in Brassica leafy vegetables [97]. In a comparative study of antioxidant molecules
in four Brassica leafy vegetables (mizuna, salad rocket, watercress, and wild rocket), the authors
observed a large variability in phytochemical concentrations [98]. For instance, watercress showed
the highest polyphenol and vitamin C content, while salad and wild rocket were characterized by
high concentrations of kaempferol and quercetin derivatives and finally mizuna exhibited significant
concentrations of isorhamnetin and sinapic acid [98]. The authors highlighted the potential value of
salad Brassica leafy vegetables as dietary sources of antioxidants conferring a wide range of positive
health effects against type 2 diabetes and cardiovascular diseases.
Kale is a leafy Brassica species considered a potent source of glucosinolates and isothiocyanates,
their main breakdown products. A study from the CDC (center of disease control and prevention)
reported kale being ranked 15th among “powerhouse” vegetables and fruits [99]. The most abundant
glucosinolates in kale were: 3-(methylsulphinyl)propyl, 2-propenyl and also 4-(methylsulphinyl)butyl
glucosinolates. Genotypic variation within eight cultivars of kale (“Starbor”, “Beira, “Scarlet”,
“Premier”, “Olympic Red”, “Toscano”, “Dwarf Siberian”, and “Red Russian”) revealed that “Beira”
and “Olympic Red” were characterized by the highest total concentration of glucosinolates and
were proposed as functional foods [100]. In another experiment carried out by Hahn et al. [101]
on 25 kale cultivars, the authors observed a great variation in glucosinolate profiles. Similarly,
Ferioli et al. [102] reported higher variation in the aliphatic compared to the indole glucosinolates
(9- and 5-fold, respectively) across 25 kale cultivars harvested from different European countries (Italy,
Portugal, and Turkey). The presence of isothiocyanates in Brassica leafy vegetables has been reported
to confer anti-diabetic, anti-inflammatory and anti-cancer properties [103–108]. Although less popular,
even “ornamental cabbage” or kale (Brassica oleracea L. var. acephala DC.) have genotypes characterized
by the accumulation of different pigments [109–111]. Brassica leafy vegetables, in particular kale, are
considered additionally as a rich source of carotenoids (lutein and β-carotene), as well as chlorophylls
(a and b). Carotenoid concentrations of 33 kale cultivars were analyzed and quantified [112]. Zeaxanthin
was the most abundant carotenoid in 21 cultivars. Moreover, American and hybrid cultivars and
accessions were characterized by high concentrations of zeaxanthin, whereas, German landraces,
German commercial varieties, Italian, and red-colored kale varieties exhibited high concentrations of
chlorophyll a and b [112].
Emerging market trends catering to shifting consumer perceptions of quality [32], have resulted
in colored Brassica leafy vegetables (e.g., violet kale or pack choi) containing anthocyanins garnering
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the attention of nutritionists and horticultural scientists. Recently, Mageney et al. [112] proposed
that the anthocyanin content could be used as a marker to differentiate between varieties/cultivars.
Testing green and red-pigmented pack choi, Zheng et al. [113] observed that red pack choi produced
higher concentrations of carotenoids, total phenolic compounds, total flavonoids, glucosinolates, and
anthocyanins compared to its green counterpart. Importantly, the regular intake of anthocyanins
from such colored leafy vegetables has been positively correlated with the prevention of various liver
diseases, and also with the reduction of colon cancer, hepatic inflammation and oxidative stress [114].
The main pigments isolated in the studied leafy vegetables are presented in Table 1.
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cyanidin-3-glucoside (1.40–3.07 g/100 g fw)
[42,43,46,48]
Carotenoids
all-E-violaxanthin (23.9–33.4 μg/g fw),
9′-Z-neoxanthin (11.3–14.6 μg/g fw),
all-E-Luteoxanthin, all-E-lactucaxanthin
(19.7–23.0 μg/g fw), all-E-lutein





all-E-violaxanthin (15.9–37.1 μg/g fw),
9′-Z-neoxanthin (5.0–11.4 μg/g fw),
all-E-Luteoxanthin, all-E-lactucaxanthin
(7.5–17.4 μg/g fw), all-E-lutein (16.4–36.3 μg/g
fw), and all-E-β-carotene (4.2–12.9 μg/g fw)
[42]
Chlorophylls Chlorophyll a and b (6.95–26.92 mg/100 g fwand 4.60–10.30 mg/100 g fw, respectively) [43,48]
Anthocyanins Cyanidin-3-glucoside (0.192–0.260 g/100 g fw) [48]
Basil (Ocimum
basilicum L.). Purple/red Anthocyanins
Anthocyanin A (0.325–0.423 mg/g
dw),-anthocyanin B (0.057–0.641 mg/g dw),
anthocyanin C (0.362–0.877 mg/g dw),
anthocyanin D (0.063–0.662 mg/g dw),
cyanidin-based (1.78–3.18 mg/g dw)
pigments- and peonidin-based (19.8% fw)
pigments,
cyanidin-3-(6,6′-di-p-coumaroyl)-sophoroside-
5-glcucoside (7.5 mg/g extract)
[63,68,115,116]
Green Carotenoids
Lutein (4.99–6.64 mg/100 g fw or
22.1–24.0 mg/100 g dw), β-carotene
4.42–6.01 mg/100 g fw, zeaxanthin
(0.30–0.45 mg/100 g fw or 1.8 mg/100 g dw)
[62,64]
Perilla (Perilla
frutescens L. Briit) Red Anthocyanins
Cyanidin and cyanidin derivatives (6.44 mg/g
dw), shisonin (0.126–0.416 mg/g dw),
malonylshishonin (0.462–1.116 mg/g dw)
[83,117–120]
Swiss chard (Beta
vulgaris var. cicla L.)
Yellow Betaxanthins Vulgaxanthin I, miraxanthin V [121,122]
Red/purple Betacyanins Betanin, isobetanin, betanidin,and isobetanidin [123]
3. Fruit Vegetables
3.1. Tomato
Tomato (Solanum lycopersicum L.) is an important fruit vegetable, widely consumed all over
the world due to its rich nutrient content, special taste, and diverse ways of consumption (fresh,
soups, juices, purees, dried, and sauces) [124]. Fruit color and pigments content are two important
traits that largely reflect tomato fruit quality, as well as the antioxidant activity which is mainly
correlated to the hydrophilic (e.g., soluble phenolic compounds and vitamin C) than to the lipophilic
compounds (e.g., carotenoids, vitamin E, and lipophilic phenols) [125]. Fruit color is mainly related
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to pigments content, such as chlorophyll, carotene, lycopene, phytoene and anthocyanin, and their
relative proportions at different maturity stage [126]. The most abundant carotenoid is lycopene,
followed by phytoene, phytofluene, ζ-carotene, γ-carotene, ß-carotene, neurosporene, and lutein [127].
Color development is due to the chlorophyll degradation and the synthesis of carotenoids as fruit is
developed and ripen. Therefore, the genetic development of tomato fruit color and pigments content is
an interesting research area to improve fruit quality and satisfy the diverse consumers’ demands [128].
The consumption of tomato and related food products is associated with the decrease of various
diseases incidence such as chronic degenerative diseases, cardiovascular disease, and age-related
macular degeneration (AMD) in human health [129]. Raiola et al. [124] reported the nutritional
importance of tomato phytochemicals against inflammation processes and prevention of chronic
non-communicable diseases (e.g., obesity, diabetes, coronary heart disease, and hypertension).
Anthocyanins normally are not produced in tomato fruit, however, some wild tomato species,
such as S. chilense, S. cheesmaniae, S. lycopersicoides, and S. habrochaites biosynthesize anthocyanins in
the sub-epidermal tissue of the fruit, and some alleles from those genotypes have been introgressed
into cultivated genotypes [130]. Therefore, combining the dominant Anthocyanin fruit (Aft) gene
from S. chilense and the recessive atroviolacea (atv) gene from S. cheesmaniae into a cultivated tomato
background, anthocyanins biosynthesis has been achieved [131,132].
Purple tomatoes have antioxidants and phytochemical properties in both flesh and peel, often
in superior levels than those found in conventional red tomatoes [133]. A genetically modified
(GM) purple tomato was found to have additional health-promoting effects by prolonging the life of
cancer-susceptible mice compared to tomatoes with conventional (red) color [134]. Extracts from fruit
of purple tomato (breeding line V118) showed significant and dose dependent anti-inflammatory effect
against paw edema in an in vivo study with rat models (edema inhibition: 7.48%–13.8%), suggesting
that anthocyanins may play a role in the anti-inflammatory effect [135]. Interestingly, during the
last 20 years there has been an increasing interest in developing highly consumed food, such as
flavonoids-rich tomato fruit. To that direction, transgenic approaches have been applied to modify the
biosynthesis of phenylpropanoids, in order to alter the tomato flavonoid biosynthesis [130].
Phenolic content is varied at different developmental stages of tomatoes, as sun black (SB) tomato
had 5.8 and 8.6 mg GAE/g dw phenolic content at mature green and red ripening stage, respectively,
contents that were 152% and 134% higher than wild type (WT) [130]. Li et al. [136] reported similar
total phenolic content (659.11 mg GAE/100 g dw) for purple tomato as has been reported for other
tomato varieties (from 290 to 500 mg GAE/100 g dw) [137]. Individual components of phenolics may
also vary among purple and red varieties, as the main phenolic compounds content (chlorogenic acid,
naringenin, and rutin) was higher (65.56, 12.82, and 52.39 mg/100 g dw, respectively) [136] in purple
tomatoes compared with red tomatoes were chlorogenic acid, naringenin, and rutin content was 2.67,
1.84, and 6.61 mg/100 g dw [138] and 16.7, 2.2, and 16.9 mg/100 g dw, respectively [139]. Apart from
chlorogenic acid, naringenin, and rutin Li et al. [136] reported other phenolic compounds in purple
tomatoes such as p-coumaric acid (15.68±0.74 mg/100 g dw), gentistic acid (15.25 ± 0.76 mg/100 g dw),
ferulic acid (14.51 ± 0.99 mg/100 g dw), caffeic acid (13.65 ± 0.83 mg/100 g dw), and protocatechuic
acid (8.95 ± 0.16 mg/100 g dw). Indeed, chlorogenic acid content depends on the developmental stage
of fruit and varied from 0.5 to 1.3 mg/g dw in sun black (SB) tomato extracts [130]. Moreover,
composition of flesh and peel in tomato mutants differed as flesh contained chlorogenic acid
(7.96± 0.75 mg/100 g fw), quercetin (5.03± 1.02 mg/100 g fw), luteolin (0.45± 0.01 mg/100 g fw), and total
phenolics (1.18 ± 0.06 mg/g fw), while in peel the respective compounds content was: chlorogenic acid
(8.43 ± 0.15 mg/100 g fw), quercetin (5276.15 ± 15.10 mg/100 g fw), luteolin (21.28 ± 1.07 mg/100 g fw),
and total phenolics (5.95 ± 0.27 mg/g fw) [133].
Among the several phytochemicals identified in plants, cis- and trans-resveratrol
(3,4,5-trihydroxystilbene) are polyphenols that belong to the stilbene class; however, only the trans form
is biologically active in the human body [140]. Numerous biocidal activities exerted by resveratrol
have been reported such as antioxidant, antidiabetic and estrogenic activity, anticancer effects through
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the preservation of the regular cell cycle, the inhibition of tumor invasion and angiogenesis, and
cardiovascular effects through the reduction of the expression of endothelial adhesion cells and the
inhibition of cell apoptosis and platelet aggregation [141–145]. However, resveratrol’s daily intake by
humans has still to be established [143]. Vagula et al. [146] quantified trans-resveratrol in S. americanum
Mill. fruit, which ranged between 1.07 and 0.796 μg/g for fruit pulp and peel, respectively, and these
levels were significantly higher when compared to freeze-stored fruit (0.1353 μg of trans-resveratrol/g
of sample) and to other berries [146].
Vasco et al. [147] reported the higher antioxidant capacity of purple (purple-red variety) tamarillo
or tree tomato (Solanum betaceum Cav.), compared to the golden-yellow variety and reported 9.3 μmol
trolox/g fw, 3.0 μmol trolox/g fw and 40 μmol trolox/g fw for seed-jelly, pulp, and peel tissues of
purple fruits compared to 3.8 μmol trolox/g fw, 2.3 μmol trolox/g fw and 22 μmol trolox/g fw for
seed-jelly, pulp and peel tissues of yellow fruits, respectively. Similarly, Sestari et al. [133] reported
increased antioxidant capacity (DPPH) in peel (38.12 ± 4.27 μmol trolox/g fw) compared to flesh
(8.64 ± 0.45 μmol trolox/g fw) in tomato mutants. Interestingly, the oxygen radical absorption capacity
assay (ORAC) value for the hydrophilic extracts in purple tomato reported by Li et al. [136] was
323.23 μmol trolox/g dw, which was 2-fold higher than the ORAC value of the traditional tomato
cultivar San Marzano (140 μmol trolox/g dw) reported by Ninfali et al. [148]. Similar observations were
made by Blando et al. [130] who stated 3-fold higher trolox equivalent antioxidant capacity (TEAC)
value (31.6 μmol trolox/g dw) in sun black tomatoes compared with the wild type (10.3 μmol trolox/g
dw) at the red-ripening stage. Moreover, antioxidant capacity of purple fruit was higher at the ripe
(red ripe stage-RR) fruit compared to the unripe (mature green stage-MG) ones, probably explained by
the great increase in polyphenols accumulation during ripening (from 5.8 to 8.6 mg GAE/g dw, in MG
and RR, respectively) [130]. In the same study, total ascorbic acid content was higher in sun black than
wild type fruits (37.3 ± 1.4 vs. 27.1 ± 1.1 mg 100/g fw, respectively) [130].
The antioxidant capacity of fruit is not only related to phenolics and ascorbic acid but also to the
carotenoids, flavonoids, and anthocyanins content. Lycopene, the main phytochemical of tomatoes,
is known for its important role in human health related functionalities [149]. Lycopene supplementation
in an in vivo study with iodoacetamide-induced colitis rats showed reduced tissue malondialdehyde
(MDA) levels, the histological signs of colon injury, and increased superoxide dismutase levels in the
red blood cells [150]. In the study Li et al. [136], lycopene was the dominant carotenoid (185.01 μg/g
dw) in breeding line V118, followed by β-carotene (47.11 μg/g dw) and lutein (2.66 μg/g dw). About
8.1% of the total carotenoids in V118 were cis-carotenoids, a lower value compared to that of most of
the tomato varieties studied [136]. Moreover, Li et al. [128] reported that purple fruit (cv “Zi Ying”)
had increased antioxidant capacity compared to green fruit (cv “Lv Ying”), with lycopene content of
36.51 ± 2.86 mg/kg fw and β-carotene 13.38 ± 1.31 mg/kg fw in purple fruit versus lycopene content
of 1.35 ± 0.05 mg/kg fw and β-carotene 6.80 ± 0.32 mg/kg fw in green fruit. In a comparative study,
Hazra et al. [151] pointed out the dietary role of purple tomato (AftAft dgdg genotype) due to the
increased values in ascorbic acid (31.56 ± 2.41 mg/100 g fw), lycopene (6.13 ± 0.39 mg/100 g fw),
β-carotene (0.65 ± 0.14 mg/100 g fw), and anthocyanin (20.73 ± 2.86 mg/100 g fw), compared to the
overall mean value of 31 hybrids.
Li et al. [136] reported a total carotenoid content of breeding line V118 of 234.78 μg/g dw, being
within the range of the average amounts reported for red tomatoes (132–583 μg/g dw) [152]. At the red
ripe stage, total carotenoids did not differ between the sun black (SB) and wild type (WT) tomatoes;
however, the β-carotene content was significant higher in the SB sample, whereas the lycopene content
was lower [130]. Similarly, Vasco et al. [147] reported higher β-carotene levels in purple tamarillo
than in yellow tomato variety. Generated double and triple mutants (Anthocyanin fruit/high pigment
2(Aft/hp2) and Anthocyanin fruit/atroviolacium/high pigment 2 (Aft/atv/hp2)) of purple tomatoes
had higher lycopene and β-carotene levels and up to 63% of vitamin C compared to tomato cultivar
Micro-Tom, suggesting accumulating trends of relevant phytochemicals in near-isogenic lines [133].
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Anthocyanins, the most abundant flavonoid constituents in pigmented fruit and vegetables,
posse potential health beneficial effects, such as antioxidant, anti-inflammatory, anticancer, and
antidiabetic activities [153,154]. Anthocyanins also had notable effects against inflammation
by inhibiting cyclooxygenase-2 (COX-2) expression, inducible nitric oxide protein and mRNA
expression [155]. The “Giant” and “New Zealand” purple cultivars, had total anthocyanins content of
102.35 ± 1.46 mg/100 g dw and 168.88 ± 2.65 mg/100 g dw, but also revealed high antioxidant activity
which might be related to their overall phenolic composition [156]. Zhang et al. [157] reported the role
of anthocyanins in postharvest storage of tomatoes as in purple tomatoes, anthocyanins doubled the
self-life of fruit by delaying over-ripening and reducing susceptibility to Botrytis cinerea.
Li et al. [136] through an LC-MS study reported three major anthocyanins, which were
mainly acylglycosides of petunidin and malvidin. Among these anthocyanidins, petunidin was
the predominant aglycone (91.9%), and the rest of the minor aglycones accounted for only 9.1%
of the total anthocyanidins [136]. Moreover, petunidin is not usually synthesized in vegetables
and fruit, and little is known about its health benefits, however in tomato mutants petunidin
revealed considerable amounts (>60 mg/100 mg fw) in fruit peels of the lines combining Aft and
hp2 genes [133]. The total anthocyanin content in breeding line V118 was 72.31 mg/100 g dw,
including 9.04, 50.18, and 13.09 mg/100 g dw of petunidin-3-O-caffeoyl-rutinoside-5-O-glucoside,
petunidin-3-O-(p-coumaryl)-rutinoside-5-O-glucoside, and malvidin-3-O-(p-coumaryl)-rutinoside-
5-O-glucoside, respectively [136]. Moreover, Blando et al. [130] reported that petanin (Petunidin
3-(6-(4-(E-p- coumaroyl)rhamnosyl)glucoside)-5-glucoside (petanin)) and negretein (Malvidin
3-(6-(4-(E-p-coumaroyl)rhamnosyl)glucoside)-5-glucoside) represented 56.6% and 21.4% of the total
anthocyanins content in sun black (SB) fruit peel, respectively, whereas no anthocyanins were detected
in wild type (WT) tomato fruit.
The content of anthocyanins in the Del/Ros1 transgenic tomato is equally distributed within
fruit, with 5.1 ± 0.5 g/kg dw being detected in the peel and 5.8 ± 0.3 g/kg dw in the flesh,
but not detected in seeds [7]. These values are higher than those reported for well-known
anthocyanin-rich foods such as red raspberry (3.9 g/kg dw; [158]), strawberry (3.2 g/kg dw; [158]),
and mulberry (2.1 g/kg dw; [159]). In a study with transgenic plants, the predominant anthocyanins
in the Del/Ros1 transgenic tomato were delphinidin-3-(trans-coumaroyl)-rutinoside-5-glucoside and
petunidin-3-(trans-coumaroyl)-rutino side-5-glucoside, which contributed to nearly 86% of the total
anthocyanins content, while two new anthocyanins, malvidin-3-(p-coumaroyl)-rutinoside-5-glucoside
and malvidin-3-(feruloyl)-rutinoside-5-glucoside making up to 6% of the total anthocyanins content,
were also reported [7]. Three mutant genes have been identified that can lead to the production of
anthocyanins in the peel of the fruit, namely Anthocyanin fruit (Aft), Aubergine (abg), and atroviolacea
(atv), while the Aft gene was also identified in crosses with Solanum chilense Dunal [160]. This gene is
located in chromosome 10 and its presence in tomato leads to the production of anthocyanin pigments,
mainly delphinidin, malvidin and petunidin, as well as to higher levels of the flavonols quercetin
(3.6-fold), and kaempferol (2.7-fold), in tomato fruit [160,161].
Tamarillo crop is attracting research interest lately due to the high content in antioxidants and
phytochemicals. The tamarillo, a non-climacteric edible fruit, is quite popular in local markets,
especially in South America, consumed in juices or fresh and being highly appreciated due to high
polyphenols levels [156], β-carotene (provitamin A), vitamin B6, vitamin C (ascorbic acid), vitamin E,
and iron contents [162]. Among phenols, the presence of anthocyanins (delphinidin, cyanidin, and
pelargonidin glycosides) and hydroxycinnamoyl derivatives (e.g., 3-O-caffeoylquinic acids, caffeoyl
glucose and feruloyl glucose) have been described in several reports [147,163,164], while recently
rosmarinic acid has been also identified [156]. The hydroxycinnamoyl derivatives show antioxidant
properties and have been related to protective effects on human health [165]. In particular, the caffeoyl
ester of rosmarinic acid has various biocidal activities, such as antiviral, antibacterial, anti-inflammatory,
and antioxidant effects [166]. Other compounds were tentatively identified as different rosmarinic
acid glucosides, caffeoyl glucoside, feruloyl glucoside, and ferulic acid dehydrodimers. Pelargonidin
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3-O-rutinoside and delphinidin 3-O-rutinoside were the main anthocyanins in purple cultivars of
tomato fruit [167]. Vasco et al. [147] reported anthocyanins content of 38 mg/100 g fw in purple
tamarillo which was higher than previous reports in yellow fruit (8.5 mg/100 g fw) [167].
Both Solanum americanum Mill. and S. villosum Mill. are important medicinal plants of the
Solanaceae family, however the blackish-purple (S. americanum) and reddish-orange (S. villosum) colored
fruit are mostly consumed in India, Ethiopia, Ghana, China, and Brazil [168]. Mohy-Ud-Din et al. [169]
reported the different important steroidal glycoalkaloids likeβ-Solamargine,α-Solamargine, Solasonine,
α-Solanine, solasodine, and Solanidine, with latter being well-recognized for its anticancer
activities [170].
3.2. Eggplant
Eggplant (Solanum melongena L.) fruit are very popular vegetables grown worldwide in subtropical
and tropical regions [171]. They considered as one of the top 10 vegetable in terms of antioxidant
capacity [172] and contain a variety of antioxidants and phytochemicals such as, ascorbic acid,
phenolics, and flavonoids that provide health benefits [173]. The most abundant phenolic compound is
5-O-caffeoylquinic acid, known as chlorogenic acid (ChA), which is considered as the main contributor
to the overall antioxidant capacity [174,175]. However, eggplant fruit are poor sources of provitamin
A and vitamin E, with average values of 27 IU 100/g fw and 0.30 mg/100 g fw, respectively [173].
American purple fruit are the most commonly marketed type, though white cultivars have gained
consumers acceptance in recent years.
Eggplants are quite versatile vegetables and could be subjected to a number of different
processing and cooking methods which may further affect fruit antioxidant capacity [176].
Akanitapichat et al. [173] reported that the antioxidant activities of eggplant were correlated
(r = 0.531–0.796) with the total amounts of phenolics and flavonoids. Significant correlation was
found between hepatoprotective activities and total phenolics/flavonoids content (r = 0.637–0.884) and
antioxidant activities (r= 0.585–0.958), indicating the contribution of the polyphenols present in eggplant
to its hepatoprotective effect (human hepatoma cell line HepG2) against tert-Butylhydroperoxide
(t-BuOOH)-induced toxicity [173]. Akanitapichat et al. [173] reported that total phenolics content
in purple fruit was of 1002.67 ± 8.33 mg GAE/100 g extract. Nisha et al. [176] suggested a higher
content of total phenolics and anthocyanins in a purple small-sized fruit variety (106.98 mg/100 g fw
and 0.756 mg/100 g fw, respectively) than the three other examined varieties (purple moderate-sized
fruit (80.31 mg/100 g fw and 0.525 mg 100/g fw, for total phenolics and anthocyanins, respectively),
green long-sized (50.79 mg/100 g fw and 0.0475 mg/100 g fw, for total phenolics and anthocyanins,
respectively), and purple big-sized (49.02 mg/100 g fw and 0.53 mg/100 g fw, for total phenolics and
anthocyanins, respectively)). In the same study, it was reported that purple small-sized variety revealed
the greatest antioxidant activity.
Flavonoids represent only about 10–15% of total phenolics [177] and hydroxycinnamic acid
derivatives, particularly free chlorogenic acid is the major phenolic antioxidant regardless of the
genotype [177,178]. However, the chlorogenic acid content in eggplant is influenced by both genetic
and environmental factors, including the fruit developmental stage, cultivar, and crop and postharvest
management [179]. For example, the chlorogenic acid content was 16% higher in purple eggplants
compared to white eggplant slices [180]. According to Akanitapichat et al. [173] who compared five
eggplant varieties, the purple fruit had higher total flavonoids content (3954.2 ± 6.06 mg catechin
equivalents-CE/100 g extract) content compared with green and white ones. Sadilova et al. [181] reported
that flavonoids isolated from S. melongena showed potent antioxidant activity against chromosomal
aberrations induced by Doxorubicin. The purple eggplant had high antioxidant activity of DPPH
and ABTS with EC50 of 66.74 ± 4.60 μg/mL and 53.18 ± 0.71 μg/mL, compared with green and white
varieties [173].
In purple-fruited genotypes of pepper and eggplant the abundance of anthocyanin levels is
superior in unripe fruits and decrease upon ripening, often to complete disappearance [182]. It is
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noteworthy that eggplant fruit reaches its commercial maturity long before its physiological ripeness,
as practically it is harvested at the immature fruit stage [183]. The anthocyanin concentration in the
purple fruit eggplant cultivars is higher in comparison to other deeply colored fruits and vegetables,
e.g., 2.34-fold that of grapes, and 7.08-fold that of red onions [5]. In purple pigmented eggplants,
the antioxidant anthocyanins (delphinidin derivatives) is limited as found at the peel tissue which
represents less than 5% of the total fruit weight [178,184]. Examining the anthocyanins content of wild
type (WT), purple-black (S9-1), green (L6-4), and white (U36-1) eggplants, Xi-Ou et al. [185] found
that the anthocyanin content of purple-black (S9-1) was higher than that in WT eggplant, while green
eggplant (L6-4) had the lowest levels of anthocyanins. In another study, Zhang et al. [186] reported the
total anthocyanins content from purple eggplant (cv Zi Chang) skin to be 1.24 mg/g dw. Moreover,
nasunin (delphinidin-3-(p-coumaroylrutinoside)-5-glucoside), an anthocyanin isolated from the skin of
purple eggplant fruit, is associated with both inhibition of hydroxyl radical generation and superoxide
scavenging activity [173,187].
Extracts from eggplant fruit skin were demonstrated to possess high capacity in scavenging of
superoxide free radicals and inhibiting hydroxyl radical generation by chelating ferrous iron [187].
Additionally, eggplant extract resulted in hypolipidemic activity in rats fed normal as well as high
fat diets [188], suppressed tumor growth and metastasis [189], and inhibited inflammation that can
lead to atherosclerosis [190]. Not only fruit but various parts of the plant are useful in the treatment of
inflammatory conditions, cardiac debility, neuralgia, ulcers of nose, cholera, bronchitis, and asthma,
while they possess analgesic and hypolipidemic properties [191]. S. melongena is also a natural source
of vitamin A affecting the eye health in children [192].
3.3. Pepper
Pepper (Capsicum spp.) is one of the oldest domesticated and utilized crops and the genus
Capsicum consists of approximately 31 species of which the five domesticated species are C. annuum,
C. baccatum, C. chinense, C. frutescens, and C. pubescen [193]. Average world production and cultivated
area of dry and green peppers are estimated at 3.9 and 34.5 million tons respectively, harvested from
1.8 and 1.9 million hectares respectively [27]. Pepper fruit have high nutritive value, as they are
rich in vitamin C (ascorbic acid), provitamin A (β-carotene), vitamin E (tocopherols), flavonoids and
capsaicinoids, and other carotenoid pigments such as lycopene and zeaxanthin [194]. The noticeable
level of phenolic compounds and carotenoid pigments also contributes to the antioxidant properties of
sweet pepper [195].
Immature fruits are usually colored in white, green, purple, and black shades and gradually color
changes to yellow, orange, red and brown as fruit maturity advances [196,197]. The differences in fruit
color is mainly due to the differential accumulation of flavonoids and carotenoids [198]. Anthocyanin
accumulation in the outer epidermis of immature pepper fruit is responsible for the purple or black
color at 30 d after anthesis [199] and turns to red color at 50 d after anthesis [182].
Liu et al. [182] compared the flavonoids biosynthesis at 30 d after anthesis for green, white, and
purple varieties, and reported that anthocyanins, flavones, and flavonols content was significantly
higher in purple variety than in the other varieties, with delphinidin, luteolin, chrysoeriol and quercetin
derivatives being the most abundant polyphenols. Delphinidin, cyanidin, and malvidin derivatives
were the major anthocyanins in colored peppers among the 16 anthocyanins detected of which
delphinidin 3,5-diglucoside and delphinidin 3-O-rutinoside were specifically accumulated in purple
peppers [182]. In the same study, it was reported that the purple color of fruit is related to the high
accumulation of cyanidin and delphinidin derivatives at 30 d after anthesis.
In chili peppers, anthocyanins’ presence and pigmentation of purple or black and magenta is also
possible, and is usually found in flowers, fruit, and foliage [200]. Several reports highlighted the presence
of anthocyanins in chili pepper fruit, but so far delphinidin is the only anthocyanidin identified [200,201].
Similarly, Sadilova et al. [181] reported delphinidin-3-trans-coumaroylrutinoside-5-glucoside (nasunin
89%) and delphinidin-3-cis coumaroylrutinoside-5-glucoside (4.6%) as the main anthocyanins (averaged
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at 320 μg/g fw) in German chili pepper (C. annuum L.), while similar results were found in two Mexican
chili peppers [202]. Moreover, hydroponically grown dark violet pepper (cv. “Zorro”) had the highest
concentration of quercetin and catechin when compared to orange, red and yellow fruit cultivars [203].
Capsanthin-capsorubin synthase (CCS), as a unique enzyme in pepper and tiger lily, converts
antheraxanthin and violaxanthin into capsanthin and capsorubin, respectively [204]. Although the
exact mechanism is under investigation, Liu et al. [182] reported that the highly active CCS drives
antheraxanthin to be converted into capsanthin in purple fruit, which reduces the flux to violaxanthin,
eventually resulting in significantly lower levels of antheraxanthin and violaxanthin in purple than in
green and white fruit varieties.
3.4. Lablab and Common Bean
Lablab (Lablab purpureus L.), an ancient legume species, serves as a vegetable and is widely
cultivated throughout the tropics, subtropics and temperate zones [205]. Fruit are green pods, 6 cm
long by 2 cm wide, flattened, contain 4–5 seeds and turn light brown-purple when mature [206].
Al-Snafi [207] and Momim et al. [208] reviewed the phytochemical properties of lablab and its
medicinal importance, exhibiting antidiabetic, anti-inflammatory, analgesic, antioxidant, cytotoxic,
hypolipidemic, antimicrobial, insecticidal, hepatoprotective, antilithiatic, antispasmodic effects.
Moreover, Momim et al. [208] and Deoda et al. [209] reported that the juice derived from the fruit pods
was used as astringent, digestive, stomachic, to expel worms and for the treatment of inflamed ears
and throats. Soetan [210] studied the pharmacological potentials of three varieties (“Rongai brown”,
“Rongai white”, and “Highworth black”) of L. purpureus seeds and showed that raw and aqueous
extracts contained various phytochemicals including trypsin inhibitors, hemagglutinin, cyanogenic
glycosides, oxalates, phytates, tannins, and saponins, with greater contents in raw material compered
to aqueous extracts. Other biocidal effects have been reported including antilithianic activity [209],
hepatopreotective effects [211], and inhibited trypsin and plasmin activity [212].
Momim et al. [208] reported significant antioxidant capacity (DPPH) with the lowest IC50 found
in purple lablab compared to the white one (430.00 μg/mL vs 853.13 μg/mL). In the same study, total
flavonoids content in purple fruit was 32.09 ± 0.36 mg quercetin equivalent/g fw while in green lablab
it was 42.55 ± 5.77 mg quercetin equivalent/g fw. Bhaisare et al. [206] reported vitamin C content of
81.00 ± 0.16 mg/g and vitamin E content of 73.66 ± 0.08 mg/g in fresh bean seeds of L. purpureus.
Total content of anthocyanins in purple (cv. “Hong Fu”) pods was about 1.58 mg/g, while
low amounts were detected in green (cv. “Qing Feng”) ones. Compared to green pods, five kinds
of anthocyanins (malvidin, delphinidin, and petunidin derivatives) were found in purple pods
by HPLC-ESI-MS/MS and the major compounds were identified as delphinidin derivatives [213].
Besides, nine kinds of polyphenol derivatives, namely quercetin, myricetin, kaempferol, and apigenin
derivatives were detected by UPLC-ESI-MS/MS and the major components were quercetin and
myricetin derivatives [213].
Common bean (Phaseolus vulgaris L.) is another legumes species with pods of varied colors,
including black, red, blue, and violet [214,215]. Anthocyanins content may vary significantly depending
on the genotype, while polyphenols content is highly associated with the antioxidant activities of
pods [216]. Tsuda et al. [217] reported that pelargonidin-3-glucoside, cyanidin-3-glucoside, and
delphinidin-3-glucoside isolated from P. vulgaris (black bean) seed coat, as well as their standard
aglycones, have strong antioxidative activity in a liposomal system and reduced formation of
malondialdehyde by UVB irradiation [217]. According to Mazewski et al. [218], purple beans
contain mostly condensed tannins which are responsible for the antiproliferative activities against
human colon cancer cell lines (HCT-116 and HT-29).
3.5. Pepino
Pepino (Solanum muricatum Aiton), a close relative to tomato and potato, is an herbaceous Andean
domesticated species grown for its juicy, sweet, and aromatic fruit, with increasing commercial and export
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interest in South America from exotic fruit markets [219]. Fruit color may be white, cream, yellow, maroon,
or purplish [220]. Unripe pepino fruit is green while 51 days from fruit set, newly-acquired purple stripes
appear, resulting in fruit softening along with decreases in total pectin and hemicellulose content [221].
Various health benefits were revealed for pepino, including treatment of diabetes, stroke, high
blood pressure, heartburn (indigestion), cancer, kidney, constipation, and hemorrhoids [220], activities
mostly attributed to the significant amounts of vitamin C, carotenoids, and phenolics [222]. Moreover,
Hsu et al. [222] reported the antioxidative, anti-inflammatory, and antiglycative effects of pepino extract.
In the same study, aqueous and ethanol extracts had similar content of total phenolic acids (averaged
at 1145 mg/100 g dw) but aqueous extracts were richer than ethanol extracts in terms of ascorbic
acid (43.8 vs. 6.6 mg/100 g dw), total flavonoids (875 vs. 461 mg/100 g dw), cinnamic acid (75.7 vs.
23.0 mg/100 g dw), ferulic acid (82.3 vs. 11.8 mg/100 g dw), rosmarinic acid (47.2 vs. 8.4 mg/100 g dw),
quercetin (126.5 vs. 90.3 mg/100 g dw), and naringenin (57.2 vs. 14.7 mg/100 g dw) [222].
The main pigments isolated in the fruit vegetables are presented in Table 2.
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4.1. Broccoli and Cauliflower
Broccoli (Brassica oleracea L., var. italica Plenk) and cauliflower (B. oleracea L., var. botrytis) are the
two most popular vegetable crops belonging to the Brassicaceae family. Native of the Mediterranean
Basin, both species are adapted to a wide range of environmental conditions and are cultivated in all
five continents, with an annual production that reached about 26 million tons in 2017, from an estimated
harvested area of over 1.39 million hectares worldwide [27]. Primarily known and appreciated for their
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typical organosulfur compounds [224–226], broccoli, cauliflower, and other Brassica species are also a
rich source of anthocyanins which are responsible of the purple pigmentation of some varieties [18,227].
Typically green, some cultivars and populations of broccoli are characterized by a purple pigmentation
of the sepals of the inflorescence [227,228]. Branca et al. [228] found high levels of anthocyanins in
a Sicilian broccoli landrace called “Broccolo nero” (Black broccoli) grown around Mount Etna and
characterized by a dark violet pigmentation of the inflorescence, stem, and leaf midribs. In a recent
work, Yu et al. [227] identified and mapped a major locus and two minor loci associated with the
purple sepal trait in broccoli, while the authors hypothesized that the development of purple color may
be induced by cold temperatures. In another recent study, Rahim et al. [229] working on the hypocotyl
of young green and purple broccoli seedlings identified seven putative candidate genes (BoPAL,
BoDFR, BoMYB114, BoTT8, BoMYC1.1, BoMYC1.2, and BoTTG1) responsible for the biosynthesis of
anthocyanins. Among those, BoTT8 was expressed considerably more in purple hypocotyl compared
to the green ones. Testing the in vitro cytotoxic effect of Sicilian black broccoli stem and leaf extracts
at different concentrations (0.05%, 0.1%, 0.5%, 1%, and 5%) against HT29 (colon cancer) and A2058
(melanoma cancer) cells after 24 h treatment in presence or not of the myrosinase enzyme (responsible
for the hydrolyzation of glucosinolates), Terzo et al. [230] found that the juice was less toxic in presence
of myrosinase especially at higher concentration of the extract (1%–5%), suggesting that factors other
than the glucosinolate content, such as polyphenols (including anthocyanins) could be responsible
for the cytotoxic effects against HT29 and A2058 cancer cells. Examining the anthocyanin profile of
three cultivars of heat-tolerant purple sprouting broccoli, Rodríguez-Hernández et al. [231] found that
cyanidin 3-O-diglucoside-5-O-glucoside derivatives were the major acylated anthocyanins, and each
cultivar and plant portion (leaves, inflorescence) had a particular prominent acylated anthocyanin.
The same study revealed that compared to green broccoli cv. “Marathon”, purple sprouting broccoli
was characterized also by higher levels of glucosinolates. Similarly, Verkerk et al. [232] observed
exceptionally high glucoiberin content (396.5μmol/100 g FW) in purple sprouting broccoli cv “Bordeaux”
compared to other green broccoli genotypes, which suggests that there is some sort of interaction
between purple pigmentation and glucosinolate profile of broccoli. In another study, analyzing the
acylated anthocyanin profile of purple sprouting broccoli and three other green broccoli varieties
at the sprouting stage, Moreno et al. [233] observed a significantly higher content of anthocyanins
in the purple genotype compared to the green ones and observed that the quantity and quality of
anthocyanin pigments were highly variable among the tested genotypes. Out of seventeen anthocyanins
identified in the four genotypes only three isomers were predominant in all the genotypes examined:
Cyanidin 3-O-(acyl)diglucoside-5-O-glucoside, cyanidin 3-O-(acyl1)(acyl2)diglucoside-5-O-glucoside,
and cyanidin 3-O-(acyl1)(acyl2)diglucoside-5-O-(malonyl)glucoside. The purple sprouting genotype
was characterized by a higher content of cyanidin 3-O-(sinapoyl)(sinapoyl)diglucoside-5-O-glucoside,
cyanidin 3-O-(sinapoyl)diglucoside-5-O-glucoside, cyanidin 3-O-(feruloyl)diglucoside-5-O-glucoside,
cyanidin 3-O-(sinapoyl)(feruloyl)diglucoside-5-O-(malonyl)glucoside, and cyanidin 3-O-(sinapoyl)
(sinapoyl)diglucoside-5-O-(malonyl)glucoside (Table 3). In agreement with previous studies,
Moreno et al. [233] concluded that broccoli sprouts could be an excellent source of bioactive
compounds rich of flavonoids, including acylated anthocyanins, along with glucosinolates, vitamins,
and minerals [234–236], and that future studies should evaluate the potential of further enhancing the
content of bioactive compounds in broccoli sprouts.
In the case of cauliflower, while most of the cultivars have been traditionally selected for their
white curds [237], many local landraces and commercial cultivars are characterized by colored heads
with characteristic pigmentation ranging from green to dark violet. In Italy, green cauliflowers are
traditionally grown in Lazio and Marche, while dark violet selections are typically grown in Sicily,
Puglia, and other Southern regions characterized by high levels of solar radiation which make it
more challenging to produce white curds as traditionally required by the European market [228,238].
Lately, the interest for colored cauliflower varieties substantially increased due to the potential
health-beneficial properties of the phenolic compounds that provide the pigmentation of plant
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tissues [239]. Anthocyanins are in fact responsible for the purple–violet pigmentation also in the
case of cauliflower and are considered highly beneficial for human health [8]. The biosynthesis of
anthocyanins in cauliflowers is regulated mainly at transcriptional level, and in a particular purple
cauliflower mutant it has been demonstrated that the tissue-specific activation of the gene BoMYB2
up-regulated the expression of both BobHLH1 and BobHLH2, leading to the formation of a complex
regulation network MYB–bHLH–WD40 (MBW), consisting of MYB, basic Helix-Loop-Helix (bHLH),
and WD40 proteins, which in turn activates the structural genes responsible for the biosynthesis of
anthocyanins [18,240]. β-carotene accumulation has been also observed in cauliflower curds due to
a rare carotenoid gene (Or orange) mutation that activates the biosynthesis of carotenoids in tissues
that otherwise would be white [241,242]. Nevertheless, such mutation received limited attention at
commercial level and is more relevant to advance our understanding of the carotenoid biosynthesis
regulation [243,244].
Analyzing by LC–MS/MS nine Sicilian landraces of violet cauliflower, Scalzo et al. [19]
identified cyanidin-3-(6-p-coumaryl)-sophoroside-5-glucoside as the main anthocyanin along with
p-coumaryl and feruloyl esterified forms of cyanidin-3-sophoroside-5-glucoside. Scalzo et al. [19]
and Kapusta et al. [245] examined also the stability of anthocyanins after processing (blanching,
microwave-heating, convection steaming and freezing, and conventional water cooking) and observed
substantial changes with the formation of isomers from cyanidin-3-sophoroside-5-glucoside rather
than the hydrolysis of anthocyanins, suggesting good stability especially after microwave-heating
which could be interesting for food processing applications.
4.2. Cabbage and Kale
Among the Brassica species, cabbage (Brassica oleracea L. var. capitata) and Savoy cabbage (B. oleracea
L. var. sabauda L.) are other two popular cole crops grown all over the world for their “heavy” heads
constituted by leaves surrounding the terminal buds and that can be green or red-purple [246]. As for
broccoli and cauliflower, the pigmentation of red cabbage genotypes is due to the accumulation of
anthocyanins. Comparing four green and four red cabbage genotypes, Yuan et al. [247] observed that
the structural genes involved in the biosynthesis of anthocyanins (CHS, F3H, F30H, DFR, LDOX, and
GST), were steadily up-regulated in red genotypes for the entire growing period. The same authors
observed that the expression of the structural genes responsible for the biosynthesis of anthocyanins
was up-regulated in correspondence of nitrogen and phosphorous deficiency. Consistently with the
mechanism of transcriptional regulation observed in purple cauliflower, in correspondence of the
structural gene up-regulation it was observed a simultaneous increase of the transcript levels of the
bHLH gene BoTT8, and of the MYB transcription factor BoMYB2. In a recent study analyzing the gene
associated with the purple pigmentation of ornamental cabbage characterized by green external leaves
and inner purple leaves, Jin et al. [109] found that phytoregulators such as abscisic acid (ABA) and
ethylene (ET) play a key role in promoting the biosynthesis of anthocyanins. The same study identified
14 and 19 putative candidate genes involved in the biosynthesis of ABA and ET, respectively, and
among those two ABA-biosynthesis related genes (BoNCED2.1, BoNCED2.2) and two ET-biosynthesis
related genes (BoACS11, BoACO4) were expressed significantly more in purple leaves than in green
leaves and were strongly correlated with the total anthocyanin content of the purple inner leaves.
Analyzing the anthocyanin profile of red cabbage using HPLC/DAD-ESI/Qtrap MS,
Arapitsas et al. [248] separated and identified up to 24 anthocyanins all characterized by
cyanidin as aglycon, mono- and/or di-glycoside, non-acylated, or acylated with aromatic
and aliphatic acids. Similarly, using HPLC-DAD-MS/MS, Wiczkowski et al. [249] identified
twenty cyanidin derivatives, with cyanidin-3-diglucoside-5-glucoside as the base structure, and
cyanidin-3-diglucoside-5-glucoside, cyanidin-3-(sinapoyl)(sinapoyl)-diglucoside-5-glucoside, and
cyanidin-3-(p-coumaroyl)-diglucoside-5-glucoside were the most abundant non-acylated anthocyanins.
Moreover, Koss-Mikołajczyk et al. [250] identified nineteen different cyanidin derivatives, with
cyanidin-3-(feruloyl)-diglucoside-5-glucoside and cyanidin-3-(sinapoyl)(sinapoyl)-diglucoside-5-
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glucoside having been the most predominant. Similar results were obtained by other authors,
who however using different analytical procedures and equipment identified a lower number of
anthocyanins [19,251].
Analyzing raw and pickled red cabbage, consistently with other studies McDougall et al. [252]
identified eighteen anthocyanin structures, most of which had cyanidin-3-diglucoside-5-glucoside
as the core structure non-acylated, mono-acylated or di-acylated with p-coumaric, caffeic, ferulic
and sinapic acids, but pelargonidin-3-glucoside and new cyanidin-3-O-triglucoside-5-O-glucoside
di-acylated with hydroxycinnamic acids were also identified. The same authors examining the stability
of anthocyanins after simulated gastrointestinal digestion found that anthocyanin structures were
quite stable, and acylated structures were markedly more stable than non-acylated anthocyanins,
nevertheless the after-digestion total recovery of anthocyanins was about 25%.
Feeding twelve volunteers with increasing doses (100, 200, and 300 g) of steamed red cabbage
containing 1.38 μmol of anthocyanins/g (containing 30 acylated and 6 non-acylated anthocyanins),
Charron et al. [253] evaluated the red cabbage anthocyanin bioavailability analyzing the excretion of
intact and metabolized anthocyanin compounds in the urine. After 24 h, from the excreted urine were
recovered 3 non-acylated and 8 acylated intact anthocyanins and 4 glucuronidated and methylated
anthocyanin metabolites. Overall, the recovery of anthocyanins in excreted urine was four times higher
for non-acylated compared to the acylated anthocyanins.
Comparing the biological activities (antioxidant, cytotoxic, anti-genotoxic, and influence on
enzymatic activities) of the extract of green and red cabbage Koss-Mikołajczyk et al. [250] found that
the anthocyanin content and profile was highly correlated with the antioxidant capacity of tested plant
extracts measured through different spectrophotometric assays (ABTS, FC, DPPH, and FRAP), and
by testing the cellular antioxidant activity. Instead, all the other biological activities tested were not
correlated with the content of neither anthocyanins nor glucosinolate derivatives, suggesting that the
food matrix effect may be more relevant than the biological activity of the single compound. This aspect
should be further examined considering that other cabbage-like vegetables may be subject to different
processing and anthocyanins and glucosinolates may have different levels of stability depending on the
type of thermal or non-thermal processing and even the effect of the food matrix may change [19,254].
4.3. Artichoke
Native of the Mediterranean Basin and domesticated in Southern Italy during the Roman
Empire [255,256], artichoke [Cynara cardunculus L. var. scòlymus (L.) Fiori] or globe artichoke constitutes
a rich source of bioactive compounds and an important component of the Mediterranean diet to
which are attributed a number of medicinal properties [20,21]. Artichoke is a major vegetable crop
gaining popularity as a natural functional food. Grown on about 122,390 ha worldwide, over 1.5
million tons of artichoke heads were produced in 2017 [27]. As traditional producer and consumer of
artichokes, Italy (33.1% of globe artichoke harvested area), Spain (13.4%), France (6.2%), and a few other
European countries in the Mediterranean area continue to dominate the production of artichoke at
global level. Nevertheless, their share is decreasing as the cultivation of this crop and its consumption
are gradually expanding in other regions and reached important land investment in Egypt (10,159 ha),
Algeria (5532 ha), Tunisia (3687 ha), Turkey (2994 ha), and Morocco (2923 ha) within the Mediterranean
Basin, westward in Perú (8646 ha), Argentina (4472 ha), United States (2914 ha), and Chile (1464 ha),
as well as eastward, especially in China (11,803 ha) that has the third largest investment on artichoke
crops after Italy and Spain [27]. As a perennial crop, artichoke produces a robust stalk and large
leaf biomass (about 75–80% of the above-ground plant biomass) from which during the reproductive
phase the floral stems emerge sustaining the primary edible portion constituted by the immature
inflorescences called heads or capitula. The capitula is constituted by a fleshy receptacle (the base
of the inflorescence) with the inner heart made of tender bracts protected by more fibrous external
bracts. The immature inflorescences are a rich source of macro- and microminerals, dietary fibers,
inulin, vitamins, sesquiterpene lactones, and phenolic compounds including a series of flavonoids
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compounds and anthocyanins that are responsible for the pigmentation of the bracts characterizing
the heads of different genotypes [20,21,257,258]. The pigmentation of the heads is in fact along with
other morphology parameters (shape, presence of spines on bracts) and agronomic characteristics
(earliness), one of the main factors used to classify artichoke varietal types. Based on the pigmentation
of the heads, artichoke landraces and new hybrids are distinguished in two groups, namely green and
pigmented artichokes. The pigmentation of the heads is considered an important quality parameter
affecting consumer acceptance in different regions [20,259], and often it is anticipated in the name
of the varietal type especially for the pigmented varietal type like in the case of the French “Violet
de Provence”, “Violet de Hyères”, and “Violet du Gapeau”, or the Italian “Violetto di provenza”,
“Violetto di Sicilia”, “Violetto Toscano”, “Violetto di S. Erasmo”, and “Violetto di Chioggia” [260].
In a recent study on the inheritance of artichoke bract pigmentation, Portis et al. [261] found a good
level of heritability for bract pigmentation. However, previous studies show that there is large
variations of the pigmentation of the bracts within the same landrace, and in the case of artichoke
the biosynthesis and accumulation of anthocyanins is highly influenced by environmental conditions
and especially by temperatures [261,262]. Artichoke pigmentation is considered a complex trait in
which several metabolic pathways could be involved. In 1969, Pochard et al. [263] proposed that
the anthocyanin pigmentation in artichoke could be genetically determined by one or two major
genes with the involvement of several modifiers. Later, based on the segregation pattern observed in
populations obtained crossing inbreed lines and clones and self-pollinated clones of different genetic
origins, Cravero et al. [264] proposed that the pigmentation of artichoke heads may be controlled
genetically by two independent genes P and U with a simple recessive epistasis, where plants of
genotype PP or Pp allow the biosynthesis of anthocyanins and result in purple bracts whereas pp
genotype inhibits anthocyanin synthesis resulting in green bracts; at the same time genotypes UU or Uu
are characterized by a non-uniform pigmentation encoded by the allele P, and uu genotypes develop
uniformly pigmented bracts in presence of the allele P. While further studies should confirm this simple
model, the variability of the pigmentation observed within the same genotype suggests that the genetic
basis for anthocyanin pigmentation of artichoke bracts is more complex and likely the two loci model
proposed is regulated by several modifier genes or multiple alleles that determine the expression of
the intensity of the pigmentation in artichoke heads [261,262,264]. More recently, De Palma et al. [265]
isolated and functionally characterized CcF3’H as the first structural gene of the flavonoid biosynthesis
(encoding for flavonoid 3’-hydroxylase) from C. cardunculus. While Blanco et al. [266] isolated and
functionally characterized CcMYB12, the artichoke putative homologue of the transcription factor
R2R3-MYBs expressing proteins that regulate the biosynthesis of flavonoids and anthocyanins in
many species.
Analyzing the polyphenolic profile of artichokes in different genotypes, it is possible to identify
two main classes of phenolic compounds, namely hydroxicinnamic acids (C3-C6 skeleton) and
flavonoids (C6-C3-C6 skeleton). Within the first class chlorogenic, 3,5-O-dicaffeoylquinic, and
1,5-O-dicaffeoylquinic acids are the predominant compounds followed by other minor mono- and
di-caffeoylquinic acids [20,21,267]. Among the flavonoids that quantitatively represent about
10% of the total phenolic compound in artichoke [20], the flavones apigenin-7-O-glucuronide,
apigenin-7-O-rutinoside, apigenin-7-O-glucoside, luteolin-7-O-glucuronide, luteolin-7-O-rutinoside,
luteolin-7-O-glucoside, naringenin-7-O-rutinoside, and naringenin-7-O-glucoside are the predominant
compounds, followed by the anthocyanins including cyanidin, peonidin, and delphinidin
derivatives [20,21,257,267,268]. Other studies have revealed that specific phenolic compounds
are accumulated only in certain genotypes and certain plant portions even within the same
capitula [269,270].
The first attempts to identify the anthocyanin profile of green and purple artichokes were
conducted in the late 1970s [20]. However, only later Schütz et al. [271] analyzing by HPLC the
pigmented bracts of seven different varietal types of artichoke isolated and identified the main
anthocyanins as cyanidin 3,5-diglucoside, cyanidin 3-glucoside, cyanidin 3,5-malonyldiglucoside,
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cyanidin 3-(3′′-malonyl)glucoside, and cyanidin 3-(6′′-malonyl)glucoside along with some minor
compounds such as peonidin 3-glucoside, peonidin 3-(6′′-malonyl)glucoside, and delphinidin glycoside.
The same authors observed that the anthocyanin profile varies between different genotypes, nevertheless
limited information is available on the genotypic variation of these compounds in artichoke. Analyzing
new hybrids and local landraces characterized by bracts with different levels of pigmentation,
Bonasia et al. [272] observed that “Violetto di Provenza” and “Tempo” characterized by higher
pigmentation had also the highest total phenolic content in the heart and external bracts and in
the external bracts, respectively. Examining the content of total anthocyanins in bracts, leaves, and
floral stems of two genotypes grown in Tunisia, namely “Violet d’Hyéres” and “Blanc d’Oran”,
Dabbou et al. [273] found that leaves of “Blanc d’Oran” had the highest concentration of anthocyanins
(20.5 μg/g DW) while bracts and floral stems had the lowest concentration (8.3 and 5.9 μg/g DW,
respectively). Instead, lower variability between different plant portions was observed in the case of
“Violet d’Hyéres” that on average had a total anthocyanin concentration of 14.2 μg/g DW). These results
suggest that even the leaves of artichoke plants which represent a big portion of plant biomass may
constitute a good source of anthocyanins besides being a source of other phenolic compounds [274].
A very limited number of studies have been conducted to evaluate specifically the biological activity of
artichoke anthocyanins [257]. The main bioactive effect attributed to anthocyanins, flavonoids, and other
phenolic compounds extracted from artichoke plant tissues is their antioxidant activity demonstrated
by several in vitro and in vivo studies [20,21,275,276]. Anthocyanins have also shown lipid lowering
effects in a placebo-control double-blind study by reducing serum LDL cholesterol by 7.9%, triglycerides
by 23.0%, apolipoprotein by 16.5%, and apolipoprotein C-III by 11.0%, and increasing HDL cholesterol
by 19.4% compared with placebo after administration of 160 mg of anthocyanins for 24 weeks twice
daily [277]. Intake of anthocyanins seems to have positive effects on the cardiovascular system by
also reducing arterial stiffness [278]. In another study, it was observed that artichoke leaf extracts and
artichoke flavonoids up-regulate the gene expression of endothelial-type nitric oxide synthase (eNOS,
a vasoprotective molecule) in human endothelial cells [279]. While in a follow-up study Xia et al. [280]
observed that treatment of human coronary artery smooth muscle cells (HCASMC) with artichoke
leaf extracts and particularly with cynarin and cyanidin induced a down-regulation of inducible
nitrous oxide synthase (iNOS, a pro-inflammatory molecule that can cause vascular dysfunctions),
suggesting that artichoke flavonoid compounds may have great therapeutic potential. In recent years, a
number of studies contributed to demonstrate that artichoke heads and leaf extracts and, in some cases,
specific phenolic compounds have health-beneficial properties including anti-inflammatory activity,
anti-bacterial activity, hepatoprotective activity, hypocholesterolemic and low density lipoproteins
(LDL) oxidation inhibition effect, hypoglycemic effect, as well as anticancer activity [20,21,257].
Nevertheless, in most of the cases these biological activities cannot be attributed to a single compound,
but are determined by the combined synergistic effect of different compounds [20,21]. In this perspective,
the matrix effect is fundamental in determining the bioaccessibility, bioavailability, and the effect of
polyphenols, especially considering that polyphenols and anthocyanins in particular have a relatively
low bioavailability being quickly transformed into derivatives of phenolic acids [21,281–283].
4.4. Asparagus
Used since ancient time for the diuretic and medicinal properties of its spears [284], cultivated
asparagus (Asparagus officinalis L.) is now a popular vegetable grown worldwide on over 1.5 million
hectares producing over 8.9 million tons of spears [27]. Native of Eastern Europe, cultivated asparagus is
grown at commercial level mainly in China, followed far behind by Perú, Mexico, Germany, Spain, USA,
Italy, Japan, France, and the Netherlands. The edible portion of this herbaceous perennial is constituted
by its spears or young stems produced by the underground crown, which may be green, green-purple,
or purple when harvested above ground or white when purposely harvested before exposed to sunlight.
Asparagus spears are considered a rich source of minerals [285], amino acids and dietary fibers [286],
saponins [287,288], vitamins and volatile sulfur organic compounds [289], and especially of phenolic
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compounds and flavonoids [290], including anthocyanins that are responsible for the purple color of
the bracts of green spears or of the whole spears in purple asparagus genotypes [23,154,291]. Being rich
of all these bioactive compounds it is difficult to isolate the effect of anthocyanins and specific pigments,
nevertheless several studies have demonstrated the antioxidant properties of anthocyanins in the
species [284]. Comparing green, white, and purple spears, Maeda et al. [291] found that purple spears
had significantly higher levels of rutin compared to green spears, while rutin was not detected in white
asparagus spears. The same authors observed a positive correlation between spears total polyphenol
content, rutin, and DPPH radical scavenging activities, suggesting that purple asparagus may provide
higher levels of antioxidants compared to green and white asparagus [291]. In this perspective, while
most of the cultivars have been selected to produce green spears and have a relatively small content of
anthocyanins, and even less pigments when etiolated to produce white spears, more recently, as for
other crops, specific functional breeding programs have developed purple cultivars characterized by
high levels of anthocyanins to satisfy the need of consumers attracted by new colors and seeking richer
sources of natural antioxidants [291]. Most of the modern commercial cultivars of green and white
asparagus are diploid (2n = 20) and were developed from an old population called “Purple Dutch” from
which French growers selected two stocks called “Precoce d’Argenteuil” and “Tardive d’Argenteuil”
which were subsequently used to develop modern cultivars and hybrids in The Netherlands, France,
Germany, United Kingdom, and in the USA [292,293]. Although any green asparagus genotype may be
used to produce etiolated white spears, Dutch, French, and German breeding programs have selected
cultivars suitable specifically for white spears production to satisfy the European market requirements
by reducing as much possible the content of anthocyanins that may develop and accumulate in the tips
of white-harvested spears even during storage [292,294]. On the other hand, using “Violetto d’Albenga”
a tetraploid local population traditionally grown in Northern Italy, likely derived from interspecific
crossing between A. officinalis and A. maritimus [295] and characterized by the production of larger,
sweeter, and less fibrous spears ranging in color from green to dark purple, breeding programs in the
US and New Zealand have developed in the early 1990s the first cultivars producing purple spears
such as “Purple Passion” [296] and “Purple Pacific” and “Stewarts Purple” [297].
Using HPLC and NMR to analyze the fresh peel of “Purple Passion” asparagus, Sakaguchi et al. [23]
isolated two major anthocyanins identified as: cyanidin 3-[3”-(O-β-d-glucopyranosyl)-6”-(O-α-
l-rhamnopyranosyl)-O-β-d-glucopyranoside], and cyanidin 3-rutinoside characterized by high
antioxidant activity as determined through ORAC (Oxygen Radical Absorbance Capacity) assay.
Recently, Dong et al. [298] comparing the anthocyanin profile of three purple asparagus cultivars
(“Jing Zi-2”, “Purple Passion”, and “Pacific Purple”) with a green control (“Jing Lv-1”), identified
sixteen anthocyanins, with peonidin, cyanidin and their glycoside derivatives being the predominant
compounds. In the same study, through transcriptomics and quantitative real-time polymerase chain
reaction (qRT-PCR) analysis, several anthocyanin synthesizing genes (PAL, C4h, 4CL, CHS, CHI,
F3H, F3’H, DFR, ANS, and 3GT) and transcription factors genes (bHLH137-like, TT2-like, WD40-like,
bZIP61-like, and MADS18-like) that regulates the biosynthesis of anthocyanins like reported for
other species were identified and showed to be differentially expressed between purple and green
cultivars [298]. The expression of the same genes and the content of anthocyanins were examined
also comparing spears grown in the presence of light and in the dark. In accordance with previous
studies [299,300], results demonstrated that anthocyanin biosynthetic and regulatory genes are
considerably down-regulated in absence of light and pigments are not synthesized in dark conditions,
suggesting that light conditions are a key factor for anthocyanin biosynthesis and accumulation.
This is further corroborated by the findings of Huyskens-Keil et al. [301] who showed the effects
of light quality (white, red, blue, UV-C) on the activity of phenylalanine ammonia-lyase (PAL) and
peroxidase (POD) and the synthesis and accumulation of anthocyanins in basal and apical segments of
white asparagus spears during postharvest storage. Postharvest conditions and handling may in fact
considerably affect the stability of anthocyanins. In another recent study, Barberis et al. [302] reported
that dipping the spears of “Purple Passion” for 5 min in a 3 mM solution of oxalic acid (pH 2.9) reduced
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the lightness of the spears after 12 days only by 13% compared to spears treated with water (control
pH 8) or with 1 mM oxalic acid (pH 6) solution, suggesting that the low pH treatment enhanced the
stability of the anthocyanin pigments. Analyzing the phenolic profile of green and purple asparagus
at harvest and during storage, in accordance with Sakaguchi et al. [23] the same authors [302] found
that cyanidin glucosyl rutinoside, cyanidin rutinoside and peonidin rutinoside (at harvest 774.2, 125.5,
and 84.8 mg/kg, respectively) were the main anthocyanins identified in “Purple Passion” spears and
determining the typical purple color. During storage, the first anthocyanin decreased overtime and was
negatively affected by oxalic acid treatment, cyanidin rutinoside increased over time, while peonidin
rutinoside remained stable.
4.5. Sweet Corn
Native to America, corn (Zea mays L.) has been cultivated in Central America by indigenous
populations at least since 3500 BC [303]. When the European explorers arrived in North America,
Iroquois Indians living in the region corresponding to the current state of Pennsylvania and New York
grew a variety of sweet corn (Zea mays L. saccharata Sturt.) that turned blue upon ripening, along
with other multi-colored varieties [304]. The first samples of maize seeds that arrived in Spain were
described as characterized by different colors ranging from white to black [305,306]. Initially grown
for curiosity, with the arrival of seeds from North America adapted to higher latitudes, and thus
more suitable to the European photoperiod and climate conditions, the new cereal crop started to
spread from Spain to the rest of Europe. The rapid diffusion of maize in Europe is also testified by
the painter Giuseppe Arcimboldo, in his famous painting “Summer” made in 1573 in which a maize
ear is visible [305]. With the process of selection initially conducted in Europe the new crop lost its
multi-color pigmentation with the exceptions of a few local populations and assumed the typical white
or yellow color of the varieties currently cultivated worldwide.
With over 1.134 million metric tons of corn produced at global level in 2017 [27], corn is by far the
first cereal produced in the world, second in terms of acreage only to wheat. Among the different types
of maize, sweet corn is particularly important as it is used for human consumption worldwide. In the
US, first producer of sweet corn, in 2017 were harvested 464,600 acres (about 188.000 ha) of sweet corn
generating a crop value of over $892 million [307]. About 75% of the sweet corn is produced for the
fresh market and the remaining portion is used for canned and frozen food processing, making sweet
corn the second most important processing vegetable after processing tomato.
Sweet corn is derived from a natural genetic mutation of field corn (dent corn) that was first
reported in Pennsylvania in 1770, although it was probably cultivated before by native Americans [308].
The mutant genotype sugary (su) accumulates more sugar in the endosperm (10.2%) than the standard
starchy maize (3.5%) resulting in sweeter taste. Years later, several sugary sweet corn varieties
have been selected. These traditional varieties characterized mainly by white or yellow kernels, are
harvested before complete physiological ripening when the level of sugar is maximum and have
short shelf-life because after harvest the sugar is rapidly converted to starch [309]. Subsequently,
sweeter hybrid varieties have been developed by selecting sugar-enhanced (se) mutants characterized
by double content of sugar (20–35%), tender kernels, creamy texture and good corn flavor. Yet, more
recently supersweet varieties have been developed selecting shrunken-2 (sh2) mutants characterized
by even higher sugar content at the immature milky stage (29.9%) and extended shelf life, with
lighter shrunken kernels. Lately high sugar hybrids are developed combining su, se, and sh2 genes to
obtain optimal combinations of sugar, texture, taste, and long shelf life [309,310]. Most of the sweet
corn hybrids grown and consumed today at commercial level are characterized by yellow (60%),
white (20%), or bicolor (20%, yellow and white) kernels. Nevertheless, in recent years, the interest in
reviving ancient colored sweet corn varieties or developing new pigmented varieties characterized by
high content of carotenoids [311] and especially anthocyanins is increasing [305,312–316] due to the
potential functional properties of anthocyanin-rich genotypes [317,318], as well as to the increasing
demand of natural colorants [22,319,320]. The biosynthesis of anthocyanins in maize aleurone (external
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part of the endosperm) and pericarp (external part of the kernel) of the kernels or in plant tissues
involve over twenty structural and regulatory genes that have been identified and functionally
characterized as reviewed by Petroni et al. [305,321–323]. The wide range of colors observed in
maize kernels is mainly due to the biosynthesis and accumulation of carotenoids and flavonoids.
Carotenoids such as β-carotene, zeaxanthin and lutein which are lipid-soluble pigments and are
responsible for the color of kernels ranging from yellow to deep orange [311,324]. Maize flavonoids
include two main classes of pigments: (i) phlobaphenes which are water-insoluble 3-deoxyflavanoid
pigments that accumulate in the pericarp of the kernels and the cob and are responsible for the
development of kernel colors ranging from orange to brick red [315]; and (ii) anthocyanins which
are water-soluble pigments responsible for the development of pink, red, purple, and blue color in
the aleurone and pericarp of the kernels as well as in other plant tissues. Within the anthocyanins,
the main class of pigments identified are cyanidin, peonidin, and pelargonidin derivatives with the
first two providing bluish-red color and the latter being responsible for more orange-red color [22].
The combination of carotenoids and flavonoids in pericarp and aleurone generates an incredible
variety of shades [22] and may be influenced also by the condensation with flavanols [319,320,325,326]
or other modifications of the anthocyanin compounds. Analyzing the anthocyanin profile of the
kernels of six different purple maize genotypes, González-Manzano et al. [326] identified the dimer
catechin-(4a-8)-cyanidin-3,5-O-diglucoside and other flavanol-anthocyanin condensed pigments along
with several related anthocyanin pigments such as cyanidin-3-glucoside, cyanidin-3-malonylglucoside,
peonidin-3-glucoside, peonidin-3-malonylglucoside, pelargonidin-3-dimalonylglucoside, and other
derivatives. Malonyl- and dimalonyl acylated anthocyanins are particularly interesting for their
higher stability as natural colorants [22]. Analyzing the extract of corn cobs and kernels of a
Chinese purple corn, Yang and Zhai [327] identified cyanidin-3-glucoside, pelargonidin-3-glucoside
and peonidin-3-glucoside including their malonated derivatives. Besides the great potential of
maize pigments as natural food colorants [22,319], there is great interest in the development of
anthocyanin-rich maize functional food products [305,311,312,321,328]. Several studies have reported
the potential health-beneficial properties of anthocyanin-rich maize [305,317,329]. Examining the
phenolic and anthocyanin content of eighteen Mexican maize genotypes, Lopez-Martinez et al. found
that total anthocyanins ranged from 1.54 to 850.9 mg of cyanidin-glucoside equivalents/100 g of
whole grain flour. Purple genotypes rich in anthocyanins exhibited also the greatest antioxidant
activity [330]. Andean purple corn had higher antioxidant activity and antiradical kinetics than
blueberries and higher or similar level of anthocyanins [331]. Similarly, analyzing 49 lines of waxy
corn (Zea mays L. var. ceratina) characterized by different colors Harakotr et al. [332] found a large
variability of phenolic and anthocyanin compounds and a positive correlation coefficient between
anthocyanins and 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging ability (r = 0.94) and
between anthocyanins and Trolox equivalent antioxidant capacity (TEAC, r = 0.88). Introduction in the
diet of anthocyanin-rich corn may contribute to prevent also obesity and diabetes. Tsuda et al. [317]
found that feeding high fat (HF) mice for 12 weeks with cyanidin 3-glucoside-rich purple corn
significantly reduced HF body weight and white and brown adipose tissues compared to HF mice
not receiving purple corn supplement. The HF diet induced also hyperglycemia, hyperinsulinemia,
and hyperleptinemia, whereas the same physiological conditions were not observed in HF mice
receiving the purple corn supplement. Moreover, an increase of tumor necrosis factor (TNF)-α mRNA
level was observed in the HF-diet while it was not observed in the HF group receiving the purple
corn supplement which suppressed the mRNA of enzymes involved in fatty acid and triacylglycerol
synthesis and reduced the level of sterol regulatory element binding protein-1 mRNA in white adipose
tissue. Using near-isogenic maize lines which differed only in the presence or not of anthocyanins, and
feeding rats with anthocyanin-rich and anthocyanin-deprived maize for 8 weeks it was observed that
in the group fed with anthocyanin-rich corn cardiac tissue damaged following ischemic conditions was
reduced by about 30% compared to the group fed with anthocyanin-deprived corn [333]. An increase
of myocardial glutathione and omega-3 fatty acids levels in blood indicated that diet supplementation
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with anthocyanins regulated the cardiac antioxidant defense and the conversion of α-linolenic acid
to omega-3 fatty acids [333,334]. In an in vivo study, using db/db mice fed with 10 mg/kg of purple
corn extract for 8 weeks, Kang et al. [335] found that anthocyanin-rich purple corn extracts reduced
glomerular angiogenesis of diabetic kidneys by inhibiting the induction of vascular endothelial
growth factor (VEGF) and hypoxia inducible factor (HIF)-1a induced by hyperglycemic condition.
Kang et al. results demonstrated that purple corn extract inhibited glomerular angiogenesis caused
by chronic hyperglycemia and diabetes by disturbing the Angpt-Tie-2 ligand-receptor system linked
to the renal VEGF receptor 2 (VEGFR2), suggesting that purple corn extract could be used to target
abnormal angiogenesis in diabetic nephropathy leading to kidney failure [335]. Yet, in a recent study
Mazewski et al. [336] found that anthocyanin-rich purple and red corn may potentially contribute to
inhibiting human colon cancer cell proliferation by promoting apoptosis and suppressing angiogenesis.
The main pigments isolated in vegetables consumed for various plant parts are presented in
Table 3.
Table 3. The main pigments isolated in vegetables consumed for plant parts other than fruit and leaves.











(0.0653–0.3716 mg/100 g fw), cyanidin
3-O-(sinapoyl)diglucoside-5-O-glucoside
(0.0119–0.0158 mg/100 g fw), cyanidin
3-O-(feruloyl)diglucoside-5-O-glucoside
(0.0201–0.0765 mg/100 g fw), cyanidin
3-O-(sinapoyl)(feruloyl)diglucoside-5-O-
(malonyl)glucoside (0.013–0.048 mg/100 g fw), and
cyanidin 3-O-(sinapoyl)(sinapoyl)diglucoside-5-O-








































cyanidin 3,5-diglucoside (0–11.7 mg/kg dw),
cyanidin 3-glucoside (0.3–194.1 mg/kg dw), cyanidin
3,5-malonyldiglucoside (0.5-218.0 mg/kg dw),
cyanidin 3-(3′′-malonyl)glucoside (0–47.3 mg/kg
dw), and cyanidin 3-(6′′-malonyl)glucoside
(7.6-1234.3 mg/kg dw) along with some minor
compounds such as peonidin 3-glucoside, peonidin












cyanidin 3-rutinoside (774.2 mg/kg fw), cyanidin
glucosyl rutinoside (125.5 mg/kg fw), peonidin
rutinoside (84.8 mg/kg fw)
[23,298,302]
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Table 3. Cont.







Maize kernels Yellow – deeporange Carotenoids
β-carotene (2.62 μg/g dw),
β-cryptoxanthin (3.96 μg/g dw), zeaxanthin
(23.74 μg/g fw),
zeinoxanthin (0.75 μg/g dw),
lutein (8.2 μg/g dw),


























Vegetable products are pivotal in human health and their daily consumption is highly
recommended due to their high content in phytochemicals with diverse beneficial health effects.
The vegetable crops presented in this review, namely leafy and fruit vegetables and species where other
plant parts are consumed, are well known and widely consumed throughout the world, although their
colored variants are not always accepted by consumers and proper marketing is needed to introduce
them to the public. Currently, the food and beverage industry is seeking for natural alternatives of
synthetic compounds to satiate market demands for “non-chemical additives” food products. Therefore,
the broad color palette the presented vegetables exhibit not only could diversify human diet and make
food products more attractive to consumers and increase their appeal, but also could be proved as
valuable sources of natural coloring agents. Under the circumstances, future research should focus on
the identification of those promising coloring agents and the establishment of efficient and sustainable
techniques for their isolation. Other future requirements, include breeding and agronomic protocols
that could improve pigments content in the final produce, as well as post-harvest and processing
conditions to increase extraction efficiency of natural coloring agents. Finally, the mechanisms of
actions related with the health effects and antioxidant activities of coloring compounds have to be
revealed and valorized in the pharmaceutical and food industry for the design of novel functional
foods and drugs.
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Abstract: The discovery of several revitalizing molecules that can stop or reduce the pathology of
a wide range of diseases will be considered a major breakthrough of the present time. Available
synthetic compounds may provoke side effects and health issues, which heightens the need for
molecules from plants and other natural resources under discovery as potential methods of replacing
synthetic compounds. In traditional medicinal therapies, several plant extracts and phytochemicals
have been reported to impart remedial effects as better alternatives. Murraya koenigii (M. koenigii)
belongs to the Rutaceae family, which is commonly used as a medicinally important herb of Indian
origin in the Ayurvedic system of medicine. Previous reports have demonstrated that the leaves, roots,
and bark of this plant are rich sources of carbazole alkaloids, which produce potent biological activities
and pharmacological effects. These include antioxidant, antidiabetic, anti-inflammatory, antitumor,
and neuroprotective activities. The present review provides insight into the major components of
M. koenigii and their pharmacological activities against different pathological conditions. The review
also emphasizes the need for more research on the molecular basis of such activity in various cellular
and animal models to validate the efficacy of M. koenigii and its derivatives as potent therapeutic agents.
Keywords: Murraya koenigii; antioxidant; bioactive compounds; pharmacological activity;
traditional medicine
1. Introduction
Presently, huge numbers of people in developing countries depend on medicinal plants for
healthcare, skin care, economic benefits, and cultural development. For centuries, medicinal plants
have been widely used in traditional medicine in countries like India, China, Germany, Thailand, etc. [1].
The World Health Organization (WHO) projected that 80% of the population relies on traditional
medicine, which is clearly elucidated by the 19.4 billion USD global revenue for herbal remedies in
2010 [2]. Moreover, the demand for traditional medicinal plants is increasing; for instance, the market
for medicinal plants is expanding at an annual rate of 20% in India. Likewise, in China, 30% to
50% of the total medicinal consumption is from preparations of traditional medicine [3]. Nearly
76.7% of the citizens of Thailand have reported mainly using traditional herbal medicine for their
primary healthcare [4]. Around 90% of the German population uses natural remedies for certain health
issues [5]. Therefore, the medicinal plants used in traditional medical treatments are significant in both
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developing and industrialized countries. This is clearly demonstrated by the worldwide market for
traditional medicine. This market continues to gradually increase [6].
Murraya koenigii (M. koenigii) (L) Spreng (Family: Rutaceae) is usually known as “curry leaves”.
The tropical and subtropical regions in the world have large distributions of M. koenigii [7]. Among
the 14 global species belonging to the genus of Murraya, only two, M. koenigii and M. paniculate, are
available in India. M. koenigii is more important due to its huge spectrum of traditional medicinal
properties. For centuries, this plant has been used in diverse forms and holds a place of pride in
Indian Ayurvedic medicine, known as “krishnanimba” [8]. Different parts of M. koenigii, such as its
leaves, root, bark, and fruit, are known to promote various biological activities. Aromatic bioactive
constituents in the leaves of M. koenigii retain their flavor and other qualities, even after drying [9–14].
M. koenigii leaves are slightly bitter in taste, pungent in smell, and weakly acidic. They are used as
antihelminthics, analgesics, digestives, and appetizers in Indian cookery [15,16]. The green leaves
of M. koenigii are used in treating piles, inflammation, itching, fresh cuts, dysentery, bruises, and
edema. The roots are purgative to some extent. They are stimulating and used for common body
aches. The bark is helpful in treating snakebites [17–20]. The essential oil extracted from M. koenigii
leaves is reported to possess anti-oxidative, hepatoprotective [21–24], antimicrobial, antifungal [25–27],
anti-inflammatory, and nephroprotective activities in animal models [28–30]. The medicinal properties
of M. koenigii have been accredited to several chemical constituents of different carbazole alkaloids
and other important metabolites, like terpenoids, flavonoids, phenolics, carbohydrates, carotenoids,
vitamins, and nicotinic acid from different parts of the M. koenigii plant.
In recent years, greater attention has been paid to the use of M. koenigii in traditional medicines
and home remedies. On the other hand, limited studies have been conducted for evaluating the
pharmacological and medicinal efficacy of M. koenigii in promoting health benefits and curing
disease [31–36]. This review will discuss the traditional medicinal use of M. koenigii and its bioactive
compounds, highlighting their pharmacological effects. This review aims to present a well-managed
summary and possible recommendation on existing studies to provide information regarding the
current reports that can direct future research. Therefore, instead of discussing a few selected studies in
a specific time interval, the present review will discuss and cover previous and existing major studies
on M. koenigii related to the topics chosen. The details, like phytochemical screening, identification,
and pharmacological activities, will be systematically categorized, compared, and summarized.
We hypothesized that, through all of these efforts, a good summary on pharmacological activities that
could initiate future perspectives with the utmost clarity could be produced.
The pharmacological activities of M. koenigii are discussed in detail in Figure 1.
Figure 1. Pharmacological activities of Murraya koenigii.
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2. Murraya koenigii (M. koenigii)
2.1. Traditional Uses of M. koenigii
Essential oils and fresh leaf powder of M. koenigii are useful in seasoning food items and
preparing ready-to-eat foods. Owing to the higher antimicrobial activities of the essential oil from
leaf extracts [37,38], this oil can also be used as perfume and flavor agents in traditional practice.
Fresh curry leaves are boiled with a coconut oil mixture until they are reduced to a black residue to
produce an excellent hair tonic for retaining a normal hair tone and improving hair growth. Curry
leaves have a traditional use, either whole or in parts, as antidiarrheal, antifungal, blood purifying,
anti-inflammatory, and anti-depressant agents [39–41].
2.2. Medicinal Uses of M. koenigii
M. koenigii has numerous disease remedial activities, for instance, different parts of the plant,
such as the leaves, roots, and bark, can be prepared as tonics for inducing digestion and flatulence or
as antiemetics [25,42]. After decoction, the leaves become bitter to the taste and are helpful in reducing
fever. The juice of the root is given to manage renal pains [43]. The leaves and roots can be given as an
anthelmenticku, analgesic, cure for piles, body heat reducer, and thirst quencher and are also helpful in
reducing inflammation and itching. They are also useful in managing leucoderma and blood disorders.
When eaten raw, the green leaves can offer a cure for dysentery, and when they are boiled in milk,
the paste has good application prospects for curing poisonous bites and eruptions [44].
2.3. Phytochemistry of M. koenigii
A wide range of phytochemicals have been isolated from the leaves, roots, and stem bark of
M. koenigii. M. koenigii extracts of leaves, root, stem bark, fruits, and seeds have yielded alkaloids,
flavonoids, terpenoids, and polyphenols, as shown in Table 1. The plant leaves contain a substantial
amount of proximate composition; the moisture is 63.2%, protein is 8.8%, carbohydrate is 39.4%,
total nitrogen is 1.15%, fat is 6.15%, total sugars are 18.92%, starch is 14.6%, and crude fiber is 6.8%.
The leaves have been reported as a significant source of several vitamins, such as vitamin A (B-carotene),
with a level of 6.04 ± 0.02 mg/100 g; vitamin B3, (niacin), with a level of 2.73 ± 0.02 mg/100 g; vitamin
B1 (thiamin), with a level of 0.89 ± 0.01 mg/100 g; calcium, with a level of 19.73 ± 0.02 mg/100 g;
magnesium, with a level of 49.06 ± 0.02 mg/100 g; and sodium, with a level of 16.50 ± 0.21 mg/100 g.
The alcohol-soluble extract has a value of 1.82%, ash has a value of 13.06%, acid-insoluble ash has a
value of 1.35%, cold water (20 ◦C) extractive has a value of 27.33%, and maximum of hot-water-soluble
extractive has a value of 33.45% [15,45]. Wide ranges of carbazole alkaloids, essential oils, terpenoids,
and flavonoids have numerous beneficial roles. Table 2 summarizes the major chemical constituents of
M. koenigii and its pharmacological activities.
Table 1. Phytochemical compounds identified from M. koenigii.
Compound Molecular Formula Plant Part References
Alkaloids
Mahanine C23H25NO2 Leaves, stem bark, and seeds [45–49]
Mahanimbine C23H25NO Leaves, roots, seeds, and fruits [47–49]
Murrayanol C24H29NO2 Leaves, roots, and fruits [47–49]
Koenimbine C19H19NO2 Leaves, seeds, and fruits [46–49]
O-Methylmurrayamine A C19H20NO2 Leaves [45–48]
Koenigicine C20H21NO3 Leaves [45–48]
Koenigine C19H19NO3 Leaves and stem bark [47–49]
Murrayone (Coumarine) C15H14O4 Leaves [45–48]
Mahanimbicine C23H25NO Leaves [45–48]
169
Antioxidants 2020, 9, 101
Table 1. Cont.
Compound Molecular Formula Plant Part References
Bicyclomahanimbicine C23H25NO Leaves [45–48]
Phebalosin C15H14O4 Leaves [45–48]
Isomahanimbine C23H25NO Leaves and roots [45,46,48]
Koenimbidine C20H21NO3 Leaves and roots [45,46,48]
Euchrestine B C24H29NO2 Leaves [45,46]
Bismurrayafoline E C48H56N2O4 Leaves [45,46]
Isomahanine C23H25NO2 Leaves, seeds, and fruits [45,46,49]
Mahanimbinine C23H27NO2 Leaves and seeds [45,46,49]
Girinimbilol C18H19NO Leaves [45,46]
Pyrayafoline-d C23H25NO2 Leaves and stem bark [45,46,49]
Glycozoline C14H13NO Leaves [45,46]
Cyclomahanimbine C23H25NO Leaves [45,46]
Isomurrayazoline C23H25NO Leaves [45,46]
Mahanimboline C23H25NO2 Leaves [49]
Mukonicine C20H21NO3 Leaves [49]
Isolongifolene C15H24 Leaves [49]
Mukonal C13H9NO2 Stems [49]
Mukeic acid C14H11NO3 Stems [49]
9-Carbethoxy-3-methyl carbazole C16H15NO2 Roots and stems [49]
9-Formyl-3-methyl carbazole C14H11NO Roots and stems [49]
Murrayazolinol C23H25NO2 Stems bark [49,50]
Mahanimbinol C23H27NO Stems bark [49,50]
Mukoeic acid C14H11NO3 Stem bark [49,50]
Osthol C15H16O3 Stem bark [49,50]
Umbelliferone C9H6O3 Stem bark [49,50]
Murrayanine C14H11NO2 Stem bark [49,50]
Mukoenine-A C18H19NO Roots and stem bark [49,50]
Mukoenine-B C23H25NO2 Roots and stem bark [49,50]
Mukoline C14H13NO2 Roots [49,50]
Mukolidine C14H11NO2 Roots and stem bark [49,50]
(M)-murrastifoline-F C28H24N2O2 Roots and stem bark [49,50]
3-Methyl-9H-carbazole-9-carbaldehyde C14H11NO Roots [49,50]
Bismahanine C46H48N2O4 Roots and stem bark [49,50]
Bikoeniquinone A C27H20N2O3 Roots and stem bark [49,50]
Bismurrayaquinone C26H16N2O4 Roots and stem bark [49,50]
3-Methylcarbazole C13H11N Roots [49]
Murrayafoline A C14H13NO Roots [49]
Murrayakonine A C37H36N2O2 Leaves and stems [39]
Murrayakonine B C23H23NO2 Leaves and stems [39]
Murrayakonine C C24H25NO3 Leaves and stems [39]
Murrayakonine D C23H25NO2 Leaves and stems [39]
Girinimbine C18H17NO Roots, stem bark, and seeds [49,51]
Murrayacine C18H15NO2 Stem and bark [49,51]
Murrayazoline C23H25NO Stem and bark [49,51]
Flavonoids
Quercetin C15H10O7 Leaves [52]
Apigenin C15H10O5 Leaves [52]
Kaempferol C15H10O6 Leaves [52]
Rutin C27H30O16 Leaves [52]
Catechin C15H14O6 Leaves [52]
Myricetin C15H10O8 Leaves [52]
4-O-β-d-Rutinosyl-3-methoxyphenyl-
1-propanone C22H32O12 Leaves [53]
1-O-β-d-Rutinosyl-2(R)-ethyl-1-pentanol C19H36O10 Leaves [53]
8-Phenylethyl-O-β-d-rutinoside C20H30O10 Leaves [54]
Terpenoids
Blumenol A C13H20O3 Leaves [53]
Icariside B1 C19H30O8 Leaves [53]
Loliolide C11H16O3 Leaves [53]
Blumenol A C13H20O3 Leaves [53]
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Icariside B1 C19H30O8 Leaves [53]
(−)-Epiloliolide C11H16O3 Leaves [55]
(−)-α-pinene C10H16 Leaves [55]
(−)-β-pinene C10H16 Leaves [55]
(+)-β-pinene C10H16 Leaves [55]
(+)-sabinene C10H16 Leaves [55]
Squalene C30H50 Leaves and bark [56]
β-sitosterol C29H50O Leaves and bark [56,57]
Polyphenols
Selin-11-en-4α-ol C15H26O Leaves and bark [56]
2-hydroxy-4-methoxy-3,6-dimethylbenzoic
acid C10H12O4 Bark [56]
Table 2. The major bioactive compounds of M. koenigii and its pharmacological activities.
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2.4. Bioavailability Study of M. koenigii-Derived Active Constituents
An in vivo pharmacokinetic study revealed that after oral administration of the bioactive
compounds at the rate of 0.1 gm/kg body weight (b.w.), the maximum systemic concentration
(Cmax) of koenimbine was 1.81 ± 0.55 μM and koenidine was 2.82 ± 0.53 μM, and the time required
to reach the maximum concentration was 49.8 ± 8.4 min and 240 ± 0.00 min, respectively [58].
Bhattacharya et al. demonstrated the bioavailability of mahanine—another important bioactive
compound of M. koenigii—in mice through blood serum estimations based on high-performance liquid
chromatography (HPLC) analysis. Mahanine, at a dose of 100 mg/kg of body weight, was found to
take 60 min to reach the maximum concentration in blood serum [59].
3. Molecular Mechanism and Activities of M. koenigii
3.1. Antioxidants
Reactive oxygen species (ROS), such as singlet oxygen (O2), hydrogen peroxide (H2O2),
the superoxide anion (O2•−), and the hydroxyl radical (•OH), are often generated as byproducts of
cellular metabolic reactions and exogenous induction. These ROS create homeostatic imbalances, which
lead to the generation of oxidative stress, which in turn, induces cell death and tissue injury [60]. ROS in
elevated levels can damage biomolecules such as nucleic acids, proteins, and lipids [61]. Even though
the antioxidant defense systems like enzymatic antioxidants and non-enzymatic antioxidants are
functioning, uncontrolled ROS accumulation during the life cycle promotes the development of
age-dependent diseases, like cancer, atherosclerosis, arthritis etc. [62]. Natural antioxidants from
plant sources have been considered a promising therapy for the prevention and treatment of these
diseases, especially neurodegenerative disorders, cardiovascular diseases, cancer, and other conditions.
Various natural bioactive compounds, such as mahanine, mahanimbine, isolongifolene, koenimbine,
girinimbine, isomahanine, koenoline, and O-methylmurrayamine, are present in M. koenigii and exhibit
remarkable antioxidant properties [63,64].
The leaf extracts of M. koenigii have high antioxidant activities [65]. Rao et al. evaluated the
antioxidant activities of water and an ethanol extract of M. koenigii assessed by the, α-diphenyl-β-
picrylhydrazyl (DPPH) free radical scavenging assay, with quercetin as a positive control. The ethanolic
extract of M. koenigii showed an 80% scavenging activity, which was similar to the activities exhibited
by the control antioxidant compound quercetin [66]. Gupta et al. evaluated the antioxidant activities
of acetone, alcohol, and aqueous extracts of M. koenigii by the DPPH free radical scavenging assay, with
ascorbic acid as a positive control. The extracts of M. koenigii exhibited activities with an half-maximum
effective concentration (EC50) value of acetone of 81.81 ± 19.92 at 4.7 μg/mL, alcohol of 79.80 ± 18.68 at
4.1 μg/mL, and aqueous extract of 62.82 ± 13.62 at 4.4 μg/mL, which was comparable to the EC50 value
exhibited by ascorbic acid (the positive control), which was 97.13 ± 12.64 at 2.69 μg/mL [67]. Zahin et al.
also evaluated the antioxidant activities of both ethyl acetate and petroleum ether fractions of M. koenigii
through DPPH radical scavenging assay, cupric reducing antioxidant capacity (CUPRAC), and ferric
reducing antioxidant power (FRAP) assays, with ascorbic acid as a positive control. The benzene
fraction of M. koenigii was found to be the most active free radical scavenger, exhibiting an 88.3%
decrease at a concentration of 100μg/mL, followed by ethyl acetate at 79.5% and petroleum ether at
78.7%, while positive controls of ascorbic acid and butylated hydroxytoluene (BHT) at a concentration
of 100μg/mL inhibited 93.1% and 86.5% DPPH absorption, respectively. Similarly, the antioxidant
activity created by reducing activity and CUPRAC assays indicated the highest reducing potential in
the benzene fraction, followed by petroleum ether and ethyl acetate. The activity was greater than that
of ascorbic acid and on par with that of BHT [68].
Yogesh et al. evaluated the antioxidant activity of berry extracts of M. koenigii by DPPH free
radical scavenging activity and reducing power assays. The results indicated that an M. koenigii
berry extract is a powerful free radical scavenger compared to known antioxidants, such as butylated
hydroxytoluene, ascorbic acid, and tannic acid [69]. Tomar et al. evaluated the total antioxidant activity
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of acetone and petroleum ether extracts of younger and older M. koenigii leaves by estimating the
H2O2 scavenging activity. The acetone extract of old leaves was found to have a maximum activity
at 151.58%, and for young leaves in petroleum ether, the value was 72.23% [70]. Waghmare et al.
evaluated the antioxidant property of fruit extracts of M. koenigii with DPPH free radical scavenging
activity, inhibition of nitric oxide radical (NO) and thiobarbituric acid reactive substances (TBARS)
activity, and reducing power assays, and •OH was also estimated, with vitamin C as a positive control.
The fruit extract of M. koenigii exhibited antioxidant activities, and the EC50 value of the extracts for
the DPPH assay was 2.6 mg/mL; for the NO radical, was 2.9 mg/mL; for TBARS, was 3.1 mg/mL; for
the reducing power assay, was 2.7 mg/mL; and for H2O2, was 3.3 mg/mL, which were comparable to
the EC50 value of 5 mg/mL exhibited by the vitamin C positive control [71]. The antioxidant activities
exhibited by the crude extracts of M. koenigii were probably due to the presence of flavonoids and
phenolic derivatives. The above studies revealed that various extracts of M. koenigii display high
antioxidant activity. The studies also indicated the potential for this plant to be a natural source of
strong antioxidant substances that can be used in therapy for human diseases induced by ROS.
3.2. Oxidative Stress
Chemical species with one or more unpaired electrons are called free radicals. In biological
systems, the term “free radicals” refers to reactive oxygen species (ROS). Major ROS include O2•−,
H2O2, and •OH [72]. In addition to ROS, reactive nitrogen species (RNS), including peroxynitrite
(NO3−), NO, and S-nitrosothiols, also contribute to the generation of oxidative stress. Both ROS and
RNS arise as intermediates in several metabolic processes and are specifically produced as part of the
cellular defense against invasive pathogens. Free radicals also regulate many processes, including
cellular growth, glucose metabolism, and proliferation [73].
Apart from certain beneficial effects, free radicals induce various deleterious effects. In a
non-specific manner, ROS can react on significant biomolecules, which leads to deleterious effects like
a loss of enzyme activity, genetic mutations and permeability alterations in the cell membrane, and
RNS-induced protein S-nitrosylation [74]. Because DNA is constantly attacked by the free radicals,
around 75,000 to 100,000 DNA damage events might occur in each cell per day. •OH is the most
reactive species and interacts with all biological molecules, including the C-8 position of guanine to
form 8-hydroxyguanine, which is one of the most frequently found oxidized bases in DNA [75].
An increase in the free radical concentration in the body can cause subsequent oxidative and
cellular damage to lipids, proteins, RNA, and DNA [76]. The leaf extract of M. koenigii has recently
been shown to possess potential antioxidant activity and protection against oxidative stress induced in
diabetes [77]. The aqueous leaf extract of M. koenigii has been shown to reduce lipid peroxidation and
decrease cellular damage, thereby protecting the liver from ethanol-induced toxicity [31]. Khan et al.
reported the antioxidant effect and preventive effect of curry leaves in cadmium-induced oxidative
stress, cardiac tissue damage, and alterations in normal cardiac functions in rats [78]. Mitra et al.
reported the heavy metal chelating activity of an M. koenigii leaf extract. They found that there was a
significant decrease in the tissue cadmium level when the rats were pre-treated with the M. koenigii leaf
extract before cadmium administration [79].
3.3. Mitochondrial Dysfunction
Mitochondria are the primary source of high-energy metabolism within the cell. Mitochondria are
known as the powerhouse of the living cell. Mitochondria also regulate calcium homeostasis and play a
role in scavenging free radicals and controlling programmed cell death and/or the apoptosis-signaling
pathway [80]. Mitochondrial damage leads to reduced adenosine triphosphate (ATP) production,
increased ROS generation, impaired calcium buffering, damage to mitochondrial DNA (mtDNA),
an altered mitochondrial morphology, and alterations in mitochondrial fission and fusion. All these
events eventually lead to cell death [81]. It is currently believed that the majority of ROS are
generated by mitochondrial complexes I and III, likely due to the release of electrons by NADH and
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dihydroflavine-adenine dinucleotide (FADH2) into the electron transport chain (ETC). Mitochondrial
dysfunction is a characteristic of all chronic diseases and aging. It is characterized by a loss of efficiency
in the ETC, as well as reductions in the synthesis of high-energy molecules [82]. These diseases include
neurodegenerative diseases like Parkinson’s disease (PD), Alzheimer’s disease (AD), amyotrophic
lateral sclerosis, multiple sclerosis, Huntington’s disease, cardiovascular diseases, auto-immune
diseases, diabetes, and others [83,84].
Mitochondria, as essential organelles, have a noteworthy role in the viability of neuronal cells.
Excess ROS formation is due to complex I inhibition inducing impairments in the mitochondrial
membrane potential (MMP) and the pro-apoptotic members are believed to permeabilize the outer
mitochondrial membrane due to the formation of oligomeric pores, which permits the release
of apoptogenic molecules from the intermembrane space. Recent studies have evaluated the
neuroprotective activities of isolongifolene and structurally similar compounds, such as girinimbine,
murrayazoline, and O-methylmurrayamine A isolated from M. koenigii. By using different in vitro
assays, a study reported that the above bioactive compounds exhibited the ability to restore the MMP
levels and repair the mitochondrial damage [85–87].
3.4. Inflammation
Tissue injury, cell damage, infections due to pathogens, and alterations in biochemicals lead to a
biological response called inflammation. In neurological disorders, the important components involved
in inflammatory processes are believed to be mast cells, ependymal cells, microglia, astrocytes, and
macrophages [88]. Microglia, a type of neuronal support cell acting as resident macrophages located
throughout the brain by changing their morphology, actively respond to inflammation and participate
in removing damaged neurons and pathogens. An ethanol extract from M. koenigii leaves showed
significant analgesic and anti-inflammatory activity when explored using carrageenan-induced hind
paw edema in albino rats [89]. Another study also confirmed the anti-inflammatory activity of an
M. koenigii leaf extract in carrageenan-induced paw edema [90]. Additionally, the study recognized the
analgesic activity of curry leaves with several experimental models. M. koenigii leaf extracts effectively
attenuate the pain which is induced by an intraperitoneal injection of acetic acid and subplantar
injection of formalin in mice, and the analgesic effect was elucidated with the writhing responses and
pain responses in the late phase. Furthermore, it was reported that higher concentrations (20 and
40 mg/kg, per os (p.o.)) reduced the early-phase inflammatory responses induced by formalin [91].
Khurana et al. evaluated the in vitro and in vivo efficacy of a hydroalcoholic extract of M. koenigii
curry leaves rich in carbazole alkaloids against lipopolysaccharide (LPS)-induced inflammation in
RAW 264.7 cells. The activity of inflammatory cytokines interleukin 1 beta (IL-1β), interleukin-6
(IL-6), tumor necrosis factor (TNF-α), and p65-NFκB was significantly reduced by the hydroalcoholic
extract of M. koenigii. In addition, the hydroalcoholic extract of M. koenigii reduced the expression
of nitrotyrosine (NT), myeloperoxidase (MPO), IL-1β, intercellular adhesion molecule 1 (ICAM-1),
and cyclooxygenase (COX-2), and increased the expression of Nrf2 [92]. Iman et al. evaluated the
anti-inflammatory activity of an extract of M. koenigii and its bioactive compound girinimbine against
lipopolysaccharide/interferon-gamma-induced RAW 264.7 cells. The girinimbine showed reduced
levels of NO overproduction and pro-inflammatory cytokine levels IL-1β and TNF-α in the peritoneal
fluid. These findings strongly suggest that girinimbine could act as an anti-inflammatory agent by
suppressing inflammation [85]. Another study also confirmed the anti-inflammatory activity of an
M. koenigii leaf extract. Bioactive compounds like murrayakonine A, O-methylmurrayamine A, and
mukolidine were reported for their efficiency in inhibiting TNF-α and IL-6 release in LPS-induced
inflammation in human peripheral blood mononuclear cells (PBMCs) [39]. The above studies have
shed light on the mechanism of the anti-inflammatory activity of M. koenigii leaves and their active
compounds, which are comparable to nonsteroidal anti-inflammatory drugs (NSAIDs).
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3.5. Apoptosis
Apoptosis is a physiological programmed cell death mechanism which is essential for the flawless
growth and development of organisms. Furthermore, it is a lively physiological course causing the
self-destruction of cells that comprises lethal biochemical and morphological changes in the nucleus
and cytoplasm. During cellular strain like oxidative stress and DNA damage, the process of apoptosis
can arise, particularly in cells with high proliferation rates and a high expression of pro-apoptotic
genes [93]. Intrinsic and extrinsic pathways regulate apoptosis, but both pathways are associated and
the molecules involved in those pathways can influence one another.
Previous findings have demonstrated that an M. koenigii extract and its primary active compounds
regulate multiple signaling pathways, including phosphatidylinositol 3 kinase (PI3K)/protein kinase
B (AKT), mammalian target of rapamycin (mTOR) and mitogen-activated protein kinase (MAPK).
M. koenigii and its primary active compounds exert complementary effects on oxidative stress and the
alteration of proteins [94,95]. They are associated with mitochondrial-mediated apoptotic pathways.
Murrayazoline and O-methylmurrayamine were shown to induce the downregulation of Akt/mTOR,
suggesting downstream targeting of the cell survival pathway and an ability to potentiate the antitumor
activity of D.L. Dexter (DLD-1) colon cancer cells; interestingly, this inhibition of the Akt/mTOR pathway
could possibly activate the intrinsic apoptotic program [86]. Mahanine and isomahanine derived from
M. koenigii leaves exert anticancer effects on oral squamous cell carcinoma cells via the induction of
microtubule-associated protein 1 light chain 3, type II (LC3B-II), and cleaved caspase-3, suggesting the
inhibition of autophagic flux [96]. In human leukemic cells, Mahanine was reported to induce apoptosis
by interrupting signal transfer between Apo-1/Fas signaling and the Bid protein and via mitochondrial
pathways in humans [59]. Recently, it was reported that girinimbine, a carbazole alkaloid isolated from
M. koenigii, inhibited the growth of and induced apoptosis in human hepatocellular carcinoma cells
(HepG2) [97]. In addition, Xin et al. reported that girinimbine inhibited ovarian cancer cell proliferation
in a dose-dependent manner. It also inducted apoptosis and cell cycle arrest due to inhibition of the
PI3K/AKT/mTOR and Wnt/b-catenin signaling pathways [98].
The alkaloid koenimbin found in M. koenigii was shown to extend pro-apoptotic activities in
MCF-7 cancer cells by inhibiting glycogen synthase kinase-3 beta (GSK-3β). Koenimbin induces
apoptotic cell death, phosphorylation, the accumulation of β-catenin, and the activation of nuclear
factor-κB (NF-kB) in cancers. Moreover, koenimbin suppresses the expression of various anti-apoptotic
genes involved in the regulation of cell proliferation and apoptosis [99]. Koenimbine has also been
reported to trigger caspase activation, induce the release of cytochrome c, decrease the anti-apoptotic
proteins, and increase the pro-apoptotic proteins, and all of these events lead to intrinsic apoptotic
pathway activation [99]. Another study demonstrated that pyrayafoline-D and murrafoline-I isolated
from M. koenigii could induce apoptosis in HL-60 cells. The same study also induced the loss of
mitochondrial membrane potential and the subsequent activation of caspase-9/caspase-3, leading to
the activation of apoptotic pathways [100].
4. Beneficial Pharmacological Activities of M. koenigii and Its Primary Active Derivatives
4.1. Antifungal Activity
The antifungal activity of M. koenigii has been reported in various studies. For example, the essential
oil of the leaves was reported to possess antifungal activity [18]. The antifungal activity of the leaves of
M. koenigii is due to the presence of phytochemical constituents of complex molecular structures and
diverse action mechanisms, viz. alkaloids, terpenoids, flavonoids, phenolics, tannins, and saponins,
which are known for their antimicrobial properties. Different investigations support the traditional use
of the plant as an antifungal agent. In vitro antifungal activity may explain the use of curry leaves
for the treatment of diarrhea, dysentery, and skin eruptions in folklore medicines [19]. Bioactive
compounds of M. koenigii appreciably hold the ability of mycelial growth inhibition and thereby
promote antifungal activity. The antifungal activity of M. koenigii against a wide range of pathogenic
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fungi has been studied. Penicillium notatum, Aspergillus flavus, Aspergillus niger, Fusarium moniliforme,
Mucor mucedo, Penicillium funiculosum etc., were isolated from infected saplings and spoiled foods
based on alterations of their growth characteristics, mycelial morphology, and spore morphology
(Table 3) [27]. The ethanolic extract of M. koenigii exhibited notable effects on the hyphal morphology;
namely, an increase in branching potential, which resulted in the development of short slender branches
of hyphae with swollen tips. Such effects are usual for any antifungal compound. Bioactive compounds
like girinimbine, murrayanine, marmesin-1′-O-beta-D’galactopyranoside, mahanine, murrayacine,
mukoeic acid, murrayazolinine, girinimbilol, pyrafoline-D, and murrafoline-I are present in stem bark.
Girinimbine, murrayanine, and marmesin-1′-O-beta-D’galactopyranoside have notable anti-fungal
activity [20,101].
4.2. Antibacterial Activity
The unsystematic use of antibiotics promotes the development of multiple drug-resistant
pathogenic strains of bacteria, which are very harmful, and there is a lack of proper treatment
procedures for these ailments. Therefore, the need to search for new antimicrobials remains. Currently,
in addition to antibiotics and chemically-synthesized drugs, curiosity for alternative medicines, such
as natural or herbal medicines, is increasing. They may have fewer side effects or toxicity owing to
their natural sources [102].
Combating microbial infections without side effects is always a tedious process. In this regard,
in addition to classical antibiotics and synthetic drugs, there is an ongoing hunt for potent molecules
from natural herbal medicines [102]. M. koenigii extracts have demonstrated antibacterial effects on
a wide variety of microorganisms. Methanol and ethanol extracts of M. koenigii leaves were found
to be effective against the bacterial strains Escherichia coli (E. coli), Staphylococcus, Streptococcus, and
Proteus. Hence, M. koenigii leaves could be efficiently used as a natural remedy in everyday meals
for the prevention of several bacterial infections [103]. Pyranocarbazoles isolated from M. koenigii
exhibited antibacterial activity on bacterial strains of Staphylococcus aureus and Klebsiella pneumonia [40].
Green synthesized silver nanoparticles (AGNPs) from M. koenigii exhibited therapeutic efficacy against
multidrug resistant MDR bacteria [103]. M. koenigii essential oil showed antibiofilm activity against
Pseudomonas aeruginosa and it was reported that M. koenigii essential oil treatment revealed an 80%
reduction in biofilm formation by P. aeruginosa. Microscopic analyses confirmed the drop in biofilm
formation in Pseudomonas aeruginosa when treated with M. koenigii essential oil. The presence of
antibiofilm substances like spathulenol (5.85%), cinnamaldehyde (0.37%), and linalool (0.04%) was
reported in gas chromatography-mass spectrometry (GCMS) studies [104]. M. koenigii counteraction on
uropathogenic bacteria isolated from clinical samples was reported in a different study [105]. M. koenigii
was tested for its antibiotic action against Mycobacterium species, which was appreciable, like first-line
anti-tuberculosis drugs. M. koenigii half maximal inhibitory concentration ((IC50) 400 μg/mL) was
found to be more effective against Mycobacterium smegmatis compared to water extracts and petroleum
ether. An M. koenigii ethanol extract exhibited significant synergistic antibacterial activity against
Mycobacterium smegmatis and Mycobacterium bovis bacillus calmette-guerin (BCG) in combination with
the anti-tuberculosis drug rifampicin [106].
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4.3. Hepatoprotective Effect
Liver diseases are a worldwide concern, and accessible medical treatments have an inadequate
efficacy. Since ancient times, herbs have been used when treating various disease conditions; plant
extracts and natural compounds have significant applications as hepatoprotective agents. The liver is the
site of drug metabolism and the detoxification site of toxic products, and so it is the organ most exposed
to xenobiotics [107]. M. koenigii extended hepatoprotective activity when crude aqueous extracts were
investigated against ethanol-induced hepatotoxicity in experimental animals. M. koenigii was reported
to extend a protective effect in liver impairments in chronic alcoholism and was proved to be effective
in maintaining the enzymatic oxidant status [108]. Water extracts of carbazole alkaloids and tannin of
M. koenigii were explored for their hepatoprotective activity against ethanol-induced hepatotoxicity in
a HepG2 cell line model. They exhibited excellent hepatoprotective activity, maintaining the enzymatic
and non-enzymatic antioxidant level at a near normal value and also maintaining the integrity of the
cells [31]. An M. koenigii hydro-ethanolic leaf extract was reported to attenuate the CCl4 hepatotoxic
effects in rats. M. koenigii-pretreated rats showed a significant decrement in activity levels of hepatic
markers and also maintained the level of enzymatic antioxidants [16].
4.4. Immunomodulatory Activity
The immune system makes a network and regulates processes important for maintaining the
health of an organism by hindering the entry and invasion of microbes. Impairments in the immune
system lead to conditions from chronic inflammation to cancer [109]. In an investigation on the humoral-
and cell-mediated immune response to ovalbumin, the immunomodulatory activity of a methanolic
extract of M. koenigii leaves was evaluated using a carbon clearance test. A considerable increase in the
NO production indicated the increased phagocytic activity of macrophages. The M. koenigii extract
holds promise as an immunomodulatory agent, which acts by stimulating humoral immunity and
the phagocytic function [110]. The M. koenigii leaf extracts were reported to have certain effects in
regulating mice immunology related to oxidative stress metabolism. An M. koenigii leaf extract can
exhibit an immunomodulatory effect through which it can regulate the oxidative stress metabolism in
diabetic mice [111].
4.5. Nephroprotective Activity
M. koenigii has been used as a nephroprotective agent in a diabetic-induced rat model [9].
The M. koenigii leaf extract was found to be efficient in maintaining normal levels of serum creatinine,
blood urea nitrogen, total serum protein, serum Na+, urine output, urinary creatinine, urinary urea,
total urinary protein, and urinary Na+. Furthermore, the M. koenigii extract maintained the standard
pattern in in vivo antioxidants, renal myeloperoxidase (MPO) activity, and histopathology of kidneys
against unilateral renal ischemia reperfusion injury. Therefore, the extract of M. koenigii was clearly
demonstrated to be useful in treating kidney disorders in rats [112]. The nephroprotective activity of
M. koenigii was elucidated in experimental investigations, which showed decreased levels of blood
urea nitrogen (BUN), serum creatinine (Cr), and lipid peroxidation (LPO). An M. koenigii extract
is efficient against cyclophosphamide-induced nephrotoxicity, which was clearly revealed through
the maintenance of high levels of glutathione (GSH) and superoxide dismutase (SOD) compared to
the cyclophosphamide-treated group [28]. M. koenigii protective activity has been shown to induce
significant dose-dependent decreases in serum urea and creatinine levels, as well as marked increases
in the levels of plasma antioxidant capacity, in diabetic rats, compared to controls. More noteworthy is
the histological integrity of kidneys, which showed comparable tissue regeneration induced by the
aqueous extract [9].
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4.6. Antidiabetic Activity
Most prominently in developing countries, medicinal plants play a helpful role in managing
diabetes mellitus due to their cost effectiveness. Diabetes mellitus, a metabolic disorder, is becoming
a serious threat to human health. During the past few years, many phytochemicals responsible for
anti-diabetic effects have been isolated from plants. Alkaloids present in the leaves of M. koenigii
have been explored and reported to have inhibitory effects on the aldose reductase enzyme, glucose
utilization, and other enzyme systems for extending anti-diabetic effects [38]. M. koenigii was tested
for the α-glucosidase inhibitory property and was found to inhibit α glycosidase. Alpha-glucosidase
inhibitors are widely used in the treatment of patients with type 2 diabetes [113]. A study reported
that an ethanolic extract of M. koenigii showed a significant reduction in blood glucose levels, and
this effect of reducing blood glucose by M. koenigii is mediated by antioxidant properties and insulin
mimetic effects. In addition, M. koenigii exhibited a profound antioxidant effect by reducing the
malondialdehyde (MDA) level, increasing the GSH level, and significantly decreasing the homeostatic
model assessment (HOMA)-insulin resistance index. On the whole, it is evident that M. koenigii
possesses antidiabetic activity and has antioxidant effects in rats [10].
4.7. Anticancer Activity (In Vivo and In Vitro)
M. koenigii possesses potential secondary metabolites that could be developed as anticancer agents.
In one study, the cytotoxic activity was evaluated for three extracts: hexane, ethyl acetate, and methanol
of M. koenigii leaves against the HeLa cell line. The extracts were reported as being potently cytotoxic
in nature in HeLa cancer cells. These results established the potential of M. koenigii as an anticancer
agent in vitro [11]. Additional evidence for the anticancer activity of M. koenigii has been obtained
from rodent cancer cell lines, as well as different in vivo cancer models [12–14,22–24,114,115]. In an
early study, histopathological evidence showed that M. koenigii extract treatment generated a decline
in neoplasms in the colon [85]. A methanolic extract of M. koenigii was reported to have the ability
to reduce proliferation in breast cancer cell lines [116]. The total alkaloid extracted from M. koenigii
leaves has been shown to have promising cytotoxic activity in breast cancer cells, with an IC50 of
14.4 μg/mL [117]. The anticancer activity of mahanine and isomahanine in human oral squamous cell
carcinoma CLS-354 has also been reported [96].
Girinimbine, another M. koenigii-derived carbazole alkaloid, showed growth inhibitory activity in
human hepatocellular carcinoma and lung cancer cells in vitro [118]. Rutin, quercetin, kaempferol, and
apigenin, present in leaf extracts of M. koenigii, showed the dose-dependent inhibition of endogenous
26S proteasome activity in MDA-MB-231 cells [52]. Therefore, M. koenigii contains remarkable anticancer
compounds, especially mahanine, which has been reported to show anticancer activity targeting
different signaling pathways [46]. Girinimbine, a carbazole alkaloid, has been found to have a good
role in total leukocyte migration and result in an appreciable reduction in pro-inflammatory cytokine
levels. The various activities of M. koenigii against different cancer cell lines are shown in Figure 2.
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Figure 2. Apoptosis induced by M. koenigii bioactive compounds in cancer. Bcl2: B-cell lymphoma 2;
Bcl2-XL: B-cell lymphoma-extra-large; P-Bad: P plasmid araB araA araD; ROS: reactive oxygen species;
Chk1/2: checkpoint kinase; Go/G1: cell cycle phase; JAK1: janus kinase 1; STAT3: signal transducer
and activator of transcription 3; AKT: protein kinase B (also known as AKT); mTOR: mammalian target
of rapamycin; P53/p57: tumor protein; Hsp90: heat shock protein.
4.8. Neuroprotective Activity
Supplementation with M. koenigii leaf extracts has been reported in the management of a wide
spectrum of neurodegenerative diseases, like AD, PD, and others [30,33–35,41]. M. koenigii promotes
neuroprotective potential against orofacial dyskinesia induced by resperine. Additionally, it stabilizes
the levels of protective antioxidant enzymes like SOD, catalase (CAT), and GSH, and inhibits LPO in
the forebrain regions of reserpine-treated animals. Furthermore, it has been shown to significantly
inhibit reserpine-induced abnormalities in behavior. Similarly, treatment with M. koenigii significantly
restored the levels of protective antioxidant enzymes (that is, SOD, CAT, and GSH) and inhibited LPO
in the forebrain region when compared with reserpine, and it also inhibited catalepsy induced by
haloperidol [36]. Isolongifolene (ILF), a tricyclic sesquiterpene of M. koenigii, has been reported to
render neuroprotective effects against rotenone-induced mitochondrial dysfunction, oxidative stress,
and apoptosis in a cellular model. Cytotoxicity, oxidative stress, and mitochondrial dysfunction
were also attenuated by ILF in SH-SY5Y cells, which down-regulated Bax and caspases-3, -6, -8, and
-9 expression, and up-regulated Bcl-2 expression. IFL was proved to regulate p-P13K, p-AKT, and
p-GSK-3 beta expressions [87]. Preclinical studies have reported that M. koenigii leaves could enhance
memory in rats [119]. The possible neuroprotective potential of amethanolic extract of M. koenigii
leaves was exhibited in a two-vessel occlusion (2VO) rat model of partial global cerebral ischaemia.
The Morris water maze test was implemented to assess the rats’ cognitive function postoperatively.
Brain samples were histopathologically examined for viable neurons within the CA1 hippocampal
region. Test findings showed that M. koenigii leaves positively improved memory and learning
impairments. M. koenigii leaf extracts modestly improved memory in rats with chronic partial global
cerebral ischemia [120]. The various activities of M. koenigii against neurotoxicity are shown in Figure 3.
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Figure 3. Neuroprotective effect in in vitro and in vivo studies produced by bioactive compounds
from M. koenigii. PI3: phosphatidylinositol 3 kinase; GSK3β: Glycogen synthase kinase 3 beta; Ach:
Acetylcholine; Bax: Bcl2-Associated X protein.
4.9. Radioprotective and Chemoprotective Activity
A methanolic extract of M. koenigii was demonstrated to render protection in chromosomal damage
against radiation and cyclophasphamide in vivo. Radiation leads to a rise in all types of aberrations,
like the fragmentation of chromatids and breakages in chromosomes, rings, and dicentrics. Treatment
with a methanolic extract of M. koenigii before radiation significantly reduced the aberrations. M. koenigii
can significantly exert bone marrow protection against radiation and cyclophasphamide [121].
4.10. Wound Healing Effect
Wound healing is a complex and multifactor process involving numerous biochemical and cellular
processes which helps in the restoration of functional and anatomical continuity. M. koenigii leaves
extend wound healing in male albino rats through significantly increased wound contraction and
reduced epithelialization, supporting the collagen synthesis which was evident in histopathological
studies [122].
5. Conclusions
The current review summarizes the medicinal uses, phytochemistry, and pharmacological properties
of M. koenigii. M. koenigii is a source of several bioactive compounds, including alkaloids, polyphenol,
terpenoids, and flavonoids. M. koenigii and its derivatives appear to exhibit appreciable pharmacological
activities, like anticarcinogenic, proapoptotic, antiangiogenic, antimetastatic, immunomodulatory, and
antioxidant properties. The molecular mechanisms underlying these activities of M. koenigii and its
derivatives are due to their diversified role in combinations of cell signaling pathways at multiple
levels in various diseases. M. koenigii and its derivatives mitigate oxidative stress, neurotoxicity,
neuroinflammation, neuronal loss, and cognitive dysfunctions. However, like other polyphenols,
to a certain extent, M. koenigii activities are limited by its bioavailability and in such conditions,
enhancement of the efficiency should be conducted. Therefore, future studies need to include more
experimental studies on bioavailability and efficiency enhancement in clinical investigations.
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Abstract: Cis-dichlorodiammineplatinum II (CDDP) is a chemotherapeutic agent that induces
nephrotoxicity by different mechanisms, including oxidative stress, mitochondrial dysfunction,
autophagy, and endoplasmic reticulum stress. This study aimed to evaluate if the protective effects of
the antioxidant alpha-mangostin (αM) in CDDP-induced damage in proximal tubule Lilly laboratory
culture porcine kidney (LLC-PK1) cells, are related to mitochondrial function preservation. It was
found that αM co-incubation prevented CDDP-induced cell death. Furthermore, αM prevented the
CDDP-induced decrease in cell respiratory states, in the maximum capacity of the electron transfer
system (E) and in the respiration associated to oxidative phosphorylation (OXPHOS). CDDP also
decreased the protein levels of voltage dependence anion channel (VDAC) and mitochondrial complex
subunits, which together with the reduction in E, the mitofusin 2 decrease and the mitochondrial
network fragmentation observed by MitoTracker Green, suggest the mitochondrial morphology
alteration and the decrease in mitochondrial mass induced by CDDP. CDDP also induced the
reduction in mitochondrial biogenesis observed by transcription factor A, mitochondria (TFAM)
decreased protein-level and the increase in mitophagy. All these changes were prevented by αM.
Taken together, our results imply that αM’s protective effects in CDDP-induced toxicity in LLC-PK1
cells are associated to mitochondrial function preservation.
Keywords: alpha-mangostin; cisplatin; nephrotoxicity; mitochondria function; mitophagy
1. Introduction
Cis-dichlorodiammineplatinum II (CDDP) is a platinum compound frequently used in many
types of cancers [1,2]. However, the main side-effect of CDDP is its nephrotoxicity, especially in
proximal tubule epithelial cells. It is estimated that 20 to 30% of patients treated with CDDP developed
transient episodes of acute kidney injury, which can progress to chronic kidney disease, depending on
the dose and individual pharmacokinetics [2]. The CDDP-toxicity mechanisms involve DNA damage,
oxidative stress, mitochondrial damage, endoplasmic reticulum (ER) stress, autophagy, and apoptotic
cell death [3,4].
In recent years, the use of biomolecules with antioxidant activity has been widely studied to mitigate
the nephrotoxic effects induced by CDDP [5]. Alpha-mangostin (αM), a bioactive compound with direct
antioxidant properties that can be extracted from the Garcinia mangostana tree, has been broadly used in
Antioxidants 2019, 8, 133; doi:10.3390/antiox8050133 www.mdpi.com/journal/antioxidants195
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Asian traditional medicine and its nephroprotective effect has been demonstrated experimentally [6,7].
αM is a prenylated xanthone with antioxidant, anti-inflammatory, and anti-apoptotic properties [8,9].
Additionally, our research group demonstratedαM’s protective effects in CDDP-induced nephrotoxicity,
related to the prevention of oxidant and nitrate stress increase, glutathione decrease, tumor necrosis
factor alpha (TNF-α) and p53 increase, and apoptosis induction [3,7,9]. Recently, the modulation of
mitochondrial function, autophagy, and ER stress have been related to αM’s protective effects in cancer
and diabetic nephropathy models [10–12]. However, the participation of these processes in αM’s
protection in CDDP-induced nephrotoxicity has not been studied yet.
Mitochondria are double membrane organelles, which regulate important functions related
to energetic homeostasis and cell death. Additionally, mitochondria are considered as one of the
main reactive oxygen species (ROS) producers in the cell [13]. It is a widely accepted concept that
mitochondrial damage is one of the principal mechanisms involved in CDDP-induced nephrotoxicity.
CDDP induces mitochondrial membrane potential loss, as well as alterations in bioenergetics, dynamics
(balance between fusion and fission), biogenesis and mitophagy, which favor the induction of
apoptosis [14–17]. Additionally, the higher dependence of mitochondrial adenosine triphosphate (ATP)
production in the proximal tubule compared with other nephron segments, make the proximal tubule
more susceptible to CDDP-damage [2,13].
On the other hand, autophagy is a multistep pathway that degrades and recycles damaged
macromolecules and organelles, to maintain intracellular homeostasis. This process involves the
sequestration of damaged components inside a double membrane vesicle (autophagosome) and
their subsequent degradation when the autophagosome fuses with the lysosome (autolysosome) [18].
Although autophagosome and autolysosome formation involves multiple protein complexes and
multiple steps, the increase of the lipidated microtubule-associated protein 1 light chain 3 alpha
(LC3) form (commonly refer as LC3-II) and the decrease of p62 levels have been widely used to
evaluate the induction of autophagy [19]. In the CDDP nephrotoxicity model, it has been suggested
that autophagy induction acts as a protective mechanism early on [20–22]. Recent studies also
show that mitophagy (a mitochondrial-specific type of autophagy) has a protective role in CDDP
nephrotoxicity [22,23]. Under mitochondrial damage or depolarization, the induction of mitophagy
helps to maintain the mitochondrial quality control and, therefore, the cellular homeostasis [19].
In CDDP-induced nephrotoxicity, the mitophagy clearance of damaged mitochondria mediated by the
phosphatase and tensin homologue (PTEN) induced kinase 1/parkin RBR E3 ubiquitin protein ligase
(PINK1/Parkin) pathway has shown protective effects [22,24].
This study aimed to evaluate if the protective effects of αM in CCDP-induced damage in Lilly
laboratory culture porcine kidney (LLC-PK1) cells, was related to αM regulation of mitochondrial
function and autophagy (especially mitophagy).
2. Materials and Methods
2.1. Reagents
Alpha-mangostin (αM) was obtained as described in our previous studies [25] from Garcinia
mangostana (DNP International Inc., Whittier, CA, USA) with 98% purity. The LLC-PK1
(ATTC® CL-101) epithelial cell line, derived from proximal tubular cells of the porcine
kidney, was acquired from American Type Culture Collection (ATCC, Rockville, MD,
USA). Cis-dichlorodiammineplatinum II (CDDP), trypan blue, fluorescein diacetate (FDA),
tris(hydroxymethyl)aminomethane, sodium deoxycholate, 4-nonylphenyl-polyethylene glycol (NP-40),
sodium fluoride (NaF), D-(+)-glucose, sodium pyrophosphate (Na4P2O7), sodium orthovanadate
(Na3VO4), Triton X-100, glycerophosphate, 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid
(HEPES), Tween 20, glycerol, ethylenediaminetetraacetic acid (EDTA), dimethyl sulfoxide (DMSO),
antimycin A, ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid (EGTA), dinitrophenol
(DNP), magnesium chloride (MgCl2) tetrahydrate, oligomycin, rotenone, sodium L-ascorbate,
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sodium azide (NaN3) and tetramethyl-p-phenylene diamine (TMPD), sodium phosphate monobasic
(NaH2PO4), sodium phosphate dibasic (Na2HPO4), sodium dodecyl sulfate (SDS), ponceau S,
chloroquine diphosphate salt (CQ), wortmannin and antibodies against microtubule-associated
protein light chain 3B (LC3, L7543), ubiquitin-binding protein p62 (p62, P0067) and α-tubulin (α-Tub,
T9026) were purchased from Sigma Aldrich (St. Louis, MO, USA). Dulbecco’s Modified Eagle’s
Medium (DMEM), fetal bovine serum (FBS), and penicillin/streptomycin were purchased from Biowest
(Riverside, MO, USA). Calcium chloride (CaCl2), sodium bicarbonate (NaHCO3), sodium chloride
(NaCl), and hydrochloric acid (HCl) were purchased from J.T. Baker (Xalostoc, Edo. Mex, Mexico).
Potassium chloride (KCl) was purchased from Mallinckrodt plc. (St. Louis, MO, USA). Protease
inhibitor cocktail was purchased from Roche Applied Science (Mannheim, Germany). MitoTrackerTM
Green FM was purchased from Thermo Fisher Scientific. Antibodies against malondialdehyde (MDA,
ab6463), peroxisome proliferator-activated receptor gamma (PPARγ) coactivator 1α (PGC-1α, ab54481),
4-hydroxynonenal (4HNE, ab5605), parkin RBR E3 ubiquitin protein ligase (Parkin, ab15954) and total
oxidative phosphorylation (OXPHOS, ab110413) rodent western blot (WB) antibody cocktail were
purchased from Abcam (Cambridge, MA, USA). Antibodies against nuclear respiratory factor 1 (NRF1,
sc-33771), voltage dependence anion channel (VDAC, sc-8828), phosphatase and tensin homologue
(PTEN) induced kinase 1 (PINK1, sc-33796), transcription factor A, mitochondria (TFAM, sc-19050)
were purchased from Santa Cruz Biotechnology (Dallas, TX, USA). Antibody against mitofusin 2
(MFN2, D2D10) was purchased from Cell Signaling Technology (Danvers, MA, USA). All the other
reagents were analytical grade.
2.2. Cell Culture and Cell Viability
The LLC-PK1 cells were cultured in DMEM medium, supplemented with 10% FBS and
penicillin/streptomycin (100/50 U/mL) in a humidified incubator with 5% CO2 atmosphere at 37 ◦C.
The experiments were carried out at a density of 50,000 cell/cm2, passaged 9 to 30 times since the
acquired cryovial was opened. The cells were grown in 100 mm culture dishes and when they reached
90% confluence, were planted in the corresponding experimental plates. After 24 h of growth in 10%
FBS medium, LLC-PK1 cells were exposed to 0 to 5 μM αM, 5 to 40 μM CDDP or co-incubation of αM
and CDDP for 24 h in 1% FBS medium. Stock 10 mM αM was dissolved in DMSO and a posterior
dilution of 1:100 in phosphate buffer saline (PBS) (100 μM) was used to prepare each experimental
concentration. A stock 0.5 mg/mL (1.670 mM) of CDDP in 0.9% saline solution was used for different
CDDP concentrations. Additional treatment consisted of pre-treatment with 30 μM CQ (2 h) or 10 nM
wortmannin (1 h previous and during different treatment: αM, CDDP or αM+CDDP) as autophagy
inhibitors. After pre-treatment, αM and/or CDDP were added for 24 h. One bright field image was
captured in triplicate with a 20× objective after treatments, using a Cytation 5 Cell Imaging Multi-Mode
reader (BioTek Instruments, Winooski, VT, USA).
Cell viability was measured by the FDA assay according to a previously described method [26] in
96-well tissue culture microplates, where fluorescence is directly proportional to cell viability.
2.3. Cell Respirometry
The oxygen consumption experiments in intact cells were performed using a high-resolution
respirometry equipment O2k meter (Oroboros Instruments, Innsbruck, Austria) according to a method
previously described [27]. Cells were pretreated with the corresponding schemes of αM, CDDP or
co-incubation for 24 h. Subsequently, cells were washed with PBS, harvested with trypsin, and quantified
by the trypan blue assay. Determinations were made using 2 mL of culture medium with 10% FBS. Each
experiment was initiated by the addition of approximately 2.5 million cells, the respiratory parameters
were defined as: 1. Routine respiration, corresponding to oxygen consumption with presence only
of cells. 2. Leak, corresponding to cellular oxygen consumption in the presence of 5 μM oligomycin.
3. Maximum capacity of electron transfer system (E) was achieved by titrations with 5 μM DNP. 4.
Respiratory control (RC) corresponding to the ratio basal/leak. 5. Respiration associated with oxidative
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phosphorylation (P) was calculated by the formula Routine-Leak. All parameters were corrected by
subtracting the non-mitochondrial respiration, obtained by the addition of 1 μM rotenone plus 5 μM
antimycin A, and normalized by the number of cells.
Complex I (CI)-linked respiration was measured in a different experiment by the rest of routine
respiration minus the respiration after inhibition with 1 μM rotenone. The activity of complex IV (CIV)
was evaluated in intact cells in culture medium with 10% FBS supplemented with 0.5 μM rotenone
plus 2.5 μM antimycin A. Oxygen consumption was stimulated by the addition of 0.5 mM TMPD plus
2 mM ascorbate. CIV activity was corrected by oxygen consumption in the presence of the appropriate
inhibitor (100 mM NaN3). The results were normalized by the number of cells.
2.4. Total Protein Extract and Western Blot
LLC-PK1 cells were grown on 60 mm plates, after treatment were washed twice with cold PBS
and lysed by addition of 400 μL of cold radioimmunoprecipitation assay buffer (RIPA) buffer (50 mM
Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.5% sodium deoxycholate, 1% NP-40, 0.1% SDS)
with protease and phosphatase inhibitors (25 mM NaF, 1 mM Na3VO4, 1 mM PMSF, 1 mM Na4P2O7,
0.5 mM glycerophosphate and 1X protease inhibitors cocktail) for 30 min at 4 ◦C with stirring. Lysates
were centrifuged 15,000 × g during 10 min at 4 ◦C and the supernatant was collected and stored
at −70 ◦C until the experiment was carried out. The protein concentration was quantified by the
Lowry assay [28]. Equal amounts of protein (15 μg) were separated on 10% to 15% in sodium dodecyl
sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) as appropriate. Proteins were transferred
onto Immobilion PVDF membranes for fluorescent application on wet transfer and blocked with 5%
non-fat dry milk for 1 h. Then incubated overnight at 4 ◦C with the appropriate primary antibody:
MDA (1:2000), 4HNE (1:3000), PGC-1α (1:100), NRF1 (1:200), TFAM (1:500), VDAC (1:500) OXPHOS
cocktail (1:1500), MNF2 (1:1000), PINK1 (1:1000), Parkin (1:1000), LC3 (1:1500), p62 (1:1000) and α-Tub
(1:8000). Then the membranes were incubated with the corresponding fluorescent secondary antibodies
(1:10000) for 1 h at room temperature in darkness. Protein bands were detected in an Odyssey scanner
(Li-COR Biosciences, Lincoln, NE, USA) and protein band intensity was analyzed by Image StudioTM
Life Software Li-COR Odyssey, which led us to normalize to correct for loading variations between
bands and give us signal counts measured in a single pixel per unit time through Z-Factor Calculation.
In all cases, except OXPHOS subunits, α-TUB served as loading control. Thus, once the protein target
was detected, we proceeded to detect its loading control. For that, the membranes were rinsed only
with Tris-buffered saline, 0.1% Tween 20 (TBS-T 1x) 3 times for 5 min and then the membranes were
incubated with primary α-TUB antibody, following the usual steps as for protein target. The OXPHOS
subunits were referred to reversible Ponceau staining as loading control as described by Romero-Calvo
et al. [29]. Briefly, after transfer, the membranes were incubated in 1% Ponceau S solution for 2 min.
Immediately after, membranes were rinsed with PBS to remove staining saturation, clearly visible
bands. Membranes were placed between transparent sheets and scanned in conventional equipment
at 300 dpi as TIFF document (HP Scanjet G4050). Again, membranes were rinsed until the staining
completely disappeared. Finally, membranes were blocked with 5% non-fatty milk in TBS buffer,
and the usual steps were continued.
2.5. Mitochondrial Mass by MitoTracker Green
The mitochondrial mass was indirectly evaluated by a fluorometric assay using MitoTracker green
(MTG). After treatment, cells were washed with DMEM w/o FBS and then incubated with 0.5 μM
MTG for 20 min at 37 ◦C. After that, the cells were washed two times with mammalian Ringer Krebs
Medium. Micrographs were taken with a 20× objective size with numerical aperture 0.45, and zoomed
in with Cytation 5 imaging, GFP filter (Ex/Em, 469 nm/525 nm).
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2.6. Statistical Analysis
Data are presented as the mean±standard deviation (SD). Data were analyzed by one-way
ANOVA followed by the corresponding Dunnett or Tukey post-test. Comparison between time
course and protein level as independent variables of all treatment were performed using two-way
ANOVA followed by Bonferroni post-test using the software Graph-Pad Prism 5 (San Diego, CA, USA).
A p-value lower than 0.05 was considered to deduce representative changes of the behavior studied
with respect to each treatment.
3. Results
3.1. αM Prevented CDDP-Induced Cell Death
LLC-PK1 cells were incubated with various CDDP concentrations: 5, 10, 20, 30, and 40 μM
(Figure 1A) and it was observed that at 30 μM CDDP, reduced approximately 50% of cell viability, as we
previously reported [26]. Later, cells were incubated with αM concentrations between 1 and 5 μM.
As we expected, αM was not toxic up to 5 μM (Figure 1B). To evaluate protection by αM, αM and
30 μM CDDP were co-incubated. We observed that αM protected the cells against CDDP-induced
cytotoxicity in a concentration-dependent manner and the protection with the least concentration
was found at 4 μM (Figure 1C). So, the subsequent experiments were carried out with 4 μM αM and
30 μM CDDP.
Figure 1. Protective effect of alpha mangostin (αM) against cis-dichlorodiammineplatinum II (CDDP)
induced cell death. Lilly laboratory culture porcine kidney (LLC-PK1) cells were treated with (A) 0–40
μM cisplatin, (B) 0–5 μM αM or (C) co incubated with 30 μM CDDP and increasing concentrations
of αM for 24 h. After treatment, cell viability was measured by the fluorescein diacetate (FDA) assay.
The data are presented as mean ± SD, n = 5–7. *** p < 0.001, ** p < 0.01 and * p < 0.05 vs. control (0).
### p < 0.001 and ## p < 0.01 vs. CDDP.
CDDP’s toxicity is partially associated with oxidative stress. To evaluate the effect of
CDDP-induced oxidative stress, we evaluated the lipid peroxidation markers 4HNE and MDA
by Western blot (WB). As we show in Figure 2, CDDP increased the level of MDA (Figure 2A,B) but
not those of 4HNE (Figure 2C,D). αM was unable to prevent CDDP-induced MDA increase.
3.2. αM’s Protection is Associated to the Preservation of Mitochondrial Bioenergetics
The main nephrotoxic mechanism of CDDP is mitochondrial damage [13,14]. Therefore,
we determined if the preservation of mitochondrial bioenergetics was related to protection by αM.
So, we evaluated the respiratory states in the whole cells. As shown in Figure 3, CDDP-treatment
reduced the Routine respiration, the Leak of respiration, the maximum capacity of the electron transfer
system (E) and the respiration associated to oxidative phosphorylation (P) at 24 h. Interestingly,
due to both Routine and Leak respiration reduced, the respiratory control (RC) did not change with
CDDP-treatment (Figure 3E). All respiratory state alterations were reversed by αM co-treatment.
Importantly αM alone did not alter any respiratory parameters at this concentration (Figure 3).
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Figure 2. Changes in oxidative stress markers in LLC-PK1 cells treated with αM, CDDP or both. After 24
h of αM-, CDDP-treatment or both, the oxidative stress was evaluated by the lipoperoxidative markers
(A) malondialdehyde (MDA) and (C) 4-hydroxynonenal (4HNE). (A) and (C) show the densitometry
data and (B) and (C) show the representative blots. The data are presented as mean ± SD, n = 6–7.
** p < 0.01 vs. control. ## p < 0.01 vs. CDDP. α-Tub = alpha-tubulin.
Figure 3. αM co-treatment prevents CDDP induced a decrease in respiratory parameters at 24 h.
(A) Cellular routine respiration = Routine, (B) leak of respiration, (C) maximum capacity of electron
transfer system = E, (D) respiration associated to oxidative phosphorylation = P, (E) respiratory control
= RC. The data are presented as mean ± SD, n = 3–5. ** p < 0.01 and * p < 0.05 vs. control. ### p < 0.001
and # p < 0.05 vs. CDDP.
The decrease in all the respiratory states without changes in RC, suggested that the mitochondrial
bioenergetics alterations were related to a reduction in the activity of the whole electron transport
system (ETS). So, we evaluated the CI-linked respiration, the CIV activity and the percentage of routine
respiration attributable to CI. The CDDP-treatment diminished CI-linked respiration but had no effect
200
Antioxidants 2019, 8, 133
on CIV activity and the percentage of basal respiration attributable to CI was not reduced (Figure 4).
These results, together with the decrease in E, imply a reduction in whole ETS activity induced by
CDDP, which could be caused by a reduction in mitochondrial mass.
Figure 4. Determination of respiratory parameters at 24 h in LLC-PK1 cells treated with αM, CDDP or
both. (A) Complex I (CI)-linked respiration, (B) percentage of respiration attributable to CI and (C)
activity of complex IV (CIV). The data are presented as mean ± SD, n = 4–6. * p < 0.05 vs. control.
## p < 0.01 vs. CDDP.
3.3. Mitochondrial Respirometry Alterations are Associated to Mitochondrial Mass Decrease Related to
Mitochondrial Biogenesis Reduction
To determine if the reduction in the respiration states was linked to a decrease in mitochondrial
mass, the protein levels of VDAC and some mitochondrial complex subunits were evaluated by WB.
We evaluated mitochondrial subunits using an cocktail contained antibodies to labile mitochondrial
subunits. So, they allow to evaluate the changes in the mitochondrial proteins of the ETS in
the membrane only. Furthermore, several models of acute and chronic kidney damage have
previously reported a reduction in protein levels of these subunits as well as in levels of their
messengers, which has been related to a reduction in mitochondrial biogenesis and bioenergetics
in such models [30–35]. Figure 5 shows that CI-NDUFB8 (Figure 5A), CII-SDHB (Figure 5B) and
CIV-MTCO1 (Figure 5C) subunits were decreased with CDDP-treatment, whereas the CV-ATP5A
subunit was unchanged (Figure 5D). Moreover, we found a decrease in VDAC protein levels with
CDDP-treatment (Figure 5F,G), which was partially prevented by αM-treatment. To corroborate
these results, we obtained representative images of the mitochondrial mass using MTG, a selective
mitochondrial fluorescent label [36] and also MFN2, fusion marker. Figure 6A shows the images of
CDDP treated cells, where a fragmented mitochondrial network was observed, with loss of continuity
and fluorescence focal points. In addition, we found the MNF2 level in CDDP treatment that was
avoided by αM co-treatment suggests fusion diminishing (Figure 6B,C). Together, these results support
the idea that CDDP increases mitochondrial mass reduction and fragmentation, while αM can partially
preserve it.
To determine if the observed reduction in mitochondrial mass was related to alterations in
mitochondrial biogenesis, we evaluated the levels of mitochondrial biogenesis proteins PCG-1α,
NRF1, and TFAM. Interestingly NRF1 levels were upregulated in all treatments (Figure 7B), although
we expected a reduction. The implications of these changes are deliberated in the discussion
section. Furthermore, although we did not observe changes in PGC-1α (Figure 7A) CDDP-treatment
downregulated TFAM levels (Figure 7C) and αM co-treatment prevented it. These results suggest
that mitochondrial mass reduction is partially attributable to the decrease in mitochondrial biogenesis
induced by CDDP.
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Figure 5. CDDP-induced toxicity is related to a decrease in mitochondrial proteins. LLC-PK1 cells
were treated with αM, CDDP or both for 24 h. After treatment, western blotting of total oxidative
phosphorylation (OXPHOS) cocktail in the whole cell (A–D,F) voltage-dependent anion channel
(VDAC) as mitochondrial mass markers were quantified and (E,G) representative protein expression is
shown. Densitometry values were normalized by Ponceau red staining. The data are presented as
mean ± SD, n = 4–8. *** p < 0.001, ** p < 0.01 and * p < 0.05 vs. control. +++ p < 0.001 vs. (αM + CDDP).
NDUFB8 =NADH: ubiquinone oxidoreductase subunit B8, SDHB = succinate dehydrogenase complex
iron–sulfur subunit B, MTCO1 =mitochondrial cytochrome c oxidase I catalytic subunit, ATP5A = ATP
synthase F subunit alpha, α-Tub = alpha-tubulin.
Figure 6. CDDP-induced toxicity is related to a decrease of mitochondrial fusion. LLC-PK1 cells
were treated with αM, CDDP or both for 24 h. After treatment, (A) representative micrographs of
MitoTracker green, mitochondrial mass marker, at 20x and posterior zoom 1:1 and western blotting of
(B) Fusion marker, mitofusin 2 (MNF2) level and representative blot in (C). The data are presented
as mean ± SD, n = 6–8. *** p < 0.001 vs. control. ### p < 0.001, ## p < 0.01 vs. CDDP. + p < 0.05 vs.
(αM+CDDP). α-Tub = alpha-tubulin.
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Figure 7. Modulation of mitochondrial biogenesis in LLC-PK1 cells treated with αM, CDDP or both.
After 24 h of treatment, protein levels of (A) peroxisome proliferator-activated receptor gamma (PPARγ)
coactivator 1-alpha (PGC1α), (B) nuclear respiratory factor 1 (NRF1), (C) mitochondrial transcription
factor A (TFAM) were quantified. Representative blots are shown in (D). The data are presented as
mean ± SD, n = 5–7. *** p < 0.001. ### p < 0.001 and ## p < 0.01 vs. CDDP. α-Tub = alpha-tubulin.
3.4. The Induction of Mitophagy is Related to Protection by αM
Dysfunctional mitochondria are usually eliminated through diverse processes, such as
mitophagy [13], so we evaluated if mitophagy was related to CDDP-induced decrease in mitochondrial
mass. Figure 8 shows that CDDP increased both PINK1 (Figure 8A) and Parkin (Figure 8B) protein
levels and this increase was prevented by αM co-incubation. As the mitophagy process can be related
to general macroautophagy, we pre-incubated LLC-PK1 cells with 30 μM CQ for 2 h before αM or
CDDP-treatment, and with 10 nM of wortmannin 1 h before and during treatment, as autophagy
inhibitors (Figure 9). Although autophagy inhibition has been related to the worsening of CDDP injury,
Figure 9A shows that, apparently, CQ only has an effect on CDDP-treatment and does not have any
effect over the protection by αM. CQ pre-treatment did not reduce cell viability in αM+CDDP-treatment.
Wortmannin, as well as CQ, did not have any effect over the protection by αM (Figure 9B). Probably
protection by αM has a mechanism independent of the induction of autophagy. Figure 9C shows
micrographs representative of all treatments. CDDP treated cells showed less density at 24 h, as well
as cell swelling and loss of structure compared to the control group. αM co-treatment prevented
CDDP-alterations. In addition, in CQ and wortmannin + CDDP. we observed similar damage to the
CDDP group. However, CQ or wortmannin did not alter the morphological characteristic compared
with the αM+CDDP treatment.
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Figure 8. Modulation of mitophagy induction in LLC-PK1 cells treated with αM, CDDP or both.
After 24 h of αM-, CDDP-treatment or both, mitophagy proteins (A) phosphatase and tensin homologue
(PTEN)-induced kinase 1 (PINK1) and (B) parkin RBR E3 ubiquitin protein ligase (Parkin) were
evaluated. Representative blots are shown in (C). The data are presented as mean ± SD, n = 6–7.
* p < 0.05 vs. control. # p < 0.05 vs. CDDP. α-Tub = alpha-tubulin.
Figure 9. Effect of autophagy inhibition on the protection induced by αM vs. CDDP. LLC-PK1 cells
were pretreated with (A) 30 μM chloroquine (CQ) for 2 h, as an inhibitor of degradation of cargo in the
final autophagy phase, or (B) 10 nM wortmannin for 1 h and during the experiment, as an inhibitor of
phosphoinositide 3-kinase (PI3K) in the initial autophagy phase induction. After pre-treatment, the cells
were co-incubated with 4 μM αM and/or 30 μM CDDP for 24 h. Cell viability was determined, and (C)
representative micrographs were taken. The data are presented as mean ± SD, n = 4–6. *** p < 0.001
vs. control. ### p < 0.001, ## p < 0.01 and # p < 0.05 vs. cisplatin. +++ p < 0.001 and ++p < 0.01
vs. (αM+CDDP). ddd p < 0.001 vs. (stressor+αM+CDDP). eee p < 0.001, ee p<0.01 and e p < 0.05 vs.
(stressor+CDDP).
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Figure 10C shows that CDDP-treatment induced an increase in p62 levels at 24 h, and a slight
increase in microtubule-associated protein 1 light chain 3 alpha I (LC3-I) (Figure 10A) and the
LC3-II/LC3-I ratio (Figure 10B). The increase in p62 is relevant because of the fact that p62 has been
reported as one of receptors involved in PINK1/Parkin-mediated mitophagy balance [37] and aberrant
p62 levels may be the result of mitochondrial dysfunction [38], which together with the autophagy
results (Figure 9), suggest that mitophagy is involved in the observed mitochondrial mass decrease
induced by CDDP.
Figure 10. Time-course effect of αM and CDDP on autophagy stress markers. LLC-PK1 cells were
incubated with 4 μM αM, 30 μM CDDP or both during 0, 2, 4, 6, 8, 16, and 24 h. After each treatment,
(A) microtubule-associated protein 1 light chain 3 alpha I (LC3-I), (B) lipidated form of LC3 (LC3-II),
and (C) ubiquitin-binding protein p62 (p62) protein levels were evaluated. Panels A, B, and C show
quantitative data, and panel D shows representative blots. Data are presented as mean ± SD, n = 3–5.
** p < 0.01 vs. control and ### p < 0.01 vs. CDDP. α-Tub = alpha-tubulin.
4. Discussion
Cisplatin (CDDP) is highly deleterious at proximal tubule level given its high density of
mitochondria because of its reabsorption function [13]. Its nephrotoxicity is attributable to high
CCDP accumulation in the kidneys and adverse impacts on the renal transport system. CDDP entry
into the tubular cells by passive diffusion or by a number of cellular transporters including human
copper transport protein 1 (Ctr1) and the organic cation transport 2 (OCT2), which are highly expressed
on renal tubular cells [39]. Although this transport is expressed in other tissue, diverse strategies
have demonstrated its importance in nephrotoxicity development [2]. Inside cells, CDDP metabolism
results in its activation to a more potent toxin and glutathione-cisplatin-conjugate derivate and
compromises glutathione level and synthesis [40]. CDDP can bind to proteins of cytosol, mitochondria,
and ER [2,40,41]. Furthermore, CDDP binding to nuclear and especially mitochondrial DNA, trigger
mitochondrial dysfunction [2]. Although hydration and diuretics are used as a strategy to prevent
CDDP-induced nephrotoxicity, the optimal strategy to prevent this pathology is still being sought [1].
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For this reason, new strategies are being developed that include using phytochemical compounds such
αM [5].
αM has many biological functions [6,8]. There are three studies that demonstrated
nephroprotection versus CDDP, without interfering with urinary secretion or antiproliferating
activity [3,7,9]. Alpha-mangostin is not specific to tubular cells; however, it preserves the renal
function. Pharmacokinetics studies have shown that it can be quantified in the kidney and liver [6]
as well as its nephroprotective effects [3,7,9,11]. αM protection in CDDP nephrotoxicity related to
its antioxidant properties has been described [3,7,9]. To study αM mechanism we used the LLC-PK1
cell line because it is very stable, undergoing little to no transformation or neoplastic change after
numerous passages [42] and it shows tubular cells characteristics [43,44]. We corroborated in LLC-PK1
cells that αM co-incubation protects against CDDP-induced (30 μM) viability decrease (Figure 1C).
The protection was found at 4 μM and 5 μM, however, no differences were found between 4 and
5 μM (Figure 1), this time using a much purer αM extract than the previous report [9,25]. It has
been previously reported by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
viability assay 7.5 μM αM reduced viability cell [10], we reproduced this experiments with 1, 2.5, 5, 7.5,
and 10 μM and found that αM can reduce near 50% viability at 7.5 μM (data not show). For this reason,
we decide to use the minimum αM concentration in the present study. Our group has previously
demonstrated that CDDP induces oxidative stress in vitro, and αM was able to prevent the increase in
ROS and the decrease in glutathione (GSH) [9]. In our study, αM was unable to prevent MDA increase
(Figure 2A). We are tempted to speculate that the use of different markers (MDA versus ROS and GSH)
may explain the differences in both studies.
In this study, we demonstrated that CDDP induced mitochondrial bioenergetics alterations,
characterized by the reduction in the respiratory parameters: routine, leak, E, and P (Figure 3),
as well as CI-linked respiration (Figure 4). The absence of change in RC (Figure 3E), suggests that the
CDDP-induced respiratory state alterations were related to a decrease in whole ETS activity rather
than a reduction in a specific complex. Which was congruent with the absence of a reduction in
the percentage of basal respiration attributable to CI (Figure 4B) and would be responsible for the
decrease in OXHPOS capacity (Figure 3C). It was also demonstrated for the first time that αM prevents
the bioenergetics alterations induced by CDDP as we can see by the preservation of all evaluated
mitochondrial parameters in the co-treatment group (Figures 3 and 4). Mitochondrial dysfunction
has been widely recognized as an important factor in renal disease, especially in tubular damage [13].
Furthermore, in the CDDP model, the oxidative stress and the mitochondrial dysfunction favor the
activation of apoptosis, which contributes to renal damage [15,17,45]. So, the protection by αM would
be, at least in part, attributable to mitochondrial preservation (Figures 3 and 4), which explains the
protection of tubular epithelial cells.
Furthermore, the decrease in the levels of VDAC and respiratory complex subunits (Figure 5A–F),
implies that the observed mitochondrial bioenergetics alterations are attributable to mitochondrial
mass reduction and may also be attributable to mitochondrial network fragmentation. This is
congruent with a previous report that demonstrates a shift of mitochondrial dynamics towards
fission in CDDP-induced nephropathy [14]. Although the co-treatment with αM had no effect in the
evaluation of mitochondrial protein subunit levels (Figure 5A–F), it prevented the alteration in the
morphology of the mitochondrial network (Figure 5G), which is congruent with the preservation of
mitochondrial dynamics, demonstrated by other antioxidants, such as curcumin in CDDP-induced
damage nephropathy [14].
Our results also suggest that the observed reduction in mitochondrial mass is attributable to
decreased mitochondrial biogenesis. We found a decrease in TFAM levels in CDDP-treated cells
(Figure 6C,D), but PGC1α levels did not change (Figure 6A), suggesting a reduction in mitochondrial
biogenesis. We suggest this, first, because although PGC-1α expression did not change, its activity
also has to be considered. PGC-1α is regulated via phosphorylation by protein kinase B (AKT) and
adenosine monophosphate-activated protein kinase (AMPK), as well as deacetylation by sirtuins [46].
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In fact, it has been reported by Ortega-Dominguez [14] that CDDP decreased sirtuin-3 the levels,
which triggers the increase in lysine acetylated levels. Therefore, this evidence supports the idea
that PGC-1α is inactive in the cisplatin group. Second, as with PGC-1α, NRF1 expression does not
necessarily correlate with its activity. NRF1 activity can be regulated by phosphorylation and/or by
interactions with PGC-1α, PGC-1β, and PRC [14,46]. In this sense, TFAM levels determination is an
indirect proof of its activity. About it, CDDP exacerbated NRF1 levels, whereas TFAM decreased. So,
it can be suggested that CDDP-induced NRF1 overexpression is not functional, unlike the co-incubation
with αM. Taken together, we can suggest cisplatin suppress the mitochondrial biogenesis pathway.
Interestingly, we found increased levels of NRF1 in CDDP-treated cells (Figure 6B). This induction can
be explained by the fact that the promoter of the NRF-1 gene possesses antioxidant response elements.
Therefore, the nuclear factor erythroid 2-like 2 (Nrf2) can induce its expression [47]. Although we did
not evaluate Nrf2 induction in this work, our group has previously reported that CDDP induces the
increase in heme oxygenase-1 (HO-1) levels in LLC-PK1 [26], leading to Nrf2 activation, so the observed
NRF1 increase can be the consequence of an adaptive response of Nrf2 activation. On the other hand,
it was documented that αM can induce Nrf2 activation in retinal cells and liver tissue [48,49], which can
also explain the observed increase in NRF1 levels in co-treatment and αM groups (Figure 6B,D),
but more experiments are necessary to demonstrate Nrf2 induction.
In view of the fact that mitochondrial mass is regulated by biogenesis and mitophagy [13],
we evaluated the mitophagy markers Pink1/Parkin. Co-incubation with αM avoided Parkin (Figure 7B)
and PINK1 (Figure 7A) increase induced by CDDP. Recently, mitophagy was described as a response
mechanism in CDDP-induced nephrotoxicity, and the PINK/Parkin pathway was suggested as the
main route to remove damaged mitochondria [22–24]. The mitophagy machinery can be shared with
the macroautophagy, but can also be independently-activated [19]. We show that pharmacological
autophagy inhibition with CQ or with wortmannin did not have any effect in the protection by αM and
did not increase CDDP toxicity (Figure 8). However, the increase in p62 levels (Figure 9C,D) and the
no change of the LC3 ratio in CDDP-treatment at 24 h suggest that increases of PINK/Parkin can use
the p62 protein as an adaptor, as suggested in a previous report [37]. However, it is also known that
the accumulation of misfolded proteins leads to aberrant p62 expression [38]. Altogether, our results
support the idea of a partial preservation of mitochondrial mass and function by αM-treatment.
We found 4 μM of αM did not change the respiratory parameters (Figures 3 and 4) nor the
expression of mitochondrial proteins (Figure 5), except CII-SDHB (Figure 5B) and CIV-MTCO1
(Figure 5C). Unfortunately, nowadays, we do not have enough information to explain the origin
of these changes. However, it is important to note, that although these subunits decreased in αM
treatment, the functional respirometry studies did not show changes in any of the evaluated parameters
with respect to the control group (Figures 3 and 4). This implies the observed CII-SDHB and CV-ATP5A
decrease did not change the mitochondrial bioenergetics in the αM treatment with respect to the control.
And we did not observe changes in the mitochondrial network by MTG (Figure 6A). Additionally,
αM alone did not induce mitochondrial biogenesis (Figure 7) or mitophagy activation (Figure 8),
implying that at least at this concentration, αM has no negative effects on mitochondrial function.
In support of this, studies in heart tissue (200 mg/kg) and hepatic cells (30 μM) describe that αM
can avoid mitochondrial dysfunction (preventing the decrease in activity and levels of antioxidant
proteins and in RC, as well as ROS increase) induced by isoproterenol or free fatty acids increase [50,51].
By contrast, reports also describe that high αM concentrations (above 25 μM) can induce mitochondrial
alterations in mitochondria isolated from kidneys [52], indicating that αM effects are tissue- and
concentration-dependent. Although there are no clues regarding αM induced proliferation in normal
cells, we evaluated GRP94, an ER chaperon, with 4 μM αM and found can it induce proliferation at 24
h of incubation (data not show). GRP94 is a glycoprotein related to protein folding, stores of calcium
and targeting proteins to ER-associated degradation (ERAD), the client protein of GRP94 is related to
specialized functions in immunity, grown signaling, and cell adhesion [53]. Probably, GRP94 induction
207
Antioxidants 2019, 8, 133
in αM treatment can be related to grown signaling and cell adhesion, and this can explain this result,
but more experiments are necessary.
As we show in the integrative scheme (Figure 11) our results suggest that 30 μM CDDP-treatment
induces alterations in LCC-PK1 cells principally by reducing mitochondrial function and mass, which is
partially attributable to mitochondrial biogenesis reduction and mitophagy activation. αM can prevent
mitochondrial bioenergetics alterations and the induction of mitophagy. These mechanisms would be
involved in the protective effects observed in LLC-PK tubular cells.
Figure 11. Integrative scheme. CDDP induces (1) the increase MDA level, (2) decrease respiratory states
(except respiratory control, RC), the mitochondrial network fragmentation, the mitochondrial fusion
protein 2 (MNF2) decrease and induce mitophagy (PINK1/Parkin and p62 increase). Furthermore,
CDDP induces (3) TFAM reduction which reduces mitochondrial protein (VDAC and OXPHOS) and
probably mitochondrial transcription, and also induces an NRF1 increase. The αM prevented all
alterations, except NRF1 induction. Created with BioRender.com.
5. Conclusions
αM’s protective effects in CDDP-induced toxicity in LLC-PK1 are mostly attributable to
mitochondrial mass and function preservation.
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Abstract: The antioxidant activity and phenolic composition of the aerial part of Amaranthus caudatus
at seven stages of development were investigated. Total phenolic content, ABTS•+, DPPH•, and O2•−
scavenging activity, ferric-reducing antioxidant power (FRAP), and Fe2+ chelating ability were
evaluated. The phenolic profile was characterized by 17 compounds. Rutin was predominant in all
growth stages, although its content, similar to the quantity of other phenolics, changed during the
growth cycle. Flavonols were most abundant in the plants of early flowering and grain fill stages.
In contrast, the highest content of hydroxycinnamic acid derivatives was found in the early vegetative
stage. The results of antioxidant assays also showed significant differences among plant stages.
Generally, the lowest antioxidant activity was found in the shooting and budding stages. Significantly
higher activity was observed in amaranths in earlier (vegetative) and later (early flowering and grain
fill) stages, suggesting that plants in these stages are valuable sources of antioxidants.
Keywords: amaranth; morphological stage; scavenging activity; ferrous ions chelating ability;
reducing power; phenolic compounds; rutin; growth cycle
1. Introduction
Amaranth (Amaranthus spp.) is a gluten-free pseudocereal that is cultivated primarily in Mexico
and South America, but also thrives in all temperate-tropical areas of the world [1]. Moreover, in certain
regions of the world, such as eastern Africa, amaranth leaves are consumed as a vegetable because it is a
fast-growing plant available most of the year. There has been a renewed interest in this ancient and highly
nutritious food crop due to the excellent nutritional value of seed and leaves [2–4]. Both seeds and leaves
are rich sources of proteins, which constitute up to 15–43% and 14–30% of fresh matter (FM), respectively.
Amaranth proteins have a well-balanced amino acid composition [4], high bioavailability [3], and good
functional properties [5]. Dietary fiber, vitamins and precursors of vitamins (ascorbic acid, riboflavin,
tocols, carotenoids), as well as minerals (Ca, Fe, Mg, K, Cu, Zn, and Mn) are other important nutrients
present in seeds and leaves of amaranth. Their contents are high compared to these in some cereals and
green leafy vegetables [1,2,4]. Nutrient composition causes an increasing interest in amaranth as a food
ingredient, especially in the production of gluten-free products [6,7].
In addition to macro- and micronutrients, amaranth contains secondary plant metabolites,
which may play a significant role in the human diet due to their potential health beneficial effects [8].
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Considerable research has been conducted over the past years on phenolic compound profile of
amaranth seeds [8–11] and their functional and bioactive properties [12–15]. However, recent
findings confirmed that leaves and other aerial parts of Amaranthus also are important sources of
phenolic compounds [16–18]. Among phenolic compounds, those belonging to hydroxycinnamic
acids, benzoic acids, and flavonols and their glycosides were identified in amaranth leaves, flowers,
and stalks [18,19]. Steffensen et al. [20] found additional hydroxycinnamyl amides in aerial parts of
young plants. Phenolic compounds are well-known as antioxidants. Conforti et al. [21] showed that
amaranth leaf extracts contained phenolics, inhibited nitric oxide production, and scavenged free
radicals. The reducing potential and antioxidant activity in lipid systems of various parts of amaranth
shoot system were determined as well [16,19,22]. Other phytochemicals with antioxidant activity
which occur in amaranth are betalains, especially betacyanins [23]. The contents of these pigments vary
among Amaranthus species and genotypes [24]. If they are present in the plant, they are accumulated
mainly in seedlings, leaves, and inflorescences.
Although the phenolic compound and betacyanin profiles of individual botanical parts of amaranth
as well as their antioxidant potential are well-known, information about effects of the growth cycle
on these phytochemicals and their activity is still scarce. It is important to identify the changes in
antioxidant activity and phenolic compound composition by the growth stage of the amaranth.
In a previous paper [25], we reported the nutritive characteristics of A. caudatus, and in particular,
we evaluated the effects of plant aging on the chemical composition, gross energy, in vitro true
digestibility, neutral detergent fiber digestibility and fatty acid profile. However, to the best of our
knowledge, no research has been conducted to investigate the change of antioxidant activities and
phenolic composition of extracts of A. caudatus during plant growth. Barba de la Rosa et al. [26] stated
that the knowledge of Amaranthus spp. as a source of phytochemicals will increase their importance as
a potential source of antioxidant compounds in the human diet.
The aim of this study was to compare the antioxidant activity, TPC, and individual phenolic
compounds of A. caudatus during plant growth, to identify the ideal growing stage to achieve the
maximum antioxidant properties, and to optimize its use as a source of antioxidants for use in
food production.
2. Materials and Methods
2.1. Chemicals
The Folin-Ciocalteu phenol reagent (FCR), gallic acid, 2,2-diphenyl-1-picrylhydrazyl (DPPH),
2,2’-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), 2,4,6-tri(2-pyridyl)-s-triazine (TPTZ),
6-hydroxy-2,5,7,8-tetramethyl-chroman-2-carboxylic acid (Trolox), ferrozine, caffeic acid, quercetin,
p-coumaric acid, ferulic acid, rutin, and kaempferol-3-O-rutinoside were obtained from Sigma-Aldrich
(St. Louis, MO, USA). Methanol, acetonitrile, sodium carbonate, ferric chloride, ferrous chloride, ferrous
sulfate, and potassium persulfate were acquired from Avantor Performance Materials (Gliwice, Poland).
The ACL kit was purchased from Analytik Jena (Jena, Germany).
2.2. Plant Material
A. caudatus seeds were generously donated by Pedon S.p.A. (Molvena, Italy). The amaranth
stands were seeded in the spring in field trials (Department of Veterinary Science of the University
of Turin) located in Grugliasco, Piedmont, NW Italy (293 m a.s.l., 45◦03’57.9”N 7◦35’36.9”E), and no
irrigation or fertilizers were applied after sowing. The herbage samples were collected in the morning
after evaporation of dew and never collected on rainy days. Sampling was performed according to
Peiretti et al. [25] at seven progressive morphological stages from early vegetative to grain fill stage
from May to July 2014. Plants were cut to a 1–2 cm stubble height with edging shears from two replicate
2 m2 subplots randomly located in 2 × 7 m2 plots.
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2.3. Extraction
Plant samples were lyophilized (FreeZone Freeze Dry System, Labconco, Kansas City, MO, USA)
and ground. Three-gram portions of materials were suspended in 30 mL of 80% (v/v) methanol.
The closed bottles containing suspensions were shaken for 15 min in a water bath (SW22, Julabo,
Seelbach, Germany) at 65 ◦C. After filtration, the residues were extracted twice more. Combined filtrates
for each sample were dried by evaporation of methanol under vacuum at 50 ◦C (Rotavapor R-200,
Büchi Labortechnik, Flawil, Switzerland) and lyophilization of remaining water. Yield of extraction (%)
was calculated on the basis of weight of plant sample and dry extract.
2.4. Total Phenolic Content
The colorimetric reaction with FCR was carried out to determinate the total phenolic content
(TPC) [27]. The 0.25 mL of extract solution in methanol (1.25 mg/mL), 0.25 mL of FCR, 0.5 mL of
saturated sodium carbonate solution, and 4 mL of water were mixed. After 25 min, the reaction
mixtures were centrifuged (5 min, 5000× g, MPW-350R, MPW Med. Instruments, Warsaw, Poland),
and the absorbance of supernatants was measured at 725 nm (DU-7500 spectrophotometer, Beckman
Instruments, Fullerton, CA, USA). TPC was expressed as gallic acid equivalents (GAE) per g of extract
or per g of FM of plant.
2.5. Trolox Equivalent Antioxidant Capacity
The Trolox equivalent antioxidant capacity (TEAC) was determined according to the assay reported
by Re et al. [28]. ABTS•+ was generated and diluted as in the original description. Next, solutions
of ABTS•+ (2 mL) and amaranth extracts (20 μL with a concentration of 2.5 mg/mL) were vortexed
and heated at 30 ◦C (TH-24 block heater, Meditherm, Warsaw, Poland) within 6 min. After incubation,
absorbance was measured at 734 nm (DU-7500 spectrophotometer). The results were expressed as
μmol Trolox equivalents (TE) per g of extract or per g of FM of plant.
2.6. Ferric-Reducing Antioxidant Power
The Benzie and Strain method [29] was used to evaluate the ferric-reducing antioxidant power
(FRAP) of amaranth extracts. First, FRAP reagent was prepared. Next, the portions of 2.25 mL of this
reagent were mixed with 225 μL of water and 75 μL of aqueous solution of amaranth extracts (1 mg/mL).
Absorbance of mixtures was recorded at 593 nm after incubation at 37 ◦C for 30 min. FRAP results were
expressed as μmol Fe2+ equivalents per g of extract or per g of FM using the calibration curve for FeSO4.
2.7. Photochemiluminescence Assay
In the photochemiluminescence (PCL) assay, superoxide radical anions (O2•−) were generated
from luminol [30]. The antiradical activity against these radicals was determined using the ACL
(antioxidant capacity of lipid-soluble substances) kit (Analytik Jena, Jena, Germany). The amaranth
extracts were dissolved in methanol to a concentration of 0.25 mg/mL. The portions of 10 μL of solutions
were mixed with 2.3 mL of methanol (reagent 1), 200 μL of buffer solution (reagent 2), and 25 μL of
luminol (reagent 3). The Photochem device (Analytik Jena) supported by PCLsoft software was used
to perform reactions and calculate the results, which were expressed as μmol of Trolox equivalents
(TE) per g of extract or per g of FM of plant.
2.8. Fe2+ Chelating Ability
The ability of amaranth extracts to chelate ferrous ions was determined by a method with
ferrozine [31] that was modified to be performed with multi-well plates [32]. Extract solution in
water (0.25 mg/mL), 0.4 mM FeCl2 × 4H2O and 5 mM ferrozine were mixed in a ratio of 10:1:2 (v/v/v).
After 10 min, absorbance was measured at 562 nm using an Infinite M1000 microplate reader (Tecan,
Männedorf, Switzerland). The chelating ability was expressed as percentage of Fe2+ bound.
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2.9. Scavenging of the DPPH Radicals
The DPPH• scavenging activity of amaranth extracts was evaluated by the method of
Brand-Williams et al. [33]. Extract solutions in methanol over a range of concentrations from
2–10 mg/mL were prepared. To 100 μL of these solutions, 0.25 mL of 1 mM DPPH and 2 mL of
methanol were added. After 20 min, absorbance of the mixtures was read at 517 nm. The curves of
absorbance values vs. concentration of samples (mg/assay) were plotted. Additionally, EC50 values
defined as concentration of extract (mg/mL reaction mixture) needed to scavenge the 50% of initial
DPPH• were evaluated.
2.10. Analysis of Phenolic Compounds
The HPLC-DAD Shimadzu system (Shimadzu, Kioto, Japan), which consisted of a CBM-20A
controller, DGU-20A5R degassing unit, two LC-30AD pumps, SIL-30AC autosampler, SPD-M30A diode
array detector (DAD), and CTO-20AC oven, was used to analyze the phenolic compound of the amaranth
extracts. Extracts dissolved in 80% (v/v) methanol were injected (10 μL) into a Luna C8(2) (4.6 × 150 mm,
particle size 3 μm, Phenomenex, Torrance, CA, USA) column [34]. The mobile phase consisted of
solvents A (acetonitrile-water-trifluoroacetic acid, 5:95:0.1, v/v/v) and B (acetonitrile-trifluoroacetic
acid, 100:0.1, v/v): From 0–16 min, the eluent composition was changed from 0–24% B. The flow rate
was 1 mL/min. The oven temperature was 25 ◦C and detector wavelength ranged from 200 to 600
nm. The content of individual phenolic compounds in the extracts was expressed on the basis of a
calibration curve of the corresponding standards or structurally related substances.
For identification of extract compounds, HPLC-MS/MS analysis was carried out using a liquid
chromatography (LC) system coupled with a quadrupole ion trap mass spectrometer (QTRAP®
5500 LC-MS/MS System, AB Sciex, Framingham, MA, USA). Operating MS/MS conditions were the
following: Nitrogen curtain gas flow rate of 25 L/min, collision gas glow rate of 9 L/min, ion spray
source voltage of −4.5 kV, temperature of 350 ◦C, nebulizer gas flow rate of 35 L/min, and turbo
gas flow rate of 30 L/min. Negative-mode of electrospray ionization (ESI–) was used. Qualification
was based on multiple reaction monitoring (MRM) of selected ion pairs in the first quadrupole (Q1)
and third quadrupole (Q3). The presence of compounds previously identified in aerial parts of
amaranth [10,18–20,35] were verified.
2.11. Statistical Analysisl
The plant growth experiment was carried out in duplicate. Antioxidant assays and HPLC-DAD
separations were performed for at least three repetitions. All results were presented as means ±
standard deviations (SD). Significance of differences among mean values were estimated by one-way
ANOVA and Fisher’s LSD test at a level of p < 0.05 (GraphPad Prism; GraphPad Software, San Diego,
CA, USA). Principal component analysis (PCA) allowed examination of the relationships between
TPC, individual phenolic compound contents and values of antioxidant assays obtained for amaranth
at different growth stages.
3. Results and Discussion
3.1. Total Phenolic Content
The extraction yield and TPC of the aerial parts of amaranth at different growth stages, expressed
on the basis of both extract and fresh matter, are reported in Table 1. The extraction yield did not
differ statistically (p ≥ 0.05) for plants in vegetative, shooting and budding stages, while lower values
were recorded for early flowering and grain fill stages of amaranth. The TPC ranged from 18.3 to
33.7 mg GAE/g extract. TPC expressed on the basis of plant fresh matter was in the range of 0.68 to
1.11 mg/g. The highest values were observed in the earliest (early and medium vegetative) and the
oldest (early flowering and grain fill) stages of plant. The lowest TPC was noted for extracts obtained
from the shooting and budding stages. Li et al. [19] compared phenolic contents of different botanical
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parts of three Amaranthus species (A. hypochondriacus, A. caudatus, and A. cruentus) and found that
the leaves had the highest TPC while the seeds and stalks contained the lowest. Therefore, in our
study, the high TPC levels found in the amaranth of vegetative stages could be related to the major
proportion of leaves with respect to stalks present in these plant growth stages compared to the others.
A similar trend was reported in other pseudocereals, such as quinoa [36], as well as soybean [32],
where authors found that extracts obtained from the early and late vegetative stages were characterized
by the highest TPC. The TPC of amaranth extract of early flowering stage plants presented in Table 1
was in agreement with those reported for methanol-water and acetone extracts from separate leaves
(24.8–32.3 mg GAE/g extract) and flowers (27.2–33.3 mg GAE/g extract) collected from a flowering stage
of A. hybridus [16]. In turn, higher TPC (2.9 mg GAE/g FM) was noted for the five-week-old A. caudatus
leaves [26] corresponding to an intermediate between early and medium vegetative stages in our study.
Table 1. Yield of extraction and total phenolic content (TPC) of the amaranth extract and fresh matter







mg GAE/g Extract mg GAE/g FM
Early vegetative 34 24.3 ± 0.3 ab 33.7 ± 4.5 a 0.94 ± 0.14 abc
Medium vegetative 41 26.3 ± 3.2 a 31.1 ± 3.5 ab 1.04 ± 0.05 ab
Late vegetative 55 27.4 ± 0.6 a 27.9 ± 0.4 b 0.81 ± 0.03 bcd
Shooting 62 26.7 ± 0.5 a 18.6 ± 2.9 c 0.68 ± 0.16 d
Budding 69 26.6 ± 0.4 a 18.3 ± 3.4 c 0.71 ± 0.15 cd
Early flowering 74 22.7 ± 0.5 bc 27.4 ± 0.6 ab 1.11 ± 0.03 a
Grain fill 78 20.3 ± 1.7 c 27.3 ± 3.5 ab 0.88 ± 0.07 abc
GAE, gallic acid equivalents. abcd Means with the different lowercase letters in the same column are significantly
different (p < 0.05).
3.2. Antioxidant Activity
The antioxidant activity of amaranth samples of each growth stage was determined as radical
scavenging activity (TEAC, PCL-ACL, and DPPH assay) and ability to reduce Fe3+ to Fe2+ (FRAP).
Additionally, Fe2+ chelating ability of extracts was determined because phenolic compounds form
stable complexes with ferrous ions, and in this way, decrease the extent of free ions to Fenton’s reaction
in which highly reactive •OH are generated [31]. The results of antioxidant activity are presented in
Table 2 and Figures 1 and 2. The significantly higher TEAC was recorded for amaranth in vegetative,
early flowering and grain fill stages as opposed to in shooting and budding stages (p < 0.05), both when
results were expressed on the basis of extract and fresh matter of plant. The FRAP ranged from 469 to
830 μmol Fe2+/g extract with the highest value observed for the early vegetative stage and the lowest,
again, for the shooting and budding stages of the plant. The FRAP expressed on plant fresh matter
basis was less varied between amaranth growth stages (17.4–24.6 μmol Fe2+/g). The PCL-ACL ranged
from 422 to 858 μmol TE/g extract and from 16.5 to 23.9 μmol TE/g FM, respectively. For both types
of PCL-ACL expression, amaranth in vegetative stages had significantly higher activity compared to
plants in subsequent morphological states (p < 0.05). In turn, the Fe2+ chelating ability of extracts
ranged from 16.1—19.9% for late vegetative and shooting stages to 37.5% for the medium vegetative
stage (Figure 1). The changes of antiradical activity against DPPH• of amaranth extracts with increasing
assay content as well as the EC50 values, are presented in Figure 2. The DPPH• scavenging activity
expressed as EC50 showed significant differences between certain growth stages of amaranth (p < 0.05).
The highest antiradical activity was obtained for extracts from plants in the early flowering and grain
fill stages with the lowest EC50 value. The highest EC50 values (294–317 μg/mL), which did not differ
statistically from each other (p ≥ 0.05), were found for late vegetative, shooting, and budding stages.
To the best of our knowledge, the changes of antioxidant activity of amaranth aerial parts during
the growth cycle have not been previously demonstrated, although the differences in the antioxidant
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potential of various morphological parts of the plant were shown [16,19,37]. In general, FRAP, DPPH•,
or ABTS•+ scavenging capacity decreased in this order: Leaves ≥ flowers >> stem > seeds. Among some
amaranth species, this relationship was demonstrated for A. caudatus [19]. It is known that environmental
factors, such as light and temperature, also play an important role in amaranth antioxidant metabolism.
Khandaker et al. [38] found that the antioxidant activity of leaves of red amaranth (A. tricolor) was
higher under full sunlight intensity than under dark conditions. Modi [39] studied the effect of growth
temperature on yield, nutritional value, and antioxidant activity of the leaves of five Amaranthus spp.
(A. hybridus var. cruentus, A. hypochondriacus, A. tricolor, A. thunbergii, and A. hybridus) harvested at 20, 40,
and 60 days after sowing and found significant differences between growth temperature and stage of
development. Authors concluded that for greater nutritional benefit, Amaranthus should be grown under
warm conditions and that younger leaves are preferable. The maximum antioxidant activity, independent
of the temperature and species considered, was found in leaves after 60 days of sowing, corresponding to
an intermediate stage between late vegetative and shooting found in our study.
Figure 1. Fe2+ chelating ability of the amaranth extracts. EV, early vegetative; MV, medium vegetative;
LV, late vegetative; S, shooting; B, budding; EF, early flowering; GF, grain fill. Different letters above
bars indicate significant differences among means (p < 0.05).
 
Figure 2. DPPH• scavenging activity of the amaranth extracts. EV, early vegetative; MV, medium
vegetative; LV, late vegetative; S, shooting; B, budding; EF, early flowering; GF, grain fill. Different
letters above bars indicate significant differences among means (p < 0.05).
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Early vegetative 259 ± 27 ab 7.23 ± 0.91 bc 830 ± 27 a 23.1 ± 1.3 ab 858 ± 24 a 23.9 ± 1.2 a
Medium vegetative 283 ± 27 a 9.52 ± 0.34 a 665 ± 83 b 22.3 ± 1.5 ab 698 ± 43 b 23.6 ± 2.8 a
Late vegetative 272 ± 18 ab 8.58 ± 0.38 ab 648 ± 25 b 20.4 ± 1.2 abc 681 ± 42 b 21.5 ± 1.8 ab
Shooting 176 ± 6.0 c 6.44 ± 0.69 c 475 ± 31 c 17.4 ± 2.4 c 486 ± 3.9 cd 17.8 ± 1.4 bc
Budding 171 ± 8.1 c 6.67 ± 0.53 c 469 ± 75 c 18.3 ± 3.5 bc 422 ± 43 d 16.5 ± 2.2 c
Early flowering 218 ± 23 bc 8.83 ± 0.87 ab 606 ± 15 bc 24.6 ± 0.4 a 483 ± 20 cd 19.6 ± 0.7 bc
Grain fill 236 ± 45 ab 7.62 ± 1.13 bc 640 ± 112 b 20.7 ± 2.7 abc 558 ± 34 c 18.1 ± 0.3 bc
TEAC, Trolox equivalent (TE) antioxidant capacity; FRAP, ferric-reducing antioxidant power; PCL-ACL,
photochemiluminescence-antioxidant capacity of lipid-soluble substances. abcd Means with the different lowercase
letters in the same column are significantly different (p < 0.05).
3.3. Phenolic Compound Profile
The HPLC-DAD analysis showed that the phenolic profile was characterized by 17 compounds
(Figure 3). The absorption maxima of UV-Vis spectra of compounds and MRM Q1/Q3 ion pairs used
for their identification are listed in Table 3. Compounds 10, 13, and 17 were identified as caffeic acid,
rutin, and kaempferol-3-O-rutinoside, respectively, by comparison with standards. Their presence
in the extracts was confirmed by HPLC-MS/MS analysis. This analysis allowed also showing the
presence of twelve hydroxycinnamic acids (1–12) and quercetin glucoside (15) in the extracts. Two other
compounds (14 and 16) were tentatively identified as hydroxycinnamic acid derivatives based on
the shape of UV spectra with maxima absorption at 315–329 nm and a shoulder at the shorter
wavelength [34]. Most of the identified compounds (caffeic acid, caffeoyl-, coumaroyl- and feruloyl-
glucaric isomers, feruloyl- and caffeoyl- quinic acids, rutin, kaempferol-3-O-rutinoside, and quercetin
glucoside) were detected previously in leaves, seeds, and other aerial parts of A. caudatus [10,18–20].
Coumaroylquinic acids were found in stems of A. spinosus [35]. In turn, the free phenolic acids, such as,
ferulic, p-coumaric, p-hydroxybenzoic, vanillic, sinapic, gallic, and protocatechuic acids, as well as
betacyanins, were not identified in amaranth in the present study, although, according to literature
data, they were determined in leaves, flowers, stalks and seeds of A. caudatus [10,11,19,40]. The lack of
identification of betacyanins in our samples probably results from the selection of the betacyanin-free
A. caudatus genotype for experiments.
Figure 3. HPLC-DAD chromatogram of the phenolic compounds present in the amaranth extract.
219
Antioxidants 2019, 8, 173









1 4.80 301sh;327 371/209; 371/173 Caffeoylglucaric acid 1
2 5.52 301sh;327 371/209; 371/173 Caffeoylglucaric acid 2
3 5.75 302sh; 327 371/209; 371/173 Caffeoylglucaric acid 3
4 6.31 302sh; 328 371/209; 371/173 Caffeoylglucaric acid 4
5 6.54 303sh; 328 371/209; 371/173 Caffeoylglucaric acid 5
6 6.95 304sh; 327 371/191; 371/209 Coumaroylglucaric acid 1
7 7.47 304sh; 327 371/191; 371/209 Coumaroylglucaric acid 2
8 8.18 299sh; 326 385/191; 385/209 Feruloylglucaric acid
9 8.84 303sh; 327 353/191; 353/173 Caffeoylquinic acid
10 9.78 296sh; 324 179/135; 179/107 Caffeic acid
11 9.93 301sh; 314 337/173; 337/155 Coumaroylquinic acid
12 11.21 304sh; 329 367/173; 367/155 Feruloylquinic acid
13 12.75 256, 354 609/301; 609/463 Rutin
14 13.32 302sh; 315 - Hydroxycinnamic acid derivative
15 13.49 256, 354 463/301 Quercetin glucoside
16 13.95 303sh; 329 - Hydroxycinnamic acid derivative
17 14.40 265; 348 593/285 Kaempferol-3-O-rutinoside
1 Compound number corresponds to peak number in Figure 3. 2 Retention time (tR) of HPLC-DAD separation. 3
Maximum absorption (λmax) of UV-Vis spectrum in HPLC-DAD analysis. 4 Ion pair of multiple reaction monitoring
(MRM) of HPLC-MS/MS analysis.
The contents of individual phenolic compounds (1–16) in different growth stages of amaranth,
expressed both per gram of extract and per gram of fresh matter of plant, are presented in Tables 4
and 5, respectively. Compound 17 (kaempferol-3-O-rutinoside) was not quantified because its content
in the samples was very low (< 1 μg/g FM). The predominant compound in all samples was rutin
(15.0–36.2 mg/g extract; 418–1169 μg/g FM), and its content consisted of approximately 95% of the
sum of flavonols. Compounds 11 and 16 were the most abundant hydroxycinnamic acid derivatives.
The huge amount of rutin in comparison with other phenolic compounds was in line with literature
data on aerial components, especially leaves, of different species of amaranth [19,20,41]. In turn,
high content of hydroxycinnamic acid derivatives with very high quantity of caffeic acid derivatives
was found by Neugart et al. [18] in A. cruentus leaves. These authors reported a 3.3–3.4-fold higher
content of caffeic acid derivatives than quercetin glycosides in leaves harvested at the 8-12 leaf stage.
In our study, the content of hydroxycinnamic acid derivatives predominated over the quantity of
flavonols in the early vegetative stage, but with a lower difference between values (718 vs. 439 μg/g
FM). Plant growth stage significantly affected the amount of individual phenolic compounds (Tables 4
and 5). The rutin content (and sum of flavonols) increased for subsequent growth stages of plant, and
the highest value was measured in early flowering and grain fill stages at the same level (p ≥ 0.05).
Interestingly, on the contrary, the sum of hydroxycinnamic acid derivatives was found to be the highest
in amaranth of the early vegetative stage, and this value decreased with age of amaranth for values
expressed both on the basis of extract and fresh matter of plant. Our observation regarding the changes
of rutin content during the amaranth growth cycle confirmed the trends previous reported by Kalinova
and Dadakova [42]. These authors determined the rutin contents in leaves, flowers, stems, and seeds of
six Amaranthus spp. (A. caudatus, A. hypochondriacus, A. hybrid, A. retroflexus, A. cruentus, and A. tricolor)
and found that the rutin content in leaves was related to the developmental stage of the crop and that
it usually increased with plant aging.
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3.4. Principal Component Analysis
The PCA was carried out to clarify the relationship between the different growth stages of
amaranth aerial parts and the evaluated variables. The data set obtained for 16 phenolic compounds,
five antioxidant assays, and TPC with respect to seven growth stages was subjected to PCA. The results
are presented in Figure 4. The first two principal components (PC1 and PC2) significantly explained
most of the variations–87.08% of the total variance. The clustering of growth stages with three separate
groups: 1–vegetative stages (early, medium, and late vegetative), 2–shooting and budding stages, and
3–early flowering and grain fill stages was obtained as shown in plot A (Figure 4). The variables that
were differentiating distribution of each growth stage were depicted in plot B (Figure 4). The early,
medium, and late vegetative stages were associated with the most antioxidant assays: TEAC, FRAP,
PCL-ACL, and Fe2+ chelating ability. The TPC and content of some hydroxycinnamic acid derivatives
(compounds 1–5, 7, 10–12, 14, and 16) also affected this group of stages. In turn, the third group of
growth stages (early flowering and grain fill) was clearly related to content of flavonols and three
remaining hydroxycinnamic acid derivatives (compounds 6, 8, and 9). The DPPH assay was negatively
correlated with other antioxidant activity assays because the EC50 values were used in PCA. In the plot,
the DPPH assay influenced the distribution of shooting and budding stages due to their low DPPH•
scavenging activity with high EC50 values.
Figure 4. Principal component analysis (PCA) plots of the data set of variables: Total phenolic content
(TPC), individual phenolic compound (1–16), and antioxidant assays obtained for amaranth in different
growth stages. EV, early vegetative; MV, medium vegetative; LV, late vegetative; S, shooting; B, budding;
EF, early flowering; GF, grain fill; TEAC, Trolox equivalent antioxidant capacity; FRAP, ferric-reducing
antioxidant power; PCL-ACL, antioxidant capacity in photochemiluminescence assay; CHEL, Fe2+
chelating ability. (A): Distribution of growth stages, (B): Distribution of variables.
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4. Conclusions
Comparison of antioxidant activity and phenolic composition of the aerial parts of A. caudatus
showed growth cycle dependent effects. The amaranth in shooting and budding stages had the
lowest antioxidant activity and the lowest total phenolic content. The earlier (vegetative) and
later (early flowering and grain fill) stages formed two groups, both with high antioxidant activity,
though with differing dominant classes of phenolic compounds. The content of flavonols (mainly rutin)
increased with growth cycle, and these compounds could be primarily responsible for the antioxidant
activity of amaranth in early flowering and grain fill stages. In plants in vegetative stages, especially
the early vegetative stage, the participation of hydroxycinnamic acid derivatives in the pool of phenolic
compounds was high. The contribution of these compounds to high antioxidant activity of amaranth
in vegetative stages seemed significant. It is worth noting the predominance of rutin quantity among
individual phenolic compounds in all A. caudatus growth states, as well as its increasing content during
the growth cycle.
The extracts obtained from amaranth in vegetative, early flowering, and grain fill stages, due to their
high content of hydroxycinnamic acid derivatives and rutin, can be a valuable source of antioxidants
that can be exploited for the production of nutraceuticals or used as a functional food ingredient.
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16. Kraujalis, P.; Venskutonis, P.R.; Kraujalienė, V.; Pukalskas, A. Antioxidant properties and preliminary
evaluation of phytochemical composition of different anatomical parts of amaranth. Plant Foods Hum. Nutr.
2013, 68, 322–328. [CrossRef] [PubMed]
17. Jiménez-Aguilar, D.M.; Grusak, M.A. Minerals, vitamin C, phenolics, flavonoids and antioxidant activity of
Amaranthus leafy vegetables. J. Food Compos. Anal. 2017, 58, 33–39. [CrossRef]
18. Neugart, S.; Baldermann, S.; Ngwene, B.; Wesong, J.; Schreiner, M. Indigenous leafy vegetables of Eastern
Africa—A source of extraordinary secondary plant metabolites. Food Res. Int. 2017, 100, 411–422. [CrossRef]
19. Li, H.; Deng, Z.; Liu, R.; Zhu, H.; Draves, J.; Marcone, M.; Sun, Y.; Tsao, R. Characterization of phenolics,
betacyanins and antioxidant activities of the seed, leaf, sprout, flower and stalk extracts of three Amaranthus
species. J. Food Compos. Anal. 2015, 37, 75–81. [CrossRef]
20. Steffensen, S.K.; Pedersen, H.A.; Labouriau, R.; Mortensen, A.G.; Laursen, B.; de Troiani, R.M.;
Noellemeyer, E.J.; Janovska, D.; Stavelikova, H.; Taberner, A.; et al. Variation of polyphenols and betaines
in aerial parts of young, field-grown Amaranthus genotypes. J. Agric. Food Chem. 2011, 59, 12073–12082.
[CrossRef]
21. Conforti, F.; Marrelli, M.; Carmela, C.; Menichini, F.; Valentina, P.; Uzunov, D.; Statti, G.A.; Duez, P.;
Menichini, F. Bioactive phytonutrients (omega fatty acids, tocopherols, polyphenols), in vitro inhibition of
nitric oxide production and free radical scavenging activity of non-cultivated Mediterranean vegetables.
Food Chem. 2011, 129, 1413–1419. [CrossRef]
22. Ozsoy, N.; Yilmaz, T.; Kurt, O.; Can, A.; Yanardag, R. In vitro antioxidant activity of Amaranthus lividus L.
Food Chem. 2009, 116, 867–872. [CrossRef]
23. Miguel, M.G. Betalains in some species of the Amaranthaceae family: A review. Antioxidants 2018, 7, 53.
[CrossRef] [PubMed]
24. Cai, Y.; Sun, M.; Wu, H.; Huang, R.; Corke, H. Characterization and quantification of betacyanin pigments
from diverse Amaranthus species. J. Agric. Food Chem. 1998, 46, 2063–2070. [CrossRef]
25. Peiretti, P.G.; Meineri, G.; Longato, E.; Tassone, S. Chemical composition, in vitro digestibility and fatty acid
profile of Amaranthus caudatus herbage during its growth cycle. Anim. Nutr. Feed Technol. 2018, 18, 107–116.
[CrossRef]
26. Barba de la Rosa, A.P.; Fomsgaard, I.S.; Laursen, B.; Mortensen, A.G.; Olvera-Martínez, L.; Silva-Sánchez, C.;
Mendoza-Herrera, A.; González-Castañeda, J.; De León-Rodrígueza, A. Amaranth (Amaranthus
hypochondriacus) as an alternative crop for sustainable food production: Phenolic acids and flavonoids with
potential impact on its nutraceutical quality. J. Cereal Sci. 2009, 49, 117–121. [CrossRef]
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Abstract: Purslane (Portulaca oleraceae L.) is a widespread weed, which is highly appreciated for its
high nutritional value with particular reference to the content in omega-3 fatty acids. In the present
study, the nutritional value and chemical composition of purslane plants in relation to plant part
and harvesting stage were evaluated. Plants were harvested at three growth stages (29, 43 and 52
days after sowing (DAS)), while the edible aerial parts were separated into stems and leaves. Leaves
contained higher amounts of macronutrients than stems, especially at 52 DAS. α-tocopherol was the
main isoform, which increased at 52 DAS, as well total tocopherols (values were in the ranges of
197–327 μg/100 g fresh weight (fw) and 302–481 μg/100 g fw, for α-tocopherol and total tocopherols,
respectively). Glucose and fructose were the main free sugars in stems and leaves, respectively,
whereas stems contained higher amounts of total sugars (values were ranged between 0.83 g and
1.28 g/100 g fw). Oxalic and total organic acid content was higher in leaves, especially at the last
harvesting stage (52 DAS; 8.6 g and 30.3 g/100 g fw for oxalic acid and total organic acids, respectively).
Regarding the fatty acid content, stems contained mainly palmitic (20.2–21.8%) and linoleic acid
(23.02–27.11%), while leaves were abundant in α-linolenic acid (35.4–54.92%). Oleracein A and C
were the major oleracein derivatives in leaves, regardless of the harvesting stage (values were in the
ranges of 8.2–103.0 mg and 21.2–143 mg/100 g dried weight (dw) for oleraceins A and C, respectively).
Cytotoxicity assays showed no hepatotoxicity, with GI50 values being higher than 400 μg/mL for all
the harvesting stages and plant parts. In conclusion, early harvesting and the separation of plant parts
could increase the nutritional value of the final product through increasing the content of valuable
compounds, such as omega-3 fatty acids, phenolic compounds and oleracein derivatives, while at the
same time, the contents of anti-nutritional compounds such as oxalic acid are reduced.
Keywords: α-linolenic acid; fatty acids; hepatotoxicity; omega-3 fatty acids; Portulaca oleraceae;
phenolic compounds; oleracein derivatives; purslane; tocopherols
1. Introduction
Purslane (Portulaca oleracea L.) is a widespread weed belonging to the Portulacaceae family,
with extensive distribution throughout the world [1]. It is also a basic component of the so-called
Mediterranean diet and an ingredient of many salad dishes [2]. Although it is considered a very
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invasive weed [3], it is also highly appreciated for the high nutritional value of its edible plant parts,
due to their high content in omega-3 fatty acids and, particularly, in α-linolenic acid [4]. Other valuable
components of purslane edible parts include minerals, such as calcium, potassium and phosphorus,
macronutrients such as proteins and carbohydrates [5], as well as tocopherols, carotenoids and ascorbic
acid [6,7]. Moreover, phenolic compounds and oleracein derivatives of extracts of purslane leaves have
been attributed with antioxidant properties [8], while their content may be affected by cooking and
food additives [9]. P. oleracea is tolerant under stress conditions, such as heat, drought and salinity
stress, a trait that could be useful within the ongoing climate change context and provide alternative
solutions to farmers in climate-affected regions [10].
Several studies have reported the effects of cultivation practices, growing conditions and genetic
factors on the chemical composition of purslane. In particular, Rahdari et al. [11], Uddin et al. [12]
and Teixeira and Carvalho [13] reported that salinity stress may significantly affect proximate and
mineral composition, while salinity stress also has an impact on polyphenol and carotenoid content and
antioxidant activity [14]. Genetic material is also important for obtaining edible parts of high nutritional
value, since many studies have suggested significant differences in the chemical compositions of
purslane accessions and genotypes, especially regarding fatty acid and oxalic acid content [6,15] and
bioactive properties [16]. Cultivation practices such as planting date or fertilization rates can also
be proven as useful means towards the modulation of the chemical composition of purslane edible
parts [17,18]. In addition, cultivation systems may affect the nutritional value of purslane aerial parts,
with soilless culture showing promising results in regards to improving fatty acid composition and
decreasing oxalic acid content [19]. High oxalic acid content is considered as an antinutrient factor,
and apart from cultivation systems, the proper harvesting stage and cultivar selection, as well as
the modulation of nutrient solution composition may also be helpful in decreasing its content and
increasing the overall nutritional value of purslane edible parts [15,20]. Harvesting stage and plant
parts also have a significant impact on macronutrients (total solids, proteins, ash, and carbohydrates)
and mineral content [5], as well as on phenolic compounds, oleracein derivatives and organic acid
profile [4].
The aim of the present work was to study the effect of harvesting stage on the chemical composition
of purslane edible parts, as well as the distribution of the main nutrient components and phytochemicals
within the aerial parts of the plant (leaves and stems). Considering the importance of omega-3 fatty
acids and oxalic acid for purslane’s nutritional value, special attention was given to oxalic acid and
fatty acid content, along with the plant part selection and harvesting stage, which could be used as
simple cultivation practices to increase the nutritional and added value of the final product. Finally,
the characterization of phenolic compounds and oleracein derivatives in the aerial plant parts (leaves
and stems) in relation to harvesting stage was also performed.
2. Materials and Methods
2.1. Plant Material and Growing Conditions
This trial was carried out at the experimental field of the University of Thessaly, in Larissa
(Greece; 39◦37’18.6” N, 22◦22’55.1” E), during the summer of 2016. Seeds of common purslane
(Portulaca oleracea L.) were obtained from Hortus Sementi Srl. (Budrio, Italy) and were sown directly
in soil on 06/06/2016. Prior to sowing, a base dressing of 100 kg/ha with 10-10-10 fertilizer (N-P-K)
was applied. Irrigation was applied with sprinklers at regular intervals (once a week, starting on
the day of sowing). The soil was sandy clay loam (38% sand, 36% silt, and 26% clay), with pH = 7.4
(1:1 soil/H20) and organic matter content = 1.3%. No pesticides or other agrochemicals were applied
during cultivation. Harvesting took place at three different growth stages, namely on 05/07/2016
(29 days after sowing (DAS)), on 19/07/2016 (43 DAS), and on 28/07/2016 (52 DAS).
After each harvesting stage, the aerial plant parts were divided in stems and leaves. Fresh samples
of plant tissues were placed in a forced-air oven, and dry weight was recorded after drying the samples
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at 70 ◦C until constant weight. Batch samples of fresh plant tissues were stored at −80 ◦C and were
then lyophilized. The lyophilized samples were ground to powder with a pestle and mortar, and were
put in plastic air-sealed bags and stored at −80 ◦C until further analysis.
For phenolic and oleracein composition, as also for cytotoxicity, a hydroethanolic extract was
prepared using 1 g of dried sample with 30 mL ethanol/water (80:20 v/v), under magnetic stirring for
1 h. After filtration through a Whatman filter paper N◦. 4, the plant residue was re-extracted and the
combined filtrates were evaporated at 40 ◦C (rotary evaporator Büchi R-210, Flawil, Switzerland) and
subsequently lyophilized to obtain a dry extract.
2.2. Chemical Analyses
2.2.1. Standards and Reagents
Acetonitrile 99.9% of HPLC grade was from Fisher Scientific (Lisbon, Portugal). Ellipticine was
purchased from Sigma-Aldrich (St. Louis, MO, USA), as also were acetic acid, sulforhodamine B
(SRB), trypan blue, trichloroacetic acid (TCA), and Tris-(hydroxymethyl)aminomethan (TRIS). Phenolic
compound standards were from Extrasynthèse (Genay, France). RPMI-1640 medium, fetal bovine
serum (FBS), Hank’s balanced salt solution (HBSS), l-glutamine, nonessential amino acids solution
(2 mM), penicillin/streptomycin solution (100 U/mL and 100 mg/mL, respectively), and trypsin-EDTA
(ethylenediaminetetraacetic acid) were from Hyclone (Logan, UT, USA). All other chemicals were of
analytical purity and obtained from common suppliers. Water was treated via the purification system
Milli-Q water (TGI Pure Water Systems, Greenville, SC, USA).
2.2.2. Nutritional Compounds and Energetic Value
Nutritional compounds of the samples were analyzed (moisture, fat, ash, proteins and
carbohydrates) following the Association of Analytical Communities (AOAC) procedures [21]. Briefly,
moisture content was determined using an air oven at 105 ± 5 ◦C until constant weight. Crude protein
was evaluated by the macro-Kjeldahl method (N × 6.25) using an automatic distillation and titration
unit (model Pro-Nitro-A, JP Selecta, Barcelona, Spain), ash content was determined by incineration at
600 ± 15 ◦C, and the crude fat was determined by extraction with petroleum ether using a Soxhlet
apparatus (Behr Labor Technik, Dusseldorf, Germany). Total carbohydrates were determined by the
difference according to the equation: total carbohydrates (g/100 g fresh weight (fw)) = 100 − (g moisture
+ g fat + g ash + g proteins).
Energy was determined according to the Atwater system following the equation: (kcal/100 g fw)
= 4 × (g proteins + g carbohydrates) + 9 × (g fat).
2.2.3. Tocopherols
Tocopherols were determined in the lyophilized samples following a procedure previously
described by Dias et al. [22]. The separation of compounds was performed using a high performance
liquid chromatography system (Knauer, Smartline system 1000, Berlin, Germany) coupled to a
fluorescence detector (FP-2020; Jasco, Easton, PA, USA) programmed for excitation at 290 nm and
emission at 330 nm, using the internal standard (IS; tocol, Matreya, Pleasant Gap, PA, USA) method
for quantification. After separation, the compounds were identified by comparison with authentic
standards. The quantification was based on the fluorescence signal response of each standard, using
the internal standard method. The results were expressed in μg per 100 g of fresh weight (fw).
2.2.4. Free Sugars
The lyophilized samples were extracted using a methodology previously described by the
authors [23]. The separation of compounds was performed using a HPLC system (Knauer, Smartline
system 1000, Berlin, Germany) coupled with a refraction index detector (Knauer Smartline 2300).
The mobile phase consisted of an acetonitrile:water mixture (70:30 v/v, acetonitrile HPLC-grade,
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Lab-Scan, Lisbon, Portugal), and separation was achieved using a Eurospher 100-5 NH2 column
(4.6 × 250 mm, 5 μm, Knauer, Berlin, Germany). After separation, the compounds were identified by
comparison with standards and quantification was performed by the IS method (melezitose). Results
were processed using the Clarity 2.4 software (DataApex, Prague, Czech Republic) and expressed in g
per 100 g of fw.
2.2.5. Organic Acids
The lyophilized samples were extracted using a methodology previously described and optimized
by the authors [23]. The analysis was performed by Ultra-Fast Liquid Chromatography coupled with a
Diode-Array Detector (UFLC-DAD; Shimadzu 20A series UFLC, Shimadzu Corporation, Kyoto, Japan).
Compounds were identified and quantified by comparison of the retention time, spectra and peak
area, recorded at 215 nm, with those obtained from commercial standards. The results were recorded
and processed using LabSolutions Multi LC-PDA software (Shimadzu Corporation, Kyoto, Japan) and
were expressed in g/100 g fw.
2.2.6. Fatty Acids
Fatty acids were determined by gas-liquid chromatography with flame ionization detection
(GC-FID; DANI1000, Contone, Switzerland), after the extraction and derivatization procedures
previously described by Obodai et al. [24]. Fatty acid identification and quantification were performed
by comparing the relative retention times of fatty acid methyl ester (FAME) peaks of the tested
samples with commercial standards (fatty acid methyl esters (FAMEs) reference standard mixture
37, Sigma-Aldrich, St. Louis, MO, USA). Results were expressed as the relative percentage for each
detected fatty acid, using CSW 1.7 software (Data Apex 1.7, Prague, Czech Republic).
2.2.7. Phenolic Compounds and Oleracein Derivatives
Phenolic compounds and oleracein derivatives were evaluated using an ultra-performance liquid
chromatography (UPLC) system equipped with a diode array detector (280 nm, 330 nm and 370 nm
as preferred wavelengths) coupled to an electrospray ionization mass spectrometry detector (MS)
(Dionex Ultimate 3000 UPLC and Linear Ion Trap LTQ XL, Thermo Scientific, San Jose, CA, USA),
operating under the conditions described by Bessada et al. [25]. Data acquisition was carried out
with the Xcalibur® data system. The identification was made by comparison of retention times,
UV-VIS and mass spectra of the sample compounds with those obtained from the available standards,
as also with reported data from the literature, and tentatively identified by using the fragmentation
pattern. The estimation of phenolic compounds and oleracein derivatives was carried out using the
calibration curves obtained from standards, which were constructed based on their UV-VIS signals; the
quantification of all compounds was performed at 330 nm. In the case of a non-available standard
compound, the most similar structural compound available in the laboratory was used to perform
the quantification. A manual integration using the baseline to valley integration mode with baseline
projection was performed to obtain the area of the peaks. The results were expressed in mg/100 g dried
weight (dw).
2.3. Cytotoxicity
2.3.1. Cytotoxicity in Non-Tumor Liver Cell Primary Culture
Hepatotoxic activity was evaluated following the method described by Abreu et al. [26], using a
primary cell culture (PLP2) prepared from a porcine liver. Extracts were tested at a final concentration
range from 400 to 1.56 μg/mL. Briefly, a cell culture was prepared from a freshly harvested porcine
liver (obtained from a local slaughter house) and designated as PLP2 [26]. Briefly, the liver tissue was
rinsed in Hank’s balanced salt solution containing 100 U/mL penicillin + 100 μg/mL streptomycin,
and was divided into 1 × 1 mm3 explants. Some of them were placed into 25 cm2 tissue flasks
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containing Dulbecco’s Modified Eagle’s medium (DMEM, supplemented with 10% fetal bovine serum,
2 mM non-essential amino acids, 100 U/mL penicillin, and 100 mg/mL streptomycin) and incubated
at 37 ◦C under a humidified atmosphere with 5% CO2. A phase contrast microscope was used for
direct monitoring of the cell cultivation every 2 to 3 days. Before reaching the confluence, cells were
subcultured and plated in 96-well plates at a density of 1.0× 104 cells/well, and cultivated in commercial
DMEM medium supplemented with 10% FBS, 100 U/mL penicillin and 100 μg/mL streptomycin.
The results were measured through the Sulforhodamine B method, where the amount of pigmented
cells is directly proportional to the total protein mass and therefore to the number of bounded cells.
Results were expressed as GI50 values (concentration that inhibits 50% of cell growth) and Ellipticine
was used as a positive control.
2.3.2. Cytotoxicity in Human Tumor Cell Lines
Four human tumor cell lines were used: MCF-7 (breast adenocarcinoma), NCI-H460 (non-small
cell lung cancer), HeLa (cervical carcinoma) and HepG2 (hepatocellular carcinoma), as previously
described by Barros et al. [23]. MCF-7, HeLa and HepG2 were obtained from the European Collection
of Cell Cultures (ECACC, Salisbury, UK) and NCI-H460 was kindly provided by the National Cancer
Institute (NCI, Bethesda, MD, USA). Extracts were tested at a final concentration range from 400 to
1.56 μg/mL. RPMI-1640 medium containing 10% heat-inactivated FBS and 2 mM glutamine was used
to routinely maintain the adherent cell cultures at 37 ◦C, in a humidified air incubator containing 5%
CO2. For the experiments, each cell line was placed at an appropriate density (1.0 × 104 cells/well)
into 96-well plates. The cell growth inhibition was measured using sulforhodamine B, results were
expressed as GI50 values and Ellipticine was used as a positive control.
2.4. Statistical Analysis
The experimental design was a completely randomized design (CRD), with three replications
per treatment (harvesting stage, plant part). For the statistical analysis of chemical composition
and bioactivity assays, three samples were analyzed for each treatment, whereas all of the assays
were carried out in triplicate. Statistical analysis was conducted with the aid of Statgraphics 5.1.plus
(Statpoint Technologies, Inc., VA, USA). Data were evaluated by a two-way ANOVA for the main
effects, whereas the means of values were compared by Tukey’s honestly significant difference (HSD)
test (p = 0.05) in the case of harvesting stage effect, and by Student’s t-test (p = 0.05) in the case of plant
part effect.
3. Results and Discussion
The statistical analysis of the data showed a significant interaction between plant parts and
harvesting stage for all the recorded parameters. Therefore, the interpretation of the data refers to
the combined effect of both factors. Moisture content and proximate analysis results are presented in
Table 1. The moisture content of leaves was the highest at 29 and 43 DAS and decreased at 52 DAS with
plant maturity, whereas stems contained more water at 43 DAS, followed by the harvesting stages of 52
and 29 DAS. For macronutrient content (fat, proteins, ash, and carbohydrates) and the energetic value
of plant tissues, the highest content in leaves was observed at the last harvest (52 DAS), which could be
probably attributed to a concentration effect. Moreover, the opposite trend was observed in the case of
stems, where harvesting at 29 DAS resulted in the highest content of ash and carbohydrates and the
highest energetic value. However, fat content did not differ significantly between the first (29 DAS) and
the last harvest (52 DAS), whereas protein content was the highest at the last harvest (52 DAS). Similar
trends regarding the macronutrient content at different harvesting stages have been previously reported
by Mohamed and Hussein [5], who also suggested an increase in fat, protein and ash content with
increasing maturity, whereas they also reported an opposite trend for carbohydrate content. The values
for moisture and macronutrient content detected in our study were in the same range as those reported
by Ezekwe et al. [17], who studied eight purslane accessions planted at different dates, as well with the
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study described by Teixeira and Carvalho [13], who evaluated the effect of salinity on the proximate
composition of Portulaca oleracea cv. “Golden leaf” for two growing seasons. The only difference with
the above-mentioned reports was observed in lipid content, which was lower in our study. This finding
could be attributed to differences in genotype, harvesting stage and growth conditions. According to
Jin et al. [10], stress conditions such as heat, drought and salinity may accelerate protein catabolism
and result in lower protein content. In addition, Teixeira and Carvalho [13] suggested that apart from
harvesting stage (49 and 57 DAS), growing season (spring and summer) may also have an effect on the
proximate composition of purslane leaves.
Significant differences in moisture content were also observed between both plant parts, with
leaves having a higher moisture content only at the first harvest stage (29 DAS), since developing plants
gradually become succulent and contain more water in stems than leaves (Table 1). Similar results have
been reported by Oliveira et al. [4], who also detected higher moisture content in leaves compared
to stems, regardless of purslane genotype. Macronutrient content and energetic value also differed
between plant parts at the studied harvesting stages. In particular, leaves contained more fat and
proteins at the first harvest, whereas stems had a higher content of carbohydrates and ash and a higher
energetic value at the same harvesting stage. Moreover, leaves had higher macronutrient content
and energetic value than stems at the second and the last harvesting stages (apart from carbohydrate
content at the second harvest), which could be partly attributed to the lower moisture content values
and the resulting concentration effect. Oliveira et al. [4] also reported differences in fat content between
leaves and stems of purslane plants from four different locations in Northern Portugal, whereas there
were significant differences in the reported values compared to our study, probably because plants were
collected in the wild instead of being cultivated. Moreover, no details regarding the harvesting stage
were available in the study of Oliveira et al. [4] in order to make direct comparisons with our study.
According to Ezeabara et al. [27], moisture, fat, protein and ash contents were higher in leaves than in
stems, when plants were harvested at flowering stage, whereas the opposite trend was observed for
carbohydrate content. These results are in agreement with the values of the last harvest of our study,
indicating that late harvests increase the nutritional value of leaves in comparison to stems, due to
maturation progress and the decrease in moisture content.
The contents of individual and total tocopherols in relation to the harvesting stage and plant part
are presented in Table 2. Tocopherols, also known as vitamin E, are significant bioactive compounds
with antioxidant properties against lipid peroxidation of biological membranes [28]. α-tocopherol
was the main detected isoform in both leaves and stems, followed by γ-, β- and δ-tocopherols.
Leaves contained significantly higher amounts of all isoforms and total tocopherols, regardless of the
harvesting stage, while harvesting at later stages (52 DAS) had a beneficial effect on the content of most
of the individual and total tocopherols. The only exception was observed for γ-tocopherol content,
which was the highest at early growth stages (29 DAS). A contrasting trend was observed in the case of
stems, where the highest content of individual and total tocopherols was recorded at the stage of 29
DAS, except for β-tocopherol where no significant differences were observed between harvesting at
29 and 43 DAS. Similarly to our study, Szalai et al. [7] reported that α- and γ-tocopherols were the
main detected tocopherols in fully mature leaves of three purslane microspecies, although they did
not detect the other two vitamin E isoforms (β- and δ-tocopherols) that were present in our study.
Moreover, the highest content of α- and total tocopherols at the last harvesting stage (52 DAS) could
be attributed to unfavorable growing conditions (namely, high temperatures and high transpiration),
which could induce tocopherols’ biosynthesis as a means of plants’ antioxidant defense [29].
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The free sugar composition of leaves and stems in relation to harvesting stage is presented in
Table 2. The main detected sugars were glucose and fructose, followed by sucrose and trehalose,
which were detected in lower amounts. Stems contained significantly higher amounts of fructose,
glucose, sucrose and total free sugars than leaves, regardless of harvesting stage, whereas trehalose
content was higher in leaves compared to stems when harvesting took place at late growth stages
(43 and 52 DAS). In addition, an increase in glucose and fructose content was observed at late growth
stages (43 and 52 DAS) for both leaves and stems, which was also depicted in the total sugar content
of plant parts. Sugar composition was similar to our previously reported study, where six different
purslane genotypes were evaluated in terms of chemical composition [15], whereas any differences
in individual sugars’ content could be explained mostly by genotypic differences and barely by the
environmental conditions and cultivation practices, which were identical in both studies. Moreover,
Mohamed and Hussein [5] suggested glucose as the main detected sugar, while fluctuating trends
were observed in sugar content between plant parts at different growth stages (30, 49 and 59 days
after planting). The lower amounts of sucrose in leaves compared to fructose and glucose could be
attributed to the use of fixed carbon for the biosynthesis of fructose and glucose and the concurrent
export of sucrose from leaves to be used as a biosynthetic substrate [30].
The organic acid content of plant parts in relation to harvesting stage is presented in Table 3.
Four organic acids were detected in leaves and stems, namely oxalic, malic, quinic and citric acids,
regardless of the harvesting stage. However, the composition of individual organic acids differed
significantly between plant parts and harvesting stages. In particular, leaves contained mostly quinic
and oxalic acids at all the harvesting stages, although quinic acid content was significantly higher at
the last growth stage (52 DAS). On the other hand, stems contained oxalic, quinic and malic acids at
the earliest growth stage (29 DAS), whereas quinic acid decreased significantly with plant maturity.
Similarly, Oliveira et al. [4], who studied organic acid content in the leaves and stems of different
purslane genotypes, detected significant differences between plant parts, although the magnitude of
these differences varied depending on the genotype. In contrast to our study, Szalai et al. [7] detected
oxalic, malic and ascorbic acids in the leaves of three purslane microspecies, a difference that could
be attributed mostly to the effect of harvesting stage. However, it is worth mentioning the effect of
genotype on organic acid profile and content, which is also important and has been already confirmed
in previous studies [4,15].
Table 3. Composition in organic acids (g/100 g fw) of purslane stems and leaves in relation to harvesting
stage (mean ± SD).
Harvest Stage
(DAS) *
Plant Part Oxalic Acid Quinic Acid Malic Acid Citric Acid Total Organic Acids
29
Stems 7.70 ± 0.07a 6.36 ± 0.04a 6.39 ± 0.07b 5.00 ± 0.03a 25.5 ± 0.2a
Leaves 6.2 ± 0.1b 6.82 ± 0.01c 3.00 ± 0.03a 3.26 ± 0.01a 19.2 ± 0.1b
43
Stems 4.77 ± 0.01c 1.31 ± 0.01c 6.56 ± 0.07a 1.57 ± 0.04c ¥ 14.22 ± 0.04c
Leaves 5.7 ± 0.1c 8.4 ± 0.2b 1.90 ± 0.04b 1.53 ± 0.02b ¥ 17.6 ± 0.1c
52
Stems 7.16 ± 0.02b 3.57 ± 0.04b 5.38 ± 0.06c 2.78 ± 0.01b 18.89 ± 0.04b
Leaves 8.6 ± 0.2a 16.8 ± 0.5a 1.67 ± 0.01c 3.24 ± 0.03a 30.3 ± 0.2a
80 Seeds 0.470 ± 0.005 nd tr tr 0.470 ± 0.005
Student’s t Plant part ** <0.001 <0.001 <0.001 <0.001 <0.001
nd: not detected; tr: traces; * DAS: days after sowing; ¥: no significant difference was observed between plant parts.
Different Latin letters (a–c) in the same column refer to significant differences between harvest stages for the same
plant part (stems or leaves) at p = 0.05. ** Comparison of means of different plant parts (stems and leaves) from the
same harvest was performed with Student’s t-test at p = 0.05.
Purslane is considered as one of the richest plant sources of omega-3 fatty acids. The composition
of leaves and stems in relation to harvesting stage is presented in Table 4. The main detected fatty
acids in both stems and leaves were linoleic, palmitic, α-linolenic, behenic, oleic and lignoceric acids,
although the abundance of individual compounds varied among the studied plant parts and harvesting
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stages. The major compound in stems was palmitic acid, followed by linoleic and α-linolenic acids.
In addition, the highest content of palmitic and linoleic acids was detected at 29 DAS, whereas
α-linolenic acid content was the highest at 43 DAS. In contrast, the fatty acid profile of leaves differed
significantly from that of stems, with α-linolenic acid contributing the most to the overall fatty acid
content, especially at the first two harvesting stages (29 and 43 DAS). The same fatty acids have been
previously reported by Oliveira et al. [4], who also suggested α-linolenic, palmitic, oleic, stearic and
behenic acids as the main fatty acids in leaves. However, the reported profile of individual fatty
acids differed from that in our study, without additional information regarding harvesting stage being
available. Similarly, Guil-Guerrero and Rodríguez-García [31] suggested a different profile of fatty
acids in phospholipid and neutral lipid fractions of purslane leaves, which contained higher amounts
of omega-6 (n6) than omega-3 (n3) fatty acids. Moreover, in our study the overall α-linolenic acid
content (the sum of the contents of stems and leaves) was the highest (0.1 g/100 g fw) at the earliest
harvesting stage (29 DAS), despite the significantly higher fat content of leaves at the late harvesting
stage (0.1 g/100 g fw at 52 DAS; see Table 1). Similar amounts of α-linolenic acid (1.06 g/100 g dw) were
reported by Guil-Guerrero and Rodríguez-García [31], although they also suggested that purslane
leaves contain higher amounts of linoleic than α-linolenic acid. The highest polyunsaturated fatty acids
(PUFA)/saturated fatty acids (SFA) ratio was observed in stems and leaves at the middle (43 DAS) and
late harvesting stages (52 DAS), respectively. In contrast, the lowest n6/n3 fatty acid ratio in stems and
leaves was recorded at the earliest harvesting stage (29 DAS). In addition, for all the studied harvesting
stages and plant parts, the PUFA/SFA ratio was higher than 0.45, while the n6/n3 ratio was lower than
4.0, indicating a high nutritional value of the edible plant parts [32]. Moreover, the detected values for
the above-mentioned ratios of our study were within the same range as the ones recorded in the study
of Fontana et al. [19].
The identified phenolic compounds and oleracein derivatives in both plant parts of purslane are
presented in Table 5, while quantification data are presented in Table 6 and Figure 1. A total of five
compounds were identified in the hydroethanolic extracts of purslane aerial plant parts (Table 5). These
compounds included three phenolic acids (caffeic acid derivatives, peaks 2, 3 and 4) and two oleracein
derivatives (phenolic alkaloids, peaks 1 and 5). Caffeic acid (peak 2) was identified in comparison
with a commercial standard, whereas compound 4 was identified as a caffeic acid derivative, thus its
pseudomolecular ion was not clearly identified due to the very small amounts present. Compound 3
([M −H]− at m/z 385) presented a unique MS2 fragment at m/z 223 (sinapic acid), with a loss of a hexosyl
moiety (162 u), being tentatively identified as sinapic acid hexoside. Compounds 1 ([M −H]− at m/z
664) and 5 ([M − H]− at m/z 502) corresponded to oleracein derivatives, being identified as oleracein C
and A, respectively, taking into account previous findings in the literature regarding P. oleracea [33,34].
Oleraceins are cyclodopa alkaloids, which have been previously reported by Xiang et al. [35], who
identified five oleraceins in dried purslane plants, among other compounds. Moreover, Farag and
Shakour [36] suggested that the presence of these compounds in purslane aerial parts may be used as a
criterion for the classification of different Portulaca taxa. To the best of our knowledge, the rest of the
identified compounds have not been previously reported in purslane aerial parts.
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Figure 1. Chromatographic profile of the hydroethanolic extract obtained from purslane stems, recorded
at 330 nm. Peak numbers correspond to the compounds already mentioned in Table 5.
The composition of phenolic compounds and oleracein derivatives differed among the tested plant
parts and harvesting stages (Table 6). Concerning the quantification of oleraceins, p-coumaric acid
was the standard applied to perform the quantitative analysis (an available compound with a similar
structure); therefore, these compounds were quantified as equivalents to this phenolic acid. Leaves
contained significantly higher amounts of individual and total phenolic compounds and oleracein
derivatives compared to stems, regardless of harvesting stage. Moreover, harvesting at early stages
(29 DAS) resulted in significantly higher contents of phenolic compounds and oleracein derivatives,
especially in the case of leaves. Meanwhile, in stems the content of oleracein C was the highest at
the same harvesting stage (29 DAS), resulting in the highest total contents of phenolic compounds
and oleracein derivatives, accordingly. As mentioned previously for the case of tocopherols (see
Table 2), phenolic compounds and oleracein derivatives may also contribute to the overall defense
mechanisms of purslane; therefore, the increased content at the earlier stages could be attributed to
the protective purposes of developing leaves. Similar results regarding the effect of harvesting stage
on the compositions of phenolic compounds and oleracein derivatives have been reported by Lim
and Quah [37], who also observed a decrease in total phenolic compounds and oleracein derivatives
in leaves with increasing maturity. The differences in the compositions of phenolic compounds and
oleracein derivatives could be attributed to differences in the tested genotypes [35,37], to different
cultivation regimes and growing conditions [14,18] and also to extraction protocols [38].
The cytotoxic effects on PLP2 non-tumor cell lines of the samples showed no hepatotoxicity, with
GI50 values being higher than 400 μg/mL for all the harvesting stages and plant parts (data not shown).
Concerning the evaluation of in vitro activity against the four tumor cells lines, the extracts did not
present any activity at the tested concentrations (data not show), with GI50 values being higher than
400 μg/mL.
The hepatoprotective effects of ethanolic extracts of purslane aerial parts have been previously
reported by Eidi et al. [39], whose findings are in agreement with the results of our study.
Similarly, ethanolic and aqueous extracts of air-dried purslane leaves showed hepatoprotective
properties against paracetamol-induced liver damage [40]. Moreover, previous studies have
suggested weak to moderate inhibitory effects against two mutagens (benzo[a]pyrene (B[a]P)
and 2-Amino-3-methyl-imidazo[4,5-f]quinolone (IQ)) and no mutagenic activity on Salmonella
typhimurium [41], while Choi and Ryeom [42] and Zhao et al. [43] reported significant antitumor
activity against leukaemia and cervical carcinoma cell lines, respectively.
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4. Conclusions
The results of the present study showed a significant effect of plant parts and harvesting stages
on the nutritional value and chemical composition of purslane. Leaves contained higher amounts of
macronutrients than stems, especially at 52 DAS, while α-tocopherol was the main vitamin E isoform,
which increased at 52 DAS resulting in the highest overall tocopherol content. Glucose and fructose
were the main sugars in stems and leaves, respectively, while stems contained higher amounts of
total sugars in comparison to leaves. Regarding oxalic acid as well as total organic acids, the highest
contents were recorded in leaves, especially at the last harvesting stage (52 DAS). The edible plant parts
contained both omega-6 and omega-3 fatty acids, although leaves were more abundant in α-linolenic
acid than stems, which contained mostly palmitic and linoleic acids. Phenolic compounds and oleracein
derivatives were also detected in plant parts, with oleraceins A and C being the main compounds
detected in leaves, regardless of harvesting stage. In conclusion, early harvesting and the separation of
plant parts could increase the nutritional value of the final product through increasing the content
of valuable compounds, such as omega-3 fatty acids, phenolic compounds and oleracein derivatives,
while at the same time, the contents of anti-nutritional compounds such as oxalic acid are reduced.
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Abstract: Lonicera caerulea L. (haskap) berries are widely known for their richness in anthocyanins.
In this study, such fruits were assessed for their nutritional and chemical composition, but also as
sources of anthocyanins with great colouring properties to be applied in foodstuff. Haskap presented
high levels of water, four free sugars (mainly fructose and glucose), five organic acids (mainly
citric, malic, and quinic), α- and γ-tocopherol, twenty fatty acids (with prevalence of linoleic acid),
and eight phenolic compounds, among which six were anthocyanins (mainly cyanidin-3-O-glucoside).
The extract presented great antioxidant properties, evaluated through TBARS and OxHLIA assays,
as well as antimicrobial capacity against six bacteria and six fungi. Two colourants were obtained
by spray-drying haskap juice with maltodextrin and a mixture of maltodextrin and arabic gum.
These formulations were stable over 12 weeks of storage at room and refrigerated temperature,
without significant variations in colour parameters and in anthocyanins concentration. They were
considered safe for consumption once neither microbial contamination nor cytotoxicity in non-tumour
cells were detected. The results obtained allow for the consideration of haskap as a promising
source of colourants to be applied not only in the food industry, but also in other fields that rely on
artificial colourants.
Keywords: Lonicera caerulea L.; anthocyanins; antioxidant; antimicrobial; colouring formulations
1. Introduction
Lonicera caerulea L., commonly known as blue honeysuckle, honeyberry, sweet berry honeysuckle,
edible honeysuckle, haskap, haskup, hasukappu, and haskappu [1], is a shrub that can be mainly found
in Russia (Peninsula of Kamchatka), northeastern Asia, and Japan, but also appears—only rarely—in
Europe, the Alps, and Scandinavia [2]. Its dark blue to purple fruits were recognized by the Japanese
Aborigines as the “Elixir of Life” due to the fact of its multiple therapeutic properties [3], which has
led to its consumption both in fresh and processed forms, namely, in juices, cakes, jams, ice creams,
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and nuts. In fact, the antioxidant activity of haskap berries has been reported as comparable to that of
blackberry, raspberry, blueberry, strawberry, yellow hawthorn, and blackcurrant [4]. Moreover, several
biological activities have been associated to this fruit, namely, protection against the incidence and
mortality of cancer and ischemic heart disease, reduction in blood pressure, prevention of osteoporosis
and anaemia, curative effects in gastrointestinal disorders, and aging process delay, in addition to
antitumorigenic properties, antimicrobial, antidiabetic, and antimutagenic properties [2,5].
Haskap fruits are mainly composed of fibre, protein, calcium, and magnesium, but also possess
high concentrations of glucose and fructose, presenting traces of sucrose and sorbitol. They are a
rich source of polyunsaturated fatty acids, with considerable levels of linoleic acid [5,6], and are also
recognized for their high concentration in ascorbic acid. Indeed, haskap is often called a “super
fruit” because its ascorbic acid content is three to ten times higher than in blueberries, which are
considered one of the richest sources of this organic acid [3,5]. Regarding phenolic compounds, these
fruits are particularly rich in phenolic acids such as chlorogenic, neochlorogenic, and caffeic acids,
anthocyanins, proanthocyanidins, and other flavonoids such as quercetin (their respective glycosides)
and catechins. The richness of haskap in anthocyanin compounds has been reported in different
studies, where it has been shown that the main anthocyanin of these fruit is cyanidin 3-glucoside,
comprising 79–92% of its total content [5]. Other anthocyanins present in lower quantities are cyanidin
3,5-diglucoside (4.27%), cyanidin 3-rutinoside (2.07%), peonidin 3-glucoside (3.44%), and pelargonidin
3-glucoside (0.83%) [4]. Given this peculiar wealth in anthocyanin compounds, these fruit can also
be considered great sources of natural colourants with a colouration range from red to purple, pink,
or blue, with application in different sectors such as food, pharmaceuticals, and cosmetics, among
others. With that in mind, the present study aimed to provide a complete chemical characterization
(phenolic compounds, sugars, organic acids, tocopherols, and fatty acids) of haskap berries, including
their nutritional value and bioactive properties (e.g., antioxidant and antimicrobial). Furthermore,
it also aimed for the development of colourant formulations obtained from haskap juice and stabilized
through a spray-drying technique using different stabilizing agents, which increases their affinity with
different food matrices and, more importantly, their shelf life. The stability of the obtained colourants
was assessed along 12 weeks of storage, with special focus on its colouring capacity (anthocyanins
concentration), bioactivity, and microbiological quality.
2. Materials and Methods
2.1. Samples
Fresh mature fruits of Lonicera caerulea var. Kamtschatica of Wojtek cultivar, from Poland, were provided
by “Ponto Agrícola Unipessoal, Lda.” (Portugal). Part of the sample was frozen, lyophilised, and reduced
to a fine and homogeneous powder and another part was used to prepare the colouring formulations.
2.2. Nutritional Value and Chemical Composition
2.2.1. Nutritional Value
Haskap samples were evaluated regarding fat, ash, protein, carbohydrates, and energetic value,
according to the AOAC procedures [7]. The results were expressed in g per 100 g of fresh fruit and
kcal per 100 g of fresh fruit (for energy).
2.2.2. Free Sugars
These sugars were extracted from the lyophilized fruit and were further injected in HPLC
equipment (Knauer, Smartline system 1000, Berlin, Germany) coupled to a refractive index detector
(RI detector, Knauer Smartline 2300) as described by Barros et al. [8]. Separation was achieved with
a Eurospher 100-5 NH2 column (250 mm × 4.6 mm, 5 μm, Knauer), with an isocratic elution using
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acetonitrile/deionized water (70:30, v/v) at a flow rate of 1 mL/min, operating at 35 ◦C. The internal
standard method was applied, and the results were expressed in g per 100 g of fresh fruit.
2.2.3. Organic Acids
Organic acids were extracted from the lyophilized fruit and analyzed via ultra-fast liquid
chromatography (UFLC) coupled to photodiode array detector (PDA), employing a Shimadzu 20A
series UFLC (Shimadzu Cooperation), according to Barros et al. [8]. Separation was achieved using a
SphereClone reverse phase C18 column (250 mm × 4.6 mm, 5 μm, Phenomenex, Torrance, CA, USA),
with an isocratic elution using sulphuric acid (3.6 mM) at a flow rate of 0.8 mL/min, operating at 35 ◦C.
The results were expressed in g per 100 g of fresh fruit.
2.2.4. Tocopherols
After an extraction procedure following the recommendations of Pereira et al. [9], the tocopherols
were injected in a Knauer Smartline system 1000 (HPLC, Berlin, Germany) with a fluorescence detector
(FP-2020; Jasco, Easton, USA). Separation was achieved using a Polyamide II normal-phase column
(250 mm × 4.6 mm, 5 μm, YMC Waters, Milford, MA, USA), with an isocratic elution using n-hexane
and ethyl acetate (70:30, v/v) at a flow rate of 1 mL/min, operating at 35 ◦C. The internal standard
method was applied, and the results are expressed in mg per 100 g of fresh fruit.
2.2.5. Fatty Acids
To determine these compounds, and after performing the extraction and derivatization procedures,
the analysis was achieved through a DANI model GC 1000 instrument equipped with a split/splitless
injector, a flame ionization detector (FID) at 260 ◦C and a Zebron–Kame column (30 m × 0.25 mm ID ×
0.20 μm df, Phenomenex, Torrance, California, USA) [8]. The fatty acids identification was possible by
comparison of the relative retention times of fatty acid methyl ester (FAME) peaks from samples with
standards. The obtained data was analyzed using the Clarity DataApex 4.0 Software and expressed in
relative percentage of each fatty acid.
2.3. Extracts Preparation
2.3.1. Phenolic Compounds (Non-Anthocyanic) and Bioactive Properties Analysis
From the powdered sample, ethanolic extracts were prepared by stirring 1 g of the sample with
30 mL of an hydroethanolic solution (80:20, v/v) for 1 h. After the extraction procedure, the samples were
filtered through a Whatman No. 4 filter paper and afterwards, the residue was again extracted with an
additional 30 mL of the same solvent in the same conditions. The resulting samples were combined
and evaporated under reduced pressure at 35 ◦C (rotary evaporator Büchi R-210, Flawil, Switzerland)
to remove the ethanol, and the remaining aqueous mixture was frozen at −20 ◦C and lyophilised.
2.3.2. Anthocyanins Analysis
The extract was prepared according to the above described conditions, with a slight modification:
trifluoroacetic acid (TFA; 0.1%) was added to the extraction solvent.
2.4. Phenolic Compounds
The obtained extracts were re-suspended in the same solvent in a concentration of 5 mg/mL,
filtered (0.2 μm), and finally injected in the HPLC equipment (Dionex Ultimate 3000 UPLC, Thermo
Scientific, San Jose, CA, USA), using a diode-array detector (280, 330, 370, and 520 nm wavelengths)
and linked to an electrospray ionization mass spectrometry (Linear Ion Trap LTQ XL, Thermo Scientific,
San Jose, CA, USA) working in negative (non-anthocyanin compounds) and positive (anthocyanin
compounds) mode, according to methodology described by Bessada et al. [10] and Gonçalves et al. [11].
Data were collected and analyzed using the Xcalibur® program (Thermo Finnigan, San Jose, CA,
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USA). Separation was achieved using a Water Spherisorb S3 ODS-2 reverse phase C18 column (3 μm,
4.6 mm × 150 mm, Waters, Milford, MA, USA) for non-anthocyanin compounds and with an AQUA®
reverse phase C18 column (5 μm, 150 mm × 4.6 mm, Phenomenex, Torrance, CA, USA) for anthocyanin
compounds, working at 35 ◦C, using previously described gradients [10,11].
The compounds present in the samples were determined according to their UV-Vis and mass
spectra and retention times in comparison with authentic standards, and also using information present
in the literature. For the quantification, a 7 level calibration curve was obtained of different standard
compounds. The contents in the individual phenolic compounds were expressed in mg per g of extract
and in mg per g of colourant.
2.5. Bioactive Properties
2.5.1. Antioxidant Activity
The lipid peroxidation inhibition was evaluated trough the TBARS assay, which mainly consists
of using porcine (Sus scrofa) brain homogenates and the antioxidant potential was measured by the
decrease in thiobarbituric acid reactive substances (TBARS) as described by Pereira et al. [12]. These
results were expressed in μg/mL corresponding to the EC50 value (sample concentration providing
50% of antioxidant activity). Another antioxidant assay applied was the anti-haemolytic activity of the
obtained extracts, evaluated through the oxidative haemolysis inhibition assay (OxHLIA), according to
Lockowandt et al. [13]. These results were expressed in μg/mL corresponding to the IC50 value, which
is the concentration capable of promoting a Δt haemolysis delay of 60 and 120 min. Trolox was used as
a positive control in both of the assays.
2.5.2. Antimicrobial Activity
For the antimicrobial potential, several microorganisms were analyzed including different
bacterial strains and fungi. The bacterial strains were Gram-positive (Bacillus cereus (food isolate),
Staphylococcus aureus (ATCC 6538), and Listeria monocytogenes (NCTC 7973)) and Gram-negative
Escherichia coli (ATCC 35210), Enterobacter cloacae (human isolate), and Salmonella typhimurium
(ATCC 13311)); and the fungi were Aspergillus fumigatus (ATCC 1022), Aspergillus versicolor (ATCC 11730),
Aspergillus niger (ATCC 6275), Penicillium funiculosum (ATCC 36839), Penicillium ochrochloron
(ATCC 9112), and Trichoderma viride (IAM 5061). The antibacterial activity was evaluated according
to Soković et al. [14] and the antifungal potential was assessed according to Soković et al. [15].
The minimum inhibitory concentration (MIC) was determined for both bacteria and fungi, as were
the minimum bactericidal (MBC) and minimum fungicidal (MFC) concentrations. Streptomycin and
ampicillin were used as positive controls for the bacteria and ketoconazole and bifonazole for the fungi.
2.6. Juice Preparation
Fresh L. caerulea fruits were blended in order to obtain a juice rich in anthocyanins. Then, the juice
was centrifuged, filtered through Whatman No. 4 filter paper, and divided into four equal parts,
in plastic waterproof bags, non-temperature sensitive, for further pasteurization and subsequent
microbial load analysis and spray-drying at different conditions.
2.7. Pasteurization
To perform the pasteurization, the bags containing the samples were immersed in a water bath at
95 ◦C until 90 ◦C was achieved inside the bags. From that moment on, the bags were left to stand inside
the bath for 60 s and were then cooled by covering the bags with ice until 3 ◦C was reached inside the
bags. This temperature was chosen due to the fact of its effectiveness in eliminating amicroorganisms
usually present in this kind of product, without anthocyanin degradation. One of the bags containing
the pasteurized sample was used to assess the microbial load, according to sub-Section 2.9.3, and the
remaining three bags were stored at 3 ◦C for ~15 h for further spray-drying.
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2.8. Spay-Drying
The samples were dried by a spray-drying technique according to the work of Moser et al., namely,
by using 80% of maltodextrin or 80% of a mixture maltodextrin:arabic gum (1:1, w/w), as drying the
adjuvants was aimed at analyzing the efficiency of the drying process and the adequacy of the use of
maltodextrin and arabic gum materials [16]. The latter’s material’s percentage of 80% was relative
to the total solids content of the prepared samples, and it was selected after an optimization study
involving the testing of different percentages of maltodextrin or the mixture of maltodextrin + arabic
gum; it was found that the samples with 80% arabic gum materials was the one that led to higher
process yields. The solutions of haskap juice with the selected materials were prepared immediately
before atomization. Briefly, the haskap juice samples were mixed with the drying adjuvants and
thereafter homogenized by stirring for 10 min at room temperature. The used spray-drying equipment
was a Mini Spray Dryer B-290 Büchi (Flawil, Switzerland) programmed in the normal operation mode
(nozzle diameter: 0.7 mm; atomized volume: 200 mL, solids content < 33%). After an optimization
process, the optimal operation conditions were established as having an inlet temperature of 140 ◦C,
outlet temperature of 72 ◦C, aspiration 90%, and the pump working at 20% (6 mL/min). The yield of
the process was calculated as being the ratio between the weight of the obtained powder (dry basis)
and the weight of the solid content of the initial atomized solution in dry basis.
After spray-drying, a portion of each powdered sample was used to perform the required analyses
immediately after preparation (t0) and the remaining amount was divided into 2 equal portions, in sterile
flasks protected from light, stored at room (23 ◦C) and refrigerated (3 ◦C) temperatures, respectively.
2.9. Stability of the Colouring Formulations
2.9.1. Anthocyanins Concentration
To verify if the colouring properties of the formulations were maintained over time, the concentration
of anthocyanins in the powders was assessed, as described in Section 2.4., after their preparation (t0)
and at different stages of storage, more specifically 4, 8, and 12 weeks, both for room and refrigerated
temperature stored samples.
2.9.2. Colour Parameters
To measure the colour of the developed colouring formulations, a colourimeter (model CR-400,
Konica Minolta Sensing, Inc., Osaka, Japan) equipped with specific tool for granular materials (model
CR-A50) was used as reported by the authors Pereira et al. [17]. The analysis of the colour parameters
was made in the CIE L*a*b* colour space, through the illuminant C and the diaphragm aperture was
8 mm. The obtained data were analyzed using a “Spectra Magic Nx” (version CM-S100W 2.03.0006
software, Konica Minolta). The colour measurements were achieved after preparing the colorant
preparation (t0) and every 4 weeks of storage, until it reached 12 weeks of shelf life.
2.9.3. Microbial Load
After pasteurization and spray-drying, the samples were analyzed; the powder (1 g) was mixed
with peptone water (PW, 9 mL) and serial decimal dilutions of the initial suspension in PW were
prepared until achieving 10−6. From these solutions, different counts were performed:
Aerobic plate count (total viable count; ISO 4833-2:2013). The dilutions were inoculated in PCA (plate
count agar) by the pour plate technique, in duplicate (LOQ = 1 log CFU/g): 1 mL of suspension was
pipetted onto the plate and 15 mL of melted PCA (kept at 50 ◦C in a water bath or incubator) were
poured; it was homogenized and left to solidify. It was incubated at 30 ◦C for 72 h, in reversed position;
when the plates had between 15 and 300 colonies, the count was performed.
Coliforms (and E. coli; ISO 4832:2006). The dilutions were inoculated in VRBLA (violet, red bile
lactose agar) using the pour plate technique, in duplicate (LOQ = 1 log CFU/g): 1 mL of suspension
was pipetted onto the plate and 15 mL of melted VRBLA (kept at 50 ◦C in a water bath or incubator)
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was poured; it was homogenized and left to solidify. On top of the medium, a top layer of 4 mL of
VRBLA was poured and it was left to solidify. It was incubated at 30 ◦C for 48 h, in reversed position.
When the plates had between 10 and 150 colonies, the count was performed.
Yeasts and Moulds (ISO 21527-1/2:2008). The dilutions were inoculated in DRBC (dichloran rose
bengal chloramphenicol) using the spread plate technique, in duplicate (LOQ = 1.7 log CFU/g): 0.2 mL
of suspension were pipetted onto a plate containing 15 mL of the medium and were spread with a
disposable spreader. It was incubated at 25 ◦C for 5 days, in the upright position. When the plates had
less than 150 colonies, the count of yeast and mould colonies was performed separately after 2 and
5 days of incubation.
Bacillus cereus (ISO 7932:2004). The dilutions were inoculated in MYP (mannitol yolk polymyxin)
using the spread plate technique, in duplicate (LOQ = 1.7 log CFU/g): 0.2 mL of suspension were
pipetted onto a plate containing 15 mL of the medium and were spread with disposable spreader.
It was incubated at 30 ◦C for 24–48 h, in reversed position. When the plates had between 10 and
150 colonies, the count was performed.
The microbial load of the different colouring formulations was assessed after their preparation (t0)
and after 12 weeks of storage at room and refrigerated temperature.
2.9.4. Cytotoxic Activity in Non-Tumour Cells
The cytotoxicity was determined using a primary culture of porcine liver non-tumour cells,
PLP2. The cells growth was monitored by the use of a phase contrast microscope. The cells were
sub-cultured and plated in 96 well plates (density of 1.0 × 104 cells/well) with the culture medium
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with FBS (10%), penicillin (100 U/mL),
and streptomycin (100 μg/mL) according to Corrêa et al. [18]. The results were expressed in μg/mL of
the sample concentration able to inhibit 50% of the net cell growth. Ellipticine was used as positive
control. The cytotoxicity was assessed after the colourants preparation (t0) and after 12 weeks of
storage at room and refrigerated temperature, to guarantee their safety for food application.
2.10. Statistical Analysis
For each analysis, three samples were assessed, and the assays were carried out in triplicate.
The results were analyzed using one-way analysis of variance (ANOVA) post-hoc Tukey and are
expressed as mean values and standard deviation (SD). This treatment was carried out using the SPSS
v.22.0 program (IBM Corp., Armonk, New York, USA).
3. Results and Discussion
3.1. Nutritional and Chemical Composition
3.1.1. Nutritional Composition
The results obtained for the nutritional composition of haskap fruits are presented in Table 1.
The fresh fruit presented 82.9 ± 0.1 g/100 g fw of water (17.1 ± 0.1 g/100 g of dry matter),
and carbohydrates as major macronutrients (15.87± 0.06 g/100 g fw). It also presented 0.87 ± 0.04 g/100 g
fw of protein, 0.38 ± 0.02 g/100 g fw of fat, and 0.00127 ± 0.00008 g/100 g fw of ash, which led to
70.37± 0.09 kcal/100 g fw of energetic contribution. In a previous study performed by Palíková et al. [19],
haskap revealed a similar water content (82.7 g/100 g fw), but significantly higher concentrations
of protein and ash (1.6 and 0.5 g/100 g fw, respectively), thus also presenting a higher energy
(330 Kcal/100 g fw) [19]. Also, in a work performed with three cultivars of haskap, Borealis and
Indigo Gem cultivars revealed similar contents of dry matter (17.7 ± 0.6 and 15.91 ± 0.04 g/100 g fw,
respectively) and carbohydrates (15.6 ± 0.7 and 14.30 ± 0.08 g/100 g fw, respectively), whereas
the Tundra cultivar showed lower concentrations of both (12.4 ± 0.2 and 10.19 ± 0.2 g/100 g fw of
water and carbohydrates, respectively), thus presenting higher levels of protein, fat, and ash [20].
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Other cultivars were previously assessed, namely, Czelabinka, Duet, Jolanta, and Wojtek (focused
on in the present study), and presented similar dry matter amounts (16.1 ± 1, 17 ± 1, 15 ± 1,
and 14 ± 2 g/100 g fw, respectively), and higher concentrations of ash (0.096 ± 0.003, 0.095 ± 0.007,
0.09 ± 0.02, and 0.067 ± 0.001 g/100 g fw, respectively) [21]. On the other hand, in a study performed
with the Kamtschatica variety from Khabarovsk (Russia), lower amounts of fat and carbohydrates were
found (0.01 ± 0.01 and 0.9 ± 0.1 g/100 g fw), but the sample revealed higher quantities of water, protein,
and ash (88 ± 4, 2.1 ± 0.2, and 0.5 ± 0.1 g/100 g fw) [6]. The differences could be explained by several
possible factors, such as soil and cultivation conditions, given the different origin of the samples, or the
maturation state, which clearly influences fruits composition [1,22], among many others.
Table 1. Nutritional value and free sugars, organic acids, and tocopherols composition of haskap fruits.
Nutritional value
Moisture (g/100 g fw) 82.9 ± 0.1
Fat (g/100 g fw) 0.38 ± 0.02
Protein (g/100 g fw) 0.87 ± 0.04
Ash (g/100 g fw) 0.00127 ± 0.00008
Carbohydrates (g/100 g fw) 15.87 ± 0.06
Energy (kcal/100 g fw) 70.37 ± 0.09
Free sugars
Fructose (g/100 g fw) 4.021 ± 0.006
Glucose (g/100 g fw) 3.86 ± 0.05
Sucrose (g/100 g fw) 0.027 ± 0.002
Unknown (g/100 g fw) 0.181 ± 0.007
Total (g/100 g fw) 7.91 ± 0.06
Organic acids
Oxalic acid (g/100 g fw) 0.041 ± 0.002
Quinic acid (g/100 g fw) 0.37 ± 0.01
Malic acid (g/100 g fw) 0.77 ± 0.01
Ascorbic acid (g/100 g fw) 0.0248 ± 0.0003
Citric acid (g/100 g fw) 2.76 ± 0.01
Total (g/100 g fw) 3.93 ± 0.01
Tocopherols
α-Tocopherol (mg/100 g fw) 0.77 ± 0.03
γ-Tocopherol (mg/100 g fw) 0.162 ± 0.003
Total (mg/100 g fw) 0.93 ± 0.03
3.1.2. Free Sugars
Regarding free sugars (Table 1), fructose and glucose (4.021 ± 0.006 and 3.86 ± 0.05 g/100 g fw,
respectively) were the most abundant ones, but lower concentrations of sucrose and an unknown sugar
were also found. The total amount detected in this study (7.91 ± 0.06 g/100 g fw) was very similar to the
one reported by Palíková et al. (7.2 g/100 g fw), with fructose (3.2 g/100 g fw) and glucose (2.9 g/100 g fw)
as free sugars detected [19]. These latest were also found in other studies, in concentrations of 2.80
and 2.90 g/100 g fw (fructose), and 3.64 and 3.2 g/100 g fw (glucose) [19,23]. As for Wojtek cultivar
studied herein, sucrose was also previously detected by Oszmiański et al. (0.04 g/100 g fw) in the same
cultivar [23].
3.1.3. Organic Acids
A total of 3.93 ± 0.01 g/100 g fw of organic acids was quantified (Table 1), with citric acid as the
most abundant one (2.76 ± 0.01 g/100 g fw), followed by malic and quinic acids in lower amounts
(0.77 ± 0.01 and 0.37 ± 0.01 g/100 g fw, respectively), and also oxalic and ascorbic acids (0.041 ± 0.002
and 0.0248 ± 0.0003 g/100 g fw, respectively). Comparing these results with the ones reported by
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other authors for this cultivar, some variations can be observed, for instance Wojdyło et al. detected
0.154 ± 0.005 g/100 g fw of citric acid, followed by malic, oxalic, quinic, and ascorbic acids (0.039 ± 0.002,
0.0115 ± 0.0003, 0.0098 ± 0.0007, and 0.0017 ± 0.0002 g/100 g fw, respectively), which concentrations
were significantly lower than the ones found in the present study [21]. These authors also detected
phytic and shikimic acids in concentrations of 0.047 ± 0.005 and 0.0039 ± 0.0002 g/100 g fw, which were
not detected in this work.
3.1.4. Tocopherols
In what concerns tocopherols (Table 1), two isoforms were detected, α and γ, with a clear
prevalence of α-tocopherol (0.77 ± 0.03 in a total of 0.93 ± 0.03 mg/100 g fw). In a previous investigation,
haskap fruits also revealed α-tocopherol as the most abundant isoform (0.42 mg/100 g fw), despite the
lower concentration detected, in comparison to the one found in the present study. In the referred
work, the authors also found β, γ, and δ-tocopherol [19].
3.1.5. Fatty Acids
A total of 20 fatty acids was found in haskap fruits (Table 2). Linoleic acid was the most abundant
one (71.79 ± 0.08%), which mostly contributed to the prevalence of polyunsaturated fatty acids
(77.69 ± 0.03%) in the sample. Regarding monounsaturated fatty acids (14.403 ± 0.006%), the one
present in the highest concentration was oleic acid (14.153 ± 0.006%), and in the case of saturated
fatty acids (7.91 ± 0.02%), palmitic acid contributed with the highest percentage (5.39 ± 0.01%).
The same observations were made by Caprioli et al., which also reported linoleic, oleic, and palmitic
acids (66.8, 22.8, and 5.3%, respectively) as the most abundant polyunsaturated, monounsaturated,
and saturated fatty acids (69.8, 24.2, and 6.1%, respectively) [6]. Given the fact that linoleic acid
intake is related to the prevention and control of adverse blood pressure levels in general populations,
the results obtained could explain some of the beneficial properties of this fruit [24].
Table 2. Fatty acids composition of haskap fruits.
Fatty Acid Relative %
Caproic acid (C6:0) 0.078 ± 0.001
Caprolic acid (C8:0) 0.067 ± 0.001
Capric acid (C10:0) 0.012 ± 0.001
Lauric acid (C12:0) 0.366 ± 0.003
Myristic acid (C14:0) 0.304 ± 0.008
Myristoleic acid (C14:1) 0.067 ± 0.001
Pentadecylic acid (C15:0) 0.092 ± 0.002
Palmitic acid (C16:0) 5.39 ± 0.01
Palmitoleic acid (C16:1) 0.098 ± 0.001
Margaric acid (C17:0) 0.082 ± 0.001
Stearic acid (C18:0) 0.986 ± 0.001
Oleic acid (C18:1n9) 14.153 ± 0.006
Linoleic acid (C18:2n6) 71.79 ± 0.08
γ-Linoleic acid (C18:3n6) 1.4 ± 0.1
Linolenic acid (C18:3n3) 4.24 ± 0.01
Arachidic acid (C20:0) 0.158 ± 0.001
Eicosenoic acid (C20:1) 0.086 ± 0.001
Eicosadienoic acid (C20:2) 0.227 ± 0.002
Behenic acid (C22:0) 0.306 ± 0.001
Lignoceric acid (C24:0) 0.069 ± 0.004
SFA 7.91 ± 0.02
MUFA 14.403 ± 0.006
PUFA 77.69 ± 0.03
SFA: saturated fatty acids; MUFA: monounsaturated fatty acids; PUFA: polyunsaturated fatty acids.
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3.2. Phenolic Composition
The phenolic composition of haskap berries is presented in Table 3, being identified as constituting
one phenolic acid and six anthocyanins. 5-O-Caffeoylquinic acid was identified by comparison
with a commercial standard and was present in a concentration of 0.589 ± 0.002 mg/g of extract.
In other studies involving haskap fruits, other phenolic compounds (non-anthocyanin) were detected,
such as protocatechuic, gentisic, ellagic, ferulic, caffeic, and coumaric acids [19]. On the other hand,
Oszmiánski et al. [23] found eight phenolic acids, five flavan-3-ols, twelve flavonols, and five flavones.
These differences could possibly be explained by the different processing conditions to which the
samples were subjected, such as defrosting processes or the maturation stage, climate, harvest,
or even storage conditions [2,5,6]. Indeed, several examples can be found for the effect on polyphenolic
composition of the different treatments to which the fruits were subjected, for instance, Ochmian et al. [1]
packed the berries in polyethylene bags and stored them at−32 ◦C for 6 months, while Khattab et al. [25]
stored them for 6 months at −18 ◦C; comparing the results obtained, the samples stored at higher
temperatures revealed lower concentrations of phenolic compounds. But besides storage temperature,
other factors can affect the phenolic composition; in fact, steam bleaching of the fruits prior to freezing
clearly increased the retention of these compounds, whereas storage at −32 ◦C did not reveal such
an influence [25]. There are other reports on the pre-treatment of these berries that also report the
contribution of the process to the variation of the phenolic composition; for example, in a study
performed by Wojdyło et al. [21], the fruits were cut directly into liquid nitrogen and freeze-dried
before grounding and storing at −70 ◦C, which also led to the preservation of such compounds [21].
Besides, the influence of the maturation stage of these fruits also revealed a clear influence on the
polyphenolic composition, with late harvest haskap presenting significantly higher concentrations
than early-harvested fruits [1]; more specifically, for Wojtek cultivar, the early berries presented lower
contents (174.95 mg/100 g) than the late-harvest berries, in which an increase of 27% was verified.
For the Brazowa cultivar, similar observations were made, with an enhancement of 65% of the initial
concentration (144.84 mg/100 g) [26,27].
Regarding anthocyanins (Table 3), these were identified according to the peak characteristics, such as
retention time, wavelength of maximum absorption and mass spectral data. Three cyanidin derivatives
(cyanidin-O-hexoside-O-hexoside, cyanidin-3-O-glucoside, and cyanidin-O-rhamnoside- O-hexoside),
two peonidin derivatives (peonidin-3-O-glucoside and peonidin-O-rhamnoside-O-hexoside), and a
pelargonidin derivative (pelargonidin-3-O-glucoside) were identified, as shown in Figure 1.
The compounds represented by peaks two, four, and five were positively identified by comparison with
commercial standard chromatographic characteristics. The compound corresponding to peak 1 ([M]+ at
m/z 611) presented two MS2 fragments, presenting two losses of hexosyl units (m/z at 287; −162–162 u),
being identified as cyanidin-O-hexoside-O-hexoside. Also, the compounds represented by peaks three
([M]+ at m/z 595) and six ([M]+ at m/z 609) were identified as cyanidin-O-rhamnoside-O-hexoside
and peonidin-O-rhamnoside-O-hexoside, respectively, revealing a loss of one hexosyl (−162u) and
rhamnosyl (−146u). The most abundant anthocyanin was cyanidin-3-O-glucoside, representing 63% of
the total anthocyanin concentration (61.7 ± 0.1 of 97.9 ± 0.2 mg/g of extract). The results obtained are
in accordance with those reported by Oszmiański et al [23]., but in this study, cyanidin-3-O-glucoside
represented 88% of the total content, and another seven anthocyanins were found. Ochmian et al. [1]
and Wojdyło et al. [21] also reported this anthocyanin as the one present in the highest concentration
(83–90% and 71–89% of the total concentration).
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Figure 1. Chromatographic profile of the phenolic compounds found in the haskap fruit hydroethanolic
extract, recorded at 520 nm (1: cyanidin-O-hexoside-O-hexoside; 2: cyanidin-3-O-glucoside;




The antioxidant activity of the haskap fruit extract and colouring formulations was determined
by two in vitro assays, the lipid peroxidation inhibition assay (TBARS) and the oxidative haemolysis
inhibition assay (OxHLIA), as presented in Table 4. In the TBARS assay, the extract revealed a large
amount of antioxidant activity, with an EC50 value of 29.9 ± 0.3 μg/mL, which was significantly lower
than the one presented by the positive control, Trolox (139 ± 5 μg/mL). Regarding the OxHLIA assay,
the extract also revealed strong activity, which was capable of delaying the oxidative haemolysis
for 120 min, in a concentration of 938 ± 49 μg/mL, which despite being higher than that needed
for Trolox, was still a good result for a natural extract. Regarding the colouring formulations, both
samples revealed a lower antioxidant activity in the TBARS assay than the extract, but the fact that
they contained only 20% of haskap juice must be taken into consideration. Nevertheless, in the
OxHLIA assay, the differences were not so severe, with the formulations containing maltodextrin (80%)
and maltodextrin (40%) + arabic gum (40%) revealing, respectively, a higher (737 ± 16 μg/mL) and
similar (976 ± 9 μg/mL) capacity to inhibit the oxidative haemolysis, for 120 min, than the extract
(938 ± 49 μg/mL). Among formulations, the one prepared with maltodextrin presented higher lipid
peroxidation inhibition capacity than that prepared with maltodextrin and arabic gum, but higher
concentrations of this formulation were needed to inhibit the oxidative haemolysis.
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The results obtained in the present study are not directly comparable to the ones reported in
previous studies, as the applied antioxidant assays are different; however, the haskap extracts did
reveal a good performance in tests such as TEAC (Trolox-equivalent antioxidant capacity), FRAP
(ferric reducing antioxidant power), ORAC (oxygen radical absorbance capacity), DPPH (2,2-diphenyl-
1-picrylhydrazyl radical scavenging activity), and ABTS (2,2′-azinobis-(3-ethylbenzothiazoline-6-
sulfonic acid) [20,28], notwithstanding the fact that these methods are based on chemical reactions that
are not so comparable to those occurring in biological systems, such as the ones used in the present
study which were based on porcine brain tissues and sheep blood erythrocytes.
3.3.2. Antimicrobial Activity
The antibacterial and antifungal properties of haskap extract and colouring formulations are
presented in Table 4 as MIC (minimum inhibitory concentration), MBC (minimum bactericidal
concentration), and MFC (minimum antifungal concentration) values. The extract was able to inhibit
the growth of all the studied bacterial strains in concentrations of 3.41 (L. monocytogenes, E. coli,
E. cloacae, and S. typhimurium) and 6.81 (B. cereus, S. aureus, and L. monocytogenes) mg/mL. Interestingly,
these were also the concentrations needed to obtain a bactericidal effect in these microorganisms,
which could mean that the compounds responsible for haskap extract antibacterial activity have
mainly a bactericidal capacity [29]. In what concerns the antibacterial properties of the colorants,
in general, the formulation prepared with maltodextrin revealed lower MIC and MBC values than
the other colorant, and in some cases, it was also more active than the extract in inhibiting bacterial
growth. Regarding antifungal properties, the extract revealed a stronger activity in T. viride and
A. versicolor, with lower MIC (2.13 and 6.81 mg/mL, respectively) and MFC (13.63 and 13.63 mg/mL,
respectively) values. In fact, the MIC value presented by the extract for T. viride was even lower
than those showed by the positive controls Ketoconazole (4.75 mg/mL) and Bifonazole (5.70 mg/mL).
Regarding the formulations, the same tendency could be observed for this fungus, in which both
colorants revealed a strongest inhibitory activity than the positive controls (1.26 and 2.54, in the case
of haskap + maltodextrin and haskap + maltodextrin+arabic gum, respectively). For the colorant
prepared with maltodextrin, the MIC value against P. ochrochloron was also lower (2.52 mg/mL) than
the ones found for the positive controls (3.8 mg/mL). This formulation was more active against all
fungi than the one containing maltodextrin and arabic gum as well as the extract. Raudsepp et al. [30]
previously reported the capacity of this fruit extract to inhibit Bacillus subtilis, Kocuria rhizophila, E. coli,
Lactobacillus acidophilus, and Campylobacter jejuni. To the best of our knowledge, this is the first report
on haskap fruits’ antifungal properties, which limits our possibilities of comparing the results obtained
herein with the data in the literature; nevertheless, all the samples (extract and colouring formulations,
specially haskap +maltodextrin) revealed promising results in these microorganisms.
3.4. Anthocyanins Composition and Stability of the Colouring Formulations
The main compounds responsible for the colouring properties of haskap fruits are their
anthocyanins; thus, an analysis of these compounds in the juice samples was performed and
five of the six anthocyanins detected in the previously described hydroethanolic extract were
found in the colouring formulations: cyanidin-O-hexoside-O-hexoside, cyanidin-3-O-glucoside,
cyanidin-O-rhamnoside-O-hexoside, peonidin-3-O-glucoside, and peonidin-O-rhamnoside-O-hexoside.
The difference in the detected compounds could be explained by the different kind of extract, which
for anthocyanins analysis was hydroethanolic and for the colorant’s preparation was the centrifuged
fruit juice; or even the temperature to which the juice was subjected in the pasteurization and
spray-drying processes.
Regarding the spray-drying process, due to the high concentration of sugars in haskap juice, it was
not possible to prepare a control sample without the stabilizing materials, thus, two formulations were
successfully prepared with good yields: haskap + maltodextrin (80%) and haskap + maltodextrin
(40%) + arabic gum (40%), presenting yields of 46 and 51%, respectively.
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To evaluate the stability of the prepared formulations, the total concentration of these compounds
was considered, alongside with the colouring parameters (L*: lightness, white–black; a*: red colour
intensity, red–green; and b*: yellow colour intensity, yellow–blue), both measured at 4, 8, and 12 weeks
for samples stored at room and refrigerated temperature. In terms of lightness, the formulation
containing maltodextrin + arabic gum allowed higher values (Figure 2a), as well as for the red
(Figure 2b) and yellow (Figure 2c) colours’ intensity. Even though this formulation presented better
results concerning colour parameters, the anthocyanin levels were very similar for both preparations
(Figure 2d). Nevertheless, it presented a higher stability over time, with less notorious variations with
time and storage temperature than the colorant containing only maltodextrin, as it can be observed
in Figure 2a–c. The slight variation observed in the total anthocyanin concentration confirmed the
efficient protection of these compounds over time, making spray-drying a suitable methodology for
anthocyanin-based colorants development.
In order to guarantee the safety of the prepared colorants, the samples were submitted to microbial
load evaluation considering the microorganisms that could represent a risk for the formulation’s
stability over the time by causing degradation. These formulations were also evaluated in terms
of cytotoxicity in non-tumour cells to assure the safety of their consumption. These analyses were
performed after samples preparation (t0) and after 12 weeks of storage. According to the obtained
results (data not shown), no microbial counts were possible to detect, meaning that the pasteurization
process together with application of the spray-drying technique were able to maintain the stability of
the colouring formulations. The spray-drying technique allowed the formulation to be in powder form,
which drastically decreases the microbial contamination over time. Regarding cytotoxicity, the samples
did not reveal any toxic effects on the non-tumour cells at the maximum tested concentration of
400 μg/mL, corroborating its safety for application in foodstuff, which is a very important result, once
the objective was to prepare food colourants.
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4. Conclusions
Lonicera caerulea L. was assessed in terms of nutritional and chemical composition and revealed to
be mostly composed of water and carbohydrates. It presented four different free sugars, five organic
acids, two tocopherol isoforms, and twenty fatty acids, mostly polyunsaturated. Two non-anthocyanic
phenolic compounds were detected, with 5-O-caffeoylquinic acid as the most abundant one, and six
anthocyanins, with a prevalence of cyanidin-3-O-glucoside. The fruit hydroethanolic extract revealed
excellent antioxidant properties and considerable antibacterial and antifungal activity. From the
berries juice, it was possible to obtain two colouring formulations by spray-drying the samples with
maltodextrin and a combination of maltodextrin with arabic gum. The developed colorants revealed
good antioxidant and antimicrobial properties and did preserve their anthocyanin compounds and
related coloration along twelve weeks of storage at room and refrigerated temperature, with neither
microbial contamination nor cytotoxicity issues. Thus, food colorants obtained from L. caerulea should
be considered for food application, in detriment to the most commonly used artificial ones, but also in
other industries, such as cosmetics, textiles, or pharmaceuticals, among others. Further studies for the
stabilization of these kinds of colourants should also be considered as well as the exploitation of other
anthocyanin-rich natural sources.
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Abstract: The present study aimed, on the one hand, to improve the yield of microwave assisted
extraction (MAE) of polyphenols from beech bark by using a design of experiments (DoE) approach.
On the other hand, beech bark extracts (BBE) were characterized in terms of their phytochemical
profile and evaluated for biological potential (antioxidant, antibacterial, antifungal, antimutagen,
anti-α-glucosidase, and anti-tyrosinase). The extraction time varies with the amount of extracted total
phenolic content (TPC). The microwave power favors TPC extraction but in different proportions.
The optimum conditions which gave the highest TPC (76.57 mg GAE/g dry plant material) were
reached when the microwave power was 300 W, extraction time was 4 min, and the solvent was an
ethanol–water (50:50) mixture. The practical value of TPC after a controlled experiment was 76.49 mg
GAE/g plant material. The identified compounds were vanillic acid, gallic acid, epicatechin, catechin,
protocatechuic acid, chlorogenic acid, ferulic acid, and isoquercitrin. The antioxidant potential of
BBEs was demonstrated by in vitro experiments. The BBEs were active against Staphylococcus aureus,
Pseudomonas aeruginosa, Salmonella typhimurium, Escherichia coli, and Candida species. All extracts
were antimutagenic and expressed an inhibition on α-glucosidase and tyrosinase activity. Regarding
antimutagen activity, the assayed extracts may be considered to have low or no antimutagen effects.
Keywords: antioxidant; antibacterial; antifungal; antimutagen; anti-α-glucosidase; anti-tyrosinase;
beech bark; microwave assisted extraction; optimization
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1. Introduction
Bark plays an important role in protecting woody vascular plants, especially through its content
in bioactive compounds with an antimicrobial effect [1]. The bark of woody plants is considered to
be a by-product of the forestry and wood industry. This can be an important source of bioactive
compounds with a high recovery potential. Numerous studies show the importance and value of bark.
Moreover, bark extracts can have biological effects, such as antioxidant, antibacterial, anti-inflammatory,
anti-tumor, etc., [2–6]. It has been determined that the bio-activity of bark natural extracts is mainly
due to their content in phenolic compounds [7,8].
The beech (Fagus sylvatica L.) is one of the most widespread woody vascular plants in Europe and
particularly in Romania, with a high economic value [9]. Beech wood is mostly used for fire wood or in
the wood processing industry. After processing beech wood, a significant amount of bark is obtained.
Some literature data highlights that beech bark can be a rich source of bioactive compounds [10,11].
Furthermore, in a previous study some of the phenolic compounds obtained from beech bark by hot
water extraction were identified (vanillic acid, catechin, taxifolin and syringin) [11,12]. Hofmann et al.
identified 37 compounds in beech bark extracts, including catechin, epicatechin, quercetin, taxifolin,
procyanidins, syringic acid, and coumaric acid [12]. Regarding the biological activity of beech bark
extracts, literature information is quite limited. In previous works, the antibacterial and antitumor
activity of beech bark aqueous extracts, obtained by classical extraction, was evaluated [11,13]. Beech
bark extracts induced a decrease in A375 melanoma cell viability [13] and antimicrobial activity against
Staphylococcus aureus including methicillin-resistant strains [11]. In another study, Hofmann et al. [10]
found that the most efficient antioxidants in beech bark were the (+)-catechin, procyanidin B dimer 2,
(−)-epicatechin, and coniferin isomer 2. Consequently, the research directions are oriented towards the
identification and isolation of the bioactive compounds and the description of their mechanisms of
action at the level of living organisms, finally with possibility of exploitation and functionalization on
an industrial scale.
The main objectives of the current study were: (1) to optimize the extraction yield of phenolic
compounds from beech bark (BB) based on an original experimental design; (2) the characterization of
the phytochemical profile of optimized beech bark extracts (BBE); (3) the evaluation of the biological
potential (antioxidant, antibacterial, antifungal, antimutagen, and enzyme inhibitory activity) of the
optimized BBE.
2. Materials and Methods
2.1. Chemicals
The reagents used in this study were acetone, ethanol, methanol, hydrochloric acid (37%), and
Folin-Ciocâlteu reagent, all of which were purchased from Merck (Darmstadt, Germany).
The standards used for both spectrophotometric and LC-MS/MS analysis were: quercetin
(≥95%), hyperoside (quercetin 3-D-galactoside, ≥97%), isoquercitrin (quercetin 3-D-glucoside, ≥98%),
quercitrin (quercetin 3-rhamonoside, ≥78%), (+)-catechin (≥96%), (−)-epicatechin (≥90%), vanillic acid
(≥97%), syringic acid (≥95%), protocatechuic acid (3,4-dihydroxybenzoic acid, ≥97%), campesterol
(~65%), ergosterol (≥95%), and stigmasterol (~95%) purchased from Sigma-Aldrich, gallic acid (≥98%)
purchased from Merck (Darmstadt, Germany), and beta-sitosterol (≥80%) purchased from Carl Roth
(Karlsruhe, Germany).
2.2. Plant Sample
The beech (Fagus sylvatica L.) bark samples were collected from Gurghiu Mountains, Toplit,a
region, Mures, County, Romania, during November and December 2017. The age of the test trees was
about 15–20 years. Only the bark was collected from the stems of the beech trees and (2.0 kg each)
splintered manually. The species was identified and authenticated by Dr. Corneliu Tanase from the
Department of Pharmaceutical Botany, the first author of the manuscript. The beech bark was air-dried
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at room temperature (10.5% humidity) and milled in a GRINDOMIX GM 2000 mill to a mean particle
size diameter of 0.5 mm. The biomass was directly used without any pre-treatments.
2.3. Extraction
The extraction process was carried out based on a DoE (Design of Experiments) developed using
Modde software, version 11.0 (Sartorius Stedim Data Analytics AB, Umeå, Sweden). The D-optimal
design type, which is based on the selection of the experiments so that they are spread over the largest
area of the variability matrix, allowed the study of two quantitative factors which varied on different
levels, namely the microwave power, with 4 levels of variation (300, 450, 600, 800 W) and the extraction
time, varied over 3 levels (2, 3, 4 min). The amount of extracted total phenolic content (TPC) using
different solvent types (water, ethanol–water 50:50 and 80:20) was introduced in the DoE as 3 separate
responses, which allowed a good comparison of the solvents’ TPC extraction capacities (Table 1).
Table 1. Variables, symbols, and levels of variation used in the experimental design.
Variables Symbol Level of Variation
Independent Variables (Factors)
Extraction time (min) X1 2 3 4
Microwave power (W) X2 300 450 600 800
Dependent Variables (Responses)
Extraction solvent-water BBE 1
Extraction solvent—50:50 ethanol–water BBE 2
Extraction solvent—80:20 ethanol–water BBE 3
Notes: mg GAE/g = gallic acid equivalents per gram plant material.
Bark was weighed (2 g) and mixed with 20 mL of solvent (water, 50:50 ethanol–water, 80:20
ethanol–water) in Falcon tubes. The Microwave extraction (MAE) was performed using a domestic
microwave oven (Samsung MS23K3513). 7. After extraction, solvent was added to give a final volume
of 20 mL. Each tube was centrifuged (Hettich, Micro 22R, Andreas Hettich GmbH & Co., Tuttlingen,
Germany) 15 min at 3000 rpm, maintaining the extraction temperature. The supernatant was carefully
separated, and the solvent was removed under vacuum at 40 ◦C using a rotary evaporator (Hei-VAP,
Heidolph Instruments GmbH & Co., Schwabach, Germany).
2.4. Quantitative Determinations of Total Phenolic Content
The total phenolic content (TPC) of the BBE extracts was determined by Folin-Ciocâlteu
spectrophotometric method according to a method described previously [14]. Gallic acid was
used as a reference standard, and the content of phenolics was expressed as gallic acid equivalents
(GAE) per gram of dry plant material (mg GAE/g dry plant material).
2.5. Phytochemical Analysis by LC-MS/MS
For the description of bark extracts’ phytochemical composition a validated analytical method of liquid
chromatography tandem mass spectrometry was employed (LC-MS/MS). The analysis was performed
using an Agilent 1100 HPLC Series system (Agilent, Santa Clara, CA, USA) which was equipped with
binary gradient pump, degasser, auto sampler, column thermostat, and UV detector. The LC system was
coupled with an Agilent Ion Trap 1100 SL mass spectrometer (LC/MSD Ion Trap VL).
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The LC-MS/MS analytical method was previously developed and validated [15,16] and was used for
the identification of 18 polyphenols in BBE samples: caftaric acid, gentisic acid, caffeic acid, chlorogenic
acid, p-coumaric acid, ferulic acid, sinapic acid, hyperoside, isoquercitrin, rutin, myricetol, fisetin,
quercitrin, quercetin, patuletin, luteolin, kaempferol, and apigenin. For the chromatographic separation
of polyphenols, a reverse-phase analytical column was used (Zorbax SB-C18, 100 mm × 3.0 mm i.d.,
3.5 μm). The mobile phase was a mixture of methanol: acetic acid 0.1% (v/v) and a binary gradient
was used. The elution started with a linear gradient, beginning with 5% methanol and ending at
42% methanol for 35 minutes; then isocratic elution followed for 3 min with 42% methanol. For the
chromatographic data processing, the ChemStation and DataAnalysis software (Agilent, Santa Clara,
CA, USA) were used.
Moreover, in order to identify other six polyphenols in BBE samples (epicatechin, catechin, syringic
acid, gallic acid, protocatechuic acid, and vanillic acid) a second LC-MS method was employed [15].
For the separation of the aforementioned compounds, the same analytical column as previously
specified was used. Likewise, the mobile phase consisted of a mixture of methanol: acetic acid 0.1%
(v/v) and a binary gradient was used. The elution started with 3% methanol for 3 min, followed by
8% methanol until 8.5 min when 20% methanol was used and kept for the next 10 min, and then the
column was rebalanced with 3% methanol. The flow rate was set at 1 mL/min and the sample injection
volume was 5 μL. The MS detection mode was selected for detection of the polyphenolic compounds.
The ionization on the MS system was in negative mode using an electrospray ion source (capillary
+3000 V, nebulizer 60 psi (nitrogen), dry gas nitrogen at 12 L/min, dry gas temperature 360 ◦C). Each
identified polyphenol was further quantified in BBE extracts. The results were expressed as milligrams
of phenolic compound per gram of herbal material.
2.6. Antioxidant Activity Assays
The capacity to scavenge the DPPH, monitored according to the method described by
Martins et al. [15,17] was performed by using a SPECTRO star Nano microplate reader (BMG Labtech,
Offenburg, Germany). The results were expressed as Trolox equivalents (TE) per gram of dry extract
(mg TE/g of dry extract).
The radical scavenging activity of the beech bark extracts against ABTS was measured according
to Mocan et al. [18]. The results were expressed as milligrams of TE per gram of dry extract (mg TE/g
dry extract).
In FRAP assay, the reduction of Fe3+-TPTZ to blue-colored Fe2+-TPTZ complex was monitored [19].
Briefly, the FRAP reagent was prepared by mixing ten volumes of acetate buffer (300 mM, pH 3.6), one
volume of TPTZ solution (10 mM TPTZ in 40 mM HCl) and one volume of FeCl3 solution (20 mM
FeCl3·6H2O in 40 mM HCl). The reaction mixture (25 μL sample and 175 μL FRAP reagent) was
incubated for 30 min at room temperature (in the dark) and the absorbance was measured at 593 nm
(SPECTROstar Nano Multi-Detection Microplate Reader with 96-well plates, BMG Labtech, Ortenberg,
Germany). A TroloxTM calibration curve (0.01–0.10 mg/mL) was plotted, and the results were expressed
as milligrams of TE per milligram of dry extract (mg TE/mg dry extract).
2.7. Antidiabetic (Glucosidase inhibitory) Assay
The α-glucosidase inhibitory assay was measured according to method described previously [20,21].
In brief, 50 μL of sample diluted in 50 μL 100 mM-phosphate buffer (pH 6.8) in a 96-well
microplate, were mixed with 50 μL yeast α-glucosidase for 10 min before 50 μL substrate (5 mM,
p-nitrophenyl-α-D-glucopyranoside prepared in same buffer) were added. The release of p-nitrophenol
was measured at 405 nm, 20 min after incubation. The blanks for test samples were prepared, and acarbose
was used as a standard inhibitor, the results being expressed as IC50 or percentage of inhibition (where the
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sample was not enough active to be able to calculate an IC50 value for a tested concentration of 8 mg/mL)
using the following formula:
Inhibition (%) = [(Abscontrol − Abssample)/Abscontrol] × 100 (1)
2.8. Tyrosinase Inhibitory Activity
Tyrosinase inhibitory activity of each sample was determined by method previously described by
Chen et al. [22] using a SPECTROstar Nano Multi-Detection Microplate Reader with 96-well plates
(BMG Labtech, Ortenberg, Germany). Samples were dissolved in water containing 5% DMSO; for each
sample four wells were designated as A, B, C, D; each one contained a reaction mixture (200 μL) as
follows: (A) 120 μL of 66 mM phosphate buffer solution (pH = 6.8) (PBS), 40 μL of mushroom tyrosinase
in PBS (46 U/mL) (Tyr), (B) 160 μL PBS, (C) 80 μL PBS, 40 μL Tyr, 40 μL sample, and (D) 120 μL PBS,
40 μL sample. The plate was then incubated at room temperature for 10 min; after incubation, 40 μL of
2.5 mM L-DOPA in PBS solution were added in each well and the mixtures were incubated again at
room temperature for 20 min. The absorbance of each well was measured at 475 nm, and the inhibition
percentage of tyrosinase activity was calculated by the following equation, using a kojic acid solution
(0.10 mg/mL) as a positive control:
%I =
(A− B) − (C−D)
(A− B) × 100 (2)
2.9. Assay of Antimicrobial Activity
2.9.1. Bacteria and Culture Conditions
For bacterial strains were used: one gram positive strain, Staphylococcus aureus (ATCC 49444),
and three gram negative strains, namely Pseudomonas aeruginosa (ATCC 27853), Salmonella typhimurium
(ATCC 14028) and Escherichia coli (ATCC 25922). The strains were cultured on Muller-Hinton agar
stored at 4 ◦C.
2.9.2. Microdilution Method
The modified microdilution technique was used to evaluate the antimicrobial activity. Cell
suspensions were adjusted to a concentration of approximately 2 × 105 CFU/mL in a final volume of
100 μL per well. The inoculum was stored at 4 ◦C for further use. Minimum inhibitory concentrations
(MICs) were performed using 96-well plates. Dilutions of the extracts were carried out in wells
containing 100 μL of Muller-Hinton broth and 10 μL of inoculum was added to all the wells.
The microplates were incubated for 24 h at 37 ◦C. The MIC was detected following the addition of 20 μL
(0.2 mg/mL) of resazurin solution to each well, and the plates were incubated 2 h at 37 ◦C. The MIC was
identified as the lowest concentration that prevented the color change from blue to pink. The minimum
bactericidal concentrations (MBCs) were determined by serial subcultivation of 2 μL into 96-well plates
containing 100 μL of broth per well and further incubation for 48 h at 37 ◦C. The lowest concentration
with no visible growth was defined as MBC, indicating 99.5% killing of the original inoculum.
2.9.3. Antifungal Activity
Antifungal activities were investigated by using the following fungi: Candida albicans (ATCC 10231),
Candida parapsilosis (ATCC 22019), and Candida zeylanoides (ATCC 20356). Spore suspension (1.5 × 105)
was obtained by washing agar plates with sterile solution (0.85% saline, 0.1% Tween 80 (v/v)), then
added to each well for a final volume of 100 μL. The minimum inhibitory (MIC) and minimum
fungicidal (MFC) concentrations assays were performed using the microdilution method by preparing
a serial of dilutions in 96-well plates. The extracts were diluted in 0.85% saline (10 mg/mL), then added
to microplates containing Broth Malt medium with inoculum and incubated for 72 h at 28 ◦C on a
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rotary shaker. The lowest concentrations without visible growth (at the binocular microscope) were
defined as minimal inhibitory concentrations (MICs). The fungicidal concentrations (MFCs) were
determined by serial sub-cultivation of 2 μL of tested extracts dissolved in medium and inoculated
for 72 h, into microtiter plates containing 100 μL of broth per well and further incubation for 72 h at
28 ◦C. The lowest concentration with no visible growth was defined as MFC indicating 99.5% killing of
the original inoculum. The fungicide fluconazole (Sigma F 8929, Santa Clara, CA, USA) was used as
positive control (1–3500 μg/mL). All the experiments were performed in duplicate and repeated thrice.
Water was used as a negative control.
2.10. Mutagen and Antimutagen Activity
Mutagen and antimutagenity of samples were examined using the plate incorporation method [23]
described in detailed by Sarac and Sen [24]. 4-NPD (4-nitro-o-phenylenediamine) 3 μg/plate and NaN3
8 μg/plate were used as positive controls for S. thyphimurium TA98 and S. thyphimurium TA100 (negative
control—ethanol:water 1:1, v/v). The concentration of BBE was 5 mg/plate. The antimutagenity of the
reference mutagens in the absence of the BBE was defined as 0% inhibition, and the antimutagenity
was calculated according to the formula given by Ong et al., [25] as it follows: % Inhibition = [1 − T/M]
× 100, where, T is the number of revertants per plate in the presence of mutagen and the BBE and M
is the number of revertants per plate (without BBE) in the positive control. The data was presented
as mean ± standard deviation (SD). Antimutagenity was recorded as follows: strong: 40% or more
inhibition; moderate: 25%–40% inhibition; low/none: 25% or less inhibition [26].
2.11. Statistical Analysis
All samples were analyzed in triplicate (n = 3) and the results were expressed as the mean ±
Standard Deviation (SD). The statistical analysis of the obtained experimental data was also performed
by using the Modde 11.0 DoE software (Sartorius Stedim Data Analytics AB, Umeå, Sweden), which
automatically calculated the statistical parameters necessary for the evaluation of the fitting quality,
including the ANOVA test.
3. Results and Discussion
3.1. Fitting of the Experimental Data with the Models
The quantitative factors studied were the microwave power, with 4 levels of variation (300, 450,
600, 800 W) and the extraction time, varied over 3 levels (2, 3, 4 min). The total phenolic contents
(TPCs) extracted with different solvent types (water, ethanol–water 50:50 and 80:20) were introduced in
the DoE as 3 separate responses, which allowed a good comparison of their TPC extraction capacities.
As presented in Table 2, the design matrix calculated by the DoE software comprised
15 experimental runs, including three replicates that were used to confirm the experimental
reproducibility, and to allow the identification of potential errors. Moreover, in order to reduce
foreseeable results, the experimental runs were performed in a randomized order, dictated by the
software. After performing all experimental runs, the registered response values were centralized
and further introduced into the DoE matrix, where the fitting of the data has been accomplished by
applying a multiple linear regression (MLR) algorithm. The fitting quality was evaluated by using the
recommended, most reliable statistical parameters, i.e., the goodness of fit (R2), prediction capacities
(Q2), model reproducibility given by the three performed replicates and model validity represented by
the ANOVA test.
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BBE 1 BBE 2 BBE 3
(TPC mg GAE/g Dry Plant Material ± SD)
N1 1 2 300 51.53 67.27 62.26
N2 6 4 300 47.44 76.46 61.87
N3 3 3 300 50.53 69.59 64.77
N4 2 2 450 56.79 66.43 66.20
N5 7 4 450 48.19 77.53 66.00
N6 5 3 450 54.55 70.32 67.86
N7 11 4 600 52.79 72.43 70.95
N8 10 3 600 58.61 72.06 70.20
N9 8 2 800 71.80 73.02 64.12
N10 14 2 800 72.31 72.46 64.27
N11 4 4 800 56.15 73.23 65.97
N12 12 4 800 55.68 73.32 66.07
N13 9 3 600 58.91 72.09 69.81
N14 15 3 600 59.00 71.91 70.33
N15 13 3 600 59.10 71.92 69.93
Notes: values with bold—outliers, TPC—total phenolic content expressed as mg GAE/g—gallic acid equivalents per
dry plant material. BBE 1—extracts obtained with water 100%, BBE 2 extracts obtained with ethanol–water 50:50,
BBE 3 extracts obtained with ethanol–water 80:20. Each value is the mean ± SD of three independent measurements.
Firstly, in order to improve the raw model by identifying and eliminating potential outliers, two
graphs were generated for each response separately; the residuals plot (Figure 1a) which illustrates the
residuals on a cumulative normal probability scale and the observed vs. predicted plot (Figure 1b)
which allows the investigation of individual points that deviate from the diagonal line. By analyzing
the two plots, outliers—marked with gray in Table 3, have been identified and eliminated, providing
in this way an excellent fitted model, with high prediction capacities, as shown in the summary of
fit chart (Figure 1c). In order to confirm the statistical validity of the model, the ANOVA test was
performed (Supplementary file, Table S1). The registered p values were <0.001 for the model, describing
a statistically valid design, indicating a significant impact of the factors on the responses. The p values
registered for the lack of fit were > 0.099, showing that the model has insignificant lack of fit [27].
The generated coefficient plot (Figure 1d) allows the evaluation of factors’ (independent variables)
effects over the obtained responses, this type of diagram is used to evaluate the significance and
influence of the model terms, each term or interaction being represented as a scaled and centered
coefficient. In the present case, the diagram, shows that the extraction time varies inversely (for water
100%) or directly (for ethanol–water 50:50) with the amount of extracted TPC. The microwave power
favors TPC extraction but in different proportions.















(TPC mg GAE/g Plant Material)
water BBE 1 2 800 72.05 69.76 96.82
50:50 ethanol–water BBE 2 4 300 76.55 76.31 99.69
80:20 ethanol–water BBE 3 3.1 600 70.09 69.75 99.51
Notes: BBE 1—extracts obtained with water 100%, BBE 2—extracts obtained with ethanol–water 50:50, BBE
3—extracts obtained with ethanol–water 80:20.
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Figure 1. Graphical summary of (a) residuals normal probability; (b) observed vs. predicted
(c) summary of fit; (d) scaled and centered coefficients (TPC100—total phenolic content in extracts
obtained with water 100%, TPC50/50—total phenolic content in extracts obtained with ethanol–water
50:50, TPC80/20—total phenolic content in extracts obtained with ethanol–water 80:20).
3.2. Optimization of the Extraction Parameters
The fitting and analysis of the data obtained after performing all the experimental runs stipulated
in the DoE matrix, led to an in depth understanding of the variables’ influence over the microwaved
extraction process. Further, the optimization module of the DoE software has been used in order to
calculate the optimal combination of extraction parameters, having as target the highest extraction
yield obtained by using stable parameters. The optimization has been performed separately for each
type of extraction solvent, the software also being able to predict not only the optimal combination of
extraction parameters, but also the extracted TPC value.
After performing the stipulated optimal runs, results of the experimentally obtained TPC were
compared with the DoE predicted ones, the registered recovery percent being >96% for BBE1 and
close to 100% for BBE2 and BBE3, highlighting the high prediction capacity of the model. The optimal
extraction parameters, DoE predicted- and experimentally-obtained TPC values are presented in
Table 3.
3.3. Identification and Quantification of Individual Polyphenols
The optimized extracts obtained from the beech bark (water—BBE1, 50% (v/v) ethanolic—BBE2
and 80% (v/v) ethanolic—BBE3) were investigated in terms of their phytochemical profile. For the
individual polyphenols identification and quantification, the previously described LC-MS/MS analytical
methods were employed. The results of this analysis are summarized in Table 4 [15].
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Table 4. Quantitative (μg/g dry plant material) evaluation of the recovery of main bioactive compounds










BBE1 22.7 ± 2.72 300.7 ± 44.22 24.2 ± 3.02 1.9 ± 0.14 3.3 ± 0.29 49.9 ± 7.28
BBE2 39.6 ± 3.24 577.4 ± 56.58 7.5 ± 0.78 NF 6.2 ± 0.41 18.0 ± 1.52
BBE3 33.4 ± 3.55 465.1 ± 51.62 5.8 ± 0.68 NF 5.7 ± 0.74 16.1 ± 1.55
Notes: NF—not found, below limit of detection; BBE1—extracts obtained with water 100%, BBE2—extracts obtained
with ethanol–water 50:50, BBE3—extracts obtained with ethanol–water 80:20. Data are shown as mean ± standard
deviation (SD).
From the 18 phenolic compounds analyzed by the LC-MS/MS method, chlorogenic acid, ferulic
acid and isoquercitrin, were identified in all tested BBEs. Quercetin was identified only in beech bark
extract obtained with 100%water (BBE1). From the phenolic compounds identified by this method,
only ferulic acid found in BBE1, was quantified (43.7 ± 5.03 μg/g dry plant material). The polyphenols
(epicatechin, catechin, syringic acid, protocatechuic acid, and vanillic acid) analyzed by the other
LC-MS method were identified and quantified in all tested BBEs (Table 4). Gallic acid was identified
only in BBE1.
In previous studies some of the phenolic compounds obtained from beech bark were identified,
including catechin, epicatechin, quercetin, taxifolin, procyanidins, syringic acid, coumaric acid [11,12].
3.4. Assay of the Antioxidant Activity
The antioxidant activity of optimized beech bark extracts was evaluated by DPPH, FRAP and
TEAC assays. The beech bark extracts exhibited scavenging activity against all radicals as shown in
Table 5. The strongest antioxidant activity is recorded for BBE2, where the strongest amount of phenols
was recorded. Many bark extracts have been evaluated for their antioxidant capacities, commonly
associated to their content of phenolic compounds [28–30]. Beech bark contains some of biologically
active components, such as catechin, epicatechin, syringic acid, vanillic acid etc., indicating that the
antioxidant activity of the extracts can be at least partially ascribed to these bio-components (Table 4).
Grzesik et al. [31] studied the antioxidant properties of five catechins, compared with other natural or
synthetic compounds. They concluded that catechins showed the strongest ABTS scavenging capacity
and the strongest stoichiometry of Fe3+ reduction in the FRAP assay [31]. Besides the direct antioxidant
properties of catechins, they may show synergistic interaction with endogenous antioxidants and act
as indirect antioxidants as well [32,33].
Table 5. Antioxidant activity of optimized beech bark extracts.
Sample Code
TPC mg GAE/g of
Dry Extract
DPPH mg TE/g of
Dry Extract
TEAC mg TE/g of
Dry Extract
FRAP mg TE/g of
Dry Extract
BBE 1 69.76 ± 1.54 676.29 ± 19.80 472.08 ± 67.07 625.13 ± 9.62
BBE 2 76.49 ± 2.41 741.43 ± 59.44 619.85 ± 20.75 783.24 ± 31.24
BBE 3 69.86 ± 1.04 505.02 ± 42.02 464.41 ± 37.42 592.84 ± 44.02
TPC—total phenolic content, DPPH—2,2-diphenyl-1-picrylhydrazyl, TEAC—Trolox equivalent antioxidant capacity,
FRAP—ferric reducing ability of plasma, BBE1- extracts obtained with water 100%, BBE2—extracts obtained with
ethanol–water 50:50, BBE3—extracts obtained with ethanol–water 80:20 ± Standard deviation.
3.5. Assay of the Antimicrobial Activity
The antimicrobial (antibacterial and antifungal) activity of BBEs was tested against four bacteria
and three fungi, selected based on their relevance for public health. Staphylococcus aureus was the
most sensitive strain towards all tested samples, with similar values of MIC (1.56 mg/mL) and MBC
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(3.12 mg/mL) (Table 6). Additionally, all tested extracts showed a good antibacterial activity on E. coli,
P. aeruginosa, and S. typhimurium strains (MIC—3 mg/mL, and MBC—6 mg/mL).
The antibacterial activity of phenolic compounds has been demonstrated in various studies [4,6].
The previous study of the aqueous beech bark extract, underlined the antimicrobial activity against
methicillin-resistant S. aureus [11].
Concerning the antifungal activity of the samples (Table 7), all tested Candida species, exhibited
the highest sensitivity to aqueous extract of beech bark (BBE1) with 25 mg/mL MIC and 50 mg/mL MFC
(Table 7). The effect of ethanolic extracts (BBE2, BBE3) on Candida species was absent at a concentration
of 50 mg/mL.
Thus, the antibacterial activity of BBE could be attributed at least in part to phenolic compounds.














Minimum Inhibitory Concentration (MIC)
BBE1 1.56 3 3 3
BBE2 1.56 3 3 3
BBE3 1.56 3 3 3
Minimum Bactericidal Concentration (MBC)
BBE1 3.12 6 6 6
BBE2 3.12 6 6 6
BBE3 3.12 6 6 6
Notes: BBE1—extracts obtained with water 100%, BBE2—extracts obtained with ethanol–water 50:50, BBE3—extracts
obtained with ethanol–water 80:20.









Minimum Inhibitory Concentration (MIC)
BBE1 25 25 25
BBE2 NF >50 >50
BBE3 NF >50 >50
Minimum Fungicidal Concentration (MFC)
BBE1 50 50 50
BBE2 NF >50 >50
BBE3 NF >50 >50
Notes: BBE1—extracts obtained with water 100%, BBE2—extracts obtained with ethanol–water 50:50, BBE3—extracts
obtained with ethanol–water 80:20.
3.6. Antimutagenity Activity
The aim was to investigate the mutagen and antimutagen activities of BBE by the bacterial reverse
mutation assay in Salmonella typhimurium (S. typhimurium) strains. The antimutagenity of BBE against
S. typhimurium TA 98 and TA 100, was tested by comparing the numbers of induced revertants and
spontaneous revertants. According with Table 8, TA98 and TA100 strains increase in the number
of revertant colonies compared with the negative control when the bacteria was treated with BBE
at 5 mg/plate concentration, thereby indicating an antimutagenic activity. Thus, all extracts were
antimutagenic to the frameshift TA98 or TA100 S. typhimurium strains.
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To determine the potential antimutagen activity of the BBE to prevent DNA damage by
4-NPD/NaN3 (positive mutagen/carcinogen), BBE were incubated together with 4-NPD/NaN3.
The results are presented in Table 8. The percentage of inhibition of mutagen activity of 4-NPD/NaN3
(antimutagenity) of the beech bark extracts ranged from 3.6 to 17.01% in S. typhimurium TA98 and
from 15.47 to 16.33% in S. typhimurium TA100. The BBE1 had the highest value for antimutagen
activity (17% for S. typhimurium TA98 and 16.33% for S. typhimurium TA100). The antimutagen effect
is considered low when the inhibitory effect is less than 25%, moderate when the inhibitory effect is
between 25%–40% and strong when the effect is more than 45% [26,34]. Thus, based on the literature
data, beech bark extracts assayed in this study may be considered to have low or no antimutagen effects.





Mean ± SD Inhibition % Mean ± SD Inhibition %
Negative Control 9.25 ± 3.6 a 9.25 ± 2.4 b
BBE1 a 161 ± 3.6 17,01 292 ± 6.4 16,33
BBE2 a 187 ± 4.4 3.60 295 ± 6.4 15.47
BBE3 a 172 ± 3.8 11.34 294 ± 6.2 15,75
4-NPD c 193 ± 3.4 - - -
NaN3 c - - 349 ± 15.22 -
Notes: a BBE1—extracts obtained with water 100%, BBE2—extracts obtained with ethanol–water 50:50,
BBE3—extracts obtained with ethanol–water 80:20; b Values expressed are means ± SD of three replications;
c 4-NPD and NaN3 were used as positive controls for S. thyphimurium TA98 and TA100 strains, respectively.
3.7. In Vitro Enzyme Inhibitory Properties of Beech Bark Extracts—α-Glucosidase (Antidiabetic) and
Tyrosinase Inhibitory Activity
Diabetes mellitus is a chronic, life-long disorder and is characterized by high blood glucose levels.
One of the ways of treating diabetes mellitus is based on glucose absorption delay by inhibiting
enzymes such as α-glucosidase in digestive organs [35]. By inhibiting α-glucosidase in the intestine,
the rate of oligosaccharides hydrolysis is low, and the carbohydrate digestion process extends into the
lower part of the small intestine [36]. Many studies have demonstrated the α-glucosidase inhibitory
activity of some bark herbal extracts, proving their strong biochemical potential [37,38]. For example,
different extracts of Canarium tramdenum bark were evaluated in terms of α-glucosydase inhibition
showing a strong inhibitory activity. The different enriched extracts in terpenoids and phenolics
appeared as a promising source of natural α-glucosidase inhibitors [38].
As shown in Table 9, the α-glucosidase inhibitory activity was determined for all BBEs and was
higher in comparison with the standard acarbose (Table 9). The order of α-glucosidase inhibition is
BBE3 > BBE1 > BBE2 > acarbose corresponding to IC50 values 38, 92, 168, and 838 μg/mL, respectively.






1. BBE1 92 NF
2. BBE2 168 45.99 ± 5.26%
3. BBE3 38 NF
4. Acarbose 838 -
5 Kojic acid (1 mg/mL) - 97.61 ± 0.24%
Notes: BBE1—extracts obtained with water 100%, BBE2—extracts obtained with ethanol–water 50:50, BBE3—extracts
obtained with ethanol–water 80:20, PI—procent of inhibition, NF—not found.
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Tyrosinase inhibitors are compounds capable of reducing enzymatic reactions, especially from
the skin, which makes them commercially relevant for cosmetic industry [39]. At a concentration
of 4.025 mg/mL, inhibitory effects have been shown only for BBE2 sample. However, kojic acid (a
standard inhibitor) showed an excellent tyrosinase inhibitory activity of 97.61 ± 0.24%.
4. Conclusions
The results of this study indicate that MAE is an efficient extraction method of phenolic compounds
from beech bark. The optimum conditions which gave the highest TPC (76.57 mg GAE/g dry plant
material) were reached when the microwave power was 300 W, the extraction time was 4 min, and the
solvent was a mixture of ethanol–water (50:50). The practical value of TPC after a control experiment
was 76.49 mg GAE/g dry plant material.
The extracts obtained in optimum conditions were characterized by HPLC-MS/MS. The identified
compounds in all tested BBEs were: vanillic acid, epicatechin, catechin, protocatechuic acid, chlorogenic
acid, ferulic acid, and isoquercitrin. Quercetin and gallic acid were identified only in beech bark extract
obtained with 100%water.
The beech bark extracts exhibited free-radical-scavenging activity in all assays, and were active
against S. aureus, P. aeruginosa, S. typhimurium, and E. coli. All tested Candida species were sensitive to
beech bark aqueous extract. Additionally, all extracts were active on α-glucosidase. The beech bark
extracts assayed may be considered to have low or no antimutagen effects.
This study documented that Fagus sylvatica L. bark possesses antioxidant activity and has
α-glucosidase inhibitory effects, by several in vitro experiments. Ethanol and water extracts can be
considered as promising sources of natural antioxidants, antimicrobian agents, and α-glucosidase
inhibitors. The isolation of bioactive constituents and investigations on several biomedical properties
of F. sylvatica bark should be conducted in future experiments.
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Abstract: In the present work, the ultrasonic-assisted extraction (UAE) of total flavonoids (TF) from Pteris
cretica L. was optimized by response surface methodology (RSM) on the basis of a single-factor experiment.
The optimized UAE parameters were as follows: Ethanol concentration 56.74%, extraction time 45.94 min,
extraction temperature 74.27 ◦C, and liquid/solid ratio 33.69 mL/g. Under the optimized conditions, the total
flavonoids yield (TFY) was 4.71 ± 0.04%, which was higher than that obtained by heat reflux extraction
(HRE). The extracts were further analyzed by HPLC, and five major flavonoids, including rutin, quercitrin,
luteolin, apigenin, and luteolin-7-O-glucoside, were identified and quantified. Furthermore, the results
of the antioxidant test showed that the TF extract obtained under optimized UAE conditions exhibited
good 2,2-diphenyl-1-picrylhydrazyl radical (DPPH•) and 2,2-azino-bis(3-ethylbenzothiazoline-6-sulfonic
acid) radical (ABTS+•), nitric oxide radical (NO•) scavenging activities, and ferrous ion (Fe2+) chelating
capacity, with IC50 values of 74.49, 82.92, 89.12, and 713.41 μg/mL, respectively. Results indicated that the
UAE technique developed in this work was an efficient, rapid, and simple approach for the extraction of
flavonoids with antioxidant activity from P. cretica.
Keywords: Pteris cretica L.; flavonoids; ultrasonic-assisted extraction; optimization; response surface
methodology; HPLC analysis; antioxidant activity
1. Introduction
Pteris cretica L., a perennial evergreen herb, belongs to the genus Pteris (Pteridaceae). The genus
Pteris, geographically distributed over the tropical and subtropical regions of the world, consists
of approximately 250 species, many of which have been cultivated for ornamental, culinary, and
medicinal purposes [1,2]. Historically, several species of the genus Pteris have been used as folk
medicine to treat burn injuries, indigestion, diarrhea, furuncles, eczema, apoplexy, jaundice, snakebites,
and hemorrhages in China [3,4]. Due to the outstanding medicinal potential, modern investigations
on the Pteris species have been performed extensively, which reveal that these plants contain various
bioactive components, including flavonoids [5–7], sesquiterpenoids [3,8,9], and diterpenoids [9–11].
Flavonoids isolated from plants of this genus, including kaempferol, quercetin, rutin, apigenin,
luteolin, and luteolin 7-O-sophoroside, especially contribute to various pharmacological effects, such as
antibacterial [12], antioxidant [13], and anti-benign prostatic hyperplasia [14] potentials.
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As is known to all, extraction is a preliminary step in phytochemical research, which is also
a necessary step in pharmaceutical research. Conventional extraction methods, including maceration,
decoction, heat reflux, and Soxhlet extraction, are time-consuming, costly, and inefficient [15].
Fortunately, ultrasonic-assisted extraction (UAE) makes up for those shortcomings because the
cavitation, vibration, crushing, and mixing effects in media produced by ultrasound can break the cell
wall and increase the mass transfer process effectively [16]. In addition, UAE can not only avoid the
heat-induced destruction of bioactive ingredients, but also helps to improve the safety of products [17].
Hence, UAE as an alternative technique has been widely used for the extraction of natural bioactive
compounds, especially flavonoids, for instance, flavonoids from Medicago sativa Linn [18], Ampelopsis
grossedentata leaves [19], and Olea europaea leaves [20]. To the best of our knowledge, research on the
extraction of flavonoids from P. cretica have not been reported.
Admittedly, extraction yield and pharmacological action depend greatly on the comprehensive
effect of several various factors, including the extraction method, solvent type, extraction time,
extraction temperature, pH, and liquid/solid ratio [21]. Therefore, to maximize the extraction yield
of bioactive substances and pharmacological effects, optimization of the extraction process is quite
essential. Recently, response surface methodology (RSM) as an advanced chemometric tool has been
frequently applied to the optimization of the extraction process [22]. RSM design can reduce the
number of experimental trials, resulting in lower reagent consumption and less laboratory work.
Additionally, RSM design yields a mathematical model to account for the reciprocal influence of
various independent variables [23]. Box–Behnken design (BBD), one type of RSM, is easier to interpret
and perform in comparison with other designs [24].
The present study is an attempt to establish an efficient UAE technique for total flavonoids from
P. cretica. First, the effects of four independent variables, including ethanol concentration, extraction
time, extraction temperature, and liquid/solid ratio, on the yield of total flavonoids were investigated.
Second, the reciprocal actions of independent variables were investigated followed by the optimization
of the UAE process using RSM. Third, a heat reflux extraction experiment was carried out to verify the
efficiency of the UAE method developed. Fourth, a comparison of flavonoid profiles of the extracts
obtained by UAE under optimized conditions and heat reflux extraction (HRE) was performed by
HPLC. In addition, the antioxidant activity of extracts obtained by optimized UAE was evaluated by
2,2-diphenyl-1-picrylhydrazyl radical (DPPH•), 2,2-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)
radical (ABTS+•), nitric oxide radical (NO•) scavenging activities, and Fe2+ chelating activity.
2. Materials and Methods
2.1. Chemicals and Reagents
Rutin, quercetin, luteolin, apigenin, and luteolin-7-O-glucoside standards were obtained from
Shanghai Yuanye Bio-Technology Co., Ltd. (Shanghai, China). HPLC grade trifluoroacetic acid (TFA)
and methanol were obtained from Aladdin Reagent Co., Ltd. (Shanghai, China). Ascrobic acid,
2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS),
ethylenediaminetetraacetic acid disodium salt (EDTA-2Na), sodium nitroprusside (SNP), potassium
persulfate (K2S2O8), and trolox were obtained from Sigma-Aldrich (St. Louis, MO, USA). Other chemicals
used (analytical grade) were bought from Kemio Chemical Reagent Co., Ltd. (Tianjin, China).
2.2. Plant Material
P. cretica was collected from Kunming City, Yunnan Province, China. A voucher specimen
(FWJ-20180301) was deposited in the College of Life Science, Dalian Minzu University, Dalian, China.
The plant material was dried under natural ventilation until reaching constant weight. The plant
material was then powdered and stored in an air-tight container for further use.
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2.3. Optimization of UAE of TF from P. cretica
2.3.1. Single-Factor Experiments
The UAE of TF from P. cretica was performed in a water-bath sonicator (KQ5200DE, 40 kHz
frequency and 200 W nominal power, Kunshan Ultrasonic Instrument Co., Jiangsu, China). To study
the influence of ethanol concentration on the total flavonoids yield (TFY), 5.0 g of pretreated samples
were placed into glass conical flasks (250 mL) and soaked with ethanol solvents (varying from 30–80%,
v/v), the time for extraction was set at 30 min, the temperature applied for extraction was set at 70 ◦C,
and the liquid/solid ratio was set at 30 mL/g. To select the optimum extraction time, different extraction
times (10, 20, 30, 40, 50, and 60 min) were tested under the conditions of ethanol concentration 60%,
extraction temperature 70 ◦C, and liquid/solid ratio 30 mL/g. To choose the best extraction temperature,
different extraction temperatures (40, 50, 60, 70, 80, and 90 ◦C) were studied under the following
conditions: Ethanol concentration 60%, extraction time 40 min, and liquid/solid ratio 30 mL/g. Finally,
the effect of liquid/solid ratios of 15, 20, 25, 30, 35, and 40 mL/g on the extraction yield was evaluated
under the following conditions: Ethanol concentration 60%, extraction time 40 min, and extraction
temperature 70 ◦C. After each UAE, the extraction solution was filtered, and the sample residue was
re-extracted twice under the same extraction conditions. The combined extractive solution was then
concentrated in vacuo and the extract was stored at −20 ◦C for further analysis.
2.3.2. RSM Design
Based on the results of single-factor experiments, the UAE of TF from P. cretica was further
optimized by RSM. In this work, the BBD with four variables (ethanol concentration X1, extraction
time X2, extraction temperature X3, and liquid/solid ratio X4) at three levels (−1, 0, 1) was carried out
to evaluate the effect between every two variables on the response value (TFY Y). The BBD procedure
of RSM resulted in a total of 29 randomized experiments, and a quadratic model used to analyze
experimental data was shown as follows:












where Y is the response value; α0 refers to the intercept; αi, αii, and αij refer to the linear, quadratic, and
interactive coefficients, respectively; Xi and Xj represent the independent variables (i  j).
2.4. Conventional Heat Reflux Extraction (HRE)
A comparative study between the HRE and UAE was carried out to estimate the efficiency of
the UAE process established in this work. The HRE of TF from P. cretica was performed under the
optimized UAE conditions with slight modifications. In brief, 5.0 g of the pre-prepared sample was
extracted three times under reflux with 170 mL of 57% ethanol at 75 ◦C, each time for 2 h. After the
HRE, the extract was processed as the method described in Section 2.3.1.
2.5. Measurement of Total Flavonoids Content (TFC)
The total flavonoids content (TFC) was measured using the aluminium chloride colourimetric
method reported by with slight modifications [25]. First, to 0.5 mL of the sample solution, 0.15 mL of
NaNO2 (5%, w/v) was added. After the mixture was stirred for 5 min, 0.15 mL of (10%, w/v) AlCl3 was
added. After another 5 min, 1 mL of NaOH (1 M) was added. The solution was then made up to a final
volume of 5 mL by the addition of ultrapure water. After complete addition, the reaction mixture was
further incubated at ambient temperature for 20 min, and the absorbance was immediately recorded at
510 nm with an UV-vis Spectrophotometer (UV-2600, Shimadzu, Kyoto, Japan). Rutin was used as
a reference, and the TFC was calculated according to the regression equation: y = 11.2736x− 0.0028
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(R2 = 0.9997, final rutin concentration 18.12–72.48 μg/mL), where y is the absorbance, x is the content
(μg/mL), and the TFY was calculated by the equation given below:




where C represents the TFC (mg/mL); V represents the total volume of extractive solution (mL); and W
represents the dry weight of plant material (mg).
2.6. HPLC Analysis
An HPLC system (Shimadzu Co., Kyoto, Japan) equipped with a multi-channel pump (LC-20AD)
and a diode array detector (SPD-M20A) was used to analyze the extracts from P. cretica obtained by UAE
under optimized conditions and HRE. A YMC-Pack ODS-A column (5 μm, 250 mm × 4.6 mm id; YMC
Co., Tokyo, Japan) was employed for all separations at 25 ◦C. The mobile phase was composed of 0.5%
TFA in ultrapure water (solvent A) and methanol (solvent B). The elution procedure was as follows:
0–25 min, 25–45% B; 25–40 min, 45–65% B; 40–60 min, 65–90% B; 60–65 min, 90–25% B, with a flow rate
of 0.5 mL/min. Detection was carried out at the wavelength of 254 nm. The flavonoids in extracts from
P. cretica were identified on the basis of comparison of the retention time and ultraviolet spectrum of
standards, and the quantification of flavonoids was performed by the external standard method.
2.7. Method Validation
The method was validated for linearity, limit of detection (LOD), limit of quantification (LOQ),
precision (inter-day and intra-day precision), stability, and accuracy following the International
Conference on Harmonization (ICH) guideline and the previous reports [26,27].
Linearity was examined through the triplicate analysis of mixed standard solutions at six different
concentrations, and the calibration curves were constructed by linear regression analysis of the
integrated peak areas (y) versus concentrations (x). LOD and LOQ for each analyte under the HPLC
conditions were determined at the signal-to-noise ratio (S/N) of 3 and 10, respectively.
Intra-day and inter-day variations were chosen to evaluate the precision of the developed HPLC
method. Intra-day precision was assessed by six injections of a mixed standard solution within a single
day, and inter-day precision was validated with the mixed standard solution used above once a day for
3 consecutive days. The precision of this method was expressed as relative standard deviation (RSD).
Stability was evaluated by analyzing the same sample at 0, 2, 4, 6, 8, and 12 h at room temperature.
The accuracy test was performed by the standard addition method. The authentic standards at three
different concentration levels (low, medium, and large) were added to the sample, then extracted
and quantified based on the established procedures. The recovery was counted according to the
following formula:
Recovery (%) =
total detected amount− original amount
added amount
× 100 (3)
2.8. Evaluation of Antioxidant Activity
2.8.1. Assay of DPPH• Radical Scavenging Activity
The DPPH• radical scavenging capacity of total flavonoid extracts of P. cretica was investigated on
the basis of the method reported by Shukla et al. [28] with a minor modification. Briefly, 0.8 mL of
the DPPH solution (0.1 mM in ethanol) was mixed with 2.4 mL of total flavonoid extract solution at
different concentrations (25–250 μg/mL in ethanol). The reaction mixture was then shaken well and
incubated at room temperature for 30 min. The absorbance of the reaction mixture was recorded at
517 nm. Ascrobic acid was used as a positive control in this work. The percentage of DPPH• radical
scavenging was calculated using the following equation:
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where A0 represents the absorbance of the reaction system without the extract and the A1 represents
the absorbance of the reaction system in the presence of the extract. The test was carried out in
triplicate, and the IC50 was defined as the concentration of the extract that resulted in a 50% inhibition
of DPPH• radical.
2.8.2. Assay of ABTS+• Radical Scavenging Activity
The method reported by Awe et al. [29] was adopted for the assay of ABTS+• radical scavenging
activity. First, ABTS was dissolved in phosphate buffered saline (PBS, 0.01 M, pH 7.4) to a 7 mM
concentration. The ABTS solution was then mixed with an equal volume of K2S2O8 solution (2.45 mM)
in the dark at room temperature to produce ABTS+•. After 16 h, the ABTS+• solution was adjusted to
a suitable absorbance (0.70 ± 0.02) using water at 734 nm. To 2.0 mL of the prepared ABTS+• solution,
0.5 mL of various concentrations of extract solution (25–150 μg/mL) was added. The reaction mixture
was then incubated in the dark at room temperature. A total of 10 mins later, the absorbance of the
mixture was immediately recorded at 734 nm. Trolox was used as a positive control in this experiment,
and the percentage of ABTS+• radical scavenging was calculated using the Equation (4).
2.8.3. Assay of NO• Radical Scavenging Activity
The assay of NO• radical scavenging activity was carried out following the procedure of
Shukla et al. [28] with a minor modification. Briefly, 5 mM of SNP in PBS solution (0.01 M, pH 7.4)
was prepared and mixed immediately with 2.0 mL of various concentrations of P. cretica extract
(25–250 μg/mL). After 150 min of incubation at room temperature, 1.0 mL of Griess reagent
(1% sulfanilamide in 2% H3PO4 and 0.1% naphthylethylenediamine dihydrochloride) was added.
The absorbance of the chromophore formed during the reaction was then recorded at 546 nm. Ascrobic
acid was used as a positive control in this work, and the percentage of NO• radical scavenging was
calculated using Equation (4).
2.8.4. Assay of Fe2+ Chelating Activity
The ferrous ion chelating activity of the extract was measured using the modified method
reported by Tohma et al. [30]. In brief, this assay was carried out by mixing 1.0 mL of extract solution
(50–1600 μg/mL) with 0.1 mL of FeCl2 solution (2.0 mM), 0.2 mL of ferrozine solution (5.0 mM) and
2.7 mL of deionized water. After 10 min of incubation at room temperature, the absorbance of reaction
mixture was recorded at 562 nm, and EDTA-2Na was used as a positive control. The Fe2+ chelating
activity was calculated according to Equation (4).
2.9. Statistical Analysis
All the experiments were performed in triplicate, and the results were shown as mean ± standard
deviation (SD). A variance analysis (ANOVA) is used and the comparison of the averages is carried out
by the test of Duncan, and differences were regarded as significant when the p < 0.05. The Design-Expert




3.1.1. Effect of Ethanol Concentration on the TFY
In general, aqueous ethanol is an excellent solvent for the extraction of flavonoids from plants,
and the selection of an appropriate ethanol concentration is a crucial step to improve extraction yield.
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In the present work, the impact of ethanol concentration on the TFY was studied first. As shown
in Figure 1a, the TFY increased dramatically when the ethanol concentration varied from 30% to
60%. However, the extraction yield exhibited a downward trend when the ethanol concentration was
above 60%, which was possibly due to the fact that higher ethanol concentration could more easily




Figure 1. Effects of four independent variables on the total flavonoids yield (TFY): (a) Ethanol
concentration; (b) extraction time; (c) extraction temperature; and (d) liquid/solid ratio.
3.1.2. Effect of Extraction Time on the TFY
In this work, the influence of extraction time (10–60 min) on the TFY was researched. As shown in
Figure 1b, the initial increase of extraction time (10–40 min) resulted in an obvious improvement in the
TFY. The extraction yield decreased slightly with the further increase in extraction time, which could
be ascribed to the fact that longer extraction time will lead to an increase in the amount of dissolved
impurities and the degradation of some flavonoids [32]. Thus, 40 min was regarded as the optimum
extraction time.
3.1.3. Effect of Extraction Temperature on the TFY
There is no doubt that temperature is a significant factor influencing the extraction yield. Hence,
in order to obtain the optimum extraction temperature, UAE processes were performed at 40, 50,
60, 70, 80, and 90 ◦C, respectively, and the results were shown in Figure 1c. There was a significant
increase in the TFY (varying from 2.09 ± 0.07% to 4.41. ± 0.05%) with increasing extraction temperature
from 40 to 60 ◦C. However, at higher extraction temperature (more than 60 ◦C), the TFY declined.
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One of the possible reasons for this was that the structure of the flavonoids was destroyed under high
temperature [33]. Thus, 60 ◦C was selected as the optimal extraction temperature.
3.1.4. Effect of Liquid/Solid Ratio on the TFY
The effect of liquid/solid ratio (15–40 mL/g) on the TFY was in Figure 1d. The TFY increased
with the increasing liquid/solid ratio and reached a maximum (4.64 ± 0.05%) at 35 mL/g. Whereas,
extraction yield reached a plateau phase when the liquid/solid ratio continued to rise above 35 mL/g.
A high liquid/solid ratio would give rise to an increase in the cost of recovery. Hence, the optimal
liquid/solid ratio was set at 35 mL/g.
3.2. Optimization of UAE Process by RSM
3.2.1. Model Fitting and Statistical Analysis
Due to the association between variables, BBD with four factors and three levels was employed to
optimize the individual parameters. BBD matrix and response values were listed in Table 1. Subsequently,
statistical regression analysis of experimental data was carried out, and a second-order polynomial
equation yielded was represented as below:
Y = 4.59− 0.068X1 + 0.27X2 + 0.27X3 + 0.015X4
−0.23X1X2 − 0.29X1X3 + 0.098X1X4 + 0.14X2X3
−0.19X2X4 − 0.098X3X4 − 0.54X12 − 0.38X22
−0.55X32 − 0.33X42
(4)
where X1, X2, X3, and X4 are the ethanol concentration, extraction time, extraction temperature, and
liquid/solid ratio, respectively. Y is the predicted value of TFY.
Table 1. Box–Behnken design matrix and experimental values for the TFY.
Run X1 (%) X2 (min) X3 (◦C) X4 (mL/g) Y (%)
1 60 (0) 40 (0) 70 (0) 35 (0) 4.64
2 70 (1) 30 (−1) 70 (0) 35 (0) 3.56
3 60 (0) 30 (−1) 70 (0) 40 (1) 3.87
4 60 (0) 30 (−1) 80 (1) 35 (0) 3.39
5 60 (0) 40 (0) 80 (1) 30 (−1) 4.08
6 50 (−1) 40 (0) 70 (0) 40 (1) 3.60
7 50 (−1) 40 (0) 60 (−1) 35 (0) 2.95
8 60 (0) 40 (0) 70 (0) 35 (0) 4.61
9 50 (−1) 50 (1) 70 (0) 35 (0) 4.27
10 50 (−1) 40 (0) 70 (0) 30 (−1) 3.97
11 70 (1) 40 (0) 70 (0) 40 (1) 3.63
12 60 (0) 40 (0) 80 (1) 40 (1) 4.04
13 60 (0) 40 (0) 60 (−1) 40 (1) 3.58
14 60 (0) 40 (0) 70 (0) 35 (0) 4.61
15 60 (0) 50 (1) 80 (1) 35 (0) 4.23
16 60 (0) 40 (0) 70 (0) 35 (0) 4.62
17 60 (0) 40 (0) 60 (−1) 30 (−1) 3.23
18 60 (0) 50 (1) 60 (−1) 35 (0) 3.61
19 60 (0) 30 (−1) 70 (0) 30 (−1) 3.38
20 70 (1) 40 (0) 60 (−1) 35 (0) 3.46
21 60 (0) 50 (1) 70 (0) 40 (1) 4.01
22 70 (1) 40 (0) 80 (1) 35 (0) 3.48
23 60 (0) 40 (0) 70 (0) 35 (0) 4.48
24 70 (1) 50 (1) 70 (0) 35 (0) 3.64
25 50 (−1) 40 (0) 80 (1) 35 (0) 4.13
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Table 1. Cont.
Run X1 (%) X2 (min) X3 (◦C) X4 (mL/g) Y (%)
26 60 (0) 50 (1) 70 (0) 30 (−1) 4.28
27 70 (1) 40 (0) 70 (0) 30 (−1) 3.61
28 50 (−1) 30 (−1) 70 (0) 35 (0) 3.27
29 60 (0) 30 (−1) 60 (−1) 35 (0) 3.33
The fitness and adequacy of the regression model were evaluated using a variance analysis (ANOVA), and results
were given in Table 2. F-value (41.92) and p-value (<0.0001) of the regression model indicated that the established
model was very significant. Whereas, F-value (3.28) and p-value (0.1317) of the lack of fit indicated that the lack of
fit was not significant as compared with the pure error. In addition, the determination coefficient (R2) obtained
for this model was 0.9767, implying that the model could satisfactorily fit the variability of the TFY. The predicted
R2 of 0.8764 was in reasonable agreement with the adjusted R2 of 0.9534, implying that the predicted values were
highly consistent with the experimental values. In this study, the linear coefficients (X1, X2, and X3), quadratic
term coefficients (X12, X22, X32, and X42), and the cross product coefficients (X1X2, X1X3, X2X3, and X2X4) had
statistically significant effects on the TFY (p < 0.05).
Table 2. The analysis of variance for the second-order polynomial model.
Source Sum of Squares Df Mean Square F-Value p-Value
Model 6.28 14 0.45 41.92 <0.0001
X1 0.055 1 0.055 5.11 0.0403
X2 0.87 1 0.87 81.73 <0.0001
X3 0.85 1 0.85 79.22 <0.0001
X4 0.0027 1 0.0027 0.25 0.6233
X1X2 0.21 1 0.21 19.77 0.0006
X1X3 0.34 1 0.34 31.43 <0.0001
X1X4 0.038 1 0.038 3.55 0.0804
X2X3 0.078 1 0.078 7.32 0.0170
X2X4 0.14 1 0.14 13.49 0.0025
X3X4 0.038 1 0.038 3.55 0.0804
X12 1.90 1 1.90 177.64 <0.0001
X22 0.95 1 0.95 88.74 <0.0001
X32 1.95 1 1.95 182.59 <0.0001
X42 0.70 1 0.70 65.06 <0.0001
Residual 0.15 14 0.011
Lack of fit 0.13 10 0.013 3.28 0.1317
Pure error 0.016 4 0.004
Cor total 6.43 28
R2 0.9767
Adjusted R2 0.9534
3.2.2. Response Surface Analysis
The three-dimensional (3D) response surface images illustrate the mutual influence of any two
independent variables on the dependent variable while keeping other variables at the 0 level, and the
shape of the 3D response surface plots provides information on the influence degree. To be specific,
elliptical or saddle shapes of the 3D surfaces usually represent the interaction between two independent
variables on the dependent variable, which is relatively significant, whereas a gently sloping surface
indicates that the interaction between two factors on the dependent variable is relatively mild [34,35].
Figure 2a–f offered a visual interpretation of the interactions between two variables (X1X2, X1X3,
X1X4, X2X3, X2X4, and X3X4) on the response variable (Y). Figure 2a–c showed the influences of
ethanol concentration (X1) with extraction time (X2) and extraction temperature (X3) on the extraction
yields of TF, respectively. The initial increase of X1 (50% to about 57%) led to an increase in TFY and
followed by a decline thereafter (about 57% to 70%). Similarly, as could be seen from Figure 2a,d,e,
a rapid rise in TFY was obtained when X2 varied from 30 to about 46 min, then the extraction yield of
TF was decreased slowly with increasing extraction time. Figure 2b,d,f indicated that with an increase
of X3 from 60 to about 74 ◦C, the TFY increased quickly, followed by a slight decline with further
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increase in X3. According to Figure 2c,e,f, it could be found that a maximum level of TFY was obtained
at a X4 of 34 mL/g. The graphs also indicated that the influence of X4 on the TFY is insignificant
(p > 0.05). In addition, as evident from Figure 2c, the interaction effect of X1 and X4 had a insignificant
influence on the TFY from P. cretica (p > 0.05).
(a) (b) (c) 
(d) (e) (f) 
Figure 2. Response surface plots showing interaction between different variables (X1: Ethanol
concentration; X2: Extraction time; X3: Extraction temperature; and X4: Liquid/solid ratio) on the TFY.
3.2.3. Validation of the Optimized Model
The optimal conditions for UAE of TF from P. cretica obtained by RSM were as follows: Ethanol
concentration (X1) 56.74%, extraction time (X2) 45.94 min, extraction temperature (X3) 74.27 ◦C,
and liquid/solid ratio (X4) 33.69 mL/g. Under optimized UAE conditions, the theoretical TFY was
4.74%. Subsequently, in order to prove the reliability of the prediction model, the confirmatory
experiments were carried out under the optimized extraction conditions. Confirmatory experiments
gave a satisfactory result that the TFY was 4.71 ± 0.04%, which was well-matched with theoretical
value. Therefore, it could be concluded that the regression model was appropriate for the optimization
of the UAE process of TF from P. cretica.
In this study, HRE was also performed to confirm the superiority of UAE of TF from P. cretica.
The results demonstrated that the TFY obtained by UAE under optimized conditions was higher than
that obtained by HRE (3.48 ± 0.05%). Additionally, a lot of previous literatures have reported that UAE
gave a higher TFY obtained by UAE when compared with HRE. This phenomenon was believed to
be caused by cavitation, vibration, crushing, mixing, and other comprehensive effects produced by
ultrasound, which enhanced the extractability of flavonoids [36].
3.3. Method Validation for Quantitative Analysis of Five Flavonoids
Table 3 listed the linear equation, correlation coefficient (R2), linear range, LOD, and LOQ of
each compound determined. It could be found that all calibration curves showed good linearity
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(R2 ≥ 0.9995) within the tested concentration range. For these compounds, the LOD values ranged from
0.014 to 0.094 μg/mL, while the LOQ values ranged from 0.16 to 1.31 μg/mL. The results of precision,
stability, and accuracy tests were shown in Table 4. All RSD values of the intra-day and inter-day
precision ranged from 0.94–2.43% and 1.87–2.51%, respectively, which indicated good precision of the
developed method. The results of the stability test showed that the RSD values of peak areas of the five
compounds were ≤2.56%, which indicated that the sample was stable for 12 h at room temperature.
According to the calculation, the mean recoveries of five compounds ranged from 98.93 to 101.3%,
with RSD values ranging from 0.85 to 2.19%, which demonstrated a good accuracy of the developed
method. In sum, the verification tests demonstrated that the developed method was feasible for the
simultaneous quantification of five compounds from P. cretica.
Table 3. Linear regression, limit of detection (LOD), and limit of quantification (LOQ) of the five
tested compounds.
Analytes Linear Equation R2 Linear Range (μg/mL) LOD (μg/mL) LOQ (μg/mL)
luteolin-7-O-glucoside y = 73104x− 11077 0.9995 5.00–100 0.051 0.67
Rutin y = 62441x + 21414 0.9998 5.00–100 0.094 1.31
Quercitrin y = 135884x + 32168 0.9997 2.50–100 0.042 0.44
Luteolin y = 146356x− 48920 0.9998 1.00–100 0.014 0.16
Apigenin y = 86719x− 22486 0.9999 1.00–100 0.026 0.34
Table 4. Precision, stability, and recovery of the five tested compounds.
Analytes
Precision (RSD, %) Stability
(RSD, %)
Recovery
Intra-Day Inter-Day Mean Recovery (%) RSD (%)
Luteolin-7-O-glucoside 1.34 2.51 2.56 99.67 0.85
Rutin 2.11 1.87 2.48 100.4 1.48
Quercitrin 0.94 2.02 1.89 101.3 2.19
Luteolin 1.52 1.98 2.05 98.93 1.83
Apigenin 2.43 2.16 2.33 99.21 2.07
3.4. Analysis of Flavonoids in the Extracts by HPLC
Without any doubt, pharmacological activity of P. cretica depends on its chemical constituents.
Therefore, flavonoid profiles in the P. cretica extracts were analyzed by HPLC. Figure 3 indicated that
the HPLC chromatograms of extracts obtained by UAE and HRE showed highly similar characteristics.
A total of five flavonoids, including luteolin-7-O-glucoside, rutin, quercetin, luteolin, and apigenin, were
identified, and their elution times were 37.340, 39.021, 43.031, 50.568, and 54.306 min, respectively. Based
on the results of HPLC quantitative analysis, the contents of the five flavonoids (mg/g plant material,
dry weight) were in the following descending order: Luteolin-7-O-glucoside (3.237 ± 0.015 mg/g) >
rutin (1.483 ± 0.009 mg/g) > apigenin (0.803 ± 0.013 mg/g) > luteolin (0.679 ± 0.007 mg/g) > quercitrin
(0.582 ± 0.011 mg/g). However, the contents of five flavonoids extracted by HRE were all lower
compared to the UAE: Luteolin-7-O-glucoside (2.862 ± 0.005 mg/g) > rutin (1.133 ± 0.007 mg/g) >
apigenin (0.659 ± 0.011 mg/g) > luteolin (0.486 ± 0.009 mg/g) > quercitrin (0.574 ± 0.013 mg/g). Thus,
it could be concluded that the UAE was a promising extraction method for the separation of bioactive
flavonoids from P. cretica in the future. To our knowledge, this work was the first quantitative analysis
of these five flavonoids in P. cretica.
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Figure 3. HPLC profiles of standards mixture (a) and P. cretica extract obtained by optimized
ultrasonic-assisted extraction (UAE) (b). P. cretica extract obtained by heat reflux extraction (HRE) (c).
Peaks (1): Luteolin-7-O-glucoside, (2) rutin, (3) quercitrin, (4) luteolin, and (5) apigenin.
3.5. Antioxidant Activity
3.5.1. DPPH• Radical Scavenging Activity
The DPPH• radical scavenging activity assay is a fairly common method to evaluate the antioxidant
activity of natural products [37]. A comparison of the ascorbic acid and the P. cretica extract obtained
by optimized UAE was performed, and the results are shown in Figure 4. It was observed that the
DPPH• radical scavenging effect of the P. cretica extract was increased with increasing concentration.
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The P. cretica extract at the test concentrations of 25, 50, 100, 150, 200, and 250μg/mL showed 21.23 ± 2.78,
40.45 ± 3.04, 56.17 ± 2.45, 65.56 ± 3.14, 77.13 ± 2.98, and 85.94 ± 2.37% DPPH• radical scavenging,
respectively. The IC50 value of the P. cretica extract was 74.49 μg/mL, while for ascorbic acid it was
35.19 μg/mL. The results indicated that the UAE extract of P. cretica had a good potential for scavenging
DPPH• radical. It has been reported that DPPH• radical scavenging activity of plant extracts is
ascribable to the presence of flavonoids [38].
Figure 4. Scavenging activity of P. cretica extract obtained by optimized ultrasound-assisted extraction
against DPPH• radical compared with ascorbic acid.
3.5.2. ABTS+• Radical Scavenging Activity
One of the most widely used organic radicals for the determination of antioxidant activity of
natural products is the radical cation derived ABTS [39]. The results of ABTS+• radical scavenging
activity of the P. cretica extract at different concentrations (25–150 μg/mL) were shown in Figure 5. It was
found that the P. cretica extract had a scavenging activity on the ABTS+• radical in a dose dependent
manner. The IC50 value of standard trolox was 30.10 μg/mL, while the IC50 value of the P. cretica extract
was 82.92 μg/mL. A 150 μg/mL of the P. cretica extract exhibited 78.41 ± 2.97% inhibition. From these
results, it could be stated that the P. cretica extract was a good ABTS+• radical scavenger.
Figure 5. Scavenging activity of the P. cretica extract obtained by optimized ultrasound-assisted
extraction against ABTS+• radical compared with trolox.
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3.5.3. NO• Radical Scavenging Activity
Despite the potential health benefits of NO• radical, its role in causing oxidative damage is
becoming progressively prominent [40]. In this work, the scavenging effect of the P. cretica extract
on NO• radical was studied. Figure 6 showed that the P. cretica extract within the concentration
range tested (25–250 μg/mL) exhibited NO• radical scavenging activity in a dose-dependent manner.
Especially, the P. cretica extract exhibited a maximum percentage scavenging of 82.71 ± 1.54%, which
was comparable to the NO• radical scavenging activity of ascorbic acid. The IC50 value of ascorbic
acid was 51.60 μg/mL, and for the P. cretica extract it was 89.12 μg/mL. Results indicated that P. cretica
might serve as an excellent NO• radical scavenger due to the high level of flavonoids. It has been
reported that the flavonoids are very powerful NO• radical scavengers [41].
Figure 6. NO• radical scavenging activity of the P. cretica extract obtained by optimized
ultrasound-assisted compared with ascorbic acid.
3.5.4. Fe2+ Chelating Activity
It has been reported that Fe2+ is a powerful pro-oxidant among various metal ions and Fe2+
chelation may prevent oxidative damage through retarding metal-catalyzed oxidation and inhibiting
ROS production [42]. In this work, the Fe2+ chelating activity of the P. cretica extract was determined
and compared with a chelating standard (EDTA-2Na). As shown in Figure 7, at different test doses of
50, 100, 200, 400, 800, and 1600 μg/mL, the Fe2+ chelating activity of the P. cretica extract was 4.74 ± 1.77,
9.98 ± 1.89, 18.65 ± 1.86, 31.56 ± 2.48, 51.87 ± 2.17, and 74.21 ± 1.83%, respectively, with an IC50 value
of 713.41 μg/mL. According to these results, it could be concluded that the P. cretica extract had certain
Fe2+ chelating activity.
Figure 7. Fe2+ chelating activity of the P. cretica extract obtained by optimized ultrasound-assisted
compared with EDTA-2Na.
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4. Conclusions
In this work, the UAE was proved to be a sample, rapid, and effective procedure for the extraction of
TF from P. cretica, and the process parameters optimized by RSM were as follows: Ethanol concentration
56.74%, extraction time 45.94 min, extraction temperature 74.27 ◦C, and liquid/solid ratio 33.69 mL/g.
Under optimized UAE conditions, the TFY was 4.71 ± 0.04%, which was higher than that obtained by
HRE. Moreover, HPLC analysis indicated that luteolin-7-O-glucoside, rutin, quercitrin, luteolin, and
apigenin were the predominant flavonoids in P. cretica. It was also found that UAE is more suitable
than HRE for the extraction of these compounds. In addition, the P. cretica extract obtained through the
optimized UAE method exhibited good DPPH•, ABTS+•, and NO• scavenging activities. The results
of the present wok should contribute to the further and deeper investigation of P. cretica, which might
be used as a novel source of natural antioxidants.
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Abstract: This work aimed to characterize compositional and bioactive features of Aloe vera leaf
(fillet, mucilage, and rind) and flower. The edible fillet was analysed for its nutritional value, and all
samples were studied for phenolic composition and antioxidant, anti-inflammatory, antimicrobial,
tyrosinase inhibition, and cytotoxic activities. Dietary fibre (mainly mannan) and available
carbohydrates (mainly free glucose and fructose) were abundant macronutrients in fillet, which also
contained high amounts of malic acid (5.75 g/100 g dw) and α-tocopherol (4.8 mg/100 g dw). The leaf
samples presented similar phenolic profiles, with predominance of chromones and anthrones, and the
highest contents were found in mucilage (131 mg/g) and rind (105 mg/g) extracts, which also revealed
interesting antioxidant properties. On the other hand, the flower extract was rich in apigenin
glycoside derivatives (4.48 mg/g), effective against Pseudomonas aeruginosa (MIC = 0.025 mg/mL and
MBC = 0.05 mg/mL) and capable of inhibiting the tyrosinase activity (IC50 = 4.85 mg/mL). The fillet,
rind, and flower extracts also showed a powerful antifungal activity against Aspergillus flavus, A. niger,
Penicillium funiculosum, and Candida albicans, higher than that of ketoconazole. Thus, the studied Aloe
vera samples displayed high potential to be exploited by the food or cosmetic industries, among others.
Keywords: Aloe barbadensis Mill.; nutritional composition; neutral sugars; phenolic compounds;
organic acids; antioxidant capacity; antimicrobial activity; tyrosinase inhibitory activity; cytotoxicity
1. Introduction
Aloe vera (also known as Aloe barbadensis Mill.) is a flowering succulent plant of the family
Asphodelaceae currently naturalized in many tropical and sub-tropical countries. In traditional
medicine, it has been widely used for centuries to treat skin disorders and other ailments, as well
as for its purgative effect [1]. Today, this species is used worldwide as a valuable ingredient for
functional foods (such as healthy drinks and other beverages), cosmetics (including creams, lotions,
soaps, and shampoos), and drugs (such as tablets and capsules) [2].
The dagger-shaped leaves are the most used part of the plant, in which two major fractions can be
identified, namely the outer, photosynthetically active green cortex, usually known as rind, and the
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inner parenchyma, known as pulp or fillet. Furthermore, the leaf secretes two different exudates—the
reddish-yellow latex produced by the pericyclic cells under the cutinized epidermis and the transparent,
slippery mucilage or gel produced by the thin-walled tubular cells in the inner parenchyma [3,4].
The gel is approximately 98% moisture, and the non-aqueous remainder largely consists of acemannan
(a bioactive acetylated glucomannan) and other polysaccharides, sugars, minerals, organic acids,
and vitamins [1,4–6]. Traditionally, it is used topically to treat wounds, minor burns, and skin
irritations and internally to treat constipation, coughs, ulcers, and diabetes, among other ailments [1,7].
The latex, on the other hand, contains hydroxyanthracene derivatives, including anthraquinone C-
and O-glycosides, and is a natural drug well-known for its cathartic effect and also used as a bittering
agent in alcoholic beverages [8,9].
Today, Aloe vera is produced on a large scale in many countries around the world to supply the still
growing and economically important industry [1]. For production of Aloe vera gel, the leaves can be
processed either by grinding the inner fillet after removing the rind (treated as bio-waste) and rinsing
away the latex, or the whole leaf. However, in the second case, a subsequent filtration/purification step
is required to remove unwanted constituents, especially those from latex [10,11]. The gel has been
marketed fresh or in powdered concentrate and included in different formulations for food, health,
medicinal, and cosmetic purposes [9,10,12].
Over the last few decades, the Aloe vera leaf has been the subject of several scientific studies that
aimed to characterize its chemical and biological properties [4–6,13,14]. Still, there are compositional
and bioactive parameters that deserve further study, and the flower remains an underexploited plant
part. Moreover, a lack of information on the exact part of the plant analysed or even the species
involved is common in many works. There are confusing descriptions, mostly about the inner part of
the leaf, due to the different terms that have been used interchangeably, such as fillet, pulp, mucilage,
gel, and parenchyma, among others. Technically, these terms do not refer to the same part, since fillet
or pulp refer to the fleshy inner part of the leaf including the cell walls, while gel or mucilage refer to
the viscous clear liquid contained within the parenchyma cells [4].
This comprehensive study was performed to evaluate and compare compositional and bioactive
features of different parts of Aloe vera, namely leaf (which was divided into fillet, mucilage and rind)
and flower. More specifically, it was intended to determine the nutritional and chemical composition
of the edible fillet and the profiles in phenolic compounds of the four sample extracts, as well as their
antioxidant, anti-inflammatory, antimicrobial, tyrosinase inhibition, and cytotoxic capacities. This will
provide accurate and up-to-date research information on Aloe vera.
2. Materials and Methods
2.1. Chemicals
All standard compounds used for chromatographic quantifications (47885-U, 2-deoxyglucose, α,
β, γ, and δ tocopherols, oxalic, quinic, malic, ascorbic, citric, and fumaric acids, from Sigma-Aldrich
(St. Louis, MO, USA); tocol, from Matreya (Pleasant Gap, PA, USA); chlorogenic acid, p-coumaric
acid, apigenin-6-glucoside, apigenin-7-glucoside, and luteolin-6-C-glucoside, from Extrasynthèse
(Genay, France); and aloin, from Alfa Aesar (Ward Hill, MA, USA)) and bioactivity assays (trolox, kojic
acid, dexamethasone, ellipticine, streptomycin, and ketoconazole, from Sigma-Aldrich) had a purity
level of at least 95%. All other reagents were of analytical grade and purchased from common sources.
2.2. Plant Material
Freshly cut Aloe vera samples (leaves and flowers) of certified organic production were supplied
by “aCoruela do Alentejo,” a company located in the parish of São Brás e São Lourenço, municipality
of Elvas, Portugal. Twelve three-year-old leaves with about 10 cm × 45 cm were weighed, and the
green rind was separated from the inner fillet with a knife. Then, the transparent slippery exudate
consisting mainly of gel was collected from the mucilage layer of the outer leaf pulp adjacent to the
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rind. The weight of the different leaf parts was determined to calculate the weight percentage (wt%).
A batch of each plant part (fillet, mucilage, rind, and flower) was then lyophilized (FreeZone 4.5,
Labconco, Kansas City, MO, USA), reduced to a fine powder (~20 mesh), and homogenized to obtain a
representative sample that was kept at −20 ◦C until analysis.
2.3. Compositional Analysis of Fillet
2.3.1. Proximate Composition
The edible fillet was analysed for moisture, protein, fat, ash, and crude fibre contents following
the AOAC procedures [15]. Briefly, the crude protein content (N × 6.25) was estimated by the
macro-Kjeldahl method, using an automatic distillation and titration unit (Pro-Nitro-A, JP Selecta,
Barcelona); the crude fat content was determined by Soxhlet extraction with petroleum ether; the ash
content was determined by incineration in a muffle furnace at 550 ± 15 ◦C; and the crude fibre content
was estimated by the Weende method through an acid/alkaline hydrolysis of insoluble residues.
The available carbohydrate content was determined by the anthrone method [16]. The dietary fibre
content was estimated by difference. The results were given as g per 100 g of plant material.
The energy value was calculated as follows: 4 × (g protein + g available carbohydrates) + 9 × (g
fat) + 2 × (g dietary fibre) [17] and given as kcal per 100 g of plant material.
2.3.2. Fatty Acids, Tocopherols, and Organic Acids
Fatty acids were analysed in a DANI GC 1000 (DANI instruments, Contone, Switzerland) equipped
with a split/splitless injector and a flame ionization detector (FID) at 260 ◦C. The fatty acids obtained
by Soxhlet extraction were methylated with methanol:sulphuric acid:toluene 2:1:1 (v:v:v) during at
least 12 h in a bath at 50 ◦C and 160 rpm. Then, deionised water was added to obtain phase separation,
and the fatty acid methyl esters (FAME) were recovered with diethyl ether. The upper phase was
dehydrated and filtered through 0.2 μm nylon filters for injection. Chromatographic separation was
performed on a Zebron-Kame column (30 m × 0.25 mm i.d. × 0.20 μm film thickness, Phenomenex,
Torrance, CA, USA). The oven temperature program was as follows: the initial temperature of the
column was 100 ◦C, held for 2 min, then a 10 ◦C/min ramp to 140 ◦C, 3 ◦C/min ramp to 190 ◦C,
30 ◦C/min ramp to 260 ◦C, held for 2 min [18]. The carrier gas (hydrogen) flow rate was 1.1 mL/min,
measured at 100 ◦C. Split injection (1:50) was carried out at 250 ◦C. The identification was made
by chromatographic comparison of the retention times of the sample FAME peaks with those of
commercial standards (standard 47885-U). The results were processed using the Clarity 4.0.1.7 Software
(DataApex, Podohradska, Czech Republic) and given as relative percentage of each fatty acid.
Tocopherols were analysed in a high-performance liquid chromatography (HPLC) system
(Knauer, Smartline system 1000, Berlin, Germany) coupled to a fluorescence detector (FP-2020,
Jasco, Easton, MD, USA) programmed for excitation at 290 nm and emission at 330 nm, following
an previously described analytical procedure [19]. The samples (500 mg) were spiked with a BHT
solution (10 mg/mL) and tocol (internal standard, 50 μg/mL) and homogenized with methanol (4 mL)
by shaking in vortex (1 min) and then with hexane (4 mL). After that, a saturated NaCl aqueous
solution (2 mL) was added, the mixture was homogenized, centrifuged (5 min, 4000× g) and the clear
upper layer was collected. The extraction was repeated twice with hexane. The obtained extracts were
dried under a nitrogen stream, redissolved in 2 mL of n-hexane, dehydrated, and filtered through
0.22 μm disposable syringe filters for injection. Chromatographic separation was performed in normal
phase on a Polyamide II column (5 μm particle size, 250 × 4.6 mm; YMC, Kyoto, Japan). Elution was
performed with a mixture of n-hexane and ethyl acetate (70:30, v/v). The detected compounds were
identified by chromatographic comparisons with authentic standards (α, β, γ, and δ isoforms) and
quantified using the internal standard method. The results were processed using the Clarity 4.0.1.7
Software and given as μg per 100 g of plant material.
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Organic acids were analysed in a ultra-fast liquid chromatography system (Shimadzu 20 A series
UFLC, Shimadzu Corporation, Kyoto, Japan) coupled to a photodiode array detector (UFLC-PDA),
as previously described [20]. The samples (1 g) were stirred with meta-phosphoric acid (25 mL)
for 45 min and filtered, first through Whatman No. 4 paper and then through 0.2μm nylon filters.
Chromatographic separation was achieved in reverse phase on a C18 column (5 μm particle size,
250 × 4.6 mm; Phenomenex, Torrance, CA, USA). The elution was performed with sulphuric acid
(3.6 mM). PDA detection was carried out at 215 and 245 nm (for ascorbic acid). The detected compounds
were identified and quantified by chromatographic comparison of the peak area with calibration
curves obtained from commercial standards (oxalic, quinic, malic, ascorbic, citric, and fumaric acids).
The results were processed using the LabSolutions Multi LC-PDA software and expressed in mg per
100 g of plant material.
2.3.3. Sugars and Glycosidic-Linkage Composition
The fillet sample was dialysed with a membrane cut-off of 12–14 kDa to recover the high molecular
weight (HMW) compounds. Neutral sugars of the initial and dialysed samples were analysed by gas
chromatography-flame ionization detection (GC-FID) after conversion to their alditol acetates [21,22].
The quantification was carried out using 2-deoxyglucose as internal standard. Monosaccharides were
released from polysaccharides with pre-hydrolysis of the samples using 0.2 mL of 72% (w/w) H2SO4
for 1 h at room temperature followed by 2.5 h hydrolysis in 1 M H2SO4 at 100 ◦C. After hydrolysis,
the reduction (NaBH4) and acetylation (acetic anhydride using methyl imidazole as catalyst) of the
monosaccharides were performed. The alditol acetates were analysed using a DB-225 column (30 m,
0.25 mm i.d., 0.25 μm film thickness) and a GC-FID PerkinElmer-Clarus 400 [23,24]. Free sugars were
also quantified on the initial sample (not dialysed) using the same method, by omitting the hydrolysis
in the abovementioned steps. The oven temperature program was as follows: 220 ◦C, hold for 7 min,
to 240 ◦C at a rate of 5 ◦C/min. The temperature of injector was 220 ◦C, and the detector was 240 ◦C.
Hydrogen was used as the carrier gas.
Glycosidic-linkage composition of the dialysed sample (HMW) was determined by GC-qMS
of the partially methylated alditol acetates as previously described [22]. The polysaccharides were
methylated using CH3I, hydrolysed (TFA 2M) and the resultant monosaccharides were reduced
(NaBD4) and acetylated. The partially methylated alditol acetates (PMAAs) obtained were analysed by
gas chromatography mass spectrometry (GC-qMS) on a Shimadzu GCMS-QP2010 Ultra [25]. The GC
was equipped with an SGE HT5 (Supelco, Bellefonte, PA, USA) fused silica capillary column (30 m
length, 0.25 mm i.d., and 0.10 μm of film thickness).
2.4. Bioactive Analysis of Fillet, Mucilage, Rind, and Flower
2.4.1. Preparation of Hydroethanolic Extracts
The powdered fillet, mucilage, rind, and flower samples (~1 g) underwent solid-liquid extraction
twice with a 80:20 (v/v) ethanol:water mixture (30 mL) for 1 h at room temperature, and the supernatants
were then filtered through Whatman no. 4 filter paper [26]. Ethanol was separated from the filtrates
in a rotary evaporator (Büchi R-210, Flawil, Switzerland), and the aqueous phase was lyophilized to
obtain dried extracts.
2.4.2. Analysis of Phenolic Compounds
The dried extracts (10 mg) were dissolved in a 80:20 (v/v) ethanol:water mixture (2 mL) and filtered
through 0.22-μm disposable syringe filters. The analysis was performed in a HPLC-DAD-ESI/MSn
system (Dionex Ultimate 3000 UPLC, Thermo Scientific, San Jose, CA, USA), as previously described [27].
Chromatographic separation was made in a Waters Spherisorb S3 ODS-2 C18 column (3 μm,
4.6 mm × 150 mm; Waters, Milford, MA, USA). Double online detection was carried out with a
diode array detector (DAD, using 280 and 370 nm as preferred wavelengths) and a Linear Ion
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Trap (LTQ XL) mass spectrometer (MS, Thermo Finnigan, San Jose, CA, USA) equipped with
an electrospray ionization (ESI) source. Phenolic compounds were identified by comparison of
their retention times and UV-vis and mass spectra with those obtained from standard compounds,
when available; otherwise, compounds were tentatively identified comparing the obtained information
with available data reported in the literature. For quantitative analysis, a calibration curve for each
available phenolic compound standard (aloin A (280 nm: y = 3859.4x + 21,770, R2 = 0.9996; and
370 nm: y = 7184.4x + 17,013, R2 = 0.9996); chlorogenic acid (y = 168,823x – 161,172, R2 = 0.9999);
p-coumaric acid (y = 301,950x + 6966.7, R2 = 0.9999); apigenin-6-glucoside (y = 107,025x + 61531,
R2 = 0.9989); apigenin-7-glucoside (y = 10,683x – 45,794, R2 = 0.9906); and luteolin-6-C-glucoside
(y = 4087.1x + 72,589, R2 = 0.9988)) was constructed based on the UV signal. Quantification of
the phenolic compounds that are not commercially available as standards was performed by using the
most similar available standard molecule. The results were expressed as mg per g of extract.
2.4.3. Evaluation of Bioactive Properties
Antioxidant Activity
The extracts antioxidant capacity was evaluated by the in vitro assays of oxidative haemolysis
inhibition (OxHLIA), thiobarbituric acid reactive substances formation inhibition (TBARS),
and β-carotene bleaching inhibition (β-CBI), following methodologies previously described [28,29].
Extract concentrations ranging from 5 to 0.0159 mg/mL were used. Trolox was the positive control.
OxHLIA assay—An erythrocyte solution (2.8%, v/v; 200 μL) was mixed with 400 μL of either
extract solution in PBS, PBS solution (control), or water (for complete haemolysis). After pre-incubation
at 37 ◦C for 10 min with shaking, AAPH (200 μL, 160 mM in PBS, from Sigma-Aldrich) was added,
and the optical density (690 nm) was measured every 10 min in a microplate reader (Bio-Tek Instruments,
ELX800) until complete haemolysis [28]. The results were expressed as IC50 values (μg/mL) at a Δt of
60 min, i.e., extract concentration required to keep 50% of the erythrocyte population intact for 60 min.
TBARS assay—A porcine brain cell solution (1:2, w/v; 0.1 mL) was incubated with the extract
solutions (0.2 mL) plus FeSO4 (10 μM; 0.1 mL) and ascorbic acid (0.1 mM; 0.1 mL) at 37 ◦C for
1 h. Then, trichloroacetic (28% w/v, 0.5 mL) and thiobarbituric (TBA, 2%, w/v, 0.38 mL) acids were
added, and the mixture was heated at 80 ◦C for 20 min. After centrifugation at 3000× g for 10 min,
the malondialdehyde (MDA)-TBA complexes formed in the supernatant were monitored at 532 nm
(Specord 200 spectrophotometer, Analytik Jena, Jena, Germany) [29]. The results were expressed as
EC50 values (μg/mL), i.e., extract concentration providing 50% of antioxidant activity.
β-CBI assay—A β-carotene-linoleic acid emulsion (4.8 mL) was mixed with the extract solutions
(0.2 mL) and the absorbance was measured at 470 nm as soon as mixed (AβT0) and after 2 h of
incubation at 50 ◦C (AβT0). The β-CBI capacity was calculated as follows: (AβT2/AβT0) × 100 [29].
The results were expressed as EC50 values (μg/mL).
Antimicrobial Activity
The extracts were tested against the Gram-negative bacteria Staphylococcus aureus (ATCC 11632),
Staphylococcus epidermidis (clinical isolate Ibis 2999), Staphylococcus lugdunensis (clinical isolate Ibis 2996),
Micrococcus flavus (ATCC 10240), and Listeria monocytogenes (NCTC 7973), and the Gram-positive bacteria
Escherichia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 27853), and Salmonella Typhimurium
(ATCC 13311), as described by Soković et al. [30]. The fungi Aspergillus flavus (ATCC 9643), Aspergillus
niger (ATCC 6275), Penicillium funiculosum (ATCC 36839), Candida albicans (clinical isolate Ibis 475/15),
Trichophyton mentagrophytes (clinical isolate Ibis 2979/18), Trichophyton tonsurans (clinical isolate Ibis16/17),
Microsporum gypseum (clinical isolate Ibis 3277/18), and Microsporum canis (clinical isolate Ibis 2990/18)
were tested as described by Soković and van Griensven [31]. The microorganisms were obtained from
the Mycological laboratory, Department of Plant Physiology, Institute for Biological Research “Sinisa
Stanković,” University of Belgrade, Serbia. Streptomycin and ketoconazole were the positive controls
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used for the antibacterial and antifungal activities, respectively. The results were given as minimum
inhibitory (MIC) and minimum bactericidal (MBC) or fungicidal (MFC) concentrations (mg/mL).
Anti-Inflammatory Activity
The extract capacity to inhibit the lipopolysaccharide (LPS)-induced nitric oxide (NO) production
by a murine macrophage cell line (RAW 264.7) was determined as nitrite concentration in the
culture medium [32]. Dexamethasone was used as a positive control, and negative controls
were performed without LPS. NO production was determined using a Griess Reagent System kit
containing sulfanilamide, N-1-naphthylethylenediamine dihydrochloride (NED), and nitrite solutions.
The results were expressed as EC50 values (μg/mL), i.e., extract concentration providing 50% of NO
production inhibition.
Tyrosinase Inhibitory Activity
The extracts capacity to inhibit the tyrosinase activity was measured according to the method of
Chen et al. [33], using l-3,4-dihydroxyphenylalanine (l-DOPA) as substrate. For each extract, four wells
of a 96-well plate were designated as A, B, C, and D, and each one contained a reaction mixture (200 μL)
as follows: (A) 66 mM PBS (pH 6.8; 120 μL) and mushroom tyrosinase in PBS (46 U/mL; 40 μL); (B)
PBS (160 μL); (C) PBS (80 μL), tyrosinase (40 μL), and aqueous extract solution with 5% DMSO (40 μL);
and (D) PBS (120 μL) and aqueous extract solution with 5% DMSO (40 μL). After incubation of the
reaction mixtures for 10 min at room temperature, 2.5 mM l-DOPA in PBS (40 μL) was added and the
plate was incubated again for 20 min. The absorbance was measured at 475 nm (SPECTROstar Nano,
BMG Labtech, Ortenberg, Germany). A kojic acid solution (0.10 mg/mL) was used as positive control.
The inhibition percentage of the tyrosinase activity was calculated as follows:
I(%) =
(A− B) − (C−D)
(A− B) × 100 (1)
IC50 values were then calculated from the obtained inhibition percentage values.
Cytotoxic and Hepatotoxic Activities
The extracts cytotoxicity was evaluated by the sulforhodamine B (from Sigma-Aldrich) assay
against five human tumour cell lines (acquired from Leibniz-Institut DSMZ): metastatic melanoma
(MM127), breast adenocarcinoma (MCF-7), non-small cell lung carcinoma (NCI-H460), cervical
carcinoma (HeLa), and hepatocellular carcinoma (HepG2), as previously described [34]. The same
assay was also used to evaluate the extracts hepatotoxicity against a non-tumour cell line (porcine liver
primary cells, PLP2) [35]. Ellipticine was used as positive control. The results were expressed in GI50
values (μg/mL), i.e., extract concentration providing 50% of cell growth inhibition.
2.5. Statistical Analysis
All analyses were performed in triplicate, and the results were presented as mean ± standard
deviation. All statistical tests were performed at a 5% significance level using SPSS Statistics software
(IBM SPSS Statistics for Windows, Version 22.0, IBM Corp., Armonk, NY, USA:). The fulfilment of
the one-way analysis of variance (ANOVA) requirements, specifically the normal distribution of the
residuals and the homogeneity of variance, was tested by means of the Shapiro Wilk’s and Levene’s
tests, respectively. Depending on the homoscedasticity, the dependent variables were compared using
Tukey’s honestly significant difference (HSD; when homoscedastic, p > 0.05) or Tamhane’s T2 multiple
comparison (when heteroscedastic, p < 0.05) tests.
Differences between two samples were analysed by applying a two-tailed paired Student’s t-test;
significant differences were considered when the p-value was lower than 0.05.
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A Pearson’s correlation was run in SPSS to evaluate whether there is a relationship between the
identified compounds and the measured bioactivities.
3. Results and Discussion
3.1. Nutritional Composition of Fillet
Aloe vera fillet has been used in the food industry to develop functional foods such as beverages,
milk, yogurt, jam, jellies, ice cream, and food supplements, as well as in edible fruit coatings. It can also
be used to improve the quality of meat products [36] and is often commercialized as concentrated dry
powder. In this study, the fillet sample corresponded to 58 ± 4% of the total leaf weight, while 31 ± 2%
consisted of green rind.
The nutritional composition of Aloe vera fillet is presented in Table 1. This inner part of the leaf
consists of 98± 1 g/100 g of moisture, the same amount that was found in the mucilage. Similar moisture
contents (98–99 g/100 g) were previously reported [5,9,37]. Lower values were found in the rind and
flower samples (87 ± 1 and 84 ± 1, respectively; Table S1).
Table 1. Nutritional value and organic acids and tocopherols composition of Aloe vera fillet.
Nutritional Component Fresh Fillet Dry Powder
Moisture (g/100 g) 1 98 ± 1 -
Protein (g/100 g) 0.044 ± 0.001 2.60 ± 0.05
Ash (g/100 g) 0.150 ± 0.003 9.0 ± 0.2
Fat (g/100 g) 0.0168 ± 0.0006 1.00 ± 0.04
Available carbohydrates (g/100 g) 0.630 ± 0.006 37.4 ± 0.3
Dietary fibre (g/100 g) 0.84 ± 0.02 50.1 ± 0.3
Crude fibre (g/100 g) 0.120 ± 0.003 7.1 ± 0.2
Energy (kcal/100 g) 4.54 ± 0.05 269 ± 3
Oxalic acid (mg/100 g) 2.39 ± 0.04 142 ± 2
Quinic acid (mg/100 g) 11.63 ± 0.07 689 ± 4
Malic acid (mg/100 g) 97 ± 1 5750 ± 66
Total organic acids (mg/100 g) 111 ± 1 6581 ± 73
α-Tocopherol (μg/100 g) 81 ± 2 4813 ± 104
β-Tocopherol (μg/100 g) 3.59 ± 0.06 213 ± 3
γ-Tocopherol (μg/100 g) 6.7 ± 0.1 396 ± 8
δ-Tocopherol (μg/100 g) 1.78 ± 0.02 106 ± 1
Total tocopherols (μg/100 g) 93 ± 2 5527 ± 98
1 The results are presented as mean ± standard deviation.
Dietary fibre was a predominant macronutrient in Aloe vera fillet, with 50.1 ± 0.3 g/100 g dw,
followed by available carbohydrates, which corresponded to 37.4 ± 0.3 g/100 g dw (Table 1). A slightly
higher dietary fibre content (57.64 g/100 g dw) was described by Femenia et al. [5] in fillet samples
of Aloe vera cultivated in Ibiza, Spain. In turn, the fraction corresponding to crude fibre was isolated
through acid and alkaline digestion of the sample and may consist of cellulose and small amounts
of hemicellulose and lignin [38], which do not dissolve in the used solutions of sulphuric acid and
potassium hydroxide. This small amount of insoluble fibre may correspond to the cell walls of the
parenchyma cells that contain the gel. A higher crude fibre content (12.95 g/100 g dw) was previously
reported in Aloe vera samples from Coquimbo, Chile [39].
The fresh fillet revealed reduced levels of protein and fat and slightly higher amounts of
ash (minerals) (Table 1). This sample was, therefore, characterized by a low energy value
(269 ± 3 kcal/100 g dw). These values are lower than that previously reported for fat (4.21 g/100 g dw)
and ash (15.37–17.64 g/100 g dw) but slightly higher for the protein content (3.72–7.26 g/100 g dw) [5,39].
Potassium and calcium were previously found as major minerals in fillet samples [5] and may contribute
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to the wound healing capacity of this medicinal plant. Such compositional variations can be justified
by the different geographical and edaphoclimatic conditions where the Aloe samples were grown.
As shown in Table 1, oxalic, quinic, and malic acids were detected in the fillet. Malic acid was
the most abundant, with a concentration of 97 ± 1 mg/100 g of fresh fillet and 5.75 ± 0.07 g/100 g of
dried powder. This acid is a natural component of aloe gel and an excellent freshness indicator. It was
also detected along with the other two acids in the mucilage sample (Table S1). In fact, it was more
abundant in the mucilage collected from the vascularized layer of the leaf, but the amount of total
organic acids found in fillet and mucilage did not differ significantly. Bozzi et al. [9] also detected
malic acid in fresh Aloe vera gel and others, like citric, lactic, and succinic acids, in commercial gel
powders. However, citric acid (which can be found in the rind; Table S1) is added to the concentrated
powders as a natural preservative by adjusting the gel pH prior to its concentration and drying in order
to improve flavour and prevent oxidation. In turn, lactic and succinic acids should be absent from
these concentrates, since they are indicators of bacterial fermentation and enzymatic degradation [9].
As presented in Table S1, ascorbic acid was not detected in the fillet and mucilage samples, but it was
found in the green rind. Fumaric acid, in turn, was detected in rind and flower.
Tocopherols are important fat-soluble chain-breaking antioxidants. As shown in Table 1, the four
isoforms were detected in the fillet, and α-tocopherol (4.8 ± 0.1 mg/100 g dw) was the most abundant,
followed by γ- and β-tocopherols. Therefore, a 100 g portion of dried fillet provides about 69%,
44%, and 32% of the recommended dietary allowances of vitamin E for children from 4–8 and
9–13 years old and individuals with 14 or more years old, respectively (values calculated based on the
α-tocopherol content) [40]. Bashipour and Ghoreishi [41] obtained a lower amount (1.53 mg/100 g dw)
of α-tocopherol from Aloe vera samples grown in Isfahan, Iran, when applying optimized supercritical
CO2 extraction conditions. Comparable α-tocopherol levels (4.70 mg/100 g dw) were reported by
López-Cervantes et al. [42] in Aloe vera flowers harvested in south Sonora, México.
The fatty acids composition of Aloe vera fillet is presented in Table 2. Eighteen fatty acids were
detected, with predominance of palmitic (C16:0, 32.1 ± 0.6%), stearic (C18:0, 16.4 ± 0.2%), linoleic
(C18:2n6, 15.0 ± 0.2%), and oleic (C18:1n9, 12.9 ± 0.1%) acids. Thus, 67 ± 1% of the lipid fraction is
constituted by saturated fatty acids (SFA) and 32.9 ± 0.4% corresponds to mono- and polyunsaturated
(MUFA and PUFA) fatty acids. Essential PUFA such as C18:2n6 and linolenic acid (C18:3n3) play
important biological functions and are involved in the modulation of inflammatory and chronic
degenerative diseases [43]. Despite this, its concentration in the fillet is very low compared to other
compounds identified with possible health-promoting effects. Odd-chain SFA, including pentadecanoic
(C15:0) and heptadecanoic (C17:0) acids, were also found (Table 2). These two fatty acids have been
gaining research interest because they are important as quantitative internal standards and biomarkers
for assessing dietary food intake and the risk of coronary heart disease and type II diabetes mellitus [44].
A previous study also reported C18:2n6, C18:3n3, lauric acid (C12:0) and myristic acid (C14:0) in Aloe
vera gel [45]. Regarding other Aloe species, the fatty acids C18:2n6, C16:0, lignoceric (C24:0), C18:0,
tricosanoic (C23:0), behenic (C22:0), and C18:3n3, among others, were described in Aloe ferox gel [46];
and C18:3n3, C18:2n6, C16:0, C18:0, C18:1n9, and C14:0 were found in a whole leaf extract of Aloe
arborescence [47].
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Table 2. Fatty acids composition of Aloe vera fillet.
Fatty Acid Relative Percentage (%) 1
Caproic acid (C6:0) 0.51 ± 0.01
Caprylic acid (C8:0) 0.21 ± 0.01
Capric acid (C10:0) 0.70 ± 0.01
Lauric acid (C12:0) 6.83 ± 0.09
Myristic acid (C14:0) 3.57 ± 0.06
Pentadecanoic acid (C15:0) 0.41 ± 0.02
Palmitic acid (C16:0) 32.1 ± 0.6
Heptadecanoic acid (C17:0) 0.92 ± 0.02
Stearic acid (C18:0) 16.4 ± 0.2
Oleic acid (C18:1n9c) 12.9 ± 0.1
Linoleic acid (C18:2n6c) 15.0 ± 0.2
α-Linolenic acid (C18:3n3) 4.00 ± 0.07
Arachidic acid (C20:0) 0.689 ± 0.008
Heneicosanoic acid (C21:0) 0.212 ± 0.002
Behenic acid (C22:0) 1.14 ± 0.01
Erucic acid (C22:1) 0.95 ± 0.01
Tricosanoic acid (C23:0) 0.86 ± 0.04
Lignoceric acid (C24:0) 2.54 ± 0.01
Saturated fatty acids (SFA) 67 ± 1
Monounsaturated fatty acids (MUFA) 13.8 ± 0.04
Polyunsaturated fatty acids (PUFA) 19.0 ± 0.2
1 The results are presented as mean ± standard deviation.
3.2. Sugars and Glycosidic-linkage Composition of Fillet
Table 3 shows that the fillet sample contained 64 g/100 g dw of sugars, mainly glucose, uronic acids,
and mannose. In this sample, 35 g/100 g dw of the sugars were found in the free form, determined as
glucose and mannose (Table 1). The identification of the alditol acetate corresponding to mannose is
probably due to the presence of fructose, as the methodology used converts fructose in glucitol (57%)
and mannitol (43%) [48]. These results show that fillet sample contained 8 g/100 g dw of fructose and
27 g/100 g dw of glucose. A previous study reported fructose and glucose contents ranging from 0.56 to
9.62 g/100 g dw and 4.57 to 28.27 g/100 g dw, respectively, in fresh gel and powdered gel concentrates
of Aloe vera [9], thus comprising the value quantified in this study.
Table 3. Carbohydrates of the initial and dialysed Aloe vera fillet identified as alditol acetates.
Fillet Sample
Carbohydrate (mol%) Total Carbohydrate
Ara Xyl Man Gal Glc UA (g/100 g) RSD (%)
Initial sample
Total sugars 1.0 2.0 21.4 3.5 50.1 22.0 64.0 3
Free sugars 9.7 90.3 34.9 12
HMW 1.4 1.5 65.2 3.2 15.9 12.7 76.5 6
HMW: high molecular weight (sample dialysed with a membrane cut-off of 12–14 kDa). Ara: arabinose; Xyl: xylose;
Man: mannose; Gal: galactose; Glc: glucose; UA: uronic acids; RSD: relative standard deviation.
Upon dialysis (12–14 kDa cut off), the weight of the obtained high molecular weight (HMW)
material accounted for 39.9%. The sample obtained after dialysis (HMW) was composed by 77% of
sugars, mainly mannose (65%), although glucose was also present (16%). To disclose the polysaccharides
composition of the HMW sample, a methylation analysis was performed (Table 4).
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Table 4. Glycosidic-linkage composition of the dialysed Aloe vera fillet.
Glycosyl Linkage
HMW (> 14 kDa)






















HMW: high molecular weight (sample dialysed with a membrane cut-off of 12–14 kDa). RSD: relative
standard deviation.
The glycosidic-linkage composition of dialysed Aloe vera fillet shows a mannan composed by
a backbone of (β1→4)-mannose residues [4,6], as observed by the high amount of the (1→4)-linked
mannose residues (74.0%). Although (β1→4)-glucose residues may be present as insertions of the
mannan backbone [49], these can have also indicate the presence of a glucan, possibly cellulose.
Aloe vera mannan is also reported to be acetylated at the C-2 and C-3 positions and containing some side
chains, mainly of galactose attached to C-6 [4,6]. The analysis performed using alkali conditions does
not allow to maintain the acetyl groups. Nevertheless, the presence of (1→2,4)- and (1→3,4)-linked
mannose residues are probably resultant from resistant acetylation positions of the mannan (Table 4).
The branching percentage (3.2%), which can be estimated by the ratio between the (1→4,6)- mannose
and the total amount of mannose, is in accordance with the presence of terminally-linked galactose
and arabinose residues, identified in both pyranose (0.5%) and furanose (0.4%) forms [6]. The ratio
calculated by the relative amount of total mannose divided by the amount of terminally linked mannose
shows that this polysaccharide had a higher molecular weight than those previously reported [6].
3.3. Phenolic Composition of Fillet, Mucilage, Rind, and Flower
Data related to the phenolic compounds identification in the obtained Aloe vera extracts are
presented in Table 5, namely the retention time, λmax in the UV-vis region, pseudomolecular ion, ions of
major fragments in MS2, and tentative identification (the obtained extraction yields and the phenolic
contents that can be found in fresh and dried samples are shown in Table S1). The chromatographic
profiles recorded at 280 and 370 nm are shown in Figures 1 and 2. Up to 17 phenolic compounds
were identified in the leaf extracts and eight in the flower extract, which were classified into four
groups—phenolic acids, flavonoids, chromones, and anthrones. Most of these compounds have already
been previously reported in Aloe vera [50–53], so that their identities were attributed by interpreting
data acquired from HPLC-DAD-ESI/MSn with those of literature.
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Figure 1. HPLC phenolic profiles of Aloe vera rind and mucilage extracts recorded at 280 nm (A1 and
B1, respectively) and 370 nm (A2 and B2, respectively). See Table 5 for peak identification.
Figure 2. HPLC phenolic profile of Aloe vera flower extract recorded at 370 nm. See Table 5 for
peak identification.
The chromones aloesin or aloeresin B (peak 1) and 2’-p-methoxycoumaroylaloresin (peak 17)
and the anthrones 10-hydroxyaloin B (peak 9), 10-hydroxyaloin A (peak 10), aloin B or isobarbaloin
(peak 14), aloin A or barbaloin (peak 15), malonyl aloin B (peak 16), and malonyl aloin A (peak 18) were
detected in the three studied parts of the Aloe vera leaf (Table 6). The mucilage contained the highest
content (131 ± 3 mg/g extract) of phenolic compounds, mostly anthrones (62.1%) and chromones
(34.6%), followed by two luteolin glucosides (3.3%). This result is in accordance with the literature,
which states that the vascularized layer that covers the inner fillet is rich in anthraquinone glycosides
and anthrone derivatives [3]. The rind was ranked second, with 105 ± 3 mg/g extract of phenolic
compounds, of which 44.9% anthrones and 43.8% chromones; it also contained luteolin and apigenin
glucosides and the phenolic acid p-coumaroylquinic acid. However, the chromone levels found in the
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rind did not differ statistically from those of the mucilage (Table 6). Although the phenolic profiles of
the fillet and mucilage were similar, a significantly lower concentration (11.2 ± 0.2 mg/g extract) of
these secondary metabolites was found in the fillet. In addition, this leaf part had an equal ratio of
anthrones and chromones (Table 6).
Table 6. Content of phenolic compounds in Aloe vera leaf (fillet, mucilage, and rind) and flower extracts.
See Table 5 for peak identification.
Peak Content (mg/g Extract) 1 Statistics
Fillet Mucilage Rind Flower H 2 p-Value 3
1 5.4 ± 0.4 c 39 ± 3 a 34.4 ± 0.7 b - 0.176 <0.001
2 - - 4.8 ± 0.2 - - -
4 - 3.5 ± 0.2 tr - - -
5 0.180 ± 0.008 - 0.31 ± 0.01 - 0.560 <0.001*
6 0.145 ± 0.002 - - - - -
7 - - 6.67 ± 0.04 - - -
8 tr 0.79 ± 0.01 b 3.3 ± 0.1 a - 0.095 <0.001
9 tr 3.2 ± 0.2 a 2.83 ± 0.06 b - 0.120 <0.001
10 tr 5.1 ± 0.4 a 3.8 ± 0.2 b - 0.149 <0.001
11 - 3.35 ± 0.06 2.4 ± 0.2 - 0.286 <0.001*
12 - - 1.64 ± 0.05 - - -
13 - - 3.23 ± 0.04 - - -
14 0.24 ± 0.03 c 13.3 ± 0.1 a 4.3 ± 0.3 b - 0.240 <0.001
15 1.24 ± 0.06 c 22.2 ± 0.5 a 9.9 ± 0.4 b - 0.292 <0.001
16 1.43 ± 0.08 c 16.6 ± 0.4 a 7.8 ± 0.4 b - 0.350 <0.001
17 0.13 ± 0.04 c 6.08 ± 0.08 b 6.9 ± 0.4 a - 0.139 <0.001
18 2.4 ± 0.1 c 17.6 ± 0.2 a 12.8 ± 0.8 b - 0.157 <0.001
20 - - - 0.30 ± 0.01 - -
21 - - - tr - -
22 - - - 2.42 ± 0.04 - -
23 - - - tr - -
24 - - - 0.94 ± 0.01 - -
25 - - - 0.96 ± 0.01 - -
26 - - - tr - -
27 - - - 0.152 ± 0.009 - -
Σ Phenolic acids 0.33 ± 0.01 a - 0.31 ± 0.01 a,b 0.30 ± 0.01 b 0.735 0.022
Σ Flavonoids - 4.3 ± 0.2 b 11.6 ± 0.1 a 4.48 ± 0.05 b 0.298 <0.001
Σ Anthrones 5.3 ± 0.3 c 81 ± 1 a 47 ± 2 b - 0.291 <0.001
Σ Chromones 5.5 ± 0.5 b 45 ± 3 a 46 ± 1 a - 0.259 <0.001
Σ Phenolic
compounds
11.2 ± 0.2 c 131 ± 3 a 105 ± 3 b 4.78 ± 0.05 d 0.134 <0.001
tr: traces. 1 The results are presented as mean ± standard deviation. 2 Homoscedasticity (H) was tested by the
Levene’s test: p > 0.05 indicates homoscedasticity and p < 0.05 indicates heteroscedasticity. 3 Statistically significant
differences (p < 0.05) among two samples* were assessed by a Student’s t-test and among more than two samples
were assessed by a one-way ANOVA (and indicated by different letters), using Tukey’s honestly significant difference
(HSD) or Tamhane’s T2 multiple comparison tests, when homoscedasticity was verified or not, respectively.
Variations in the phenolic profiles of Aloe species have been reported. According to Fan et al. [50],
aloesin is more abundant in A. barbadensis and A. ferox than in A. chinensis and A. arborescens. In these
species, aloin A predominated over aloin B (according to our results), and lower concentrations were
also found in A. chinensis. In general, higher contents and more complex phenolic compounds were
reported in A. barbadensis. Kanama et al. [54] found minimal qualitative variations in the phenolic
profiles of A. ferox exudate samples obtained from different regions of South Africa. Despite this,
aloin B content varied from 18.4 to 149.7 mg/g, aloin A ranged from 21.3 to 133.4 mg/g, and aloesin
from 111.8 to 561.8 mg/g of dried exudate. This result corroborates the data presented in Table 6,
since aloesin predominated over both aloins, despite lower levels have been quantified in our samples.
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6′-Malonylnataloin (peak 13), a malonylated derivative of the rare anthrone nataloin, was detected
in the rind extract (Table 6). This anthrone C-glycoside is considered of great importance in systematic
discrimination of different Aloe species and has been reported in A. vera, A. arborescens, A. ellenbeckii,
A. eru, A. grandidentata, A. brevifolia, and A. ferox [52,55].
The quantification of aloins (as hydroxyanthracene derivatives) is recommended in routine quality
control analyses of Aloe samples. These compounds are highly valorised in the pharmaceutical industry,
allowed in dietary supplements, and used in small quantities as a bittering agent in alcoholic beverages.
However, because of their laxative properties, levels of aloin A and B in Aloe leaf preparations
intended for oral consumption were limited by the International Aloe Science Council to 10 ppm
(10 mg/kg) or less [56]. These levels can be controlled and limited by adding purification steps in the
manufacturing process.
The phenolic profile of Aloe vera flower (Figure 2) was different from that of leaf (Figure 1),
being constituted mainly by the flavonoids apigenin-6,8-C-diglucoside, apigenin-2”-O-pentoxide-C
-hexoside, apigenin-6-C-glucoside, and traces of luteolin glucoside derivatives (accounting for 93.4% of
the extract), and by the phenolic acid 5-O-caffeoylquinic acid (Table 5). As shown in Table 6, this extract
had the lowest levels (4.78 ± 0.05 mg/g extract) of phenolic compounds. As far as we know, it is the first
time that some of these compounds are described in Aloe vera flower. No anthraquinone glycosides
were detected in this part of the plant as previously stated by Keyhanian and Stahl-Biskup [51].
3.4. Bioactive Properties of Fillet, Mucilage, Rind, and Flower
3.4.1. Antioxidant Capacity
The results of the antioxidant capacity of the Aloe vera extracts are presented in Table 7. For the
OxHLIA assay, data were given as IC50 values, corresponding to the extract concentration capable of
protecting 50% of the erythrocyte population from oxidative haemolysis for 60 min; whereas, for the
TBARS and β-CBI assays, data were expressed as EC50 values, meaning the extract concentration
capable of providing 50% of antioxidant activity. In both cases, the lower the EC50 or IC50 values,
the higher the antioxidant capacity.
The mucilage extract (at 47 ± 2 μg/mL) was the most effective in inhibiting the formation of
TBARS. This cell-based assay allowed for the measuring the extract capacity to inhibit the formation of
malondialdehyde and other reactive substances, which are generated from the ex vivo decomposition
of lipid peroxidation products resulting from the oxidation of the porcine brain cell membranes.
The rind extract provided the best protection against oxidative haemolysis (IC50 value,
56 ± 4 μg/mL) and β-carotene bleaching (EC50 value, 51 ± 4 μg/mL). In the OxHLIA assay,
the erythrocytes were exposed to the haemolytic action of hydrophilic radicals that resulted from
the thermal decomposition of the peroxyl radical initiator AAPH and, subsequently, to the action
of lipophilic radicals generated through a lipid peroxidation phenomenon as a result of the initial
attack [57]. In the β-CBI assay, β-carotene underwent discoloration in the absence of antioxidant
extract, which results in a reduction in the absorbance of the test solution with increasing reaction
time. The presence of antioxidants hindered the bleaching extension by neutralizing the linoleic
hydroperoxyl radicals formed in the reaction emulsion [58]. These results are consistent with those of
Lucini et al. [59], which concluded that the green rind is more antioxidant than the inner parenchyma.
Pearson’s analysis indicated a strong correlation between the antihaemolytic and β-carotene
bleaching inhibition capabilities and the flavonoids content (r = −0.778, p = 0.003, and r = −0.865,
p < 0.001, respectively). In fact, the higher IC50 and EC50 values obtained with these two in vitro
assays, respectively, were achieved with fillet extract (Table 7), in which no flavonoids were detected
(Table 6). On the other hand, TBARS inhibition was strongly correlated with malic acid contents
(r = −0.946, p <0.001) and moderately with the levels of anthrones (r = −0.667, p = 0.018) and chromones
(r = −0.676, p = 0.016). The results of a previous work [60] suggested that the antioxidant capacity of
Aloe vera gel extract might be ascribed to a synergistic action of bioactive compounds. The same study
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also evidenced that the gel extract is able to protect the erythrocyte membrane from AAPH-induced
oxidative injury and partially restore its normal protein profiles. This observation may support the fact
that the best results of the antioxidant activity of the present study were achieved with the OxHLIA
assay because the extracts had IC50 values closer to those of trolox.
Table 7. Antioxidant, anti-tyrosinase, and antimicrobial capacities of Aloe vera leaf (fillet, mucilage,
and rind) and flower extracts and positive controls.
Fillet Mucilage Rind Flower
Positive
Control
Antioxidant Activity 1 Trolox
OxHLIA (IC50, μg/mL) 378 ± 18 a 105 ± 8 b 56 ± 4 c 80 ± 4 b,c 20.4 ± 0.4 d
TBARS (EC50, μg/mL) 87 ± 4 b 47 ± 2 c 97 ± 3 b 347 ± 14 a 5.4 ± 0.3 d
β-CBI (EC50, μg/mL) 78 ± 6 a 63 ± 4 b 51 ± 4 c 59 ± 4 b,c 0.20 ± 0.01 d
Anti-Tyrosinase Activity Kojic Acid
IC50 (mg/mL) or I(%) 2 na 30.38 ± 0.01% 27.2 ± 0.7% 4.85 ± 0.07 0.078 ± 0.001
Antibacterial Activity Streptomycin
MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC
Staphylococcus aureus 0.60 0.80 0.60 0.80 0.60 0.80 0.60 0.80 0.006 0.012
Staphylococcus epidermidis 0.60 0.80 0.40 0.80 0.40 0.80 0.60 0.80 0.003 0.006
Staphylococcus lugdunensis 0.40 0.80 0.20 0.40 0.40 0.80 0.40 0.80 0.025 0.050
Micrococcus flavus 0.80 1.60 0.60 0.80 0.80 1.20 0.40 0.80 0.20 0.30
Listeria monocytogenes 1.20 1.60 0.40 0.80 0.60 0.80 0.80 1.20 0.20 0.30
Escherichia coli 0.050 0.10 0.10 0.20 0.025 0.050 0.025 0.050 0.006 0.012
Pseudomonas aeruginosa 0.10 0.20 0.050 0.10 0.10 0.20 0.025 0.050 0.025 0.050
Salmonella Typhimurium 0.80 1.20 0.80 1.20 0.40 0.80 0.80 1.20 0.25 0.50
Antifungal Activity Ketoconazole
MIC MFC MIC MFC MIC MFC MIC MFC MIC MFC
Aspergillus flavus 0.10 0.20 0.80 >1.60 0.10 0.20 0.10 0.20 0.25 0.50
Aspergillus niger 0.10 0.20 >1.60 >1.60 0.20 0.40 0.10 0.20 0.20 0.50
Penicillium funiculosum 0.050 0.10 >1.60 >1.60 0.050 0.10 0.10 0.20 0.20 0.50
Candida albicans 0.050 0.10 0.050 0.10 0.050 0.10 0.050 0.10 0.40 0.80
Trichophyton mentagrophytes 0.10 0.20 0.10 0.20 0.20 0.40 0.10 0.20 0.012 0.025
Trichophyton tonsurans 0.025 0.050 0.025 0.050 0.012 0.025 0.050 0.10 0.0015 0.003
Microsporum gypseum 0.025 0.050 0.20 0.40 0.050 0.10 0.012 0.025 0.006 0.012
Microsporum canis 0.025 0.050 0.050 0.10 0.050 0.10 0.025 0.050 0.003 0.006
na: no activity; MIC: minimum inhibitory concentration (mg/mL); MBC: minimum bactericidal concentration
(mg/mL); MFC: minimum fungicidal concentration (mg/mL). 1 Statistics for antioxidant activity: (a) homoscedasticity
was tested by the Levene’s test: p = 0.130 for OxHLIA (homoscedastic); p = 0.010 for TBARS (heteroscedastic);
and p = 0.305 for β-CBI (homoscedastic); and (b) Statistically significant differences (p < 0.05) were assessed by
a one-way ANOVA (and indicated by different letters) using Tukey’s honestly significant difference (HSD) or
Tamhane’s T2 multiple comparison tests, when homoscedasticity was verified or not, respectively: p < 0.001 in all
cases. 2 Inhibition percentage of tyrosinase activity at 8 mg/mL.
3.4.2. Antimicrobial Activity
Since Aloe vera has been used in the development of topical cosmeceutical formulations,
microorganisms of the skin flora were also tested. Staphylococcus aureus, S. epidermidis, and S. lugdunensis
are commensal bacteria of the skin that can become opportunistic pathogens and cause a number
of skin infections and also life-threatening diseases [61,62]. For these three bacteria, MIC and MBC
values ≤ 0.6 and 0.8 mg/mL, respectively, were reached with the tested extracts (Table 7). The mucilage
extract was the most effective against S. lugdunensis (with MIC and MBC values of 0.2 and 0.4 mg/mL,
respectively), a Gram-positive bacterium that has been associated with a wide variety of infections,
including skin and soft-tissue infections (furuncles, cellulitis, and abscesses), but also cardiovascular,
central nervous infections, and urinary tract infections [63]. The mucilage extract was also effective
in inhibiting and killing the Micrococcus flavus and also Listeria monocytogenes (Table 7), a food-borne
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pathogen capable of infecting both humans and animals. Occasionally, L. monocytogenes can cause
localized skin infections, especially in people dealing with infected animals. The activity against this
pathogenic bacterium was found strongly correlated with anthrones (r = −0.845 for MIC and r = −0.816
for MBC, p = 0.001) and chromones (r = −0.795 for MIC and r = −0.861 for MBC, p ≤ 0.002) and
moderately/strongly with flavonoids (r = −0.611, p = 0.035, for MIC and r = −0.781, p ≤ 0.003, for MBC).
The rind extract had the best results against Salmonella Typhimurium (S. enterica serovar
Typhimurium) (MIC of 0.4 mg/mL and MBC of 0.8 mg/mL) and rind and flower extracts against
Escherichia coli (MIC of 0.025 mg/mL and MBC of 0.05 mg/mL). In the case of Pseudomonas aeruginosa,
the flower extract was as effective as the antibiotic streptomycin in inhibiting (0.025 mg/mL) and killing
(0.05 mg/mL) this multidrug resistant opportunistic pathogen. Interestingly, this carbapenem-resistant
Gram-negative pathogen appears in the 2017 WHO list of threatening bacteria for which new antibiotics
are urgently needed [64].
As presented in Table 7, three of the Aloe vera extracts (except for mucilage) had an antifungal
activity (MIC and MFC values ≤ 0.1 and 0.4 mg/mL, respectively) against Aspergillus flavus, A. niger,
and Penicillium funiculosum superior to that of the positive control ketoconazole (MIC and MFC values
≤ 0.25 and 0.5 mg/mL, respectively). All extracts were more effective than ketoconazole in inhibiting
(MIC, 0.05 mg/mL) or killing (MFC, 0.1 mg/mL) the opportunistic yeast Candida albicans, which is
the most prevalent fungal pathogen in humans, causing candidiasis. This fungal infection affects
predominantly superficial skin and mucosa (oral and vaginal), but it can also lead to life-threatening
systemic infections [65].
Filamentous fungi causing superficial infections in keratinized tissues, namely Trichophyton
mentagrophytes, T. tonsurans, Microsporum gypseum, and M. canis, were also tested. As found for the
other microorganisms, extract concentrations ≤ 0.2 and 0.4 mg/mL were sufficient to inhibit growth
or kill, respectively, these dermatophytes (Table 7). The rind extract was the most effective against
T. tonsurans, while the flower followed by the fillet extracts were the most effective against M. gypseum
and M. canis.
3.4.3. Tyrosinase Inhibition Capacity
The extracts capacity to inhibit tyrosinase activity can be translated into their potential as skin
whitening and anti-hyperpigmentation agents, since melanin production is impaired when this enzyme
is inhibited, resulting in a less pigmented skin [66]. In this study, the flower extract was the most active
(with an IC50 of 4.85 ± 0.07 mg/mL), but still not as effective as kojic acid (IC50 of 0.078 ± 0.001 mg/mL),
the depigmenting agent used as a positive control (Table 7). The high percentage of flavonoids present
in this extract (Table 6) may justify the observed inhibitory effect. Previous studies reported that plant
extracts rich in flavonoids have a strong suppressive impact on tyrosinase, which enables its use in skin
lightening cosmeceuticals [66]. For rind and mucilage extracts, it was not possible to calculate IC50
values, so the results were given as percentage of inhibition. The fillet did not provide any value in
terms of tyrosinase inhibition. Despite this, chromones isolated from Aloe vera, including aloesin that
was found mainly in rind and mucilage, have been reported to have tyrosinase inhibitory activity [14].
3.4.4. Anti-Inflammatory and Cytotoxic Activities
Although it is claimed that Aloe vera gel has important therapeutic properties, the performed
bioassays indicated that none of the four extracts has anti-inflammatory activity or cytotoxicity
against metastatic melanoma (MM127), breast adenocarcinoma (MCF-7), non-small cell lung
carcinoma (NCI-H460), cervical carcinoma (HeLa), and hepatocellular carcinoma (HepG2) at the
tested concentrations (EC50 and GI50 values >400 μg/mL). Hepatotoxicity was also not observed against
the non-tumour PLP2 cell line, whereas a GI50 value of 8.6 ± 0.1 μg/mL was obtained for ellipticine,
the anticancer agent used as positive control. These results are somewhat supported by the study of
du Plessis and Hamman [67], in which the cytotoxic activity of Aloe vera, Aloe marlothii, Aloe speciosa,
and Aloe ferox gels was investigated against HepG2, HeLa, and human neuroblastoma (SH-SY5Y) cells.
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A decrease in cell viability was reported only at concentrations >10 mg/mL, and the half-maximal
cytotoxic concentration (CC50) values were above 1000 mg/mL, except for Aloe vera gel in HepG2 cells
(CC50 value = 269.3 mg/mL). Hussain et al. [68] reported that Aloe vera gel (extracted from dried leaves
and used directly as a drug solution) displays cytotoxic effects against the MCF-7 and HeLa cell lines
by inducing apoptosis and modulating the expression of effector molecules. In addition, no significant
cytotoxicity toward normal lymphocytes was recorded for 24 h.
Most of the cytotoxicity studies available in the literature report the use of isolated compounds
rather than crude extracts, which consist of a mixture of phytochemicals and other constituents with or
without bioactive properties. El-Shemy et al. [69] tested aloesin, aloe-emodin, and barbaloin extracted
from Aloe vera leaves against Ehrlich ascite carcinoma and found a significant inhibition as follows:
barbaloin >aloe-emodin >aloesin. The authors also described that aloe-emodin was active against the
human colon cancer cell lines DLD-1 and HT2. The antimetastatic potential of aloe-emodin on highly
metastatic B16-F10 melanoma murine cells has also been described [70].
4. Conclusions
This study showed that 58% of the total Aloe vera leaf weight corresponds to inner fillet, but the green
rind also accounted for a considerable percentage. The fillet consisted mainly of moisture, followed by
dietary fibre and available carbohydrates (mainly glucose and fructose). Malic acid, which is an excellent
freshness indicator, and α-tocopherol, a powerful fat-soluble chain-breaking antioxidant, were detected
in high amounts in this jelly-like parenchyma. Based on the glycosidic-linkage composition, it was
concluded that the fillet sample is composed mainly by mannans, possibly acemannan.
The three leaf samples revealed similar phenolic profiles, with predominance of chromones
(aloesin and 2’-p-methoxycoumaroylaloresin) and anthrones (aloin A and B, malonyl aloin A and
B, and 10-hydroxyaloin A and B). The highest contents of phenolic compounds were found in the
mucilage and rind extracts, which also revealed interesting antioxidant properties. On the other hand,
the flower extract was rich in apigenin glycoside derivatives, effective against the multidrug-resistant
P. aeruginosa, and capable of inhibiting the activity of the enzyme tyrosinase. The fillet, rind, and
flower extracts also showed a powerful antifungal activity against A. flavus, A. niger, P. funiculosum,
and C. albicans, higher than that of ketoconazole. Therefore, all the studied Aloe vera samples present
high potential to be exploited by food or cosmeceutical industries.
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-3921/8/10/444/s1,
Table S1. Moisture, organic acids and phenolic compounds composition of Aloe vera leaf (fillet, mucilage,
and rind) and flower.
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30. Soković, M.; Glamočlija, J.; Marin, P.D.; Brkić, D.; Griensven, L.J.L.D. van Antibacterial effects of the
essential oils of commonly consumed medicinal herbs using an in vitro model. Molecules 2010, 15, 7532–7546.
[CrossRef]
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Abstract: Green synthesis is one of the rapid and best ways for silver nanoparticles (AgNP) synthesis.
In the present study, synthesis and bioactivity of AgNPs has been demonstrated using water
beech (Fagus sylvatica L.) bark extract. The physical and chemical factors such as time, metal ion
solution, and pH, which play a vital role in the AgNPs synthesis, were assessed. The AgNPs were
characterized by ultraviolet-visible (UV-Vis) spectrometry, Fourier transform infrared spectroscopy
(FT-IR), and transmission electron microscopy (TEM). Antioxidant and antimicrobial activity of the
obtained AgNPs was evaluated. AgNPs were characterized by color change pattern, and the broad
peak obtained at 420–475 nm with UV-Vis confirmed the synthesis of AgNPs. FT-IR results confirmed
that phenols and proteins of beech bark extract are mainly responsible for capping and stabilization of
synthesized AgNPs. TEM micrographs showed spherical or rarely polygonal and triangular particles
with an average size of 32 nm at pH = 9, and 62 nm at pH = 4. Furthermore, synthesized AgNPs
were found to exhibit antioxidant activity and have antibacterial effect against Staphylococcus aureus,
methicillin-resistant Staphylococcus aureus (MRSA), Escherichia coli, and Pseudomonas aeruginosa. These
results indicate that bark extract of F. sylvatica L. is suitable for synthesizing stable AgNPs, which act
as an excellent antimicrobial agent.
Keywords: antioxidant; antibacterial; beech bark; silver nanoparticles; polyphenols
1. Introduction
Lately, nanotechnology focuses on synthesis and characterization of metallic and non-metallic
nanoparticles having different compositions, sizes, and shapes. Molecular aggregates with dimensions
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between 1 and 100 nm are called nanoparticles [1]. Due to their optical, magnetic, chemical,
and mechanical properties, nanoparticles are used in many areas of advanced technology such
as the electronic and optoelectronic industry; in the medical sector for diagnostics, antimicrobial
properties, and transport of the drug to a specified location in order to fulfill its purpose; and for
environmental protection and energy conversion [2]. The biosynthesis of nanomaterials becomes a
large scientific area, because nanoparticles have a low obtaining cost and a wide range of uses: catalytic,
biological and biomedical applications, physics, environmental remediation fields [3]. From all the
types of nanoparticles, silver ones are the most commonly used. However, silver is known to be a
good antimicrobial being used as an antiseptic agent [4].
The use of plant extracts in nanoparticle biosynthesis is advantageous because most plant extracts
have a high content of bioactive compounds such as: flavonoids, terpenoids, tannins, and alkaloids
responsible for reducing nanoparticles [5,6]. Silver nanoparticles (AgNPs) obtained by biosynthesis
are characterized by different shapes and sizes, depending on the nature and concentration of the
extract, pH, temperature, reaction time, and silver solution [7]. For example, flavonoids can chelate and
actively reduce metal ions in nanoparticles due to the numerous hydroxyl and carbonyl groups [8]. In a
study using leaf extracts from Magnolia kobus and Diospyros kaki, it has been observed that the presence
of terpenoids and reducing sugars has led to the synthesis of nanoparticles, whose size and shape may
vary by changing the reaction conditions [9]. Fruit extracts of Solanum virginianum have a high content
of steroidal alkaloids: solanocarpine, carpesterol, and solanocarpidin [10]. Among the high quantity
flavonoids are apigenin and quercetin which are considered as anti-capping agents and stabilizers of
the formed nanoparticles [10]. In order to elucidate the mechanism of nanoparticle biosynthesis, Mittal
et al. used extracts of Syzygium cumini fruit, observing that the presence of flavonic compounds led to
the reduction of the metal ions through a redox reaction. Furthermore, the biomolecules present in the
extract were responsible for AgNP aggregation and stabilization [11].
The shape and size of the biosynthesized nanoparticles depend on physical and chemical
factors [12]. On the other hand, the extract used is also dependent on certain factors: the type of
plant, the extraction solvent, and the extraction temperature [13,14]. In a study of turmeric extracts,
Sathishkumar et al. confirmed that pH plays an important role in controlling the size and shape of
the obtained nanoparticles. An alkaline plant extract has several functional groups that will facilitate
the reduction process and, thus, a larger number of nanoparticles will be formed [15]. However,
the optimum pH varies depending on the nature of the used ion solution.
In an experimental study using aqueous extracts of Myrtus communis as a reducer in nanoparticle
biosynthesis, it was shown that the obtained nanoparticles have the ability to neutralize free radicals [15].
Furthermore, the ability to reduce Fe3+ compared to vitamin C was tested and it was observed that the
reducing power increases with the increase of phenolic content [16]. However, using night jasmine
extracts (Cestrum nocturnum), the obtained AgNPs have an antioxidant capacity almost 5% higher than
that of vitamin C [17].
The increasingly common antibiotics resistance has led to the research of alternative treatment
methods. Thus, in order to demonstrate the antibacterial activity, different bacteria were inoculated
on culture media and it was observed that AgNPs can inhibit their growth. Inhibition was observed
in comparison with the control and the strongest inhibitory activity was demonstrated on Citrobacter
spp., Salmonella typhi, Vibrio cholerae [17]. In a recent study [18], AgNPs were synthesized from Lantana
camara. The results showed significant antimicrobial activity against Staphylococcus aureus, Pseudomonas
aeruginosa, and Escherichia coli. These results are comparable with the used standard (ciprofloxacin),
but also with petroleum ether extract and essential oil from L. camara leaves, showing that nanoparticles
have dose-dependent membrane permeation with respect to rate [18].
Taking into account the literature data, the main objectives of the current study were: (1) The
biosynthesis of AgNPs using beech bark polyphenolic extract as a new bioresource; (2) the determination
of the influence of the main factors on the biosynthesis process (type of reducing agent, time, and pH);
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(3) the characterization of the biosynthesized AgNPs by specific analyses (UV–Vis, FT-IR, and TEM);
(4) the evaluation of the antioxidant and antibacterial activity of the biosynthesized AgNPs.
2. Materials and Methods
2.1. Materials
The beech bark used for experimental research comes as waste from a wood processing company
from Vatra Dornei, Romania. Before the extraction process, the bark was dried under normal
temperature and aeration conditions (room temperature), and ground using a grinding mill type VEB
NOSSENER MASCHINENBAU 1980. After grinding, the plant product was sieved through sieve 5.
Silver nitrate (AgNO3, M—169.87 g/mol, d—4.35 g/cm3), silver acetate (AgC2H3O2, M—166.91g/mol,
d—3.26 g/cm3), Folin–Ciocalteu reagent, potassium bromide (KBr), and methanol were purchased
from Merck Company (Darmstadt, Germany), 2,2’-azino-bis (3-ethylbenzothiazoline-6-sulphonic
acid)-(ABTS) was from Sigma-Aldrich (Steinheim, Germany), 2,2-diphenyl-1-picrylhydrazyl (DPPH)
and 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox) were obtained from Alfa-Aesar
(Karlsruhe, Germany).
The following bacterial reference strains, stored at −70 ◦C in the Microbiology Laboratory
from UMFST Târgu Mures, , were used: S. aureus ATCC (American Type Culture Collection) 25923,
methicillin-resistant S. aureus (MRSA) ATCC 43300, E. coli ATCC 25922, Klebsiella pneumoniae ATCC
700603, P. aeruginosa ATCC 27853.
2.2. Extraction Method
The ultrasound-assisted extraction was made according to the method described previously [19]
with some modifications. Briefly, 10 g of beech bark was placed in an Erlenmeyer flask. Then, 100 mL
of distilled water was added. The Erlenmeyer flask was then inserted into the ultrasonic water bath
(Professional Ultrasonic Cleaner MRC: AC 150 H, 150 W, 40 KHz, heating power 300 W) preheated
to 70 ◦C, for an extraction time of 30 min. At the end of the extraction, the solution obtained was
filtered through the Buchner cone, transferring the filtrate to a 100 mL volumetric flask and filled up to
the mark with distilled water. In order to obtain a clear solution and to avoid the interference of any
bark residues in the biosynthesis process, the extract was centrifuged in centrifuge tubes, for 5 min at
5000 rpm.
2.3. Characterization of Extract
The determination of the polyphenol content was performed spectrophotometrically, using the
Folin–Ciocalteu method [20]. The total polyphenol content (TPC), expressed in mg gallic acid (GAE)/g
plant material, was calculated based on the absorbance read with the spectrophotometer at 765 nm,
taking into account the calibration curve (concentration range between 0 and 200 mg/L) of the standard
gallic acid solution.
2.4. Synthesis of Silver Nanoparticles
For the biosynthesis, 100 mL of silver nitrate/acetate solution (1 mM) was prepared in advance.
For adjusting the pH, a 50 mL HNO3/ NaOH solution (1 mM) was prepared. Biosynthesis consists
of mixing 10 mL of beech bark extract with 90 mL of silver nitrate/acetate in an Erlenmeyer glass.
From the obtained solution, the pH was measured, and the values were in the range of 5.56–5.63,
depending on the experimental version. Using the pH meter with an agitator at 800 rpm the solutions
were brought to pH = 4 using about 4 mL HNO3, and to pH = 9 using about 5 mL NaOH, depending
on the initial pH of the solution. Biosynthesis took place in the ultrasonic bath at 60 ◦C, for 3 h until the
color transformation indicated finalization of nanoparticles biosynthesis. At the time of introducing
the samples into the ultrasonic water bath, samples were taken for each experimental version in order
to record the spectrum of the initial solution. Tested solutions (TS) were: TS1—beech bark extract,
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pH = 4, silver nitrate; TS2—beech bark extract, pH = 9, silver nitrate; TS3—beech bark extract, pH = 4,
silver acetate; TS4—beech bark extract, pH = 9, silver acetate.
2.5. Characterization of Silver Nanoparticles
2.5.1. UV-Vis Analysis
The samples of synthesized nanoparticles were measured at different time intervals (T0 = 0,
T1 = 1 h, T2 = 1 h 30’, T3 = 2 h, T4 = 3 h, T5 = 24 h) based on previous results (in publication
process). The results were recorded with the Analytik Jena Specord 210 Plus190 (UV/Vis)-1100 nm
Spectrophotometer using synthetic quartz spectrophotometer cells (190–2500 nm, path length 10 mm,
volume 1.75 mL). The measurements were performed in the following parameters: 1 nm resolution,
the wavelength range between 350 and 700 nm.
2.5.2. FT-IR Analysis
For the FT-IR analysis, the AgNP dry matter was used. FT-IR analysis involves mixing the
obtained powder with KBr in the agate mortar in a ratio of 1:100. Using the FT-IR Thermo Nicolet 380
Spectrophotometer (Thermo Scientific, Waltham, USA), the measuring range 4000–400 cm−1, spectra
were recorded for each TS.
2.5.3. TEM Analysis
The nanoparticles in the solution were characterized morphologically and dimensionally using
conventional electron transmission microscopy, using a JEOL 100 U TEM microscope (Japan Electron
Optics Laboratory, Tokyo, Japan) at 100 kV. The nitrocellulose substrates coated with amorphous
carbon layers, prepared on a 300 mesh copper microgrid, served as the substrate used for nanoparticle
investigation. The thickness of the thermally evaporated carbon layer was about 4 nm. The SERS
(Surface-Enhanced Raman Scattering) spectra were recorded in solution with a portable spectrometer
(Raman Systems R3000 CN, Edinburgh, United Kingdom) equipped with a 785 nm diode coupled to a
100 km optical fiber. The laser power was 200 mV and the integration time was 30 s.
The obtained images were processed with the ImageJ software to determine the AgNP size and
the histograms were made for each experimental version with Excel.
2.6. In Vitro Antioxidant Activities
2.6.1. Free Radical-Scavenging Activity Using 2,2-Diphenyl-1-picrylhydrazyl (DPPH)
The antioxidant activity was monitored according to the DPPH method described by
Martins et al. [21] with modifications. This method was performed by using a SPECTRO star Nano
microplate reader (BMG Labtech, Offenburg, Germany). The reaction mixture in each of the 96-wells
consisted of 30 μL of sample solution (in an appropriated dilution, according to the reference range of
the calibration curve) and a 0.004% methanolic solution of DPPH. The mixture was further incubated
for 30 min in the dark, and the reduction of the DPPH radical was determined by measuring the
absorption of the sample at 515 nm. Trolox was used as a standard reference and the results were
expressed as Trolox equivalents (TE) per g of dry weight (mg TE/g dw TS).
2.6.2. Trolox Equivalents Antioxidant Capacity (TEAC) Assay
The radical scavenging activity of the tested solutions against the stable synthetic 2,2’-azino-bis
3-ethylbenzothiazoline-6-sulphonic acid (ABTS) radical cation was measured using the method
previously described by Mocan et al. [22]. Briefly, 20 μL of sample is mixed with 200 μL of radical
solution and incubated for 6 min. The absorbance of the final solution is measured at 760 nm after the
incubation period. A Trolox calibration curve was plotted as a function of the percentage of ABTS
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radical scavenging activity. The final results were expressed as milligrams of TE per gram of dry
weight tested solutions (mg TE/g dw TS).
2.7. Antibacterial Activity
2.7.1. Minimal Inhibitory Concentration (MIC) of Silver Nanoparticles
In order to determine the MICs of the obtained AgNPs against tested bacterial strains, we used
the microdilution method, as previously described [20]. To obtain binary dilutions from the TS, 200
μL TS was added in the first column of the microplate. One-hundred microliters of sterile water
were added in all the other wells of the microplate. One-hundred microliters from the first column
were transferred with a multichannel pipette into the second column of the microplate. These steps
were repeated until the last column, from which, the last 100 μL was discarded. Ten microliters of
0.5 McFarland bacterial suspension were mixed with 9990 μL of Mueller-Hinton broth medium 2X
and 100 μL from this bacterial inoculum were dispensed in each well of the microplate. Additionally,
wells with culture medium only, culture medium with TS (negative controls), and culture medium
with bacterial inoculum (growth control) were prepared. The microplates were incubated at 37 ◦C for
24 h. MIC was considered in the last well in which no bacterial growth was noted. For TS with a high
degree of turbidity, resazurin was used as an indicator of bacterial growth [23]. After the plates were
incubated for 24 h at 37 ◦C, 3 μL 0.015% resazurin was added to each well, and the plates were further
incubated for 2–4 h. A color change of resazurin, from purple to pink, indicated a bacterial growth.
The last well in which the resazurin color did not change was considered MIC.
2.7.2. Minimal Bactericidal Concentration (MBC) of Silver Nanoparticles
From each well in which no bacterial growth was observed in the MIC method, 1 μL of suspension
was spot-inoculated on blood agar with a calibrated bacteriological inoculation loop. MBC was
considered the first TS concentration where no bacterial growth was observed on blood agar.
2.7.3. AgNP Effect on Bacterial Growth Rate (GR)
The following bacterial strains were used: S. aureus ATCC 25923 (SA); E. coli ATCC 25922;
P. aeruginosa ATCC 27853. To determine the growth rate, the solution with the highest bactericidal
activity was chosen (TS4). For the determination of GR, the steps described in a previous work were
performed [20]. The content of the microplate well in which MIC was noted was reproduced in a 2 mL
Eppendorf tube and it was incubated at 37 ◦C. At the initial moment and after 3 and 6 h of incubation,
50 μL of bacterial suspension were removed, serial diluted, and from these dilutions, 50 μL were evenly
seeded on the surface of Mueller-Hinton agar with a bacteriological inoculation loop. The plates were
incubated for 18–24 h and the colonies were automatically counted using “Flash & Go Automatic
Colony Counter” instrument (IUL Instruments S.A., Bacelona, Spain) from the plate with the most
countable colonies. As control for the bacterial growth, the same protocol was used, in the absence of
TS. Mathematical adjustments were performed to compensate the dilution from where the colonies
were counted and the inoculation volume.
2.8. Statistical Analysis
All analytical determinations were performed in triplicate, and the results are expressed as the
mean ± standard deviation. The statistical significance was assessed by GraphPad InStat 3 software
(GraphPad Software, San Diego, Canada), at a significance threshold value of p < 0.05.
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3. Results
3.1. Characterization of Aqueous extracts
The aqueous extract was characterized in terms of total phenolic content (TPC), which is considered
responsible for silver ion reduction and AgNP synthesis. Thus, the total phenolic content was found to
be 20.59 mg GAE/g plant material.
3.2. Characterization of AgNPs
The first sign of nanoparticle formation is the color transformation of the solution. The influence
of the extract and of the used pH has an important role and it is observed that the solutions change
their color becoming brownish-red at pH = 9 and brown at pH = 4 (Figure 1). The appearance of the
opaque aspect is achieved as the biosynthesis time passes.
Figure 1. Color transformation of beech bark extract solution with AgNO3 at pH = 4 (test solution 1
(TS1)) and pH = 9 (TS2).
3.2.1. UV-Visible Spectral Analysis of AgNPs
The optical and electronic properties of the obtained silver nanoparticles are observed by UV-Vis
spectrophotometric analysis. Many factors that influence the absorption spectrum shift have been
analyzed, observing that the wavelength at which the maximum absorbance is recorded is dependent
on the time, pH, and silver ion solution. The biosynthesis time, visually determined, is 3 h for each
experimental version, but the time of appearance of the nanoparticles is different and can be observed
by UV-Vis spectra analysis (Figure 2). Use of beech bark extract (TS1) after 3 h of maintenance in
the ultrasonic bath leads to the formation of AgNPs. The maximum absorbance was recorded at the
wavelength of 475 nm (Figure 2a). The recording of the UV-Vis spectrum for TS2 shows a maximum
absorbance corresponding to the wavelength 425 nm from time 0 (Figure 2b). For TS3, it can be
observed that the time of appearance of AgNPs is 3 h and the maximum absorbance corresponds to
the wavelength of 450 nm (Figure 2c). At basic pH (TS4), under the same experimental conditions it is
observed (Figure 2d) that the appearance of the maximum absorbance corresponds to the wavelength
420 nm.
UV-Vis spectra recordings show that the wavelengths recorded for the TS are mainly pH dependent.
Thus, at pH = 4, maximum absorbances are recorded at wavelengths in the range of 450–475 nm. When
using the basic pH, the UV-Vis spectra shows a shift of the maximum absorbances at a wavelength
range between 411 and 431 nm. These results are supported by the literature data in which the
use of acidic pH records lower maximum absorbances [15]. The value of the acidic pH leads to the
agglomeration of the nanoparticles. Thus, on the UV-Vis spectrum, there is a lower absorbance peak
compared to the use of a basic pH which favors obtaining a larger number of nanoparticles and smaller
dimensions. Thus, at basic pH, the reaction rate increases followed by crystallization into smaller
particles, which involves the nucleation process and the growth of small nanoparticles [15,24]. In a
study using extracts from oak bark, rich in polyphenolic compounds and tannins, it was shown that the
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synthesis rate of AgNPs increases with increasing pH. The pH with value 9 has the highest absorbance;
above this value the synthesis rate decreases [25]. Analyzing the experimental versions comparatively,
depending on the used silver solution, no significant differences were found.
Figure 2. UV–visible absorption spectra of synthesized silver nanoparticles using tested solutions:
(a) TS1—beech bark extract, pH= 4, AgNO3; (b) TS2—beech bark extract, pH= 9, AgNO3; (c) TS3—beech
bark extract, pH = 4, AgC2H3O2; (d) TS4—beech bark extract, pH = 9, AgC2H3O2.
3.2.2. FT-IR Analysis of Biosynthesized AgNP
FT-IR analyses were conducted to identify the biomolecules that might be responsible for reducing
the Ag+ ions in the beech bark extract, and also those that may be involved in the stabilization of
silver nanoparticle synthesis. Figure 3 shows the spectrum of aqueous beech bark extract, where the
bands corresponding to the –O–H bonds at 3414 and 1608 cm−1 specific to the carbonyl group can
be observed.
The recording of the FT-IR spectra in the case of AgNPs obtained by reducing AgNO3 (TS1–TS2)
with the polyphenolic compounds in the aqueous beech extract shows the appearance of a band at the
value of 1512 cm−1 and intensifies the band corresponding to the wavenumber 1384 cm−1 (Figure 4).
These show that certain compounds in the aqueous extract modify their structure, thus, generating
AgNPs. For TS3–TS4 solutions, there were no different results compared to TS1–TS2.
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Figure 3. Fourier transform infrared spectra of aqueous bark extract.
Figure 4. Fourier transform infrared spectra of gold nanoparticles (AgNPs): A—TS2 (AgNPs obtained
with AgNO3 at pH = 9), B—aqueous bark extract, C—TS1 (AgNPs obtained with AgNO3 at pH = 4).
3.2.3. The Analysis by Transmission Electron Microscopy (TEM) of Biosynthesized AgNP
Transmission electron microscopy was used in order to characterize the obtained nanoparticles
in terms of their morphology and size. Thus, the TEM photomicrographs obtained were
analyzed using ImageJ program, obtaining information about the surface and diameter of the
biosynthesized nanoparticles.
In Figure 5, it is observed that the AgNPs synthesized are nanometric and uniformly distributed.
Regarding the morphology of the nanoparticles, it can be observed that it varies, encountering
polygonal, spherical, and even triangular shapes at TS1 (Figure 5a). In contrast, at basic pH (TS2) only
spherical shapes are observed (Figure 5c). The particles synthesized in TS1 have sizes between 10 and
420 nm (Figure 5b), with an average of 118.75 nm, and about 44% of these have a diameter below
100 nm. Regarding the size of the nanoparticles obtained at pH 9 (TS2) they fall in the range of 2–80 nm,
with an average of 44.02 nm and 100% of the measured nanoparticles have dimensions smaller than
100 nm (Figure 5d).
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Analyzing the synthesized AgNPs in the presence of the extract obtained from the beech bark
and AgNO3 (Figure 6), the results are similar to those presented previously. The morphology of the
obtained AgNPs at pH = 4 (TS3) is varied, in this case observing polygonal, triangular, and spherical
shapes (Figure 6a). In contrast, at basic pH (TS4) it can be observed that the AgNP morphology is
constant, with only the spherical shape being met (Figure 6c). AgNPs obtained in the basic medium
have dimensions in the range of 2–80 nm, with an average of 32.43 and 100% being smaller than 100 nm
in diameter (Figure 6d).
The results obtained with the help of TEM confirm the results presented above, regarding the
basic pH which favors the formation of a larger number of smaller nanoparticles. Thus, comparing
the tested solution, it is found that at pH = 9 all AgNPs have dimensions below 100 nm, and at pH
= 4, about half of AgNPs have dimensions below 100 nm. These findings, related to shape and size,
are also confirmed by other researchers who analyzed synthesized nanoparticles in the presence of
extracts obtained from the bark of woody plants [26,27]. The particles synthesized in TS3 have sizes
between 10 and 200 nm (Figure 6b), with an average of 62.2 nm.
Thus, from literature data, AgNPs with a larger surface area, provide better contact with
microorganisms [28]. These particles are able to penetrate into the cell membrane or attach to the
bacterial surface based on their size. In addition, they have been reported to be highly toxic to bacterial
strains and their antibacterial efficacy is increased by decreasing the particle size [29].
Figure 5. Graphical representation of AgNPs synthesized in the presence of the extract obtained from
the beech bark and AgC2H3O2: (a) TS3— TEM photomicrograph; (b) histogram of the distribution of
AgNP size distribution in TS3; (c) TS4—TEM image; (d) histogram of the distribution of AgNP size
distribution in TS4. (TS3—beech bark extract, pH = 4, AgC2H3O2; TS4—beech bark extract, pH = 9,
AgC2H3O2).
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Figure 6. Graphical representation of AgNP synthesized in the presence of the extract obtained from
the beech bark and AgNO3: (a) TS1— TEM photomicrograph; (b) histogram of the distribution of the
AgNP size distribution in the TS1; (c) TS2—TEM image; (d) histogram of the distribution of AgNP
size distribution in TS2 (TS1—beech bark extract, pH = 4, AgNO3; TS2—beech bark extract, pH = 9,
AgNO3).
4. Antioxidant Activity of AgNPs
The antioxidant activity of synthesized AgNPs was evaluated by DPPH and TEAC radical
scavenging assays. The beech bark AgNPs exhibited free-radical-scavenging activity using both assays
as shown in Table 1. The activity against DPPH and ABTS confirmed the antioxidant potential of the
beech bark AgNPs. Significantly higher TEAC values were noted for TS1–TS2 as compared to TS3–TS4.
Many AgNPs solutions have been evaluated for their antioxidant capacities, commonly associated
with the content of phenolic compounds from plant extracts [17,30,31]. Beech bark contains a range
of biologically active components, such as tannins and polyphenols, indicating that the antioxidant
activity of the AgNPs has been enhanced by these bio-components.




DPPH mg TE/g of
Sample
TEAC mg TE/g of
Sample
TS1 pH = 4, AgNO3 11.68 ± 0.34 35.05 ± 0.69
TS2 pH = 9, AgNO3 10.64 ± 0.35 37.23 ± 0.35
TS3 pH = 4, AgC2H3O2 10.52 ± 0.21 28.61 ± 0.21
TS4 pH = 9, AgC2H3O2 8.52 ± 0.15 20.39 ± 0.30
TE—Trolox equivalents; TS1—beech bark extract, pH = 4, AgNO3; TS2—beech bark extract, pH = 9, AgNO3;
TS3—beech bark extract, pH = 4, AgC2H3O2; TS4—beech bark extract, pH = 9, AgC2H3O2. ± Standard deviation.
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5. Antimicrobial Activity of AgNPs
To evaluate the antibacterial activity of the AgNPs against gram-negative bacteria (E. coli ATCC
25922, K. pneumoniae ATCC 700603, P. aeruginosa ATCC 27853) and gram-positive ones (S. aureus ATCC
25923 and MRSA ATCC 43300), MIC and MBC values were obtained. Afterwards, we studied how the
TS influenced the bacterial growth rate (at the initial moment and after 3 and 6 h of incubation).
For therapeutic consideration, only antimicrobial activity obtained below 1 mM concentration was
considered. The MIC and MBC of nanoparticles against pathogenic bacterial strains are as mentioned
in Table 2. Thus, it is found that almost all tested solutions exhibit inhibitory activity on the growth of
tested bacteria (except TS1, where the MIC was determined only for MRSA, at the maximum analyzed
concentration). It can be seen that AgNPs obtained at pH = 9 (TS2, TS4) favor the inhibitory activity
for the tested bacterial strains. They have a lower MIC compared to those obtained at pH = 4 (TS1,
TS3). TS2 (for E. coli, K. pneumoniae, and P. aeruginosa) and TS4 (for S. aureus, E. coli, K. pneumoniae, and
P. aeruginosa) have lower MIC and MBC compared to those obtained for the control beech bark extract.
For the most part, the MBC was registered for the TS where the MIC was determined, the results being
presented in Table 2. The lowest MBC was recorded for TS4 (MRSA, E. coli, and P. aeruginosa) and for
TS2 (E. coli).
As can be seen from Figure 7, TS4 had a bactericidal effect on E. coli and inhibited the growth of
S. aureus and P. aeruginosa after 6 h of incubation.
Figure 7. Graphical and visual representation of the growth rate for S. aureus (A,D), E. coli (B,E), P.
aeruginosa (C,F) in the presence of TS4 (beech extract + AgC2H3O2 pH = 9) and in the absence of TS4
(Control) at: initial time—H0, 3 h—H1, and 6 h—H2.
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Table 2. Antimicrobial activity of AgNPs against pathogenic bacteria.













































ATCC—American Type Culture Collection; MIC—minimal inhibitory concentration; MBC—minimum bactericidal
concentration; MRSA—methicillin-resistant S. aureus, BBE—beech bark extract; AgNO3—silver nitrate;
AgC2H3O2—silver acetate; TS1—beech bark extract, pH = 4, AgNO3; TS2—beech bark extract, pH = 9, AgNO3;
TS3—beech bark extract, pH = 4, AgC2H3O2; TS4—beech bark extract, pH = 9, AgC2H3O2.
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The antibacterial mechanism might beexplained by the interaction between silver nanoparticles
and bacterial DNA. AgNPs can cause DNA damage, and ultimately bacterial cell death. This effect has
been demonstrated on S. aureus and E. coli strains [32].
However, the antibacterial mechanism is different, depending on the type of bacteria to be
inhibited. For example, silver nanoparticles have an inhibitory effect on Helicobacter pylori, stating
two theories of action: small amounts of AgNPs enter the bacterium and inhibit the respiratory chain,
while another theory considers that AgNPs inhibit urease from H. pylori [33]. Evidence of bacterial
growth inhibition have also been demonstrated for strains of S. aureus, Streptococcus pneumoniae,
Proteus mirabilis, and E. coli [34].
6. Conclusions
Following the performed analyses, it was found that the biosynthesis of silver nanoparticles is
time and pH dependent. UV-Vis analysis shows that basic pH accelerates biosynthesis independently
of the ion salt used. This is also supported by TEM analysis in which the appearance in large quantities
and smaller size of AgNPs was demonstrated in all the versions where the basic pH was used.
FTIR analysis demonstrated that certain functional groups of the compounds present in the
aqueous extracts contributed to the formation of AgNPs, a fact supported by the intense bands around
1384 cm−1.
AgNPs tested solutions showed antioxidant activity as well as inhibitory and bactericidal activity.
The lowest MBC was obtained for TS4 (0.19 mg/mL) against E. coli ATCC 25922. The small nanoparticles
at pH = 9 have a lower MIC/MBC compared to those synthesized at pH = 4. This result could be
explained by the fact that alkaline pH favors the penetration of AgNPs into the bacterial cell, having
an inhibitory or bactericidal effect.
By determining the growth rate, it was observed that for E. coli, the tested AgNPs had a bactericidal
effect; while for S. aureus and P. aeruginosa the growth was inhibited.
These results indicate that bark extract of Fagus sylvatica L. is suitable for synthesizing stable
AgNPs which act as an antimicrobial agent.
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Abstract: Tree nut by-products could contain a wide range of phytochemicals, natural antioxidants,
which might be used as a natural source for dietary supplements. The aim of the present study was
to evaluate the phenolic and sterolic composition, as well as the antioxidant and other biological
activities, of hazelnut involucre (HI) extracts. Experimental designs were developed in order to
select the optimum extraction conditions (solvent, temperature, time) using turbo-extraction by
Ultra-Turrax for obtaining extracts rich in bioactive compounds. Qualitative and quantitative analyses
were performed by LC-MS and LC-MS/MS and they revealed important amounts of individual
polyphenols and phytosterols, molecules with antioxidant potential. The richest polyphenolic HI
extract with the highest antioxidant activity by TEAC assay was further evaluated by other in vitro
antioxidant tests (DPPH, FRAP) and enzyme inhibitory assays. Additionally, the cytotoxic and
antioxidant effects of this extract on two cancerous cell lines and on normal cells were tested. This is
the first study to analyze the composition of both hydrophilic and lipophilic bioactive compounds
in HI extracts. Our findings reveal that this plant by-product presents strong biological activities,
justifying further research, and it could be considered an inexpensive source of natural antioxidants
for food, pharmaceutical, or cosmetic industry.
Keywords: hazelnut involucre; antioxidants; polyphenols; phytosterols; biological activity;
experimental design; LC-MS; turbo-extraction; Ultra-Turrax; enzymatic inhibition
1. Introduction
The interest in traditional bioactive herbal compounds with less detrimental effects on human
body than their synthetic counterparts is growing. Many clinical trials and cohort studies showed
that consumption of foods (vegetables, fruits, nuts) rich in biologically active molecules with
demonstrated antioxidant capacity, through different mechanisms of actions, has the potential to protect
against cardiometabolic diseases, neurodegenerative disorders, cancer, or age-related sarcopenia and
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frailty [1–5]. Increased intake of antioxidants from tree nuts and peanuts influences risk factors
associated with aging and can extend health span and lifespan [6].
Hazelnut (Corylus avellana L.) is known for the nutritional and therapeutic properties of its fruits,
rich sources of healthy fatty acids, vitamins, minerals, and polyphenols [7,8]. Polyphenols, common
secondary plant metabolites characterized by several hydroxyl groups linked to a phenol ring, can act
synergistically with other phytochemicals to lower the oxidation and inflammation processes which
may trigger many pathological conditions or age-related chronic diseases [9–11]. These biologically
active molecules donate electrons or hydrogen atoms to reactive free radicals preventing lipid oxidation
or cellular damage and acting as natural antioxidants with many health benefits [12]. In addition,
plant polyphenols act as signaling molecules and can participate in many enzymatic pathways [13].
Recently, special interest was given to tree nut by-products, waste plant matrices, with great
potential as sources of biologically active compounds. As little is known about the biochemical profile
of hazelnut involucre (HI) [14], we intended to extend the knowledge about this promising by-product.
In a previous study, we successfully applied a d-optimal experimental design to optimize the bioactive
compound extraction from walnut septum, another tree nut by-product [15]. In that experiment,
acetone was more efficient than ethanol to extract both polyphenols and phytosterols from the plant
matrix. The objectives of this study were the optimization of the extraction process in order to identify
the optimal extraction conditions for attaining rich bioactive compound extracts from HI and the
emphasizing of key biological activities for the optimally selected extract, which would justify further
research on this plant matrix. The first aim of our study was the analysis of phenolic and phytosterol
compounds from HI based on experimental designs. Turbo-extraction (TE) by Ultra-Turrax, an efficient
and economical extraction method, with higher outcomes compared to other methods, was chosen [15].
Three extraction variables, stirring time, pH, and percentage of water in acetone, were selected to define
the optimal extraction conditions. LC-MS analysis was chosen for the identification and quantification
of several individual polyphenols and phytosterols from involucre. Based on the obtained results,
optimal conditions were selected to achieve the HI extract with the highest content of polyphenolic
compounds and the highest antioxidant activity (AA) determined by Trolox equivalent antioxidant
capacity (TEAC) assay. The biological activities of this optimal extract were further examined by
other in vitro antioxidant assays (DPPH and FRAP), for enzymatic inhibitory capacity (tyrosinase and
α-glucosidase), and a potential cytotoxic effect on lung and breast cancer cell lines.
2. Materials and Methods
2.1. Chemicals
2,2-Diphenyl-1-2,4,6-trinitro-phenyl hydrazine (DPPH), 2,4,6-tris(2-pyridyl)-S-triazine (TPTZ) (≥99%),
3,4-dihydroxy-l-phenylalanine (l-DOPA) (≥98%), 6-hydroxy-2,5,7,8-tetramethylchromane-
2-carboxylic acid (Trolox) (≥97%), 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt
(ABTS) (≥98%), dimethyl sulfoxide (DMSO) (≥99%), ferric chloride, hydrogen peroxide 30% solution, kojic
acid, mushroom tyrosinase, N-acetyl-l-cysteine (≥99%), phosphate buffer, p-nitrophenyl-β-d-glucuronide
(PNPG), sodium carbonate, vanillin (99%), resazurin, neutral red, 2,7 dichloro-fluorescein diacetate
(DCFH-DA), acetic acid (≥99%) were acquired from Sigma Aldrich (Schnelldorf, Germany).
Acetone, Folin–Ciocâlteu reagent, hydrochloric acid (HCl) (37%), sodium phosphate (≥99%) were
acquired from Merck (Darmstadt, Germany). α-Glucosidase solution (Saccharomyces cerevisiae, EC 3.2.1.20)
was obtained from Sigma (Darmstadt, Germany). Aluminum chloride (≥98%) was acquired from Carl
Roth (Karlsruhe, Germany), Dulbecco’s modified Eagle medium (DMEM) from Gibco (Paisley, UK), and
fetal bovine serum (FBS) from Sigma Aldrich (Steinheim, Germany).
All solvents were of LC grade and all reagents were of analytical grade.
The standards used for both spectrophotometric and liquid chromatography–mass spectrometry
(LC-MS) analyses were: apigenin (≥95%), caffeic acid (≥98%), brassicasterol (≥98%), caftaric acid (≥97%),
(+)-catechin (≥96%), chlorogenic acid (≥95%), (−)-epicatechin (≥90%), fisetin (≥98%), gentisic acid
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(≥98%), l-glutathione (≥98%), hyperoside (quercetin 3-d-galactoside) (≥97%), isoquercitrin (quercetin
3-β-d-glucoside) (≥98%), kaempferol (≥97%), luteolin (≥98%), myricetin (≥96%), patuletin (≥98%),
p-coumaric acid (≥98%), protocatechuic acid (3,4-dihydroxybenzoic acid) (≥97%), quercetin (≥95%),
quercitrin (quercetin 3-rhamonoside) (≥78%), rutoside (quercetin-3-O-rutinoside) (≥97%), syringic acid
(≥95%), vanillic acid (≥97%), campesterol (~65%), ergosterol (≥95%), stigmasterol (~95%) acquired from
Sigma-Aldrich, ferulic acid (≥99%), gallic acid (≥98%) acquired from Merck (Darmstadt, Germany),
beta-sitosterol (≥80%), sinapic acid (≥98%) acquired from Carl Roth (Karlsruhe, Germany).
2.2. Plant Samples
Hazelnut (Coryllus avelana L.) involucre of high quality was provided by an organic orchard in Cluj
County, Romania. In the autumn of 2017, hazelnuts were harvested and separated from the involucre.
The by-product was dried in the shade for three days at 18–22 ◦C, and then it was delivered to the
Faculty of Pharmacy, “Iuliu Hatieganu” University of Medicine and Pharmacy Cluj-Napoca, Romania.
Preparation of the Extracts
The involucre was ground in a coffee grinder (Argis, RC-21, Electroarges SA, Curtea de Arges,
Romania) for 5 min and the powder was screened through a 200 μm Retsch sieve. HI was weighed
(2 g) and mixed with the extraction solvent (20 mL) in Falcon tubes. TE was accomplished using an
Ultra-Turrax homogenizer (T 18; IKA Labortechnik, Staufen, Germany) for 1 to 3 min (12,000 rpm)
and a Vortex RX-3 (Velp Scientifica, Usmate, Italy) for 2 min. The homogenates were centrifuged
(Hettich, Micro 22R, Andreas Hettich GmbH & Co., Tuttlingen, Germany) 15 min at 5000 rpm.
The supernatant was carefully separated and, using a rotary evaporator (Hei-VAP, Heidolph Instruments
GmbH & Co., Schwabach, Germany), the solvent was removed under vacuum at 45 ◦C. The dry residue
was taken up in water, placed in amber glass vials, and lyophilized (Advantage 2.0, SP Scientific,
Warminster, PA, USA). After lyophilization, the samples (weight between 6 and 520 mg) were stored
at room temperature. For further analyses, the lyophilized extracts were dissolved in 70% EtOH
(10 mg/mL), if not specified otherwise. All assays were performed in triplicate.
Twod-optimal experimental designs, implemented by Modde software, version 11.0 (Sartorius Stedim
Data Analytics AB, Umeå, Sweden), were developed for the extraction process optimization. Three factors,
stirring time, pH, and percentage of water in acetone, were the independent variables for both d-optimal
experimental designs. The total phenolic content (TPC), total flavonoid content (TFC), condensed tannin
content (CTC), and the AA-TEAC were the dependent variables in the first experimental design used
in the screening step (Table 1). The extracts were prepared according to this first experimental design.
The individual concentrations of the bioactive compounds quantified by LC/MS methods were the
dependent variables in the second experimental design used in the optimization step (Table 2).





Stirring time (min) (X1) 1 2 3
pH (X2) 3 5 7
Water in solvent (%, v/v) (X3) 0 25 50
Dependent variables (responses)
Total phenolic content (TPC, mg GAE/g dw 1) (Y1)
Total flavonoid content (TFC, mg QE/g dw 2) (Y2)
Condensed tannin content (CTC, mg CE/g dw 3) (Y3)
Antioxidant activity (AA, mg TE/g dw 4) (Y4)
1—mg GAE/g dw = gallic acid equivalents per dry weight of hazelnut involucre, 2—mg QE/g dw = quercetin
equivalents per dry weight of hazelnut involucre, 3—mg CE/g dw = catechin equivalents per dry weight of hazelnut
involucre, 4—mg TE/g dw = Trolox equivalents per dry weight of hazelnut involucre.
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Stirring time (min) (X1) 1 2 3
pH (X2) 3 5 7
Water in solvent (%, v/v) (X3) 0 25 50
Dependent variables (responses)
Epicatechin (μg/g dw) (Y1)
Catechin (μg/g dw) (Y2)
Syringic acid (μg/g dw) (Y3)
Gallic acid (μg/g dw) (Y4)
Protocatechuic acid (μg/g dw) (Y5)
Vanillic acid (μg/g dw) (Y6)
p-Coumaric acid (μg/g dw) (Y7)
Ferulic acid (μg/g dw) (Y8)
Hyperoside (μg/g dw) (Y9)
Isoquercitrin (μg/g dw) (Y10)
Quercitrin (μg/g dw) (Y11)
Stigmasterol (μg/g dw) (Y12)
Campesterol (μg/g dw) (Y13)
Beta-sitosterol (μg/g dw) (Y14)
dw—dry weight hazelnut involucre.
2.3. Determination of Total Bioactive Compounds
2.3.1. Total Phenolic Content
The TPC of the HI extracts was assessed by Folin–Ciocâlteu (FC) spectrophotometric method
as previously reported [15,16]. A Synergy HT multi-detection microplate reader with 96-well plates
(BioTek Instruments, Inc., Winooski, VT, USA) was used for high sample throughput. At first, 20 μL of
each sample (HI extracts diluted five times) were mixed with 100 μL of FC reagent (diluted 1:10) and,
after 3 min, 80 μL of sodium carbonate solution (7.5% w/v) was added. The mixtures were incubated
in the dark at room temperature for 30 min. The absorbance was measured at 760 nm against a
solvent blank. Gallic acid was used as a reference standard, and the TPC was expressed as gallic acid
equivalents (GAE) per dry weight (dw) of involucre (mg GAE/g dw).
2.3.2. Total Flavonoid Content
The TFC of the HI extracts was assessed according to a method previously described [17]. In a
96-well plate, 100 μL of sample extract was added to 100 μL of 2% AlCl3 aqueous solution. The plate
was incubated in the dark at room temperature for 15 min and the absorbance was measured at 420 nm
against a solvent blank. The TFC was expressed as quercetin equivalents (QE) per dw of involucre
(mg QE/g dw).
2.3.3. Condensed Tannin Content
The CTC in HI extracts was assessed according to a modified version of the vanillin assay
formerly described [18]. In a 96-well plate, 50 μL of HI sample was added to 250 μL 0.5% vanillin
in 4% concentrated HCl in methanol. After the plate was incubated in the dark at 30 ◦C for 20 min,
the absorbance was measured at 500 nm against a solvent blank. The CTC was expressed as catechin
equivalents (CE) per dw of involucre (mg CE/g dw).
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2.4. Determination of the Antioxidant Activity
2.4.1. TEAC Assay
The antiradical activity of HI extracts was assessed according to the TEAC assay previously
described [17]. Briefly, 20 μL of the sample was mixed with 200 μL of ABTS radical solution,
incubated for 6 min, and the absorbance of the mixture was measured at 760 nm. The scavenging
activity against ABTS radical cation was calculated and used to plot the Trolox calibration curve.
The AA according to this assay was expressed as Trolox equivalents (TE) per dw involucre (mg TE/g
dw). This assay was used during the screening phase of the study for the evaluation of AA of all HI
extracts obtained within the experimental plan in order to optimize the extraction method.
2.4.2. DPPH Radical Scavenging Activity
The antiradical activity of HI extracts against the free radical DPPH was measured using a method
previously described [19]. In a 96-well plate, 30 μL of sample solution was mixed with a 0.004%
methanol solution of DPPH, and then incubated in the dark for 30 min. The absorbance was measured
at 517 nm against a solvent blank. Trolox was used as a reference standard and the results were
expressed as TE per dw extract (mg TE/g dw extract). This assay was performed only on the richest
polyphenolic HI extract.
2.4.3. FRAP Assay
The reduction capacity of the HI extract was assessed by ferric reducing antioxidant power (FRAP)
assay (analyzes the reduction of Fe3+-TPTZ to the blue-colored Fe2+-TPTZ) using a slight modified
previously described method [20]. Briefly, a quantity of 25 μL sample was incubated with 175 μL
FRAP reagent (300 mM acetate buffer, pH 3.6: 10 mM TPTZ in 40 mM HCl: 20 mM FeCl3·6H2O in
40 mM HCl, 10:1:1, v/v/v) in the dark for 30 min. The absorbance was measured at 593 nm and the
results were expressed as TE per dw extract (mg TE/g dw extract). This assay was done only on the
richest polyphenolic HI extract.
2.5. Phytochemical Analysis by LC-MS
The phytochemical profiles of the lyophilized HI extracts were analyzed by LC-MS. For this
assay, an Agilent 1100 HPLC Series system (Agilent, Santa Clara, CA, USA), equipped with degasser,
binary gradient pump, column thermostat, autosampler, and UV detector, coupled with an Agilent Ion
Trap 1100 SL mass spectrometer (LC/MSD Ion Trap VL) were used.
2.5.1. Identification and Quantification of Individual Polyphenolic Compounds
An LC-MS method previously described [21,22] was used for the identification of individual
polyphenols in the HI extracts. The 18 external standards were: apigenin, caffeic acid, caftaric acid,
chlorogenic acid, ferulic acid, fisetin, gentisic acid, hyperoside, isoquercitrin, kaempferol, luteolin,
myricetin, patuletin, p-coumaric acid, quercetin, quercitrin, rutoside, and sinapic acid (Table S1). In brief,
the chromatographic separation was performed on a reverse-phase analytical column (Zorbax SB-C18,
100 mm × 3.0 mm i.d., 3.5 μm particles) with a mixture of methanol/acetic acid 0.1% (v/v) as mobile
phase and a binary gradient. The elution started with a linear gradient, beginning with 5% methanol
and ending at 42% methanol at 35 min, isocratic elution followed with 42% methanol for the next 3 min,
rebalancing with 5% methanol in the next 7 min. The flow rate was 1 mL/min, the injection volume
was 5 μL, and the column temperature was 48 ◦C. The detection procedure was performed on both
UV and MS mode. The UV detector was set at 330 nm until 17 min (for the detection of polyphenolic
acids), then at 370 nm until the end of analysis time (for the detection of flavonoids and their aglycones).
The MS system operated using an electrospray ion (ESI) source in negative mode (capillary 3000 V,
nebulizer 60 psi (nitrogen), dry gas temperature 360 ◦C, and dry nitrogen gas at 12 L/min).
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Another LC-MS method (LC-MS method II) previously described [23] was used to detect the other
six polyphenols (epicatechin, catechin, syringic acid, gallic acid, protocatechuic acid, and vanillic acid)
in HI extracts (Table S2). The chromatographic separation was accomplished on the same analytical
column and in the same chromatographic conditions as mentioned before but with a slightly different
binary gradient (start: 3% methanol; at 3 min: 8% methanol; at 8.5 min: 20% methanol; at 10 min:
rebalance column with 3% methanol). The detection of the compounds was performed on MS mode.
All identified polyphenols were measured both in the HI non-hydrolyzed and hydrolyzed extracts
(equal amounts of extract and 4 M HCl kept 30 min on 100 ◦C water bath) on the basis of their peak
areas and comparison with a calibration curve of their corresponding standards. The results were
expressed as micrograms of phenolic compounds per dw of involucre (μg/g dw).
2.5.2. Identification and Quantification of Phytosterols
The phytosterols in the HI extracts were determined according to an LC-UV-MS/MS method
previously described [24]. In brief, apparatus and chromatographic analytical column were the
same, but elution of compounds was performed in an isocratic mode, mobile phase containing
acetonitrile/methanol (90:10, v/v), with a flow rate of 1 mL/min at 45 ◦C and 5 μL injection volume.
For the detection of the analytes, the same ion trap mass spectrometer was used, fitted with an
atmospheric pressure chemical ionization (APCI) interface in a positive mode. Operating conditions
(dry nitrogen gas temperature 325 ◦C at a flow rate of 7 L/min, nebulizer pressure 60 psi, capillary
voltage −4000 V) were adjusted for achieving maximum sensitivity values.
The full identification of compounds was performed by comparing the retention times and mass
spectra with five external standards (ergosterol, brassicasterol, stigmasterol, campesterol, beta-sitosterol)
(Table S3). Under the ionization conditions used for their determination, all sterols lose a water molecule
and their pseudo-molecular ions are in the form M−H2O+H+ [25]. The multiple reactions monitoring
(MRM) analysis mode was used for detection in order to avoid or reduce the interference from the
background. The quantification was performed based on the intensity of major daughter ions in the mass
spectra [25]. The results were expressed as micrograms of phytosterols per dw involucre (μg/g dw).
The Agilent ChemStation (vA09.03) and DataAnalysis (v5.3) software were used for the acquisition
and investigation of chromatographic data.
2.6. Selection and Biological Activities of the Optimal Hazelnut Involucre Extract
Based on the experimental data obtained during the screening and the optimization steps,
the extract with the richest polyphenolic content and the best antioxidant activity by TEAC assay was
further selected as the optimal HI extract in order to evaluate its biological effects. The antioxidant
activities by DPPH and FRAP assays, the enzymatic inhibitory potential (tyrosinase and α-glucosidase),
and the cytotoxicity and antioxidant effects on cellular cultures were further evaluated for this extract.
All determinations were performed in triplicate on the lyophilized extract.
2.6.1. Enzyme Inhibitory Activities
Tyrosinase Inhibitory Activity
The tyrosinase inhibitory activity of HI extract was calculated using a slightly modified previously
described method [26]. In a 96-well plate, four wells were designated (HI lyophilized extract dissolved
in water containing 5% DMSO) as follows: (A) 46 U/mL (40 μL) mushroom tyrosinase (MT) in 66 mM
phosphate buffer (PB), pH 6.6 (120 μL); (B) only PB (160 μL); (C) PB (80 μL), MT (40 μL) and the sample
(40 μL); (D) PB (120 μL) and the sample (40 μL). After incubation at room temperature for 10 min,
2.5 mM L-DOPA prepared in PB (40 μL) was added in all wells. After room temperature incubation for
20 min, the absorbance was measured at 475 nm. The tyrosinase inhibitory activity was calculated
using kojic acid as an external standard (0.01–0.10 mg/mL). The inhibition percentage of enzymatic
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activity was assessed by the following equation: [(A − B) − (C − D)] × 100/(A − B). The results were
expressed as milligram kojic acid equivalents (KAE) per dw extract (mg KAE/g dw).
α-Glucosidase Inhibitory Assay
The α-glucosidase inhibitory activity was performed using the protocol previously described [27].
Briefly, 50 μL sample solution (2 mg HI lyophilized extract/mL), 50 μL glutathione (0.5 mg/mL), 50 μL
of 10 mM PNPG (p-nitrophenyl-β-d-glucuronide) solution, and 50 μL α-glucosidase solution in PB
(pH 6.8) were mixed in a 96-wells microplate and incubated at 37 ◦C for 15 min. Similarly, the blank
was prepared by adding a sample solution to all reaction reagents without the enzyme (α-glucosidase)
solution. The reaction was finally stopped by adding 50 μL of 0.2 M sodium carbonate. The absorbance
for sample and blank were read at 400 nm and then the absorbance of blank was subtracted from the
absorbance of the sample.
2.6.2. Biological Activities of HI Extract on Cell Lines
Cell Culture
The normal human gingival fibroblasts (HGF) (CLS Cell Lines Service, Eppelheim, Germany),
and the cancerous cell lines A549 (human lung adenocarcinoma) and T47D-KBluc (human breast
cancer) (ATCC, Manassas, United States of America) were maintained in Dulbecco’s modified Eagle
medium (DMEM) supplemented with 10% fetal bovine serum (FBS) on culture flasks at 37 ◦C in a
humidified incubator with 5% CO2 supplementation. The medium was changed every two to three
days and the cells were subcultured once they reached 70%–80% confluence.
Preparation of Extract Solutions
A 100 mg/mL stock solution was prepared in dimethyl sulfoxide (DMSO) from lyophilized extract.
The stock solution was further diluted in DMSO to obtain working solutions of 0.25, 6.25, 12.5, 18.75, 25,
37.25, 50, and 75 mg/mL. These working solutions were then used to obtain the desired concentrations,
ranging from 400 to 1 μg/mL, in the cell culture medium.
Viability Assays
Cells were seeded in 96-well plates and left to attach for 24 h. Dead and unattached cells were
washed with PBS while the remaining viable cells were further exposed for 24 h/48 h to the HI
extract. Following the exposure, the cells were washed with PBS and viability was assessed by two
complementary assays, Alamar Blue assay, and Neutral Red assay.
Alamar Blue (AB) assay was used to measure the metabolic ability of exposed cells to convert
resazurin, a non-fluorescent compound, to resorufin, a fluorescent product. The cells were exposed
to a resazurin solution of 200 μM for 3 h and the fluorescence was measured at λexcitation = 530/25,
λemission = 590/35, using Synergy 2 multi-mode microplate reader.
Neutral Red (NR) assay was used to measure the ability of the exposed cells to incorporate the
supravital dye neutral red. The cellular uptake of this dye reveals the capacity of the cell to maintain
pH gradients through the production of ATP. Briefly, 150 μL 40 μg/mL neutral red dye was added to
each well. The cells were incubated with the dye at 37 ◦C for 2 h. Afterwards, the cells were washed
twice with PBS and accumulated dye was extracted by adding a solution containing 50% ethanol,
49% water, and 1% glacial acetic acid to each well. Cell viability was determined by measuring the
fluorescence at λexcitation = 530/25, λemission = 620/40, using Synergy 2 multi-mode microplate reader.
The experiments were performed with three biological replicates, each one including six technical
replicates. The results were expressed as relative values compared to the negative control (100%)
(cells exposed to culture medium containing 0.2% DMSO).
335
Antioxidants 2019, 8, 460
IC50 values were calculated, when possible, from the dose-response curves obtained for each
condition using a four-parameter logistic curve, in order to allow a comparison between the
conditions tested.
Dichloro-Fluorescein Diacetate (DCFH-DA) Assay
The ability of the HI extract to protect against the oxidative stress in T47D-KBluc, A549, and HGF
cells was monitored using the reactive oxygen species (ROS) sensitive 2,7 dichloro-fluorescein diacetate
(DCFH-DA) dye. After a 24 h treatment with non-toxic HI extract concentrations, the cells were washed
with PBS and further loaded with 50 μM DCFH-DA in Hanks’ balanced salt solution (HBSS) for 2 h.
Following incubation, the excess of DCFH-DA was washed, and the cells were exposed to 250 μM
H2O2 for 2 h. The conversion of DCFH-DA to the fluorescent compound dichlorofluorescein (DCF)
was measured using Synergy 2 multi-mode microplate reader at λexcitation = 485/20, λemission = 528/20.
The potency of HI extracts, to mitigate the induction of oxidative stress after H2O2 treatment, was
compared to N-Acetyl Cysteine (NAC) treatment (20 mM solution).
2.7. Statistical Analysis
All samples were analyzed in triplicate (n = 3) and the outcomes were reported as the
mean ± standard deviation (SD). The data were statistically analyzed by Student’s t-test using
Microsoft Office Excel computer software and by one-way analysis of variance (ANOVA) with
post hoc Dunnett’s test using SigmaPlot 11.0 computer software. The difference showing a p level of
0.05 or lower was considered statistically significant.
3. Results and Discussion
3.1. Fitting the Experimental Data with the Models
The matrix of the experimental design containing the 17 formulations generated by the software
and the results achieved after performing all the experimental runs are summarized in Table 3.
For data fitting, the partial least squares (PLS) method was employed and several statistical
parameters were further used to assess the fitting results. The coefficient of correlation (R2) represents
the variation of the response explained by the selected model, or goodness of fit, while the Q2
indicates the model capacity to be predictive. Furthermore, ANOVA test was employed to assess the
experimental model validity, significance and lack of fit. The model proved good predictive ability,
as shown by Q2 > 0.7, and a good correlation between the predicted and observed values was found,
as suggested by R2 > 0.9 (Table 4). Differences of less than 0.2–0.3 between R2 and Q2 indicate a
high predictive power of a good model. Models proved adequate validity (>0.4) corroborated with a
reduced lack of fit for each evaluated response. The reproducibility values were >0.95, which means
that the replicates generated similar responses by working under identical experimental conditions,
thus making the experimental setup adequate for the purpose of the study. The results of ANOVA
test showed a significant influence of the evaluated factors over TPC, TFC, CTC, and AA-TEAC,
with p-value for the regression <0.001 (Table 4). Considering the results shown in Table 4, the fitting
models were found to be appropriate to describe the experimental data, as the values for the lack of fit
were not significant in extent with the pure error. The regression equation coefficients for the responses
are presented in Table S4.
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The influence of the extraction conditions (factors) on the quantified individual compound levels
(responses) was studied using the second experimental design during the optimization step (Table 2).
The factors were the same as in the screening step and the responses were the levels of the 14 bioactive
compounds (polyphenols and sterols) (Table 5). Moreover, the samples were hydrolyzed and the
results of the recovery for the main bioactive compounds were compared to those obtained from
non-hydrolyzed samples (Table S5). The statistical parameters R2, Q2, regression, lack of fit and pure
error were determined for fitting the experimental data with the experimental design. The selected
model presented good quality, with R2 values between 0.75 and 0.94 and Q2 results in the range of
0.47–0.84. For all the evaluated responses, the results of ANOVA test for the model had statistical
significance (p < 0.05) and lack of fit p-values in the range of 0.064–0.91 (Table S6). Considering the
values obtained for these statistical parameters, the experimental data for the bioactive compounds
were adequately described by the fitting models, with a quadratic model statistically significant
and a low lack of fit. The evaluated responses were significantly influenced by the chosen factors.
The regression equation coefficients for all the bioactive compounds determined in HI extracts are
shown in Table S7.
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3.2. The Influence of Experimental Conditions on TPC, TFC, CTC, and AA-TEAC
As it can be noticed from the results for TPC, TFC, CTC, and AA-TEAC (Table 3), the responses
were influenced by the factors used in the experimental design.
The stirring time was in the range of 1–3 min, the pH varied from acidic to neutral (3–5–7),
and the two solvents used were water and acetone mixed in various proportions (0%–25%–50%
water in acetone). The best extraction yields were obtained when using binary-solvent systems,
while mono-solvent systems displayed a lower extraction power. These findings confirm the rational
choice of the solvent mixture based on the previously reported determination of bioactive compounds
in a study that aimed to evaluate the recovery efficiency from walnut septum extracts [15]. For a
higher extraction yield, the best solvent mixture is between a polar, protic solvent (water) with a polar,
relatively acidic, aprotic solvent (acetone). The best results for TPC, TFC, CTC, and AA-TEAC were
obtained for pH 3 and 50% water in acetone, proving a positive relationship between the content
of bioactive compounds and the antioxidant activity. The influences of working conditions on TPC,
TFC, CTC, and AA-TEAC as scaled and centered coefficient plots are depicted in Figure 1, while the
response surfaces for predicting the extraction efficiency for the aforementioned parameters are shown
in Figure 2. From these figures, it can be observed that the factor with the highest positive impact on
the recovery of bioactive compounds is the amount of water in the mixture solvent, a higher amount of
water being associated with an increased extraction yield. In addition, the water amount proved to
have a statistically significant influence upon TPC, TFC, CTC, AA-TEAC, and bioactive compound
recovery (see Tables S4 and S7). The optimal extraction conditions for TPC, TFC, CTC, and AA-TEAC,
generated by the software used, are given in Table 6.
Figure 1. Influence of working conditions on total phenolic content (TPC), total flavonoid content
(TFC), condensed tannin content (CTC), and antioxidant activity (AA) by TEAC assay of hazelnut
involucre extracts, presented as scaled and centered coefficient plots. X1, stirring time (min); X2, pH;
X3, water in solvent (% v/v).
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Figure 2. Response surface for predicting the recovery yield for total phenolic content (TPC),
total flavonoid content (TFC), condensed tannin content (CTC,) and antioxidant activity (AA) by
TEAC assay for hazelnut involucre extracts with regard to: X1, stirring time (min); X3, water in solvent
(% v/v); X2, pH = 5. The regions in red represent the domains of working conditions assuring the
maximum extraction yield for the evaluated bioactive compounds.
Table 6. Optimum experimental conditions for improved recovery of TPC, TFC, CTC, AA-TEAC from
hazelnut involucre extracts.
Parameters TPC TFC CTC AA-TEAC
Stirring time (min) 3 3 3 3
pH 3 3 3 3
Water in solvent (%) 50 50 50 50
Predicted 345.96 38.41 269.67 1253.09
Determined 370.42 41.97 279.30 1291.22
Bias (%) 7.07 9.26 3.57 3.04
TPC: Total phenolic content expressed as mg GAE/g dw = gallic acid equivalents per dry weight of hazelnut
involucre; TFC: Total flavonoid content expressed as mg QE/g dw = quercetin equivalents per dry weight of hazelnut
involucre; CTC: Condensed tannin content expressed as mg CE/g dw = catechin equivalents per dry weight of
hazelnut involucre; AA-TEAC: Antioxidant activity by TEAC assay expressed as mg TE/g dw = Trolox equivalents
per dry weight of hazelnut involucre.
3.3. Quantitative Determinations of Total Bioactive Compounds
As expected from previous studies [28], better extraction results of phenolic compounds found
in HI, and responsible for the antioxidant activity and human health benefits, were obtained using a
binary-solvent mixture of water and acetone.
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3.3.1. Total Phenolic Content
A significant difference in TPC values was noticed when an equal mixture of water and acetone
was used compared to pure acetone. The value for the richest phenolic compound extract was
377.43 mg GAE/g dw HI when aqueous acetone solvent was used (N6, run order 7, Table 3). Because no
similar data were found in the literature, where TPC was expressed using another phenolic compound
reference (CE vs. GAE), we could not effectively compare the results. Thus, in the study of Alasalvar et
al. [29], the TPC in hazelnut green leafy cover extracted with an aqueous 80% acetone or 80% ethanol
were 201 or 156 mg catechin equivalent (CE)/g extract, respectively. The TPC in hazelnut green leafy
cover obtained by Shahidi et al. [14], using a 80:20 (v/v) ethanol/water mixture as extraction solvent,
was 127.3 mg CE/g extract, while the TPC for hazelnut skin, hard shell, tree leaf, and kernel were 577.7,
214.1, 134.7, and 13.7 mg CE/g extract, respectively. As seen in another study [30], TPC in tree nut
by-products is several times higher compared to nut kernels. The quantification of TPC in different
hazelnut kernel extracts exposed values in the range of 11.17–14.77 mg GAE/g [31] and 10.21–23.28 mg
GAE/g [32].
Esposito et al. [33] detected quantities of 193.8 mg GAE/g methanol hazelnut shell extract for TPC,
while Masullo et al. [34], for the same by-product, noticed that TPC was 340.44 μg GAE/mg extract,
corresponding to 340.44 mg GAE/g.
3.3.2. Total Flavonoid Content
Flavonoids exhibit both in vitro and in vivo biological activities and may elicit health benefits
including cardiovascular protection [35]. In this study, the highest value for the TFC was
43.10 ± 1.59 mg QE/g dw involucre (N6, run order 7, Table 3). As in the case of phenolics, the best
values for total flavonoids were obtained at equal volumes of water and acetone in the solvent mixture.
To the best of our knowledge, there is no research regarding the flavonoid content in HI,
therefore TFC values for nuts and other by-products were used as a comparison. The highest flavonoid
content in walnut septum was 9.76 ± 0.23 mg QE/g [15], while hazelnuts presented TFC values between
0.09 ± 0.01 and 0.36 ± 0.07 mg rutin equivalent/g extract [36].
3.3.3. Condensed Tannin Content
Condensed tannins or proanthocyanidins had revealed positive effects on neurogenesis,
cognitive improvement, and prevention of neuron death in neurodegenerative diseases such as
Alzheimer’s disease [37].
In our study, the best value for CTC was 280.69± 7.85 mg CE/g dw HI, using as solvent 50% aqueous
acetone solution (N6, run order 7, Table 3). Kim et al. [38] noticed values of 4.91 mg proanthocyanidins
per gram of hazelnuts, while Lainas et al. [39] detected higher amounts of condensed tannins, 31.30 mg
CE/g natural hazelnuts and 36.70 mg CE/g roasted hazelnut skin. The quantities for CTC obtained by
Alasalvar et al. [29] were 385 and 542 mg CE/g extract from green leafy cover extracted with 80% ethanol
in water and 80% acetone in water, respectively. The variations observed between the CTC results are
due to different extraction conditions performed on various herbal matrices. The results of CTC found
in the current study are in line with those obtained by Alasalvar et al. [29] on the same matrix.
3.4. Determination of Antioxidant Activity
The antioxidant capacity of phenolic compounds depends basically on the number and position
of the substituents on the aromatic ring [12]. However, because of their reduced bioavailability, due to
extensive phase 2 metabolism, polyphenols might function more as up-regulators of the antioxidant
activity than as direct antioxidants [40].
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3.4.1. TEAC Assay
The antioxidant activity against the stable synthetic ABTS radical cation of different HI extracts is
depicted in Table 3. This analysis is based on electron transfer reactions in order to assess the radical
scavenging activity of several compounds. The highest values for AA were for 50% aqueous acetone
extracts, with the strongest activity of 1296.51 ± 19.25 mg TE/g dw involucre (5.18 ± 0.08 mmol TE/g
dw involucre). The AA for green leafy cover noticed by Shahidi et al. [14] was 117 μmol TE/g extract
after extraction with 80% ethanol, while the values for hazelnut kernel, skin, hard shell, and tree
leaf were between 29 and 148 μmol TE/g extract. Alasalvar et al. [29] reported AA values of 1.29
and 1.14 mmol TE/g extract obtained from green leafy cover using 80% acetone and 80% ethanol,
respectively. In another source, the antioxidant activities were in the range of 3063–3573 μmol TE/100 g
dw natural hazelnuts [41]. The AA of hazelnut by-product extracts was 4–5-fold greater than that of
kernel extracts, meaning that hazelnut by-product extracts compared to hazelnut kernel extract would
have a stronger antioxidant activity.
3.4.2. DPPH Radical Scavenging Activity
The DPPH radical scavenging assay was applied to measure the capability of HI to deactivate
and scavenge this stable free radical. Antioxidant molecules can reduce DPPH free radicals,
through hydrogen atom-donating capacity, and the absorbance will decrease faster if the antioxidant
potential of the extract is more powerful [42].
In our study, the in vitro DPPH radical scavenging activity was 292.23 mg TE/g involucre extract
obtained using 50% aqueous acetone solvent, at pH 3, and 3 min stirring time. The reported DPPH
values on related matrices were between 84.9% and 93.6%, and 8.1% and 41.1% for natural hazelnuts
and roasted hazelnuts, respectively [32]. In the study of Oliveira et al. [43], the EC50 values for hazelnut
leaves obtained for DPPH radical scavenging were <0.3 mg/mL, while Masullo et al. [34] found the
highest DPPH scavenging activity value (EC50 = 54.3 μg/mL) for hazelnut shells corresponding to the
highest TPC value. Similarly, Yuan et al. [44] found a value of around 11 mg GAE/g for the richest TPC
hazelnut shell extract. As there were no data regarding the DPPH assay for HI, a comparison with the
results of other studies was not possible.
3.4.3. FRAP Assay
The FRAP assay, a fast and sensitive way for measuring the antioxidant capacity in samples via
the reduction of ferric iron (Fe3+) to ferrous iron (Fe2+) by the antioxidants present in the samples, is a
significant indication of the antioxidant activity.
In our analysis, the reducing power for the richest polyphenolic HI extract achieved using
water/acetone (1:1) at pH 3 and stirring time 3 min was 350.52 mg TE/g involucre extract. FRAP data for
related matrices were 12.0 mg GAE/g hazelnut shell [44] and 400.97 mg TE/g walnut septum extract [15].
Our findings are in agreement with previous studies, which show a positive correlation between
phenolic compounds and the antioxidant activity [45,46].
3.5. The Influence of Experimental Conditions on Individual Bioactive Compounds
The individual polyphenols and phytosterols that were identified and quantified by LC-MS and
LC-MS/MS in HI extracts are presented in Table 5. For epicatechin (Y1), catechin (Y2), syringic acid
(Y3), gallic acid (Y4), protocatechuic acid (Y5), and vanillic acid (Y6) (Figure S1), the highest extraction
yield was obtained for 2 min of stirring, at pH of 7, in a mixture of acetone/water (3:1). For p-coumaric
acid (Y7) and ferulic acid (Y8) (Figure S2), the best recovery was attained for 1 min stirring time, pH 5,
solvent mixture of acetone/water (3:1), while for hyperoside (Y9), isoquercitrin (Y10), and quercitrin
(Y11) (Figure S3), the highest extraction power was observed for 3 min of stirring, at pH 3, in a mixture
of solvents acetone/water in equal proportions (1:1). As far as stigmasterol and beta-sitosterol are
concerned, their best recovery was obtained after 2 min of stirring the HI extracts in a mixture of
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solvents acetone/water (3:1) at pH 5, while the extraction of campesterol was the highest when stirring
the sample for 3 min, at pH 5, in a mixture of acetone/water (3:1) (Table 5) (Figure S4).
From the 11 depicted polyphenols, catechin and protocatechuic acid were found in the highest
quantity, whereas from the three revealed phytosterols, beta-sitosterol presented the highest amount.
The influence of the working conditions on the evaluated bioactive compound recovery from HI
extracts is depicted in Figure 3. Furthermore, for predicting the recovery of bioactive compounds
considering the working conditions, the response surfaces were generated and presented in Figure 4.
By analyzing the two figures, it can be concluded that the amount of water in the solvent mixture
exhibited the highest impact on the recovery of bioactive compounds, followed by the stirring time.
The pH displayed a minimum impact on the extraction yield.
Figure 3. Cont.
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Figure 3. Influence of working conditions on the bioactive compound recovery from hazelnut involucre
extracts, depicted as scaled and centered coefficient plots. X1, stirring time (min); X2, pH; X3, water in
solvent (% v/v).
We consider this information especially valuable because it presents the optimal experimental
conditions for obtaining the maximum extraction yield.
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Figure 4. Response surface for prediction of bioactive compound recovery from hazelnut involucre
extracts with respect to: X1, stirring time (min); X2, pH; X3, water in solvent (% v/v). The regions in red
represent the domains of working conditions assuring the maximum extraction yield for the evaluated
bioactive compounds.
3.5.1. Quantification of Individual Polyphenols
From the 18 phenolic compounds analyzed by the validated LC-MS method, only five polyphenols
(p-coumaric acid, ferulic acid, hyperoside, isoquercitrin, quercitrin) were quantified in the HI extracts.
Using the LC-MS method II, all six polyphenols (epicatechin, catechin, syringic acid, gallic acid,
protocatechuic acid, and vanillic acid) were quantified in the HI extracts. For this method, the coefficient
of linearity (R2) was in the range of 0.9922–0.9997 and the accuracy bias was ≤15% [15].
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The highest values for epicatechin and catechin were 3.73 and 243.02 μg/g dw HI, respectively
(Table 5). Montella et al. [47] attained higher amounts of epicatechin and catechin, 342 and 2500 μg/g
hazelnut skin extracts, a by-product richer in polyphenols.
The maximum amounts for syringic acid, gallic acid, protocatechuic acid, and vanillic acid
were 5.53, 91.93, 227.37, and 25.41 μg/g dw HI, respectively. In other matrices, Jakopic et al. [8]
found quantities of 0.52 μg gallic acid and 2.92 μg protocatechuic acid per gram of hazelnut kernels,
while Montella et al. [47], for the same hydroxybenzoic acids, gallic and protocatechuic acids, obtained
concentration of 62.1 and 21.1 μg/g hazelnut skin extracts, respectively.
The best quantities for two cinnamic acid derivatives, p-coumaric, and ferulic acids were 6.58 and
3.97 μg/g dw HI, respectively (Table 5). For the same two acids, Shahidi et al. [14] obtained values of
1662 and 327 μg/g green leafy cover extracts, respectively. Again, it is worth stating that many factors,
including cultivar type, location, agricultural practices or growing conditions, degree of ripeness,
storage conditions, and industrial processing, can affect the chemical composition of tree nut kernels
and their by-products [11].
The highest quantities for hyperoside, quercitrin, and isoquercitrin were 51.72, 17.74,
and 114.26 μg/g dw HI, respectively.
The 17 hazelnut involucre extracts were hydrolyzed (as previously mentioned) and further
analyzed by LC-MS for quantification of the main polyphenolic compounds (epicatechin, catechin,
syringic acid, gallic acid, protocatechuic acid, vanillic acid). When comparing the non-hydrolyzed
to the hydrolyzed samples (Table S5), the evaluated bio compounds registered a downward trend.
This could be explained by the degradation of these polyphenols during the hydrolysis process,
which was more significant than their release from the biological matrix or polymeric compounds.
3.5.2. Quantification of Phytosterols
The three phytosterols (stigmasterol, campesterol, beta-sitosterol) found in HI extracts were
quantified on the basis of their peak areas and evaluation with a calibration curve of the corresponding
standards [25]. The richest extract in campesterol was 45.04 μg/g dw HI, while the highest quantities
of stigmasterol and beta-sitosterol were 197.30 and 5305.01 μg/g dw HI extracts, respectively (Table 5).
Phytosterols are known for the decreasing effect against total cholesterol and LDL-cholesterol,
important risk factors in cardiovascular diseases [48]. Moreover, the consumption of plant sterols has
been shown to increase the antioxidant activity [49]. Our study found quantities of phytosterols in HI
which are in line with those in nuts [50] and proved that this by-product can be a source of natural
sterols with several health benefits.
3.6. Enzyme Inhibitory Activities
3.6.1. Selection of the Optimal HI Extract
Polyphenols are bioactive compounds with potent antioxidant activity exercised by several
mechanisms. In brief, they can act as direct and/or indirect antioxidants modulating many
important cellular signaling pathways, such as: The nuclear factor erythroid 2-related factor
2/electrophile-responsive elements (Nrf2/EpRE) (involved in cell protection and detoxification) and the
nuclear factor kappa B (NF-κB) (involved in the induction of pro-inflammatory processes). Polyphenols
protect cells against free radicals and ROS, inhibiting mutagenesis and carcinogenesis by promoting
apoptosis and autophagy in tumor cells. Moreover, they are epigenetic modulators, having real
anticancer potential demonstrated in many in vitro and in vivo assays [5]. At the molecular level,
extracts rich in polyphenols obtained from tree nut skin or by-products [15] showed inhibitory activity
on key enzymes related to pathological conditions including type 2 diabetes mellitus (T2DM), obesity or
skin hyperpigmentation [5].
Based on the experimental findings from the screening and optimization steps, the HI extract with
the highest content in total polyphenols also displayed the best antioxidant capacity by TEAC assay
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(N6, run order 7, Table 3). Besides, this extract is the richest in hyperoside, isoquercitrin, and quercitrin
(Table 5), flavonoids which are powerful antioxidants [15]. The extract was further evaluated for other
biological activities: The antioxidant activities by two other assays, DPPH and FRAP (results presented
above), the tyrosinase and α-glucosidase inhibitory activities, and the cytotoxic and antioxidant
activities on tumor and normal cell lines.
3.6.2. Tyrosinase Inhibitory Activity
Tyrosinase is a key enzyme, which catalyzes melanin production, primarily responsible for the
pigmentation of human skin, hair, and eyes. It also catalyzes the synthesis of neuromelanin in the human
brain, and overproduction of neuromelanin is linked with neuronal damage and neurodegeneration
in Parkinson’s disease and Huntington’s diseases. Tyrosinase was also associated with vegetable
and fruit browning, which can lead to rapid postharvest degradation [51]. Tyrosinase inhibition
may prevent skin hyperpigmentation and neurodegeneration. Therefore, tyrosinase downregulation,
through natural inhibitors of this crucial enzyme, specifically targets melanogenesis in the cell with no
side effects.
In our study, the tyrosinase inhibitory activity of 50% aqueous acetone HI extract was
165.17 ± 1.88 mg KAE/g. To the best of our knowledge, there were no previous studies of tyrosinase
inhibitory activity of HI, thus no direct comparison could be made. Other plant matrices offered lower
results, 129.98 ± 3.03 mg KAE per gram of walnut septum [15] and 2.28 ± 0.01 mg KAE/g of hazelnut
extract [36]. Thus, HI may be an alternative natural source as a tyrosinase inhibitor in preventing
hyperpigmentation, economical and convenient for the cosmetic and food industry.
3.6.3. α-Glucosidase Inhibitory Activity
Delayed glucose absorption and reducing postprandial blood glucose levels are antidiabetic
strategies. The inhibition of the activity of α-glucosidase, an enzyme located on the epithelium
of the small intestine, and the slowing of starch metabolism can be part of dietary therapy in the
treatment of diabetes. Several plant extracts, rich in phenolic compounds and having structural features
which may block the active sites of the enzyme, were shown to inhibit intestinal α-glucosidase [52].
Yeast α-glucosidase assay can be a fast and inexpensive method to screen for potential α-glucosidase
inhibitors [27].
In our study, the IC50 for the 50% aqueous acetone HI extract was 0.10 mg/mL, which was much
lower compared to acarbose, at 0.80 mg/mL, revealing HI extract as a more potent α-glucosidase
inhibitor than acarbose, the anti-diabetic drug used in the treatment of T2DM. The enzyme inhibitory
value for hazelnut was 7.57 ± 0.01 mmol acarbose equivalents per gram of extract [36].
It is possible that the enzymatic inducing effect of HI extract on both tyrosinase and α-glucosidase
may be induced not only by the content of polyphenols but also by other compounds present in the
extract. However, further research is needed to complete the phytochemical profile of this by-product
and for the elucidation of the mechanisms of action.
3.7. Biological Activities of HI Extract on Cell Lines
3.7.1. Viability Assay
Exposure of T47D-KBluc and A549 cell lines to the polyphenolic richest HI extract resulted in a
dose-dependent decrease in cellular viability, with a comparable susceptibility to the extract observed
for both cancerous cell lines in both assays. The calculated IC50, defined here as the concentration of
the HI extract that induces the cellular death of 50% of the total viable cells, at 24 h and 48 h after
exposure of the cell lines, based on the data from Alamar Blue and Neutral Red assays are presented in
Table 7. In comparison with the T47D-KBluc cell line, the A549 cell line appeared to be more sensitive
to the toxic effects of the HI extracts. In addition, when the A549 cells were exposed for 24 h to the
HI extract, a hormetic effect was observed at intermediate concentrations in the case of Alamar Blue
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assay (Figure 5). The toxicity of the extract was more prominent after 48 h exposure for all the cell
lines tested, with IC50 reaching almost half of the values observed at 24 h post-exposure in the case
of A549 and T47D-KBluc (Table 7). Contrary to the results observed when using cancerous cell lines,
exposure of the normal HGF cells to the HI extract resulted in a mild cytotoxic effect, observed only at
the highest tested doses.
A549 - Alamar Blue A549 - Neutral Red
T47D-KBluc - Alamar Blue T47D-KBluc - Neutral Red
HGF-1 - Alamar Blue HGF-1 - Neutral Red
Figure 5. Cytotoxic effect of the HI extract observed using Alamar Blue assay on T47D-KBluc (A),
A549 (C), and HGF (E) and using Neutral Red assay on T47D-KBluc (B), A549 (D), and HGF (F).
The results are expressed as relative means ± standard deviations (six technical replicates for each of
the three biological replicates) where the negative control (DMSO 0.2%) is 100%. (*) indicates significant
differences compared to negative control (ANOVA + Dunnett’s; p < 0.05).
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Table 7. IC50 values (μg extract/mL) obtained by Alamar Blue and Neutral Red assays for T47D-KBluc,
A549, and HGF at 24 h and 48 h post-exposure.
Cell Lines
24 h 48 h
Alamar Blue Neutral Red Alamar Blue Neutral Red
T47D-KBluc 281.41 ± 22.7 294.56 ± 4.03 123.62 ± 1.97 125.042 ± 1.15
A549 180.28 ± 4.6 222.10 ± 15.05 112.53 ± 1.44 83.06 ± 1.33
HGF >400 >400 >300 >300
T47D-KBluc: Human breast cancer; A549: Human lung adenocarcinoma; HGF: Human gingival fibroblasts.
Similarly to the results reported by Gallego et al. [53], the present results corroborate to the idea
that extracts from different parts of hazelnut plant can exert a cytotoxic effect on cancerous cell lines.
A direct comparison between our study and the previously mentioned study is not possible as only
a limited number of higher concentrations were tested in the latter study, while the extracts were
obtained from stems and leaves of hazel trees [53]. In agreement with other studies in the literature,
due to the presence of active compounds such as polyphenols, flavonoids, or other plant-specific
compounds such as taxanes present in Corylus avellana L., plant-derived extracts can inhibit the growth
of breast, gastric, and pulmonary tumor-derived cell lines [54–57].
3.7.2. DCFH-DA Assay
In order to evaluate a potential antioxidant effect of the HI extract, three concentrations (25, 50,
75 μg/mL) that did not affect the cellular viability were selected and further tested on the two cancerous
cell lines and on the normal HGF cells (Figure 6). The treatment with the HI extract alone modified the
oxidative status of all three cell lines, with a statistical decrease of ROS being observed at the highest
tested doses. Similar to the HI extract, NAC treatment alone led to a decrease in the basal oxidative
status compared to the negative control. Exposure to H2O2 alone resulted in an approximately threefold
increase of the signal when compared to the negative control, while pre-exposure to the antioxidant
NAC decreased the ROS generation by approximately 50%. Pre-incubation with HI extract decreased
the ROS in a dose-dependent manner, reaching statistical significance at the two highest doses of 50
and 75 μg/mL. In the case of T47D-KBluc cells, at the highest dose, the reduction of oxidative stress
was almost equal to the one exerted by NAC.
 
Figure 6. Antioxidant effect of the HI extract evaluated using DCFH-DA assay on T47D-KBluc, A549,
and HGF. The cellular model was pre-exposed to the extract (25, 50, and 75 μg/mL) or NAC (20 mM) for
24 h, and further incubated with 50 μM DCFH-DA. The antioxidant effect of the HI extract was assessed
after 2 h from oxidative stress induced by exposure to 250 μM H2O2. The results are expressed as
relative means ± standard deviations (six technical replicates for each of the three biological replicates)
where the negative control (DMSO 0.2%) is 100%. (*) indicates significant differences compared to
H2O2 exposure alone; (#) indicates significant differences compared to negative control (ANOVA +
Dunnett’s; p < 0.05).
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The obtained results are in agreement with the previously detailed antioxidant activity observed
in the non-cellular assays, but due to insufficient data present in literature, no direct comparison
was possible.
4. Conclusions
This study characterized the phytochemical profile of hazelnut (Corylus avellana L.) involucre and
described the optimal experimental conditions for maximizing the extraction efficiency of biologically
active compounds from this tree nut by-product. We aimed to obtain hazelnut involucre extracts with
high contents of phenolics, strong antioxidant capacity, and biological potential based on experimental
designs. Besides, the phytochemical profile of the extracts using LC-MS methods was assayed. In order
to determine the ideal extraction conditions, several parameters (stirring time, pH, solvent) were
coupled with chemical analysis and statistical tools. From the eleven polyphenols (epicatechin, catechin,
syringic acid, gallic acid, protocatechuic acid, vanillic acid, p-coumaric acid, ferulic acid, hyperoside,
isoquercitrin, quercitrin) and three phytosterols (stigmasterol, campesterol, beta-sitosterol) determined
and quantified, catechin (up to 0.243 mg/g dw HI), protocatechuic acid (up to 0.227 mg/g dw HI),
and beta-sitosterol (up to 5.305 mg/g dw HI) were found in the highest amount. From the extraction
conditions, the amount of water in the solvent proved to have a statistically significant influence upon
all evaluated responses.
The best extraction conditions to attain the richest extract in total phenols were accomplished using
turbo-extraction by Ultra-Turrax at stirring time 3 min, pH 3, and 50% acetone in water (v/v) as extraction
solvent, while the best extraction conditions for sterols were 75% acetone in water (v/v), pH 5, and stirring
time 2 or 3 min. The richest extract in polyphenols presented strong in vitro antioxidant activity in
classical tests (TEAC, DPPH, FRAP) as well as in two cancer cell line assays (T47D-KBluc and A549).
Cytotoxic and antioxidant effects of HI extract were more intense on these cancer cells than on a normal
cell line (HGF). These results are promising and justify further research to characterize HI as a valuable
source of bioactive compounds and to assay its anticancer potential. Moreover, the richest polyphenol
HI extract demonstrated good enzyme inhibitory potential on tyrosinase (165.17 ± 1.88 mg KAE/g) and
α-glucosidase (eight times stronger inhibition than acarbose), two key enzymes involved in age-related
diseases. Phytosterols, compounds with proven cardioprotective effects and antioxidant capacity,
are other valuable molecules found in HI.
The results of our study successfully accomplished the proposed objectives and justify future
scientific investigations, including a comprehensive identification of individual polyphenols. Moreover,
the content in bioactive compounds, correlated with good results for antioxidant and enzyme inhibitory
activities, warrants more research in order to understand the bioavailability of specific molecules and
to reveal their potential mechanisms of action for future use of hazelnut involucre in the cosmetic
industry, in addition to food and pharmaceutical production.
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Abstract: The reduction of sulfur dioxide in wine is a consumer’s demand, considering the allergic
effects that may occur in people who are sensitive to it. Stilbenes are candidates of great interest
for this purpose because of their antioxidant/antimicrobial activities and health properties, and also
because they are naturally found in the grapevine. In the present study, the in vitro toxicity of an
extract from grapevine shoots (with a stilbene richness of 45.4%) was assessed in two human cell lines.
Significant damage was observed from 30 μg/mL after 24 h, and 40 μg/mL after 48 h of exposure.
Similarly, the ultrastructural study revealed a significant impairment of cell growing. The extract was
able to protect cells against an induced oxidative stress at all concentrations studied. In view of the
promising results, a more exhaustive toxicological assessment of the extract is needed to confirm the
safety of its further use as additive in wine.
Keywords: cytotoxicity; stilbene; wine; antioxidant; Caco-2; Hep-G2
1. Introduction
The most widely used preservative in the wine industry is sulfur dioxide (SO2) so far. Nevertheless,
the exposure to SO2 may have health side effects such as dermatitis, urticarial, angioedema, diarrhea,
abdominal pain, bronchoconstriction, and anaphylaxis [1]. Therefore, alternatives to the use of SO2 in
wines are required. Moreover, the International Organization of Vine and Wine (OIV), in agreement with
previous European Commission regulations (Ruling nº 606/2009) [2], recommended that the total SO2
content should not exceed 150 mg/L in red wines and 200 mg/L in white and rosé organic/conventional
wines [3]. In this regard, the wine industry is developing strategies to reduce and/or replace SO2.
The most promising tools for the replacement of SO2 in wine are the use of physical methods
(ultrasounds, ultraviolet, pulsed electric fields, high hydrostatic pressure, etc.) and the addition of
different compounds (dimethyl dicarbonate, bacteriocin, phenolic compounds, enzymes, colloidal
silver complex, etc.) [1]. An alternative must be accomplished with SO2 action on antioxidant and
antimicrobial capacity, wine oenological parameters, and organoleptic characters. However, despite
the antimicrobial and antioxidant properties presented by these methods, these technologies require
complex and expensive equipment. Most importantly, none of them have proven to be as effective as
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SO2 by itself so far [1,3]. For the scientific community and the wine industry, it is a challenge developing
new alternatives to completely or partly eliminate the use of SO2 in the winemaking process to produce
healthier wines but maintaining the quality requirements of consumers [4]. Consumers’ demand
for natural food additives can lead more food manufacturers to substitute synthetic antioxidants
for natural antioxidant compounds [5]. In this sense, the use of phenolic compounds should be
highlighted due to the favorable results recently obtained. Natural extracts rich in stilbenes have
been assayed for this purpose. Grape stems extracts are especially rich in flavonoids and stilbenes,
with high concentrations of trans-resveratrol and ε-viniferin, showing high antioxidant activity and
good antimicrobial properties [6–9]. Thus, wines treated with extracts obtained from grapevine shoots
have reported excellent enological parameters, higher color intensity, and purity than wines treated
with SO2, and satisfactory organoleptic features analysis [10,11]. Therefore, grapevine shoots have a
promising development as a source of naturally available additives.
Despite natural additives are perceived as posing no health risk to consumers, the safety of these
compounds needs to be assured before its commercialization [5]. In this concern, the toxicological
studies required by the European Food Safety Authority (EFSA) comprise toxicokinetics, genotoxicity,
and in vivo toxicity studies [12]. The first approach to the toxicity effect of any compound should be
the in vitro cytotoxicity tests to define basal cytotoxicity, directly related to cell death induction. These
studies are very useful to set the concentration range to perform further in vitro testing (genotoxicity
studies) and confirm its safety to be used in the food industry [13].
In this regard, the cytotoxicity of different stilbenes have been already assayed in different cell lines.
The viability of cultured macrophages, tumor-derived human T cells, and human epidermoid carcinoma
cells have been reported to be inhibited by resveratrol and piceatannol in a concentration-dependent
manner [14]. Vineatrol® (an extract of grapevine-shoot containing resveratrol and other stilbenes)
has exhibited a higher antiproliferative effect than resveratrol per se in various cancer cells assayed
in vitro [15–17]. However, resveratrol and Vineatrol®30 exerted a concentration-dependent cytotoxic
effect on V79 cells, the effect being much more pronounced with resveratrol than with Vineatrol® [8].
Therefore, although the effect of some of the major stilbenes contained in the grapevine shoot extract
is known, the concomitant presence of different stilbenes and other substances may modulate the
individual response. As instance, Vineatrol® has a different antiproliferative activity than their main
compounds, with a possible synergistic effect of both resveratrol and ε-viniferin [17]. For this reason,
the cytotoxicity study of the extract is mandatory considering that it is not possible to infer the
summative effect of stilbenes.
In addition, it is known that stilbenes have antibacterial, antifungal, cardioprotective,
neuroprotective, and pharmacological properties including antiaging effects [18,19]. While
its antioxidant ability can be highlighted, stilbenes are capable of scavenging or activating
cellular-enzymatic antioxidant defenses decreasing the production of intracellular reactive oxygen
species (ROS) [20]. However, phenolic compounds usually exhibit both antioxidant and prooxidant
activities at different doses [21,22]. Consequently, the scavenging activity of the grapevine shoot extract
is studied in the present work together with the oxidative stress status and the protective and reversion
properties of this extract against an oxidant agent in Caco-2 and HepG2 cell lines.
Considering the promising use of this stilbene-rich extract in the wine industry, the present work
studies the cytotoxicity of the extract, including Caco-2 (colorectal adenocarcinoma cells) and HepG2
(epithelial liver cancer cells). Furthermore, an exhaustive morphological assay was carried out in
order to evidence ultrastructural cellular injures that would clarify the mechanism of action of the
extract. In addition, the alteration in the oxidative status and glutathione (GSH) content as well as the
protective/reversion effect were investigated in both cell lines after short term exposure to this extract.
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2. Materials and Methods
2.1. Supplies, Chemicals and Model Systems
Culture medium, fetal bovine serum, and cell culture reagents were provided by Gibco (Biomol,
Sevilla, Spain). The rest of the chemicals were purchased from Sigma-Aldrich (Madrid, Spain) and
VWR International Eurolab (Barcelona, Spain).
The human cell lines Caco-2 and HepG2 were maintained as described in Gutierrez-Praena et al.
(2012) [23].
2.2. Stilbene-Enriched Extract
The method used for the preparation of stilbene extract was reported in a previous work [24].
Grapevine shoots were harvested in 2015 in Bordeaux region (France) and were composed of a mixture
of Merlot and Cabernet Sauvignon varieties of Vitis vinifera. Before extraction, shoots were dried in
open air for at least two months. Finely ground grapevine shoots were extracted with two times 20 L
of acetone-water (6:4, v/v) at room temperature under agitation, twice for 12 h. After filtration, acetone
was removed by evaporation under reduced pressure and the aqueous phase was lyophilized. Finally,
the extract was deposited on an Amberlite XAD-7 column and washed with water. The column was
then eluted with acetone. The efficiency of this process is 5.5% giving 55 g of stilbene extract per
kilogram of stems.
Furthermore, the extract was fractionated by centrifugal partition chromatography (CPC) using
the method of Biais et al. (2017) [7]. Briefly, the extract was eluted using the biphasic Arizona solvent
system K in descending mode with the organic phase acting as stationary phase. For each run, 10 g
of the extract were injected. Peak detection was monitored at 254, 280, 306, and 320 nm leading to
six fractions. Only the fractions containing stilbenes were collected. The nine main stilbenes were
quantified by HPLC-DAD, indicating that the stilbene-enriched extract contained at least 45.38% ± 5%
of total stilbenes (w/w) [25]. Compounds were identified by UV spectrum and retention time from
standards. Trans-resveratrol was quantified at 306 nm as trans-resveratrol; piceatannol was quantified at
320 nm as trans-piceid; ε-viniferin, r2-viniferin and ω-viniferin were quantified at 320 nm as ε-viniferin;
hopeaphenol, isohopeaphenol, pallidol, miyabenol, and ampelopsin A were quantified at 280 nm as
ampelopsin A [25].
2.3. Test Solutions
The range of the extract concentrations for the cytotoxicity tests was selected considering the
concentration to be incorporated in wine (100 μg/mL). Serial test solutions (0–100 μg/mL) were prepared
from stock solution (1000 μg/mL) in dimethyl sulfoxide (DMSO), being the final concentration in
DMSO below 0.5%.
Concentrations of the extract used for both oxidative stress assays were calculated based on the
cytotoxicity study previously performed. The mean effective concentration (EC50) value obtained
(31.18 μg/mL and 20.56 μg/mL in HepG2, and 55.77 μg/mL and 39.02 μg/mL in Caco-2 cells for 24 h
and 48 h, respectively) was chosen as the highest exposure concentration, along with the fractions
EC50/2 and EC50/4.
To measure protection and reversion abilities, test solutions of the extract to cell viability greater
than 75% were selected (EC50/2 and EC50/4).
2.4. Cytotoxicity Assays
The exposure concentrations were prepared in medium, with the highest concentration being
100 μg/mL. For the control group culture medium without the extract was used. Moreover, a control of
solvent (0.5% of DMSO) has also been included. The exposure concentrations were added to both cells
and the cytotoxicity assays were performed after 24 and 48 h of exposure.
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Neutral red uptake (NR) was evaluated according to Borenfreund and Puerner (1984) [26] with
modifications [27]. MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)- 2-(4-sulfophenyl)-
2H- tetrazolium salt) reduction was measured according to the procedure of Baltrop et al. (1991) [28].
Moreover, total protein content (TP) was performed according to the procedure described by Bradford
(1976) [29].
2.5. Morphological Study under Light and Transmission Electron Microscope
Light and electron microscope observations were performed according to Gutiérrez-Praena et al.
(2019) [30]. Cultured cells were exposed to three different concentrations of the extract, the EC50 value,
and their fractions (EC50/2, EC50/4). HepG2 were exposed to 7.79, 15.59 and 31.18 μg/mL and Caco-2
cells were exposed to 13.90, 27.88, and 55.77 μg/mL.
2.6. Oxidative Stress and Antioxidant Ability Assays
The oxidative stress endpoints measured, ROS content and GSH levels, were carried out following
the methods described in Gutiérrez-Praena et al. (2012) [23]. The results of both assays were expressed
as relative light units (RLU).
For the estimation of the protection and reversion abilities of extract, H2O2 100 μM was
administered to induced changes in the cell membranes and antioxidant system in HepG2 and
Caco-2 cells [31].
For the protection assay, after discarding the previous medium, exposure solutions (EC50/2 and
EC50/4) of the extract were first added to the cells and incubated at 37 ◦C for 24 h or 48 h. After the
treatment time, the medium was discarded and then exposed to 100 μM H2O2 for 2 h. Similarly, Caco-2
and HepG2 were pre-treated with H2O2 for 2 h for the reversion assay and a later exposure of the
extract for 24 or 48 h. Unexposed cells were included in the figures in order to compare the results
with basal levels of ROS and GSH. A control of DMSO was also incorporated in all plates.
Then, both abilities were evaluated by measuring the ROS levels and GSH content as
previously described.
2.7. Calculations and Statistical Analysis
All experiments were performed three times per assay. The data for all experiments were given as
the arithmetic mean percentage ± standard deviation in relation to control. Statistical analysis was
performed using analysis of variance (ANOVA) followed by Dunnett’s multiple comparison tests.
Differences were considered significant in respect to the control group at p < 0.05 (*), p < 0.01 (**) and
at p < 0.001 (***).
3. Results
3.1. Presence of Stilbenes in the Extract
The main compounds were ε-viniferin (16.34%, w/w), trans-resveratrol (8.07%, w/w), isohopeaphenol
(4.11%, w/w), ampelopsin A (3.21%, w/w), pallidol (3.12%, w/w), ω-viniferin (2.77 %, w/w), miyabenol C
(2.75%, w/w), r2-viniferin (2.24%, w/w), hopeaphenol (2.01%, w/w), and piceatannol (0.76%, w/w). The
stilbene-enriched extract contained 45.38% (w/w) of total stilbenes.
3.2. Cytotoxicity Studies
Both cell types exposed to the extract underwent a concentration and time-dependent decrease in
all endpoints. In HepG2 cells, after 24 h of exposure, the MTS assay indicated a significant reduction in
the cellular viability at concentrations of 40 μg/mL and above, showing greater alteration than the TP
and NR assays (Figure 1A). Similarly, the most sensitive endpoints after 48 h were MTS reduction and
NR uptake (Figure 1B). Considering the EC50 values, toxic effects were more evident in HepG2 cells in
the longer exposure time, being 31.2 ± 2.4 μg/mL for 24 h, and 20.6 ±2.7 μg/mL for 48 h of exposure.
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Figure 1. Reduction of tetrazolium salt (MTS), neutral rep uptake (NR), and total protein content (TP)
of HepG2 cells exposed for 24 h (A) and 48 h (B) to 0–100 μg/mL of the stilbene extract (45%). All values
expressed as mean ± SD. Significant differences in respect to the control from p < 0.01 (**).
After the exposure of Caco-2 cells to the extract, all assays showed similar concentration-dependent
reduction in cell viability. MTS assay indicated a marked reduction in the cellular viability, being the
EC50 value in this endpoint of 55.8 ± 4.0 μg/mL and 39.0 ± 2.7 μg/mL after 24 h and 48 h, respectively.
These decreases were significantly different from the control group at the concentration 40 μg/mL and
above at 24h, but when cells were exposed to the extract for two days, the cell viability was significantly
reduced from 30 μg/mL (Figure 2).
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Figure 2. Reduction of tetrazolium salt (MTS), neutral rep uptake (NR), and total protein content
(TP) of Caco-2 cells exposed for 24 h (A) and 48 h (B) to 0–100 μg/mL of the stilbene extract (45%).
All values expressed as mean ± SD. Significant differences in respect to the control from p < 0.05 (*) and
p < 0.01 (**).
3.3. Light and Electron Microscopic Observation in HepG2 and Caco-2 Cells
HepG2 and Caco-2 cells exposed to different concentrations of the extract experienced a significant
impairment of cell growing which compromised the survival of the cells at high concentrations.
Under light microscope, unexposed HepG2 cells underwent normal mitotic processes (Figure 3A).
However, when cells were treated with 15.6 and 31.2 μg/mL of the extract they revealed an intense
lipid degeneration in the cytoplasm with vacuoles that tends to confluency (Figure 3B,C). Moreover,
aberrant mitotic figures were also detected, which suggest that the extract was able to stop the cell
growing at any step, including mitosis (Figure 3B,C).These morphological features were also observed
under electron microscopy with cells showing big lipid drops (Figure 3D–F).
The damage observed in Caco-2 cells exposed to the extract was less profuse in comparison to
HepG2 cells, although a marked vacuolization was shown as well as cell death. In fact, the presence
of apoptotic nuclei was more frequent in the case of Caco-2 cells. Whereas cells underwent normal
mitotic process in the control group (Figure 4A), aberrant mitosis can be observed from the lowest
concentration assayed (13.9 μg/mL) (Figure 4B) showing the first stages in the process of apoptosis
characterized by a continuous ring of condensed chromatin at the interior surface of the nuclear
envelope (Figure 4C). Caco-2 cells were analyzed by transmission electron microscopy showing
a nucleus with an irregular surface, decondensed chromatin, and very developed nucleoli with
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well-known fibrillar center. Autophagosomal vacuoles were observed in the cytoplasm (Figure 4D).
Similar findings were observed in the ultrastructural study, with the lowest concentration showing
lipid degeneration (Figure 4E,F). In addition, Caco-2 cells showed big citoplasmatic inclusions as a
result of autophagic processes that lead to cell death (Figure 4E,F).
 
Figure 3. Morphology of HepG2 cells after 24 h of exposure to the extract observed by light microscopy
(A–C, bars = 25 μm) and electron microscopy (D–F, bars = 2 μm). Unexposed control cultures (A) and
HepG2 cells exposed to 7.79 μg/mL of the stilbene extract (45%) (D), 15.59 μg/mL of the extract (B,E)
and 31.18 μg/mL of the stilbene extract (45%) (C,F). (A) Unexposed cells undergoing mitotic processes
(arrow heads). (B) and (C) Lipid degeneration with confluent lipid drops (arrow) and aberrant mitotic
figures (arrow head). (D) Cells showing nucleus (N) and nucleolus (n); mitochondria (m); lipid drops
(L). (E) Big lipid drops (L); nucleus (N) and nucleolus (n) are also observed. (F) High amount of lipid
drops that tends to confluency (L).
 
Figure 4. Morphology of Caco-2cells after 24 h of exposure to the stilbene extract (45%) observed by
light microscopy (A–C, bars = 25 μm) and electron microscopy (D–F, bars = 2 μm). Unexposed control
cultures (A,D), and Caco-2 cells exposed to 13.9 μg/mL of the extract (B,E) and 27.88 μg/mL of the extract
(C,F). (A) Unexposed cells undergoing mitotic processes (black arrow). (B) Cells undergoing aberrant
mitosis (black arrow). (C) Cells showing apoptotic nuclei condensation (arrow head). (D) Unexposed
cells showing normal nucleus with an irregular surface (N), nucleolus (n) with large fibrillar center
(white arrow), and autophagosomes (Ap) in the cytoplasm. (E) Damaged nucleus and mitochondria are
observed as well as big lipid drops. Autophagosomes (Ap) evidenced degenerative process. (F) Lipid
drops (L), autophagosomes (Ap), and autophagic vacuoles (AV) are shown.
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3.4. Oxidative Stress Assays
The control of solvent evidenced no significant changes when cells were exposed to 0.3% of DMSO.
However, HepG2 cells experienced a significant decrease in ROS levels when they were exposed to all
the concentrations of the extract tested after 24 and 48 h, showing a greater decrease after the exposure
to 20.6 μg/mL (Figure 5A). Moreover, GSH content underwent concentration-dependent enhancements
in comparison to the negative control group after both times of exposure (Figure 5B).
Figure 5. ROS content (A) and GSH content (B) in HepG2 cells exposed to 0–31.18 μg/mL or
0–20.56 μg/mL stilbene extract (45%) during 24 h or 48 h, respectively. All values are expressed as
mean ± SD. Differences were considered significant compared to the control group from p < 0.05 (*),
p < 0.01 (**) and p < 0.001 (***).
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When Caco-2 cells were exposed to increasing concentrations of the extract, ROS content was
significantly reduced (Figure 6A). GSH activity was increased significantly at the highest concentrations
assayed, 55.77 μg/mL and 39.02 μg/mL for 24 and 48 h, respectively, with enhancements of 1.6 folds
compared to the control negative group (Figure 6B).
Figure 6. ROS content (A) and GSH content (B) in Caco-2 cells exposed to 0–55.77 μg/mL or
0–39.02 μg/mL stilbene extract (45%) during 24 h or 48 h, respectively. All values are expressed as
mean ± SD. Differences were considered significant compared to the control group from p < 0.05 (*),
p < 0.01 (**) and p < 0.001 (***).
3.5. Antioxidant Assays
The antioxidant ability of the extract was evaluated taking into account their capacity to protect
the cells against a further exposure of H2O2 or their capacity to revert the damage induced by this
substance after a previous exposure by measuring both ROS and GSH levels. No significant changes
were recorded when cells were exposed to 0.3% of DMSO (data not shown).
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The results showed that the extract was able to protect HepG2 cells against an induced oxidative
stress at all concentrations studied, showing a marked decrease of ROS content at both treatment
times (Figure 7A). Similarly, after the pre-treatment with H2O2 for 2 h, the extract presented a greater
reversion role in a concentration and time-dependent manner. This reduced ROS content even lower
than basal levels at the highest concentrations tested for 24 h and after 48 h of exposure of all studied
concentrations (Figure 7B). By contrast, in both protection and reversion assays, GSH levels of the
hepatic cells were not affected by the administration of 7.8 μg/mL during 24 h and 5.1 μg/mL for 48 h
of the extract, while they experienced a significant increase when they were exposed to the highest
concentration (Figure 7C,D). After the pre-treatment with 15.6 μg/mL and 10.3 μg/mL during 24 h and
48 h respectively and a later exposure of H2O2, the results showed higher GSH levels than basal content.
Figure 7. ROS (A) and GSH content (C) in HepG2 cells first pretreated with 0–15.59 μg/mL or with
0–10.28 μg/mL of the stilbene extract (45%) for 24 h or 48 h, respectively, and a later exposure to H2O2
100 μM for 2 h. ROS (B) and GSH (D) content in HepG2 cells exposed to H2O2 100 μM first and a
later 24 h or 48 h-treatment with 0–15.59 μg/mL or 0–10.28 μg/mL, respectively. Cells exposed to H2O2
100 μM 2h were used as control. All values are expressed as mean ± SD. Differences were considered
significant compared to the control group from p < 0.01 (**) and p < 0.001 (***).
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The cell line Caco-2 presented lower protection and reversion capacity when compared to the
effects observed in HepG2 cells. In the protection assay, the extract was able to significantly reduced
ROS content with respect to the control group treated with H2O2 at all concentrations assayed after both
pre-treatment times (Figure 8A). Similar results were obtained when Caco-2 cells were exposed to H2O2
prior the extract (Figure 8B). At the highest concentrations assayed ROS content was reduced down to
basal levels. With respect to GSH levels, in both reversion and protection assays, GSH content were
higher than basal levels after both times of treatment at the highest concentration assayed. The results
showed a significant increase between control group with H2O2 treatment and those exposed to the
highest concentration tested of the extract for 24 h and 48 h prior H2O2 (Figure 8C). Moreover, after the
exposure to H2O2 for 2 h, only Caco-2 cells treated with 22.9 μg/mL during 24h or with 19.5 μg/mL for
48 h presented a significant increase of GSH levels (Figure 8D).
Figure 8. ROS (A) and GSH content (C) in Caco-2 cells first pretreated with 0–27.88 μg/mL or with
0–19.51 μg/mL of the extract for 24 h or 48 h, respectively, and a later exposure to H2O2 100 μM for
2 h. ROS (B) and GSH (D) content in HepG2 cells exposed to H2O2 100 μM first and a later 24 h or
48 h-treatment with 0–27.88 μg/mL or 0–19.51 μg/mL respectively. Cells exposed to H2O2 100 μM 2 h
were used as control. All values are expressed as mean ± SD. Differences were considered significant
compared to the control group from p < 0.01 (**) and p < 0.001 (***).
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4. Discussion
Previous reports have revealed the interesting properties of stilbene-rich extracts form
grapevine-shoot to be used in the vine and wine industry [3,10,23,32]. Therefore, the cytotoxicity study
in human cell lines (Caco-2 and HepG2) is a key step in order to evaluate its safety. The cytotoxicity
study performed in the present work evidenced that our extract (45% of stilbenes) reduced cell viability
from 40 μg/mL after 24 h of exposure and from 30 μg/mL at 48 h in both cell lines. Similarly, Vineatrol®
(29% of stilbenes) inhibits cell proliferation in another human colon carcinoma cell line (SW480 cells),
showing a concentration and time-dependent reduction in the MTT assay [16]. The latter extract also
affected cell cycle progression of different human cancer cell lines (SW480, SW620, and HTC 116),
making them more prone to suffer cytotoxic effects of toxicants [33]. Moreover, these authors have
previously reported that Vineatrol® disrupts cells proliferation more efficiently than resveratrol on
HepG2 cells [17].
Studies using single stilbenes are more numerous in comparison to those using stilbenes extracts.
In this sense, a concentration-dependent cytotoxicity of resveratrol and piceatannol have been reported
in cultured macrophages, tumor-derived human T cells, and human epidermoid carcinoma cells [14].
These results showed cell inhibition at high concentration of resveratrol (50 μmol/L) in all cell types,
while at low concentration (5 μmol/L) stimulation of macrophages was detected. Moreover, Colin et al.
(2009) reported that the mixture of trans-resveratrol and ε-viniferin (Vineatrol®) as well as resveratrol
itself affect cell cycle progression of human colon cancer cell lines [33]. Similarly, both resveratrol
and Vineatrol® exerted a concentration-dependent cytotoxic effect on V79 cells, the effect being
much more pronounced with resveratrol than with Vineatrol® [8]. In addition, Mizuno et al., 2017
reported that different modifications of stilbenes have different cytotoxic effect in CHO-K1 and HepG2
cells [34]. The latter authors hypothesized that the cell viability decrease may be reduced because of
the appearance of necrosis or late stages of apoptosis when the metabolic activity is harshly reduced.
This finding has been observed in the morphological study carried out in the present work, showing
the first stages of apoptosis such as condensed chromatin in the nuclear envelope in Caco-2 cells
exposed to the stilbene extract. Similarly, nuclear staining of the human colorectal cells SW480,
evidenced that resveratrol-analogs and Vineatrol® preparation caused a nuclear redistribution of
cyclin A, could be the first step for apoptosis considering that this finding was observed in both
normal and apoptotic cells [33]. SW480 cells experienced apoptosis in a dose and time-dependent
way. Moreover, the resveratrol tetramer, r-viniferin, provoked a cell cycle arrest followed by apoptosis
in the prostate cancer cell line LNCaP, being this effect higher than in the exposure to resveratrol
where apoptosis was not observed [35]. Also, different cultures of leukemic cells from chronic B cell
malignancies and normal peripheral blood-derived mononuclear cells were exposed to Vineatrol®.
Whereas impairment of cell proliferation and apoptotic processes were observed in exposed leukemic
cells, the survival of normal peripheral blood mononuclear cells was little affected in the presence
of these polyphenolic compounds and higher concentrations were required in order to elicit cell
death [15]. This finding is particularly interesting since normal cells are usually more sensitive than
cancer cell lines, highlighting the anti-cancer effect of stilbenes [36,37]. Ji et al. (2018) reported that
cancer cells observed under microscope became flattened and elongated, which were morphological
changes of cellular senescence [38]. In addition, resveratrol arrested cancer cell proliferation in a
concentration-dependent way. However, no effect was recorded in cell viability for non-tumorigenic
human breast epithelial cells MCF-10A. In this regards, Elshaer et al. (2018) reviewed the anti-cancer
mechanisms of resveratrol by inducing autophagy and apoptosis [39]. In addition to death cell and
autophagy, other morphological changes were observed in cells exposed to stilbenes. Scanning electron
microscopy revealed that resveratrol altered the morphology of T cells and skin cells at concentrations
≥50 μmol/L, especially affecting the cell membrane [14]. Besides cell death, previous degradation steps
have been evidenced in the present work. Hence, one of the most remarkable morphological features
were presence of big lipid drops evidencing lipid degeneration, probably due to the degenerative
processes in the organelles [40].
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The defense against oxidative damage is one of the most commonly described characteristics of
stilbenes [21]. However, phenolic compounds frequently exhibit prooxidant or antioxidant activities
depending on the dose, alkali pH, high concentrations of transition metal ions, and the presence
of oxygen molecules [21,41,42]. In this regard, Cotoras et al., (2014) assessed in vitro and in vivo
antioxidant and prooxidant properties of phenolic compounds obtained from Vitis vinifera pomace,
evidencing a prooxidant effect by accumulation of ROS [43]. By contrast, our results suggest that
the extract modulates important functions related to the maintenance of Caco-2 and HepG2 redox
environment, preventing the increase in ROS levels induced by H2O2, and even reverting them down
to basal levels, but no prooxidant effect was recorded. Goutzourelas et al. (2015) also found that two
extracts from stems of Greek grape varieties significantly decreased the ROS levels by 21.8 ± 2.0% and
16.5 ± 3.7%, respectively, compared to the control group, in C2C12 cells after 24 h of exposure [44].
This antioxidant activity can be explained by the ability of polyphenols to enhance antioxidant
mechanisms, such as GSH synthesis, which acts as a scavenger to directly remove hydroxyl radical
and singlet oxygen and participates in the elimination of hydrogen peroxide. In addition, Müller et al.
(2009) found that the grapevine-shoot extract Vineatrol®30, acted as a free radical scavenger and
potent antioxidant enhancing the glutathione peroxidase activity at non-cytotoxic concentrations in
V79 Chinese hamster lung fibroblast cells [8]. Similarly, an increase of GSH levels in endothelial cells
was observed after 24 h of exposure of polyphenolic extracts derived from the stems of three Greek
grape varieties [45].
5. Conclusions
Besides all beneficial abilities of stilbenes, such as antioxidant activity, they may also have potential
toxic effects. In this regard, the present work entail the first approach to the toxicological studies
required before being used in wines. The cytotoxicity study evidenced that the stilbene extract reduced
cell viability in both cell lines in the range of concentrations from 40–100 μg/mL after 24 h of exposure
and from 30–100 μg/mL at 48 h of exposure. In addition, ultrastructural changes were observed from
15.6 μg/mL in HepG2 cells and 27.9 μg/mL in Caco-2 cells, which highlighted the higher sensitivity
of the morphological study in comparison to the cytotoxicity endpoints. Moreover, this work also
presents a wide assessment of the prooxidant and antioxidant profile of our extract in human cells,
which had not been previously studied. In general, at the exposed concentrations, the extract presented
a protective and reductive role against an induced oxidative stress. Taking into account all these
findings as a starting approach, more research is needed to establish effective and safe concentrations
of this stilbene extract intended to be used in wines as a preservative.
Author Contributions: Formal analysis, C.M.-P., T.R. and E.C.-V.; Funding acquisition, S.P. and E.C.-V.;
Investigation, C.M.-P., M.P., F.J.M. and T.R.; Methodology, C.M.-P., M.P., F.J.M. and T.R.;; Project administration,
E.C.-V. and S.P.; Resources, T.R. and E.C.-V.; Supervision, M.P. and S.P.; Writing—original draft, C.M.-P., F.J.M. and
S.P.; Writing—review & editing, C.M.-P., T.R., E.C.-V. and S.P.
Funding: This work was supported by the Ministerio de Economía, Industria y Competitividad and INIA for
the financial support for this project (RTA2015-00005-C02-02). Moreover, it was also supported by the Bordeaux
Metabolome Facility and MetaboHUB (ANR-11-INBS-0010 project).
Acknowledgments: The authors thank the CITIUS Biology Service (University of Seville) for the technical
assistance offered. Moreover, we would like to thank M.M. Merchán-Gragero, M-L. Iglesias and A. Palos-Pinto for
their technical assistance.
Conflicts of Interest: The authors declare no conflict of interest. The funders had no role in the design of the
study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to
publish the results.
References
1. Guerrero, R.F.; Cantos-Villar, E. Demonstrating the efficiency of sulphur dioxide replacements in wine:
A parameter review. Food. Sci. Technol. 2015, 42, 27–43. [CrossRef]
369
Antioxidants 2019, 8, 467
2. EC, European Parliament and of the Council. Directive 2006/52/EC of the European Parliament and of the
Council of 5 July 2006 amending directive 95/2/EC on food additives other than colours and sweeteners and
Directive 94/35/EC on sweeteners for use in foodstuffs. Off. J. Eur. Union 2006, 204, 10–22.
3. Cruz, S.; Raposo, R.; Ruiz-Moreno, M.J.; Garde-Cerdán, T.; Puertas, B.; Gonzalo-Diago, A.; Moreno-Rojas, J.M.;
Cantos-Villar, E. Grapevine-shoot stilbene extract as a preservative in white wine. Food Packag. Shelf Life
2018, 18, 164–172. [CrossRef]
4. Santos, M.C.; Numes, C.; Saraiva, J.A.; Coimbra, M.A. Chemical and physical methodologies for the
replacement/reduction of sulfur dioxide use during winemaking: Review of their potentialities and
limitations. Eur. Food Res. Technol. 2012, 234, 1–12. [CrossRef]
5. Shahidi, F.; Ambigaipalan, P. Phenolics and polyphenolics in foods, beverages and spices: Antioxidant
activity and health effects—A review. J. Funct. Foods 2015, 18, 820–897. [CrossRef]
6. Anastasiadi, M.; Pratsinis, H.; Kletsas, D.; Skaltsounis, A.L.; Haroutounian, S.A. Grape stem extracts
Polyphenolic content and assessment of their in vitro antioxidant properties. LWT-Food Sci. Technol. 2012, 48,
316–322. [CrossRef]
7. Biais, B.; Krisa, S.; Cluzet, S.; Da Costa, G.; Waffo-Teguo, P.; Mérillon, J.M.; Richard, T. Antioxidant and
Cytoprotective Activities of Grapevine Stilbenes. J. Agric. Food Chem. 2017, 65, 4952–4960. [CrossRef]
8. Müller, C.; Ullmann, K.; Wilkens, A.; Winterhalter, P.; Toyokuni, S.; Steinberg, P. Potent Antioxidative Activity
of Vineatrol®30 Grapevine-shoot Extract. Biosci. Biotechnol. Biochem. 2009, 73, 1831–1836. [CrossRef]
[PubMed]
9. Ruiz-Moreno, M.J.; Raposo, R.; Cayuela, J.M.; Zafrilla, P.; Piñeiro, Z.; Moreno-Rojas, J.M.; Mulero, J.;
Puertas, B.; Giron, F.; Guerrero, R.F.; et al. Valorization of grape stems. Ind. Crop. Prod. 2015, 63, 152–157.
[CrossRef]
10. Raposo, R.; Ruiz-Moreno, M.J.; Garde-Cerdán, T.; Puertas, B.; Moreno-Rojas, J.M.; Gonzalo-Diago, A.;
Guerrero, R.F.; Ortíz, V.; Cantos-Villar, E. Grapevine-shoot stilbene extract as a preservative in red wine.
Food Chem. 2016, 197, 1102–1111. [CrossRef]
11. Raposo, R.; Chinnici, F.; Ruiz-Moreno, M.J.; Puertas, B.; Cuevas, F.J.; Carbú, M.; Guerrero, R.F.;
Ortíz-Somovilla, V.; Moreno-Rojas, J.M.; Cantos-Villar, E. Sulfur free red wines through the use of grapevine
shoots: Impact on the wine quality. Food Chem. 2018, 243, 453–460. [CrossRef] [PubMed]
12. EFSA (European Food Safety Authority). Guidance for submission for food additive evaluations. EFSA J.
2012, 10, 2760.
13. Maisanaba, S.; Llana-Ruiz-Cabello, M.; Gutiérrez-Praena, D.; Pichardo, S.; Puerto, M.; Prieto, A.I.; Jos, A.M.;
Cameán, A.M. New advances in active packaging incorporated with essential oils or their main components
for food preservation. Food Rev. Int. 2017, 33, 447–515. [CrossRef]
14. Radkar, V.; Hardej, D.; Lau-Cam, C.; Billack, B. Evaluation of resveratrol and piceatannol cytotoxicity in
macrophages, T cells, and skin cells. Arhiv za Higijenu Rada i Toksikologiju 2007, 58, 293–304. [CrossRef]
[PubMed]
15. Billard, C.; Izard, J.C.; Roman, V.; Kern, C.; Mathiot, C.; Mentz, F.; Kolb, J.P. Comparative Antiproliferative
and Apoptotic Effects of resveratrol, ε-viniferin and vine-shots Derived Polyphenols (Vineatrols) on Chronic
B Lymphocytic Leukemia Cells and Normal Human Lymphocytes. Leuk. Lymphoma 2002, 43, 1991–2002.
[CrossRef]
16. Marel, A.K.; Lizard, G.; Izard, J.C.; Latruffe, N.; Delmas, D. Inhibitory effects of trans-resveratrol analogs
molecules on the proliferation and the cell cycle progression of human colon tumoral cells. Mol. Nutr.
Food Res. 2008, 52, 538–548. [CrossRef]
17. Colin, D.; Lancon, A.; Delmas, D.; Lizard, G.; Abrossinow, J.; Kahn, E.; Jannin, B.; Latruffe, N. Antiproliferative
activities of resveratrol and related compounds in human hepatocyte derived HepG2 cells are associated with
biochemical cell disturbance revealed by fluorescence analyses. Biochimie 2008, 90, 1674–1684. [CrossRef]
18. Guerrero, F.R.; García-Parrilla, M.C.; Puertas, B.; Cantos-Villar, E. Wine, resveratrol and health: A review.
Nat. Prod. Commun. 2009, 4, 635–658. [CrossRef]
19. Richard, T.; Poupard, P.; Nassra, M.; Papastamoulis, Y.; Iglésias, M.L.; Krisa, S.; Waffo-Teguo, P.; Mérillon, J.M.;
Monti, J.P. Protective effect of ε-viniferin on b-amyloid peptide aggregation investigated by electrospray
ionization mass spectrometry. Bioorg. Med. Chem. 2011, 19, 3152–3155. [CrossRef]
370
Antioxidants 2019, 8, 467
20. Frombaum, M.; Le Clanche, S.; Bonnefont-Rousselot, D.; Borderie, D. Antioxidant effects of resveratrol and
other stilbene derivatives on oxidative stress and NO bioavailability: Potential benefits to cardiovascular
diseases. Biochimie 2012, 94, 269–276. [CrossRef]
21. Ferguson, L.R. Role of plant polyphenols in genomic stability. Mutat. Res. 2001, 475, 89–111. [CrossRef]
22. Ozkan, A.; Erdogan, A. A comparative evaluation of antioxidant and anticancer activity of essential oil
from Origanum onites (Lamiaceae) and its two major phenolic components. Turk. J. Biol. 2011, 35, 735–742.
[CrossRef]
23. Gutiérrez-Praena, D.; Pichardo, S.; Jos, A.; Moreno, F.J.; Cameán, A.M. Biochemical and pathological toxic
effects induced by the cyanotoxin Cylindrospermopsin on the human cell line Caco-2. Water Res. 2012, 49,
1566–1575. [CrossRef] [PubMed]
24. Gabaston, J.; El Khawand, T.; Waffo-Teguo, P.; Decendit, A.; Richard, T.; Mérillon, J.M.; Roman, P. Stilbenes
from grapevine root: A promising natural insecticide against Leptinotarsa decemlineata. J. Pest Sci. 2018, 91,
897–906. [CrossRef]
25. Guerrero, R.F.; Biais, B.; Richard, T.; Puertas, B.; Waffo-Teguo, P.; Merillon, J.M.; Cantos-Villar, E. Grapevine
cane’s waste is a source of bioactive stilbenes. Ind. Crop. Prod. 2016, 94, 884–892. [CrossRef]
26. Borenfreud, E.; Puerner, J.A. A simple quantitative procedure using monolayer culture for cytotoxicity assays.
J. Tissue Cult. Methods 1984, 9, 7–9. [CrossRef]
27. Zhang, S.Z.; Lipsky, M.M.; Trump, B.F.; Hsu, I.C. Neutral red (NR) assay for cell viability and
xenobiotic-induced cytotoxicity in primary cultures of human and rat hepatocytes. Cell Biol. Toxicol.
1990, 6, 219–234. [CrossRef]
28. Baltrop, J.A.; Owen, T.C.; Cory, A.H. 5-((3-carboxyphenyl)-3-(4,5 dimethilthiazolyl)-3-(4- sulfophenyl)
tetrazolium, inner salt (MTS) and related analogs of 2- (4,5- dimethylthiazolyl)- 2,5- diphenylterazolium
bromide (MTT) reducing to purple water soluble formazan as cell viability indicators. Bioorg. Med. Chem. Lett.
1991, 1, 611. [CrossRef]
29. Bradford, M.M. A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein
Utilizing the Principle of Protein-Dye Binding. Anal. Biochem. 1976, 72, 248–254. [CrossRef]
30. Gutiérrez-Praena, D.; Guzmán-Guillén, R.; Pichardo, S.; Moreno, F.J.; Vasconcelos, V.; Jos, A.; Cameán, A.M.
Cytotoxic and morphological effects of microcystin-LR, cylindrospermopsin, and their combinations on the
human hepatic cell line HepG2. Environ. Toxicol. 2019, 34, 240–251. [CrossRef]
31. Wijeratne, S.S.K.; Cuppett, S.L.; Schlegel, V. Hydrogen Peroxide Induced Oxidative Stress Damage and
Antioxidant Enzyme Response in Caco-2 Human Colon Cells. J. Agric. Food Chem. 2005, 53, 8768–8774.
[CrossRef] [PubMed]
32. Schnee, S.; Queiroz, E.F.; Voinesco, F.; Marcourt, L.; Dubuis, P.H.; Wolfender, J.L.; Gindro, K. Vitis vinifera
canes, a new source of antifungal compounds against Plasmopara viticola, Erysiphe necator, and Botrytis cinerea.
J. Agric. Food Chem. 2013, 61, 5459–5467. [CrossRef] [PubMed]
33. Colin, D.; Gimazane, A.; Lizard, G.; Izard, J.C.; Solary, E.; Latruffe, N.; Delmas, D. Effects of resveratrol
analogs on cell cycle progression, cell cycle associated proteins and 5fluoro-uracil sensitivity in human
derived colon cancer cells. Int. J. Cancer 2009, 124, 2780–2788. [CrossRef] [PubMed]
34. Mizuno, C.S.; Ampomaah, W.; Mendonça, F.R.; Andrade, G.C.; Nazaré da Silva, A.M.; Goulart, M.O.;
Alves dos Santos, R. Cytotoxicity and genotoxicity of stilbene derivatives in CHO-K1 and HepG2 cell lines.
Genet. Mol. Biol. 2017, 40, 656–664. [CrossRef] [PubMed]
35. Empl, M.T.; Albers, M.; Wang, S.; Steinberg, P. The Resveratrol Tetramer r-Viniferin Induces a Cell Cycle
Arrest Followed by Apoptosis in the Prostate Cancer Cell Line LNCaP. Phytother. Res. 2015, 29, 1640–1645.
[CrossRef]
36. Yilmazer, A. Cancer cell lines involving cancer stem cell populations respond to oxidative stress. Biotechnol. Rep.
2018, 17, 24–30. [CrossRef] [PubMed]
37. De Filippis, B.; Ammazzalorso, A.; Fantacuzzi, M.; Giampietro, L.; Maccallini, C.; Amoroso, R. Anticancer
Activity of Stilbene-Based Derivatives. Chem. Med. Chem. 2017, 12, 1–14. [CrossRef] [PubMed]
38. Ji, S.; Zheng, Z.; Liu, S.; Ren, G.; Gao, J.; Zhang, Y.; Li, G. Resveratrol promotes oxidative stress to drive DLC1
mediated cellular senescence in cancer cells. Exp. Cell Res. 2018, 370, 292–302. [CrossRef]
39. Elshaer, M.; Chen, Y.; Wang, X.J.; Tang, X. Resveratrol: An overview of its anti-cancer mechanisms. Life Sci.
2018, 207, 340–349. [CrossRef]
371
Antioxidants 2019, 8, 467
40. De Bortoli, M.; Taverna, E.; Maffioli, E.; Casalini, P.; Crisafi, F.; Kumar, V.; Caccia, C.; Polli, D.; Tedeschi, G.;
Bongarzone, I. Lipid accumulation in human breast cancer cells injured by iron depletors. J. Exp. Clin.
Cancer Res. 2018, 37, 75. [CrossRef] [PubMed]
41. Blokhina, O.; Virolainen, E.; Fagerstedt, K.V. Antioxidants, oxidative damage and oxygen deprivation stress:
A review. Ann. Bot. 2003, 91, 179–194. [CrossRef] [PubMed]
42. Llana-Ruiz-Cabello, M.; Gutiérrez-Praena, D.; Puerto, M.; Pichardo, S.; Jos, A.; Cameán, A.M. In vitro
pro-oxidant/antioxidant role of carvacrol, thymol and their mixture in the intestinal Caco-2 cell line.
Toxicol. In Vitro 2015, 29, 647–656. [CrossRef] [PubMed]
43. Cotoras, M.; Vivanco, H.; Melo, R.; Aguirre, M.; Silva, E.; Mendoza, L. In vitro and in vivo evaluation of the
antioxidant and prooxidant activity of phenolic compounds obtained from grape (Vitis vinifera) pomace.
Molecules 2014, 19, 21154–21167. [CrossRef] [PubMed]
44. Goutzourelas, N.; Stagos, D.; Spanidis, Y.; Liosi, M.; Apostolou, A.; Priftis, A.; Haroutounian, S.;
Spandidos, D.A.; Tsatsakis, A.M.; Kouretas, D. Polyphenolic composition of grape stem extracts affects
antioxidant activity in endothelial and muscle cells. Mol. Med. Rep. 2015, 12, 5846–5856. [CrossRef]
[PubMed]
45. Goutzourelas, N.; Stagos, D.; Housmekeridou, A.; Karapouliou, C.; Kerasioti, E.; Aligiannis, N.;
Skaltsounis, A.L.; Spandidos, D.A.; Tsatsakis, A.M.; Kouretas, D. Grape pomace extract exerts antioxidant
effects through an increase in GCS levels and GST activity in muscle and endothelial cells. Int. J. Mol. Med.
2015, 36, 433–441. [CrossRef] [PubMed]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution




Methyl Jasmonate Reduces Inflammation and
Oxidative Stress in the Brain of Arthritic Rats
Heloisa V. Pereira-Maróstica 1, Lorena S. Castro 1, Geferson A. Gonçalves 1, Francielli M.S. Silva 2,
Lívia Bracht 1, Ciomar A. Bersani-Amado 2, Rosane M. Peralta 1, Jurandir F. Comar 1,
Adelar Bracht 1 and Anacharis B. Sá-Nakanishi 1,*
1 Department of Biochemistry, University of Maringá, 7020900 Maringá, Brazil;
heloisavialle@gmail.com (H.V.P.-M.); losacastro@hotmail.com (L.S.C.); gefersonag2@gmail.com (G.A.G.);
lbracht@uem.br (L.B.); rmperalta@uem.br (R.M.P.); jfcomar@uem.br (J.F.C.); abracht@uem.br (A.B.)
2 Department of Pharmacology and Therapeutics, University of Maringá, 87020900 Maringá, Brazil;
franciellimss@gmail.com (F.M.S.S.); cabamado@uem.br (C.A.B.-A.)
* Correspondence: absnakanishi@uem.br
Received: 10 July 2019; Accepted: 4 October 2019; Published: 15 October 2019
Abstract: Methyl jasmonate (MeJA), common in the plant kingdom, is capable of reducing articular and
hepatic inflammation and oxidative stress in adjuvant-induced arthritic rats. This study investigated
the actions of orally administered MeJA (75–300 mg/kg) on inflammation, oxidative stress and selected
enzyme activities in the brain of Holtzman rats with adjuvant-induced arthritis. MeJA prevented the
arthritis-induced increased levels of nitrites, nitrates, lipid peroxides, protein carbonyls and reactive
oxygen species (ROS). It also prevented the enhanced activities of myeloperoxidase and xanthine
oxidase. Conversely, the diminished catalase and superoxide dismutase activities and glutathione
(GSH) levels caused by arthritis were totally or partially prevented. Furthermore, MeJA increased
the activity of the mitochondrial isocitrate dehydrogenase, which helps to supply NADPH for the
mitochondrial glutathione cycle, possibly contributing to the partial recovery of the GSH/oxidized
glutathione (GSSG) ratio. These positive actions on the antioxidant defenses may counterbalance the
effects of MeJA as enhancer of ROS production in the mitochondrial respiratory chain. A negative
effect of MeJA is the detachment of hexokinase from the mitochondria, which can potentially impair
glucose phosphorylation and metabolism. In overall terms, however, it can be concluded that MeJA
attenuates to a considerable extent the negative effects caused by arthritis in terms of inflammation
and oxidative stress.
Keywords: adjuvant-induced arthritis; rheumatoid arthritis; methyl jasmonate; brain mitochondria;
hexokinase; oxidative stress
1. Introduction
Methyl jasmonate (MeJA) is a cyclopentanone widely spread over the plant kingdom where
it functions as signaling molecule associated with biotic and abiotic stress [1]. It was first isolated
from the flowers of jasmine (Jasminum grandiflorum), whose infusions have been traditionally used
to relieve stress, depression, irritability and memory deficit [2]. MeJA has been reported to present
anti-tumor activity without affecting healthy cells [3]. In fact, MeJA was revealed to be cytotoxic
against various murine and human cancer cell lines [1,3]. In the cancer cells the compound mainly
affects the mitochondria, where it detaches the outer membrane-bound hexokinase, stimulates the
production of reactive oxygen species (ROS), depletes ATP and induces apoptosis [4,5].
MeJA shares structural similarity with anti-inflammatory prostaglandins and, therefore, has been
lately investigated as a promising anti-inflammatory agent [3,6]. The compound itself and its synthetic
derivatives inhibit the synthesis of tumor necrosis factor alpha (TNFα), interleukin 1 beta (IL-1β),
Antioxidants 2019, 8, 485; doi:10.3390/antiox8100485 www.mdpi.com/journal/antioxidants373
Antioxidants 2019, 8, 485
interleukin 6 (IL-6), prostaglandin E and nitric oxide (NO) in murine macrophages (RAW264.7)
stimulated by lipopolysaccharide (LPS) [6–8]. A recent study also showed that orally administered
MeJA improves the systemic and articular inflammation in rats with adjuvant-induced arthritis,
an experimental model of human severe rheumatoid arthritis [9]. Thus, MeJA emerges also as a
promising agent for treatment of rheumatoid arthritis and other systemic inflammatory disorders.
Rheumatoid arthritis is a chronic and autoimmune inflammatory disease that can lead to
progressive joint destruction and affects approximately 1.0% of the adult population worldwide [10,11].
An accentuated hyperplasia of the synovial membrane and cartilage and intense production of
pro-inflammatory cytokines (TNFα, IL-1β and IL-6) are normally associated with rheumatoid
arthritis [12]. The overproduction of reactive species and metalloproteinases are additionally stimulated
by cytokines and mediate the tissue injury [13,14]. Rheumatoid arthritis is a systemic disease and in
addition to affecting the joints, it evokes inflammatory and oxidative alterations in other organs, such
as lungs, liver and heart [12]. In fact, the oxidative stress biomarkers are modified in the serum of
patients with rheumatoid arthritis and in the extra-articular tissues of animal models of rheumatoid
arthritis [14–19]. Metabolic alterations also occur in rheumatoid arthritis, as for example, the condition
of muscle wasting known as rheumatoid cachexia [20]. The hepatic metabolism is also significantly
modified in rats with adjuvant-induced arthritis, a phenomenon associated with pronounced oxidative
stress in the organ [17,21–23].
Inflammation in rheumatoid arthritis also affects the brain where it causes fatigue and reduced
cognitive function [12]. Cerebral atrophy and other structural modifications have been reported
in patients with severe rheumatoid arthritis [24,25]. The levels of ROS, NO, lipoperoxides and
protein carbonyl groups are increased in the brain of rats with adjuvant-induced arthritis, particularly
in the mitochondria, where the transmembrane potential is also increased [26]. These alterations
are accompanied by decreased levels of reduced glutathione (GSH) and diminished activities of
antioxidant enzymes. Additionally, the activity of the pro-oxidant enzyme xanthine oxidase (XO) and
the pro-inflammatory enzyme iNOS are increased in the brain of arthritic rats [26].
An earlier study has shown that intraperitoneally administered MeJA attenuates the memory
dysfunction, decreases the levels of prostaglandin E, TNFα and IL-1 and suppresses the expression of
COX-2 and iNOS in the brain of mice with LPS-induced neuroinflammation [27]. In addition, MeJA
reverses in mice the memory impairment caused by scopolamine and unpredictable chronic mild stress
(UCMS), phenomena that were associated with the improvement in the brain’s levels of oxidative
stress biomarkers, specifically lipoperoxides and GSH [28,29]. Considering these actions of MeJA on
the cerebral tissue of mice, it is reasonable to hypothesize that MeJA will be capable of attenuating the
inflammation and oxidative stress in the brain of arthritic rats. The present work was thus planned to
investigate the effects of orally administered MeJA on inflammation and on the oxidative status of
the brain of rats using the model of adjuvant-induced arthritis. Because orally administered MeJA
stimulated ROS production in isolated hepatic mitochondria [9], this work has also evaluated the
production of ROS in isolated brain mitochondria from healthy and arthritic rats as well as the activities
of several mitochondrial dehydrogenases. Furthermore, the activity of hexokinase was also evaluated,
as the liver of arthritic rats presents a considerably enhanced glucose phosphorylation capacity [30].
The data obtained in the current study should allow to infer about the possible actions of MeJA on the
brain of patients with severe rheumatoid arthritis.
2. Materials and Methods
2.1. Chemicals
Methyl jasmonate, o-phthalaldehyde (OPT), 2,4-dinitrophenylhydrazine (DNPH),
1,1′,3,3′-tetraethoxypropane, horseradish peroxidase, nitrate reductase, β-nicotinamide adenine
dinucleotide (NADH), 2′-7′-dichlorofluorescein-diacetate (DCFH-DA), oxidized dichlorofluorescein
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(DCF), reduced glutathione (GSH) and oxidized glutathione (GSSG) were purchased from Sigma
Chemical Co (St. Louis, MO, USA). All other chemicals were of analytical grade.
2.2. Animals and Induction of Arthritis
Male Holtzman rats weighing approximately 180 g were obtained from the Center of Animal Breeding
of the University of Maringá (UEM, Maringá, Brazil) and kept in the Animal Care Unit of our laboratory
under standard temperature (24 ± 3 ◦C) in a 12 h light/dark cycle. The animals were maintained in steel
cages (three rats/cage) and fed ad libitum with laboratory diet (Nuvilab®, Colombo, Brazil). For arthritis
induction, animals were subcutaneously injected in the left hind paw with 0.1 mL (500 μg) of Freund’s
adjuvant (heat inactivated Mycobacterium tuberculosis, derived from the human strain H37Rv), suspended in
Nujol® (Sigma Chemical Co-St. Louis, MO, USA) [31]. Rats of similar weights and age were used as controls.
The procedures followed the guidelines of the Brazilian Council for the Control of Animal Experimentation
(CONCEA) and were previously approved by the Ethics Committee for Animal Experimentation of the
State University of Maringá (Protocol number CEUA 4475171016).
2.3. Experimental Design
Forty-two animals were randomly distributed into seven groups: controls (C), which received
corn oil; controls (C300) treated with MeJA at the dose of 300 mg/kg; arthritic rats (A), which received
corn oil; arthritic rats (A75, A150 and A300) treated with MeJA, respectively, at the doses of 75, 150 and
300 mg/kg; and arthritic rats (AIBU) treated with ibuprofen (30 mg/kg). This procedure was repeated
three times (42 × 3 = 126 rats in total) throughout the study. Animals were orally treated (by gavage)
once a day with MeJA, corn oil or ibuprofen during the 18 days after arthritis induction. The doses of
MeJA were defined according to previous studies showing that they are biologically active and well
tolerated when the compound is administered to rodents [9,32].
2.4. Brain Homogenate Preparation and Mitochondria Isolation
Fasted (12 h) rats were anesthetized with an overdose of sodium thiopental (100 mg/kg) and the
brain immediately removed, freeze-clamped and stored in liquid nitrogen. The tissue was homogenized
in a van Potter–Elvehjem homogenizer with nine volumes of ice-cold 0.1 M potassium phosphate buffer
(pH 7.4) and an aliquot was separated as total homogenate. The remaining homogenate was centrifuged
(11,000g/15 min) and the supernatant separated as homogenate supernatant. Brain mitochondria were
isolated by differential centrifugation as previously described [33] with some modifications. The fresh
brain was placed in ice-cold solution containing 200 mM mannitol, 76 mM sucrose, 1 mM ethylene
glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid (EGTA), 0.1 mM PMSF (phenylmethylsulfonyl
fluoride) and 10 mM 2-amino-2-hydroxymethyl- propane-1,3-diol (TRIS; pH 7.4). The brain was cut
into small pieces and homogenized in a van Potter–Elvehjem homogenizer. The homogenate was
then first centrifuged at 650g for 10 min and the mitochondria in the supernatant were sedimented
by centrifuging at 8000g (10 min). The resulting mitochondria were washed and resuspended in the
same buffer. An aliquot of this preparation was used to prepare disrupted mitochondria by a repeated
freeze-thawing procedure in liquid nitrogen.
2.5. Brain Oxidative Stress and Inflammatory Parameters
Protein carbonyl groups were measured spectrophotometrically in the brain homogenate
supernatant using 2,4-dinitrophenylhydrazine (DNPH) as previously described [34]. The molar
extinction coefficient (ε) of 2.20 × 104 M−1 cm−1 was used in the calculations.
The levels of lipoperoxides were quantified by means of the thiobarbituric acid reactive substances
(TBARS) assay [35]. The content in TBARS was calculated from the standard curve prepared with
1,1′,3,3′-tetraethoxypropane.
The content of ROS was quantified via the 2′-7′-dichlorofluorescein-diacetate (DCFH-DA)
assay [36], which quantifies the oxidation of DCFH to the fluorescent 2′,7′-dichlorofluorescein (DCF) in
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the presence of ROS. The formation of DCF was measured by spectrofluorimetry (Shimadzu RF-5301;
504 nm for excitation and 529 nm for emission). Although ROS have short half-lives, decomposition in
frozen tissue is not very pronounced and the fractional loss and inactivations are independent of their
concentrations, so that the proportions between the various conditions are preserved when they are
assayed at the same time [9,17].
The rate of mitochondrial ROS production was estimated by measuring the linear fluorescence
increase (504 nm for excitation and 529 nm for emission) due to DCF formation from DCFH via
oxidation by H2O2 in the presence of horseradish peroxidase [37]. Briefly, intact mitochondria (0.5 mg)
were suspended in 2 mL of a mixture containing 250 mM mannitol, 1.36 μM DCFA-DA, 10 mM HEPES
buffer (pH 7.2), 10 μM rotenone and 10 mM succinate as respiratory substrate. Fluorescence was
recorded during 10 min under agitation. The results were expressed as nmol min−1 (mg protein)−1.
The production of NO was indirectly quantified by measuring the levels of nitrite plus nitrate in
the brain homogenate supernatant. Nitrate was first converted into nitrite by adding nitrate reductase
and the total nitrite was quantified by the Griess reagent [38].
Reduced (GSH) and oxidized (GSSG) glutathione were measured in the brain homogenate
by spectrofluorimetry (excitation at 350 nm and emission at 420 nm) with the o-phthalaldehyde
(OPT) assay [39]. The activities of catalase, superoxide dismutase (SOD), xanthine oxidase (XO)
and myeloperoxidase (MPO) were assayed by spectrophotometry in the supernatant of the brain
homogenate. The catalase activity was estimated spectrophotometrically at 240 nm using H2O2
as substrate [40]. The activity of SOD was estimated by the pyrogallol autoxidation method [41].
The activity (MPO) was measured by spectrophotometry with o-dianisidine [42]. The XO activity was
estimated as the increase in absorbance at 295 nm due to uric acid formation [43].
2.6. Mitochondrial Transmembrane Potential (ΔΨm) and Enzyme Activities
Mitochondrial membrane energization (transmembrane potential; ΔΨm) was measured by
spectrofluorimetry using safranin as fluorescent probe [44]. The wavelengths for excitation and
emission were 520 and 580 nm, respectively. Energization was achieved by addition of 50 μM
succinate plus 2 μM rotenone and the full de-energization was achieved by the addition of carbonyl
cyanide-4-(trifluoro-methoxy) phenylhydrazone (FCCP; 10 μM).
The activity of NADH dehydrogenase in disrupted mitochondria was estimated by
spectrophotometry at 420 nm using potassium ferricyanide as the electron acceptor and the results
were calculated using the molar extinction coefficient (ε) of 1.04 × 103 M−1 cm−1 [45].
The ATPase activity was measured in intact (coupled and uncoupled) and disrupted mitochondria
as previously described [46]. Briefly, intact mitochondria were incubated in a medium (0.5 mL)
containing 50 mM KCl, 0.2 M sucrose, and 10 mM Tris–HCl (pH 7.4) plus 0.2 mM EGTA and 5.0 mM
ATP for 20 min, at 37 ◦C. The reaction was initiated by the addition of ATP and stopped with 5%
trichloroacetic acid. The ATPase activity was quantified by measuring inorganic phosphate release
from ATP.
The activity of succinate dehydrogenase was measured by spectrophotometry (500 nm) in a
medium containing 100 mM triethanolamine (pH 8.3), 0.5 mM EDTA, 2 mM KCN, 6.5 μM phenazine
methosulfate, 0.6 mM iodonitrotetrazolium, and aliquots of disrupted mitochondria [40]. The reaction
was initiated with the addition of 10 mM succinate. Values were calculated using the molar extinction
coefficient (ε) of reduced iodonitrotetrazolium (1.93 × 104 M−1 cm−1).
The activity of malate dehydrogenase was assayed by spectrophotometry at 340 nm in a medium
(1.5 mL) containing 120 mM phosphate buffer (pH 7.8), 0.25 mM NADH, and aliquots of the supernatant
obtained after centrifuging disrupted mitochondria at 10,000g. The reaction was started by the addition
of 0.1 mM oxaloacetate [47]. Values were calculated using the molar extinction coefficient (ε) of NADH
(6.22 × 103 M−1 cm−1).
The activity of the NADP+-dependent isocitrate dehydrogenase was assayed in a reaction medium
(1 mL) containing 0.1 M TRIS (pH 7.4), 2 mM MgCl2, 2 mM NADP+, and aliquots of the supernatant [48].
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The reaction was started by the addition of 1.25 mM isocitrate and the increase in absorbance was
monitored at 340 nm (ε = 6.22 × 103 M−1 cm−1).
The activity of L-glutamate dehydrogenase was measured in a reaction medium (1 mL) containing
50 mM triethanolamine (pH 8.0), 0.1 M ammonium sulfate, 95 μM NADH, 2.5 mM EDTA, 1 mM
ADP, and aliquots of the supernatant described above [49]. The reaction was started by addition of
α-ketoglutarate (8.0 mM) and the decrease in absorbance was monitored at 340 nm.
The activity of α-ketoglutarate dehydrogenase was measured in a medium containing 100 mM
phosphate buffer (pH 7.4), 2 mM NAD+, 0.2 mM thiamine pyrophosphate, 1 mM MgCl2, 0.1%
Triton X-100, 0.3 mM dithiothreitol, 10 mM α-ketoglutarate and aliquots of disrupted mitochondria
suspensions [40]. The reaction was initiated by the addition of coenzyme A (0.2 mM) and monitored
spectrophotometrically as the reduction of NAD+ at 340 nm (ε = 6.22 × 103 M−1 cm−1).
2.7. Brain Hexokinase (HK) Activity
Fresh brains were homogenized in medium containing 200 mM mannitol, 76 mM sucrose, 1 mM
EGTA, 0.1 mM PMSF and 10 mM TRIS (pH 7.4). The homogenate was centrifuged at 650g for 8 min.
The activity of the hexokinase (HK) in the cytosol was measured using the liquid fraction obtained by an
additional centrifugation of the brain homogenate supernatant (40 min at 29,000g) [50]. This procedure
precipitates the mitochondria and other cell components. The incubation medium contained in a final
volume of 1 mL: 100 mM Tris-HCl (pH 7.2), 20 mM glucose, 2 mM ATP, 10 mM MgCl2, 1.5 mM NAD+,
5 units of glucose 6-phosphate dehydrogenase from Leuconostoc mesenteroides and 50 μL of high speed
centrifugation supernatant. The reaction was monitored spectrophotometrically at 340 nm (ε = 6.22 ×
103 M−1 cm−1).
2.8. Statistical Analysis
Statistical analysis was done using the GraphPad Prism Software (version 5.0).
Statistical significance was inferred from ANOVA one-way with Newman–Keuls post-hoc testing.
The 5% level of significance was adopted (p < 0.05).
3. Results
3.1. Indicators of Inflammation and Oxidative Stress
The results of the measurements of indicators of inflammation and oxidative stress in the brain of
the various groups of experimental animals are shown in Figure 1. Figure 1a,b illustrates the effects
of arthritis and the MeJA and ibuprofen treatments on the myeloperoxidase (MPO) activity and the
nitrite plus nitrate levels. The latter are indicators for the NO production. The MeJA treatment did not
affect the MPO activity in healthy rats. In arthritic rats, however, in which the activity of MPO was
increased 2.5-fold, the MeJA treatment caused progressive diminutions as the doses were increased.
At the highest dose (300 mg/kg) the MPO activity was close to the activity in the control animals and in
the rats treated with ibuprofen. The levels of nitrite plus nitrate were increased approximately 1.4-fold
in the brain of arthritic rats. Here again the MeJA treatment did not modify these levels in control
rats. In arthritic rats both the MeJA and the ibuprofen treatments diminished the elevated nitrite plus
nitrate levels. For the MeJA dose of 300 mg/kg the nitrite plus nitrate levels were very close to those
observed in control rats or in ibuprofen-treated rats.
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Figure 1. Effects of the methyl jasmonate (MeJA) treatment on parameters of inflammation and oxidative
stress in the brain. The activity of (a) myeloperoxidase (MPO); and (b) the levels of nitrite plus nitrate;
(c) protein carbonyl groups; (d) thiobarbituric acid reactive substances (TBARS); and (e) reactive oxygen
species (ROS) were measured as described in Materials and Methods. C, controls treated with corn oil; C300,
controls treated with 300 mg/kg MeJA; A, arthritic rats treated with corn oil; A75, A150 and A300, arthritic
rats treated with 75, 150 and 300 mg/kg MeJA, respectively; AIBU, arthritic rats treated with 30 mg/kg
ibuprofen. Data are the means± standard errors of the mean of five animals for each experimental condition.
Statistical analysis: ANOVA one-way with Newman–Keuls post-hoc testing. * p < 0.05, different from the
controls (C); #p < 0.05, different from non-treated arthritic rats (A).
Figure 1c–e shows the levels of protein carbonyls, lipid peroxides (TBARS) and reactive oxygen
species (ROS) that were found in the brain of arthritic and control rats and the effects of MeJA and
ibuprofen treatments. The levels of carbonyl groups and TBARS were increased 1.7- and 2.2-fold,
respectively, in the brain of arthritic rats. No modifications were found when MeJA was given to healthy
rats. In arthritic rats the MeJA doses of 75 and 150 mg/kg were also ineffective in modifying the protein
carbonyls and TBARS levels. Actually, there was even a small tendency toward higher values, though
lacking statistical significance. Treatment with 300 mg/kg MeJA, however, produced clear decreases
in the levels of carbonyl groups and TBARS to values close to the control ones. The levels of ROS
were increased 1.4-fold in the brain of arthritic rats. The MeJA treatment of control rats was without
effect. Here again the lower MeJA doses were ineffective and only the 300 mg/kg dose produced a
significant and pronounced decrease to a value close to that of the control condition. Treatment of
arthritic animals with ibuprofen did not improve any of the oxidative stress indicators.
3.2. GSH Levels
Figure 2 shows the levels of reduced glutathione (GSH) and the GSH/GSSG ratio. The levels of
GSH and the GSH/GSSG ratio were 35% and 70% lower, respectively, in the brain of arthritic animals.
The level of GSSG was not modified by arthritis, but it was slightly increased in rats treated with
75 and 150 mg/kg MeJA and ibuprofen (not shown). Treatment of arthritic rats with 300 mg/kg MeJA,
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but not with ibuprofen, increased the level of GSH to a value close to the control one. In consequence,
an almost similar increase in the GSH/GSSG ratio was also found at the 300 mg/kg dose, although a
decreasing tendency was apparent at lower doses.
Figure 2. Effects of the MeJA treatment on (a) glutathione (GSH) levels and (b) GSH/ oxidized
glutathione (GSSG) ratios. Symbols are those defined in Figure 1. Data are the means ± standard errors
of the means of five animals for each experimental condition. Statistical analysis: ANOVA one-way
with Newman–Keuls post-hoc testing. *p < 0.05, different from the controls (C); #p < 0.05, different
from non-treated arthritic rats (A).
3.3. Mitochondrial ROS Generation and Membrane Potential
In isolated respiring rat liver mitochondria, it has been found that MeJA increases net ROS
generation [9]. For this reason, experiments were done in which the action of MeJA treatment on ROS
generation by brain mitochondria was measured. Figure 3a shows the results obtained when brain
mitochondria isolated from rats under various conditions were incubated in a medium containing
succinate as the electron donor. ROS generation was measured as the fluorescence increase due to
the formation of the indicator DCF. In mitochondria from arthritic rats, ROS generation was clearly
increased by a factor of 1.36. Treatment with MeJA did not reverse this modification although there was
some tendency in this direction. There was also a small tendency toward increasing ROS generation
in mitochondria from healthy rats treated with MeJA. ROS generation is a dynamic variable which
could be dependent on the continuous presence of MeJA. Since the latter is no longer present in
mitochondria from treated rats, attempts were made at investigating the short term effects of the
compound. The results shown in Figure 3a represent the possible reversible and short-term effects
of MeJA on ROS generation in isolated mitochondria from healthy and arthritic rats in the range of
up to 10 mM. They show that the compound increased ROS generation in brain mitochondria from
both healthy and arthritic rats. The increments relative to the starting conditions were similar for
both healthy and arthritic conditions in the range up to 1.25 mM. After this concentration there was a
declining tendency, more pronounced in mitochondria from healthy rats.
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Figure 3. Effects of MeJA on ROS production and membrane potential in brain mitochondria from
healthy and arthritic rats. (a) ROS production in mitochondria isolated from healthy and arthritic rats,
treated or not with different MeJA doses (C, controls; C300, controls treated with 300 mg/kg MeJA; A,
arthritic rats; A75, A150 and A300, arthritic rats treated with 75, 150 and 300 mg/kg MeJA, respectively).
(b) ROS production by brain mitochondria isolated from healthy and arthritic rats and incubated with
varying concentrations of MeJA. (c) Membrane potential (ΔΨm) of brain mitochondria isolated from
healthy and arthritic rats, treated or not with different MeJA doses. (d) Membrane potential (ΔΨm) of
brain mitochondria isolated from healthy and arthritic rats and incubated with varying concentrations
of MeJA. Data are the means ± standard errors of the mean of five animals for each experimental
condition. Statistical analysis: ANOVA one-way with Newman–Keuls post-hoc testing. *p < 0.05,
different from the corresponding controls.
It is generally accepted that ROS generation in mitochondria shows a positive correlation with
the membrane potential [51]. The measurements illustrated by Figure 3c,d were done in order the
explore this relationship in terms of the effects of arthritis and MeJa. As described in the Materials
and Methods section, energization was achieved by the addition of succinate, the same substrate used
in the experiments in which ROS generation was measured. Figure 3c reveals a clearly increased
membrane energization in mitochondria from arthritic rats. This correlates nicely with the increased
rates of ROS generation shown in Figure 3a. The effects of MeJA treatment, however, are unclear, as no
statistically significant modifications were detected even though there is a general tendency toward
a lower energization. When mitochondria isolated from control and arthritic rats were incubated
with varying MeJA concentrations in the range of up to 10 mM in order to explore possible reversible
actions (Figure 3d), only minimal modifications were observed. These were restricted to the control
rats, in which there was a small increment at high MeJA concentrations.
3.4. Antioxidant and Prooxidant Enzyme Activities
Figure 4a,b shows the influence of arthritis and the subsequent MeJA treatment on the activities of
the antioxidant enzymes catalase (CAT) and superoxide dismutase (SOD). The CAT and SOD activities
were 25% and 40% lower, respectively, in the brain of arthritic rats. Treatment with 150 and 300 mg/kg
MeJA or ibuprofen increased the catalase activity to values close to the control ones. Treatment of
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arthritic rats with 75, 150 and 300 mg/kg MeJA, but not with ibuprofen, increased the SOD activity to
values close to the control ones.
Figure 4. Effects of MeJA treatment on enzymes linked to the oxidative homeostasis. (a) Catalase;
(b) superoxide dismutase; (c) total xanthine oxidase; (d) mitochondrial xanthine oxidase. Abbreviations:
C, controls; C300, controls treated with 300 mg/kg MeJA; A, arthritic rats; A75, A150 and A300, arthritic
rats treated with 75, 150 and 300 mg/kg MeJA, respectively; AIBU, arthritic rats treated with 30 mg/kg
ibuprofen. Data are the means ± standard errors of the mean of five animals for each experimental
condition. Statistical analysis: ANOVA one-way with Newman–Keuls post-hoc testing. *p < 0.05,
different from the controls (C); # p < 0.05, different from non-treated arthritic rats (A).
Figure 4c,d illustrates the actions of arthritis and MeJA on the activity of xanthine oxidase (XO),
which can be considered a prooxidant enzyme whose activity is usually recognized as an important
source of reactive oxygen species in the brain [26]. In the brain homogenate from arthritic rats the
activity of XO was increased 1.4-fold. The treatment with 300 mg/kg MeJA almost abolished this
increase. The activity of XO was also increased 1.4-fold in isolated brain mitochondria of arthritic
rats. In this case the treatment of arthritic rats with MeJA showed a well-defined dose-dependent
diminution to values close to the control ones.
3.5. Mitochondrial Enzymes Linked to Oxidative Metabolism
Several mitochondrial enzymes linked to oxidative metabolism were assayed with the purpose of
searching for possible modifications in energy metabolism and in reactions leading to the production
of NADPH for feeding the glutathione cycle with reducing equivalents. To the latter category belong
L-glutamate dehydrogenase (which also operates with NADP+) and the NADP+-dependent isocitrate
dehydrogenase. The activity of the first one was not modified by arthritis or by the subsequent MeJA
treatment (not shown). The NADP+-dependent isocitrate dehydrogenase, however, was diminished
in arthritic rats by 23%, as shown in Figure 5a. The MeJA treatment increased this enzyme in both
healthy and arthritic rats. In the latter, this effect led to a complete prevention of the diminution caused
by arthritis.
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Figure 5. Effects of MeJA treatment on selected mitochondrial enzyme activities. (a) Succinate
dehydrogenase; (b) isocitrate dehydrogenase; (c) L-malate dehydrogenase; (d) NADH dehydrogenase.
Abbreviations: C, controls; C300, controls treated with 300 mg/kg MeJA; A, arthritic rats; A75, A150 and
A300, arthritic rats treated with 75, 150 and 300 mg/kg MeJA, respectively; AIBU, arthritic rats treated
with 30 mg/kg ibuprofen. Data are the means ± standard errors of the mean of five animals for each
experimental condition. Statistical analysis: ANOVA one-way with Newman–Keuls post-hoc testing.
* p < 0.05, different from the controls (C); # p < 0.05, different from non-treated arthritic rats (A).
The other enzymatic activities linked to oxidative metabolism that were measured were ATPase,
α-ketoglutarate dehydrogenase, L-malate dehydrogenase, succinate dehydrogenase and NADH-
dehydrogenase. No modifications by arthritis or MeJA treatment were found for the first two.
The other three, however, suffered modifications. Succinate dehydrogenase was increased by a factor
of 1.8 in arthritic rats; almost the same increment was caused by the MeJA treatment of healthy rats.
The latter effect was apparently maintained in arthritic rats in which the already higher activity was
further increased by the MeJA treatment. For the 300 mg/kg dose this led to an increase of 2.76-fold
when compared to the healthy controls. The activities of the other two enzymes were diminished
by arthritis. The L-malate dehydrogenase activity was diminished by 30%. Although the MeJA
treatment of healthy rats produced an increase in the L-malate dehydrogenase activity, this effect
was not prominent enough in arthritic rats so as to conduct to a significant recovery. The diminution
of NADH dehydrogenase caused by arthritis amounted to 31%. The treatment of healthy rats with
300 mg/kg MeJA did not produce modifications. However, the same treatment of arthritic rats almost
completely prevented the diminution of the NADH-dehydrogenase activity.
3.6. Hexokinase Activity
The liver of arthritic rats presents a considerably increased glucose phosphorylation capacity [30],
which is diminished when the rats are treated with MeJA [9]. For these reasons and because glucose
oxidation may be related to the oxidative state of the brain tissue, experiments were done in which
the influence of arthritis and MeJA on the hexokinase activity was investigated. Figure 6 illustrates
the results that were obtained. Figure 6a shows the measurements of the hexokinase activity in the
cytosolic fraction of brains from healthy and arthritic rats, treated or not with the current different
MeJA doses. Arthritis had no significant effect on the hexokinase activity present in the cytosolic
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fraction. The MeJA treatment, on the other hand, increased the hexokinase activity in the cytosolic
fraction obtained from healthy rats. A similar effect was found in arthritic rats treated with MeJA, with
a maximal effect at the dose of 300 mg/kg.
Figure 6. Effects of MeJA treatment on hexokinase activity. (a) Hexokinase activities in the cytosolic
fraction of brains from healthy and arthritic rats, treated or not with different MeJA doses (C, controls;
C300, controls treated with 300 mg/kg MeJA; A, arthritic rats; A75, A150 and A300, arthritic rats treated
with 75, 150 and 300 mg/kg MeJA, respectively). (b) Hexokinase activities in the cytosolic fraction of
brains from healthy and arthritic rats incubated with various MeJA concentrations with or without
previous centrifugation to eliminate mitochondria and other cell components. Data are the means
± standard errors of the mean of five animals for each experimental condition. Statistical analysis:
ANOVA one-way with Newman–Keuls post-hoc testing; *p < 0.05, different from the corresponding
controls (C); #p < 0.05, different from non-treated arthritic rats (A).
In brain cells the hexokinase is attached to the mitochondrial membrane and it is known that
MeJA is able to detach the enzyme [5]. Since mitochondria were absent in the cytosolic fraction used
for the hexokinase assay, the possibility exists that the higher hexokinase activities found in the brain of
MeJA-treated animals can actually represent detached enzyme due to the continuous presence of MeJA
in the tissue. To investigate this possibility the series of experiments shown in Figure 6b were done.
MeJA was added at varying concentrations to the low-speed centrifugation supernatant of the brain
homogenate either before or after the high-speed centrifugation for precipitating the mitochondria
and other cell components. The time of exposure to MeJA was in all cases 30 min. The hexokinase
activity in the cytosolic fractions was represented against the MeJA concentrations. Up to the MeJA
concentration of 2.5 mM, precipitation of the mitochondria did not modify the activity of hexokinase
found in the cytosolic fraction, although a small increasing tendency was found for both types of
incubations. Above this concentration, however, the hexokinase activity continued to increase with
the MeJA concentration in those preparations in which the mitochondria were still present when
the compound was added. In the preparations in which the mitochondria had been precipitated
previous to the addition of MeJA, the hexokinase activity ceased to increase. The enhancement of the
activity when the incubation containing mitochondria was used probably reflects the detachment of
the hexokinase bound to the organelles caused by MeJA. The detached hexokinase, shown in Figure 6b,
calculated as the difference between incubations with and without mitochondria, was similar for the
healthy and arthritic condition.
4. Discussion
The actions of MeJA in the brain of arthritic rats clearly point in the direction of a diminution
of both inflammation and oxidative stress. The modifications that MeJA caused, however, were
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multivariate and complex, and frequently not restricted to the arthritic rat. The scheme in Figure 7
offers an overview of the actions of MeJA in the brain cells in opposition to the modifications induced by
arthritis, which should be a helpful guide in the discussion that follows. The scheme in Figure 7 assumes
that MeJA easily crosses biological membranes including the blood brain barrier, as demonstrated
experimentally and indeed expected from a lipid soluble substance [3,52]. The black arrows refer
mainly to the modifications caused by arthritis whereas the red dotted arrows indicate the main sites of
action of MeJA. In the brain, the increased oxidative stress induced by arthritis has been attributed to
both an increased production of ROS and an impaired ROS scavenging system [26]. In fact, previous
reports and the results of this study show that the activity of XO and mitochondrial ROS production
are increased in the arthritic condition, while the GSH levels and the activity of superoxide dismutase
and catalase are reduced in the brain [26,53]. This imbalance between pro- and antioxidant systems
results in higher levels of ROS, protein oxidation and lipoperoxides in the arthritic brain.
Figure 7. Events modifying inflammation and the oxidative state in the brain of rats with
adjuvant-induced arthritis and the actions of methyl jasmonate (MeJA). The scheme is based mainly
on the results of the present study and literature data. The symbol ⇑ means up-regulation and ⇓
means down-regulation. Black arrows indicate events in the absence of MeJA and red arrows indicate
the effects of MeJA. Abbreviations: TNF-α, tumor necrosis factor alpha; IL-1β, interleukin 1 β; GSH,
reduced glutathione; GSSG, oxidized glutathione; ROS, reactive oxygen species; NO, nitric oxide;
HK, hexokinase; SOD, superoxide dismutase; CAT, catalase; IDH, isocitrate dehydrogenase; MDH,
malate dehydrogenase; KDH, alpha-ketoglutarate dehydrogenase; SDH, succinate dehydrogenase; XO,
xanthine oxidase; Δψm, mitochondrial membrane potential; VDAC: voltage-dependent anion channel.
In the present study the indicators of inflammation in the brain of arthritic rats that were
measured are the activity of MPO and the level of nitrite plus nitrate as an indicator of the NO
concentration. The MPO activity has been considered as one of the best inflammatory and oxidative
stress markers for several inflammatory diseases [54]. The nitrite (NO2−) plus nitrate (NO3−) levels,
on the other hand, are an index of NO production and indirectly also of the inflammatory cytokines.
Inflammatory cytokines stimulate glial cells to produce nitric oxide (NO) by the inducible NO synthase
(iNOS) in the brain [55,56]. Both the activity of MPO and the nitrite plus nitrate levels, appeared
substantially increased in arthritic rats and both were reduced to the control levels by the MeJA
treatment at the doses of 150 and 300 mg/kg. These effects were similar to ibuprofen (30 mg/kg),
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an anti-inflammatory agent currently used to attenuate the symptoms of rheumatoid arthritis. This is
consistent with a previous study showing that orally administered MeJA improves the systemic and
articular inflammation in rats with adjuvant-induced arthritis [9]. The mechanism by which MeJA
decreases inflammation is not yet sufficiently known, but it has been reported that it influences the
activation of nuclear factor kappa B (NF-κB). Experiments have shown that MeJA attenuates the
LPS-induced activation of NF-κB in RAW267.4 cells and reduces the expression of NF-κB in the brain
of mice with LPS-induced neuroinflammation [7,27]. In the latter, intraperitoneally administered
MeJA additionally inhibits the production of IL-1β, IL-6, TNFα and prostaglandin E, possibly by glial
cells, as illustrated by Figure 7. It also downregulates the expression of iNOS and COX-2 in the brain.
These results were recently corroborated by the observation that MeJA reduces the levels of TNF-α
and IL-6 and nitrite in the brain of mice with neuroinflammation induced by rotenone, a phenomenon
that is also likely to be related to the downregulation of the NF-κB expression [57]. In addition, in mice,
MeJA improves the memory dysfunction associated with the neuroinflammation [27]. The effective
doses of MeJA in the present study, i.e., 150 and 300 mg/kg, may be relatively high for clinical purposes,
but it must be stressed that they have been associated to a notable absence of toxicity [3,9,32].
Comparison of the dose dependences of the decreases in the inflammatory indicators (MPO and
nitrite plus nitrate), on one side, with the dose dependences of the decreases in the oxidative stress
indicators (protein carbonyls, TBARS and ROS), on the other side, reveals that there was a dose shift
toward higher ones in the latter actions (see Figure 1). Diminution of oxidative stress occurred only at
the highest dose. At the lowest doses there was even an increasing tendency of the oxidative stress
indicators. This may bear relation to the fact that MeJA actually exerts a dual role, i.e., although it
certainly acts as an antioxidant agent, it can also be regarded as a prooxidant agent in spite of its
anti-inflammatory action. The prooxidant action is exerted in the respiratory chain. The latter is an
important source of reactive oxygen species [58] and our experimental data show that the compound
increases ROS output in respiring brain mitochondria in accordance to previous observations in rat
liver mitochondria [9]. This effect depends on the presence of MeJA as it was not preserved when
the mitochondria were isolated from the brain tissue of treated rats. Furthermore, this action was
not different in healthy and arthritic rats. It is unlikely that the phenomenon bears relation to the
membrane potential, as MeJA did not modify this parameter. Its mechanism remains to be clarified.
The net diminution in oxidative stress caused by MeJA derives, thus, from its effects on ROS
generation systems other than the mitochondrial electron transport chain or from its role as an enhancer
of the antioxidant defenses. In the first category one may include ROS-producing enzymes whose
activity is increased by the inflammatory mediators of arthritis. One such enzyme, which is generally
considered an important source of ROS in the brain, namely xanthine oxidase, was analyzed in the
present work (see Figure 7). Xanthine oxidase, under specific circumstances, is able to generate H2O2,
superoxide anion and nitric oxide [26,59,60]. Its activity, which was substantially increased by arthritis,
was gradatively diminished to control values by MeJA, especially in the mitochondria. This may be
an important factor that helps to reduce the production of ROS in the mitochondria under in vivo
conditions. With respect to the antioxidant defenses, MeJA clearly restored the activity of both catalase
and superoxide dismutase. These actions can be attributed at least in part to an inhibition of the
production of proinflammatory cytokines (see Figure 7). MeJA also caused a recovery in the GSH levels
and in the GSH/GSSG ratio, corroborating the conclusion that the compound enhances the antioxidant
defenses. In this respect the increase in the activity of isocitrate dehydrogenase induced by MeJA may
play a significant role as the production of NADPH can occur directly via the action of this enzyme.
Consequently, preservation of the activity of the mitochondrial isocitrate dehydrogenase by the MeJA
treatment in arthritic rats is expected to contribute to the preservation of a high NADPH/NADP+
ratio. This, in turn, will contribute to an increased regeneration of GSH and reduction of the oxidative
stress via the glutathione system. Similar MeJA actions were also found in the liver of arthritic
rats [9], which were attributed to microRNA 101-mediated upregulation of the nuclear factor erythroid
2-related 2 (Nfr2), a redox-sensible transcription factor that upregulates antioxidant defense genes,
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including catalase and enzymes required for GSH synthesis and sources of NADPH like isocitrate
dehydrogenase [61–63].
In addition to isocitrate dehydrogenase, adjuvant-induced arthritis also modified the activities of
other respiratory enzymes, namely NADH dehydrogenase, L-malate dehydrogenase and succinate
dehydrogenase. This is in line with previous reports that inflammatory mediators and reactive oxygen
or nitrogen species may affect mitochondrial functions in brain cells and in human chondrocytes [64–67].
The MeJA treatment did not modify the diminished L-malate dehydrogenase activity, but it prevented
the diminished NADH dehydrogenase activity. Surprisingly the MeJA treatment further increased the
mitochondrial succinate dehydrogenase, which was possibly increased in arthritic rats by the action of
TNFα [63]. It is difficult to infer from the available data the consequences and significance of these
actions of MeJA for the mitochondrial functions.
In the brain, arthritis did not modify the hexokinase activity, contrary to what happens in the liver
where the activity of the analogous glucose phosphorylating enzyme (glucokinase) is substantially
increased, leading to augmented hepatic glycolysis [9]. In the brain the treatment with MeJA resulted
in an apparent increase in the hexokinase activity, a phenomenon that has already been described
for cancer and brain cells [5]. This apparent increase when the hexokinase is assayed in the cytosolic
fraction results from the detachment of the enzyme from the mitochondria. Although the phenomenon
was only detected at high concentrations in the present work after 30 min incubation, it is worth
mentioning that the phenomenon is time-dependent [5], which makes it a likely occurrence in animals
exposed to low doses during several days. The enzyme isoforms normally attached to the mitochondrial
membrane are types I and II. Type IV hexokinase (glucokinase), the isoform normally found in the
liver cells, is not attached to the mitochondrial membrane [5]. Our results suggest that detachment
of the hexokinase from the mitochondria in healthy and arthritic animals by MeJA was similar.
Consequently, the phenomenon should in principle not be considered as a mechanism capable of
having contributed to the antioxidant or prooxidant activities of MeJA. In cancer cells the detachment of
the hexokinase from the mitochondria is considered one of the main reasons for its cytotoxicity because
these cells depend heavily on the oxidation of glucose for survival and ATP for its phosphorylation
is more readily available at the surface of the mitochondria [68,69]. Detachment of the hexokinase
from the brain mitochondria by MeJA has not been considered neurotoxic however, probably because
the brain cells are less dependent on glycolysis for survival [5], even though a limited impairment of
glycolysis in the brain can be expected to occur.
The behavioral and cognitive changes induced by MeJA and reported by several authors require a
final set of comments. MeJA improves the cognitive dysfunction associated with neuro-inflammation.
It was reported that MeJA attenuates LPS-induced memory dysfunction via mechanisms involving
inhibition of pro-inflammatory mediators and beta-amyloid generation in mice [27]. In other
investigations the effects of MeJA were assessed in mice with memory impairment caused by
scopolamine and unpredictable chronic mild stress (UCMS) [28,29]. In these studies, MeJA affected
oxidative stress in the brain in a way that was similar to that found in the present study. In these
studies, MeJA was intraperitoneally administered at doses of up to 100 mg/kg and the oxidative status
improvement was associated with neuroprotection and reduced memory dysfunctions. This allows
to hypothesize that the antioxidant and anti-inflammatory properties of MeJA may also improve the
brain fatigue and cognitive function in patients with severe rheumatoid arthritis [12,24].
5. Conclusions
In conclusion, MeJA treatment decreased inflammation and oxidative stress in the brain of rats
with adjuvant-induced arthritis. The improvement of oxidative stress occurred in consequence of
reduced inflammation associated with increased antioxidant defenses. On the other hand, MeJA
induced the hexokinase (HK) detachment from the brain mitochondria of both healthy and arthritic rats
a phenomenon that can diminish glucose phosphorylation and metabolism in the brain. The effective
doses of MeJA were relatively high, but the results of the present study make this compound a potential
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precursor for developing anti-rheumatic and anti-inflammatory drugs. Finally, future investigations
may take into account the role of Nfr2 in the actions of MeJA and the perspective of modifications in
the metabolism of glucose in the brain tissue.
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Abstract: Sideritis perfoliata L. subsp. perfoliata is an endemic species of the Eastern Mediterranean
region with several uses in traditional medicine. The present study aims to explore the unknown
properties of S. perfoliata investigating the nutritional content as well as the antioxidant, anticancer,
antituberculosis, antiwrinkle, anti-acne, hyper/hypo-pigmentation and antibacterial activities. Mineral
content, nutritional value, the composition and antioxidant properties of the essential oil, the
antityrosinase, the antibacterial activity and anti-elastase potential of the extract, were evaluated. The
antiproliferative activity of S. perfoliata against cervical cancer (HeLa), human melanoma (UCT-Mel-1),
human hepatocellular carcinoma (HepG2) and human epidermoid carcinoma (A431) was investigated.
Cytotoxic effects on normal human keratinocyte (HaCat) and kidney epithelial (Vero) cell lines were
also determined. Sideritis perfoliata exhibited high nutritional value of proteins and minerals (K, P,
Mg, Fe, Zn, Cu). The most abundant components of the essential oil were found to be α-pinene,
β-phelladrene, valeranone, β-pinene and sabinene. The ethanolic extract of S. perfoliata displayed
moderate antioxidant potential and antibacterial activity against Prevotella intermedia. Noteworthy
elastase and moderate anticancer potential against the human liver cancer cell line (HepG2) was
observed with IC50 values of 57.18 ± 3.22 μg/mL and 64.27 ± 2.04 μg/mL respectively. The noteworthy
in vitro activity of S. perfoliata could be due to the presence of flavonoids and phenols in the leaves,
having high nutritional value. Sideritis perfoliata could potentially be useful to reduce the appearance
of wrinkles and for the treatment of liver cancer. The moderate antibacterial, antioxidant and elastase
activity of the plant can be linked to the traditional use of S. perfoliata for the treatment of wounds
and inflammation.
Keywords: Sideritis perfoliata; wrinkles; Cutibacterium acnes; antimycobacterial; melanin inhibition;
antioxidant capacity
1. Introduction
The genus Sideritis, belonging to the Lamiaceae (Labiatae) family, is comprised of more than 150
species. The genus is further divided in 2 subgenera and 7 sections [1]. The subgenus Sideritis divided
into four sections includes approximately 125 species, the majority of which are distributed in the
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Mediterranean [2]. The taxonomy of Sideritis species is highly intricate due to frequent hybridization
between species, the variation of ecotypes and the degree of polymorphism [3]. It is crucial to
distinguish the different Sideritis species and it is for this reason that secondary metabolites, in
particular diterpenoids and flavonoids, are used for the chemotaxonomic identification of species
within the genus [1]. However, modern methods such as high resolution melting analysis (HMR)
coupled with polymerase chain reaction (PCR) offer rapid detection of these species [3].
Sideritis perfoliata L. (subsp. perfoliata) belongs to section Empedoclea, and is distributed mainly
in Greece, Cyprus, Turkey and in other Balkan and East Mediterranean countries, where it grows
in the wild or is cultivated [4]. This perennial species has a woody base, opposite and entire leaves
(dentate or serrate) and is widely distributed in the Mediterranean Basin which is characterized by a
rich tradition in phytotherapy, dating back to ancient times [5]. The usage of Sideritis species in folklore
medicine has been known since the Dioskourides era (1st century) when the plant was used to treat
wounds from iron weapons like swords or knives. The name Sideritis comes from the word “sidero”
which means iron in Greek [1].
Plants of the Sideritis genus, commonly known in Cyprus, Greece and other Balkan countries
as “mountain tea”, are used as teas, for feeding and as flavoring agents. Sideritis species are used
extensively in European and Mediterranean countries as traditional medicines with anti-inflammatory,
antimicrobial, vulnerary, antioxidant, antispasmodic, analgesic, stomachic and carminative activities [1,
6,7]. Decoctions and infusions of S. perfoliata are widely used for the treatment of common cold, flu,
cough, gastrointestinal disorders such as dyspepsia and as a calmative agent [6,8]. Charami et al. [9]
reported the use of S. perfoliata for its antirheumatic, anti-ulcerative, digestive and vaso-protective
properties. Recently, botanical and pharmacological studies focusing on Sideritis, is likely due to the
above-mentioned properties which have been proven and have been attributed to the diverse chemical
profile of the genus, that is rich in flavonoids, terpenoids, coumarins, sterols and iridoids [1,7]. These
properties, the advances in technology and the current popularity and the use of natural products
for self-medication, and as dietary supplements, generates a growing interest in the pharmaceutical
industry to exploit plant-derived products to serve as discovery leads to new prototypes [10].
Medicinal and aromatic plants are enriched with antioxidants such as polyphenols, which act as
scavengers of free radicals by adsorbing and neutralizing reactive oxygen species (ROS), quenching
singlet and triplet oxygen or decomposing peroxides [9]. The Mediterranean Basin is characterized
by a rich tradition of phytotherapy dating back to ancient times, in addition to being home to the
majority of the Sideritis species. The aim of the current study was to explore the unknown properties of
S. perfoliata investigating nutritional, antioxidant, anticancer, antituberculosis, antiwrinkle, anti-acne,
hyper/hypo-pigmentation and antibacterial properties.
2. Materials and Methods
2.1. Plant Material and Growing Conditions
Sideritis perfoliata seedlings with 3–4 established leaves were purchased from the Cypriot National
Agricultural Department and grown using an organic farming cultivation protocol. Plants were grown
in a silt loam soil (6.76% clay, 39.2% sand and 54% silt) with organic matter of 3.02%, pH of 8.42,
Electrical Conductivity (EC) of 0.85 mS/cm, and CaCO3 of 21.23%, allowing the seedlings to grow
for 2.5 months. The plantation was fully irrigated with no pesticides or chemicals being applied
during the growing period. Weeds were removed manually or mechanically. Above ground (~5 cm)
plant material (~10 kg) including leaves, stems and flowers, was collected during spring at the early
flowering stage and raw material processed in the lab.
2.2. Mineral, Chlorophyll and Nutritional Content
The mineral content of the leaves was determined using six replicates (two plants pooled/replicate)
according to Chrysargyris et al. [11]. Dried plant material was ashed in a furnace (Carbolite, AAF 1100,
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GERO, Neuhausen, Germany) at 500 ◦C for 6 h and then acid digested using 2 M HCl. Determination
of Potassium (K), Calcium (Ca), Magnesium (Mg), Sodium (Na), Iron (Fe), Copper (Cu) and Zinc
(Zn) content was performed using atomic absorption spectrophotometry (PG Instruments AA500FG,
Leicestershire, UK) and Nitrogen (N) content was determined using the Kjeldahl method (BUCHI,
Digest automat K-439 and Distillation Kjelflex K-360). A colorimetric method using molybdate/vanadate
was used for the determination of Phosphorus (P) content [12].
Leaf chlorophylls were extracted with 10 mL dimethyl sulfoxide (DMSO) at 65 ◦C for 30 min. The
photosynthetic leaf pigments, Chlorophyll a (Chl a), Chlorophyll b (Chl b) and total Chlorophyll (t-Chl)
content were then calculated [13].
The nutritional value of S. perfoliata was assessed by determining moisture, protein, fat,
carbohydrate and ash composition, following AOAC procedures [14]. Briefly, nutrient content
was determined by using the macro-Kjeldahl (N × 6.25), petroleum ether Soxhlet extraction, and
incineration (600 ◦C) methods for protein, fat and moisture, respectively. The carbohydrate content























The results were expressed in g/100 g d. w.
2.3. Ethanolic Extract Preparation
Aerial parts (leaves and stems/shoots) of S. perfoliata were air dried at 42 ◦C in an oven and then
milled to a fine powder. The plant material was then macerated with pure ethanol (1:2.5 v/v) in a
shaking incubator at 160 rpm, in glass bottles. After 72 h of shaking, the material was filtered using
filter paper (Whatman No. 1, Merck, Darmstadt, Germany). The remaining ethanol was removed
using a rotary evaporation unit, until complete dryness.
2.4. Phytochemical Analysis of the Ethanolic Extract
The phytochemicals present in the ethanolic extract of S. perfoliata were determined using the
methods described by Mushtaq et al. [15] with minor changes. The stock solutions (1 mg/mL in dH2O)
of the ethanolic extract of S. perfoliata were used to determine the presence of tannins, saponins and
terpenes. The formation of a yellow brown precipitate after the addition of 2 mL of 5% FeCl3 in dH2O,
indicated the presence of tannins. The presence of saponins was determined by vigorously shaking the
stock solution and observing a stable persistent froth. The development of a reddish-brown interface
after the addition of 5 mL CHCl3, 2 mL acetic anhydride, and a few drops of concentrated H2SO4 to 2
mL of the stock solution, indicated the presence of terpenes.
Stock solutions of the ethanolic extract of S. perfoliata (1 mg/mL in methanol) were prepared to
determine the presence of alkaloids, cardiac glycosides, flavonoids and phenolics. The presence of
alkaloids was determined by first adding 1.5 mL of 1% HCl to 2 mL of the stock solution and heating
the mixture in a water bath set at 90 ◦C. Following the incubation, 6 drops of Dragendroff’s reagent
were added and a formation of an orange precipitate was indicative of the presence of alkaloids. The
presence of cardiac glycosides was determined by adding 1 mL glacial acetic acid and 1–2 drops of
FeCl3, followed by the addition of 1 mL of concentrated H2SO4 to 2 mL of the ethanolic stock solution.
The formation of a brown ring at the interface indicated the presence of a deoxysugar, characteristic of
cardenolides. The presence of flavonoids was determined by observing the presence of a pink color
after adding a few drops of concentrated HCl followed by small pieces of magnesium turnings. The
presence of phenolics, on the other hand was indicated by the presence of a blue or green color, after
the addition of 1 mL of 1% ferric chloride solution to the stock solution.
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2.5. Antioxidant Activity of the Ethanolic Extract
The nitric oxide (NO) scavenging activity of the extract was measured according to the method
described by Mayur et al. [16]. In the wells of a 96-well microtiter plate, the ethanolic extract of S.
perfoliata was allowed to react with an equal volume of sodium nitroprusside (10 mM) for 90 min at
room temperature. To the wells of the test sample, 100 μL of Griess reagent was added and to the blank
color control wells, dH2O was added. The final concentration of the extract ranged from 15.6 to 2000
μg/mL and. L-ascorbic acid was used as the positive control. The nitrite content was measured after 5
min at 546 nm and the percentage scavenging activity was determined.
To determine the DPPH scavenging activity 20 μL of extract, L-ascorbic acid (positive
control) and 100% ethanol (negative control) were allowed to react with 90 μL of 90 μM DPPH
(2,2-Diphenyl-1-picrylhydrazyl) methanolic solution in a 96-well microtiter plate. To the blank extract
color control wells, DPPH was substituted with dH2O. The final concentrations of the sample and
L-ascorbic acid ranged from 7.8 to 500 μg/mL and 1.6 to 100 μg/mL respectively. The plate was
incubated for 30 min in the dark and the absorbance measured at 515 nm using a BIO-TEK Power
Wave Multiwell plate reader (Analytical and Diagnostic Products, Weltevreden Park, South Africa).
The total antioxidant capacity was assayed by the phosphomolybdenum (PM) method [17].The
extract and gallic acid were prepared to stock solutions of 5 mg/mL. In test tubes, solutions of 0.3
mL of the samples were added to 1 mL of 0.6 M sulphuric acid (H2SO4), 1 mL of 4 mM ammonium
molybdate and 1 mL of 28 mM sodium phosphate (total of 3 mL reagent). The blank was prepared by
adding 0.3 mL of methanol instead of the extract. The test tubes were incubated at 95 ◦C for 90 min.
Absorbance was measured at 695 nm. The fifty percent inhibitory concentration (IC50) concentration
was calculated for each of the antioxidant assays.
2.6. Antiwrinkle, Hyper/Hypo-Pigmentation, Anti-Acne, Antimycobacterial Activity of the Ethanolic Extract
2.6.1. Elastase Inhibition
The antiwrinkle potential of the S. perfoliata was tested using the elastase inhibition assay as
described by Aumeeruddy et al. [18]. The reaction mixture contained 100 mM Tris buffer (pH 8.0),
0.5 M HCl and the ethanolic extract of S. perfoliata. The test concentration ranged between 3.13 and
250 μg/mL for the extract and the positive control (ursolic acid). Porcine pancreatic elastase (PPE)
(5 mM, 0.02 mL) was added to the reaction mixture and incubated for 15 min at 37 ◦C followed by
the addition of the substrate, 4 mM N-succinyl-(Ala)3-p-nitroanilide. The change in the absorbance
of the reaction mixture was measured kinetically at 405 nm for 15 min at 37 ◦C using KC Junior
software and a BIO-TEK Power-Wave XS multiwell plate reader (A.D.P, Weltevreden Park, South
Africa). One unit of elastolytic activity is defined as the release of 1 μM of p-nitroaniline/min from
N-succinyl-(Ala)3-p-nitroanilide. The IC50 value of S. perfoliata was calculated.
2.6.2. Tyrosinase Inhibition
The tyrosinase assay was conducted according to the method described by Curto et al. [19] with
slight modifications. The enzymatic rate of mushroom tyrosinase (Sigma-Aldrich Co. LLC, St. Louis,
MO, USA) was evaluated spectrophotometrically. In a 96-well plate, 70 μL of the stock solution (600
μg/mL in 0.38 mM DMSO and pH 6.5 potassium phosphate buffer) was combined with 30 μL of
tyrosinase (333 Units/mL in potassium phosphate buffer) and incubated for 5 min at room temperature.
Following incubation, 110 μL substrate (2 mM L-tyrosine) was added to each well. Final concentrations
of the test sample and the positive control, kojic acid (Sigma-Aldrich Co. LLC, St. Louis, MO, USA),
ranged between 1.5 and 200 μg/mL. The negative control consisted of 0.01% DMSO in potassium
phosphate buffer. The rate of tyrosinase was determined for the sample (Abssample), positive control
(Abspositive) and the negative control wells (Abscontrol), by measuring the absorbance over a period of
30 min at 492 nm using the BIO-TEK Power-Wave XS multi-well plate reader (A.D.P., Weltevreden
394
Antioxidants 2019, 8, 521
Park, RSA). The percentage tyrosinase inhibition for the sample was calculated as follows and the IC50
value was then calculated.







The effect of the ethanolic extract of S. perfoliata on melanin production in UCT-MEL-1 cells was
determined as described by Matsuda et al. [20]. Following culturing, as described in Section 2.7.1, the
cells were plated in 96-well plates and incubated for 24 h at 37 ◦C in the CO2 incubator. Stock solutions
of the ethanolic extract of S. perfoliata and kojic acid (400 μg/mL), were prepared in 1.25% DMSO in
phosphate buffered saline (PBS). The stock solutions were serial diluted in Dulbecco’s Modified Eagle’s
Medium (DMEM) and added to the 96-well plates, such that the final concentrations in the plates
ranged between 6.25 and 200 μg/mL and the final concentration of DMSO present was 0.6%. The
treated cells were incubated for 24 h at 37 ◦C in the CO2 incubator. Colour controls, without cells, were
prepared in the same manner. An untreated cell control was also included where media was used
instead of the sample. Following incubation, the supernatant was removed, combined with HEPES
buffer (0.4 M, pH 6.8) at a 1:1 ratio and assayed for extracellular melanin at 475 nm. The attached cells
were washed with 100 mL of PBS and lysed following the addition of 40 μL of 1 M NaOH and 10 μL
trypsin, for 16 h at room temperature. The optical density of the intracellular melanin was measured at
475 nm.
2.6.4. Antimycobacterial Activity
The antimycobacterial activity of the extract was assessed using the microtiter Alamar blue
assay [21]. Briefly, Mycobacterium smegmatis (MC2 155) was cultured and maintained on 7H11 agar
plates. A single colony was transferred into fresh 7H9 media supplemented with 2% glycerol and 0.5%
Tween 80 and allowed to grow for 24 h at 37 ◦C. The bacterial inoculum was prepared by adjusting the
24 h logarithmic culture to a concentration of 1.5× 106 CFU/mL. The extract was tested at concentrations
ranging from 15.6 to 1000 μg/mL. Ciprofloxacin (0.08–5 μg/mL) was used as the positive control and a
solvent (2.5% DMSO), untreated bacterial and negative control were included in the assay. The final
assay volume was 200 μL. The plates were covered and incubated at 37 ◦C for 18–24 h, followed by the
addition of 20 μL of Alamar blue solution. The plates were left to incubate for an additional 30 min
and the Minimum Inhibitory Concentration (MIC) was determined as the lowest concentration where
no color change could be observed from blue to pink.
2.6.5. Antibacterial Activity against Cutibacterium Acnes
Susceptibility of the Cutibacterium acnes bacteria (ATCC 6919) was tested using the microdilution
broth assay as described by Lall et al. [21]. Briefly, 0.1 mL of extract (2 mg/mL) and tetracycline
(0.2 mg/mL) were serially diluted in 100 μL of Brain Heart Infusion (BHI) broth in a 96-well plate.
Concentrations of plant extract ranged from 3.91 to 500 μg/mL, while the positive control, tetracycline
was tested from 0.39 to 50 μg/mL. Cultures of C. acnes grown for 72 h at 37 ◦C on BHI agar supplemented
with 1% glucose were inoculated in BHI broth at a concentration of 1.5 × 108 CFU/mL (OD600 = 0.132).
One hundred microlitres of the bacterial suspension was then added to the relevant test wells. The
96-well plates were then incubated at 37 ◦C for 72 h in an Anaerocult® jar with Anaerocult® A (Merck,
Darmstadt, Germany) for the generation of CO2. Control plates were included and consisted of C.
acnes without treatment, an extract vehicle DMSO treatment (2.5% v/v) and a BHI media control. After
72 h, 0.02 mL of PrestoBlue® (LTC Tech (Pty) Ltd., Johannesburg, South Africa) reagent was added.
The MIC was then determined after 1 h of incubation.
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2.6.6. Antibacterial Activity against P. Intermedia and S. Mutans
The antibacterial activity was determined using the microtiter plate assay, where the MIC was
calculated; against Streptococcus mutans (ATCC 25175) and Prevotella intermedia (ATCC 25611). In short,
a 96-well plate was supplemented with 0.1 mL of Brain Heart Infusion broth for S. mutans and Tryptone
Soy Broth for P. intermedia. To that, 100 μL of plant extract dissolved in 2.5% DMSO (50 mg/mL)
and 100 μL of Chlorhexidine (CHX) dissolved in water (1.25 mg/mL) were serially diluted down to
give concentrations ranging from 0.048 to 12.5 mg/mL and 4.8 × 10−3 to 0.625 mg/mL, for the plant
extract and positive control respectively. After which 24 h old S. mutans and P. interdia inocula (3 × 108
CFU/mL), grown at 37 ◦C under anaerobic conditions in an anaerobic jar containing Anaerocult®A,
were added. The plates were then incubated for a further 24 h, followed by the addition of 20 μL of
PrestoBlue® viability reagent. In addition to CHX, DMSO (2.5%) and the respective media were used
as negative controls [21,22].
2.7. Cytotoxicity
2.7.1. Cell Culture
The human keratinocyte (HaCat), normal African green monkey kidney (Vero), human liver
carcinoma (HepG2) and cervical cancer (HeLa) cell lines were purchased from Separation Scientific
SA (Pty) Ltd. (Johannesburg, South Africa). The human epidermoid carcinoma (A431) cell line was
purchased from Sigma-Aldrich (Pty) Ltd. (Johannesburg, South Africa). The pigmented human
malignant melanoma cell line (UCT-MEL-1) was originally isolated from the metastatic lymph nodes
of a patient from Groote Schuur Hospital, Cape Town, South Africa and was donated by Prof. Lester
Davids (University of Cape Town). The human keratinocyte (HaCat), human epidermoid carcinoma
(A431: ATCC CRL-1555) cell lines were maintained in culture flasks containing DMEM, while the
normal African green monkey kidney (Vero: ATCC CCL-81), human liver carcinoma (HepG2: ATCC
HB-8065), and human cervical cancer (HeLa: ATCC CCL-2) cell lines were maintained in Eagle’s
Minimal Essential Medium (EMEM) as previously described [23]. Both media were supplemented
with 1% antibiotics (100 U/mL penicillin, 100 μg/mL streptomycin and 250 μg/mL fungizone) and 10%
heat-inactivated fetal bovine serum (FBS). The cells were cultured to 80% confluency in a humidified
incubator set at 5% CO2 and 37 ◦C and sub cultured. Detachment was achieved through treatment
with trypsin-EDTA (0.25% trypsin containing 0.01% EDTA) for 10 min followed by the addition of
supplemented media to inhibit the reaction.
2.7.2. Cell Viability
Cell viability was measured using the method as described by Berrington and Lall [24] using the
2,3-Bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide salt (XTT) Cell Proliferation
Kit II (Merck Millipore, USA). The HepG2 cells were seeded at a concentration of 2000 cells/mL,
whereas the remaining cell lines were seeded at a concentration of 1.0 × 106 cells/mL in 96-well plates
(100 μL) and allowed to adhere for 24 h. The S. perfoliata extract was prepared at stock concentration
of 20 mg/mL, serially diluted and added to the 96-well plate at final concentrations ranging from
1.56 to 200 μg/mL. Controls included a 2% DMSO vehicle control, cells grown in medium only and
Actinomycin D at final concentration ranging from 3.9 × 10−4 to 0.05 μg/mL. Cells were incubated for
a further 72 h with the respective samples and controls. Thereafter, 0.05 mL XTT (0.3 mg/mL) was
added to the cells and incubated for 2 h where after the absorbance was measured at 490 nm (reference
wavelength of 690 nm) using a BIO-TEK powerwave XS plate reader. Blank plates were included,
which were prepared in the same manner as mentioned above, without the additional of cells, to allow
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for color compensation of the samples. The percentage viability was calculated as follows and the IC50
value was then calculated.






2.8. Essential Oil Yield and Composition
Aerial parts of S. perfoliata plants were harvested and three biological samples (pooled of three
individual plants/sample) were air-dried at 42 ◦C in an oven, chopped and were hydro-distilled for
3 h, using a Clevenger apparatus for essential oil (EO) extraction. The EOs were analyzed by Gas
Chromatography-Mass Spectrometry (GC/MS) (Shimadzu GC/MSQP-2010 Plus, Tokyo, Japan) and
their constituents were determined as described previously [25].
2.9. Total Phenolics and Antioxidant Activity of the Essential Oil
Total phenolics in the EOs was determined using the Folin-Ciocalteu method, as described
previously [26]. Results were expressed as milligrams of gallic acid equivalents per gram of EO.
The DPPH assay was used to evaluate the scavenging activity of the EO as described by Oke et
al. [27]. A volume of 400 μL of serial EO dilutions (0–100 μg/mL) or of the methanol control was mixed
with 100 μL of 0.2 mM DPPH solution (in methanol). The mixture was incubated in the dark for 30 min
and the absorbance was measured at 517 nm. Butylatedhydroxytoluene (BHT) was used as a positive
control. Results were expressed as IC50 values.
The 2,2’-azino-bis 3-ethylbenzothiazoline-6-sulphonic acid (ABTS) method was also assayed [28].
The ABTS radical was prepared by mixing 7 mM ABTS and 2.45 mM potassium persulfate and
incubated for 16 h in the dark. The solution was then diluted with 80% methanol until the absorbance
at 734 nm was 0.700 ± 0.02. Therafter, 1 mL of the diluted ABTS solution was mixed with 100 μL of the
EO dilutions (0–100 μg/mL) and dilutions of the positive control, ascorbic acid (0–250 μg/mL). The
absorbance was recorded after 5 min at 743 nm. The ABTS radical scavenging activity was expressed
as IC50 values.
The ability of the S. perfoliata oil to reduce Fe3+ was performed according to Bettaieb Rebey et
al. [29]. Dilutions of essential oils (0–100 μg/mL) and ascorbic acid (0–250 μg/mL) as positive control,
were mixed with 500 μL of 200 mM sodium phosphate buffer (pH 6.6) and 500 μL of 1% potassium
ferricyanide (K3Fe(CN)6). The mixture was incubated at 50 ◦C for 20 min. Then 500 μL of 10%
trichloroacetic acid was added and the reaction was centrifuged at 650× g for 10 min. A volume 500 μL
of the supernatant was then mixed with 500 μL of distilled water and 100 μL of 0.1% ferric chloride.
The absorbance was then measured at 700 nm. The EC50 (effective concentration) was defined as the
concentration at which the absorbance was 0.5 for the reducing power.
The EO was tested for the bleaching of β-carotene in linoleic acid system, by measuring the
coupled autoxidation of β-carotene and linoleic acid [30]. Briefly, 5 mg of β-carotene were dissolved
in 50 mL of chloroform. A 3 mL volume of the mixture was added to 40 mg of linoleic acid and 400
mg of Tween 20. Chloroform was removed using nitrogen gas, after which 100 mL of distilled water
was added to the emulsion and mixed well. Thereafter, 1.5 mL of the emulsion was added to a test
tube containing 20 μL of the essential oil or BHT. Absorbance was measured immediately (t = 0) at
470 nm, after an incubation time of 1 h in a water bath at 50 ◦C (t = 60). The antioxidant activity was
expressed as percentage inhibition compared with the negative control (0.02 mL of methanol instead of
EO) using the following equation:
Antioxidant activity (%) = 100 × (DRC − DRS)
DRC
where DRc is the degradation rate of the control, DRs is the degradation rate of the sample. DRC and
DRS were calculated using the following equation:
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where a = absorbance at t = 0 and b = absorbance at t = 60 min.
2.10. Statistical Analysis
Experiments were performed in triplicate in three independent experiments, unless otherwise
stated. Data were statistically analyzed using IBM SPSS v.21 for analysis of variance (ANOVA) and
presented as means ± standard deviation (SD). Duncan’s multiple range test (DMRT) was used for
mean comparisons when significant differences were detected (p-value < 0.05). The absolute 50%
inhibitory concentration (IC50) was calculated using the GraphPad Prism version 4.00 for Windows,
GraphPad Software (La Jolla, CA, USA).
3. Results and Discussion
3.1. Mineral, Chlorophyll and Nutritional Content
The results of the nutritional analysis of the aerial parts of S. perfoliata are demonstrated in Table 1.
This species has a high nutritional value, with 14.64% of protein which is higher than numerous edible
species which also form part of the Lamiaceae family. Like the majority of Sideritis species, it is rich in
micronutrients as previously described when compared to the potassium, phosphorus and magnesium
content of S. scardica or S. raeseri [31,32]. Mineral content of S. perfoliata might vary after application of
different cultivation practices and multiple harvest at a commercial farm [32].
Table 1. Mineral analysis, nutritional value and chlorophyll content of aerial plant tissue. Data are
presented as the mean of six replicates ± SD.
Mineral Content Nutritional Value Chlorophll Content
N (mg/kg d.w.) 23.34 ± 0.39 Dry Matter (%) 19.69 ± 0.50 Total Chlorophyll (mg/g f.w.) 0.968 ± 0.063
K (mg/kg d.w.) 27.96 ± 0.77 Moisture (%) 80.31 ± 0.50 Chlorophyll a (mg/g f.w.) 0.779 ± 0.054
P (mg/kg d.w.) 2.06 ± 0.09 Ash (%) 9.91 ± 0.51 Chlorophyll b (mg/g f.w.) 0.189 ± 0.009
Mg (mg/kg d.w.) 3.24 ± 0.42 Protein (%) 14.64 ± 0.24
Ca (mg/kg d.w.) 6.95 ± 1.78 Total Fats (%) 1.76 ± 0.05
Na (mg/kg d.w.) 0.34 ± 0.03 Carbohydrates (%) 73.52 ± 0.19
Cu (mg/kg d.w.) 62.06 ± 13.97 Energy (kcal/100 g d.w.) 368.40 ± 0.77
Zn (mg/kg d.w.) 62.22 ± 2.25
Fe (mg/kg d.w.) 149.08 ± 31.02
The total Chlorophyll content in the aerial parts of S. perfoliata was 0.986 ± 0.06 mg/g of fresh tissue
(0.779 and 0.189 mg/g for Chlorophyll a and b respectively). The Chlorophyll content of S. perfoliata
compared well with the Chlorophyll content in other Lamiaceae species. In a study by Chrysargyris et
al. reported the total Chlorophyll content of sage and lavender which were 1.18 and 1.08 mg/g fresh
weight (fw) respectively [13].
3.2. Phytochemical Analysis
The phytochemical characteristics from the ethanolic extract of S. perfoliata were analyzed.
Alkaloids, cardiac glycosides, flavonoids, phenolics, saponins, tannins and terpenes were found
to be present within the extract. These phytochemical constituents are known for their medicinal
potential. Phenols are a group of compounds that have been proven to have anti-ageing, antioxidant
and anti-inflammatory potential. This is confirmed by the noteworthy elastase inhibitory activity and
free radical scavenging potential of S. perfoliata ethanolic extract seen in the present study (Table 2).
Tannins are compounds that readily bind to proteins and interferes with protein synthesis. Flavonoids
are compounds known to have antimicrobial, anticancer and antioxidant activity. Their antimicrobial
activity is due to their ability to interact with the bacterial cell wall. The moderate anticancer potential
of the ethanolic extract of S. perfoliata against the human liver cancer cell line (HepG2) could be due
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to the presence of flavonoids in the leaves. The characteristics of saponins, identified to be present
in the ethanolic extract, include the coagulation of red blood cells and anti-inflammatory activity.
Alkaloids have been known for centuries for their medicinal potential. These compounds are cytotoxic,
antibacterial, analgesic and antispasmodic [33]. This could explain the moderate cytotoxic effect of S.
perfoliata observed in the present study (Table 2). The phytochemicals identified in this study proves
the medicinal potential of S. perfoliata and could attract the interest of pharmaceutical industries to
isolate its major components. Recently, six iridoids, three flavonoids, two phenylethanoid glucosides
and one phenolic acid have been isolated from the plant, providing new inputs on plant metabolism
related to cultivation practices, with possible industrial applications [32].
Table 2. Biological activity of Sideritis perfoliata ethanolic extract. Data presented is the average of three
replicates ± standard deviation (SD).
Assay
S. perfoliata EtOH Extract MIC
a/IC50
b ± SD (μg/mL)






P. intermedia 3.1 × 103 0.48 e
C. acnes 500 0.78 d
S. mutans 6.2 × 103 0.48 e
Cytotoxicity Vero 201.5 ± 3.32 0.02 ± 8 × 10−3 f
HaCat 134.3 ± 10.1 0.01 ± 1.4 × 10−3 f
Anticancer
HeLa 102.5 ± 0.99 1 × 10−3 ± 8 × 10−3 f
A431 133.25 ± 10.45 0.04 ± 7 × 10−3 f
UCT-MEL-1 103.15 ± 0.92 0.04 ± 2 × 10−3 f
HepG2 64.27 ± 2.04 1 × 10−3 ± 7 × 10−4 f
Antioxidant
DPPH 23.9 ± 0.85 1.90 ± 0.05 h
Nitric oxide 266.0 ± 7.1 56.2 ± 41.0 h
TAC 2.004 ± 0.28 (PM)1.596 ± 0.40 (FRC)
0.889 ± 0.26 i (PM)
2.538 ± 0.38 i (FRC)
Pigmentation Tyrosinase NI
m 2.84 ± 0.23 j
Melanin NI m 1.56 ± 0.18 j
Wrinkles Elastase 57.18 ± 3.22 18.45 ± 2.23 k
a Minimum Inhibitory Concentration, b Inhibitory concentration where 50% activity/viability is inhibited, c
Ciprofloxacin, d Tetracycline, e Chlorhexidine, f Actinomycin-D, h L-Ascorbic acid, I Gallic acid, j Kojic acid, k Ursolic
acid, NI: No inhibition at the highest concentration tested l (1000 μg/mL), m (200 μg/mL), PM—phosphomolybdenum
method, FRC—ferric reducing capacity.
3.3. Biological Activities
3.3.1. Antioxidant Activity
The results of the antioxidant activities of the extract are presented in Table 2. The human body is
constantly exposed to external factors that contribute to the development of reactive oxygen species
(ROS), resulting in oxidative stress. Studies have confirmed the contribution of oxidative stress to
the onset of various diseases such as cancer, inflammatory processes and skin diseases such as acne
vulgaris. Currently, there is a trend towards using antioxidants from a natural origin due to the
accumulation of synthetic antioxidants in the body [34,35]. Nitric oxide plays a central role in the
regulation of several physiological processes in the human body. However, nitric oxide that is a product
of sodium nitroprusside has a strong nitrosonium (NO+) character that can change and interfere with
the normal function of several cellular processes [16]. Pro-inflammatory cytokines and bacterial cell
wall components have been linked with the overproduction and release of increased amounts of nitric
oxide. The increased nitric oxide free radicals are involved in the onset of inflammation associated
with diseases such as acne vulgaris and post-inflammatory hyperpigmentation [36].
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Sideritis perfoliata displayed a moderate nitric oxide scavenging activity with an IC50 of 266.0 ± 7.1
μg/mL (Table 2). The noteworthy free radical scavenging activity for S. perfoliata can be attributed to
the high phenolic content of Sideritis spp. [37]. Previous studies done by Zengin et al. [37] speculated
the significant nitric oxide scavenging activity of S. galatica to be due to the presence of tocopherols,
carotenoids and ascorbic acid in the plant extract.
Phongpaichit et al. [38] reported an extract with an IC50 between 10 and 50 μg/mL to have a
significant antioxidant capacity. In the present study, S. perfoliata displayed noteworthy antioxidant
activity with an IC50 of 23.9 ± 0.85 μg/mL. Studies done by Güvenç et al. [39] on the DPPH antioxidant
potential of various Sideritis spp, confirmed the free radical scavenging potential of flavonoids together
with phenylethanoid glycosides present in these species.
The estimation of the total antioxidant capacity of an extract uses a combination of different
antioxidant parameters. These include determining the reducing capacity of the extract against a
specific free radical agent such as ammonium molybdate as well as calculating the phenolic content
of the extract. High phenolic content is associated with high antioxidant capacity [17,40]. The S.
perfoliata extract had significantly lower phenol content than that of the positive control gallic acid,
while showing a significantly higher capacity to scavenge the ammonium molybdate free radical
when compared with gallic acid. This means that the S. perfoliata extract has an overall moderate
antioxidant capacity.
3.3.2. Elastase Inhibition
The connective tissue of the skin has the main component of elastic fibres known as elastin. Elastic
fibres and collagenous fibres in the skin create a network and they develop in the epidermis. Elastin
is degraded by elastase; therefore, inhibition of the elastase enzyme can retain the elasticity of the
skin [41]. Sideritis perfoliata showed significant inhibition of the enzyme elastase, with an IC50 value of
57.18 ± 3.22 μg/mL (Table 2). Ursolic acid was used as the positive control, the IC50 value was 18.45
± 2.23 μg/mL. No elastase inhibition has been reported previously for S. perfoliata and species in the
same genus. The IC50 value of 57.18 ± 3.22 μg/mL indicates good enzyme inhibition, meaning that the
plant has the potential to maintain skin elasticity. Lee et al. [41] studied the elastase inhibition of Areca
catechu, and reported noteworthy activity, with an IC50 value of 42.4 μg/mL. In 2013, Ndlovu et al. [42]
investigated the elastase inhibition of Peltophorum africanum, they reported the plant to be a potential
enzyme inhibitor with an IC50 of 55.83 μg/mL.
According to the Gas Chromatography-Mass Spectrometry (GC-MS) results, the essential oil of S.
perfoliata is characterized by the presence of monoterpenes, which are known to inhibit the activity of
the elastase enzyme, according to Kacem and Meraihi [43]. They investigated the elastase inhibition of
the essential oil extracted from seeds of Nigella sativa (L.) and reported that the main components of the
essential oil were p-cymene, thymoquinone, carvone, thymol and carvacrol, which are monoterpenes.
These monoterpenes had IC50 values between 12 and 104 μM.
3.3.3. Tyrosinase and Melanin Inhibition
The effect of the S. perfoliata on melanogenesis has not yet been determined. It was reported
that the acetone and methanol extract of S. stricta, being in the same genus, exhibited 15.66 ± 0.11%
and 23.29 ± 0.56% inhibition of tyrosinase, respectively, at 200 μg/mL [44]. Similar inhibition of
tyrosinase was observed for the ethanol extract of S. perfoliata at concentrations higher than 25 μg/mL
(Figure 1). However, no inhibition was observed at concentrations lower than 12.5 μg/mL. Additionally,
no significant inhibition of melanin production in UCT-MEL-1 cells was observed at the highest
concentration tested (200 μg/mL). The inhibitors of elastase and tyrosinase enzymes can potentially
have applications as skin hyperpigmentation, anti-ageing and antiwrinkle agents as well as in the
treatment of other dermatological disorders [45].
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Figure 1. The inhibitory effect of S. perfoliata on mushroom tyrosinase at different treatment
concentrations. Data is represented as are means ± SD (n = 3).
Compounds previously isolated from S. perfoliata that have been reported for their tyrosinase
and/or melanin production inhibitory activity were acteoside, ajugoside, caffeic acid, leucoceptoside A,
lavandulifolioside and martynoside [9,46–51]. A study conducted by Song and Sim. in 2009 concluded
that acteoside inhibited both melanogenesis and the tyrosinase protein activity in B16F10 melanoma
cells, but the effects were dose-dependent [49]. The same effects of the inhibition of tyrosinase
and melanogenesis were confirmed by Son et al. [50]. Furthermore, acteoside lowered cyclic AMP
levels in cells that were stimulated by α-melanocyte stimulating hormone [49]. Acteoside inhibited
melanogenesis on a post-translational level by reducing the levels of microphthalmia associated
transcription factor (MITF) proteins, tyrosinase-related protein-1 (TRP-1) and tyrosinase [50]. It was
reported that acteoside resulted in a 25.78% reduction in tyrosinase activity at a concentration of 53
μM [48], however a more recent study reported a 50% reduction in enzyme activity at a concentration of
20.67 μM [51]. Other compounds potentialy responsible for the tyrosinase inhibitory activity, exhibited
by the ethanol extract of S. perfoliata, were caffeic acid, leucosceptoside A, lavandulifolioside and
martynoside exhibiting 27.00%, 21.65%, 12.00% and 20.55% enzyme inhibition at 90 μM, 51 μM, 44 μM
and 52 μM, respectively [47,48].
3.3.4. Antimycobacterial Activity
In a study conducted by Basile et al. [52], the acetone extracts of S. italica leaves and flowers
exhibited antibacterial activity against various strains of Pseudomonas aeruginosa, Proteus mirabilis,
Salmonella typhi and Proteus vulgaris. Moreover, Askun et al. [53] reported the antibacterial and
antimycobacterial activity of different Sideritis spp. The authors found that the methanolic extract of
S. leptoclada exhibited antibacterial activity, with an MIC of 640 μg/mL on Enterobacter aerogenes and
Salmonella typhimurium. A low mycobacterial activity was observed by the extracts of S. albiflora and S.
leptoclada with an MIC of 1568 μg/mL. A similar result was observed in the present study with the S.
perfoliata extract exhibiting an MIC greater than 1000 μg/mL.
3.3.5. Antibacterial Activity against Cutibacterium Acnes
The major causative microorganism involved in the progression of acne is Cutibacterium acnes.
This study provides the first report of the extract of S. perfoliata against C. acnes (ATCC 6919). The
ethanolic extract of this species exhibited an MIC of 500 μg/mL, while the positive control, tetracycline
had an MIC of 0.78 μg/mL (Table 2). Extracts with an MIC less than 1000 μg/mL are regarded as
active [54], which is reflected in the findings of the present study. Additionally, antibacterial activity
of S. perfoliata has been reported from its essential oil, which inhibited the growth of Staphylococcus
epidermidis with an MIC of 250 μg/mL, another microorganism involved in progression of acne [55,56].
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Kirimer et al. [55] reported the major constituent of the S. perfoliata essential oil as limonene (37.70%)
followed by sabinene (18.8%), while Ezer et al. [57] also identified limonene as the major constituent
making up 22.40% of the EO composition. The essential oils of two Korean citrus varieties containing
high quantities of limonene (81.63% and 83.38%), inhibited the growth of C. acnes (ATCC 6919) at
concentrations of 0.31 μL/mL, as reported by Kim et al. [58]. However, the essential oil of S. perfoliata in
the present study did not show high concentrations of limonene present as reported by Kirimer et
al. [55] and this could be due to different localities, method used for oil preparation, growth stage of
the plant and cultivation management.
3.3.6. Antibacterial Activity against S. mutans and P. intermedia
Streptococcus mutans and Prevotella intermedia are the main causative agents of periodontal diseases
and are known for their resistance [59–61]. According to Eloff [22] and van Vuuren [62], an extract
with an MIC lower than 8 mg/mL is considered to have some antimicrobial activity, while extracts
having an MIC below 1 mg/mL are considered worth exploring further. The S. perfoliata extract in the
present study, showed low antibacterial activity for S. mutans and moderate activity for P. intermedia
with MICs of 6.25 mg/mL and 3.125 mg/mL respectively.
The essential oils of some members of the Sideritis spp. namely; S. curvidens and S. lanata were
reported to have high antimicrobial activity against S. mutans, using the disc diffusion method.
The zones of inhibition measured at 22 mm for S. curvidens and 23 mm for S. lanata using 25 μL
of essential oil [63]. There were no previous reports of the activity of S. perfoliata on either of the
microorganisms tested in the present study, providing new knowledge on the antibacterial activity of
the examined species.
3.3.7. Cytotoxicity
Secondary metabolites from various plant species have become highly researched as alternative
therapeutic agents for various diseases, including cancer. Interestingly, in the United States more than
60% of anticancer drugs approved from between 1983 and 1994 were of natural origin [64,65]. While
their efficacy towards certain cancer types is encouraging, it is crucial that their toxicity towards normal
healthy cells remain low to obtain the highest level of efficacy and specificity towards cancer cells. The
toxicity of the ethanolic extract of S. perfoliata was investigated against cancerous and non-cancerous
cells (Table 2). According to Kuete and Efferth [66], a plant extract is considered significantly toxic if
it shows an IC50 value lower than 100 μg/mL when tested on normal cell lines in vitro, while IC50’s
between 100 and 300 μg/mL constitute moderate toxicity, those between 300 and 1000 μg/mL exhibit
low toxicity, and those above 1000 μg/mL exhibit no in vitro toxicity. When investigating cancerous
cell lines, plant extracts exhibiting IC50’s lower than 20 μg/mL are considered to have significant
anticancer activity, while moderate toxicity constitutes those values ranging between 20 and 50 μg/mL,
low toxicity between 50 and 200 μg/mL, and no toxicity towards cancerous cells for values higher
than 200 μg/mL. According to these thresholds, the ethanolic extract of S. perfoliata showed moderate
toxicity towards the non-cancerous Vero and HaCat cells with IC50 values of 201.5 ± 3.32 and 134.3 ±
10.1 μg/mL, respectively. Low toxicity towards all the cancerous cell lines was noted with IC50 values
of 103.15 ± 0.92, 133.25 ± 10.45, 64.27 ± 2.04 and 102.5 ± 0.99 μg/mL against UCT-MEL-1, A431, HepG2
and HeLa cells respectively (Table 2). Although the activity of the ethanolic extract was found to have
low toxicity against HepG2 cells, the toxicity against this cell line was much higher than on the other
cancerous cell lines. In a study by Loizzo et al. [67], the activity of the essential oil of S. perfoliata against
amelanotic melanoma (C32) and renal cell adenocarcinoma (ACHN) was found to exhibit moderate
toxicity with IC50 values of 95.58 and 100.90 μg/mL respectively, further supporting the cytotoxic
effects of the S. perfoliata. The essential oil was, however, not toxic to human breast cancer (MCF-7) and
human prostate cancer (LNCap) cells with IC50 values above 400 μg/mL.
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3.4. Essential Oil Yield, Composition and Antioxidant Activity
The essential oil yield in terms of dry weight basis, in general, for all Sideritis genus species is
considerably low, in contrast with other Lamiaceae family genera [1]. There is a reported yield of S.
perfoliata from Turkey as low as 0.08% [68]. Kirimer et al. [69] reported the yield of many Sideritis
species varying from traces to 0.85%, with S. perfoliata ranging from 0.12% to 0.36%. When S. perfoliata
subjected to drought stress (deficit irrigation) which is considered as an abiotic stress factor, EO yield
increased up to 0.75% and 0.83% at a conventional and organic cultivation [32]. In the present study
the yield was 0.30% ± 0.08%, in accordance with the species records (Table 3). The lower EO yield
could be related that the collection of plant material in our study was from an organic plantation for
seed/seedling production (‘’mother” plants) and not a commercial plantation as in previous studies [32].
They have also reported the connection between the yield and the percentage of total monoterpenes or
sesquiterpenes in the oils.
Table 3. Composition (%) of essential oils of S. perfoliata aerial parts, after GC/MS analysis and
compound identification. Values are mean percentage (%) of three replicates ±SD.
RI Compound Mean ± SD RI Compound Mean ± SD
926 α-Thujene 0.71 ± 0.09 1100 trans-Sabinene hydrade 0.47 ± 0.03
933 α-Pinene 27.92 ± 1.47 1178 Terpinen-4-ol 0.22 ± 0.04
948 Camphene 0.08 ± 0.01 1191 α-Terpineol 0.10 ± 0.02
973 Sabinene 4.59 ± 0.51 1204 γ-Terpineol 0.17 ± 0.00
977 β-Pinene 7.12 ± 0.64 1244 Carvone 0.37 ± 0.34
989 α-Myrcene 2.45 ± 0.29 1271 Geranial 0.06 ± 0.06
1003 3-Octanol 0.05 ± 0.00 1425 β-caryophyllene 2.89 ± 0.29
1005 α-Phellandrene 0.88 ± 0.09 1462 α-caryophyllene 0.09 ± 0.01
1013 3-Carene 2.29 ± 0.04 1479 Caryophyllene-9-epi 0.97 ± 0.17
1017 α-Terpinene 0.18 ± 0.01 1495 Germacrene D 1.75 ± 0.21
1024 o-Cymene 0.15 ± 0.01 1581 trans-Sesquisabinene hydrate 1.02 ± 0.14
1029 β-Phellandrene 26.59 ± 1.60 1587 Caryophyllene oxide 0.13 ± 0.01
1041 Benzene acetaldehyde 0.06 ± 0.01 1617 Cubenol-1-epi 1.83 ± 0.27
1046 trans-β-Ocimene 0.06 ± 0.01 1673 Valeranone 11.21 ± 2.05
1058 γ-Terpinene 0.38 ± 0.03 1704 δ-Dodecalactone 0.34 ± 0.07
1067 cis-Sabinene hydrate 0.09 ± 0.00 1737 Mint Sulfide 0.09 ± 0.00
1089 Terpinolene 2.48 ± 0.09 1990 Isokaurene 0.29 ± 0.10





Total of which are Monoterpenes 75.88
Total of which are Oxygenated
Monoterpenes 1.48
Total of which are Sesquiterpenes 5.71
Total of which are Oxygenated
Sesquiterpenes 14.19
Not many reports are available in literature characterizing the components of the essential oil
of S. perfoliata subs perfoliata, particularly from plants collected in Cyprus. The essential oil analysis
revealed 34 identified compounds, representing the 98.10% of the total chromatogram of the oil
profile. The most abundant components were α-pinene (27.92%), β-phelladrene (26.59%), valeranone
(11.21%), β-pinene (7.12%), sabinene (4.59%), and α-myrcene, terpinolene, careen, β-caryophyllene
with percentages 2–3%. Plants from the Eastern Mediterranean Region of Turkey also revealed the
similar oil profile, with high percentage of α and β-pinene and β-phelladrenne [70]. Loizzo et al. [67]
also found high percentages of β-phelladrene (32.85%), sabinene (12.76%), α and β-pinene (8.66% and
8.90%) when essential oils from S. perfoliata sampled in Lebanon were analyzed, in accordance with
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the analysis presented here. However, there are studies on Sideritis reporting differences between the
components and their participation in the oil chromatograph [55,68].
The antioxidant activity of the S. perfoliata oils is reported in this study for the first time. The EO
exhibited high antioxidant activity, with a two-fold increase of ABTS scavenging activity and Reducing
Power whereas a four-fold increase for β-carotene activity was observed, when compared to their
respective positive controls (Table 4). A study comparing the antioxidant activity of S. italica prepared
from the leaves and flower heads reported higher in the EO extracted from the leaves [52].
Table 4. Total phenolics, flavonoids, and antioxidants in the leaf essential oil extracted from
Sideritis perforata.
Essential Oil Positive Control
Essential oil yield (%) 0.30 ± 0.08
Total phenolics (mg GA/g of oil) 0.53 ± 0.01
DPPH IC50 (μg/mL) 17.61 ± 0.40 17.93 ± 2.56 a
ABTS IC50 (μg/mL) 10.10 ± 1.50 26.25 ± 0.41 b
Reducing Power (μg/mL) 22.62 ± 0.61 38.62 ± 0.21 b
β-carotene (AA%) 4.06 ± 0.50 18.10 ± 1.23 a
a Butylatedhydroxytoluene, b Ascorbic acid.
4. Conclusions
Sideritis perfoliata has a high protein and antioxidant content due to the presence of flavonoids
and phenolics. Moreover, we revealed the wrinkle reducing potential of S. perfoliata as it showed
noteworthy elastase inhibition. Traditionally, S. perfoliata is used for the treatment of wounds which
could be attributed to the antibacterial and antioxidant activity reported in this study. The ethanol
extract showed moderate toxicity towards the non-cancerous cell lines, whereas low toxicity was noted
against the cancerous cell lines. However, the most promising anticancer activity was noted against
human liver cancer cells.
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Abstract: Goji berries are undoubtedly a source of potentially bioactive compounds but their
phytochemical profile can vary depending on their geographical origin, cultivar, and/or industrial
processing. A rapid and cheap extraction of the polyphenolic fraction from Lycium barbarum
cultivars, applied after homogenization treatments, was combined with high-performance liquid
chromatography (HPLC) analyses based on two different methods. The obtained hydroalcoholic
extracts, containing interesting secondary metabolites (gallic acid, chlorogenic acid, catechin, sinapinic
acid, rutin, and carvacrol), were also submitted to a wide biological screening. The total phenolic
and flavonoid contents, the antioxidant capacity using three antioxidant assays, tyrosinase inhibition,
and anti-Candida activity were evaluated in order to correlate the impact of the homogenization
treatment, geographical origin, and cultivar type on the polyphenolic and flavonoid amount, and
consequently the bioactivity. The rutin amount, considered as a quality marker for goji berries
according to European Pharmacopeia, varied from ≈200 to ≈400 μg/g among the tested samples,
showing important differences observed in relation to the influence of the evaluated parameters.
Keywords: goji berry; Lycium barbarum; HPLC-DAD; antioxidant capacity; TPC; TFC; anti-tyrosinase
activity; anti-Candida activity
1. Introduction
Lycium barbarum L. is a traditional Chinese medicinal plant, specifically a shrub belonging to
Solanaceae family, whose fruits, well known as goji berries, have acquired increasing popularity in
Europe and North America in recent years. Goji berries and their derived products are considered
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a relevant source of (micro)nutrients, especially natural antioxidants, which contribute to the
extraordinary nutritional quality of this matrix [1]. In fact, a healthy functional role is recognized as
belonging to its fruits and their derived extracts and infusions, containing polysaccharides, carotenoids,
and flavonoids, as well as salts, vitamins, and other micronutrients. The original habitat of goji is not
certainly established, although more than 70 different species of Lycium exist [2]; L. barbarum represents
the most relevant species from a biological point of view [3,4]. Overall, the chemical diversity of this
fruit could provide many opportunities for food supplement development given the important growth
forecasts of the polyphenol market worldwide.
Actually, the most researched components from goji fruits are the water-soluble arabinogalactans
(Lycium barbarum polysaccharides or LBP), which are estimated to comprise up to 5–8% of the
dried fruits [5] and include in their composition six types of monosaccharides (arabinose, rhamnose,
xylose, mannose, galactose, and glucose), galacturonic acid, and almost all the proteinogenic amino
acids [6]. LBP have been shown to control blood glucose, modulate glucose metabolism leading to the
improvement of oxidative stress markers, alleviate insulin resistance, and stimulate the increase of
glucose transporter type 4 (GLUT4) expression [7,8].
Dried fruits are composed of a carotenoid fraction of 0.03–0.5% [9], in which 11 free carotenoids and
7 carotenoid esters were detected from unsaponified and saponified L. barbarum extracts [6]. Zeaxanthin
dipalmitate, which can vary from 30% to 80% of total carotenoids, represents the main molecule [10],
followed by β-carotene, neoxanthin, and cryptoxanthin at lower concentrations. The carotenoid
content of goji berry was recently the object of great interest for researchers for its beneficial effects
on retinopathy. The ability to protect the visual function and the overall antioxidant properties [11]
make this matrix an interesting ally for the prevention of the onset and the care of age-related macular
degeneration (AMD), which represents one of the main causes of vision loss, which is estimated
as cause of 5% of all cases of blindness [12]. Among carotenoids, lutein and zeaxanthin, the most
represented pigments in the macular area of the human retina, are particularly effective in the macula
protection from oxidative damage by scavenging harmful reactive oxygen species. Therefore, lutein
and zeaxanthin may play a pivotal role in preventing AMD if further studies can clarify the explicit
effects that can be expected in terms of their function regarding the development and progression of
AMD [13].
Concerning phenylpropanoids, flavonoids, and isoflavonoids, the goji berry’s protective and
antioxidant role was correlated with the presence of caffeic and chlorogenic acid, with a high
content of quercetin-3-O-rutinoside and kaempferol-3-O-rutinoside, and finally with representative
coumarins and lignans [14,15]. Furthermore, phenolics are the most abundant secondary metabolites
of plants [16]. Quercetin, kaempferol, and relative derivatives, among which rutin is the most frequent
and representative, are well-known as radical scavengers and anti-oxidants capable of preventing
cancer, cardiovascular disease, and other chronic disease onset [3,17]. In recent years, polyphenols were
shown to exert a protective role against neurodegeneration, an ability related to their antioxidant and
scavenging abilities. They could interact positively with vitamins E and C in lipid bilayer membranes
via non-covalent associations, enabling the regeneration of these endogenous antioxidants [18,19].
Very recently, goji extracts have also been considered as potential candidates for designing
innovative functional products (cosmetics and cosmeceuticals, among others) from natural matrices
in the treatment of pigmentation disorders, and L. barbarum has also shown the capacity to inhibit
the oxidation of L-DOPA, which is catalyzed by tyrosinase [20–22]. Tyrosinase is a ubiquitous
and multifunctional enzyme that can catalyze hydroxylation and successive oxidation of phenolic
compounds to quinones, regulating the melanogenesis process in humans.
Moreover, according to a preliminary in vitro study, L. shawii extracts have been reported to show
antimicrobial effects on different species of bacteria [23]. Indeed, the anti-Candida activity of plants
rich in polyphenols and polymeric flavan-3-ols has been studied [24–26]. Among the monoterpene
phenols, carvacrol was investigated for its antifungal and antibacterial effects [27], and different studies
demonstrated that this molecule not only is able to explicate a potent action against C. albicans, but
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also impairs the growth of different morphological forms, such as yeast, hyphae, and even the most
resistant forms of biofilm [28].
Considering the multifactorial parameters, such as origin, cultivar, harvest dates, climatic
factors, and applied technologies that could severely impact on the phytochemical profile and
consequently on the associated biological activity, the objective of the present work is to determine
the content and composition of the main functional constituents of four goji berry cultivars harvested
in Italy and Romania at different dates with a particular emphasis on the polyphenolic derivatives.
Their antioxidant potential, inhibitory activity on tyrosinase, and anti-fungal activity after two
different treatments of homogenization (Ultraturrax® IKA, Staufen, Germany, or domestic mixer
Girmi, Omegna, Italy) were evaluated. Besides the total phenolic and flavonoid content, the
antioxidant capacity was evaluated using three assays—2,2-diphenyl-1-picryl-hydrazyl (DPPH),
2,2′-azino-bis-(3-ethylbenzothiazoline-6-sulfonate (ABTS), and ferric reducing antioxidant potential
(FRAP)—to detect the radical scavenging activity of the investigated samples.
2. Materials and Methods
2.1. Materials
All HPLC-grade solvents were purchased from Carlo Erba (Milan, Italy) and Fluka (Milan, Italy),
whereas chemical standards were supplied by Sigma-Aldrich (Milan, Italy).
Goji berries were generously gifted by Azienda Natural Goji® (Fondi, Italy), and by two local
providers from Northwest Romania. Samples given by Azienda Natural Goji®, belonging to “Poland”
and “Wild” varieties, P and W, were harvested at different commercial harvesting periods (2015: 6 July,
23 July, 3 August; 2016: 26 July; 4 August, P1–P5 and W1–W5) in Fondi (Italy) based on their stage
maturity as determined by the producer. Samples given by the two local providers from Romania
belonged to the Biglifeberry and Erma (B, E) varieties, were from only one collection (B1, E1), and were
harvested at maturity in the summer of 2014 from two organic cultures from Ciuperceni (E variety, SM
county) and Ploscos, (B variety, Cluj county). No specific permissions were requested for the plant
sample collection, which did not involve endargered or protected species.
All samples were quickly frozen at −80 ◦C and stored at −18 ◦C until the analyses were performed,
with no direct sunlight exposure.
2.2. Sample Preparation
Sample preparation was made according to the method previously described [10]. In brief,
defrosted, washed, and wiped goji berries were homogenized at room temperature for 2 min by a T18
Ultraturrax® homogenizer (IKA®, Staufen, Germany) at 10,000 rpm (U samples) or by a domestic
mixer at 16,000 rpm (TR01, Girmi, Omegna Italy) (D samples), and the resulting purees were subjected
to the extraction procedure. Aliquots of fresh whole and homogenized samples were dehydrated to
constant weight with the only aim to evaluate their water content.
2.3. Extraction of Hydroalcoholic Fractions
Extractions were performed with a hydroalcoholic mixture (ethanol:water = 70:30, water acidified
with 0.5% acetic acid) and a small amount of cyclohexane for 3 h. The resulting suspension was
centrifuged at 12,000× g for 10 min at 4 ◦C, and the upper organic phase was discarded. The
hydroalcoholic phase, whose separation from the lower solid phase was completed using paper
filtration, was transferred to a rotary evaporator at a reduced pressure and 40 ◦C. The dryness was
completed using lyophilization. The obtained residues, protected from light and air exposure, were
either immediately analyzed or stored at –18 ◦C until further analyses.
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2.4. HPLC Analysis
Chromatographic analyses were carried out following a validated method [29] for the detection
and quantification of the main secondary metabolites.
Moreover, rutin was quantified at 360 nm according to a slightly modified method based on the
method reported by Imbaraj et al. [30] and described in a previous work [10]. Rutin was identified via
comparison of the retention time and of the UV spectra of a pure external standard and quantified using
a calibration curve (y = 62x – 0.02, R2 = 0.9972, in the range 0.5–50 μg/mL). Quercetin and kaempferol
derivatives were approximately identified using the evaluation of the UV spectra and indicatively
quantified as rutin equivalents.
2.5. Total Phenolic Content (TPC)
The TPC was assessed using the Folin-Ciocâlteu method [21] with a SPECTROstar Nano
Multi-Detection Microplate Reader in 96-well plates (BMG Labtech, Ortenberg, Germany). Briefly, a
mixture solution consisting of 20 μL of extract, 100 μL of Folin-Ciocâlteu reagent, and 80 μL of sodium
carbonate (Na2CO3, 7.5% w/v) was homogenized and incubated at room temperature in the dark
(30 min). The TPC was expressed as gallic acid equivalents (GAE) in milligrams per gram dry weight
(dw) of plant material (mg GAE/g dw plant material) after reading the absorbance of the samples at
760 nm.
2.6. Total Flavonoid Content (TFC)
The total flavonoid content (TFC) was determined using the AlCl3 method, with the absorbance of
the samples being measured at 420 nm. The results of the TFC were expressed as quercetin equivalents
(QE) in milligrams per gram dry weight (dw) of plant material (mg QE/g dw plant material) [31].
2.7. Antioxidant Activity
2.7.1. DPPH Radical Scavenging Assay
The DPPH antioxidant capacity was determined according to the method described in
Mocan et al. [32], with some modifications, by using a SPECTROstar Nano microplate reader (BMG
Labtech, Offenburg, Germany). Each of the 96 wells consisted of 30 μL of sample solution (in an
appropriated dilution) and a 0.004% methanolic solution of DPPH. After 30 min of incubation in the
dark, the absorbance of the sample was read at 515 nm. Results were expressed as Trolox equivalents
per gram of dry weight herbal extract (mg TE/g dw herbal extract).
2.7.2. Trolox Equivalent Antioxidant Capacity (TEAC) Assay
The TEAC of the samples was measured using the method previously described [21] and the
results were expressed as milligrams of Trolox equivalents (TE) per gram of dry herbal extract
(mg TE/g dw extract).
2.7.3. FRAP Assay
The FRAP assay was assessed using the method described in Damiano et al. [33] with slight
modifications. The FRAP reagent was prepared by mixing ten volumes of acetate buffer (300 mM,
pH 3.6), one volume of 2,4,6-tris(2-pyridyl)-s-triazine (TPTZ) solution (10 mM TPTZ in 40 mM HCl),
and one volume of FeCl3 solution (20 mM FeCl3·6H2O in 40 mM HCl). After mixing the samples with
the reagent (25 μL sample and 175 μL FRAP reagent), the samples were incubated in the dark for 30 min
at room temperature and the absorbance was measured at 593 nm in 96-well plates. The final results
were expressed as milligrams of Trolox equivalents (TE) per milligram of extract (mg TE/g extract).
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2.8. Tyrosinase Inhibitory Activity
The tyrosinase inhibitory activity of each sample was determined via a method previously
described [34] using a SPECTROstar Nano Multi-Detection Microplate Reader with 96-well plates
(BMG Labtech, Ortenberg, Germany). Samples were disolved in water containing 5% dimethylsulfoxide
(DMSO). For each sample, four wells were designated as A, B, C, and D, where each one contained a
reaction mixture (200 μL) as follows: (A) 140 μL of 66 mM phosphate buffer solution (pH = 6.6) (PBS),
40 μL of mushroom tyrosinase in PBS (23 U/mL) (Tyr); (B) 160 μL PBS; (C) 80 μL PBS, 40 μL Tyr, 40 μL
sample, and 80 μL PBS; and (D) 120 μL PBS and 40 μL sample. The plate was then incubated at room
temperature for 10 min; after incubation, 40 μL of 2.5 mM L-DOPA in PBS solution were added in each
well and the mixtures were incubated again at room temperature for 20 min. The absorbance of each
well was measured at 475 nm and the inhibition percentage of the tyrosinase activity was calculated





The results were expressed as mg kojic acid equivalents per gram of dry weight of extract (mg
KAE/g extract) using a calibration curve between 0.01–0.10 mg kojic acid/mL of solution.
2.9. Antifungal Susceptibility Testing
The in vitro antifungal susceptibility was evaluated using extracts, rutin, and carvacrol (Sigma
Aldrich, St. Louis, MO, USA). To evaluate the minimal inhibitory concentration (MIC) of the extracts
and compounds, a broth microdilution method was performed according to a standardized protocol
for yeasts [35].
The assay was carried out with C. albicans ATCC 24433, C. albicans ATCC 10261, and C. albicans
ATCC 90028 coming from the American Type Culture Collection (ATCC, Rockville, MD, USA). Candida
strains were grown on Sabouraud dextrose agar at 37 ◦C for 24 h. Then, cell suspensions of the
strains were prepared in a RPMI 1640 medium (Sigma-Aldrich, Milan, Italy) buffered to pH 7.0
with 0.165 mmol L–1 3-(N-morpholino)propanesulfonic acid (MOPS). The final concentration of the
inoculum was 1 × 103–5 × 103 cells mL–1. The extracts were dissolved in DMSO and diluted 100 times
in RPMI 1640 broth. Ten concentrations ranging from 1000 to 1.9 μg mL–1 for the extracts and from 64 to
0.125 μg mL–1 for the compounds were tested against Candida albicans strains in 96-well round-bottom
microtitration plates. The MIC50, MIC90, and MIC100—the lowest concentrations of extracts that caused
growth inhibitions ≥50%, ≥90%, and 100%, respectively—were evaluated. Data was reported as the
median of the MIC.
3. Results and Discussion
3.1. Polyphenols Extraction and HPLC Analysis
The selected freshly defrozen berry samples were submitted to a mild and quick, one-step
double-phase extraction (graphical abstract), which allowed us to obtain the hydroalcoholic fraction
separated by the solid residue and purified by the lipid fraction as already described in a previous
work [10]. The only centrifugation step, followed by a preliminary evaporation of ethanol and the
subsequent freeze-drying, allowed for obtaining a residue that was directly ready for the HPLC analysis
and for the evaluation using the biological tests.
Fresh samples as such, or after homogenization, were also submitted to a dehydration step to
evaluate their water content (about 88%), and the dried samples were extracted in the same conditions
that were applied to the fresh samples. Results, not shown, demonstrate that the dehydration process
did not influence the extraction yield nor the chemical composition of the hydroalcoholic fraction.
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Extraction yields (% w/w) of the hydroalcoholic fraction from goji berries performed with the
above-described conditions from the selected samples accounted for 35–60% in dry weight with mean
values around 43–46%. No statistically relevant differences were observed comparing cultivars type,
harvesting date, seasons, or adopted homogenization technique. Indeed, the homogenization process,
as shown later, had an influence on the quali-quantitative distribution of each analyte. A lower yield
(medium 378 vs 523 mg/g dry weight) was shown for the harvesting dates of season 2016 with respect
to those of 2015, but only for sample P. This could depend on the different maturation stages of the
selected samples, but it seems not relevant for an overall rating.
3.2. HPLC Analysis at 278 nm
From the analysis of the data reported in Table 1 regarding the phenolic profiling of goji berries,
we can first note that, among the 21 phenolic standards, vanillic acid, 4-hydroxy benzoic acid,
3-hydroxy-4-methoxy benzaldehyde, p-coumaric acid, t-ferulic acid, naringin, 2,3-dimethoxy benzoic
acid, benzoic acid, o-coumaric acid, quercetin, harpagoside, and t-cinnamic acid were not detected or
were present in trace amounts (below Limit Of Quantification or Limit Of Detection, data not shown).
The inter- and intra-cultivar differences were huge and did not follow a specific trend. Generally
speaking, Italian cultivars were richer in terms of phenolic compounds with respect to Romanian
ones. Among Italian cultivars (especially for Wild), the last two harvesting dates gave berries richer in
phenolic compounds regardless of the mixing treatment. Chlorogenic acid, carvacrol, and at lower
extent, sinapinic acid were the most-detected metabolites. Conversely, gallic acid, catechin, and
syringic acid were only present in some cultivars and their amounts differed a lot depending on the
applied treatment. Lastly, a few samples were also characterized by low amounts of naringenin (P2D)
and epicatechin (P4U).
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The chromatograms of the flavonoid fraction, recorded at 360 nm, showed the presence of about
10–15 peaks, according to the different analyzed cultivars, among which the most representative was
rutin. In Table 2, rutin and the total flavonoid contents are reported, calculated as rutin equivalents,
after considering all the peaks whose areas were at least 10% of rutin area and taking into account the
standard calibration curve of this molecule. Values are expressed in relation to dry weight (dw) for
a comparison with the literature data and in μg/mg extract for a better evaluation of other data on
bioactivity presented in this work and obtained by the extracts evaluation. Rutin accounted for about
185–400 μg/g dw of goji berries. In the literature, reported values of 281 [30], 296 [36], and 326 μg/g
dw [37] are found, perfectly overlapping with our results. Wider ranges between 159–629 μg/g dw were
reported in Zhang et al. [38] and higher values (730–1380 μg/g dw) were detected in Dong et al. [39].
Many different results were available in the literature regarding the other representative flavonoids
recognized mainly as quercetin hexosides, and secondly as kaempferol and isorhamnetin derivatives.
Zhang et al. [38] reported the quercetin-rhamno-di-hexoside content as 435–1065 μg/g, Donno et al. [14]
reported a hyperoside content of 116 mg/100 g fresh weight, whereas Inbaraj et al. [30] studied different
quercetin-rhamno-hexoside derivatives (in the range of 70–440 μg/g). In our chromatograms, many
different peaks were detected in the flavonoid component, although their identification was not possible.
These were reported as a sum and expressed as rutin equivalents on the basis of its calibration curve.
According to this evaluation, rutin accounted for about 20–65% of the total flavonoid components.
The selected samples did not show relevant differences among cultivars (rutin content mean values:
P = 276 ± 8.3, W = 291 ± 8.7, E = 288 ± 8.6, and B = 255 ± 7.6 μg/g), nor among applied homogenization
processes (D = 287 ± 8.6 vs. U = 279 ± 8.4 μg/g), whereas differences could be revealed in the rutin
content along the maturation stage (i.e., rutin increased by 70%, from P1 to P3, collected a month apart
in July–August 2015 and decreased by 45% from P4 to P5, collected fifteen days apart, in July–August
2016). The total flavonoid content ranged from 380–1600 μg/g with a slight difference between cultivars
P and W (770 ± 38 vs. 910 ± 45 μg/g) and no differences after homogenization treatments D and U
(815 ± 41 vs. 862 ± 43 μg/g).
Table 2. Rutin and flavonoid content of analyzed goji berries hydroalcoholic (HA) extracts. Flavonoids












P1D 467 210 790 0.45 1.69
P2D 548 263 661 0.48 1.28
P3D 528 360 658 0.68 1.25
P4D 410 330 950 0.80 2.31
P5D 340 205 564 0.60 1.66
W1D 422 371 995 0.88 2.36
W2D 472 274 699 0.58 1.48
W3D 493 256 874 0.52 1.77
W4D 430 268 1033 0.62 2.40
W5D 448 336 925 0.75 2.06
P1U 450 184 591 0.41 1.31
P2U 558 335 735 0.60 1.32
P3U 589 316 705 0.54 1.20
P4U 414 317 1598 0.77 3.86
P5U 345 238 428 0.69 1.24
W1U 456 405 1134 0.89 2.49
W2U 506 309 642 0.61 1.27
W3U 494 242 1237 0.49 2.50
W4U 464 198 1183 0.43 2.55
W5U 413 250 374 0.60 0.90
E1D 528 288 1605 0.54 3.04
B1D 420 255 752 0.61 1.79
dw: dry weight.
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As shown by the data, the rutin content increase was usually correlated with a decrease in the
amount of other flavonoid components and vice versa, but this trend was not confirmed by the P4–P5
series. The comparison between the D and U series demonstrated differences between P4D and
P4U samples only in terms of an increase of other flavonoids, whereas W5D and W5U samples were
characterized by discrepancies in terms of rutin and flavonoid amount. Overall, the different ratios
between rutin and other flavonoids in the goji phytocomplex depended on the cultivar type, but
cultivars also seemed highly influenced by the maturation step, as is clearly shown by the sample P.
3.3. Total Phenolic and Flavonoid Content
The total phenolic (TPC)/flavonoid (TFC) content assays are rapid and low-cost methods used for
the screening of herbal or food samples subjected to different processing or treatment procedures [39,40].
In this study, the highest value for the TPC was found in the W4U sample, followed by P4D, whereas
the highest TFC was obtained from the P4U and W4U samples, as seen in Table 3. Interestingly, the
lowest values for the TPC were presented by the samples collected from Romania, while Italian samples
presented overall higher values for TPC. The results obtained in this study for the Italian samples are
comparable with the ones obtained for samples collected in the Umbria region (central Italy) [41], while
the results obtained for the Romanian samples are more comparable with the findings concerning
samples collected from Northern Italy [14]. Furthermore, these results support the evidence that TPC
in our tested goji berries could vary among different genotypes and was strictly dependent on the
pre-harvest practices, cultivar/clone, environmental conditions, and maturity stage at harvest. All
these experimental variables could modulate the accumulation of specific phenolics [42], which are
majorly responsible of the antioxidant and biological activity.
Table 3. Total phenolic (TPC) and flavonoid (TFC) content, 2,2-diphenyl-1-picryl-hydrazyl
(DPPH), 2,2′-azino-bis-(3-ethylbenzothiazoline-6-sulfonate (ABTS) scavenging capacity, ferric reducing
antioxidant power (FRAP), and tyrosinase inhibition of the extracts of Lycium cultivars (values expressed























P1D 19.22 ± 0.52 4.05 ± 0.61 23.84 ± 0.31 26.29 ± 1.65 40.45 ± 0.26 2.12 ± 0.25
P2D 17.09 ± 1.59 3.58 ± 0.11 19.47 ± 0.99 24.62 ± 0.24 34.79 ± 1.13 2.50 ± 0.86
P3D 18.09 ± 0.13 3.87 ± 0.76 20.80 ± 0.74 16.77 ± 4.38 36.85 ± 0.39 2.39 ± 0.53
P4D 22.64 ± 0.97 2.89 ± 0.13 36.63 ± 0.84 36.47 ± 1.42 44.97 ± 0.48 9.69 ± 0.19
P5D 19.50 ± 0.67 2.64 ± 0.17 33.28 ± 2.03 35.58 ± 2.14 44.91 ± 0.61 6.54 ± 0.78
W1D 12.28 ± 1.87 3.18 ± 0.21 16.76 ± 1.03 18.66 ± 2.22 31.88 ± 0.58 2.59 ± 0.35
W2D 20.29 ± 0.88 4.26 ± 0.13 21.24 ± 1.46 16.77 ± 2.83 39.10 ± 1.68 3.17 ± 0.83
W3D 15.33 ± 0.16 3.45 ± 0.13 20.96 ± 0.75 17.99 ± 3.98 37.71 ± 0.33 3.33 ± 0.70
W4D 15.27 ± 0.69 2.39 ± 0.06 29.90 ± 1.57 32.97 ± 2.60 37.84 ± 0.74 8.03 ± 0.85
W5D 19.54 ± 0.70 3.56 ± 0.24 32.14 ± 3.49 40.32 ± 4.01 42.03 ± 0.20 8.42 ± 0.75
P1U 18.86 ± 0.45 3.42 ± 0.10 28.54 ± 0.59 32.58 ± 2.70 40.67 ± 1.16 5.05 ± 0.58
P2U 18.39 ± 1.57 3.87 ± 0.26 25.93 ± 1.79 21.78 ± 3.53 39.10 ± 0.46 3.50 ± 0.29
P3U 19.59 ± 0.73 3.61 ± 0.14 23.86 ± 0.59 21.11 ± 3.94 38.02 ± 0.63 3.72 ± 0.63
P4U 7.69 ± 1.78 11.03 ± 1.24 23.89 ± 2.09 10.75 ± 0.06 45.24 ± 4.69 57.60 ± 0.01
P5U 17.71 ± 0.93 2.77 ± 0.17 30.86 ± 0.86 26.23 ± 2.15 39.43 ± 0.46 6.48 ± 0.16
W1U 17.43 ± 0.30 4.02 ± 0.02 20.90 ± 0.49 19.89 ± 1.65 37.57 ± 1.13 4.33 ± 0.72
W2U 11.83 ± 0.67 3.13 ± 0.24 15.71 ± 0.05 12.20 ± 2.53 27.81 ± 0.46 4.66 ± 0.99
W3U 17.00 ± 0.65 3.24 ± 0.12 20.49 ± 0.62 17.99 ± 0.77 35.96 ± 0.38 1.56 ± 0.74
W4U 23.49 ± 3.36 10.54 ± 0.12 51.93 ± 2.97 14.98 ± 4.40 63.58 ± 13.07 62.79 ± 0.66
W5U 15.10 ± 1.41 2.58 ± 0.09 28.59 ± 2.55 29.13 ± 0.94 35.76 ± 0.30 9.30 ± 0.44
E1D 5.76 ± 0.24 10.47 ± 1.83 23.00 ± 3.66 2.18 ± 0.84 51.14 ± 4.27 59.49 ± 1.33
B1D 3.31 ± 0.66 9.29 ± 0.60 21.56 ± 2.28 na 76.78 ± 7.91 49.35 ± 4.33
na: not active.
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3.4. Antioxidant Activity
The antioxidant capacity of plant extracts and food matrices can be evaluated using several in vitro
assays. Since the results of the antioxidant effect generated by an assay are influenced by the used
protocol, a combination panel of assays is being required. The antioxidant capacity of the several goji
berries cultivars was tested using three different assays to underline the different antioxidant facets of
the investigated samples (Table 3).
3.4.1. Trolox Equivalent Antioxidant Capacity (TEAC) Assay
The TEAC assay measured the ability of goji berries’ phenolic extracts to reduce the in vitro formed
radicals. In this study, among Italian samples, the highest TEAC value was presented by sample W4U
(63.58 ± 13.07 mg TE/g extract), which also presented high values for TPC and TFC. However, the
highest value for the TEAC assay was obtained from the Romanian B1D sample (76.78 ± 7.91 mg
TE/g extract). Zhang et al. [38] reported TEAC values ranging from 47.8 ± 6.6 to 78.2 ± 4.8 μM TE/g
fresh weight for eight different Chinese goji berries genotypes, while Abdennacer et al. [43] reported a
TEAC value of 0.08 mg TE/mg dw for Lycium intricatum Boiss. fruit methanolic extracts. Nonetheless,
Mocan et al. [15] obtained values of 24.86 ± 2.15 and 25.12 ± 2.11 mg TE/g extract for 70% methanolic
extracts obtained using sonication of the same Romanian cultivars of goji berries.
3.4.2. DPPH Radical Scavenging Assay
The DPPH radical scavenging assay is among the most frequently used antioxidant assays and
offers a first approach for evaluating the antioxidant capacity of a complex mixture [44]. In the current
research, the DPPH activity of the tested goji berries ranged from na (not active, B1D sample) to the
highest value of 40.32 ± 4.01 mg TE/g extract (for the Italian W5D sample). Zhang et al. [38] obtained
values ranging between 35.88 ± 2.2 to 85.46 ± 1.9 μM TE/g fresh weight for the DPPH antioxidant
capacity assay from eight Chinese goji genotypes, while Abdennacer et al. [43] reported a value of
0.05 mg TE/mg dry weight for the methanolic extracts of fruits of Tunisian Lycium intricatum.
3.4.3. FRAP Assay
The FRAP assay is an electron transfer-based method that measures the reduction of the ferric
ion (Fe3+)-ligand complex to the intensely blue colored ferrous (Fe2+) complex via antioxidants in an
acidic environment [44]. In this study, the highest reducing power was presented by the Italian W4U
sample with a value of 51.93 ± 2.97 mg TE/g extract, followed by the P4D sample (36.63 ± 0.84 mg TE/g
extract), while the lowest value was obtained for Italian W2U sample (15.71 ± 0.05 mg TE/g extract).
Overall, the different trends and results obtained in the antioxidant capacity assays show that
the contents of total phenolics and flavonoids could not sufficiently explain the observed antioxidant
activity of fruit and plant phenolic extracts, which are mixtures of different compounds with various
activities in the tested samples [42].
3.5. Enzyme Inhibitory Activity
Tyrosinase inhibitors can be attractive for cosmetic and pharmaceutical industries as
depigmentation agents, as well as in food and agriculture industries as anti-browning compounds.
Goji berry extracts have been previously described as tyrosinase inhibitors [15] and are currently used
as natural ingredients in several market-available cosmetic or dermato-cosmetic preparations. In this
study, the tyrosinase inhibitory activity of the tested goji extracts ranged between 1.56 ± 0.74 mg KAE/g
extract for the W3U sample to 62.79 ± 0.66 for the W4U sample. The second-highest value in terms
of tyrosinase inhibition was obtained for the Romanian E1D sample (59.49 ± 1.33 mg KAE/g extract),
while the two samples from Romania generally exhibited a higher tyrosinase inhibitory potential than
samples from Italy, except sample W4U.
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3.6. Anti-Candida Activity of Extracts
Antifungal activity was demonstrated via a broth microdilution method, using the standard drug
fluconazole as a positive control. Among the different goji extracts tested against three Candida albicans
strains, P samples displayed the best inhibitory activity. In particular, P1D, P1U, W1D, W1U, E1D, and
B1D showed MIC50 values of 138 μg mL–1, 186 μg mL–1, 238 μg mL–1, 250 μg mL–1, >1000 μg mL–1,
and >1000 μg mL–1, respectively, against all Candida albicans strains. Samples harvested at different
commercial harvesting periods showed different MIC values. Interestingly, the P1D sample, harvested
on 6 July 2015, was endowed with the best antifungal activity compared to the other harvesting periods
(P2D, P3D, P4D and P5D) with a MIC100 of 476 μg mL–1, 552 μg mL–1, 609 μg mL–1, >1000 μg mL–1,
and >1000 μg mL–1, respectively against all the considered strains (Table 4).
Table 4. Antifungal activity of goji berry extracts and reference compounds expressed as an MIC (μg/mL).
Sample







50 90 100 50 90 100 50 90 100
P1D 125 250 500 281.25 312.5 625 93.75 250 500
P2D 250 250 500 375 375 750 125 250 500
P3D 250 250 500 375 500 1000 187.5 250 500
P4D 125 1000 >1000 500 1000 >1000 500 1000 >1000
P5D 250 1000 >1000 500 1000 >1000 500 1000 >1000
P1U 125 187.5 375 375 500 1000 250 375 750
P2U 250 250 500 375 500 1000 250 250 500
P3U 250 250 500 375 500 1000 250 250 500
P4U 125 250 1000 250 500 1000 250 500 1000
P5U 250 500 1000 250 500 1000 500 1000 1000
W1D 250 250 500 500 500 1000 187.5 250 500
W2D 250 250 500 500 500 1000 187.5 250 500
W3D 250 250 500 500 500 1000 250 250 500
W4D 125 1000 >1000 500 1000 >1000 500 1000 >1000
W5D 125 1000 >1000 500 1000 >1000 500 1000 >1000
W1U 187.5 250 500 500 500 1000 250 375 500
W2U 250 375 500 500 500 1000 375 375 750
W3U 250 250 500 500 500 1000 125 250 500
W4U 250 250 >1000 500 1000 >1000 500 1000 >1000
W5U 250 1000 >1000 500 1000 >1000 500 1000 >1000
E1D >1000 >1000 >1000 >1000 >1000 >1000 >1000 >1000 >1000
B1D >1000 >1000 >1000 >1000 >1000 >1000 >1000 >1000 >1000
Rutin 64 >64 >64 64 >64 >64 64 >64 >64
Carvacrol 0.25 1 2 0.25 1 2 0.125 0.25 0.5
Fluconazole 0.5 2 8 1 4 >64 0.5 2 8
* The data are expressed as a median.
Due to the presence in these extracts of considerable amounts of well-recognized antimicrobial
metabolites, we further tested rutin and carvacrol against the same fungal strains [45]. Rutin was
almost inactive with MIC values ≥64 μg/mL. Conversely, carvacrol displayed a strong inhibitory
activity against C. albicans with MIC50 ranging from 0.125 μg/mL to 0.25 μg/mL. Despite the high
amount of carvacrol present in B1D (Table 1), it displayed a weak anti-fungal activity thus suggesting
that the concurrent presence of other secondary metabolites can enhance or decrease the bioactivity of
these goji extracts.
Furthermore, considering the quantified components and the explicated anti-Candida effects, W4U
represented the sample characterized by a higher amount of detected secondary metabolites and
a positive upward trend in the biological activity. Many components, other than those quantified
using the HPLC analyses, could contribute to the TPC and TFC of the W4U sample, whose activity
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was evidently correlated not only with the single analytes, even though they represented the most
representative molecules in weight terms, but also in the complexity of the phytocomplex, evidently
characterized by many different minor components. However, this clearly shows how important the
work-up is in the preservation of many components (especially for flavonoid compounds, considering
the effect of U on P) represented in extremely low concentrations. The high flavonoid component
seemed to correlate, in particular, with a marked activity on tyrosinase.
4. Conclusions
Despite the long tradition in nutrition and medicine, the goji berry’s composition is strictly related
to the geographical origin (soil type, climate), cultivar type, harvesting time, and industrial/domestic
processing. The changes of the phytochemical profile have a deep influence on the bioactivity of this
herbal medicinal/edible product. Our investigation aimed at the identification of the main bioactive
components that are responsible for selected biological activities. The HPLC analytical fingerprint was
characterized by a variable amount of phenolic compounds, mainly depending on the geographical
origin, cultivar type, homogenization treatment, and above all, harvesting period. Moreover, we
highlighted, by means of an array of different assays, this valuable natural matrix in terms of the
antioxidant activity, anti-fungal activity, and inhibition of tyrosinase, aiming at the correlation between
the phytochemical profile and the reported bioactivity. These data could be of high interest in the
formulation of new goji-based food supplements and for further pharmaceutical development of this
valuable plant matrix.
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31. Mocan, A.; Crişan, G.; Vlase, L.; Crişan, O.; Vodnar, D.C.; Raita, O.; Gheldiu, A.M.; Toiu, A.; Oprean, R.;
Tilea, I. Comparative studies on polyphenolic composition, antioxidant and antimicrobial activities of
Schisandra chinensis leaves and fruits. Molecules 2014, 19, 15162–15179. [CrossRef]
32. Martins, N.; Barros, L.; Dueñas, M.; Santos-Buelga, C.; Ferreira, I.C.F.R. Characterization of phenolic
compounds and antioxidant properties of Glycyrrhiza glabra L. rhizomes and roots. RSC Adv. 2015, 5,
26991–26997. [CrossRef]
33. Damiano, S.; Forino, M.; De, A.; Vitali, L.A.; Lupidi, G.; Taglialatela-Scafati, O. Antioxidant and antibiofilm
activities of secondary metabolites from Ziziphus jujuba leaves used for infusion preparation. Food Chem.
2017, 230, 24–29. [CrossRef] [PubMed]
34. Masuda, T.; Yamashita, D.; Takeda, Y.; Yonemori, S. Screening for tyrosinase inhibitors among extracts of
seashore plants and identification of potent inhibitors from Garcinia subelliptica. Biosci. Biotechnol. Biochem.
2005, 69, 197–201. [CrossRef] [PubMed]
35. Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility
Testing of Yeasts, 4th ed.; CLSI document M27; CLSI: Wayne, PA, USA, 2017.
36. Le, K.; Chiu, F.; Ng, K. Identification and quantification of antioxidants in Fructus lycii. Food Chem. 2007, 105,
353–363. [CrossRef]
37. De Moura, C.; dos Reis, A.S.; da Silva, L.D.; de Lima, V.A.; Oldoni, T.L.C.; Pereira, C.; Carpes, S.T. Optimization
of phenolic compounds extraction with antioxidant activity from açaí, blueberry and goji berry using response
surface methodology. Emir. J. Food Agr. 2018, 30, 180–189.
38. Zhang, Q.; Chen, W.; Zhao, J.; Xi, W. Functional constituents and antioxidant activities of eight Chinese
native goji genotypes. Food Chem. 2016, 200, 230–236. [CrossRef]
39. Dong, J.Z.; Lu, D.Y.; Wang, Y. Analysis of flavonoids from leaves of cultivated Lycium barbarum L. Plant Foods
Hum. Nutr. 2009, 64, 199–204. [CrossRef]
40. Granato, D.; Shahidi, F.; Wrolstad, R.; Kilmartin, P.; Melton, L.D.; Hidalgo, F.J.; Miyashita, K.; Camp, J.V.;
Alasalvar, C.; Ismail, A.B.; et al. Antioxidant activity, total phenolics and flavonoids contents: Should we ban
in vitro screening methods? Food Chem. 2018, 264, 471–475. [CrossRef]
41. Ceccarini, M.R.; Vannini, S.; Cataldi, S.; Moretti, M.; Villarini, M.; Fioretti, B.; Albi, E.; Beccari, T.; Codini, M.
In vitro protective effects of Lycium barbarum berries cultivated in Umbria (Italy) on human hepatocellular
carcinoma cells. Biomed Res. Int. 2016, 2016, 7529521. [CrossRef]
42. Abeywickrama, G.; Debnath, S.C.; Ambigaipalan, P.; Shahidi, F. Phenolics of selected cranberry genotypes
(Vaccinium macrocarpon Ait.) and their antioxidant efficacy. J. Agric. Food Chem. 2016, 64, 9342–9351.
[CrossRef]
43. Abdennacer, B.; Karim, M.; Yassine, M.; Nesrine, R.; Mouna, D.; Mohamed, B. Determination of
phytochemicals and antioxidant activity of methanol extracts obtained from the fruit and leaves of Tunisian
Lycium intricatum Boiss. Food Chem. 2015, 174, 577–584. [CrossRef] [PubMed]
44. Shahidi, F.; Zhong, Y. Measurement of antioxidant activity. J. Funct. Food 2015, 18, 757–781. [CrossRef]
45. Orhan, D.D.; Ozçelik, B.; Ozgen, S.; Ergun, F. Antibacterial, antifungal, and antiviral activities of some
flavonoids. Microbiol. Res. 2010, 165, 496–504. [CrossRef] [PubMed]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution




Exploring Target Genes Involved in the Effect of
Quercetin on the Response to Oxidative Stress in
Caenorhabditis elegans
Begoña Ayuda-Durán 1, Susana González-Manzano 1, Antonio Miranda-Vizuete 2,
Eva Sánchez-Hernández 1, Marta R. Romero 3, Montserrat Dueñas 1, Celestino Santos-Buelga 1,*
and Ana M. González-Paramás 1
1 Grupo de Investigación en Polifenoles, Universidad de Salamanca, Campus Miguel de Unamuno,
37007 Salamanca, Spain; bego_ayuda@usal.es (B.A.-D.); susanagm@usal.es (S.G.-M.);
evasanher@usal.es (E.S.-H.); mduenas@usal.es (M.D.); paramas@usal.es (A.M.G.-P.)
2 Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla,
41013 Sevilla, Spain; amiranda-ibis@us.es
3 Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Experimental Hepatology and Drug
Targeting (HEVEFARM), Universidad de Salamanca, Institute for Biomedical Research of
Salamanca (IBSAL), 37007 Salamanca, Spain; marta.rodriguez@usal.es
* Correspondence: csb@usal.es
Received: 15 November 2019; Accepted: 20 November 2019; Published: 25 November 2019
Abstract: Quercetin is one the most abundant flavonoids in the human diet. Although it is well
known that quercetin exhibits a range of biological activities, the mechanisms behind these activities
remain unresolved. The aim of this work is to progress in the knowledge of the molecular mechanisms
involved in the biological effects of quercetin using Caenorhabditis elegans as a model organism.
With this aim, the nematode has been used to explore the ability of this flavonoid to modulate
the insulin/insulin-like growth factor 1(IGF-1) signaling pathway (IIS) and the expression of some
genes related to stress response. Different methodological approaches have been used, i.e., assays in
knockout mutant worms, gene expression assessment by RT-qPCR, and C. elegans transgenic strains
expressing green fluorescent protein (GFP) reporters. The results showed that the improvement of
the oxidative stress resistance of C. elegans induced by quercetin could be explained, at least in part,
by the modulation of the insulin signaling pathway, involving genes age-1, akt-1, akt-2, daf-18, sgk-1,
daf-2, and skn-1. However, this effect could be independent of the transcription factors DAF-16 and
HSF-1 that regulate this pathway. Moreover, quercetin was also able to increase expression of hsp-16.2
in aged worms. This observation could be of particular interest to explain the effects of enhanced
lifespan and greater resistance to stress induced by quercetin in C. elegans, since the expression of
many heat shock proteins diminishes in aging worms.
Keywords: quercetin; IIS pathway; C. elegans; oxidative stress
1. Introduction
Quercetin (Q) is the most abundant flavonol in the human diet, being present in a wide
variety of plant-derived foods, such as nuts, grapes, onions, broccoli, apples, or black tea.
Dietary quercetin consumption has been associated to different health benefits, including antioxidant
and anti-inflammatory effects and protection against aging-related diseases, such as cardiovascular
pathologies, cancer, and neurodegenerative disorders [1–3]. Classically, these actions have been
explained, at least in part, by its antioxidant and free-radical scavenging properties, as demonstrated
in in vitro studies [4,5], although the actual mechanisms through which quercetin and other flavonoids
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exert their in vivo effects remain unresolved. Understanding the molecular mechanisms by which Q
can exert its biological activity is important in order to develop strategies to modulate the physiological
changes associated with aging that lead to chronic diseases. Although studies with quercetin and
other flavonoids using in vivo models have increased in recent years, most of the knowledge on their
biological activity still derives from in vitro or ex vivo findings, while assays that consider complex
interactions of various processes, such as absorption, metabolism, and interaction with organs and
tissues are more limited [6].
Some important molecular pathways in complex organisms can be explored using the model
organism Caenorhabditis elegans. There is a high degree of homology between C. elegans and human
genes involved in different processes, such as aging, apoptosis, cell signaling, cell polarity, metabolism,
or cell cycle, which are conserved between mammals and the nematode [7]. In fact, C. elegans offers
promising possibilities to study mechanisms of action and effects of secondary compounds of foods
and plants, due to its simplicity of handling, conservation of metabolic pathways, and the possibility
of manipulating cell signaling routes by biotechnological methods. In addition, it is not pathogenic,
and no ethical boundaries exist to its experimental usage.
Different studies have evaluated the biological effects of quercetin and related compounds in
C. elegans. In a previous work, we have shown that growing C. elegans in the presence of 200 μM of
Q or its 3′- and 4′-O-methylated metabolites significantly prolonged the lifespan and increased the
resistance against thermal- and juglone-induced oxidative stress [8]. Further support was obtained
by checking the oxidation status of proteins in the nematode, which was greatly reduced [8]. Similar
observations were also made by other authors [9–13]. Treatment with Q was also seen to lead to a
reduction in the intracellular levels of reactive oxygen species (ROS), either in nematodes subjected to or
not subjected to stress [11,13–15]. In general, these studies show that Q possesses a relevant biological
activity in an in vivo system, which results in greater protection against oxidative processes. Regarding
worm lifespan, an extension has been found in worms grown in the presence of concentrations of
Q between 70 and 200 μM, while no lifespan extension was observed for Q concentrations outside
that range. On the contrary, a hormetic response of the worm to this phytochemical has been
demonstrated, so that the increase in the concentration of quercetin above certain levels results in
decreased survival [16]. Nevertheless, the molecular mechanisms through which these effects are
produced are still unclear, and different explanations, sometimes apparently contradictory, have been
offered by distinct authors [9–14].
The response to oxidative stress in C. elegans is regulated through several pathways, including those
of insulin/IGF-1 (IIS), c-Jun N-terminal kinases (JNK), and the signaling p38 MAPK (mitogen-activated
protein kinases) pathway [17–19]. The IIS pathway (Figure 1) controls many important biological
processes, including development, reproduction, metabolism, somatic maintenance, and stress
resistance [20]. Insulin-like peptides binding to DAF-2, the orthologue of the insulin/IGF-1
receptor in C. elegans [21], activate its tyrosine kinase activity. This activation triggers a cascade
of phosphorylation events through different kinases (AGE-1/PI3k, PDK-1, AKT-1/2, and SGK-1) that
promote the phosphorylation-dependent cytoplasmic sequestration of the factors DAF-16/FoxO, HSF-1,
and SKN-1/Nrf, preventing their transcriptional activity [22]. On the other hand, loss of insulin signaling
in C. elegans results in several cytoprotective phenotypes resistant to both thermal and oxidative stress
and also increases pathogen resistance and lifespan [23]. Flavonoids could influence cellular systems
changing the expression of different genes through the modulation of distinct transcription factors,
acting simultaneously on various signaling pathways, including the IIS pathway [24].
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Figure 1. Scheme of the insulin/IGF-1 signaling pathway (IIS) in C. elegans. The components of the
pathway that promote IIS are colored red and those that either antagonize IIS or are antagonized by IIS
are colored green.
In order to contribute to elucidate the mechanisms involved in the effects of flavonoids, in this
work, the ability of quercetin to modulate the insulin/IGF-1 signaling pathway (IIS) has been explored.
Specifically, the influence on the resistance to thermally-induced oxidative stress has been assessed
using C. elegans strains with loss-of-function mutations in genes of the IIS pathway (i.e., daf-2, age-1,
daf-16, akt-1, akt-2; sgk-1, hsf-1, skn-1, and daf-18). Additionally, the ability of Q to modify the expression
of some genes related to stress, namely daf-16, hsf-1, skn-1, hsp-16.2, hsp-70, sod-3, and gst-4, has also
been determined by RT-qPCR or using the GFP fluorescent reporter in C. elegans transgenic strains.
2. Materials and Methods
2.1. Standards and Reagents
Quercetin (Q), ampicillin sodium salt, nistatine, agar, yeast extract, fluorodeoxyuridine
(FUdR), phosphate-buffered saline (PBS), cholesterol, and 2-mercaptoethanol, were purchased from
Sigma-Aldrich (Madrid, Spain). Dimethyl sulfoxide (DMSO) was obtained from Panreac (Barcelona,
Spain). SYBR® SelectMaster Mix and high-capacity cDNA reverse transcription kit were from Applied
Biosystems (Carlsbad, CA, USA), and the Illustra™ RNAspin mini isolation kit was from GE Healthcare
(Buckinghamshare, UK).
2.2. Strains and Maintenance Conditions
The wild-type strain N2 and the mutant strains VC475, hsp-16.2(gk249) V; CB1270, daf-2 (e1370)
III; TJ1052, age-1(hx546) II; CF1038, daf-16(mu86) I; CB1375, daf-18(e1375) IV; BQ1, akt-1(mg306) V;
KQ1323, akt-2(tm812) sgk-1(ft15) X; PS3551, hsf-1(sy441) I; EU1, skn-1(zu67) IV/nT1(unc-?(n754)let-?)
(IV;V); CF1553, muls84 ((Psod-3::gfp)); TJ356, zIs356 (Pdaf-16::daf-16::gfp; rol-6 (su1006)) IV; CL2166,
dvIs19 ((Pgst-4::gfp::NLS; rol-6 (su1006)) III; AM446, rmIs223 (Phsp70::gfp; rol-6(su1006)); CL2070,
dvIs70 (Phsp-16.2::gfp; rol-6 (su1006)), as well as the E. coli OP50 bacterial strain, were obtained from
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the Caenorhabditis Genetics Center (CGC) at the University of Minnesota (Minneapolis, MN, USA).
Worms were routinely propagated at 20 ◦C on nematode growth medium (NGM) plates with E. coli
OP50 as a food source.
Synchronization of worm cultures was achieved by treating gravid hermaphrodites with bleach:
5N NaOH (2:1). Eggs are resistant whereas worms are dissolved in the bleach solution. The suspension
was shaken with a vortex mixer during 1 min and kept for a further minute on rest, this process was
repeated five times. The suspension was centrifuged (2 min, 9500 g). The pellet containing the eggs
was washed six times with an equal volume of buffer M9 (3 g KH2PO4, 6 g Na2HPO4, 5 g NaCl, 1 mL
1M MgSO4, H2O to 1 L). Quercetin solution (200 mM) in DMSO was added to the nematode growth
medium during its preparation to get a 200 μM final concentration on the plates. Control plates were
also prepared without the flavonoid but containing the same volume of DMSO (0.1% DMSO, v/v).
Around 100 to 300 μL of the M9 with eggs (depending on eggs Øconcentration) were transferred
and incubated on NGM agar plates with or without Q. When the worms reached the L4 stage, they
were transferred to new plates with or without Q but also containing FUdR at a concentration of 150
μM to prevent reproduction and progeny overgrowth. The worms were transferred every 2 days to
fresh plates with FUdR for the different treatments (with or without Q) until they reached the day of
the assay.
2.3. Stress Assays
Oxidative stress in worms was induced by subjecting the animals to 35 ◦C heat-shock treatment.
Worms were incubated at 20 ◦C on NGM-E. coli OP50 plates with or without Q until days 2 and 9 of
adulthood. Then they were transferred with a platinum wire to agar plates Ø 35 mm, 20 worms per
plate) and switched to 35 ◦C for 4, 6, or 8 h. The time was decided depending on the thermotolerance
of the specific worm strain used in the assay, which was previously checked. After that time, dead
and alive nematodes were counted. In the studies involving the use of worm mutants, in addition
to the mutant control, a parallel control using N2 wild-type (WT) worms was also included. For the
assays, ten plates were used per treatment containing 20 worms per plate, resulting in a total of
200 worms, although a small percentage of worms was usually lost in the score. Only in the case
of the skn-1 mutant (EU1) were 300 worms (20 worms per plate/15 plates) used. According to the
information supplied by the CGC, the work with this mutant required special considerations, as only
the homozygote worms with WT appearance are considered for the assay, while the uncoordinated
heterozygote worms are only employed to maintain the lineage. To have reproducible results in the
heat shock assays, that is, to have the smallest possible temperature oscillations, some precautions
were followed, in agreement with the guidelines stated in the reference paper [25]. During assays, the
door of the incubator was only opened when the survival rate had to be measured. The plates were
not stacked inside the incubator, they were placed in a row on the same shelf of the incubator, leaving
enough space between them for the air to circulate properly. The temperature was controlled with
the incubator’s own thermostat and with an external thermostat with sensors inside the incubator to
monitor possible temperature oscillations.
2.4. RT-qPCR Assays
Adult worms of the N2 C. elegans strain were treated with or without 200 μM of Q for 4 days.
The worms were collected with M9 buffer, centrifuged at 10,000 g for 1 min, and the pellet was
dissolved in 300 μL of M9, to which 3.5 μL of 2-mercaptoethanol was added. Total RNA was extracted
using the RNAspin Mini RNA Isolation Kit (GE Healthcare). In order to maximize cell breakage,
in the first stage of the extraction, 10 stainless-steel beads (2 mm) were added. The mixture was
vortex shaken vigorously and further homogenized in a Thermo Savant FastPrep 120 Cell Disrupter
System, with a speed of 5.5 m/s and run time duration of 10 s, five times. cDNA was produced
with high-capacity cDNA reverse transcription kit (Applied Biosystems) using 2 μg of total RNA per
reaction. The expression of mRNA was assessed by quantitative real-time PCR, using SYBR green as
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the detection method. The gene expression data were analyzed using the comparative 2−ΔΔCt method,
with act-1 as the normalizer [26]. Nine independent experiments were performed. Act-1 was used as a
normalizer both in the assays carried out in non-stressed and stressed worms. The information related
to gene-specific primers used in this work can be found in the Supplementary Table S1.
2.5. Fluorescence Quantification and Visualization
Synchronized L1 larvae expressing an inducible green fluorescent protein (GFP) reporter for
gst-4, hsp-16.2, hsp-70, sod-3, and daf-16 genes were grown on NMG plates in the presence or absence
of Q until the day of the assay, when they were subjected to or not subjected to thermally-induced
oxidative stress (35 ◦C, 1 h). The precise day of assay was defined when a higher intensity of the
fluorescence was observed after carrying out a screening with the different strains throughout the life
of the worm, namely, day 3 in gst-4 and day 5 in hsp-70. For the remaining strains, as no clear increase
in the fluorescence was observed, the assessment was made in young (day 2 of adulthood) and older
adult worms (day 9 of adulthood). In the cases of hsp-16.2 and hsp-70 reporter strains, after thermal
stress, the worms were allowed to recover at 20 ◦C for 2 or 3 h respectively, before pictures were taken.
The expression of gst-4, hsp-16.2, hsp-70, and sod-3 was measured by quantifying the fluorescence of
the GFP reporter. To analyze the subcellular localization of the DAF-16::GFP reporter, worms were
classified as diffuse cytoplasmic, intermediate cytoplasmic/nuclear, and strong nuclear translocation.
Approximately 35 randomly selected worms for each experiment were mounted in a 5 μL drop of
10 mM levamisole (except for DAF-16::GFP in 2% sodium azide) on a 3% agarose pad covered with a
coverslip. All fluorescence determinations were done in an Olympus BX61 fluorescence microscope
equipped with a filter set (excitation 470 ± 20 mn, emission 500 ± 20 nm) and a DP72 digital camera
coupled to CellSens Software for image acquisition and analysis. ImageJ software was used to quantify
fluorescence intensity. Three independent experiments were performed per assay and reporter strain.
2.6. Statistical Analysis
The statistical analyses were performed using the PC software package SPSS (version 23.0;
SPSS Inc., Chicago, IL, USA). Analysis of variance (ANOVA) was applied for multiple comparisons of
values to determine possible significant differences between treated and control groups. To analyze
survival to thermal stress, contingency tables were prepared, and statistical significance was calculated
using the Chi Square Test.
3. Results and Discussion
3.1. Assays in Wild Type and Mutant Worms
An enhancement in the survival was observed in N2 wild-type worms treated with Q 200 μM after
being subjected to thermal stress compared with non-treated controls. Specifically, in the assays carried
out on the second day of adulthood, the average proportion of living worms after stress was 64.78% in
the control group and 81.11% in Q-treated worms (p = 0.000), while on the ninth day of adulthood,
the survival rate was 35.1% in untreated worms and 47.2% in treated animals (p = 0.001) (Figure 2).
The molecular mechanisms involved in this enhancement of thermotolerance were explored,
checking the ability of Q to modulate the stress resistance in C. elegans mutant strains. Initially, the effect
of Q on thermal stress resistance was evaluated in worms carrying loss of function mutations in
genes of the IIS pathway, namely age-1(hx546), akt-1(mg306), daf-2(e1370), and the double mutant
akt-2(tm812); sgk-1(ft15), all of them long-lived and with greater resistance to stress than the wild-type
strain. Similar to the wild-type, mutant worms were subjected to a thermal shock (35 ◦C, 6–8 h) on days
2 and 9 of adulthood. The obtained results showed that the stress resistance was not increased in any
of the mutant worms treated with quercetin at either day 2 or 9 (Figure 3). These results suggested that
age-1, akt-1, akt-2, sgk-1, and daf-2 were necessary to mediate stress resistance induced by Q in C. elegans.
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B) 9th of adulthood 
Figure 2. Percentages of survival following thermal stress (35 ◦C, 8 h) applied at days (A) 2 and (B)
9 of adulthood in N2 wild-type C. elegans strain not treated (controls) and treated with Q (200 μM).
Statistical significance was calculated using the Chi Square Test (200–300 individuals per assay in both
controls and treated worms). The asterisks (***) indicate significant differences at p < 0.001.
Pietsch et al. [11] also studied the effect of Q in some of these mutants. As in our case, they did not
find an improvement in the survival after thermal stress in daf-2 and age-1 mutants treated with 200 μM
quercetin, concluding that that those genes were required to mediate the stress-protective effects of the
flavonol. However, they found that the treatment with Q unexpectedly produced an improvement
in the resistance to stress in the akt-2 mutant, a gene located downstream of DAF-2 and AGE-1 in
the IIS pathway. They proposed that this could be explained because SGK-1 was more important for
resistance to stress than the AKT kinases [11]. In the present study, no increase in the survival after
thermal stress was observed in the double-mutant akt-2;sgk-1 treated with Q (Figure 3), suggesting that
sgk-1 could actually be necessary to improve the resistance to stress by quercetin. Similarly, no changes
in the survival after stress were produced in Q-treated akt-1 mutants, a gene that encodes an ortholog
of serine/threonine kinase AKT/PKB and interacts with the IIS pathway. This indicates that the kinase
akt-1 was also necessary for the improvement in the resistance to stress in C. elegans.
The resistance to thermal stress in response to Q was also studied in daf-16, hsf-1, skn-1, daf-18,
and hsp-16.2 mutant worms. The transcription factors DAF-16, HSF-1, and SKN-1 produce changes
in the expression of several genes in response to a reduced IIS pathway. The genes regulated by
these transcription factors are functionally relevant, including stress response genes, such as catalases,
glutathione-S-transferases, metallothioneins, and genes that encode antimicrobial peptides, chaperones
like hsp-16.2, apolipoproteins, and lipases [27]. As it can observed in Figure 4, the treatment with Q did
not improve the survival in daf-18, skn-1, and hsp-16.2 mutants exposed to thermal stress, suggesting
that these genes would be necessary to explain the effect of Q in worm resistance against stress.
However, the treatment with Q continued to produce an improvement in the resistance to thermal
stress in daf-16 and hsf-1 mutants, indicating that the effect of Q in C. elegans was independent of these
genes. Similar results on the influence of Q were obtained in young and older adults in the studied
mutants (Figure 4).
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2nd day of adulthood 9th day of adulthood
Figure 3. Percentages of survival following thermal stress (35 ◦C, 8 h) applied at days 2 (A–D.1) and
9 (A–D.2) of adulthood in different long-lived C. elegans mutants from the IIS pathway: daf-2(e1370) (A),
age-1(hx546) (B), akt-1(mg306) and akt-2(tm812) (C); sgk-1(ft15) (D) cultivated in the absence (controls)
and presence of Q (200 μM). Statistical significance was calculated using the Chi Square Test. In both
controls and treated worms, ten plates were used per assay containing 20 worms per plate (i.e.,
200 worms in total). The asterisk (*) indicates significant differences at p < 0.05.
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Figure 4. Percentages of survival following thermal stress (35 ◦C, 6 h; except for hsp-16.2 (35 ◦C, 4 h))
applied at days 2 (A–E.1) and 9 (A–E.2) of adulthood in daf-16 (mu86) (A), hsf-1(sy441) (B), skn-1(zu67)
(C), daf-18(e1375) (D) and hsp-16.2(gk249) (E) mutants cultivated in the absence (controls) and presence
of Q (200 μM). Statistical significance was calculated using the Chi Square Test. In both controls and
treated worms, ten plates were used per assay containing 20 worms per plate (i.e., 200 worms in total),
but in the case of the skn-1 mutant, 300 worms (20 worms per plate/15 plates) were used. The asterisk
(*) indicates significant differences at p < 0.05 on comparing with control.
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3.2. q-RT-PCR Analyses
The influence of quercetin on some transcription factors and target genes of the IIS pathway was
also explored by quantification of the expression of daf-16, hsf-1, skn-1, daf-18, and hsf-16.2 by RT-qPCR
in wild type worms, both submitted and not submitted to thermal stress (5 h, 35 ◦C) after growing 4
days in the presence of the flavonol. As it can be seen in Figure 5, the treatment with Q did not modify
the expression of daf-18 either after subjecting or not subjecting the worms to thermal stress. However,
the results previously obtained with the mutants (Figure 4) indicated that daf-18 could be involved in
the protective effects of quercetin against stress. A possible explanation to this apparent contradiction
could be that the result obtained in the daf-18 mutant is rather reflecting the involvement of the
protein kinase AGE-1, as the DAF-18/phosphatase and tensin homolog (PTEN)protein is responsible
for dephosphorylating and inhibiting AGE-1/PI3K, counteracting its activity [21]. Another possibility









































B) Worms subjected to stress 
Control
Q
Figure 5. Effect of Q on the expression of daf-16, hsf-1, skn-1, daf-18, and hsp-16.2 genes in N2 C. elegans
cultivated in the absence (controls) and presence of Q (200 μM) (A) under non-stressed conditions or
(B) after subjecting them to thermal stress. The expression level was determined by RT-qPCR. act-1
was used as housekeeping control. Nine independent experiments were performed. The results are
presented as the mean values± Standard Error of the Mean (SEM). Statistical significance was calculated
using by one-way analysis of variance (ANOVA). The asterisk (*) indicates significant differences at
p < 0.05.
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Similarly, the expression of hsf-1 was not modified by the treatment with Q, neither in normal
growing conditions nor after application of thermal stress (35 ◦C, 5 h) (Figure 5). This result would
confirm that the heat transcription factor hsf-1 is not involved in the effects of Q on stress resistance,
supporting the above-described observations on hsf-1 mutants (Figure 4). In a previous study on hsf-1
loss of function mutants, Fitzenberger et al. [28] also found that this gene was not required to explain
the ability of Q to prevent the glucose-induced reduction of survival in C. elegans.
The treatment with Q did not produce changes in the expression of daf-16 (Figure 5). Together
with the findings obtained in the assays with mutants, these results seem to confirm that the effect
of Q on worm stress resistance is independent of daf-16. Other authors had already studied the
involvement of daf-16 in the effects of Q using knockout worms [10,11,13], finding that Q continued
improving longevity and resistance to thermal and hydrogen peroxide-induced oxidative stress in
daf-16 mutants, which suggest that this gene was not essential for the effects of quercetin, observations
that are consistent with the results obtained herein, either in worms subjected or not subjected to stress.
SKN-1 is the homologue of Nrf-2 transcription factor, which regulates oxidative stress response
and lifespan, mobilizing the conserved phase 2 detoxification response [29]. No differences were
found in the expression of skn-1 between worms treated or not treated with Q and not subjected to
stress (Figure 5A), which seems in agreement with the observations of Pietsch et al. [11], who reported
that quercetin induced an increase in the lifespan of skn-1 mutants under normal growth conditions,
indicating that the effects of this flavonoid in the absence of stress are independent of that gene.
However, the results obtained with the skn-1 mutants (Figure 4) indicated that this gene is a mediator
in the protective effects of Q against stress. Tullet et al. [29,30] suggested that SKN-1 is a transcriptional
co-regulator of DAF-16 regarding resistance to oxidative stress and the expression of detoxification
genes in response to a reduced IIS signal, but it extends worm half-life independently of DAF-16. This
dual function of skn-1 might be coherent with the results observed herein, where Q did not change the
skn-1 expression in absence of stress, although this gene seems to be necessary in the improvement of
resistance to thermal stress mediated by Q.
The influence of Q on thermal shock proteins HSP-16.2, whose expression is influenced by the IIS,
was also studied. As shown in Figure 5, the treatment with Q induced an increase in the expression of
hsp-16.2, either without or with stress. However, the differences were more noticeable in the absence
of stress, which could possibly be explained by the already strong induction of HSP-16.2 caused by
the thermal stress, which would make the effect induced by Q treatment less relevant. Together with
the results in the hsp-16.2 mutants, where a decrease in the resistance to thermal stress was observed
in quercetin-treated worms (Figure 4), it appears that thermal shock proteins can be involved in the
protective effects of the flavonol against stress.
All in all, the obtained results showed that, at least in part, the IIS pathway would be involved in
the improvement to thermotolerance induced by Q, entailing the genes age-1, akt-1, akt-2, sgk-1, daf-2,
daf-18, skn-1, and hsp-16.2, but independent of daf-16 and hsf-1. In addition, the involvement of these
genes was not modified by the age of the worm. Previous studies by our group with epicatechin also
showed that the enhanced stress resistance induced by this flavan-3-ol in C. elegans was also mediated
by the IIS pathway, although it did not necessarily involve the same genes, as in that case the expression
levels of the main transcription factors of the pathway (daf-16, skn-1, and hsf-1) were modified by the
compound [31]. Actually, even compounds belonging to the same flavonoid class seem to act through
different mechanisms. Thus, the lifespan extension produced by quercetin-3-O-diglucoside in C. elegans
was explained by upregulation of the genes daf-2, old-1, osr-1, and sek-1, whereas no modification was
produced in the expression of daf-16, age-1, and sir-2.1 [12]. However, assays with a flavonol-rich
extract obtained from Baccharis trimera concluded that the improvement in the stress resistance was
independent of several stress-related signaling pathways (p38, JNK, and ERK) and transcription factors
SKN-1 and DAF-16 [32].
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3.3. Assays with Fluorescent Reporters
The insulin signaling pathway transmits signals in response to the environmental conditions that
could change the expression of different genes related to stress and longevity, thus regulating important
processes such as aging, metabolism, or dauer formation. The expression of some such genes, namely
those encoding heat shock proteins (hsp-16.2 and hsp-70) and antioxidant enzymes (sod-3 and gst-4),
was assessed in order to gain further insight into the mechanisms of action underlying the effects of Q
on the modulation of lifespan and stress in C. elegans. With this aim, transgenic strains that express GFP
under the control of gst-4, sod-3, hsp-16.2, and hsp-70 promoters were employed. GFP expression levels
were analyzed in animals grown in the presence or absence of quercetin under non-stress conditions
for Pgst-4::gfp and Psod-3::gfp reporters, whereas for Phsp-70::gfp and Phsp-16.2::gfp reporters, worms
were previously submitted to a heat shock (35 ◦C, 1 h) and further allowed to recover for 3 h (hsp-70) or
2 h (hsp-16.2) at 20 ◦C.
As it can be seen in Figure 6, the treatment with Q did not produce an increase in the expression
of any of the studied genes (gst-4, sod-3, hsp-16.2, and hsp-70) in young worms of reproductive age.
Indeed, there was even a decrease in the expression of hsp-70 in the worms treated with Q (p = 0.018).
The expression of hsp-16.2 and sod-3 was also studied using reporter strains in older worms (day
9), in order to establish if the mechanism of action underlying the effects of Q was dependent on
the age of the worm. Similar results were obtained regarding the expression of sod-3 (Figure 7) as
compared to younger worms (Figure 6), finding no differences in the expression by the treatment with
Q. However, the expression of hsp-16.2 was increased by the treatment with Q at day 9 (p = 0.008)
(Figure 7), which was not observed at day 2 (Figure 6).
Some of these genes have already been studied by other authors using fluorescent reporters to
explore worm response to Q, specifically gst-4 and sod-3. Opposed results were reported regarding the
effects of Q on sod-3. Whereas, Kampkötter et al. [9] observed a decrease in the expression of sod-3
in worms exposed to 100 μM Q, Grünz et al. [13] found that growing the worms in the presence of
100 μM of Q produced a significant increase in sod-3 expression. As for the present study, no significant
changes were detected in the expression of sod-3 after treatment with 200 μM of Q in any of the two
days studied. On the other hand, Kampkötter et al. [14] observed that the expression of gst-4 was not
modified by Q 100 μM under normal growth conditions, although it decreased the expression of gst-4
when worms were subjected to oxidative stress with juglone 20 μM [14]. Those results would be in
agreement with the observations made herein, where no increase in the expression of gst-4 was found
under normal growth conditions (200 μM Q).
The results for Phsp-16::gfp obtained at different ages of the worms could help to understand
the effects of increased lifespan and improvement of resistance to stress induced by Q in C. elegans,
since many heat shock proteins are regulated positively at the beginning of adult life to further decrease
throughout life [33]. The obtained result might indicate that this decrease could be reversed by the
treatment with Q. It is pertinent to indicate that in previous studies on longevity, greater survival
started to be observed from approximately day 8 onwards in worms treated with quercetin in relation to
non-treated worms [8], suggesting changes in C. elegans metabolism favored by prolonged exposure to
the flavonol, among which, the upregulation of some heat shock proteins could be involved. Actually,
the increased lifespan and thermotolerance observed in certain mutants, such as the long-lived age-1,
have been explained by an increase in the regulation and accumulation of HSP-16 [34]. The involvement
of hsp-16.2 was also supported by the increase in the expression of hsp-16.2 found in the RT-qPCR
studies (Figure 5) and the loss of the improvement in resistance to thermal stress in the hsp-16.2 mutant
(Figure 4). On the other hand, the results showed a decrease in the reporter of hsp-70 in worms
treated with Q (Figure 6). Differences in the expression of genes encoding distinct heat shock proteins,
were also found by Pietsch et al. [15], observing that Q produced an increase in the expression of hsp-3,
hsp-12.6, hsp-16.1, and hsp-16.41, but a decrease of hsp-70 and hsp-17.
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Figure 6. Effect of Q on the expression of gst-4, hsp-16.2, hsp-70, and sod-3 after cultivation of C. elegans
in the absence and presence of Q (200 μM). (A) Representative fluorescence images of control and
Q-treated worm strains. (B) Quantification of the relative fluorescence intensities of transgenic worms.
Total green fluorescent protein (GFP) fluorescence of each whole worm was quantified using Image J
software. Three independent experiments were performed. The results are presented as the mean values
± SEM. Approximately 35 randomly selected worms from each set of experiments were examined.
Differences compared with the control (0 μM Q, 0.1% dimethyl sulfoxide (DMSO)) were considered
statistically significant at * (p < 0.05) by one-way ANOVA.
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Figure 7. Effect of Q on the expression of hsp-16.2 and sod-3 in old worms (day 9 of adulthood) after
cultivation of C. elegans in the absence and presence of Q (200 μM). Total GFP fluorescence of each
whole worm was quantified using Image J software. Three independent experiments were performed.
The results are presented as the mean values ± SEM. Approximately 35 randomly selected worms from
each set of experiments were examined. Differences compared with the control (0 μM Q, 0.1% DMSO)
were considered statistically significant at ** (p < 0.01).
The modulation of the subcellular localization of the DAF-16 forkhead transcription factor
was examined using a transgenic strain expressing a fusion protein DAF-16::GFP. The treatment
with Q did not affect the translocation of DAF-16 to the nucleus with respect to the control worms,
neither under normal growth conditions nor after thermal stress (Figure 8). The localization of
DAF-16 was also studied in older worms (day 9), obtaining similar results that at day 2 regarding its
subcellular localization.
As discussed above, the treatment with Q did not produce an increase in the expression of daf-16
in any of the assayed conditions, while it led to an increase in the resistance to thermal stress on
daf-16 mutant strains. All these results indicate that the effect of this flavonol in the improvement of
worm resistance to stress is independent of daf-16. A similar conclusion has been obtained by some
authors [10,11], although others observed greater translocation of DAF-16 from the cytosol to the
nucleus following Q treatment [9,13,14]. In this respect, Saul et al. [10] suggested that the translocation
of DAF-16 to the nucleus in response to quercetin could be more of a circumstantial effect than proof of
an underlying longevity mechanism. In fact, although DAF-16 is a key factor in the control of stress
response and longevity [17,35,36], it has also been pointed out that its translocation to the nucleus
does not guarantee a longer lifespan, suggesting that DAF-16 would not necessarily act only in the
regulation of longevity [37,38].
The finding that the effects of Q can be independent of daf-16 but dependent on daf-2 and other
components of the IIS, such as akt-1, age-1, and akt-2/sgk-1, could appear surprising. Nevertheless,
Hekimi et al. [37] and Lin et al. [39] pointed out that when the IIS pathway is altered in response
to different environmental signals, besides the stress resistance genes, other unidentified signals are
regulated by daf-2, which are not dependent on daf-16, but that are also essential for the extended
longevity in daf-2 mutants.
In the end, the obtained results indicated that two key transcription factors that could be involved
in the expression of heat shock proteins, DAF-16 and HSF-1 [40], were not related with the effects
exerted by Q on C. elegans (Figures 4 and 5). Actually, it is described that HSF-1 is not a key factor
for all HSPs [41]. Mertenskötter et al. [42] showed that in the expression of chaperone genes, protein
biosynthesis and protein degradation was positively influenced by the MAPK pathway and established
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the importance of this pathway in heat stress responses, possibly by a PMK-1-mediated activation
of the transcription factor SKN-1 in C. elegans. Other authors have also found that components of
related pathways, such as UNC-43, SEK-1, and OSR-1 are involved in the molecular mechanisms of
the response to quercetin and other polyphenols [11,43,44]. Thus, the MAPK pathways could also be
implicated in the effects of quercetin, which might contribute to explain the role of SKN-1 and the
activation of certain HSPs observed in the present study.
 
Figure 8. (A) Effect of Q on DAF-16::GFP subcellular distribution and (B) representative pictures of
the subcellular location of DAF-16::GFP, i.e., cytosolic, intermediate and nuclear. Transgenic worms
expressing the fusion protein DAF-16::GFP were cultivated in the absence (controls) and presence
of Q (200 μM) after subjecting or not subjecting the worms to thermal stress and evaluated at day 2
of adulthood.
4. Conclusions
The enhancement of the oxidative stress resistance of C. elegans induced by Q could be explained,
at least in part, by the modulation of the insulin signaling pathway, namely the genes age-1, akt-1, akt-2,
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daf-18, sgk-1, daf-2, skn-1, and hsp-16.2. However, this effect would be independent of daf-16 and hsf-1.
The implication of daf-2 and not of daf-16 in the observed effects seems to reinforce the idea that there
are signals regulated by daf-2 independent of daf-16 that are also essential for the extension of longevity
and resistance to stress.
The expression of skn-1 was not changed by the treatment with Q when worms were submitted
to stress, but the results obtained in the skn-1 mutants pointed out that it was necessary to mediate
the resistance to thermal stress. It has been reported that SKN-1 promotes longevity by a different
mechanism to the protection against oxidative damage [29,30], and also that the increase of lifespan
by Q was maintained in skn-1 mutants [11]. This could explain why quercetin does not alter skn-1
expression under normal conditions, while this gene seems involved in the increased resistance to
stress induced by Q.
The studies with transgenic strains showed that Q did not produce an increase in the expression
of the antioxidant enzymes GST-4 and SOD-3, nor of the heat shock proteins HSP-16.2 and HSP-70 in
young worms, whereas an increase was produced in the expression of HSP-16.2 in aged worms. This
observation could be important to explain, at least in part, the effects of enhanced lifespan and greater
resistance to stress produced by Q in C. elegans, since the expression of many heat shock proteins
diminishes throughout worm life, a process that might be counteracted by this flavonol.
In summary, the network of signaling pathways that could be modulated by quercetin and other
flavonoids is diverse and complex, and the molecular mechanisms of action can vary depending on the
compound. For instance, while DAF-16 and HSF-1 transcription factors were previously demonstrated
to be involved in the effects of epicatechin [31], they do not seem to be required in the stress resistance
effects of Q. In this work, just the insulin signaling pathway has been explored, but other routes are
surely involved, which should be considered in future studies.
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Abstract: 3,3′-Diindolylmethane (DIM), a metabolite of indole-3-carbinol present in Brassicaceae
vegetables, possesses various health-promoting effects. Nonetheless, the effect of DIM on
neurodegenerative diseases has not been elucidated clearly. In this study, we hypothesized DIM
may protect neuronal cells against oxidative stress-induced apoptosis by promoting the formation of
brain-derived neurotrophic factor (BDNF) and antioxidant enzymes through stabilizing the activation
of the tropomyosin-related kinase receptor B (TrkB) cascade and we investigated the effect of DIM
on oxidative stress-mediated neurodegenerative models. DIM protected neuronal cells against
oxidative stress-induced apoptosis by regulating the expression of apoptosis-related proteins in
glutamate-treated HT-22 cells. Additionally, DIM improved the expression of BDNF and antioxidant
enzymes, such as heme oxygenase-1, glutamate-cysteine ligase catalytic subunit, and NAD(P)H
quinine oxidoreductase-1, by promoting the activation of the TrkB/protein kinase B (Akt) pathway
in the cells. Consistent with in vitro studies, DIM attenuated memory impairment by protecting
hippocampal neuronal cells against oxidative damage in scopolamine-treated mice. Conclusionally,
DIM exerted neuroprotective and antioxidant actions through the activation of both BDNF production
and antioxidant enzyme formation in accordance with the TrkB/Akt pathway in neuronal cells. Such
an effect of DIM may provide information for the application of DIM in the prevention of and therapy
for neurodegenerative diseases.
Keywords: 3,3′-diindolylmethane; antioxidant enzymes; brain-derived neurotrophic factor;
hippocampal neuronal cells; neurodegenerative disease
1. Introduction
3,3′-Diindolylmethane (DIM) is a metabolite of indole-3-carbinol, which is present in Brassicaceae
vegetables containing glucosinolates (206–3895 mg/kg) [1]. Hydrolysis products of glucosinolates,
such as isothiocyanates and indol-3-carbinol, are well known for exerting health-promoting effects,
including for neurodegenerative diseases [2]. DIM, a dimer of indole-3-carbinol that is converted in
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the acidic conditions of stomach after intake [3], is known to possess beneficial effects especially in
antioxidant [4], anti-cancer [5], and hepatoprotective actions [6]. Recently, it was reported that DIM
could protect neuronal cells against inflammation [7,8] and ischemia [7,8] in brain tissue. Moreover,
DIM at the doses used did not show any serious side effects in healthy volunteers [9]. Nonetheless,
the effect of DIM on neurodegenerative diseases has not been elucidated clearly.
Neurodegenerative diseases, which are increasing along with the extension of life spans and
the occurrence of metabolic diseases, are known to be associated with the generation of reactive
oxygen species (ROS) [10], which are responsible for the apoptosis of neuronal cells [11,12]. Therefore,
the regulation of ROS generation is suggested as a key target for the treatment or prevention of
neurodegenerative diseases. Brain-derived neurotrophic factor (BDNF), which is mainly produced
from the central nervous system [13–15] and is concerned with the preservation of neuronal cells in
in vivo systems, is known to play a crucial role [16]; it participates in the proliferation and differentiation
of neuronal cells through the activation of tropomyosin-related kinase receptor B (TrkB) [17]. In addition,
BDNF protects neuronal cells against oxidative stress [16,18]. Recently, it was observed that some specific
antioxidant compounds ameliorate scopolamine-induced memory impairment by promoting BDNF
production and suppressing oxidative damage in scopolamine-exposed mice [11,12,19]. Therefore, the
regulation of BDNF formation may be a key point for the treatment or prevention of neurodegenerative
diseases such as Alzheimer’s disease.
Currently, inhibitors of acetylcholinesterase (AChE) have been used for treatment of Alzheimer’s
disease [20]. However, these inhibitors only delay the progression of Alzheimer’s disease and also
produce side effects [20]. In this respect, phytochemicals derived from vegetables may be preferable
alternatives for the prevention or treatment of neurodegenerative diseases such as Alzheimer’s disease.
In this study, we investigated whether DIM was able to protect hippocampal neuronal cells
against oxidative stress-induced apoptosis, and then we examined how DIM protects neuronal cells
against oxidative stress-induced apoptosis in both in vitro and in vivo models. Herein, we report that
the neuroprotective and antioxidant properties of DIM are closely associated with the production of
BDNF and antioxidant enzymes by activation of the pathways involving TrkB/protein kinase B (Akt)
in hippocampal neuronal cells. Such an effect of DIM may help to address the neuroprotective action
of indole-3-carbinol and some vegetables of the brassicaceae family and may provide information for
the application of DIM as a therapeutic or preventive supplement for neurodegenerative diseases.
2. Materials and Methods
2.1. Materials
Antibiotics, FBS, 0.25% trypsin-EDTA, and 2,7-dichlorofluorescein diacetate (DCFDA) were
procured from Invitrogen (Carlsbad, CA, USA). Dulbecco’s modified eagle medium (DMEM), 1× PBS,
and 1× Tris buffered saline (TBS) were purchased from Welgene, Inc. (Gyeongsan, Gyeongbuk, Korea).
EZ-Cytox cell viability assay kit was obtained from DAEIL Lab (Seoul, Korea). DIM, K252a (a TrkB
inhibitor), and MK-2206 (a specific Akt inhibitor) were procured from Cayman Chemical Company (Ann
Arbor, MI, USA). Specific antibodies against cytochrome c (ab90529), glutamate-cysteine ligase catalytic
subunit (GCLC, ab53179), and NAD(P)H quinone oxidoreductase-1 (NQO-1, ab34173) were purchased
from Abcam, Inc. (Cambridge, UK). A specific antibody against BDNF (sc-65514) was obtained from
Santa Cruz Biotechnology, Inc. (Dallas, TX, USA). Specific antibodies against apoptosis-inducing factor
(AIF, #4642), B-cell lymphoma 2 (Bcl-2, #3498), Bcl-2-associated X protein (Bax, #2772), cleaved caspase-3
(#9661), heme oxygenase-1 (HO-1, #70081), NF-E2-related factor-2 (Nrf2, #12721), phospho-Akt (#9271),
phospho-cAMP response element-binding protein (CREB, #9198), phospho-TrkB (#4619), and β-actin
(#4970) as well as a horseradish peroxidase-conjugated IgG secondary antibody were procured from
Cell Signaling Technology (Beverly, MA, USA). Muse Annexin V and Dead Cell Assay Kits were
purchased from Merck Millipore, Inc. (Darmstadt, Germany). All other chemicals which were used in
this study were analytical grade.
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2.2. Animals
ICR mice [21] were obtained from Nara Biotech Co. (Pyeongteak, Korea). Their gender, age, and
body weight were male, 6 weeks, and 25–30 g. The mice were housed in cages (five mice/cage) under
specific pathogen-free conditions (21–24 ◦C and 40–60% relative humidity) with a 12 h light/dark cycle.
In addition, they were given free access to standard rodent food (Orientbio Inc., Seongnam, Korea) and
water. All animal experiments were approved by the Committee of Animal Care and Experiment of
Chungnam National University (Daejeon, Korea) with a reference number (CNU-00973) and carried
out following the guidelines of the Animal Care and Use Committee at Chungnam National University.
2.3. Behavior Tests
2.3.1. Morris Water Maze Test
The cognitive ability of mice was evaluated by Morris water maze test, which was reported
previously [12]. One hour before the Morris water maze test, mice were administered with DIM (0,
10, or 20 mg/kg, orally). After three consecutive days, the mice were administered with scopolamine
(2 mg/kg, i.p.) after the DIM treatment.
2.3.2. Passive Avoidance Test
The cognitive ability of the mice was evaluated by the passive avoidance test, which was reported
previously [12]. One hour before the acquisition trial, the mice were orally administered with DIM
before the scopolamine challenge.
2.4. Analysis of Antioxidant or Neurobiological Biomarkers in Brain Tissues
2.4.1. Determination of Lipid Peroxidation
Lipid peroxidation was determined following a method reported previously [22]. Briefly, brains
isolated from sacrificed mice were homogenized in ice-cold 1× PBS, and then the homogenates were
centrifuged (17,000× g at 4 ◦C) for 10 min. The supernatant (100 μL) was mixed with 50 μL of 20%
aqueous trichloroacetic acid and 100 μL of 0.67% aqueous thiobarbituric acid, boiled for 10 min, and
then centrifuged (60× g, room temperature (RT) for 30 min. The absorbance of the supernatant was
measured at 532 nm using a microplate reader (DU650, Beckman Coulter, Brea, CA, USA).
2.4.2. Measurement of Glutathione
Glutathione (GSH) level in brain tissues or cell pellets was analyzed using a Quanticrom
Glutathione Assay Kit obtained from BioAssay Systems (Hayward, CA, USA) according to the
manufacturer’s protocol.
2.4.3. Activities of Glutathione Reductase and Glutathione Peroxidase
The activities of glutathione reductase (GR) and glutathione peroxidase (GPx) in brain tissues
were determined as described previously [19].
2.4.4. Activities of Acetylcholinesterase and Choline Acetyltransferase
The activities of acetylcholinesterase (AChE) and choline acetyltransferase (ChAT) in brain tissues
were determined as described previously [19].
2.5. Hematoxylin and Eosin Staining Assay
Histological analysis was conducted by following a modification of a method reported
previously [23]. Briefly, deparaffinized brain tissue slices were stained with hematoxylin-eosin.
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The stained tissue slices were embedded with mounting solution. Histological changes of the brain
tissues were observed under a light microscope with 200×magnification.
2.6. Cell Culture
The HT-22 cell line was procured from Medifron (Seoul, Korea), and HT-22 cells were maintained
in DMEM medium with 10% FBS, 100 units/mL of penicillin, and 100 μg/mL of streptomycin at 37 ◦C
in a humidified atmosphere of 5% CO2. Passages three to 11 of the cells were used in this study. All the
in vitro studies included a vehicle control group (0.1% dimethyl sulfoxide).
2.7. Cell Viability Assay
Cell viability was assessed according to a previous method [24]. HT-22 cells were preincubated
with or without DIM (0–80 μM) for 30 min before glutamate challenge. After 12 h, cell viability was
determined using the EZ-Cytox cell viability assay kit following the manufacturer’s instructions.
2.8. Measurement of Intracellular ROS Level
The intracellular ROS level was assessed according to a previous method [24]. After glutamate
treatment, HT-22 cells were stained with 10 μM DCFDA in Hank’s balanced salt solution for 30 min in
the darkness, and the fluorescence (an excitation wavelength of 485 nm and an emission wavelength of
525 nm) was measured by a microplate reader (Beckman Coulter DTX 880 Multimode Detector, Brea,
CA, USA).
2.9. Extraction of Nuclear and Cytosolic Protein
Cytosolic and nuclear proteins were fractionated using a Nuclear Extraction Kit (Cayman Chemical,
Ann Arbor, MI, USA) following the manufacturer instructions.
2.10. Immunoblot Analysis
Immunoblot analysis was carried out according to a previous method [12]. Briefly, blotted
proteins on PVDF membrane were visualized by a WEST One western blot detection system (iNtRON
Biotechnology, Inc., Gyeonggi-do, Korea). All the target protein levels were compared with loading
control levels (β-actin or Lamin B), and the results were expressed as a density ratio of each protein,
identified by a protein standard size marker (BIOFACT, Daejeon, Korea). The relative density of the
protein expression was quantitated by Matrox Inspector software (version 2.1 for Windows; Matrox
Electronic Systems Ltd., Dorval, Quebec, Canada).
2.11. Statistical Analysis
The experimental results were expressed as the mean ± SD for the in vitro data and as the mean ±
SEM for the in vivo data. One-way analysis of variance (ANOVA) was used for multiple comparisons
(GraphPad Prism version 5.03 for Windows, San Diego, CA, USA). The Dunnett test and the Tukey’s
test were applied for significant variations between treated groups. Differences at the * p < 0.05 and
** p < 0.01 levels were considered statistically significant.
3. Results
3.1. Neuroprotective Effect of 3,3′-Diindolylmethane on Glutamate-Treated HT-22 Cells
DIM possesses some beneficial properties, such as antioxidant action [4] and neuroprotective
action [7,8]. Considering this, we investigated the effect of DIM on glutamate-induced cytotoxicity
in HT-22 cells. When HT-22 cells were incubated with DIM prior to glutamate exposure, DIM at the
concentrations used (10–80 μM) enhanced cell viability up to a concentration of 80 μM (Figure 1A). In
addition, DIM dose-dependently reduced the ROS level and also restored the GSH level in the cells
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(Figure 1B,C). A DIM concentration of 40 μM was sufficient to restore the level of ROS or GSH to that
of the control group. These results suggest that DIM exerts neuroprotective activity by suppressing
oxidative stress in hippocampal neuronal cells.
Figure 1. Effect of 3,3′-diindolylmethane (DIM) on glutamate-induced cytotoxicity, and reduction of
ROS and glutathione levels in HT-22 cells. HT-22 cells, seeded on a 96 well-plates and incubated for
24 h, were incubated with or without DIM (0–80 μM) for 30 min before glutamate challenge (5 mM).
After 12 h, cell viability, ROS level, and GSH level were measured as described in Materials and
Methods. (A) Cell viability, (B) ROS level, and (C) GSH level. Data are the mean ± SD values of triple
determinations. ** p < 0.01 versus glutamate-treated group. – is absence, + is presence.
3.2. Inhibitory Effect of 3,3′-Diindolylmethane on Oxidative Stress-Induced Apoptosis
After we found that DIM protects hippocampal neuronal cells against oxidative stress,
we investigated the effect of DIM on the expression of apoptosis-related proteins in oxidative
stress-exposed neuronal cells. In the previous report, we found that the elevation of ROS formation
activated apoptosis signaling pathway in neuronal cells [12]. DIM downregulated the expression of
pro-apoptotic factors such as Bax, cytochrome c, cleaved caspase-3, and AIF, whereas it upregulated
that of Bcl-2, an anti-apoptotic factor (Figure 2). These findings suggest that DIM protects
hippocampal neuronal cells against oxidative stress-induced apoptosis by regulating the expression of
apoptosis-related proteins.
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Figure 2. Suppressive effect of 3,3′-diindolylmethane on glutamate-induced apoptosis in HT-22 cells.
HT-22 cells were seeded on a 60 mm dish, and then incubated for 24 h. The cells were challenged with
glutamate after preincubation with or without DIM (0–40 μM) for 30 min. After 12 h, the expression of
Bcl-2, Bax, cytochrome c, cleaved caspase-3, AIF, or β-actin was examined as described in Materials
and Methods. The data were contained from three independent experiments. ** p < 0.01 versus
glutamate-treated group. – is absence, + is presence.
3.3. Activatory Effect of 3,3′-Diindolylmethane on Both TrkB/CREB/BDNF Pathway and Akt/Nrf2/ARE
Pathway
It was reported that activation of the TrkB/CREB/BDNF pathway and the Akt/Nrf2/antioxidant
response element (ARE) pathway contributed to the neuroprotective action of N-acetyl serotonin [12];
therefore, we supposed that both pathways could be activated by DIM, which was found to protect
hippocampal neuronal cells against oxidative stress-induced apoptosis. DIM dose-dependently
improved the expression of p-TrkB, p-CREB, BDNF, or p-Akt and antioxidant enzymes such as HO-1,
GCLC, and NQO-1 in glutamate-treated HT-22 cells (Figure 3). In addition, DIM also promoted the
nuclear translocation of Nrf2 in glutamate-treated HT-22 cells. Especially, DIM at 40 μM almost fully
restored the expression of all the proteins. Based on these results, we suppose that DIM is able to
promote the activation of both the TrkB/CREB/BDNF pathway and the Akt/Nrf2/ARE pathway in
oxidative stress-exposed HT-22 cells. Therefore, the neuroprotective action of DIM may be closely
associated with the activation of both signaling pathways.
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Figure 3. Effect of 3,3′-diindolylmethane on phosphorylation of TrkB, Akt, or CREB, and expression of
BDNF, Nrf2, or antioxidant enzymes. The experiments were performed as described in the Figure 2
legend. The data were obtained from three independent experiments. (A) p-TrkB, p-Akt, p-CREB, and
BDNF and (B) nuclear and cytosolic Nrf2, HO-1, GCLC, and NQO-1. ** p< 0.01 versus glutamate-treated
group. − is absence, + is presence.
3.4. Suppressive Effects of K252a and MK-2206 on Neuroprotective Action of 3,3′-Diindolylmethane
Subsequently, we attempted to clarify the mechanism by which DIM promoted the activation of the
TrkB/CREB/BDNF pathway and the Akt/Nrf2/ARE pathway in oxidative stress-exposed hippocampal
neuronal cells. For this, we investigated the suppressive effects of K252a, a TrkB inhibitor, and MK-2206,
a selective Akt inhibitor, on the neuroprotective action of DIM in oxidative stress-exposed hippocampal
neuronal cells. When DIM was preincubated with HT-22 cells in combination with K252a or MK-2206
prior to glutamate treatment, the inclusion of either K252a or MK-2206 significantly attenuated the
preventive action of DIM against oxidative stress-induced cell death (Figure 4A,B). In addition, the
inhibitors reversed the inhibitory effect of DIM on the generation of ROS in glutamate-treated HT-22
cells (Figure 4C,D). Overall, these results support the notion that DIM protects hippocampal neuronal
cells against oxidative stress by promoting the expression of both BDNF and antioxidant enzymes via
activation of both the TrkB/CREB/BDNF pathway and the Akt/Nrf2/ARE pathway.
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Figure 4. Inhibitory effect of K252a or MK-2206 on neuroprotective action of DIM. HT-22 cells were
preincubated with or without DIM in combination with K252a or MK-2206 for 30 min before glutamate
challenge. After 12 h, cell viability and ROS level were measured as described in Materials and
Methods. (A), (B) Cell viability and (C), (D) ROS level. Data are the mean ± SD values of quintuple
determinations. ** p < 0.01 versus glutamate-treated group; # p < 0.05 and ## p < 0.01 versus DIM with
glutamate-treated group.
3.5. Improving Effect of 3,3′-Diindolylmethane on Scopolamine-Induced Memory Impairment in Mice
Finally, to confirm the neuroprotective action of DIM in an in vivo system, we further investigated
the neuroprotective action of DIM in scopolamine-treated mice. When mice were orally administrated
with DIM (10 or 20 mg/kg) before scopolamine challenge, DIM at 20 mg/kg decreased the time of escape
latency and increased the number of platform area crossings and latency time in scopolamine-treated
mice (Figure 5). However, DIM at 10 mg/kg did not improve the latency time in the mice, which
suggests that the administration of DIM at 10 mg/kg failed to reach the effective concentration in brain
because of the rapid metabolism of DIM [25]. Consistent with its antioxidant action in an in vitro
system, DIM reduced lipid peroxidation and also improved the level of GSH and the activities of
GR and GPx in brain tissue (Figure 6A–D). Additionally, DIM reduced AChE activity and enhanced
ChAT activity compared with the scopolamine group (Figure 6E,F), further supporting the antioxidant
action of DIM. Also, DIM prevented scopolamine-induced oxidative damage of neuronal cells in
the hippocampal CA1 and CA3 regions of mice brains (Figure 7). These findings suggest that DIM
improves scopolamine-induced memory impairment by protecting neuronal cells against oxidative
damage in the hippocampus of mice. Based on this, we suggest that the neuroprotective action
of DIM may be largely ascribed to the activation of both the TrkB/CREB/BDNF pathway and the
Akt/Nrf2/ARE pathway.
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Figure 5. Inhibitory effect of 3,3′-diindolylmethane on memory impairment induced by scopolamine in
mice. Mice were orally administrated with DIM (10 or 20 mg/kg) before scopolamine treatment (2 mg/kg,
i.p.). After 1 h, the mice were tested for Morris water maze or passive avoidance (Acquisition trial).
(A) Escape latency time, (B) number of platform area crossings, and (C) latency time. Data are the mean
± SEM values of sextuple determinations. * p < 0.05 and ** p < 0.01 versus scopolamine-treated group.
Figure 6. Effect of 3,3′-diindolylmethane on antioxidant biomarkers and cholinergic enzymes in brain
tissue of mice treated with scopolamine. Experiments were performed as described in the Figure 5
legend. Lipid peroxidation, GSH, and the activities of GPx, GR, AChE, or ChAT in brain tissues were
determined as described in Materials and Methods. (A) Lipid peroxidation, (B) GSH, (C) GPx activity,
(D) GR activity, (E) AChE activity, and (F) ChAT activity. Data are the mean ± SEM values of sextuple
determinations. * p < 0.05 and ** p < 0.01 versus scopolamine-treated group.
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Figure 7. Neuroprotective effect of 3,3′-diindolylmethane on hippocampal CA1 and CA3 regions of
mice treated with scopolamine. Experiments were performed as described in the Figure 5 legend.
Neuronal cell staining of brain tissues was carried out as described in Materials and Methods. The
results were obtained from three independent experiments. (A) CA1 region and (B) CA3 region.
** p < 0.01 versus scopolamine-treated group.
4. Discussion
DIM, a dimer of indole-3-carbinol, is known to have some beneficial effects, such as antioxidant
action [4], anti-cancer activity [5], hepatoprotection [6], and neuroprotection [7,8]. Recently, it was
reported that DIM at 10 μM completely protected neuronal cells against hypoxia through reducing
the expression of the aryl hydrocarbon receptor modulator and aryl hydrocarbon receptor induced
by hypoxia [7]. In addition, the activation of the aryl hydrocarbon receptor by α-naphthoflavone
promoted apoptosis through upregulating ROS generation in neuronal cells [26]. However, DIM could
not protect neuronal cells against hypoxia in neuronal cells treated with siRNA targeted to the aryl
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hydrocarbon receptor modulator or hydrocarbon receptor [7]. Therefore, it remains unknown how
DIM protects neuronal cells against oxidative stress-induced apoptosis.
Recently, we reported that N-acetyl serotonin protected neuronal cells against oxidative
stress-induced apoptosis through activating both the TrkB/CREB/BDNF and Akt/Nrf2/antioxidant
enzyme pathways [12], and N-palmitoyl serotonin protected neuronal cells against oxidative
stress-induced apoptosis by stabilizing the activation of the BDNF autocrine loop, although it could
not directly activate the phosphorylation of TrkB [11]. Based on these findings, we surmised that DIM
may protect hippocampal neuronal cells against oxidative stress-induced apoptosis by maintaining
the activation of both the TrkB/CREB/BDNF pathway and the Akt/Nrf2/ARE pathway. Therefore,
we investigated the effect of DIM on oxidative stress-induced apoptosis in hippocampal neuronal
cells using an in vitro study. From the results, we found that DIM protected hippocampal neuronal
cells against oxidative stress-induced apoptosis by promoting the expression of both BDNF and
antioxidant enzymes, such as HO-1, NQO-1, and GCLC. Moreover, in an in vivo study, DIM attenuated
scopolamine-induced memory impairment by protecting hippocampal neuronal cells against oxidative
damage in mice. Furthermore, such a neuroprotective effect of DIM was possibly associated with the
stabilized activation of an antioxidant enzyme-generating system such as the Akt/Nrf2/ARE pathway
in hippocampal neuronal cells. These results lead to the assumption that TrkB activation stabilized by
DIM may be related to the activation of the Akt/Nrf2/ARE pathway in neuronal cells.
One possible mechanism for the neuroprotective action of DIM may be related to the upregulation
of BDNF expression through activation of the TrkB/Akt/CREB/BDNF pathway [18]. BDNF, a ligand of
TrkB with a stronger neuroprotective action than that of other neurotrophic factors, is mainly produced
from astrocytes [13], microglia [14], and neuronal cells [15]. Here, the stimulation of TrkB by BDNF is
known to promote proliferation and differentiation of neural stem cells [17]. In the signaling pathway,
the activation of TrkB by BDNF induces the phosphorylation of Akt [27], and then the activated Akt is
able to produce BDNF through the activation of CREB in neuronal cells [28]. Thus, maintaining the
production of BDNF in neuronal cells may be an important strategy for the prevention or treatment
of neurodegenerative diseases, such as Alzheimer’s disease. Consistent with this, our present data
indicates that DIM protects hippocampal neuronal cells against oxidative stress-induced apoptosis
by elevating the phosphorylation of TrkB, Akt, and CREB. In support of this, the inclusion of K252a,
an inhibitor of TrkB, neutralized the neuroprotective effect of DIM on oxidative stress-induced cell
death of hippocampal neuronal cells. A similar result was observed previously when HT-22 cells were
incubated with glutamate in the presence of N-acetyl serotonin [12]. Therefore, we suggest that DIM
is able to protect neuronal cells by promoting the formation of BDNF through the activation of the
TrkB/Akt/CREB/BDNF pathway in oxidative stress-exposed neuronal cells.
Another possible mechanism for the neuroprotective action of DIM is associated with the formation
of antioxidant enzymes such as HO-1, NQO-1, and GCLC through the activation of the Akt/Nrf2/ARE
pathway. In support of this, DIM augmented the expression of antioxidant enzymes in accordance
with the Nrf2/ARE pathway [29]. Moreover, the action of DIM may be extended to activation of
the TrkB/Akt/Nrf2/ARE pathway; DIM activates TrkB to produce p-TrkB as mentioned earlier. In
turn, activated Akt liberates Nrf2 from the keap1-Nrf2 complex [12], and then Nrf2 is combined into
the ARE region on DNA after it translocates into the nucleus [29]. As a result, Nrf2 promotes the
formation of antioxidant enzymes, such as HO-1, NQO-1, and GCLC [29]. In support of this, our
present study showed that DIM upregulated the expression of p-TrkB and p-Akt and also improved
nuclear translocation of Nrf2. Consequently, DIM restored the level of antioxidant enzymes, such as
HO-1, NQO-1, and GCLC, to the control level in oxidative stress-exposed hippocampal neuronal cells.
In further support of the TrkB/Akt/Nrf2/ARE pathway, the inclusion of K252a, a TrkB inhibitor, or
MK-2206, a selective Akt inhibitor, nullified the suppressive effect of DIM on both ROS generation
and cell death in oxidative stress-exposed neuronal cells. Probably consistent with the in vitro results,
DIM at low doses (10–20 mg/kg) improved scopolamine-induced memory impairment by protecting
neuronal cells against oxidative damage in the hippocampal CA1 and CA3 regions of the brain in
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mice. Additionally, the cholinolytic effect of scopolamine, mainly due to an increase of AChE activity
and a decrease of ChAT activity, was remarkably abrogated by DIM. A similar result was observed
previously with N-palmitoyl serotonin [19]. A reason for these results is that DIM is capable of crossing
to the gastrointestinal tract as well as the blood–brain barrier [25]. In addition, the concentrations of
DIM are equal to 0.8 to 1.6 mg/kg (48 to 96 mg/60 kg) in humans, based on body surface area [30].
Taking these results together, it is proposed that the activation of TrkB stabilized by DIM, followed
by Akt activation, promotes the expression of both BDNF and antioxidant enzymes in neuronal
cells. Therefore, the activation of the TrkB/Akt/Nrf2/ARE pathway, accompanied by stabilization
of the TrkB/CREB/BDNF autocrine loop, may be important for the prevention and treatment of
neurodegenerative diseases. In addition, the present study shows that DIM may be a candidate
compound for the prevention and treatment of neurodegenerative diseases such as Alzheimer’s disease.
5. Conclusions
The present study demonstrates that DIM exerts a neuroprotective action by producing BDNF and
antioxidant enzymes through activation of the TrkB/Akt signal pathway in oxidative stress-exposed
hippocampal neuronal cells. In addition, DIM ameliorates cognitive ability by maintaining the
cholinergic system in scopolamine-exposed mice. These findings reveal a feature of the mechanism for
the neuroprotective action of DIM against oxidative stress-induced apoptosis in neuronal cells. Such
effects of DIM may provide further information for the application of DIM as a neuroprotective agent
for the prevention and treatment of neurodegenerative diseases. In addition, this study may be helpful
to establish new diagnostic and theranostic paradigms of neurodegenerative diseases, to explore a
new biomarker of the diagnostic criteria of neurodegenerative diseases, and to develop innovative
pharmacological protocols for the patients of neurodegenerative diseases. Further animal model
studies may be required to confirm the feasibility of the use of DIM as a neuroprotective agent for
specific neurodegenerative diseases.
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Abstract: This work studies the extraction of phenolic compounds from walnut leaves of the
hybrid Juglans major 209 x Juglans regia based on extract antioxidant capacity. Once the solid/liquid
ratio was selected (1/10 g/mL), by means of a Box-Benkhen experimental design, the influence
of temperature (25–75 ◦C), time (30–120 min), and aqueous ethanol concentration (10–90%) on
extraction yield and ferric reducing antioxidant power (FRAP), 2,2-diphenyl-1-picrylhydrazyl (DPPH),
and 2,2’-azinobis-3-ethylbenzothiazoline-6-sulfonic acid (ABTS) antioxidant activities were analyzed.
In all cases, the quadratic effect of % EtOH was the most significant, followed by the linear effect of
temperature and, for most of the responses, the effect of time was almost negligible. Response surface
analysis allowed to select the optimal extraction conditions: 75 ◦C, 120 min and 50% ethanol, which
led to the following extract properties: extraction yield, 30.17%; FRAP, 1468 nmol ascorbic acid
equivalents (AAE)/mg extract d.b.; DPPH, 1.318 mmol Trolox equivalents (TRE)/g extract d.b.; DPPH
EC50, 0.11 mg/mL; ABTS, 1.256 mmol TRE/g extract (on dry basis) and ABTS EC50, 0.985 mg/mL.
Quercetin 3-β-D-glucoside, neochlorogenic acid, and chlorogenic acid, in this order, were the main
compounds identified in this extract by ultra-performance liquid chromatography coupled with
electrospray ionization and time-of-flight mass spectrometry (UPLC/ESI-QTOF-MS), with various
potential applications that support this valorization alternative for walnut leaves.
Keywords: walnut leaves; Juglans major 209 x Juglans regia; maceration; phenolic compounds;
antioxidant activity; UPLC/ESI-QTOF-MS; response surface methodology
1. Introduction
Juglans major 209 x Juglans regia is a walnut hybrid species intended to produce good-quality
wood. Although wood is the main product, the use of other fractions that can be considered as
wastes, such as the leaves, would contribute to more profitable production and to a more sustainable
plantation management.
Walnut leaves have been intensively used in traditional medicine, and various studies have
demonstrated the antimicrobial and antioxidant properties of the extracts from the leaves of several
walnut (Juglans regia) cultivars [1–4]. Carvalho et al. [3] also demonstrated the antihemolytic and
human renal cancer cell antiproliferative activities of walnut leaf methanolic extracts. Quantitative and
qualitative determinations of the phenolic compounds present in walnut (Juglans regia) leaves have also
been carried out [1,4–6] demonstrating quite significant variations in the extract composition. Amaral et
al. [5] identified seven phenolic compounds in methanol and acidified water extracts of walnut leaves,
being quercetin 3-O-galactoside the major compound while 4-p-coumaroylquinic acid was the minor one.
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3-O-caffeoylquinic acids and quercetin O-pentoside were the main phenolic compounds among the
25 phenolic compounds identified in methanol and decoction extracts by Santos et al. [4]. Pereira et al. [1]
identified 10 compounds in aqueous extracts: 3- and 5-caffeoylquinic acids, 3- and 4-p-coumaroylquinic
acids, p-coumaric acid, quercetin 3-O-galactoside, quercetin 3-O-pentoside derivative, quercetin
3-O-arabinoside, quercetin 3-O-xyloside and quercetin 3-O-rhamnoside. In addition to phenolic acids
and flavonoids, Nour et al. [6] also reported the presence of juglone (5-hydroxy-1,4-napthoquinone) in
walnut leaves, ellagic acid as the dominating phenolic acid and myricetin, catechin hydrate and rutin
as the main flavonoids.
Different solvents have been used for the extraction of phenolic compounds from walnut leaves:
Aqueous ethanol [2,7], methanol [4,5], methanol with 1% butylated hydroxytoluene (BHT) [6],
water [1,4], acidified water [5], and chloroform [5]. In this work, looking for a green extraction process,
extraction was performed by maceration with aqueous ethanol, a bio-solvent produced from biomass,
completely biodegradable [8], and generally recognized as safe (GRAS) solvent. In addition to the type
of solvent, other factors that can affect the efficiency of the extraction process that were examined in
this work are the extraction temperature, the extraction time, and the solid to solvent ratio [9].
The aim of this work was to provide a means for the disposal and valorization of walnut leaves
based on extract antioxidant activity, giving the walnut plantation an additional value to that provided
by wood. As far as we know, this is the first work on the extraction and characterization of phenolic
compounds of walnut leaves of the hybrid Juglans major 209 x Juglans regia. An experimental
design combined with response surface methodology was used to optimize the extraction of
phenolic compounds from walnut leaves based on extract antioxidant activity. The phytochemical
characterization of the extracts was carried out and the results compared with those previously obtained
for leaves from the Juglans regia species.
2. Materials and Methods
2.1. Reagents and Standards
Acetic acid, sodium acetate, FeCl3·6H2O, HCl, l-ascorbic acid, methanol, ethanol, and potassium
persulfate were purchased from Panreac (Barcelona, Spain). 2,4,6-Tripyridyl-s-triazine (TPTZ), Trolox
(6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) and DPPH (2,2-diphenyl-1-picrylhydrazyl) were
purchased from Fluka (Steinheim, Germany). ABTS (2,2’-azinobis-3-ethylbenzothiazoline-6-sulfonic acid)
and HPLC standards: (–)-epigallocatechin, (–)-gallocatechin, catechin hydrate, chlorogenic acid, ellagic
acid, epicatechin, ferulic acid, gallic acid, isorharmnetin, kaempferol, neochlorogenic acid, p-coumaric
acid, procyanidin B2, quercetin, quercetin 3-β-D glucoside, and taxifolin, were obtained from Sigma
(Steinheim, Germany).
2.2. Materials
Walnut (Juglans major 209 x Juglans regia) leaves were collected in July 2018 in a plantation located
in A Coruña, Spain, dried at room temperature, milled, sieved, and the fraction of particle size between
0.1 and 1 mm was selected and stored protected from light till analysis.
2.3. Extraction
Walnut leaves were extracted with aqueous ethanol in an orbital shaker (UNITRONIC-OR, Selecta
(Barcelona, Spain) with temperature control at a shaking speed of 90 rpm. The solid/liquid ratio,
temperature, time, and EtOH concentration were fixed for each experiment according to the established
experimental planning (Tables 1 and 2). The extract was separated by vacuum filtration, concentrated
in a Büchi R-210 rotavapor and finally dried under vacuum to obtain a dry powder. Extraction yield
was determined as the weight loss percentage of the initial walnut leaves.
The choice of the independent variables to be analyzed and their respective variation intervals was
based on previous investigations on the extraction of phenolic compounds from various lignocellulosic
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materials using aqueous alcohols [10–12]. In the first stage, the influence of the solid/liquid ratio (1/5,
1/7.5 and 1/10 g/mL) was analyzed for fixed values of the other variables: Temperature, 50 ◦C, time, 60 min,
and ethanol concentration, 50% (Table 1). Extraction yield and extract ferric reducing antioxidant power
(FRAP) antioxidant activity were determined. All the assays were replicated, and the results expressed as
mean value and standard deviation. The existence of significant differences among the results depending
on the solid/liquid ratio used was analyzed by applying one-way ANOVA together with the Tukey’s test at
a confidence level of 95% using the IBM SPSS Statistics 24 software (New York, NY, USA).
Once S/L ratio was fixed at 1/10, a Box-Behnken experimental design was applied to analyze the
influence of temperature (x1; 25, 50, and 75 ◦C), time (x2; 30, 75, and 120 min) and aqueous ethanol
concentration (x3; 10%, 50%, and 90%) on extraction yield (Y1, g extract/100 g leaves on dry basis (d.b.))
and extract antioxidant activity determined according to the FRAP (Y2, nmol AAE/mg extract d.b.), DPPH
(Y3, mmol TRE/g extract d.b.), and ABTS (Y4, mmol TRE/g extract d.b.) assays. The phenolic profile of the
extract selected as the optimum was analyzed by ultra-performance liquid chromatography coupled with
electrospray ionization and time-of-flight mass spectrometry (UPLC/ESI-QTOF-MS).
Table 1. Influence of the solid/liquid ratio on extraction yield and ferric reducing antioxidant power
(FRAP) antioxidant activity of walnut leaf extracts (50 ◦C, 60 min, and 50% aqueous ethanol).
Exp. S/L Ratio (g/mL) Extraction Yield (%) FRAP (nmol AAE/mg Extract)
A 1/5 25.82 ± 0.25 a 1246 ± 48 a
B 1/7.5 27.04 ± 0.42 b 1350 ± 53 b
C 1/10 27.86 ± 0.04 b 1512 ± 61 c
Values are presented as mean ± standard deviation. a–c In each column, values with different letters are significantly
different (p < 0.05).





3 Y1 exp Y1 pred Y2 exp Y2 pred Y3 exp Y3 pred Y4 exp Y4 pred
1 −1 −1 0 21.03 ± 0.89 22.35 1181 ± 39 1262 1.114 ± 0.026 1.050 0.951 ± 0.026 0.964
2 −1 0 −1 20.35 ± 0.18 19.86 842 ± 46 908 0.663 ± 0.044 0.666 0.671 ± 0.027 0.774
3 −1 0 1 19.15 ± 2.13 18.71 930 ± 47 908 0.873 ± 0.013 0.852 0.807 ± 0.017 0.774
4 −1 1 0 23.89 ± 0.28 24.16 1250 ± 58 1262 1.008 ± 0.159 1.050 1.053 ± 0.049 0.964
5 0 −1 −1 23.13 ± 0.27 22.85 1160 ± 37 1041 0.913 ± 0.024 0.932 0.893 ± 0.041 0.875
6 0 −1 1 20.03 ± 1.16 19.96 1138 ± 17 1041 0.919 ± 0.039 0.932 0.866 ± 0.050 0.875
7 0 1 −1 24.52 ± 0.11 24.66 943 ± 65 1041 0.873 ± 0.037 0.932 0.869 ± 0.030 0.875
8 0 1 1 21.93 ± 1.76 21.77 876 ± 18 1041 1.003 ± 0.036 0.932 0.875 ± 0.028 0.875
9 1 −1 0 29.08 ± 1.43 28.40 1364 ± 42 1529 1.493 ± 0.106 1.396 1.166 ± 0.047 1.250
10 1 0 −1 27.01 ± 0.30 27.64 1199 ± 50 1174 1.193 ± 0.021 1.198 1.089 ± 0.035 1.060
11 1 0 1 22.35 ± 0.88 23.02 1238 ± 32 1174 1.031 ± 0.023 1.012 1.095 ± 0.032 1.060
12 1 1 0 30.17 ± 0.09 30.21 1468 ± 20 1529 1.318 ± 0.049 1.396 1.256 ± 0.017 1.250
13 0 0 0 25.85 ± 0.05 26.28 1389 ± 78 1395 1.239 ± 0.043 1.223 1.299 ± 0.049 1.315
14 0 0 0 27.19 ± 0.51 26.28 1560 ± 49 1395 1.190 ± 0.031 1.223 1.330 ± 0.032 1.315
Independent Variables Levels
−1 0 +1
x1, Temperature (◦C) 25 50 75
x2, Time (min) 30 75 120
x3, % EtOH 10 50 90
Experimental values are presented as mean ± standard deviation. Y1, extraction yield (g extract/100 g leaves d.b.);
antioxidant activity: Y2, FRAP (nmol AAE/mg extract d.b.); Y3, DPPH (mmol TRE/g extract d.b.); Y4, ABTS (mmol
TRE/g extract d.b.); x∗1, codified temperature; x
∗
2, codified time; x
∗
3, codified ethanol concentration.
2.4. Box-Behnken Experimental Design
The Box-Behnken experimental design applied consisted of 12 replicated experiments and
2 replicates in the central point (Table 2). The experiments were randomized to avoid unpredictable
effects on the responses. Experimental results were analyzed using the IBM SPSS Statistics 24 software
and fitted to polynomials of the form:
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where Y is the dependent variable or response, a0 is a scaling constant, ai represents the linear coefficients,
aij the interaction coefficients, aii the quadratic coefficients, and x∗i the independent variables coded at three
levels: −1 (lower limit), 0 (central point), and +1 (upper limit) (Table 2). Analysis of variance (ANOVA)
was applied to determine the validity of the quadratic model as well as the statistical significance of the
regression coefficients at a 95% confidence level. Moreover, to confirm the model’s accuracy, predicted
values for each dependent variable were calculated and compared with the experimental ones (Table 2).
The equations obtained for each dependent variable were visualized as response surface plots.
2.5. Analytical Techniques
In order to have a more complete characterization of the antioxidant activity of the extracts,
various methods were used, namely, the DPPH and ABTS assays based on the capacity to scavenge
free radicals and the FRAP assay that measures the capacity to reduce a metal ion.
The DPPH radical scavenging ability of the extracts was determined following the method proposed
by Barreira et al. [13] modified as described in Vázquez et al. [11]. The results were expressed as mmol
Trolox equivalent (TRE) per g extract d.b. and as the EC50 value, or extract concentration necessary to
achieve a 50% DPPH radical inhibition. ABTS scavenging activity was determined according to the method
of Re et al. [14], and the results expressed as mmol Trolox equivalent (TRE) per g extract d.b. and as the
EC50 value. The FRAP assay was done according to Szöllösi and Szöllösi-Varga [15]. The results were
expressed as nmol ascorbic acid equivalent (AAE) per mg extract d.b.
Phenolic compounds in the extract selected as the optimum were determined by
UPLC/ESI-QTOF-MS using a Bruker Elute UHPLC (Billerica, MA, USA) and a Bruker TimsTOF
(Billerica, MA, USA). Separations were performed using a Bruker Intensity Solo C18 2 μm (2.1 mm ×
100 mm) column (Billerica, MA, USA) and a binary gradient of 0.1% aqueous formic acid for mobile
phase A and 0.1% formic acid in methanol for mobile phase B at a flow rate of 0.25 mL/min. The LC
gradient was 5% B from 0 to 0.4 min, from 5% to 35% B from 0.4 to 0.5 min, from 35% to 100% B from
0.5 to 7 min, 100% B from 7 to 12 min, from 100% to 5% B from 12 to 12.1 min and 5% B from 12.1 to
15 min. Table 3 shows the regression equation for each standard compound analyzed. As observed,
all the compounds showed good linearity in a relatively wide concentration range.
Table 3. Calibration curves for the standard compounds analyzed by ultra-performance liquid
chromatography coupled with electrospray ionization and time-of-flight mass spectrometry
(UPLC/ESI-QTOF-MS).
Compound Linear Range (mg/L) Calibration Curve R2
(–)-Gallocatechin 1–200 y = 8068x + 17,932 0.9941
Catechin hydrate 1–200 y = 15,461x + 52,943 0.9958
Chlorogenic acid 1–1000 y = 8181x + 22,563 0.9936
Ellagic acid 1–1000 y = 9647x + 38,987 0.9959
Epicatechin 1–1000 y = 9780x + 17,102 0.9976
Ferulic acid 1–200 y = 3455x + 22,085 0.9936
Gallic acid 1–1000 y = 3814x + 4250 0.9977
Isorharmnetin 1–200 y = 61,453x + 78,552 0.9915
Kaempferol 1–200 y = 61,712x + 75,935 0.9923
Neochlorogenic acid 1–200 y = 10,675x + 15,125 0.9989
p-Coumaric acid 1–200 y = 4442x + 4535 0.9972
Procyanidin B2 1–200 y = 4014x + 7252 0.9925
Quercetin 1–1000 y = 45,006x + 111,541 0.9922
Quercetin 3-β-d-glucoside 1–1000 y = 13,239x + 42,498 0.9836
Taxifolin 1–200 y = 21,398x + 28,956 0.9903
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3. Results and Discussion
3.1. Effect of the Solid/Liquid Ratio on Extraction Yield and Extract Antioxidant Activity
The influence of the solvent to walnut leaves ratio on the extraction yield and extract FRAP
antioxidant activity is shown in Table 1. The extraction yield was positively influenced by decreasing S/L
from 1/5 to 1/7.5. However, a further decrease to 1/10 didn’t improve the extraction yield significantly.
On the other hand, the extract FRAP antioxidant activity increased with decreasing the S/L ratio in
the whole range analyzed. These results were in agreement with previous research on the extraction
of phenolic compounds from various plant materials [7,16,17] and can be explained by analyzing
the concentration gradient of phenolics between walnut leaves and the solvent. The lower the S/L
ratio, the greater the concentration gradient and consequently the extraction rate. Therefore, a S/L
ratio of 1/10 was selected for subsequent experiments on analyzing the impact of temperature, time,
and ethanol concentration on the extraction of phenolic compounds from walnut leaves. A greater
decrease in the S/L ratio was not considered since it would mean not only a higher solvent consumption
but also a higher energy cost in the extraction and solvent recovery stages.
3.2. Relationship between Extract Antioxidant Properties
Antioxidants may respond in a different manner to different radical or oxidant sources [18].
For this reason, three methods based on different reaction mechanisms were used to determine
the antioxidant activity of walnut leaf extracts and the relationship between them was analyzed.
A regression analysis was performed between the values of the FRAP, DPPH, and ABTS antioxidant
activities for the experiments in Table 2. As shown in Figure 1, quite good positive linear relationships
were found between the three methods used to measure the antioxidant activity, which suggests that
only one method could be used in practice to provide reliable information on the antioxidant properties
of walnut leaf extracts.
(a) (b) 
Figure 1. Linear relationships between FRAP and DPPH (2,2-diphenyl-1-picrylhydrazyl) and ABTS
(2,2-azinobis-3-ethylbenzothiazoline-6-sulfonic acid) antioxidant activities (a) and between DPPH and
ABTS antioxidant activities (b).
3.3. Optimization of the Extraction Conditions by a Box-Behnken Design
In order to determine the best extraction conditions for the extraction of phenolic compounds
from walnut leaves, a Box-Behnken experimental design was applied. The independent variables
selected were temperature, time, and ethanol concentration. The extraction conditions together with
the experimental results obtained for the dependent variables: Extraction yield (Y1), FRAP (Y2), DPPH
(Y3), and ABTS (Y4) antioxidant activities are shown in Table 2, that also shows the good agreement
between experimental and predicted values. The fitting model (Equation (1)) was found appropriate
to represent all the responses analyzed (p < 0.05). Table 4 shows the significant regression coefficients
together with the statistical parameters used to evaluate the fitting results. For all the responses,
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the quadratic effect of %EtOH (in negative mode) was the most significant, followed by the linear effect
of temperature (in positive mode), and the effects on which extraction time was involved were the
least significant or not significant at all. Equations (2)–(5) show the dependence of the responses Y1 to
Y4 on the significant independent variables, double interactions, and quadratic effects:
Y1 (%) = 26.28 + 3.024 x∗1 + 0.905 x
∗
2 − 1.444 x∗3 − 0.865 x∗1x∗3 − 3.973 x∗23 (2)
Y2 (nmol AAE/mg extract d .b .) = 1395.25 + 13.25 x∗1 − 354.50 x∗23 (3)
Y3 (mmol TRE/g extract d .b .) = 1.223 + 0.173 x∗1 − 0.093 x∗1x∗3 − 0.291 x∗23 (4)
Y4 (mmol TRE/g extract d .b .) = 1.315 + 0.143 x∗1 − 0.083 x∗21 − 0.125 x∗22 − 0.315 x∗23 (5)
Figure 2a–c show the response surfaces for the extraction yield (Y1) in the function of temperature
and ethanol concentration for extraction times of 30 (a), 75 (b), and 120 min (c). Extraction yield varied
between 17.80% and 30.55% depending on the extraction conditions. Regarding the influence of the
linear effects, temperature and time were significant in the positive mode, whereas %EtOH in the
negative mode. Only the quadratic effect of %EtOH and the double interaction temperature x %EtOH
had significant influences on the response, both in the negative mode. The highest extraction yield in
the ranges essayed of 30.55% was attained at the highest temperature and extraction time essayed,
75 ◦C and 120 min, and at an intermediate ethanol concentration, 38%.
Figures 3–5 show, respectively, the response surfaces for FRAP (Y2), DPPH (Y3), and ABTS
(Y4) antioxidant activities in function of temperature and ethanol concentration. All show a similar
trend with respect to the influence of temperature and %EtOH, showing the presence of a maximum
located in the vicinity of the design space for FRAP and DPPH and in the case of ABTS within it.
Additionally, the responses for FRAP and DPPH were independent of time. FRAP ranged between
908 and 1529 nmol AAE/mg extract d.b. (Figure 3) and depended only on the negative quadratic effect
of % EtOH and the linear effect of temperature in positive mode, reaching the highest value in the
range assayed, at 75 ◦C and 50% ethanol. With respect to DPPH, it depended additionally on the
interaction temperature x %EtOH in the negative mode, and a value of 1.40 mmol TRE/g extract d.b.
was reached at 75 ◦C and 44% ethanol (Figure 4). ABTS depended on the quadratic effects of %EtOH,
time and temperature, in this order of importance, all in the negative mode, and on the positive linear
effect of temperature. For ABTS, a maximum located in the region studied, 1.38 mmol TRE/g extract
d.b., was reached at 71.3 ◦C, 75 min, and 50% ethanol (Figure 5).
In summary, solvent concentration, temperature, and extraction time, in this order, are important
factors influencing the extraction of phenolic compounds from walnut leaves. Both extraction yield
and extract antioxidant activity depended significantly on the % ethanol used and aqueous solutions
in the range of 38% to 50% ethanol were found to be superior to the more concentrated ones in
any of the solvents, behavior that might be explained by the “likes dissolves like” principle [19].
High ethanol concentrations dissolve more lipophilic compounds, whereas higher proportions of
hydrophilic compounds are extracted at low ethanol concentrations [20]. Otherwise, extraction
yield increases when decreasing %EtOH up to 38%, whereas extract antioxidant capacity diminishes,
which can be explained due to the solubilization of other types of compounds such as proteins and
polysaccharides that impair selectivity [21]. According to these results, the ethanol concentration
selected as the optimum was 50%. Concerning extraction temperature, a temperature rise of up to 75 ◦C
increased the extraction yield as the extraction process was favored by temperature as the solubility
of phenolic compounds and the mass transfer rate were enhanced [22]. Moreover, FRAP, DPPH,
and ABTS antioxidant activity of the extracts also increased with increasing extraction temperature to
75 ◦C. However, greater extraction temperatures were not recommended as oxidation, epimerization,
and degradation of phenolic compounds was promoted [17] with the consequent decrease of the extract
antioxidant activity. Therefore, 75 ◦C was selected as the optimum temperature. Finally, 120 min
was the selected time to favor the extraction yield, as its influence on antioxidant properties was
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almost negligible. Longer extraction times were not proposed since the effects were the same as those
previously indicated for high temperatures [17].
In brief, the optimal conditions for the extraction of phenolic compounds from Juglans major
209 x Juglans regia leaves selected by analyzing together the response surfaces for all the dependent
variables (Figures 2–5) were those corresponding to Experiment 12 (Table 2): 75 ◦C, 120 min, and 50%
ethanol. Under these conditions, the predicted responses were: Y1, pred = 30.21%, Y2, pred = 1529 nmol
AAE/mg extract d.b., Y3, pred = 1.396 mmol TRE/g extract d.b. and Y4, pred = 1.25 mmol TRE/g extract
d.b. These values were equal or very close to those corresponding to the model optimum for each
response that were Y1,pred = 30.55% at 75 ◦C, 120 min, and 38% EtOH, Y2,pred = 1529 nmol AAE/mg
extract d.b. at 75 ◦C and 50% EtOH, Y3,pred = 1.40 mmol TRE/g extract d.b. at 75 ◦C and 44% EtOH and
Y4,pred = 1.38 mmol TRE/g extract d.b. at 71.3 ◦C, 75 min and 50% EtOH. Moreover, these extraction
conditions were close to those found by Vieira et al. [7] as the global optimum conditions for the
extraction of some of the main phenolic compounds found in this work, namely, 3-O-caffeoylquinic
acid and quercetin 3-O-glucoside, from walnut (Juglans regia) leaves by maceration with aqueous
ethanol (61.3 ◦C, 112.5 min, and 50.4% ethanol). 50% ethanol also led to higher antioxidant activities for
walnut (Juglans regia) green husk extracts than pure water and ethanol, although the highest extraction
yield was obtained with water [23].
Table 4. Coefficients of the models (Equation (1)) and statistical parameters.
Y1 Y2 Y3 Y4
Coeff. SE p Coeff SE p Coeff. SE p Coeff. SE p
a0 26.281 0.274 0.000 1395.250 40.672 0.000 1.223 0.019 0.000 1.315 0.028 0.000
a1 3.024 0.274 0.000 13.25 40.672 0.006 0.173 0.019 0.000 0.143 0.019 0.000
a2 0.905 0.274 0.008 - - NS - - NS - - NS
a3 −1.444 0.274 0.000 - - NS - - NS - - NS
a12 - - NS - - NS - - NS - - NS
a13 −0.865 0.387 0.049 - - NS −0.093 0.027 0.005 - - NS
a23 - - NS - - NS - - NS - - NS
a11 - - NS - - NS - - NS −0.083 0.028 0.012
a22 - - NS - - NS - - NS −0.125 0.028 0.001
a33 −3.973 0.387 0.000 −354.500 57.519 0.000 −0.291 0.027 0.000 −0.315 0.028 0.000
R2 0.964 0.789 0.947 0.951
R2corr. 0.947 0.757 0.934 0.933
SE 0.774 115.038 0.053 0.055
p 0.000 0.000 0.000 0.000
NS: Non-significant for a 95% confidence level; SE: Standard error; p: Probability; R2: Regression coefficient; R2c:
Corrected regression coefficient; a0: Scaling constant; ai: Linear coefficients; aij: Interaction coefficients; aii: Quadratic
coefficients; Y1, extraction yield (g extract/100 g leaves d.b.); antioxidant activity: Y2, FRAP (nmol AAE/mg extract
d.b.); Y3, DPPH (mmol TRE/g extract d.b.); Y4, ABTS (mmol TRE/g extract d.b.).
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Figure 2. Response surfaces for extraction yield (Y1, %) in function of temperature and ethanol
concentration for extraction times of (a) 30, (b) 75, and (c) 120 min.
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Figure 3. Response surfaces for FRAP antioxidant activity (Y2, nmol AAE/mg extract d.b.) in the
function of temperature and ethanol concentration.
Figure 4. Response surfaces for DPPH antioxidant activity (Y3, mmol TRE/g extract d.b.) in the function
of temperature and ethanol concentration.
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Figure 5. Response surfaces for ABTS antioxidant activity (Y4, mmol TRE/g extract d.b.) in the function
of temperature and ethanol concentration for extraction times of (a) 30, (b) 75, and (c) 120 min.
3.4. Characterization of the Optimum Walnut Leaf Extract
Both the experimental values and those predicted by the models (Equations (2)–(5), Table 4) for
the extraction yield and antioxidant properties of the walnut leaf extract selected as the optimum
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are presented in Table 2 (Experiment 12). Additionally, Figure 6a,b show the ABTS and DPPH
radical inhibition percentages, respectively, versus extract concentration for this walnut extract and for
Trolox, the synthetic antioxidant used as a reference. The corresponding EC50 values were 0.985 and
0.11 mg/mL, for ABTS and DDPH, respectively. The DPPH EC50 value obtained in this work was lower
(higher antioxidant activity) than those found for extracts obtained from leaves of different Juglans
regia cultivars using other solvent systems: Aqueous extracts (0.151–0.202 mg/mL) [1], methanolic
extracts (0.199 mg/mL), and petroleum ether extract (2.921 mg/mL) [3]. However, even lower EC50
values were obtained for methanolic (65.91 μg/mL) and decoction (78.97 μg/mL) extracts from certain
walnut cultivars [4]. The DPPH EC50 value obtained in this work for the optimum walnut leaf extract
was also significantly lower than that for Juglans regia green husk extracts, 0.33 mg/mL for 50% aqueous
ethanol extracts [23], and 0.41 for methanolic extracts [3], and also slightly lower than that for the
methanolic extract from walnut seeds (0.14 mg/mL) [3]. With respect to extraction yield it was slightly
higher than that reported by Carvalho et al. [3] for the methanolic extract, 27.7%, and significantly
higher than that of the petroleum ether ones, 1.1%.
Figure 6. Percentage of ABTS (a) and DPPH (b) radical inhibition against extract concentration for the
walnut leaf extract selected as the optimum with Trolox as reference.
Finally, to identify and quantify the compounds responsible for the antioxidant activity of the
optimum Juglans major 209 x Juglans regia leaf extract, it was analyzed by UPLC/ESI-QTOF-MS. Table 5
and Figure 7 show the phenolic profile determined. Fifteen phenolic compounds were identified and
quantified, with the flavonoid quercetin 3-β-D-glucoside being the major compound, representing
49.35% of the total phenolic composition, followed by chlorogenic acid (29.16%), and neochlorogenic
acid (18.34%). Both quercetin 3-β-D-glucoside and chlorogenic acid were among the main phenolic
compounds found in Juglans regia leaf extracts from some Spanish and Portuguese cultivars [1,4,7] that
also presented significant quantities of other flavonoids such as quercetin 3-O-galactoside, quercetin
O-pentoside, or quercetin O-xyloside [1,4,5,7] not identified in this work. However, the outstanding
presence of neochlorogenic acid in the Juglans major 209 x Juglans regia leaf extracts, also reported by
Pereira et al. [1], makes the main difference with the Juglans regia ones.
Concerning the interest of the main phenolic compounds identified, quercetin 3-β-D glucoside has
been attracting increasing research interest. It is widely distributed in fruits, vegetables, and cereals
and exhibits a broad number of chemoprotective effects both in vitro and in vivo, against oxidative
stress, cancer, cardiovascular disorders, diabetes, and allergic reactions [24]. Chlorogenic acids are also
present in many vegetables and fruits and some health benefits have been associated with them such
as the prevention of cardiovascular diseases and types 2 diabetes [25] and also antioxidants, anticancer,
anti-inflammatory, and immunomodulatory properties have been shown [26]. The importance of these
phenolic compounds for various industrial applications demonstrate the interest of the valorization of
Juglans major 209 x Juglans regia leaves.
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Table 5. Identified compounds in the optimized walnut leaf extract by UPLC/ESI-QTOF-MS (T = 75 ◦C,
t = 120 min, EtOH concentration = 50%, S/L ratio = 1/10 g/mL).
Compound Retention Time (min) m/z ng/mg Extract d.b. mg/100 g Leaves d.b.
(–)-Gallocatechin 2.4 305.06 14.17 0.45
Catechin hydrate 2.6 289.07 55.83 1.78
Chlorogenic acid 2.7 353.09 5737.50 183.14
Ellagic Acid 4 300.99 68.92 2.20
Epicatechin 2.8 289.07 12.08 0.39
Ferulic acid 3.6 193.04 158.58 5.06
Gallic acid 2.3 169.01 432.58 13.81
Isorharmnetin 5.4 315.05 3.17 0.10
Kaempferol 5.3 285.04 14.25 0.45
Neochlorogenic acid 2.5 353.08 9125.00 291.27
p-Coumaric ccid 3.6 163.04 10.83 0.35
Procyanidin B2 2.6 577.14 45.50 1.45
Quercetin 4.8 301.04 163.50 5.22
Quercetin 3-β-d-glucoside 3.8 463.09 15,441.67 492.90
Taxifolin 3.4 303.05 4.50 0.14
Figure 7. UPLC chromatogram of the walnut leaf extract selected as the optimum (T = 75 ◦C, t = 120 min,
EtOH concentration = 50%, S/L ratio = 1/10 (g/mL).
4. Conclusions
Phenolic compounds such as quercetin 3-β-D-glucoside (4.92 mg/g), neochlorogenic acid
(2.91 mg/g), and chlorogenic acid (1.83 mg/g) have been recovered from walnut (Juglans major
209 x Juglans regia) leaves by maceration in aqueous ethanol solutions under optimized conditions,
75 ◦C, 120 min, and 50% aqueous ethanol, selected based on extraction yield and extract antioxidant
properties. The experimental values for the optimal extract properties were: Extraction yield, 30.17%;
FRAP, 1468 nmol AAE/mg extract d.b.; DPPH, 1.318 mmol TRE/g extract d.b.; DPPH EC50, 0.11 mg/mL;
ABTS, 1.256 mmol TRE/g extract d.b. and ABTS EC50, 0.985 mg/mL. Therefore, the present work
proposes a valorization way of walnut leaves as a source of valuable compounds for various industrial
applications based on their antioxidant properties.
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Abstract: Urolithin A is a metabolite generated from ellagic acid and ellagitannins by the intestinal
microbiota after consumption of fruits such as pomegranates or strawberries. The objective of this
study was to determine the cytoprotective capacity of this polyphenol in Neuro-2a cells subjected
to oxidative stress, as well as its direct radical scavenging activity and properties as an inhibitor
of oxidases. Cells treated with this compound and H2O2 showed a greater response to oxidative
stress than cells only treated with H2O2, as mitochondrial activity (MTT assay), redox state (ROS
formation, lipid peroxidation), and the activity of antioxidant enzymes (CAT: catalase, SOD: superoxide
dismutase, GR: glutathione reductase, GPx: glutathione peroxidase) were significantly ameliorated;
additionally, urolithin A enhanced the expression of cytoprotective peroxiredoxins 1 and 3. Urolithin
A also acted as a direct radical scavenger, showing values of 13.2 μM Trolox Equivalents for Oxygen
Radical Absorbance Capacity (ORAC) and 5.01 μM and 152.66 μM IC50 values for superoxide and
2,2-diphenyss1-picrylhydrazyl (DPPH) radicals, respectively. Finally, inhibition of oxidizing enzymes,
such as monoamine oxidase A and tyrosinase, was also detected in a dose-dependent manner.
The cytoprotective effects of urolithin A could be attributed to the improvement of the cellular
antioxidant battery, but also to its role as a direct radical scavenger and enzyme inhibitor of oxidases.
Keywords: urolithin A; pomegranate; ellagic acid; dietary polyphenols; neuroprotection; peroxiredoxins
1. Introduction
Urolithins are natural polyphenolic compounds obtained from ellagic acids and ellagitannins
by the gut microbiota. Ellagic acid is a phenolic antioxidant compound present in numerous fruits,
such as pomegranates, strawberries, or nuts. Ellagitannins are a class of polymeric ellagic acid
derivatives also present in pomegranates (punicalagins and punicalins) and other sources, such as oak
or chestnut wood (castalagin, castalin, roburin A, grandinin) or Melaleuca quinquenervia leaves (castalin
and grandinin) [1–3].
The beneficial properties of these plants and foods seem to be in relation with these polyphenolic
metabolites; however, the metabolism of polyphenols from food seems to be insufficient to achieve
adequate levels of urolithins in the body. In addition, it has been proven that apparently beneficial
foods such as pomegranates have had a lot of interindividual variability due to the different urolithin
metabotypes present in the population [4]. In fact, only 1 in 3 people have the right microbiota to
perform this metabolism with maximum efficiency [5].
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Therefore, it is very important to evaluate the activity of isolated urolithins as potential therapeutic
agents. In addition, the use if urolithin A in humans and the safety profile of this compound have been
widely evaluated, with no adverse effects on health observed [6].
Although urolithins are a group of metabolites, urolithin A (UA), also known as
3,8-dihydroxyurolithin, is one of the most representative compounds. There are numerous studies that
demonstrate an important role of this compound in metabolic syndrome, improving cardiovascular
function, decreasing the formation of triglycerides, inhibiting enzymes such as lipase or glucosidase,
or relieving insulin resistance [7–9]. It has also been observed that UA may have an important role
in the prevention of certain cancers, such as colorectal or prostate cancers [10,11]. UA also has an
important role at the mitochondrial level, being able to activate mitophagy and prolonging lifespan in
Caenorhabditis elegans worms, as well as beneficial mitochondrial effects in the skeletal muscle [12,13].
The set of all these beneficial properties for health may be due to the antioxidant capacity of
polyphenols. However, there are few studies that link the antioxidant properties of this metabolite
with a potential therapeutic activity in neurodegenerative diseases, where the redox status is essential.
Therefore, the objective of this study was to evaluate whether urolithin A has antioxidant and
neuroprotective effects using Neuro-2a cells and other in vitro models involving the use of central
nervous system (CNS) enzymes or free radicals.
2. Materials and Methods
2.1. Reagents and Chemicals
Urolithin A (3,8-dihydroxyurolithin) (Figure 1) was purchased from Toronto Research Chemicals
(TRC, Toronto, ON, Canada). Neuro-2a (N2a) cell line was provided from the American
Type Culture Collection (ATCC, Manassas, VA, USA), while Monoamine oxidase A (MAO-A),
5,5′-dithiobis-(2-nitrobenzoic acid) (DTNB), Tris, galantamine, levodopa (l-DOPA), tyramine,
horseradish peroxidase, 2,2′-azobis(2-methyl-propionamidine)-di-hydrochloride (AAPH), hydrogen
peroxide (30% w/w), 2,4,6-Tris(2-pyridyl)-1,3,5-triazine (TPTZ), 2′,7′-dichloro-dihy-drofluorescein
diacetate (DCFH-DA), 3-(4,5-Dimethyl-2-thiazolyl)-2,5- diphenyltetrazolium bromide (MTT),
6-hydroxy-2,5,7,8-tetra-methylchromane-2-carboxylic acid (Trolox), bovine serum albumin (BSA),
vanillic acid, 4-aminoantipyrine, penicillin, streptomycin, tyrosinase, thiobarbituric acid (TBA),
trichloroacetic acid (TCA), bicinchoninic acid (BCA), and pyrogallol were obtained from Sigma-Aldrich
(Madrid, Spain). Clorgyline and α-kojic were from Cymit química (Barcelona, Spain). Na2CO3, HCl,
NaCl, dimethyl sulfoxide (DMSO), MeOH, and potassium phosphate were supplied from Panreac
(Barcelona, Spain). Dulbecco’s modified Eagle’s medium (DMEM), phosphate-buffered saline (PBS),
and fetal bovine serum (FBS) were acquired from Gibco (Invitrogen, Paisley, UK).
 
Figure 1. Structure of Urolithin A. Synonyms: 3,8-Dihydroxyurolithin; 3,8-Hydroxydibenzo-α-pyrone;
2′,7-Dihydroxy-3,4-benzocoumarin; δ-Lactone 2′,4,4′-Trihydroxy-2-biphenylcarboxylic acid.
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2.2. Cytoprotective Properties of Urolithin A in Neuro-2a Cells
2.2.1. Neuro-2a Cell Culture and Treatments with Urolithin A and Hydrogen Peroxide
Neuro-2a cells (ATCC® CCL-131™) were thawed and cultured in 10% FBS-supplemented DMEM
and 1% penicillin-streptomycin, seeded in a T175 flask, and placed into the incubator (5% CO2, 37 ◦C).
Once they reached the state of confluence, they were sub-cultured in a 96-well plate at a density of 1 ×
104 cells/well in DMEM (10%) and incubated (37 ◦C, 5% CO2) for 24 h before the treatment.
Stock solutions of urolithin A (438 mM) were prepared in sterilized PBS containing 1% DMSO
(final concentration in the cells less than 0.1%). The sample was vortexed and filtered with a 0.22-μm
syringe filter. Five dilution series were done from the stock solution. Stock solutions of hydrogen
peroxide (1000 μM) were prepared and incorporated into the cells at a final concentration of 250 μM
(45 min) to induce oxidative stress in the cells.
2.2.2. Mitochondrial Activity in Neuro-2a Cells Subjected to Oxidative Stress after Urolithin A
Treatment
Cells were cultured in 96-well plates at a concentration of 1 × 104 cells per well. The cytotoxicity
of urolithin A (0.5 μM–20 μM) was measured after 24 h by adding MTT (3-(4,5-dimethylthiazol
-2-yl)-2,5-diphenyltetrazolium bromide) to the cell culture. Additionally, this assay can be performed
to assess the potential cytoprotective effect of urolithin A after inducing a neuronal injury with 250 μM
hydrogen peroxide for 45 min. After treatments (24 h exposition to urolithin, 45 min to hydrogen
peroxide), cells were incubated for an additional 24 h; DMEM was then removed from every well
and replaced with MTT solution (2 mg/mL in DMEM) and incubated at 37 ◦C for 3 h. Finally, MTT
solution was removed and 100 μL of DMSO was added in each well to dissolve formazan crystals. Via
a Synergy H1 Hybrid Multi-Mode Reader (Biotek, Bad Friedrichshall, Germany), the absorbance was
read at 550 nm. Experiments were carried out in different weeks and diverse passages and expressed
as percentage of control.
2.2.3. ROS Production in Neuro-2a Cells Subjected to Oxidative Stress after Exposition to Urolithin A
Neuro-2a cells were seeded in a 96-well plate. After 24 h, the medium was replaced with PBS
supplemented with glucose and DCFH-DA (2,7-di-chloro-dihydrofluorescein diacetate, 0.01 M) for
30 min at 37 ◦C. After this time, PBS was removed and cells were washed twice with new PBS and
treated with different concentrations of urolithin A (0.5–4 μM), as well as hydrogen peroxide (250 μM).
The absorbance was checked at 480 nm (λexcitation) and 520 nm (λemission) wavelengths [14]. The kinetic
was performed over 90 min in a Synergy H1 Hybrid Multi-Mode Reader (Winooski, VT, USA). Results
were represented as a percentage of intracellular ROS production (100% of control).
2.2.4. Lipid Peroxidation in Neuro-2a Cells Subjected to Oxidative Stress after Exposition to Urolithin
A (TBARS assay)
Lipid peroxidation was assessed using the protocol by Mitsuru Uchiyama [15]. First, 100 μL
of thawed pellets were placed into 200 μL of TBA–TCA–HCl cocktail and subsequently boiled at
100 ◦C for 10 min to accelerate the reaction. The reaction was broken by placing the samples on ice
and stunning them in a vortex three times for 20 min and centrifuged at 4 ◦C (3000 rpm, 10 min).
The obtained supernatant was placed in three different wells of a 96-well plate and absorbance was
read at 530 nm using a Synergy H1 Hybrid Multi-Mode Reader.
2.2.5. Activity of Antioxidant Enzymes in Neuro-2a Cells Subjected to Oxidative Stress after
Exposition to Urolithin A
Before analyzing the activity of antioxidant enzymes, the protein content of Neuro-2a cells was
calculated by colorimetric bicinchoninic acid (BCA) assay and normalized lysis buffer for 20 min
(Ethylenediaminetetraacetic acid (EDTA) 1 mM, Tris 25 mM, NaCl 150 mM and 0.1% Triton; pH = 7.4).
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Moreover, leupeptin, pepstatin, and phenylmethylsulfonyl fluoride (PMSF) proteinase inhibitors (20,
10, and 35 μL/mL, respectively) were aggregated into the buffer. Finally, supernatant was kept for the
experiments and the precipitate was discard.
The activity of catalase was measured as follows: hydrogen peroxide (1970 μL, 15 mM) was
prepared in sodium phosphate buffer (pH = 7.5) supplemented with 30 μL of supernatant [16]; the
mixture was prepared in a quartz cuvette, measuring the absorbance for 30 secs at 240 nm, using
a Shimadzu Spectrophotometer UV-1800 (Duisburg, Germany). The activity of the enzyme was
expressed following the next equation: Catalase activity = ((ΔAbs/min) × 2 × F)/(0.0436 × Vs × C)
43.6 mL nmol−1 cm−1: molar extinction coefficient of H2O2
F: dilution factor
C: Protein concentration (mg/mL)
Vs: Sample volume (mL)
ΔAbs/min: activity of the kinetic
For superoxide dismutase (SOD), a mixture of 1555 μL of Tris–DTPA buffer (50 mM, pH 8.2),
20 μL of pyrogallol (23.78 mM) diluted in HCl (10 mM), and 25 μL total cell extracts was placed in
a quartz cuvette to measure the oxidation of pyrogallol at 420 nm for 1 min [17], using a Shimadzu
Spectrophotometer UV-1800 (Duisburg, Germany). The activity of SOD was expressed with the
following equation: % Inhibition = (ΔAbs control − ΔAbs sample)/(ΔAbs control) × 100
SOD activity = (% Inhibition × 2 × F)/(50 × Vs × C)
Glutathione reductase activity (GR) was quantified with the protocol developed by Staal et al. [18]:
1180 μL of 50 mM phosphate buffer__EDTA (6.3 mM, pH 7.4), 50 μL of total cell extracts, 35 μL
of glutathione disulfide (GSSG) 5 mM, and 35 μL of nicotinamide adenine dinucleotide phosphate
(NADPH; 2.4 mM), which were mixed in a quartz cuvette. Glutathione peroxidase activity (GPx) was
detected by mixing 1220 μL of 50 mM phosphate buffer__EDTA 6.3 mM, 20 μL of total cell extracts,
and 20 μL of glutathione (GSH) 10 mM. After 5 min in dark conditions, 20 μL of NADPH (2.4 mM) and
20 μL H2O2 63.5 mM were added to the cuvette [19,20]. GR activity was read for three minutes with
60 sec of delay at 340 nm using a Shimadzu Spectrophotometer UV-1800 (Duisburg, Germany). GPx
activity was measured for 3 min at 340 nm and expressed in UI/mg protein. GR activity = ((ΔAbs/min)
× 1.3 × F)/(0.00622 × Vs × C) GPx activity = ((ΔAbs/min) × 1.3 × F)/(0.00622 × Vs × C)
0.00622 mL nmol−1 cm−1: molar extinction coefficient of NADPH
F: dilution factor
C: Protein concentration (mg/mL)
Vs: Sample volume (mL)
ΔAbs/min: activity of the kinetic
2.2.6. Peroxiredoxin Expression in Neuro-2a Cells by Immunoblotting
In order to evaluate the effect of urolithin A on the expression of Prx1 and Prx3, Neuro-2a were
grown in 6-well culture plates and treated with 0.5–4 μM urolithin A for 24h. Twenty-four hours later,
cells were washed with PBS and scraped in lysis buffer (EDTA 1 mM, Tris 25 mM, NaCl 150 mM,
0.1% Triton; PMSF, leupeptin, and pepstatin; pH = 7.4) for 20 min. Supernatants were collected for
protein determination with the bicinconinc acid method and dilutions were prepared to obtain the
concentrations of proteins. Then, 10 μg of protein extract per sample was mixed with Laemmli buffer
with β-mercaptoethanol, loaded onto 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE), and subsequently transferred to nitrocellulose membranes. Immediately after this, protein
transfer and loading were controlled by Ponceau red staining, followed by membrane blocking with
bovine serum albumin (BSA). The following antibodies were used: anti-Peroxiredoxin 1 (ab41906;
Abcam, Cambridge, UK) and anti-Peroxiredoxin 3 (AV52341; Sigma-Aldrich, St. Louis, MO, USA).
Antibody binding was detected by chemiluminescence with species-specific secondary antibodies
labeled with horseradish peroxidase (HRP) and visualized on a digital luminescent imager analyzer
472
Antioxidants 2020, 9, 177
(Fujifilm LAS-4000, Cambridge, MA, USA). Images were quantified using ImageQuant TL software
(Global Life Sciences Solutions, Pittsburgh, PA, USA).
2.3. Urolithin A and Its Role as an Inhibitor of CNS Enzymatic Targets
2.3.1. Tyrosinase (TYR) Inhibition
Tyrosinase inhibitory activity of urolithin A was evaluated using 96-well plates and l-DOPA as
the substrate [21]. The α-Kojic acid was used as a reference inhibitor. The reaction mixture contained
10 μL of urolithin A at different concentrations in DMSO, 80 μL phosphate buffer (pH = 6.8), 40 μL of
l-DOPA, and 40 μL of tyrosinase (200 U/mL) in each well. Controls wells contained 10 μL of DMSO in
place of the sample. The absorbance was measured at 475 nm (endpoint) using a Synergy H1 Hybrid
Multi-Mode Reader (Biotek, Bad Friedrichshall, Germany). Inhibitory activity was determined as: %
Inhibition = (Absorbance Control − Absorbance Urolitihin A)/(Absorbance Control) × 100
2.3.2. Acetylcholinesterase (AChE) Inhibition
The inhibition of AChE was carried out in 96-well microplates, measuring the absorbance at
450 nm 11 times using a Synergy H1 Hybrid Multi-Mode Reader [22]. Each well contained 25 μL
of ATCI (15 mM) in MilliQ water, 50 μL of buffer B (50 mM Tris-HCl, pH = 8, 0.1% bovine serum),
125 μL of DTNB (3 mM) in buffer C (50 mM Tris-HCl, pH = 8, 100 mM NaCl, 20 mM MgCl2), and
25 μL of urolithin A at different concentrations in buffer A (50 mM Tris-HCl, pH = 8). Finally, 25 μL
of the enzyme (0.22 U/L) was added to the control and samples to complete the reaction. Blanks
contained 25 μL of buffer A instead of the enzyme. Galantamine (Sigma-Aldrich, St. Louis, MO,
USA), a drug used for Alzheimer’s disease, was assayed for comparative purposes as a reference
inhibitor. Percentages of AChE inhibition were calculated with the following formula: % Inhibition =
[1 − ((Inhibitory Slope)/(Control Slope))] × 100
2.3.3. Monoamine Oxidase A (MAO-A) Inhibition
The MAO-A inhibition assay was performed following a protocol described by Olsen et al. [23].
Here, 50 μL of urolithin A at different concentrations in DMSO, 50 μL chromogenic solution (417 mM
4-aminoantipyrine, 800 μM vanillic acid, 4 U/mL horseradish peroxidase in potassium phosphate
buffer pH = 7.6.), 100 μL of tyramine (300 μM), and 50 μL of MAO-A (8 U/mL) was supplemented into
the well. As a standard reference inhibitor, clorgyline was selected. Control wells contained 50 μL
of DMSO instead of urolithin A. The absorbance was read at 490 nm every 5 min over 30 min in a
Synergy H1 Hybrid Multi-Mode Reader (Biotek, Bad Friedrichshall, Germany). Percentages of MAO-A
inhibitions were calculated with the following formula: % Inhibition = [1 − ((Inhibitory Slope)/(Control
Slope))] × 100
2.4. Urolithin A and Its Role as a Direct Free Radical Scavenger
2.4.1. Oxygen Radical Antioxidant Capacity ORAC Assay
The capacity or urolithin A to scavenge peroxyl radicals was measured by the oxygen radical
antioxidant capacity (ORAC). Trolox was used as a reference standard for this assay. Therefore, data
were represented as μmol Trolox equivalents (TE)/mg sample. Different concentrations of urolithin A
(4.4 μM–4.4 mM) were dissolved in PBS and methanol (50:50) and placed into the wells. Urolithin A and
Trolox were incubated with fluorescein (70 mM) in 96-well plates at 37 ◦C. Finally, AAPH (12 mM) was
added and fluorescence was measured every 70 s for 1 h and 33 min at 485 nm (excitation) and 520 nm
(emission), in a Synergy H1 Hybrid Multi-Mode Reader (Biotek, Bad Friedrichshall, Germany) [24].
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2.4.2. Superoxide Radicals Generated by Xanthine/Xanthine Oxidase (X/XO) System
Another antioxidant test was performed in order to evaluate the antioxidant activity of urolithin
A using a more physiological system of superoxide radical generation [25]. Here, 22.8 μM nitroblue
tetrazolium (NBT), 90 μM xanthine, and 16 mM Na2CO3 were mixed in phosphate buffer (pH = 6.9).
Then, 240 μL of this cocktail was added to the well. Next, 30 μL of urolithin A and 30 μL of xanthine
oxidase (168 U/L) were added to start the reaction. Before measurement, the plate was incubated for
2 min at 37 ◦C. The superoxide radicals’ (O2−) scavenging activity was assessed spectrophotometrically
at 560 nm. The inhibitory activity of XO was also assayed spectrophotometrically at 295 nm. Gallic
acid was used as a reference antioxidant compound.
2.4.3. DPPH Radical Assay
Here, 2,2-diphenyl-1-picrylhydrazyl (DPPH) is a purple free radical. Antioxidant reducing
compounds are able to scavenge these free radicals, inducing a change in the color of this compound.
A methanolic stock solution of DPPH (0.11 mM) was prepared and 150 μL was added together with
150 μL of different urolithin A concentrations dissolved in MeOH. Ascorbic acid and gallic acid were
also measured as antioxidant standards. Control wells contained 150 μL of MeOH instead of urolithin
A. The plate was incubated for 30 min under dark conditions and measured at 517 nm [26]. Radical
scavenging capacity was calculated by the formula: % RSC = ((Absorbance Control−Absorbance
Urolithin A))/(Absorbance Control) × 100
2.5. Statistical Analysis
Each experiment was performed at least three times on different days and results were expressed
as the mean ± standard error (SE) of different assays. GraphPad Prism v.6 (GraphPad Software, San
Diego, CA, USA) was required to perform data analyses, nonlinear regressions, and statistics (such as
two-way ANOVA or one-way ANOVA). Statistical differences were detected by comparing IC50 values
of urolithin A and reference compounds using Student’s t-test.
3. Results
3.1. Cytoprotective Properties of Urolithin A in Neuro-2a Cells
3.1.1. Urolithin A Improves Mitochondrial Activity in Neuro-2a Cells Subjected to Oxidative Stress
(MTT Assay)
The viability of Neuro-2a cells was evaluated by the MTT assay. In this case, different physiological
concentrations of urolithin (0.5–50 μM) were tested in neurons for 24 h (Figure 2A). Results were
as expected because this range of concentration was non-toxic, as mitochondrial activity was not
significantly reduced.
The next purpose was to evaluate the protective effects of urolithin A on Neuro-2a cells using
hydrogen peroxide as a neurotoxic insult. Different conditions (100 μM to 1000 μM of H2O2) and
exposure times (15, 30, 45, 60 min) determined that incubation of hydrogen peroxide for 45 min at
250 μM was the most appropriate time period for inducing oxidative stress in N2a cells. Figure 2B
shows how urolithin A improves mitochondrial activity against hydrogen peroxide (250 μM) in this
cell line.
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Figure 2. Mitochondrial activity in Neuro-2a cells culture (MTT assay). (A) Cytotoxicity of Neuro-2a
cells after exposure to different concentrations of urolithin A. (B) Cytoprotective effects of urolithin A
versus hydrogen peroxide (250 μM). Note: * p < 0.05 versus H2O2; ## p < 0.01 versus control.
3.1.2. Urolithin A Decreases Intracellular ROS Production in Neuro-2a Cells Subjected to Oxidative
Stress (DCFHA-DA Assay)
Figure 3 shows the intracellular ROS production for 90 min. After 40 min of exposure, intracellular
ROS reached its highest formation (165%) for cells treated with hydrogen peroxide, whereas control
cells (non-treated) maintained a regular level close to 100%; cells stressed with hydrogen peroxide and
treated with urolithin A at different concentrations showed lower values for ROS production. Next,
the transition (50 min) showed a slight decrease in ROS formation for every treatment and maintained
a similar level for the rest of the experiment.
3.1.3. Urolithin A Decreases Lipid Peroxidation in Neuro-2a Cells Subjected to Oxidative Stress
(Thiobarbituric Acid Reactive Species, TBARS)
Figure 4 shows how thiobarbituric acid reactive species (TBARS) are generated. The results
are exhibited as a percentage over the control (100%). As expected, lipid peroxidation generated
by hydrogen peroxide was higher (147%) compared to control cells. Urolithin A response to lipid
peroxidation was more effective at lower concentrations (0.5 and 1 μM).
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Figure 3. ROS production in Neuro-2a cells subjected to oxidative stress by hydrogen peroxide (250 μM)
and treatments with urolithin A (0.5–4 μM). Data are expressed as percentage over control cells and the
assay was carried out for 90 min in order to measure intracellular ROS production. Note: # p < 0.005
versus control; ## p < 0.001 versus control. Significant differences appeared at the starting point for
H2O2-N2a cells over control cells (p < 0.001). However, pre-treatments with 0.5 and 2 μM urolithin A at
0 and 10 min were associated with significant differences (p < 0.01). After 20 min, significant differences
were reached at 1 μM (p < 0.01). Finally, 4 μM of the antioxidant exhibited significant differences (p <





Figure 4. Thiobarbituric acid reactive species (TBARS) formation in Neuro-2a cells. Note: * p < 0.05
versus H2O2.
3.1.4. Urolithin A Enhanced the Activity of Antioxidant Enzymes in Neuro-2a Cells Subjected to
Oxidative Stress (CAT, SOD, GR, GPx)
Results obtained after three replications in three different lysates showed a dose-dependent
tendency of catalase for the treatments with urolithin A (Figure 5A). Surprisingly, the activity of
the enzyme for the lowest concentration was even higher than the control. Therefore, the in vitro
antioxidant effect observed for this metabolite may be more effective at lower doses. When the cells
were treated only with hydrogen peroxide, the response of catalase decreased compared to urolithin A
treatments, detecting significant differences against basal cells (p < 0.005) and the metabolite (p < 0.05;
0.01; 0.001).
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Figure 5. Neuro-2a cell culture redox status. (A) Catalase activity. (B) Superoxide dismutase activity.
(C) Glutathione reductase activity. (D) Glutathione peroxidase activity. Note: * p < 0.05; ** p < 0.01;
*** p < 0.005; **** p < 0.001 versus H2O2; # p < 0.05 versus Control; ### p < 0.005 versus Control.
Different outcomes were found for the superoxide dismutase (SOD) enzyme (Figure 5B); a
dose-dependent tendency appeared up to 2 μM for SOD activity. Similar activity was observed at the
highest concentration as the lowest. Significant differences appeared at 2 μM (p < 0.05).
Comparable effects were obtained for GR and GPx activities (Figure 5C,D). Activities for 0.5 μM
urolithin A looked similar to control activities for both enzymes. Each concentration of the antioxidant
compound exerted significant differences for GR activity (p < 0.01; p < 0.005). However, significant
differences in GPx activity were only found at 2 μM urolithin A (p < 0.05).
3.1.5. Peroxiredoxins Expression
Figure 6 represents the expression of peroxiredoxins, a ubiquitous family of thiol-dependent
peroxidases involved in peroxide detoxification and redox signaling [27,28]. Prx1 was increased in a
dose-dependent manner over control cells (Figure 6A,B). Interestingly, mitochondrial Prx3 reached
higher levels at the lower urolithin concentration tested (Figure 6C,D). Urolithin A (1 and 2 μM)
treatments displayed significant differences in Prx1 expression in N2a cells over control cells (p < 0.05;
p < 0.01).
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Figure 6. Urolithin A-induced cytoprotection of Neuro-2a cells is mediated by induction of peroxiredoxin
1 and 3 (Prx1, Prx3). Prx 1 (A,B) and Prx 3 (C,D) expressions were determined by Western blot in 10 μg
of protein extract and expressed as Prx densitometry. Ponceau red staining of membranes prior to
blotting was performed to further check protein transfer and loading. Note: # p < 0.05 versus Control;
## p < 0.01 versus Control
3.2. Urolithin A Inhibits Oxidases (Monoamine Oxidase A and Tyrosinase)
As described above, the potential neuroprotective activity of urolithin A was tested on
different enzymes present in the central nervous system (tyrosinase, monoamine oxidase A, and
acetylcholinesterase). IC50 values were calculated by non-linear regression for kojic acid, clorgyline,
and galantamine reference inhibitors, respectively.
Figure 7 shows the profile of urolithin A as an enzyme inhibitor; in particular, Figure 7A compares
the reference inhibitor and urolithin against tyrosinase (IC50 values were 24.39 ± 5.97 μM and 71.44 ±
10.07 μM for kojic acid and urolithin A, respectively). Figure 7B shows how clorgyline and urolithin A
are able to inhibit MAO-A. In the case of the reference inhibitor, its IC50 value is relatively lower than
urolithin A (0.09 ± 0.02 μM and 29.41 ± 9.01 μM, respectively). Again, it is seen how the metabolite
draws a dose-dependent curve.
Finally, urolithin A was not considered as an inhibitor of AChE because very high non-physiological
concentrations (876 μM) were used to reach 50% of inhibition.
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Compounds 







Urolithin A 71.44 ± 10.07 M 29.41 ± 9.01 M nr: not reached 
Kojic acid 24.39 ± 5.97 M - - 
Clorgyline - 0.09 ± 0.02 M - 
Galantamine - - 1.99 ± 0.90 M 
Figure 7. Enzymatic inhibition of urolithin A. IC50 values were calculated by non-linear regression.
(A) Tyrosinase inhibition profiles of urolithin A and kojic acid. (B) Monoamine oxidase A (MAO-A)
inhibition profiles of urolithin A and clorgyline.
3.3. The Role of Urolithin A as a Direct Free Radical Scavenger
The direct antioxidant and reducing activities of urolithin A were measured by different free
radical scavenging methods. To verify this fact, reference antioxidants such as gallic acid and ascorbic
(vitamin C) acid were also tested and IC50 values were calculated (Figure 8).
The antioxidant activity measured by the ORAC assay was 13.1 μmol TE/mg for urolithin A; this
result reflects a great antioxidant capacity to neutralize peroxyl radicals compared to other high-content
urolithin A extracts, such as pomegranate, the activity of which was 0.49 μmol TE/mg.
Figure 8. Cont.
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Urolithin A 5.01 ± 5.01 M 152.66 ± 35.01 M 
Gallic acid 0.26 ± 0.21 M 3.10 ± 3.11 M 
Ascorbic acid - 14.81 ± 14.90 M 
Figure 8. Antioxidant activity of urolithin A against physiological (superoxide) and synthetic (DPPH)
radicals. IC50 were calculated by non-linear regression. (A) Urolithin A scavenges superoxide radicals
generated by the xanthine/xanthine oxidase system. (B) DPPH inhibition of urolithin A. Gallic acid and
ascorbic acid were used as reference antioxidants.
On the other hand, both in the inhibition of superoxide radicals and DPPH, urolithin A showed a
dose-dependent curve reaching the maximum inhibition (100%). The reference compounds achieved
better activity in terms of potency. IC50 values were 0.26 ± 0.21 μM for gallic acid and 5.01 ± 5.01 μM
for urolithin A (in the superoxide radical), while they were 3.10 ± 3.11 μM for gallic acid, 14.81 ±
14.90 μM for ascorbic acid, and 152.66 ± 35.01 μM for urolithin A (DPPH radical).
4. Discussion
Most of the studies involving natural products are performed with the original compounds found
in the plant or food matrix, and very few are carried out with the metabolites obtained after the
biotransformation in the body. Since ellagitannins are poorly absorbed in the gastrointestinal tract,
urolithins have been proposed as the bioactive metabolites responsible for the beneficial effects of
pomegranates and other plants containing ellagitannins. Pomegranate juice and extracts have exhibited
neuroprotective properties, so here we investigate whether urolithin A, one of the major intestinal
metabolites of ellagic acid, might act as a neurotherapeutic and antioxidant agent.
Neuro-2a is a neuroblastoma cell line derived from mice, which has been used because of its
ability to produce microtubular proteins. Few works have been done with urolithins using this cell line,
but it has been demonstrated that urolithin A protects against ischemic neuronal injury by activating
autophagy [29]. This research supports our results on mitochondrial activity, demonstrating that
urolithin A is not cytotoxic at this range of physiological concentrations (0.5–50 μM).
The antioxidant activity of urolithin A has already been established in different cell lines using
in vitro procedures [30–32]. However, we here investigate whether urolithin can be considered as
a neuroprotective agent due to its role as a direct free radical scavenger, as an indirect antioxidant
improving the physiological antioxidant defense system of the cells, and as an inhibitor of oxidases
such as monoamine oxidase A and tyrosinase.
Frequently, when the ROS and MDA levels decrease, the activity of the cytosolic enzymes
(superoxide dismutase, catalase) increases; previous experiments in HepG2 cells treated with urolithin
A and H2O2 have demonstrated that cells significantly increased SOD activity compared with cells
subjected to oxidative stress with H2O2 [30]; in fact, SOD activity was ameliorated by urolithin in
kidney cells from mice [33]. Computational studies performed with different pomegranate juice
constituents revealed that they can act as pro-oxidants or antioxidants. Molecular docking studies
seem to be controversial, as they have determined that urolithin A may inhibit cytosolic enzymes such
as catalase, superoxide dismutase, and glutathione [34]; however, urolithin A seems to improve the
activity of these enzymes in our present study. With the aim of elucidating molecular mechanisms
involved in the cytoprotective and antioxidant properties of urolithin A, peroxiredoxins expression
(Prx) was quantified in this work. These peroxiredoxins are antioxidant enzymes that catalyze the
reduction of hydroperoxide. Prx1 and Prx3 play a great role in response to oxidative stress. In this
way, the expression of Prx1 and Prx3 was increased when cells were treated with urolithin A, which
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translates into an antioxidant effect of urolithin A on Neuro-2a cells. Apart from the role of urolithin
A as a free radical scavenger, this phenolic compound seems to act in a more specific way through
the modulation of antioxidant enzymes. As observed above, urolithin A increased the expression
of peroxiredoxins; this fact may explain the cytoprotective properties of urolithin A improving cell
viability, decreasing ROS production, and increasing the activity of other physiological antioxidant
defense systems, such as catalase, SOD, or glutathione reductase and peroxidase. Other polyphenols,
such as resveratrol, have been described in the literature as antioxidant compounds with the ability to
induce these cytoprotective proteins known as peroxiredoxins [35]; nevertheless, this is the first time
that urolithin A is reported to increase the expression of peroxiredoxins 1 and 3.
This is also the first time that glutathione reductase and peroxidase activities were quantified in
neuronal cells subjected to urolithin A treatments. In order to assess this pro-oxidant or antioxidant
relationship of urolithin A, other researchers evaluated the in vitro antioxidant activity of the
metabolite in HepG2 cancer cells [36]; unexpectedly, urolithin A exerted a pro-oxidant effect on
these hepatoblastoma cells, however greater results were obtained in ORAC assay (6.67 ± 0.11).
Regarding oxygen radical absorbance capacity, mice treated with urolithin A exhibited significantly
different ORAC values after an hour of oral administration [37]. Nevertheless, urolithins may have
different antioxidant potency, as shown in previous studies [38], and the ORAC value of urolithin C
was lower than ours; the antioxidant properties derived from its role as a free radical scavenger were
also confirmed by the DPPH in other studies [39–41].
ROS generation is directly linked to neurodegenerative diseases, such as Alzheimer’s, Parkinson’s,
or Huntington’s diseases. In this way, after demonstrating the potential of this metabolite in
Neuro2-a cells, different bioassays were carried out involving CNS enzymatic targets known as
acetylcholinesterase (AChE), monoamine oxidase A (MAO-A), and tyrosinase; these enzymes are
considered pharmacological targets whose inhibition may lead to neuroprotective effects. Urolithin A
acted as an inhibitor of oxidase enzymes such as MAO-A and tyrosinase, thus preventing oxidative
damage of certain tissues. A human study in older adults with mild memory complaints suggests that
8 ounces of pomegranate juice taken daily over one-month improves verbal memory and alters neural
activity during a visual source memory task [42]. Synthetized urolithins have also demonstrated
comparable activity to AChE inhibitors such as rivastigmine, galantamine, and donepezil [43]. In silico
computational studies predicted that urolithins can penetrate the blood-brain barrier, preventing
β-amyloid fibrillation in a C. elegans model [44]. In addition, urolithin A has been identified as a proper
anti-inflammatory and anti-ageing compound [38]. Recently, 10 μM urolithin A was demonstrated to
possess depigmentation efficacy by suppressing tyrosinase activity, attenuating melanogenesis in B16
melanoma cells [45]. Tyrosinase has been recognised as a potential pharmacological target because
an excess of tyrosinase activity or dopamine may lead to neurotoxicity through dopamine quinone
formation; in this sense, tyrosinase inhibitors might have protective properties in neuronal cells.
MAO-A is responsible for the catalytic oxidative deamination of monoamines generating hydrogen
peroxide; for this reason, MAO-A inhibitors have been proposed as neuroprotective agents as well.
The inhibitory activity of pomegranate polyphenols on MAO-A has already been tested, which could
explain its effects in the CNS [22]; however, to the best of our knowledge this is the first report of
urolithin A as an antioxidant agent capable of neutralizing MAO-A oxidative reactions.
5. Conclusions
Urolithin A, a gastrointestinal metabolite from ellagitannins, is a promising therapeutic antioxidant
agent with potential pharmaceutical or food applications for the prevention of oxidative stress-associated
disorders, probably though the improvement of the cell antioxidant capacity by increasing the expression
of thiol-dependent peroxidases.
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